data_2kwv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kwv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.9 Cg_endo -77.57 -166.92 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.202 3.268 . . . . 0.0 107.685 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.572 HD11 ' H ' ' A' ' 493' ' ' LEU . 0.0 OUTLIER -65.06 28.4 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 176.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.583 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -63.04 -27.96 69.76 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.434 1.894 . . . . 0.0 112.992 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.98 1.93 0.77 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.72 161.77 76.41 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 122.61 0.364 . . . . 0.0 110.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.75 154.38 12.65 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.255 3.303 . . . . 0.0 112.005 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -80.12 57.55 2.73 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 122.343 1.068 . . . . 0.0 110.424 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.23 26.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.226 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 76.0 t -140.79 160.03 23.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.808 0.804 . . . . 0.0 109.441 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.17 145.16 48.99 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.673 0.749 . . . . 0.0 109.077 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.592 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.31 -28.98 70.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.406 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.92 -0.16 10.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.679 -0.638 . . . . 0.0 111.403 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.26 18.42 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.437 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.78 -18.5 5.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.074 0.95 . . . . 0.0 110.452 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -72.6 3.83 4.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.943 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -87.51 4.89 41.74 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.748 0.819 . . . . 0.0 110.463 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.02 149.54 42.7 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 123.614 0.765 . . . . 0.0 110.187 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.27 163.77 25.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.081 2.521 . . . . 0.0 111.57 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.21 63.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.53 -1.8 57.93 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.651 0.38 . . . . 0.0 110.761 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 23.2 mt -116.87 -16.83 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -54.45 -38.87 66.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.5 -7.23 57.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.42 0.688 . . . . 0.0 112.421 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.42 -20.9 17.49 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.262 0.483 . . . . 0.0 111.2 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.43 -34.3 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.42 -8.64 19.84 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 33.0 t -70.12 -43.73 70.39 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.472 0.309 . . . . 0.0 110.797 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 117.73 120.64 3.07 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -140.79 -176.22 4.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.585 0.707 . . . . 0.0 110.725 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 -172.13 4.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.796 1.638 . . . . 0.0 107.998 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 65.19 18.11 11.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.035 0.934 . . . . 0.0 112.603 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.01 146.39 31.9 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.095 0.958 . . . . 0.0 109.092 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 526' ' ' LYS . 58.2 m-80 -148.29 28.79 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.925 0.49 . . . . 0.0 112.005 -170.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.272 2.2 pp 50.92 6.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.697 1.599 . . . . 0.0 114.511 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 524' ' ' ASN . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.841 0.353 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -157.75 172.91 17.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.95 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -137.24 -179.37 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.272 0.629 . . . . 0.0 109.449 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.475 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 82.4 m-85 -132.33 100.4 4.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.64 103.09 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.626 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -85.41 135.3 33.93 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 122.455 0.302 . . . . 0.0 111.135 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.415 ' C ' ' H ' ' B' ' 9' ' ' THR . 70.7 p -83.76 176.32 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.38 0.672 . . . . 0.0 112.625 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -65.89 1.66 1.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.743 1.217 . . . . 0.0 111.001 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.415 ' H ' ' C ' ' B' ' 7' ' ' THR . 73.3 p -118.73 10.06 12.31 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.307 0.643 . . . . 0.0 111.311 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 28.36 66.27 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.892 -0.393 . . . . 0.0 113.199 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.71 146.59 49.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 26.7 m -122.78 154.31 38.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 111.547 -171.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 53.3 mt -130.75 131.94 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -82.89 134.76 35.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 69.2 mt -144.35 134.54 24.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -171.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.89 126.82 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.314 0.645 . . . . 0.0 109.433 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.26 174.23 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.898 0.879 . . . . 0.0 109.645 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.8 mm-40 -135.69 161.87 60.38 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.272 1.029 . . . . 0.0 108.631 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.45 2.24 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.31 2.674 . . . . 0.0 113.339 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.41 ' H ' ' C ' ' B' ' 18' ' ' GLU . 35.1 p -122.21 -10.2 8.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.98 0.912 . . . . 0.0 110.593 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -85.99 71.16 10.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.1 t -62.16 176.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.683 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.431 HG21 ' HE3' ' B' ' 27' ' ' LYS . 17.7 mm -51.14 -36.8 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -168.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -68.79 -21.67 64.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.371 0.987 . . . . 0.0 111.251 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -81.66 -40.38 22.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.36 -38.44 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.857 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG21 ' B' ' 23' ' ' ILE . 96.9 mttt -58.18 -23.13 54.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.524 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.62 -26.73 31.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.556 0.617 . . . . 0.0 110.73 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.85 -33.65 74.16 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.0 mt -85.85 -29.85 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -68.12 -37.6 81.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.33 -32.1 71.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.475 0.655 . . . . 0.0 111.323 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -83.01 -22.11 33.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -138.94 -31.25 0.72 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.74 9.39 19.0 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.2 mt -80.5 125.47 80.76 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.662 0.785 . . . . 0.0 109.337 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 159.38 48.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.216 2.611 . . . . 0.0 111.268 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -16.32 54.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.828 3.018 . . . . 0.0 110.851 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.47 -11.9 58.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.655 0.382 . . . . 0.0 111.999 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -120.85 -10.8 9.06 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -73.01 167.74 20.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.261 0.937 . . . . 0.0 112.04 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -159.21 90.1 0.95 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.88 1.272 . . . . 0.0 107.986 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -93.13 139.82 30.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.661 0.784 . . . . 0.0 112.201 -170.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.68 154.07 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.996 1.318 . . . . 0.0 109.145 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -151.59 142.81 23.29 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.593 1.157 . . . . 0.0 109.129 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 13.77 0.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.573 0.749 . . . . 0.0 112.615 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.7 13.86 48.96 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.275 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 161.78 31.53 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.559 1.18 . . . . 0.0 110.36 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.04 125.87 43.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.814 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.517 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.5 OUTLIER -76.0 175.35 8.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.991 -177.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -135.13 153.35 52.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 111.307 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.18 1.18 9.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.268 1.027 . . . . 0.0 111.697 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.64 11.76 27.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -112.47 -154.4 0.54 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.173 0.989 . . . . 0.0 109.563 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 4.5 p -148.97 159.56 44.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.794 1.638 . . . . 0.0 107.674 172.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 47.1 mt -63.27 -25.75 68.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -73.87 -25.45 60.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.467 1.107 . . . . 0.0 111.985 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.76 -15.96 61.65 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.09 0.556 . . . . 0.0 111.386 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.517 ' CD2' HD12 ' B' ' 50' ' ' LEU . 21.2 m-85 -125.71 25.98 6.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.367 0.667 . . . . 0.0 109.836 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p30 48.54 18.91 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 136.44 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.855 0.752 . . . . 0.0 110.187 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -130.4 -175.89 3.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.009 1.323 . . . . 0.0 109.458 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -59.93 143.89 50.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.281 0.563 . . . . 0.0 110.916 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 55.15 22.43 4.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.455 1.102 . . . . 0.0 113.331 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -72.44 -14.72 61.76 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 80.6 m 61.36 128.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.466 1.906 . . . . 0.0 112.051 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.59 178.62 6.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.941 1.296 . . . . 0.0 108.655 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -134.85 154.64 51.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -145.24 151.87 39.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.245 0.545 . . . . 0.0 110.507 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.04 161.2 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.68 170.05 16.49 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.155 0.502 . . . . 0.0 112.077 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -135.61 177.48 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.136 0.974 . . . . 0.0 109.538 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.48 ' H ' HD23 ' B' ' 73' ' ' LEU . 0.5 OUTLIER -124.41 20.87 8.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.267 1.027 . . . . 0.0 112.385 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 . . . . . 0 N--CA 1.467 0.399 0 C-N-CA 127.052 2.141 . . . . 0.0 113.94 -175.381 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 494' ' ' GLN . 93.3 Cg_endo -80.12 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 1 C-N-CA 125.408 4.072 . . . . 0.0 109.254 175.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.4 32.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.726 1.61 . . . . 0.0 113.078 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.4 pp0? -77.16 -27.95 53.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.281 0.633 . . . . 0.0 112.568 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.01 3.63 1.61 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.5 160.05 82.06 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 122.911 0.484 . . . . 0.0 109.781 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.1 149.43 15.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.52 2.813 . . . . 0.0 111.434 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -76.09 65.92 2.18 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 121.731 0.777 . . . . 0.0 112.256 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 165.76 -27.75 0.19 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.494 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.73 162.1 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 122.988 0.515 . . . . 0.0 109.948 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -131.15 144.74 51.6 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 109.868 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.522 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.16 -30.62 70.51 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.3 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -72.15 0.41 9.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.903 -0.498 . . . . 0.0 111.771 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.1 16.19 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 122.945 0.498 . . . . 0.0 110.617 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.98 -19.87 5.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.552 0.741 . . . . 0.0 109.846 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -73.49 4.77 4.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.023 0.529 . . . . 0.0 111.637 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -83.95 5.9 23.82 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.438 0.695 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.01 152.15 53.77 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 123.868 0.867 . . . . 0.0 110.174 -170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.8 164.1 25.53 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.845 2.364 . . . . 0.0 111.311 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.55 63.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.106 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 -3.29 58.4 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 122.464 0.306 . . . . 0.0 110.953 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.2 -15.27 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -54.96 -38.92 68.39 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.08 -10.4 59.36 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -89.38 -18.37 26.99 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.478 0.581 . . . . 0.0 111.186 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.91 -34.32 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.08 -9.07 14.15 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 171.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 m -63.14 -27.08 69.13 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 122.245 -0.284 . . . . 0.0 110.821 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 104.19 35.23 3.45 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -61.54 -179.96 0.2 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.613 1.197 . . . . 0.0 112.189 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.3 m -142.65 -171.97 3.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.162 -1.835 . . . . 0.0 108.91 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.76 13.13 8.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.233 1.013 . . . . 0.0 112.286 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -149.75 145.56 26.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.912 0.485 . . . . 0.0 110.252 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.553 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.2 m-80 -152.37 19.4 0.64 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.738 0.815 . . . . 0.0 110.105 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.02 -15.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.159 1.384 . . . . 0.0 112.445 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 124.072 0.949 . . . . 0.0 111.108 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.955 0.407 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.69 172.81 17.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.794 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.58 -179.64 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.548 0.739 . . . . 0.0 109.055 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -132.06 107.59 8.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -103.09 109.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.6 ttmt -93.54 139.11 31.12 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -86.9 176.0 7.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.044 0.938 . . . . 0.0 112.135 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.86 -20.84 59.46 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.577 1.151 . . . . 0.0 110.981 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -95.48 -2.83 47.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.968 -0.458 . . . . 0.0 110.471 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.56 24.64 27.8 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.278 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.55 140.07 52.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -109.42 159.23 17.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.546 -173.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -129.97 128.69 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -79.54 134.17 36.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -144.88 133.8 22.5 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -90.11 128.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.409 HG12 ' HE3' ' B' ' 29' ' ' LYS . 33.7 m -146.12 177.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 123.746 0.818 . . . . 0.0 110.104 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' B' ' 20' ' ' SER . 75.0 mm-40 -141.6 163.08 43.34 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 124.602 1.161 . . . . 0.0 108.941 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.434 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 38.2 Cg_exo -55.46 3.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.668 3.579 . . . . 0.0 113.647 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.472 ' H ' ' C ' ' B' ' 18' ' ' GLU . 19.2 t -134.0 -8.77 2.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.892 0.769 . . . . 0.0 111.482 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 8.2 m-20 -78.05 68.78 4.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.0 t -62.29 177.02 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.653 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.433 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.6 mm -51.29 -33.65 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -169.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.29 -22.14 61.99 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 119.266 0.939 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -81.79 -38.17 26.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.466 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 71.5 t -64.68 -40.54 89.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 110.138 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.433 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.6 mttt -56.86 -27.53 60.51 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.17 -23.04 44.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.427 0.558 . . . . 0.0 110.796 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.466 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 68.3 mmtt -69.76 -47.32 63.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.481 0.712 . . . . 0.0 109.434 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.44 -30.61 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.515 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.32 -39.4 78.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.71 0.29 . . . . 0.0 110.466 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.43 -31.25 70.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.31 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.35 -24.6 36.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.462 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.68 -34.53 0.68 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.63 8.7 13.7 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.74 126.48 88.45 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.13 153.78 73.98 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.672 2.248 . . . . 0.0 111.028 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.31 -17.33 39.66 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.617 2.878 . . . . 0.0 111.573 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.14 2.3 55.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.69 -16.76 10.66 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.91 164.13 24.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.619 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -154.53 124.18 6.59 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.459 ' C ' HD13 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -123.4 135.12 53.97 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.871 0.305 . . . . 0.0 111.513 -168.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.7 mp -129.53 149.92 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -151.03 143.08 24.01 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.844 1.257 . . . . 0.0 109.07 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.69 13.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.516 0.726 . . . . 0.0 112.326 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.99 14.58 48.56 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.453 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 163.42 29.33 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.486 1.143 . . . . 0.0 110.178 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.84 128.27 45.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' B' ' 59' ' ' TYR . 0.4 OUTLIER -77.18 172.82 12.64 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.015 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -135.5 156.27 49.16 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.542 0.687 . . . . 0.0 111.206 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.97 2.31 8.95 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.869 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.86 14.57 21.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -115.26 -154.13 0.54 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.375 1.07 . . . . 0.0 108.758 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 40.4 p -150.43 166.52 29.87 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.344 1.058 . . . . 0.0 108.386 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.3 -30.48 71.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 17.0 t -74.91 -29.76 61.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.351 0.66 . . . . 0.0 111.136 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.42 -16.17 63.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.723 0.409 . . . . 0.0 111.606 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.518 ' CD2' HD11 ' B' ' 50' ' ' LEU . 18.0 m-85 -130.1 25.57 5.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.654 0.781 . . . . 0.0 110.245 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 46.75 25.68 0.47 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.24 128.47 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -132.38 -171.24 2.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.71 1.204 . . . . 0.0 109.705 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -58.37 140.66 53.22 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.969 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 54.12 24.43 4.84 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.235 1.014 . . . . 0.0 113.15 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.7 m -72.22 -19.18 61.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m 60.99 135.79 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.508 1.923 . . . . 0.0 112.184 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.9 179.93 6.43 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.534 0.734 . . . . 0.0 109.145 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.58 143.72 45.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.048 0.451 . . . . 0.0 110.886 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -134.4 142.02 47.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.834 1.254 . . . . 0.0 110.495 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 85.2 t -142.93 160.26 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -147.67 171.89 14.93 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.8 175.9 5.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.508 1.123 . . . . 0.0 108.977 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tp -124.4 18.98 8.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 127.041 2.136 . . . . 0.0 113.992 -172.732 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.2 Cg_endo -74.54 -164.03 0.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 125.125 3.883 . . . . 0.0 109.616 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 32.95 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.417 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -68.54 -36.7 79.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.56 2.34 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 112.047 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.09 161.12 75.14 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 122.985 0.514 . . . . 0.0 110.06 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 499' ' ' GLY . 75.1 Cg_exo -53.19 150.95 23.41 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.988 3.125 . . . . 0.0 112.18 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.55 35.82 0.19 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.87 0.843 . . . . 0.0 112.077 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -174.24 30.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.298 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.8 t -139.16 162.52 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 C-N-CA 123.619 0.768 . . . . 0.0 108.984 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.17 143.04 50.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.496 0.665 . . . . 0.0 110.046 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.78 -30.65 70.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.169 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.41 0.38 8.39 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.698 -0.626 . . . . 0.0 111.588 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.72 17.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.719 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.35 -21.58 5.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 109.706 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -72.37 10.15 0.86 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.283 0.633 . . . . 0.0 111.68 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -93.49 8.8 39.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.874 0.87 . . . . 0.0 110.743 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 31.4 mt -123.82 153.62 67.1 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.8 0.84 . . . . 0.0 111.331 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.8 158.49 56.72 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.987 2.458 . . . . 0.0 111.14 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.8 62.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.928 0.891 . . . . 0.0 112.847 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.17 -7.29 59.64 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.649 0.658 . . . . 0.0 111.133 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.79 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -65.21 -35.2 80.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 120.857 -1.152 . . . . 0.0 110.592 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.06 -1.78 8.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.42 0.288 . . . . 0.0 111.5 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.79 5.04 8.79 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 518' ' ' SER . 19.1 mm -106.05 -39.21 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.96 -5.52 2.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.701 0.8 . . . . 0.0 109.503 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 516' ' ' ILE . 42.8 m -142.16 27.66 1.75 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.272 1.429 . . . . 0.0 110.171 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.59 39.01 2.21 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.41 9.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.692 1.997 . . . . 0.0 115.421 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.9 m -142.4 171.09 14.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.746 0.819 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 1.1 tpm_? 60.57 12.92 3.87 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.65 1.58 . . . . 0.0 114.128 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.43 140.22 21.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.44 ' C ' ' H ' ' A' ' 526' ' ' LYS . 48.5 m-80 -150.25 32.17 0.66 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.027 0.531 . . . . 0.0 111.786 -170.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.262 1.9 pp 50.95 5.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.086 1.754 . . . . 0.0 115.362 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 524' ' ' ASN . 51.5 mtmt . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.849 1.26 . . . . 0.0 112.471 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.97 173.47 16.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.651 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.41 -179.61 2.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.3 133.25 51.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.86 107.12 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -84.71 132.8 34.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.981 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -76.1 173.52 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.096 0.958 . . . . 0.0 111.424 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.18 -23.19 66.47 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.794 0.838 . . . . 0.0 110.531 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -91.84 -10.46 39.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.924 -0.485 . . . . 0.0 111.322 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 28.75 7.1 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.37 -0.443 . . . . 0.0 113.751 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -121.82 145.57 47.93 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.51 158.02 25.28 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.7 mt -133.12 134.24 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -77.43 128.91 35.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 mt -137.24 130.33 30.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.97 126.97 35.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.009 0.923 . . . . 0.0 109.354 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.57 177.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.133 0.973 . . . . 0.0 109.447 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.4 mm-40 -136.9 162.49 55.52 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 108.619 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.69 5.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.487 2.792 . . . . 0.0 113.384 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.469 ' H ' ' C ' ' B' ' 18' ' ' GLU . 22.5 t -129.86 -8.93 4.45 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.626 0.648 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -81.11 76.01 8.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.7 t -66.08 177.1 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.445 -176.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.439 HG21 ' HE3' ' B' ' 27' ' ' LYS . 11.8 mm -52.12 -35.34 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.54 -21.73 65.45 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.934 0.788 . . . . 0.0 111.038 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -82.72 -42.67 17.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.6 -40.03 87.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 124.444 1.098 . . . . 0.0 110.395 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.439 ' HE3' HG21 ' B' ' 23' ' ' ILE . 89.8 mttt -58.75 -23.17 59.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.419 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.48 35.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.601 0.637 . . . . 0.0 110.762 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.26 -33.84 75.1 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.177 -0.327 . . . . 0.0 110.13 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -85.1 -30.51 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.85 -39.16 90.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.79 -31.81 71.94 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.232 0.539 . . . . 0.0 111.07 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -86.9 -22.09 25.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -135.16 -32.1 0.96 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.6 9.85 24.34 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -81.59 129.98 63.42 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.35 151.08 76.46 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.585 2.19 . . . . 0.0 110.826 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.52 -15.03 44.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.626 2.884 . . . . 0.0 111.37 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -88.15 -7.26 57.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -119.24 -9.85 9.86 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.5 176.26 4.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.176 0.898 . . . . 0.0 112.91 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -147.06 151.48 36.97 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 127.48 2.312 . . . . 0.0 105.768 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -146.71 116.8 7.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.308 0.958 . . . . 0.0 110.165 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.11 142.23 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.574 0.75 . . . . 0.0 109.299 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.32 158.41 26.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.564 172.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.12 20.89 1.93 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.33 73.62 Favored Glycine 0 C--N 1.341 0.847 0 C-N-CA 125.084 1.326 . . . . 0.0 112.57 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 161.73 35.8 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 117.693 0.746 . . . . 0.0 109.686 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -96.62 125.71 41.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' B' ' 50' ' ' LEU . 5.1 mp -74.76 159.75 31.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -124.92 148.4 48.36 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.49 0.662 . . . . 0.0 111.801 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.66 2.39 5.32 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.467 1.107 . . . . 0.0 111.672 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 15.61 23.61 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -121.14 -150.2 0.45 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 108.655 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -151.81 156.42 40.18 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 125.738 1.615 . . . . 0.0 108.871 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.79 -25.2 62.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -73.89 -24.29 59.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.265 1.026 . . . . 0.0 111.703 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.0 -15.19 60.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.254 0.621 . . . . 0.0 111.556 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.404 ' CE2' HD13 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -112.07 17.41 19.63 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 174.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.82 22.44 1.15 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.836 1.254 . . . . 0.0 114.227 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.525 HG23 ' HG ' ' B' ' 65' ' ' SER . 71.5 mt -62.81 144.78 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -132.82 178.67 6.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.918 0.887 . . . . 0.0 109.092 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -60.92 150.87 31.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.064 0.459 . . . . 0.0 111.253 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 60.06 17.68 6.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.869 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.525 ' HG ' HG23 ' B' ' 61' ' ' ILE . 87.6 p -70.08 179.48 2.32 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 109.934 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -134.61 126.85 30.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -121.61 -171.77 2.29 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -138.41 143.96 39.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.034 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -133.76 139.04 46.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.544 1.137 . . . . 0.0 109.944 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.94 165.89 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.49 172.66 12.56 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.25 0.477 . . . . 0.0 111.804 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -123.79 169.45 11.53 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.918 0.887 . . . . 0.0 110.078 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.58 13.49 20.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.986 0.915 . . . . 0.0 112.213 -170.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 126.409 1.884 . . . . 0.0 113.866 -175.095 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 494' ' ' GLN . 84.3 Cg_endo -76.18 -163.74 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 1 C-N-CA 125.392 4.062 . . . . 0.0 109.65 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.94 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.479 1.512 . . . . 0.0 112.868 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.1 pp0? -75.43 -26.26 58.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.49 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.15 5.68 1.3 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.67 157.51 90.0 Favored Pre-proline 0 N--CA 1.448 -0.55 0 O-C-N 121.923 -0.486 . . . . 0.0 110.163 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.16 154.66 27.36 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.857 3.038 . . . . 0.0 112.169 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -79.67 58.19 2.7 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 122.147 0.975 . . . . 0.0 109.866 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.98 28.34 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.142 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.13 163.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.527 0.663 . . . . 0.0 109.349 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.09 144.03 46.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.21 -31.98 73.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.621 -177.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.38 9.88 3.54 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.282 -0.886 . . . . 0.0 110.364 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.71 10.24 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.563 1.145 . . . . 0.0 109.466 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -25.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.219 -0.925 . . . . 0.0 112.728 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -69.12 -8.32 44.31 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.85 0.75 . . . . 0.0 111.939 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -81.32 -10.55 59.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.11 0.413 . . . . 0.0 110.795 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.82 162.44 70.29 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 124.695 1.198 . . . . 0.0 110.15 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.51 165.05 33.43 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.625 2.216 . . . . 0.0 111.258 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.92 -8.89 5.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.434 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -103.05 -2.35 27.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.301 0.64 . . . . 0.0 111.544 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.07 -13.48 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.21 -2.25 33.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.318 0.647 . . . . 0.0 112.185 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -100.5 -15.32 17.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.316 0.507 . . . . 0.0 111.408 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.32 -35.42 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.31 -11.17 49.17 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 t -73.08 -45.0 59.76 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.637 0.256 . . . . 0.0 110.959 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 130.9 123.24 2.48 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -146.28 173.6 12.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.452 1.101 . . . . 0.0 109.001 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 t -153.6 -171.87 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.605 1.162 . . . . 0.0 109.127 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 62.78 21.26 12.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.705 1.202 . . . . 0.0 112.021 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -144.88 155.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.964 0.906 . . . . 0.0 109.542 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.566 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -149.05 10.7 0.8 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -173.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.4 13.55 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.869 -172.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 51.7 mtmt . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 124.448 1.099 . . . . 0.0 112.335 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -157.87 171.3 20.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.814 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -138.22 -179.73 2.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.09 108.29 8.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.03 117.04 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.58 132.52 36.25 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.392 0.277 . . . . 0.0 111.332 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.42 ' C ' ' H ' ' B' ' 9' ' ' THR . 69.4 p -83.19 179.34 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.33 7.12 0.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.04 1.336 . . . . 0.0 110.846 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.42 ' H ' ' C ' ' B' ' 7' ' ' THR . 72.4 p -125.65 11.42 7.89 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.165 -0.959 . . . . 0.0 111.981 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 28.29 66.23 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.84 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -126.55 145.56 50.48 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 159.67 22.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.481 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -127.99 125.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -73.09 133.56 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.35 130.04 21.52 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.36 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -90.36 129.0 36.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.06 -177.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.956 0.902 . . . . 0.0 109.637 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.449 ' C ' ' H ' ' B' ' 20' ' ' SER . 37.6 mt-10 -144.14 162.87 38.21 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.85 2.86 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.818 2.345 . . . . 0.0 113.063 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 18' ' ' GLU . 28.4 p -126.16 -12.06 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.679 0.791 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.49 73.18 7.41 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.5 t -62.89 175.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.252 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.424 HG23 ' HE3' ' B' ' 27' ' ' LYS . 14.9 mm -51.08 -34.47 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -169.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.44 -22.65 64.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.553 1.07 . . . . 0.0 111.412 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.79 -36.45 25.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.48 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 83.3 t -68.08 -37.63 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 124.122 0.969 . . . . 0.0 110.207 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.424 ' HE3' HG23 ' B' ' 23' ' ' ILE . 96.0 mttt -60.96 -24.28 65.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.83 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.8 52.12 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.479 0.581 . . . . 0.0 110.771 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.7 mmtt -72.97 -50.59 22.4 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.565 0.746 . . . . 0.0 109.513 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -68.49 -31.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.52 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.96 -38.82 79.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.525 0.203 . . . . 0.0 110.77 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.78 -29.35 65.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.28 0.562 . . . . 0.0 111.405 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -80.48 -25.49 38.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.056 0.943 . . . . 0.0 113.227 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -138.0 -32.8 0.72 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.93 15.36 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.1 mt -76.15 128.63 82.44 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.85 155.47 62.28 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.694 2.263 . . . . 0.0 111.133 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.14 -16.06 43.91 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.897 3.064 . . . . 0.0 111.491 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.67 -13.38 51.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -114.88 -15.19 11.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.11 155.94 38.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.331 0.969 . . . . 0.0 111.21 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.56 90.99 1.84 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.658 1.183 . . . . 0.0 108.826 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' HD11 ' B' ' 44' ' ' ILE . 18.1 mt -85.57 139.76 31.17 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.012 0.434 . . . . 0.0 111.333 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.407 HD11 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -130.97 148.16 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.828 1.251 . . . . 0.0 107.858 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -148.84 141.72 24.7 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.258 1.023 . . . . 0.0 108.686 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.96 12.29 0.08 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.592 0.757 . . . . 0.0 112.583 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.42 39.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.635 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 161.65 33.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.411 1.105 . . . . 0.0 109.766 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -95.78 145.13 25.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -99.51 169.17 9.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.712 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -136.28 153.74 51.09 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.338 0.59 . . . . 0.0 111.987 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -72.84 1.03 9.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.241 1.016 . . . . 0.0 111.54 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.59 8.79 32.42 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -110.56 -154.04 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 109.323 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.8 p -149.06 158.58 44.29 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.63 1.572 . . . . 0.0 107.434 171.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.29 -25.21 68.21 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.9 p -74.06 -24.86 59.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.59 1.156 . . . . 0.0 111.568 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.79 -16.43 61.63 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.182 0.593 . . . . 0.0 111.531 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -125.05 25.94 7.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.516 0.726 . . . . 0.0 109.6 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.33 20.06 0.26 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.427 HG23 ' HG ' ' B' ' 65' ' ' SER . 60.2 mt -60.14 136.9 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 118.572 0.624 . . . . 0.0 111.083 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -132.57 -172.62 2.95 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.26 1.424 . . . . 0.0 109.403 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -60.85 145.49 49.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.674 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 51.44 26.53 3.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.533 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.427 ' HG ' HG23 ' B' ' 61' ' ' ILE . 77.6 p -69.37 -21.17 63.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.419 1.088 . . . . 0.0 113.424 -173.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m 59.87 126.07 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.176 2.19 . . . . 0.0 112.275 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -128.7 -175.88 3.67 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.068 1.347 . . . . 0.0 107.921 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -136.99 144.44 43.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -132.28 135.69 46.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.741 . . . . 0.0 110.088 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.22 166.89 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -146.26 171.99 14.14 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -104.99 177.73 4.77 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.999 1.32 . . . . 0.0 108.345 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.75 18.8 10.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.849 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 126.652 1.981 . . . . 0.0 113.761 -173.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.421 ' CD1' ' H ' ' A' ' 491' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 38.6 Cg_exo -61.2 -162.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 125.117 3.878 . . . . 0.0 111.468 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 31.65 0.71 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.669 1.188 . . . . 0.0 110.671 169.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -68.7 -28.56 66.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.684 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.94 3.33 0.82 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.43 0.692 . . . . 0.0 112.73 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.75 160.88 81.01 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . 0.42 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 55.6 Cg_exo -51.85 157.74 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.316 3.344 . . . . 0.0 112.582 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -77.44 68.13 3.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.977 0.894 . . . . 0.0 112.375 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 157.18 -26.77 0.49 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.284 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.88 167.38 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.066 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.8 147.88 41.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.635 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -64.2 -30.28 71.35 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.851 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.1 9.41 3.73 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.213 -0.93 . . . . 0.0 110.813 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.96 9.28 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 109.522 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -19.17 0.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 113.071 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -71.55 -11.44 60.86 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.673 -0.642 . . . . 0.0 111.956 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -80.25 -9.47 59.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.016 0.371 . . . . 0.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.95 148.59 57.35 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 124.293 1.037 . . . . 0.0 109.44 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.35 164.45 23.03 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.658 2.239 . . . . 0.0 111.338 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.84 -21.52 63.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.888 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -87.42 1.45 53.36 Favored 'General case' 0 CA--C 1.524 -0.05 0 C-N-CA 122.692 0.397 . . . . 0.0 111.005 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 32.0 mt -119.34 -16.35 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -54.82 -41.39 70.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.93 -1.18 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.531 0.733 . . . . 0.0 112.487 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -105.77 -17.74 14.28 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.285 0.493 . . . . 0.0 111.9 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.49 -25.69 3.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.49 -5.79 12.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.319 0.248 . . . . 0.0 110.413 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 89.6 p -146.38 15.8 1.3 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -119.16 88.81 0.45 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 497' ' ' PRO . 10.2 mmmm -112.54 9.26 19.47 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -163.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.4 t -137.57 21.03 2.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.24 7.02 5.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.736 -0.602 . . . . 0.0 112.204 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.414 ' C ' ' ND2' ' A' ' 524' ' ' ASN . 1.1 pm0 -153.41 149.49 27.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.417 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.2 OUTLIER -144.27 17.43 1.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.28 1.032 . . . . 0.0 109.202 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.54 6.83 5.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.514 1.125 . . . . 0.0 109.876 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 49.5 mtmt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.519 1.128 . . . . 0.0 112.849 -173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 120.658 0.266 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -156.29 173.52 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.74 -179.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 123.654 0.782 . . . . 0.0 109.274 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.419 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 50.7 m-85 -133.57 94.95 3.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.114 0.483 . . . . 0.0 109.737 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -81.93 62.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.163 0.985 . . . . 0.0 111.771 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.5 ttmt -51.59 132.54 30.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.62 0.768 . . . . 0.0 111.28 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 65.9 p -76.06 175.47 8.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.128 -174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.28 -10.34 10.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.708 1.203 . . . . 0.0 110.675 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -112.67 -0.31 15.12 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 121.892 -0.505 . . . . 0.0 111.988 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 22.4 23.78 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.682 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.2 123.42 46.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.585 0.693 . . . . 0.0 110.149 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.9 OUTLIER -82.64 151.24 26.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 111.356 -177.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.35 120.42 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -77.9 136.78 38.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -149.77 137.39 20.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.385 0.274 . . . . 0.0 110.976 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.67 128.7 42.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.8 -179.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.837 0.855 . . . . 0.0 109.358 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' B' ' 20' ' ' SER . 35.4 mt-10 -142.15 164.0 36.38 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.454 0.701 . . . . 0.0 109.52 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 43.2 Cg_exo -54.72 1.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.465 3.443 . . . . 0.0 113.683 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.6 m -132.31 -7.77 3.35 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.805 0.729 . . . . 0.0 111.671 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 28.5 m-20 -81.39 68.61 7.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -63.33 178.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.191 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.467 HG23 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -52.74 -33.82 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -168.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.91 -23.43 63.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.224 0.92 . . . . 0.0 111.15 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -80.63 -41.66 23.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.04 -40.89 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 123.999 0.919 . . . . 0.0 110.077 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.467 ' HE3' HG23 ' B' ' 23' ' ' ILE . 94.5 mttt -56.55 -26.73 55.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.415 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 -28.39 34.98 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.627 0.649 . . . . 0.0 110.849 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.47 -32.82 74.64 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -86.15 -30.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -66.49 -36.31 82.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.19 -34.81 76.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.142 0.496 . . . . 0.0 111.325 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.03 -25.58 43.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.24 -31.23 0.91 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.92 10.28 22.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.1 127.36 77.09 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.0 154.13 67.09 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.807 2.338 . . . . 0.0 111.17 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.41 -14.25 41.96 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.717 2.945 . . . . 0.0 110.713 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.45 -8.78 58.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -123.42 -8.76 8.06 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.96 167.51 20.92 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.084 0.856 . . . . 0.0 111.731 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -154.24 138.94 17.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.447 ' C ' HD11 ' B' ' 44' ' ' ILE . 46.0 tp -134.92 135.58 41.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.796 0.725 . . . . 0.0 111.509 -169.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.447 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.3 mp -131.74 152.09 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.586 1.155 . . . . 0.0 108.667 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -149.31 138.67 21.53 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.59 1.156 . . . . 0.0 108.94 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.74 0.07 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.89 0.876 . . . . 0.0 112.876 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.42 13.17 36.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.407 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 159.48 36.81 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.631 1.216 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -93.8 150.52 20.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.15 170.28 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.419 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -136.38 153.89 50.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.586 0.708 . . . . 0.0 111.539 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.45 -1.01 14.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.414 1.086 . . . . 0.0 111.983 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.2 8.11 32.97 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -106.08 -155.79 0.56 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.162 0.985 . . . . 0.0 109.198 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 35.8 p -150.82 166.25 31.08 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.203 1.401 . . . . 0.0 107.958 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -29.23 70.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 12.2 t -73.4 -31.53 63.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.108 0.963 . . . . 0.0 111.329 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.93 -15.82 60.02 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.551 0.34 . . . . 0.0 111.443 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -128.28 24.9 5.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.673 0.789 . . . . 0.0 109.92 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.65 24.63 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.375 1.87 . . . . 0.0 115.541 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.9 138.53 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.627 0.649 . . . . 0.0 109.851 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.61 -175.16 3.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.662 1.185 . . . . 0.0 109.753 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -59.45 144.7 46.29 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 53.51 24.87 4.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.388 1.075 . . . . 0.0 113.238 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -74.86 -17.68 60.55 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m 59.54 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.271 1.828 . . . . 0.0 112.865 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -127.59 179.87 5.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.663 1.185 . . . . 0.0 108.522 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -134.9 97.5 3.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.098 0.475 . . . . 0.0 111.449 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.89 143.77 45.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.233 1.013 . . . . 0.0 110.497 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 44.9 t -143.71 166.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.35 168.74 22.53 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.623 -0.673 . . . . 0.0 111.722 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -79.35 176.25 9.86 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.924 0.49 . . . . 0.0 111.657 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.89 14.32 29.69 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.26 0.624 . . . . 0.0 111.477 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 . . . . . 0 N--CA 1.462 0.162 0 C-N-CA 128.054 2.542 . . . . 0.0 114.708 -176.648 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 494' ' ' GLN . 98.0 Cg_endo -77.71 -161.39 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 125.279 3.986 . . . . 0.0 108.8 175.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.06 25.5 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.2 pp0? -65.22 -23.76 67.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.549 1.14 . . . . 0.0 112.656 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.85 6.26 1.79 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . 0.484 ' CD2' HE21 ' A' ' 502' ' ' GLN . 8.2 mp -64.22 156.63 74.62 Favored Pre-proline 0 N--CA 1.447 -0.586 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 157.5 5.81 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.204 3.269 . . . . 0.0 112.252 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.92 67.23 2.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.892 0.853 . . . . 0.0 112.302 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 158.51 -29.02 0.44 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.272 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.4 163.9 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.593 0.757 . . . . 0.0 109.838 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.19 157.67 44.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.023 0.529 . . . . 0.0 110.811 -173.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.484 HE21 ' CD2' ' A' ' 496' ' ' LEU . 36.1 mm-40 -60.61 -45.51 93.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.972 0.509 . . . . 0.0 110.614 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.58 7.23 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.139 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . 0.442 ' CA ' HE21 ' A' ' 507' ' ' GLN . 20.2 m -138.49 11.3 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.597 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -17.42 5.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.359 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.34 4.6 6.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.815 0.446 . . . . 0.0 111.302 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.442 HE21 ' CA ' ' A' ' 504' ' ' VAL . 10.2 mm-40 -81.38 7.15 12.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.057 0.943 . . . . 0.0 110.698 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 27.9 mt -121.92 155.01 61.17 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 123.837 0.855 . . . . 0.0 110.621 -168.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.4 167.28 27.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.525 2.817 . . . . 0.0 111.948 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.39 -15.31 24.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.214 1.006 . . . . 0.0 112.753 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -100.72 3.35 42.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.058 0.39 . . . . 0.0 111.786 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.9 mt -118.26 -15.45 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.85 -43.8 66.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.17 1.38 13.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.398 0.679 . . . . 0.0 112.805 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -104.29 -18.5 14.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.45 0.568 . . . . 0.0 111.388 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.27 -28.55 2.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.82 -2.54 9.74 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.168 0.587 . . . . 0.0 110.138 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 90.4 p -133.09 13.62 4.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.193 0.997 . . . . 0.0 111.076 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.79 39.37 2.12 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 2.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -141.25 -174.99 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.911 0.884 . . . . 0.0 109.953 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.2 OUTLIER 65.85 6.58 4.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.884 1.274 . . . . 0.0 113.065 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.15 161.85 41.59 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.116 0.416 . . . . 0.0 110.898 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -149.79 33.75 0.69 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.762 0.825 . . . . 0.0 111.078 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.83 7.02 4.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.515 0.726 . . . . 0.0 110.741 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.453 -0.318 0 C-N-CA 124.434 1.093 . . . . 0.0 111.717 -176.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.95 173.12 17.25 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.034 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -135.0 175.81 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 53.2 m-85 -128.88 89.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.433 0.635 . . . . 0.0 110.167 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.38 103.38 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.161 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.2 ttmt -85.17 135.52 33.93 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.436 ' C ' ' H ' ' B' ' 9' ' ' THR . 58.9 p -83.85 174.96 9.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.526 0.731 . . . . 0.0 112.368 -175.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.31 3.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.14 1.376 . . . . 0.0 111.418 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.436 ' H ' ' C ' ' B' ' 7' ' ' THR . 82.6 p -118.19 4.62 11.95 Favored 'General case' 0 CA--C 1.527 0.058 0 O-C-N 121.922 -0.486 . . . . 0.0 111.537 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.26 24.4 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.251 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.35 122.39 38.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.57 0.685 . . . . 0.0 110.134 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.7 OUTLIER -79.04 152.46 30.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.816 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.25 123.24 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -79.83 131.9 35.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -143.55 133.45 24.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.287 -174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.73 126.29 35.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -145.35 177.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 123.786 0.834 . . . . 0.0 109.919 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.1 mm-40 -138.91 162.24 53.66 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 124.05 0.94 . . . . 0.0 109.709 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.436 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 49.4 Cg_exo -54.58 -0.44 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 125.0 3.8 . . . . 0.0 113.896 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -130.91 -7.2 3.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.183 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 65.2 m-20 -81.55 69.62 8.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.9 t -62.9 177.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.808 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.416 HG21 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -51.79 -34.61 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.942 0.897 . . . . 0.0 113.215 -168.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.95 -22.42 63.18 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.094 0.861 . . . . 0.0 111.271 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -81.6 -40.85 22.38 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.9 -39.12 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 124.301 1.04 . . . . 0.0 110.217 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.416 ' HE3' HG21 ' B' ' 23' ' ' ILE . 95.7 mttt -57.4 -24.84 57.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.761 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.85 -28.34 33.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.509 0.595 . . . . 0.0 110.761 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -66.34 -33.32 75.46 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.06 -30.62 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.25 -39.35 86.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.695 0.283 . . . . 0.0 110.261 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.65 -31.67 71.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 111.243 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -83.71 -23.72 31.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.78 -32.84 0.88 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.81 9.03 21.61 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -78.2 129.47 75.18 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.47 151.44 70.72 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.574 2.183 . . . . 0.0 110.456 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 -14.47 37.37 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.23 2.62 . . . . 0.0 110.828 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.14 -8.64 59.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -124.07 -9.82 7.65 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -67.61 165.75 16.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.097 0.862 . . . . 0.0 111.655 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -154.47 102.58 2.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.459 ' C ' HD13 ' B' ' 44' ' ' ILE . 28.5 tp -101.36 135.93 42.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.256 0.623 . . . . 0.0 110.949 -169.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.1 mp -129.81 154.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -118.52 -112.05 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 122.914 0.485 . . . . 0.0 110.494 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.99 -3.18 3.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.303 0.641 . . . . 0.0 111.732 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.88 3.03 2.08 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.553 1.073 . . . . 0.0 111.448 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 154.89 37.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.451 0.643 . . . . 0.0 109.567 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -87.96 128.62 35.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.619 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -76.14 172.71 12.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.602 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -133.63 153.44 51.67 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.663 0.744 . . . . 0.0 111.656 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.49 1.48 9.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 111.917 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.29 14.01 25.75 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -115.57 -154.59 0.55 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.353 1.061 . . . . 0.0 108.997 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.0 p -150.14 165.82 31.7 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.812 1.245 . . . . 0.0 108.142 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.14 -29.33 70.71 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 11.5 t -73.24 -31.36 64.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.654 0.782 . . . . 0.0 111.183 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.96 -15.7 63.23 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 122.87 0.468 . . . . 0.0 111.894 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' B' ' 50' ' ' LEU . 15.7 m-85 -130.49 26.44 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.846 0.858 . . . . 0.0 109.989 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.83 30.89 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.446 HG21 ' HG ' ' B' ' 65' ' ' SER . 73.2 mt -70.92 132.85 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.83 -174.0 3.79 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.477 1.111 . . . . 0.0 109.542 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -56.7 143.08 37.74 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.058 0.456 . . . . 0.0 111.477 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 53.45 27.79 6.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.201 1.0 . . . . 0.0 112.942 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.446 ' HG ' HG21 ' B' ' 61' ' ' ILE . 71.1 p -69.7 -27.37 64.94 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m 61.57 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.012 2.125 . . . . 0.0 112.043 -174.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.54 -179.38 5.7 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.212 1.005 . . . . 0.0 108.806 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.51 151.95 50.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -138.55 142.64 39.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.573 0.749 . . . . 0.0 111.087 -175.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.12 165.32 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 126.352 1.861 . . . . 0.0 105.983 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.35 165.86 27.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.846 -0.534 . . . . 0.0 111.295 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -73.2 174.19 8.36 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.31 17.78 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.009 0.524 . . . . 0.0 111.087 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.463 0.205 0 C-N-CA 126.845 2.058 . . . . 0.0 113.693 -173.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.739 ' CD2' ' H ' ' A' ' 491' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.59 89.28 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.972 3.781 . . . . 0.0 111.937 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.8 tt 21.46 48.87 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.163 2.585 . . . . 0.0 112.214 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -95.95 -20.08 19.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.117 -172.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -145.57 6.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.79 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.15 151.64 93.31 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.15 164.05 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.836 3.024 . . . . 0.0 111.685 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.03 132.21 53.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.273 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 78.03 -23.02 2.76 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.698 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.99 163.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.71 1.255 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.91 164.83 28.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.182 0.593 . . . . 0.0 110.398 -173.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -66.72 -41.9 87.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.114 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.64 10.9 0.73 Allowed 'General case' 0 C--O 1.23 0.062 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.56 12.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.665 0.786 . . . . 0.0 110.35 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.8 OUTLIER -134.48 -26.26 1.44 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.274 0.488 . . . . 0.0 112.073 176.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.37 -13.43 62.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.402 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 8.6 mp0 -82.19 -12.07 58.34 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.195 0.452 . . . . 0.0 110.887 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.18 153.4 84.35 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 124.249 1.02 . . . . 0.0 109.508 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 166.29 30.4 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.1 2.533 . . . . 0.0 111.582 172.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.72 -22.19 56.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.554 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.04 3.16 55.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.995 0.362 . . . . 0.0 111.669 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.8 mt -117.94 -15.37 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.1 mp0 -52.9 -44.63 67.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.84 -6.65 39.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.401 0.68 . . . . 0.0 112.469 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.86 -20.44 16.17 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.448 0.567 . . . . 0.0 111.039 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.76 -31.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.44 -3.31 8.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.745 0.418 . . . . 0.0 109.988 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -136.17 15.79 3.25 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.092 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -114.54 28.26 8.32 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.156 0.408 . . . . 0.0 112.199 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 1.45 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.2 t -136.01 32.3 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.79 -2.16 0.95 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.66 159.28 39.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -147.35 28.45 0.99 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.957 -172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.42 6.8 3.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.563 0.697 . . . . 0.0 110.073 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 C--N 1.338 0.097 0 C-N-CA 123.878 0.871 . . . . 0.0 112.222 -174.487 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -129.42 165.6 21.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.339 0.656 . . . . 0.0 110.75 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.78 166.64 2.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 164.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.542 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 8.9 m-85 -125.75 133.93 51.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -126.79 109.86 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -84.64 139.38 32.09 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.227 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.424 ' C ' ' H ' ' B' ' 9' ' ' THR . 71.8 p -84.91 177.82 7.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.073 0.949 . . . . 0.0 112.082 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.42 6.08 0.87 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.791 1.236 . . . . 0.0 110.945 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.424 ' H ' ' C ' ' B' ' 7' ' ' THR . 58.8 p -125.38 6.15 7.69 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.812 -0.555 . . . . 0.0 112.113 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.84 26.58 53.21 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 119.954 -0.359 . . . . 0.0 113.172 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -124.01 145.58 49.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.272 0.629 . . . . 0.0 109.465 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.542 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 8.0 m -122.82 147.18 46.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.215 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.9 mt -123.86 123.76 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -77.44 132.84 38.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -128.74 177.36 7.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 127.44 22.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -149.96 -179.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.087 0.955 . . . . 0.0 109.449 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.2 mm-40 -136.83 163.14 51.64 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.342 1.057 . . . . 0.0 108.358 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 2.7 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.205 2.604 . . . . 0.0 113.553 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.412 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.2 m -125.77 -6.44 6.82 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.976 0.807 . . . . 0.0 110.779 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -83.79 75.13 10.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 3.8 t -64.76 175.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.205 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.489 HG21 ' HE3' ' B' ' 27' ' ' LYS . 14.3 mm -50.49 -36.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.43 -21.78 65.54 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.325 0.966 . . . . 0.0 111.262 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -82.48 -41.85 19.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.69 -39.81 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.591 1.157 . . . . 0.0 110.134 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.489 ' HE3' HG21 ' B' ' 23' ' ' ILE . 95.8 mttt -56.09 -26.51 49.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.501 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.68 -27.76 45.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.421 0.555 . . . . 0.0 110.896 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -68.66 -33.01 73.26 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.01 -28.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.07 -39.74 82.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 122.298 -0.251 . . . . 0.0 110.329 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.63 -30.17 68.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 111.592 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -82.83 -23.7 33.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.937 0.895 . . . . 0.0 113.363 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -137.34 -35.82 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.27 9.13 13.58 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.19 127.11 84.18 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 153.18 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.558 2.172 . . . . 0.0 111.184 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.43 -16.03 42.7 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.459 2.772 . . . . 0.0 110.314 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -80.9 -6.32 58.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.769 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -121.46 -21.61 6.21 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.99 162.95 13.04 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.109 0.868 . . . . 0.0 112.998 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -152.08 127.63 10.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.406 ' C ' HD13 ' B' ' 44' ' ' ILE . 37.1 tp -127.29 132.21 50.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.957 0.344 . . . . 0.0 110.522 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.406 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -130.6 148.86 33.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 109.16 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -151.7 143.5 23.72 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.098 0.959 . . . . 0.0 109.36 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 12.48 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.772 0.829 . . . . 0.0 112.427 -172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 16.39 41.69 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.211 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.3 159.51 36.72 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.71 1.255 . . . . 0.0 110.16 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -96.08 129.26 43.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.679 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.477 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 13.6 mt -81.46 162.23 23.37 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.755 -174.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -127.48 147.76 50.31 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.445 0.64 . . . . 0.0 111.82 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.45 0.34 8.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.361 1.065 . . . . 0.0 111.691 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.18 13.53 31.2 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -118.57 -149.64 0.44 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.306 1.042 . . . . 0.0 108.942 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.466 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.19 157.17 41.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 125.747 1.619 . . . . 0.0 108.65 176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -60.56 -25.11 65.94 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -72.74 -25.21 61.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.365 1.066 . . . . 0.0 111.482 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.7 -14.68 60.35 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.342 0.657 . . . . 0.0 111.558 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -114.04 17.27 17.92 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 117.804 0.274 . . . . 0.0 110.344 175.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.54 27.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.304 1.442 . . . . 0.0 114.187 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 145.96 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -125.33 -177.42 3.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.498 0.719 . . . . 0.0 109.474 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -72.2 145.14 48.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.649 0.738 . . . . 0.0 112.086 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 58.61 16.58 4.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 111.449 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -65.23 -176.54 0.31 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.93 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -130.26 134.79 47.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.097 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -132.19 -177.03 4.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.246 1.419 . . . . 0.0 108.871 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -136.02 147.79 48.1 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.262 0.225 . . . . 0.0 110.564 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -132.73 138.94 47.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.064 0.946 . . . . 0.0 110.691 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 82.2 t -146.97 165.88 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -145.46 168.25 21.02 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.914 0.779 . . . . 0.0 112.34 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.83 175.92 3.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.435 1.094 . . . . 0.0 112.056 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tp -96.45 16.44 18.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.617 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 127.595 2.358 . . . . 0.0 114.066 -175.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 494' ' ' GLN . 86.0 Cg_endo -79.34 -167.27 0.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.86 3.707 . . . . 0.0 109.128 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 33.1 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.645 1.578 . . . . 0.0 112.837 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.9 pp0? -74.19 -28.76 61.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.445 0.698 . . . . 0.0 112.599 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.72 5.41 1.77 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.1 159.96 84.02 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 122.497 0.319 . . . . 0.0 110.668 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.0 151.07 21.72 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.535 3.49 . . . . 0.0 112.408 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -80.94 54.5 2.21 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 122.301 1.048 . . . . 0.0 109.989 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.48 28.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.833 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.52 165.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.595 0.758 . . . . 0.0 109.03 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.14 145.93 40.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.885 0.874 . . . . 0.0 108.676 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -59.79 -29.7 68.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -72.42 1.12 8.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.441 0.564 . . . . 0.0 111.642 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.53 16.54 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.22 0.608 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.81 -15.4 5.96 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.084 0.954 . . . . 0.0 109.498 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -77.85 1.5 20.21 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.95 -0.469 . . . . 0.0 111.635 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.12 3.05 40.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.95 0.5 . . . . 0.0 110.003 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.58 149.35 39.75 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.723 1.209 . . . . 0.0 109.606 -170.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.8 161.63 44.69 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.036 2.49 . . . . 0.0 110.768 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.92 -21.59 63.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.403 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.3 -6.23 59.26 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 117.823 0.283 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 44.6 mt -110.97 -17.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 172.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -55.63 -42.04 74.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.09 -13.63 62.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 111.589 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.24 -15.02 26.33 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.658 0.383 . . . . 0.0 111.344 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.8 -37.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.33 -6.96 5.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.434 0.694 . . . . 0.0 110.187 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 45.0 m -65.59 -28.27 69.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.526 -0.274 . . . . 0.0 111.134 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.4 39.16 2.65 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -61.85 -179.81 0.22 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.642 1.21 . . . . 0.0 112.418 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -149.01 -167.44 2.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.493 -1.685 . . . . 0.0 109.214 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.65 19.43 11.71 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.077 0.951 . . . . 0.0 111.975 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -142.82 145.99 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.511 0.724 . . . . 0.0 109.41 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.75 18.77 2.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.027 0.442 . . . . 0.0 111.927 -172.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.43 10.07 4.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.875 0.845 . . . . 0.0 109.671 -169.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 -179.063 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -158.1 174.23 15.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.954 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.36 175.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -124.4 117.9 25.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.37 101.73 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -82.35 134.36 35.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.898 0.479 . . . . 0.0 110.917 -173.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.412 ' C ' ' H ' ' B' ' 9' ' ' THR . 81.9 p -80.46 175.35 10.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.456 0.702 . . . . 0.0 111.649 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.91 3.67 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.261 1.025 . . . . 0.0 111.485 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.412 ' H ' ' C ' ' B' ' 7' ' ' THR . 76.5 p -119.87 9.24 11.25 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.732 -0.605 . . . . 0.0 111.787 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.26 25.51 57.09 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 120.088 -0.284 . . . . 0.0 113.133 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.81 140.65 52.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.64 158.59 25.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.117 0.484 . . . . 0.0 111.572 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.12 131.95 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 130.47 36.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -139.52 130.19 25.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.3 128.25 35.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.93 179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.596 0.758 . . . . 0.0 110.416 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.6 mm-40 -132.73 160.08 69.89 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.12 1.4 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.246 2.631 . . . . 0.0 113.304 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 18' ' ' GLU . 33.7 p -124.56 -3.66 7.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.823 0.849 . . . . 0.0 111.049 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.02 69.03 6.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.9 t -58.5 174.4 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.805 1.242 . . . . 0.0 110.722 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.633 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 16.9 mm -50.39 -31.01 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.26 -19.7 62.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.037 -1.04 . . . . 0.0 111.519 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -86.07 -45.76 11.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.504 0.722 . . . . 0.0 110.714 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.633 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.3 OUTLIER -66.6 -28.72 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 C-N-CA 122.686 0.395 . . . . 0.0 110.643 -176.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.533 ' HE3' HG23 ' B' ' 23' ' ' ILE . 90.5 mttt -56.59 -29.48 62.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.312 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.8 -29.16 40.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.246 0.475 . . . . 0.0 111.25 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.84 -34.28 73.42 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.951 0.341 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -85.92 -27.79 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -69.57 -39.49 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.01 -31.88 72.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.622 0.725 . . . . 0.0 111.172 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -83.05 -22.52 33.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.61 -31.71 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 8.46 17.63 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -76.77 127.53 83.85 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.52 157.67 58.21 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.759 2.306 . . . . 0.0 111.48 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.64 -13.78 37.95 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.722 2.948 . . . . 0.0 110.338 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.5 -8.13 58.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -126.28 -11.44 6.36 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.35 162.49 28.48 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.341 0.973 . . . . 0.0 111.785 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -154.84 125.73 7.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.433 ' C ' HD11 ' B' ' 44' ' ' ILE . 0.5 OUTLIER -122.41 139.63 53.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.005 0.366 . . . . 0.0 111.323 -168.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.433 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -134.4 150.93 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.789 1.235 . . . . 0.0 108.911 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -148.63 138.66 22.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.109 1.364 . . . . 0.0 109.05 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.5 13.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.72 0.808 . . . . 0.0 112.651 -174.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.89 15.07 40.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.077 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 157.2 42.64 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.004 1.402 . . . . 0.0 109.921 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -90.15 153.03 20.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.481 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 13.2 mt -109.53 161.94 14.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.197 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -128.49 144.27 51.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.253 0.549 . . . . 0.0 111.704 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.24 0.16 6.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.388 1.075 . . . . 0.0 111.7 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.71 11.7 32.6 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -114.69 -149.13 0.44 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.653 1.181 . . . . 0.0 108.775 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.4 p -154.5 158.49 39.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 125.807 1.643 . . . . 0.0 109.024 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.02 -29.29 68.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.64 -25.73 64.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.635 1.174 . . . . 0.0 111.723 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.11 -10.77 59.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.678 0.391 . . . . 0.0 111.054 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -117.39 17.19 14.67 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.33 13.57 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.7 143.99 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 119.027 0.831 . . . . 0.0 111.428 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 109.697 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.06 147.96 49.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.27 17.89 7.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.839 0.855 . . . . 0.0 112.068 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.5 t -70.98 175.05 5.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -132.39 133.88 44.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.479 0.712 . . . . 0.0 109.094 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.87 179.62 5.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.42 0.688 . . . . 0.0 110.045 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -134.07 138.67 45.47 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.615 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.72 137.87 48.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.666 1.186 . . . . 0.0 110.025 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -136.32 159.37 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pp -143.73 169.89 16.9 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.615 0.643 . . . . 0.0 112.733 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.17 -179.51 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 tp -126.87 18.31 7.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.898 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 . . . . . 0 N--CA 1.463 0.18 0 C-N-CA 127.412 2.285 . . . . 0.0 114.578 -173.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 494' ' ' GLN . 37.6 Cg_exo -59.09 -170.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 125.212 3.942 . . . . 0.0 112.041 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.15 29.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.809 1.243 . . . . 0.0 111.15 172.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -66.45 -34.74 78.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 112.953 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.48 11.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.841 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . 0.463 HD13 HE21 ' A' ' 502' ' ' GLN . 87.8 mt -76.81 161.0 75.46 Favored Pre-proline 0 N--CA 1.448 -0.572 0 O-C-N 122.028 -0.42 . . . . 0.0 109.975 175.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.62 155.19 5.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.293 3.329 . . . . 0.0 112.649 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.6 64.88 3.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 122.031 0.919 . . . . 0.0 112.138 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 161.3 -28.55 0.29 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.075 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.41 164.42 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -139.15 160.82 38.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.081 -0.387 . . . . 0.0 110.856 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.463 HE21 HD13 ' A' ' 496' ' ' LEU . 1.5 mp0 -59.44 -51.54 69.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.82 0.848 . . . . 0.0 108.737 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.65 3.73 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.167 -1.379 . . . . 0.0 113.262 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.56 15.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.523 0.601 . . . . 0.0 111.719 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.05 -17.8 5.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.438 1.095 . . . . 0.0 109.435 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 502' ' ' GLN . 55.6 mtmt -75.8 0.66 17.24 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 111.604 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.26 -7.82 58.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.3 mp -89.49 156.06 48.22 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.829 1.252 . . . . 0.0 109.777 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.88 167.65 25.79 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.703 2.935 . . . . 0.0 111.183 170.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.9 -16.3 49.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.806 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.09 -2.03 41.05 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.495 0.588 . . . . 0.0 111.913 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.08 -16.06 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -44.94 70.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.491 -0.756 . . . . 0.0 109.367 170.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.54 -0.97 22.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.22 0.608 . . . . 0.0 112.505 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -105.04 -17.53 14.47 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.535 0.607 . . . . 0.0 111.745 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.22 -27.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 520' ' ' LYS . 64.3 mt -74.48 -0.26 16.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.363 0.665 . . . . 0.0 110.892 172.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 44.8 m -136.03 24.76 3.3 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -142.55 -32.09 0.11 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 517' ' ' LEU . 51.0 mttt 43.96 26.52 0.14 Allowed 'General case' 0 C--N 1.339 0.139 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 169.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.8 t -148.98 173.15 13.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.32 11.6 2.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.131 1.372 . . . . 0.0 112.877 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -141.15 137.7 32.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.718 0.407 . . . . 0.0 110.255 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -150.4 23.68 0.81 Allowed 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.591 0.756 . . . . 0.0 109.778 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.28 8.28 3.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.181 0 C-N-CA 124.624 1.17 . . . . 0.0 112.539 -174.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.12 175.68 13.18 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.383 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 178.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.619 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 89.7 m-85 -134.84 99.22 4.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 110.0 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.22 133.27 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.12 134.03 53.03 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -79.52 178.18 8.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.35 1.46 . . . . 0.0 112.975 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.73 14.04 0.42 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.986 1.315 . . . . 0.0 110.499 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.0 p -132.29 11.96 4.58 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.272 -0.893 . . . . 0.0 112.095 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.05 66.62 Favored Glycine 0 C--N 1.338 0.643 0 O-C-N 122.287 -0.258 . . . . 0.0 112.745 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -120.79 142.33 49.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.619 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 23.5 m -115.63 144.8 43.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.99 126.82 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -78.17 136.98 37.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -146.16 133.15 20.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -92.86 128.74 38.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.84 178.24 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.222 1.009 . . . . 0.0 109.258 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' B' ' 20' ' ' SER . 36.1 mt-10 -143.77 163.95 33.0 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.44 4.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.397 2.732 . . . . 0.0 113.354 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.454 ' H ' ' C ' ' B' ' 18' ' ' GLU . 23.7 p -126.26 -12.41 6.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.705 0.802 . . . . 0.0 111.108 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.83 71.64 10.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.7 t -61.5 174.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.282 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.406 HG21 ' HE3' ' B' ' 27' ' ' LYS . 14.2 mm -50.25 -35.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -168.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -69.68 -22.32 63.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.421 1.009 . . . . 0.0 111.355 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -80.95 -36.49 30.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.475 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.8 t -67.13 -37.22 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 C-N-CA 123.936 0.894 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.406 ' HE3' HG21 ' B' ' 23' ' ' ILE . 97.6 mttt -61.01 -24.64 66.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.63 -23.51 53.34 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.49 0.586 . . . . 0.0 110.558 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.475 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.0 mmtt -72.99 -45.98 54.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.621 0.768 . . . . 0.0 109.282 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.04 -31.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -68.93 -38.65 79.63 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.431 0.292 . . . . 0.0 110.643 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.1 -30.29 68.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.314 0.578 . . . . 0.0 111.341 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -82.63 -22.88 34.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.73 -175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -138.71 -31.72 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.77 9.56 20.66 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -76.71 130.68 75.67 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.43 153.89 50.33 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.761 2.307 . . . . 0.0 111.045 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.35 -15.45 45.72 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.47 -13.95 60.41 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.803 0.441 . . . . 0.0 112.123 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -125.39 -16.11 5.98 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.26 165.52 18.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.609 1.095 . . . . 0.0 112.795 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -160.23 152.38 20.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 24.0 mt -135.67 146.86 48.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.033 0.379 . . . . 0.0 110.48 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 149.01 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.404 ' C ' ' H ' ' B' ' 47' ' ' GLY . 42.0 t80 -149.25 139.63 22.38 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 108.835 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 112.813 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 45' ' ' PHE . . . 99.4 13.76 37.55 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.593 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 160.71 32.38 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.457 1.128 . . . . 0.0 110.043 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -96.7 133.76 40.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.631 -170.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.25 164.06 20.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.652 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -136.82 153.71 50.72 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-O 121.475 0.655 . . . . 0.0 111.686 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -72.26 0.4 9.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.752 1.221 . . . . 0.0 111.667 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.83 13.73 26.97 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -116.08 -154.14 0.54 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.314 1.045 . . . . 0.0 109.388 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.2 p -148.44 158.34 44.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.71 1.604 . . . . 0.0 107.603 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.1 -24.9 68.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -74.2 -25.78 59.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.361 1.064 . . . . 0.0 111.892 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.68 -15.58 62.22 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.528 . . . . 0.0 111.3 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.9 24.13 7.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.315 0.646 . . . . 0.0 110.056 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 p30 47.87 20.49 0.23 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.111 1.764 . . . . 0.0 115.597 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.67 138.04 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.761 0.709 . . . . 0.0 110.188 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -128.41 -173.07 2.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.477 1.111 . . . . 0.0 110.033 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.68 141.74 58.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.801 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 54.68 22.11 3.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.381 1.072 . . . . 0.0 113.428 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -69.99 -15.37 63.02 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.7 m 57.97 133.71 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.984 2.114 . . . . 0.0 112.615 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -134.72 -177.69 4.73 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.327 1.451 . . . . 0.0 108.238 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -134.49 138.86 45.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.56 131.56 53.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.34 1.456 . . . . 0.0 110.133 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.03 159.63 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.12 165.98 26.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.791 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.23 153.94 29.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.0 109.995 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.74 23.25 6.37 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.691 1.596 . . . . 0.0 110.261 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? . . . . . 0 CA--C 1.523 -0.072 0 C-N-CA 127.053 2.141 . . . . 0.0 112.795 -170.203 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.559 ' C ' ' H ' ' A' ' 494' ' ' GLN . 40.5 Cg_exo -58.7 -171.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.861 3.707 . . . . 0.0 111.225 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 29.56 0.07 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.689 1.195 . . . . 0.0 110.622 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -64.09 -36.89 85.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.31 1.044 . . . . 0.0 112.814 -174.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.63 3.31 1.46 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.88 155.01 92.68 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.85 151.83 7.8 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.917 3.078 . . . . 0.0 111.646 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -75.23 69.1 2.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.961 0.886 . . . . 0.0 112.634 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 162.51 -29.27 0.27 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.03 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.0 165.27 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.604 0.762 . . . . 0.0 109.568 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.78 145.73 36.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.507 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.16 -28.07 67.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.45 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.33 0.72 11.26 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.605 -0.684 . . . . 0.0 111.717 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.25 16.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.359 0.599 . . . . 0.0 110.603 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -17.49 5.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.714 1.206 . . . . 0.0 109.223 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.31 3.3 7.55 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.881 -0.512 . . . . 0.0 111.65 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -85.57 -6.16 59.2 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 508' ' ' LEU . 2.7 mp -93.15 155.91 40.72 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.329 1.451 . . . . 0.0 109.704 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.74 167.58 26.89 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.02 2.48 . . . . 0.0 111.547 170.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.27 -17.54 53.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.431 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.15 3.74 51.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.545 0.338 . . . . 0.0 111.767 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.87 -14.71 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.0 -41.47 67.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.02 -1.1 30.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.628 0.771 . . . . 0.0 112.375 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.93 -18.65 14.95 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.387 0.539 . . . . 0.0 111.306 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.02 -31.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.38 -3.77 15.59 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.806 0.443 . . . . 0.0 110.495 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.3 m -131.99 10.86 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 111.41 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.48 -44.8 1.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 83.3 mttt 49.77 6.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 33.8 t -161.81 179.55 8.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.351 0.523 . . . . 0.0 109.963 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 70.43 3.04 4.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.116 1.766 . . . . 0.0 112.912 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -154.23 155.14 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.181 0.515 . . . . 0.0 110.931 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -145.55 29.12 1.15 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.54 6.95 4.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 109.851 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.457 -0.095 0 C-N-CA 125.091 1.357 . . . . 0.0 112.119 -176.636 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -158.84 176.04 12.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.867 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.66 177.42 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.3 115.54 17.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.51 126.06 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.0 ttmt -101.94 136.87 41.02 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.022 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.466 ' C ' ' H ' ' B' ' 9' ' ' THR . 73.5 p -86.74 178.66 6.95 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.104 0.962 . . . . 0.0 112.386 -171.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.0 12.96 0.17 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.981 1.312 . . . . 0.0 110.377 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.466 ' H ' ' C ' ' B' ' 7' ' ' THR . 28.1 p -126.26 5.68 7.05 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.165 -0.96 . . . . 0.0 111.758 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.57 62.3 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.592 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -125.85 140.44 52.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.493 0.646 . . . . 0.0 110.006 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -106.28 158.47 16.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.097 -175.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.24 125.89 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 19.8 m -75.41 132.28 40.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.4 mt -141.95 131.14 23.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.62 127.87 35.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.42 -179.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.777 0.831 . . . . 0.0 109.731 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.9 mt-10 -143.82 164.72 28.36 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 123.874 0.869 . . . . 0.0 108.921 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.432 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 32.9 Cg_exo -56.07 1.05 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.169 3.246 . . . . 0.0 113.449 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.7 m -131.78 -7.06 3.59 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.782 0.719 . . . . 0.0 111.651 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.73 72.14 7.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.6 t -62.82 175.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.704 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.4 -34.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.16 -23.81 63.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.726 1.148 . . . . 0.0 111.139 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -81.12 -38.33 27.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.471 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 81.8 t -66.85 -37.88 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 123.695 0.798 . . . . 0.0 109.867 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -61.99 -23.52 66.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.039 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 -22.68 52.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.459 0.572 . . . . 0.0 110.541 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.471 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 64.7 mmtt -73.55 -48.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.62 0.768 . . . . 0.0 109.862 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.62 -30.8 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -69.46 -40.04 77.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.28 -0.262 . . . . 0.0 110.66 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.68 -30.76 70.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.463 0.649 . . . . 0.0 111.456 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -80.82 -25.1 38.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.926 -1.033 . . . . 0.0 113.449 -175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -138.03 -33.65 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.68 8.97 15.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.93 127.51 86.77 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.3 153.72 61.54 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.645 2.23 . . . . 0.0 110.693 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.59 -17.88 48.41 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 110.885 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.69 -5.34 58.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.46 -15.52 6.61 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.27 165.86 17.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.682 1.128 . . . . 0.0 112.413 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.449 ' C ' HD12 ' B' ' 44' ' ' ILE . 15.8 mt -129.17 138.62 51.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 110.785 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.449 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.5 mp -131.91 148.33 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.432 1.093 . . . . 0.0 108.585 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.401 ' C ' ' H ' ' B' ' 47' ' ' GLY . 37.3 t80 -149.16 141.19 23.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.065 0.946 . . . . 0.0 109.228 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.65 12.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.752 0.821 . . . . 0.0 112.608 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 45' ' ' PHE . . . 97.51 14.63 40.37 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.458 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 158.84 37.98 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.833 1.316 . . . . 0.0 109.964 173.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -95.82 132.83 40.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.812 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.481 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.5 mt -80.23 159.79 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.156 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -128.86 150.06 50.5 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.513 0.673 . . . . 0.0 111.901 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -66.63 -18.71 65.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.737 1.215 . . . . 0.0 111.944 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.19 15.18 63.52 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -122.86 -151.56 0.48 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.429 1.091 . . . . 0.0 109.67 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 34.2 p -154.67 161.27 41.63 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.138 1.375 . . . . 0.0 108.881 174.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.54 -28.44 67.1 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.614 0.188 . . . . 0.0 111.226 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 31.0 t -75.47 -25.56 57.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.741 0.416 . . . . 0.0 110.736 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.45 -12.96 62.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.471 0.308 . . . . 0.0 111.369 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -116.39 19.45 14.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 p30 49.14 20.27 0.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.71 144.67 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 118.036 0.38 . . . . 0.0 110.043 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -130.14 -176.76 4.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.035 0.934 . . . . 0.0 109.963 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.93 146.8 54.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.24 16.82 7.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.298 1.039 . . . . 0.0 112.415 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -70.56 175.08 5.1 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -129.6 132.37 46.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.704 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -130.61 -177.1 4.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.473 1.109 . . . . 0.0 108.782 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -135.32 136.94 41.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -124.16 131.87 53.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 0.0 109.566 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -142.65 166.13 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.84 172.39 13.4 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.12 178.71 5.79 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.257 1.023 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.503 HD22 ' H ' ' B' ' 73' ' ' LEU . 0.9 OUTLIER -132.42 17.97 4.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.327 1.451 . . . . 0.0 109.041 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 . . . . . 0 CA--C 1.53 0.185 0 C-N-CA 128.499 2.72 . . . . 0.0 115.645 -169.444 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 494' ' ' GLN . 85.6 Cg_endo -77.04 -162.95 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 1 C-N-CA 125.341 4.027 . . . . 0.0 108.969 175.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -67.68 25.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.0 pp0? -66.3 -24.44 66.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.66 1.184 . . . . 0.0 112.75 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.01 7.11 1.6 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . 0.456 ' CD2' HE21 ' A' ' 502' ' ' GLN . 7.8 mp -61.72 160.34 27.93 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 158.36 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 124.011 3.141 . . . . 0.0 111.549 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.18 66.89 3.88 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.849 0.833 . . . . 0.0 112.695 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 156.44 -23.94 0.51 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.54 168.04 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.679 0.792 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.9 157.11 45.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.677 0.791 . . . . 0.0 110.563 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.456 HE21 ' CD2' ' A' ' 496' ' ' LEU . 35.6 mm-40 -61.19 -46.77 89.12 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.135 0.574 . . . . 0.0 110.692 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.94 7.87 0.84 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.63 10.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.425 0.69 . . . . 0.0 111.257 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.84 -10.54 7.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.668 0.787 . . . . 0.0 109.936 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.52 17.7 4.39 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 111.339 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -89.53 6.35 41.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.645 0.778 . . . . 0.0 110.95 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.31 62.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.925 0.89 . . . . 0.0 110.938 -170.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.35 166.4 23.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.303 3.335 . . . . 0.0 113.028 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . 0.412 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -26.69 63.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.043 0.937 . . . . 0.0 111.832 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.07 -4.8 49.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.316 0.246 . . . . 0.0 111.447 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.14 -12.88 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.253 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.412 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 26.5 mm-40 -56.02 -40.73 73.86 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.64 -14.12 62.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.374 0.67 . . . . 0.0 112.412 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -89.96 -21.5 22.4 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.201 0.455 . . . . 0.0 111.464 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.2 mp -102.43 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 53.0 mt -65.97 -0.05 2.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 516' ' ' ILE . 50.1 m -133.76 17.58 3.89 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.792 1.237 . . . . 0.0 110.126 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -98.74 35.92 4.34 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.376 0.989 . . . . 0.0 111.38 -177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 0.37 0.06 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -177.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.9 t -149.56 173.05 14.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.497 0.719 . . . . 0.0 110.069 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.9 OUTLIER 63.11 7.49 2.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.14 1.776 . . . . 0.0 113.682 -178.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -155.39 150.88 27.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.385 0.539 . . . . 0.0 111.576 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.06 35.65 1.11 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.596 1.158 . . . . 0.0 109.383 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.62 4.46 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.122 0.969 . . . . 0.0 110.765 -172.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.87 1.268 . . . . 0.0 111.969 -176.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.637 0.256 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.75 174.75 14.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.831 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.29 -178.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 123.768 0.827 . . . . 0.0 109.029 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -134.83 106.23 6.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -97.45 112.79 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -92.62 129.81 38.44 Favored 'General case' 0 C--O 1.23 0.047 0 O-C-N 122.258 -0.276 . . . . 0.0 111.392 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.474 ' C ' ' H ' ' B' ' 9' ' ' THR . 74.4 p -78.65 177.89 8.26 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.591 1.156 . . . . 0.0 112.354 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.88 17.78 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.947 1.299 . . . . 0.0 110.425 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.474 ' H ' ' C ' ' B' ' 7' ' ' THR . 49.6 p -133.15 6.35 3.88 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 121.226 -0.921 . . . . 0.0 111.911 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.57 26.78 58.43 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 122.208 -0.307 . . . . 0.0 112.55 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -124.71 143.65 50.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.755 0.822 . . . . 0.0 108.877 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.12 159.12 26.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.585 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.02 130.4 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -79.63 131.9 36.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -143.4 133.56 24.4 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.754 0.252 . . . . 0.0 110.602 -173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -92.91 128.66 38.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.48 175.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.167 0.987 . . . . 0.0 109.534 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -135.49 160.84 66.32 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 124.259 1.023 . . . . 0.0 109.108 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.33 3.67 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.585 2.857 . . . . 0.0 113.502 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.426 ' H ' ' C ' ' B' ' 18' ' ' GLU . 29.8 p -125.74 -6.7 6.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.861 0.864 . . . . 0.0 110.874 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -86.5 78.6 9.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.3 t -63.59 172.19 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.811 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.573 HG12 ' HH ' ' B' ' 59' ' ' TYR . 16.6 mm -55.05 -27.59 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -67.68 -20.24 65.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 120.644 -1.285 . . . . 0.0 110.645 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.67 -45.25 12.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 110.167 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 3.1 m -66.36 -33.52 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 123.193 0.597 . . . . 0.0 110.93 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.446 ' HE3' HG21 ' B' ' 23' ' ' ILE . 95.0 mttt -56.77 -32.11 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.862 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -27.39 46.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.251 0.478 . . . . 0.0 110.924 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -67.57 -32.59 73.45 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.187 0.449 . . . . 0.0 109.932 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -83.91 -31.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.17 -39.97 86.53 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.8 0.334 . . . . 0.0 110.273 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.18 -31.41 71.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.206 0.527 . . . . 0.0 111.183 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.6 -24.79 31.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.663 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -135.31 -35.04 0.84 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.83 7.86 16.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -77.87 128.26 79.65 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.57 154.8 55.09 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.053 2.502 . . . . 0.0 111.373 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.63 -14.41 41.92 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.352 2.701 . . . . 0.0 110.227 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.52 -8.02 59.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.84 -18.79 5.46 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.26 162.15 20.68 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.517 1.053 . . . . 0.0 112.167 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -151.58 136.15 17.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.416 ' C ' HD13 ' B' ' 44' ' ' ILE . 41.2 tp -134.18 136.23 43.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.241 0.473 . . . . 0.0 111.141 -168.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.416 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -132.52 150.74 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.266 1.026 . . . . 0.0 108.909 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -150.47 143.1 24.54 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.468 1.107 . . . . 0.0 109.287 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.94 13.42 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.545 0.738 . . . . 0.0 112.585 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.26 15.77 43.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.32 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 158.97 40.16 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.653 1.226 . . . . 0.0 109.966 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -90.74 150.32 21.67 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.811 -172.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.501 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -106.93 162.7 13.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.162 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -133.1 148.5 52.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.091 0.948 . . . . 0.0 112.542 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.51 -1.81 9.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.284 1.034 . . . . 0.0 111.905 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.47 6.2 33.71 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -107.65 -147.97 0.41 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.367 0.584 . . . . 0.0 109.699 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.2 p -152.13 155.94 38.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.85 2.06 . . . . 0.0 107.743 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.31 -24.04 67.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.185 0.448 . . . . 0.0 110.05 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -71.19 -25.32 62.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.25 1.02 . . . . 0.0 111.494 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.11 -13.99 60.19 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.101 0.56 . . . . 0.0 111.531 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.573 ' HH ' HG12 ' B' ' 23' ' ' ILE . 0.2 OUTLIER -115.06 20.7 14.83 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.29 21.21 0.34 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.83 140.11 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-O 121.213 0.53 . . . . 0.0 110.271 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.39 -173.93 3.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.912 1.285 . . . . 0.0 109.343 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.86 142.97 58.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.081 0.467 . . . . 0.0 110.717 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 54.29 25.26 5.71 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.173 0.989 . . . . 0.0 113.11 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.52 -15.44 60.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 60.11 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.34 1.856 . . . . 0.0 112.955 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.61 -178.12 4.86 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.377 1.471 . . . . 0.0 108.719 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -135.54 120.78 18.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.519 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 35.8 tp -103.25 136.03 43.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.729 1.212 . . . . 0.0 110.088 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.67 169.29 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.75 170.1 18.96 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.416 -0.803 . . . . 0.0 111.566 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.23 -177.2 5.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.795 0.838 . . . . 0.0 110.644 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.59 18.34 3.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 128.374 2.67 . . . . 0.0 114.799 -169.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.557 ' C ' ' H ' ' A' ' 494' ' ' GLN . 58.5 Cg_endo -84.63 -159.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 1 C-N-CA 125.575 4.184 . . . . 0.0 108.073 174.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.14 27.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.557 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.0 pp0? -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 0.0 113.084 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.54 5.92 1.84 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . 0.475 ' CD2' HE21 ' A' ' 502' ' ' GLN . 6.0 mp -60.85 138.48 93.66 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.17 159.99 11.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.793 2.995 . . . . 0.0 111.387 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.16 56.76 2.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.174 0.988 . . . . 0.0 109.903 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 176.24 27.75 0.03 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.423 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.95 162.34 13.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 124.128 0.971 . . . . 0.0 108.498 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.07 156.6 47.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 110.259 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.475 HE21 ' CD2' ' A' ' 496' ' ' LEU . 32.3 mm-40 -59.52 -40.64 87.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.055 0.542 . . . . 0.0 109.893 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.36 1.56 2.16 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.25 13.51 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 122.039 -0.413 . . . . 0.0 111.202 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.446 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.4 OUTLIER -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.288 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -73.66 -8.11 54.66 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.689 -0.632 . . . . 0.0 110.474 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.18 -5.74 58.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.544 1.138 . . . . 0.0 110.206 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 48.1 mt -87.1 155.81 54.92 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 123.976 0.91 . . . . 0.0 109.934 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.7 162.52 37.57 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.879 2.386 . . . . 0.0 110.811 169.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.09 -15.5 23.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.513 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -96.9 0.88 49.77 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.092 0.405 . . . . 0.0 111.343 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.2 mt -114.97 -19.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.081 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -48.89 -54.59 14.76 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.38 -11.72 3.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . 0.418 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 7.8 mm-40 -91.8 -25.28 19.09 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.103 0.41 . . . . 0.0 110.498 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.424 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 3.3 mm -95.72 -38.06 8.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 118.364 0.529 . . . . 0.0 109.691 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -10.66 58.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 22.7 t -63.97 -55.78 19.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.359 0.664 . . . . 0.0 110.847 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 135.21 133.96 3.32 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 516' ' ' ILE . 59.3 mttm -143.14 158.43 43.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.088 0.955 . . . . 0.0 109.127 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.2 m -146.88 30.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.22 1.008 . . . . 0.0 113.003 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.34 15.78 2.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.973 1.309 . . . . 0.0 111.631 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 523' ' ' GLU . 1.0 OUTLIER -139.08 151.8 47.03 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.218 1.007 . . . . 0.0 109.441 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 526' ' ' LYS . 20.7 m-80 -148.59 27.97 0.89 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.3 0.64 . . . . 0.0 111.459 -171.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.276 3.9 pp 48.13 12.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.722 1.609 . . . . 0.0 114.041 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 524' ' ' ASN . 33.9 mtmm . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 126.334 1.854 . . . . 0.0 111.606 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -158.8 174.08 15.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.166 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.58 179.22 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.45 99.62 4.72 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.55 124.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.1 ttmt -108.41 135.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.025 0.44 . . . . 0.0 111.455 -173.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -72.58 171.83 11.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.208 1.003 . . . . 0.0 112.436 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.58 -1.66 3.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.791 1.236 . . . . 0.0 110.336 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.9 p -115.93 -5.76 12.02 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.725 -0.609 . . . . 0.0 112.567 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.89 19.59 14.8 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.549 -0.584 . . . . 0.0 113.89 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -121.17 137.55 54.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.835 0.817 . . . . 0.0 109.744 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.4 OUTLIER -106.86 159.67 16.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.05 -174.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.72 127.22 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -78.67 132.84 37.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -143.96 132.98 22.8 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.655 0.264 . . . . 0.0 110.392 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.01 128.66 37.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 179.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.493 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.0 mm-40 -131.57 160.09 68.9 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.65 1.07 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.129 2.553 . . . . 0.0 113.5 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.6 m -125.27 -2.21 7.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.609 0.641 . . . . 0.0 111.067 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -80.25 68.04 6.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 2.9 t -57.4 173.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.877 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.625 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 14.1 mm -51.89 -28.29 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -168.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -73.37 -19.93 60.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.512 1.051 . . . . 0.0 111.435 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -85.35 -45.6 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.611 0.764 . . . . 0.0 110.834 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.625 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.1 OUTLIER -66.46 -28.31 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 122.667 0.387 . . . . 0.0 110.521 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.519 ' HE3' HG21 ' B' ' 23' ' ' ILE . 90.1 mttt -58.11 -29.9 65.86 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.862 172.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.95 41.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.957 0.344 . . . . 0.0 111.042 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.46 -31.19 71.78 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.074 0.397 . . . . 0.0 109.99 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.14 -30.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.65 -40.03 84.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.792 0.33 . . . . 0.0 110.204 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.72 -32.72 74.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.3 0.571 . . . . 0.0 111.223 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -82.02 -24.46 35.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.98 -34.52 0.8 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.08 8.12 15.73 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.5 mt -75.7 128.9 82.79 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.56 152.79 70.38 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.664 2.243 . . . . 0.0 111.071 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.98 -15.3 36.23 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.379 2.719 . . . . 0.0 110.566 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.84 -7.97 59.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -124.23 -15.72 6.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -65.52 164.9 13.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.139 0.881 . . . . 0.0 112.299 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -152.89 135.42 15.18 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' HD11 ' B' ' 44' ' ' ILE . 36.7 tp -131.83 138.11 48.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 118.568 0.622 . . . . 0.0 110.917 -168.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.407 HD11 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -134.93 149.18 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.306 1.043 . . . . 0.0 109.047 -172.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -153.2 146.57 24.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.016 0.926 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 15.2 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.195 0.598 . . . . 0.0 111.848 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.39 56.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.417 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 158.4 40.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.535 1.167 . . . . 0.0 109.87 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.92 144.47 26.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.721 -1.127 . . . . 0.0 107.98 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 17.2 mt -101.33 159.5 15.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.767 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -125.32 144.97 50.24 Favored 'General case' 0 CA--C 1.524 -0.054 0 CA-C-O 121.357 0.599 . . . . 0.0 112.085 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.64 -0.66 7.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.555 1.142 . . . . 0.0 111.827 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.76 11.57 38.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.79 -149.19 0.44 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 109.298 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.501 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -153.17 157.91 41.0 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.861 1.665 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.81 -28.96 69.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -68.4 -26.04 65.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.828 1.251 . . . . 0.0 111.779 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -75.13 -12.12 60.24 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.057 0.543 . . . . 0.0 111.603 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.29 17.74 14.62 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.89 27.39 1.59 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.637 1.575 . . . . 0.0 114.408 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.84 141.24 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -129.81 -174.03 3.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.696 1.199 . . . . 0.0 109.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.39 143.56 57.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.642 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 54.35 24.3 5.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.924 0.89 . . . . 0.0 113.244 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -72.4 -16.81 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.0 m 60.0 132.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.316 1.846 . . . . 0.0 112.674 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.62 -179.7 5.62 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.709 1.204 . . . . 0.0 108.776 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -135.64 122.51 21.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 110.72 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.09 140.46 36.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.107 1.363 . . . . 0.0 110.064 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.87 162.86 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.86 171.66 16.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.658 -0.651 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -91.25 174.9 7.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.429 0.692 . . . . 0.0 110.116 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.14 25.5 8.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.518 0.727 . . . . 0.0 110.268 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 113.61 -178.4 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 494' ' ' GLN . 71.6 Cg_endo -76.72 -167.1 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 1 C-N-CA 125.686 4.258 . . . . 0.0 109.862 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 32.09 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.866 1.267 . . . . 0.0 112.737 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -69.63 -35.39 75.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.73 4.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.351 0.661 . . . . 0.0 112.123 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 99.0 mt -68.98 160.98 75.78 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 122.755 0.422 . . . . 0.0 109.923 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.62 147.77 38.09 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.785 2.99 . . . . 0.0 111.642 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.83 54.69 1.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.292 1.044 . . . . 0.0 110.257 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.67 25.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.165 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 45.0 t -136.47 162.02 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 118.357 1.079 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -121.67 143.65 49.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.264 0.626 . . . . 0.0 109.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.41 ' N ' HE21 ' A' ' 502' ' ' GLN . 0.0 OUTLIER -68.96 -32.44 72.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.645 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.87 10.63 1.73 Allowed 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.303 -0.873 . . . . 0.0 110.575 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 83.1 t -129.86 8.52 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.585 1.154 . . . . 0.0 109.827 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.37 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.247 -0.908 . . . . 0.0 112.738 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -69.47 -9.15 52.51 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.479 -0.763 . . . . 0.0 112.1 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -80.74 -11.0 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.945 0.339 . . . . 0.0 110.803 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.21 150.59 68.27 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.125 0.97 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.37 163.38 26.83 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.565 2.177 . . . . 0.0 111.165 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.54 -23.59 64.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.287 0.635 . . . . 0.0 112.117 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.66 -1.22 56.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 122.352 0.261 . . . . 0.0 111.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 33.1 mt -117.44 -13.88 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -55.24 -43.56 74.67 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.81 -5.74 40.15 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.387 0.675 . . . . 0.0 112.469 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.63 -17.41 17.04 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.254 0.479 . . . . 0.0 111.967 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.3 mp -103.77 -28.47 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.61 -3.8 2.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.891 0.476 . . . . 0.0 110.049 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 516' ' ' ILE . 52.5 m -137.24 17.51 2.97 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.725 1.21 . . . . 0.0 110.709 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -115.34 43.8 1.61 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.67 0.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.0 t -145.23 178.23 8.23 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.514 0.726 . . . . 0.0 110.232 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.21 2.03 3.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.822 1.649 . . . . 0.0 112.958 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.42 141.2 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.175 0.443 . . . . 0.0 110.726 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 526' ' ' LYS . 34.4 m-80 -144.18 36.67 1.24 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.429 0.692 . . . . 0.0 110.244 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.335 0.5 OUTLIER 56.84 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.387 1.875 . . . . 0.0 114.715 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.547 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 C-N-CA 125.082 1.353 . . . . 0.0 110.352 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.277 0.084 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -157.2 173.23 17.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.05 179.98 3.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 123.823 0.849 . . . . 0.0 109.114 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -131.93 101.29 5.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.51 104.62 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -90.99 135.59 33.64 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.675 0.39 . . . . 0.0 112.02 -172.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.7 p -77.62 173.1 12.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.634 0.774 . . . . 0.0 111.973 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.94 -22.85 63.0 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.168 0.987 . . . . 0.0 110.321 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -94.61 -5.08 46.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.767 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.17 25.38 14.39 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.579 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -120.8 144.27 48.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.14 159.75 24.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 111.439 -173.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 mt -129.74 131.98 66.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 42.8 m -84.01 133.94 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.1 mt -145.39 138.29 26.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.26 127.3 44.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.9 176.73 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.069 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.0 mm-40 -135.54 161.87 60.56 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 108.795 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.63 1.59 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.293 2.662 . . . . 0.0 113.593 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.8 m -127.17 -5.89 6.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.586 0.63 . . . . 0.0 110.846 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -83.4 71.29 10.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.5 t -63.68 176.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.686 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.459 HG21 ' HE3' ' B' ' 27' ' ' LYS . 15.3 mm -51.55 -35.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -168.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.1 -20.71 65.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.296 0.953 . . . . 0.0 111.03 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -84.79 -42.73 14.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.49 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.382 1.073 . . . . 0.0 110.4 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.459 ' HE3' HG21 ' B' ' 23' ' ' ILE . 89.6 mttt -56.22 -23.61 36.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.945 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -27.11 31.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.35 0.523 . . . . 0.0 110.592 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.23 -36.43 77.2 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.052 0.387 . . . . 0.0 110.129 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -83.09 -32.43 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.07 -38.36 85.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.2 -32.56 72.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.295 0.569 . . . . 0.0 111.399 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -80.53 -24.75 39.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.205 1.002 . . . . 0.0 113.472 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.71 -31.26 0.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.58 9.44 23.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.06 131.24 76.14 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.51 157.57 61.28 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.427 2.085 . . . . 0.0 111.03 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.1 -11.07 30.8 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.868 3.045 . . . . 0.0 112.045 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.34 -5.5 29.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -126.11 3.54 7.18 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.5 -54.47 19.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 60.6 82.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.506 1.922 . . . . 0.0 110.919 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.418 ' C ' HD11 ' B' ' 44' ' ' ILE . 26.2 tp -90.1 137.09 32.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.573 1.149 . . . . 0.0 111.173 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.418 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.0 mp -133.42 149.93 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.551 1.14 . . . . 0.0 108.881 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -153.62 149.85 28.02 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.035 0.934 . . . . 0.0 109.378 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.17 16.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.626 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.38 56.42 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.124 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 160.5 37.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.449 1.125 . . . . 0.0 110.759 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.67 124.42 38.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.521 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.475 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -79.49 164.25 24.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.524 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -126.79 147.86 49.98 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.4 0.619 . . . . 0.0 111.89 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.13 -1.91 16.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.11 0.964 . . . . 0.0 111.996 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.09 14.64 44.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -120.29 -149.84 0.44 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.578 1.151 . . . . 0.0 108.988 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.95 156.84 39.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 126.068 1.747 . . . . 0.0 108.903 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -60.57 -24.41 65.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -73.31 -25.03 60.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 111.41 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -75.57 -14.07 60.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.161 0.584 . . . . 0.0 111.818 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.475 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -115.74 21.18 14.1 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 p30 49.49 19.46 0.37 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.7 138.66 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 121.338 0.589 . . . . 0.0 110.56 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -130.38 -177.52 4.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.966 1.306 . . . . 0.0 108.871 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -60.61 145.16 49.97 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.022 0.439 . . . . 0.0 110.778 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 55.66 22.78 5.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.212 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -74.4 -14.23 60.83 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 74.9 m 61.16 130.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.187 1.795 . . . . 0.0 112.11 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.88 -179.9 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.601 1.16 . . . . 0.0 108.687 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -135.59 152.77 51.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -140.14 138.47 35.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.464 1.106 . . . . 0.0 108.528 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.91 68.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.89 163.88 1.78 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -72.61 -168.75 0.47 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.319 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.97 17.38 23.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.5 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 . . . . . 0 N--CA 1.465 0.318 0 C-N-CA 127.155 2.182 . . . . 0.0 114.416 -175.385 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.435 ' H ' HD11 ' A' ' 491' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 494' ' ' GLN . 96.2 Cg_endo -81.31 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 1 C-N-CA 125.47 4.113 . . . . 0.0 109.023 178.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.93 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.326 1.85 . . . . 0.0 113.181 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.562 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.7 pp0? -71.75 -27.2 62.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.052 0.941 . . . . 0.0 112.291 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -150.17 4.41 0.54 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.75 142.87 94.49 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.253 0.479 . . . . 0.0 110.273 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.04 157.45 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.051 3.167 . . . . 0.0 111.226 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.12 57.41 2.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 122.52 1.153 . . . . 0.0 110.08 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.71 26.7 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.829 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.44 164.34 6.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.693 0.747 . . . . 0.0 109.156 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -134.45 144.0 47.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.0 109.419 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.0 -28.82 69.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.491 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -71.38 -0.9 11.28 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.694 -0.629 . . . . 0.0 111.824 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.84 18.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.0 OUTLIER -124.85 -20.93 4.86 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.24 1.016 . . . . 0.0 110.081 176.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -71.61 5.84 2.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -87.87 7.72 29.4 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.755 0.822 . . . . 0.0 110.578 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 39.1 mt -116.02 157.33 45.26 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 124.204 1.002 . . . . 0.0 111.258 -171.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.94 163.31 35.67 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.857 2.371 . . . . 0.0 110.373 167.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.19 -18.4 36.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.192 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.04 -4.93 58.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.103 0.561 . . . . 0.0 111.429 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.5 mt -117.32 -15.9 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -51.61 -50.72 59.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.86 -14.1 13.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.06 -18.35 27.47 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.641 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.5 mm -104.37 -40.93 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 505' ' ' PHE . 0.3 OUTLIER -64.62 -10.58 27.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.0 t -58.28 -35.71 72.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.113 0.565 . . . . 0.0 111.123 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 105.5 38.88 2.33 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -58.44 172.07 0.52 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.754 1.222 . . . . 0.0 111.912 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.4 m -146.37 34.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.759 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.6 15.63 4.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.745 1.218 . . . . 0.0 111.375 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.52 143.46 26.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.043 0.937 . . . . 0.0 109.176 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -148.77 38.4 0.83 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.217 0.607 . . . . 0.0 112.149 -168.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.41 19.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.804 1.642 . . . . 0.0 114.197 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -176.662 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.51 173.33 16.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.413 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.39 179.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 123.139 0.576 . . . . 0.0 109.774 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -133.18 106.28 7.49 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.43 69.39 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.908 0.483 . . . . 0.0 111.284 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -58.68 133.25 55.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.901 0.481 . . . . 0.0 111.519 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.39 175.58 10.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.59 -23.44 67.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.354 0.662 . . . . 0.0 110.228 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.2 p -89.32 -22.07 22.83 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.905 -0.497 . . . . 0.0 110.39 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.52 4.69 21.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.021 0.368 . . . . 0.0 114.021 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -83.57 153.81 24.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.97 159.17 38.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.742 0.701 . . . . 0.0 109.398 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.77 126.75 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m -79.26 129.96 34.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -140.59 133.36 28.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.21 129.22 39.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.43 178.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.864 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.1 mm-40 -132.66 161.5 63.0 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.964 0.906 . . . . 0.0 108.579 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.7 3.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.98 2.453 . . . . 0.0 113.429 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.434 ' H ' ' C ' ' B' ' 18' ' ' GLU . 59.8 m -125.79 -4.12 7.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.739 0.7 . . . . 0.0 110.825 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.1 76.92 10.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.2 t -62.34 171.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.8 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.439 HG22 ' HE3' ' B' ' 27' ' ' LYS . 12.2 mm -55.31 -28.04 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -168.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.1 -19.51 65.65 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.87 -1.144 . . . . 0.0 110.427 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -85.12 -46.11 11.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.853 0.861 . . . . 0.0 110.079 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 2.8 m -66.43 -34.48 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.118 0.567 . . . . 0.0 110.973 -173.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.439 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -56.33 -31.99 64.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.165 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.82 47.86 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.386 0.539 . . . . 0.0 110.856 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -68.1 -33.28 74.23 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.987 0.358 . . . . 0.0 110.086 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.77 -31.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.76 -39.4 87.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 -31.53 71.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.333 0.587 . . . . 0.0 111.275 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -83.95 -22.2 31.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -139.67 -30.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.53 8.26 19.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -76.17 128.56 82.56 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.67 154.8 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.493 2.128 . . . . 0.0 110.771 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.71 -14.19 38.71 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.543 2.829 . . . . 0.0 110.94 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.47 -6.21 58.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -118.99 -18.13 8.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.85 162.68 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.45 1.023 . . . . 0.0 112.339 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -155.03 128.76 8.62 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.36 128.73 36.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.893 0.315 . . . . 0.0 110.984 -168.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.77 155.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -120.96 -111.69 0.33 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 122.695 0.398 . . . . 0.0 110.685 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.85 -4.9 3.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.302 0.641 . . . . 0.0 111.689 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.97 1.69 2.0 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.596 1.093 . . . . 0.0 111.519 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 154.71 33.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.704 0.764 . . . . 0.0 109.554 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.97 129.95 35.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.348 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.466 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.0 mt -77.68 162.67 26.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.83 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -127.98 146.92 50.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.432 0.634 . . . . 0.0 111.706 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.45 -1.33 10.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.438 1.095 . . . . 0.0 111.798 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 16.05 35.13 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -121.34 -148.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.307 1.043 . . . . 0.0 109.45 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.458 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.3 p -152.36 156.19 39.08 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 126.257 1.823 . . . . 0.0 108.357 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.04 -23.99 66.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -71.88 -25.29 61.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.281 1.032 . . . . 0.0 111.545 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.43 -12.88 60.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.098 0.559 . . . . 0.0 111.515 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.09 20.77 13.61 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.7 25.21 0.4 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.12 142.4 16.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.171 0.51 . . . . 0.0 110.112 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -130.39 -173.47 3.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.058 1.343 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.89 142.54 58.24 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.0 110.409 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 55.92 21.2 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.252 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -71.85 -16.61 62.15 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 84.4 m 62.33 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.16 1.784 . . . . 0.0 112.226 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -145.47 -176.48 5.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.728 1.211 . . . . 0.0 108.708 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -136.48 104.98 5.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.37 129.77 36.23 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.694 0.798 . . . . 0.0 109.146 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.24 52.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.431 0.634 . . . . 0.0 109.378 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.85 168.88 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 114.209 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -94.47 172.28 8.29 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.498 0.719 . . . . 0.0 109.802 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.9 26.31 9.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.948 1.299 . . . . 0.0 111.734 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 124.376 1.07 . . . . 0.0 112.504 -174.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.565 ' C ' ' H ' ' A' ' 494' ' ' GLN . 87.6 Cg_endo -77.58 -167.61 0.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.95 3.766 . . . . 0.0 108.319 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -65.26 26.92 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -65.43 -28.91 69.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.471 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -148.09 6.39 0.78 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.79 159.38 85.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.59 155.0 22.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.853 3.035 . . . . 0.0 111.954 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -83.69 55.31 3.18 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 122.423 1.106 . . . . 0.0 109.509 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.74 26.5 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.995 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 86.4 t -146.74 164.35 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.49 143.13 45.66 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.036 0.934 . . . . 0.0 108.751 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.54 -24.11 67.03 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.852 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.94 1.84 4.09 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.737 -0.602 . . . . 0.0 111.601 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.53 11.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.672 0.789 . . . . 0.0 110.647 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -17.72 7.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.985 0.914 . . . . 0.0 109.875 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.72 3.15 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.957 -0.465 . . . . 0.0 111.345 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -88.65 -5.12 58.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -93.04 159.31 35.88 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.179 1.392 . . . . 0.0 110.128 -173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.22 165.48 31.81 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.295 2.663 . . . . 0.0 111.325 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.75 -12.51 10.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.027 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.5 1.17 40.81 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.058 0.543 . . . . 0.0 111.43 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 52.0 mt -119.16 -14.48 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -43.91 67.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 169.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.74 -4.42 37.43 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.424 0.689 . . . . 0.0 112.388 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -100.12 -21.64 15.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.501 0.591 . . . . 0.0 111.433 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.69 -34.41 4.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.64 -3.35 3.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.667 0.387 . . . . 0.0 110.516 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 41.5 m -137.44 18.32 2.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.361 0.664 . . . . 0.0 111.409 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.54 -39.51 5.29 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp 49.43 1.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.7 t -167.76 -172.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.981 0.809 . . . . 0.0 109.818 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 68.0 11.56 8.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.469 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -153.92 154.34 33.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.559 0.343 . . . . 0.0 110.854 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -149.72 46.93 0.94 Allowed 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.856 0.863 . . . . 0.0 110.795 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 1.1 pt? 44.14 19.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.961 1.704 . . . . 0.0 113.95 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.944 1.297 . . . . 0.0 112.625 -177.318 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -158.44 173.66 16.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.094 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.78 179.28 4.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -134.69 103.27 5.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.58 113.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.42 130.8 37.99 Favored 'General case' 0 N--CA 1.458 -0.052 0 O-C-N 122.205 -0.31 . . . . 0.0 111.222 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -72.3 174.37 7.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.417 1.087 . . . . 0.0 112.058 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.12 -5.02 8.56 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.073 0.949 . . . . 0.0 110.17 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -112.97 1.36 15.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.556 -0.715 . . . . 0.0 111.528 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.28 26.05 31.86 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.606 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -123.56 145.01 49.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.17 159.94 21.82 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.434 -174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -129.45 127.69 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -77.81 130.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -140.67 131.23 25.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.11 127.32 35.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.622 0.769 . . . . 0.0 108.998 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.1 178.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.183 0.993 . . . . 0.0 109.444 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.8 mt-10 -141.45 163.81 39.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.19 2.25 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.531 2.821 . . . . 0.0 113.62 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.433 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.7 m -129.42 -5.64 4.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.058 0.845 . . . . 0.0 111.215 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.89 68.32 9.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 9.2 t -61.25 179.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.921 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.433 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 11.4 mm -59.24 -11.91 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -168.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.85 -17.96 28.62 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.815 1.189 . . . . 0.0 110.483 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -85.02 -40.82 16.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.537 0.735 . . . . 0.0 109.993 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 20.4 m -64.36 -31.11 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 123.728 0.811 . . . . 0.0 110.155 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.53 -25.28 66.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.83 -26.44 29.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.314 0.507 . . . . 0.0 110.821 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -70.34 -36.5 74.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.096 0.407 . . . . 0.0 110.392 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -81.76 -30.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -68.16 -39.73 82.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.24 -31.21 71.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.246 0.545 . . . . 0.0 111.348 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -82.5 -24.2 34.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.57 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -136.77 -33.82 0.77 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 9.52 17.66 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.8 mt -76.64 129.87 78.15 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.83 156.1 61.18 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 111.055 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.1 -14.14 40.01 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.967 3.111 . . . . 0.0 110.804 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -90.45 -3.0 57.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -123.91 -11.81 7.59 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.88 167.64 21.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.103 0.865 . . . . 0.0 112.464 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -158.67 134.55 8.95 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.93 1.292 . . . . 0.0 108.002 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.446 ' C ' HD11 ' B' ' 44' ' ' ILE . 16.7 mt -126.47 141.49 51.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.531 0.333 . . . . 0.0 110.43 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.446 HD11 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -129.31 148.72 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -148.36 134.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.833 0.853 . . . . 0.0 109.009 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.93 19.87 0.71 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.556 0.742 . . . . 0.0 112.827 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.59 25.37 39.17 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 123.04 0.352 . . . . 0.0 112.749 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.607 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.8 ttmm -123.37 125.59 45.28 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.119 0.568 . . . . 0.0 110.756 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -76.57 110.8 11.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.531 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -68.63 171.11 8.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -174.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -132.52 152.85 51.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.676 0.751 . . . . 0.0 112.004 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.88 -1.82 15.67 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.455 1.102 . . . . 0.0 111.892 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.28 15.06 36.23 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -117.88 -154.7 0.57 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.326 1.05 . . . . 0.0 109.16 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.453 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.7 p -149.64 159.67 44.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.599 1.56 . . . . 0.0 107.9 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.62 -27.27 69.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -71.25 -25.75 62.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.34 1.056 . . . . 0.0 112.143 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.95 -16.94 61.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.828 0.451 . . . . 0.0 111.323 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.607 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.1 m-85 -128.64 26.87 5.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.187 0.595 . . . . 0.0 110.065 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.84 28.47 0.59 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.82 132.91 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.8 -173.11 3.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 109.747 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.12 142.24 37.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.093 0.473 . . . . 0.0 111.264 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 52.97 27.14 5.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.806 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.9 p -69.59 -24.96 63.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m 59.99 127.65 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.019 2.128 . . . . 0.0 112.161 -174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -131.29 -176.83 4.15 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.094 1.358 . . . . 0.0 108.238 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -135.56 135.26 40.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.93 135.16 55.0 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.748 1.219 . . . . 0.0 110.085 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -139.37 160.2 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.64 172.16 14.01 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.98 -177.19 5.7 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 123.968 0.907 . . . . 0.0 112.76 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tp -110.02 22.09 16.02 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.901 0.881 . . . . 0.0 111.422 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 126.809 2.044 . . . . 0.0 113.352 -174.675 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.1 Cg_endo -77.33 -165.47 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 125.113 3.875 . . . . 0.0 109.319 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.3 pt? -69.92 27.65 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 492' ' ' PRO . 4.2 pp0? -64.5 -25.91 68.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 0.0 111.785 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -149.88 4.8 0.57 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.88 162.16 74.8 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 122.105 -0.372 . . . . 0.0 110.561 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.61 151.42 31.39 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.183 3.255 . . . . 0.0 111.616 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.74 55.33 2.35 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 122.196 0.998 . . . . 0.0 109.939 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 168.93 31.33 0.02 OUTLIER Glycine 0 CA--C 1.527 0.816 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.019 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 49.0 t -141.86 165.03 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.801 0.801 . . . . 0.0 109.657 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.9 141.04 47.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.391 1.076 . . . . 0.0 109.306 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.17 -33.73 76.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.074 -177.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.76 5.2 3.33 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.54 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.9 11.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.513 0.725 . . . . 0.0 111.013 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.14 -13.68 8.92 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.835 0.854 . . . . 0.0 109.939 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -82.68 18.76 1.46 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.412 0.685 . . . . 0.0 111.921 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -94.46 7.69 44.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.542 0.737 . . . . 0.0 111.415 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 156.81 69.37 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.594 1.158 . . . . 0.0 110.495 -171.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.35 164.66 22.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.157 3.238 . . . . 0.0 113.054 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -59.11 -25.48 63.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.622 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.94 -6.56 51.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.47 0.308 . . . . 0.0 111.251 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 18.1 mt -118.1 -12.74 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 170.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 23.6 mm-40 -58.41 -39.7 80.46 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.84 -11.03 60.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.391 0.676 . . . . 0.0 112.204 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.69 -19.35 21.92 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.255 0.48 . . . . 0.0 111.553 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.3 mp -105.61 -27.18 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 65.7 mt -64.47 -2.96 2.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 516' ' ' ILE . 50.4 m -138.42 21.0 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.959 1.304 . . . . 0.0 110.024 173.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -107.23 46.64 1.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.476 1.036 . . . . 0.0 110.993 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -56.46 2.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.3 t -149.06 -175.95 5.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.468 0.651 . . . . 0.0 111.039 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 65.76 3.79 2.64 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.523 1.929 . . . . 0.0 114.652 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -155.36 148.58 24.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.1 0.864 . . . . 0.0 111.43 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 526' ' ' LYS . 37.1 m-80 -147.19 43.83 1.14 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.952 0.901 . . . . 0.0 111.116 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.298 3.2 pp 50.19 9.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.623 1.569 . . . . 0.0 114.051 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 524' ' ' ASN . 43.5 mtmt . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 127.752 2.421 . . . . 0.0 110.368 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.704 0.288 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.4 172.94 17.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.251 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.48 -177.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.597 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 96.2 m-85 -130.66 128.25 40.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.77 121.13 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.27 142.6 33.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -172.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -88.37 178.79 6.47 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.146 1.379 . . . . 0.0 112.912 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.97 6.47 1.54 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.839 1.255 . . . . 0.0 110.239 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -124.55 9.0 8.35 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.94 -1.1 . . . . 0.0 111.993 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.74 60.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 120.133 -0.259 . . . . 0.0 113.211 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -119.76 139.48 52.24 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.597 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 9.0 m -113.43 142.5 45.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.41 132.9 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -87.08 133.79 33.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 mt -142.6 135.04 27.78 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.47 130.3 37.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 109.086 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.57 179.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.788 0.835 . . . . 0.0 109.89 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' B' ' 20' ' ' SER . 35.4 mt-10 -140.21 163.46 43.77 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.86 2.92 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.463 2.775 . . . . 0.0 113.722 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.446 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.0 m -127.73 -7.1 5.63 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.771 0.714 . . . . 0.0 110.971 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.82 67.57 5.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.1 t -59.61 175.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.786 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.8 mm -49.94 -34.73 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.55 -21.39 61.89 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.363 0.983 . . . . 0.0 111.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -81.76 -37.21 27.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.46 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.5 t -64.77 -39.4 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.226 1.01 . . . . 0.0 109.862 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -59.04 -28.08 66.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.758 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -24.13 54.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.516 0.598 . . . . 0.0 110.6 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 69.1 mmtt -69.76 -44.54 69.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.528 0.731 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.12 -30.22 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.581 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.57 -40.74 80.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.29 -30.55 70.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.176 0.512 . . . . 0.0 111.352 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -85.63 -19.58 30.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.5 -40.01 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.361 0.528 . . . . 0.0 112.001 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.29 9.04 12.14 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.6 mt -79.18 128.53 75.62 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.34 151.98 66.08 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.76 2.306 . . . . 0.0 110.812 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.65 -15.48 41.2 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.251 2.634 . . . . 0.0 110.441 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -7.97 59.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.781 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -124.3 -13.39 7.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -69.96 165.18 22.28 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.619 1.1 . . . . 0.0 111.999 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -154.64 141.49 19.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.449 ' C ' HD13 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -135.95 139.48 43.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.567 0.621 . . . . 0.0 111.398 -169.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.449 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -130.85 148.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.751 0.82 . . . . 0.0 109.197 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -149.87 134.16 17.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.935 0.894 . . . . 0.0 108.867 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.3 19.98 0.86 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.59 0.756 . . . . 0.0 112.504 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 24.29 44.96 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 123.009 0.338 . . . . 0.0 112.55 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.609 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.7 ttmm -120.56 124.56 45.62 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 122.797 0.439 . . . . 0.0 110.432 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -75.93 108.79 9.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' B' ' 59' ' ' TYR . 1.0 OUTLIER -68.02 170.26 8.64 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.452 -174.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -132.49 153.64 50.7 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 121.64 0.733 . . . . 0.0 111.393 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.76 3.01 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.408 1.083 . . . . 0.0 111.769 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.96 16.8 20.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -118.25 -154.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.598 1.159 . . . . 0.0 109.087 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.466 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -148.88 159.58 44.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.304 1.442 . . . . 0.0 108.479 172.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.31 -27.62 69.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -25.2 60.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.361 1.064 . . . . 0.0 111.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.81 -18.88 61.42 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.302 0.641 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.609 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 22.9 m-85 -129.23 26.76 5.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.553 0.741 . . . . 0.0 109.991 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.27 31.01 0.74 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.18 125.12 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -131.18 -173.25 3.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.456 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.24 141.39 35.56 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 111.585 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.5 24.96 3.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.666 1.186 . . . . 0.0 113.627 174.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -70.67 -17.68 62.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m 59.41 130.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.17 2.188 . . . . 0.0 112.32 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -138.89 -178.34 5.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.392 1.077 . . . . 0.0 109.076 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.85 147.34 48.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.912 0.387 . . . . 0.0 111.275 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.5 tp -132.66 137.97 47.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.282 1.433 . . . . 0.0 110.033 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -143.84 165.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.37 170.56 15.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.876 0.762 . . . . 0.0 112.833 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.98 178.08 5.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.1 0.96 . . . . 0.0 111.377 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 21.54 15.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.008 -173.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 . . . . . 0 N--CA 1.463 0.217 0 C-N-CA 127.2 2.2 . . . . 0.0 114.183 -176.197 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.5 Cg_endo -80.25 -167.45 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.609 4.206 . . . . 0.0 108.905 174.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.03 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 112.972 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 492' ' ' PRO . 3.1 pp0? -76.83 -26.0 53.86 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.28 1.42 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . 0.443 HD22 HE21 ' A' ' 502' ' ' GLN . 6.5 mp -64.84 160.94 50.63 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.53 154.46 24.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.68 2.92 . . . . 0.0 110.851 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.8 66.41 5.27 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.845 0.831 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 164.22 -24.1 0.18 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.114 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.0 169.0 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.522 0.729 . . . . 0.0 110.281 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.42 153.91 51.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.716 0.806 . . . . 0.0 110.665 -175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.443 HE21 HD22 ' A' ' 496' ' ' LEU . 36.2 mm-40 -63.77 -43.73 95.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.51 8.36 0.85 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.024 0.53 . . . . 0.0 112.335 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . 0.466 ' CA ' HE21 ' A' ' 507' ' ' GLN . 19.1 m -138.2 9.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.13 0.572 . . . . 0.0 111.097 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -122.0 -20.69 6.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.336 0.654 . . . . 0.0 110.062 178.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.56 7.75 2.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.203 0.601 . . . . 0.0 111.927 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.466 HE21 ' CA ' ' A' ' 504' ' ' VAL . 14.5 mm-40 -84.29 8.63 15.36 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.996 0.918 . . . . 0.0 111.357 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.43 159.67 56.52 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 123.18 0.592 . . . . 0.0 112.215 -167.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.95 164.35 31.77 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.249 2.632 . . . . 0.0 110.567 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.89 56.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.914 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.74 -5.75 59.33 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.875 0.47 . . . . 0.0 111.691 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.51 -15.26 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -53.34 -41.66 66.0 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.337 -0.852 . . . . 0.0 108.863 169.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.29 -19.14 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.953 0.501 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -85.48 -21.51 28.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.888 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 518' ' ' SER . 2.6 mm -98.05 -31.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 118.916 0.78 . . . . 0.0 109.253 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.92 -0.97 2.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 110.078 172.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 516' ' ' ILE . 10.5 t -135.64 16.65 3.35 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.508 1.123 . . . . 0.0 110.63 177.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -100.98 38.43 3.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -1.65 0.11 Allowed 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -174.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.3 t -151.45 175.01 12.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.527 0.731 . . . . 0.0 109.919 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.48 3.78 3.0 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.701 1.6 . . . . 0.0 113.579 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.52 156.16 34.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.796 0.438 . . . . 0.0 111.04 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -156.64 27.1 0.33 Allowed 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.85 -0.27 1.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.997 0.919 . . . . 0.0 111.163 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -169.426 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.391 0.139 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.18 173.98 15.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.19 -178.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.263 1.025 . . . . 0.0 109.182 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.425 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 55.5 m-85 -133.21 86.94 2.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.485 0.66 . . . . 0.0 109.974 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -80.41 101.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.948 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.5 ttmt -85.51 140.58 30.55 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.843 0.457 . . . . 0.0 111.358 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -84.82 173.21 10.81 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.71 0.804 . . . . 0.0 111.575 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.23 -16.69 55.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.7 0.8 . . . . 0.0 110.88 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -97.47 -0.65 45.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.048 0.539 . . . . 0.0 110.538 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.67 25.98 26.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.094 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.505 ' HZ1' HG12 ' B' ' 13' ' ' ILE . 12.9 tmtt? -118.93 120.27 36.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.467 0.633 . . . . 0.0 110.491 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.8 OUTLIER -75.95 155.85 34.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.253 0.549 . . . . 0.0 110.947 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.505 HG12 ' HZ1' ' B' ' 11' ' ' LYS . 54.0 mt -133.26 112.78 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -71.65 133.87 45.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -150.23 136.53 18.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 122.309 0.243 . . . . 0.0 111.035 -174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.4 126.62 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.401 HG12 ' HE3' ' B' ' 29' ' ' LYS . 28.4 m -144.4 179.13 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.323 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.5 mm-40 -131.06 160.73 65.54 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.011 0.924 . . . . 0.0 108.803 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.19 0.6 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.769 2.98 . . . . 0.0 113.569 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.418 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.8 m -125.46 -4.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.662 0.664 . . . . 0.0 110.802 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -80.71 65.49 5.88 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -59.95 177.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.566 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.643 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 15.9 mm -52.93 -24.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 113.831 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.17 -19.73 50.21 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.694 1.134 . . . . 0.0 111.558 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.17 -44.08 13.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.613 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.643 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER -65.61 -26.22 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 123.046 0.539 . . . . 0.0 110.389 -177.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.443 ' HE3' HG21 ' B' ' 23' ' ' ILE . 91.2 mttt -59.97 -31.29 69.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 122.202 -0.311 . . . . 0.0 111.285 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.06 53.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.297 0.499 . . . . 0.0 110.597 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.401 ' HE3' HG12 ' B' ' 17' ' ' VAL . 3.9 mptp? -67.64 -36.06 80.06 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -85.57 -28.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -66.87 -39.04 87.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.39 -33.06 74.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.388 0.613 . . . . 0.0 111.386 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -83.14 -21.22 33.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -137.9 -34.59 0.67 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.511 0.596 . . . . 0.0 112.56 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.89 9.05 19.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.9 mt -77.29 130.37 74.97 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 153.85 67.55 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.47 2.113 . . . . 0.0 111.112 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.54 -15.97 38.22 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.321 2.68 . . . . 0.0 110.493 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.9 -7.82 59.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -124.03 -14.32 7.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -70.15 164.67 23.68 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 112.726 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -154.69 146.61 23.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.32 145.01 51.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.451 0.569 . . . . 0.0 111.001 -170.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.67 148.23 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.583 1.153 . . . . 0.0 108.385 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -149.14 138.91 21.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.354 1.062 . . . . 0.0 108.992 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.62 12.51 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.622 0.769 . . . . 0.0 112.669 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.03 14.19 40.31 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.524 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 159.88 33.76 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.622 1.211 . . . . 0.0 109.46 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -92.1 153.65 19.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.756 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.76 166.38 12.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -137.31 153.79 50.2 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.496 0.665 . . . . 0.0 112.191 -173.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.49 -1.89 12.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.449 1.1 . . . . 0.0 111.697 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 7.1 37.69 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.99 -154.51 0.53 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.906 0.883 . . . . 0.0 109.451 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 3.1 p -149.72 160.21 43.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.027 1.731 . . . . 0.0 107.823 173.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.63 -27.08 68.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -71.7 -26.71 62.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.92 1.288 . . . . 0.0 112.138 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.44 -15.81 61.82 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 122.749 0.419 . . . . 0.0 111.261 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -126.52 27.83 6.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.648 0.779 . . . . 0.0 109.699 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.91 28.2 0.34 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 171.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.75 140.4 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.525 0.602 . . . . 0.0 109.611 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -130.71 -174.52 3.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.602 1.161 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.81 144.29 56.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.66 21.72 3.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.861 0.865 . . . . 0.0 113.159 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -72.92 -17.32 61.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 75.4 m 61.41 139.47 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.326 1.851 . . . . 0.0 112.104 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -141.27 179.92 6.49 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.114 0.566 . . . . 0.0 109.505 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.49 139.27 43.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.405 0.282 . . . . 0.0 110.523 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.24 134.78 47.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 110.075 -172.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 52.4 t -142.13 168.47 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -142.74 170.46 15.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.975 -0.453 . . . . 0.0 111.676 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -66.78 168.47 9.54 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.595 0.758 . . . . 0.0 110.879 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.17 18.57 22.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.182 0.593 . . . . 0.0 110.591 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 127.506 2.322 . . . . 0.0 114.898 -177.742 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 491' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 494' ' ' GLN . 90.3 Cg_endo -78.89 -168.3 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 124.641 3.561 . . . . 0.0 107.711 170.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.08 31.56 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.666 1.586 . . . . 0.0 113.74 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -69.2 -32.45 71.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.944 0.897 . . . . 0.0 112.466 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.03 2.38 0.9 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 64.1 mt -71.8 150.11 92.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.99 158.49 17.24 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.779 2.986 . . . . 0.0 111.696 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.55 55.59 2.0 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 122.241 1.02 . . . . 0.0 109.673 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.41 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.094 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.31 166.14 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.762 0.825 . . . . 0.0 109.578 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -143.66 139.17 29.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.575 1.55 . . . . 0.0 107.08 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.65 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.97 -28.29 68.79 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.393 -177.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.67 3.91 5.74 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.338 -0.851 . . . . 0.0 111.161 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . 0.4 ' N ' HE22 ' A' ' 507' ' ' GLN . 27.3 m -137.23 17.36 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.472 1.109 . . . . 0.0 110.225 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.62 -19.41 1.38 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.466 0.706 . . . . 0.0 111.622 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -72.09 -0.31 11.46 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.371 -0.831 . . . . 0.0 112.649 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.4 HE22 ' N ' ' A' ' 504' ' ' VAL . 7.5 mp0 -95.95 -7.92 35.22 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.691 0.678 . . . . 0.0 109.851 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.38 159.91 78.8 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.06 163.72 37.46 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.974 2.449 . . . . 0.0 111.253 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -15.17 20.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.841 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -95.98 -1.31 49.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.552 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 54.9 mt -115.45 -16.99 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -41.75 66.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.8 -5.57 51.23 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 28.4 mm-40 -97.49 -24.1 15.74 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.806 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.4 -35.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.47 -8.0 23.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 15.3 t -72.76 -50.23 25.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.68 0.392 . . . . 0.0 111.468 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 144.37 141.91 3.82 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.841 -2.503 . . . . 0.0 106.841 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 515' ' ' GLU . 71.6 mmtt -149.36 176.73 10.3 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.931 0.893 . . . . 0.0 109.223 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -157.7 179.43 9.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.473 1.509 . . . . 0.0 108.868 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . 0.414 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.3 OUTLIER 60.83 21.73 11.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.461 1.104 . . . . 0.0 112.671 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -146.85 147.1 30.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.739 0.415 . . . . 0.0 110.247 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.6 m-80 -148.44 40.25 0.92 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.475 0.71 . . . . 0.0 110.902 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.286 4.4 pp 47.75 13.18 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.932 1.693 . . . . 0.0 114.228 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 524' ' ' ASN . 48.6 mtmt . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 126.411 1.884 . . . . 0.0 111.225 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.725 0.298 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -155.17 175.23 14.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.87 -177.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 123.958 0.903 . . . . 0.0 108.627 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.572 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 99.9 m-85 -136.36 97.72 3.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.268 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.61 135.16 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 35.5 ttmt -117.17 136.74 52.82 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.092 0.472 . . . . 0.0 111.742 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -73.12 173.84 8.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.737 1.215 . . . . 0.0 112.047 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.09 0.28 4.88 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.256 1.023 . . . . 0.0 110.792 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -118.27 -3.14 11.04 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.2 20.4 18.2 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.8 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -119.57 138.86 52.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.871 0.835 . . . . 0.0 109.86 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 6.3 m -111.41 152.38 27.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.012 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.75 131.6 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -86.37 135.05 33.66 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -146.36 134.23 21.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.696 0.225 . . . . 0.0 110.939 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.93 125.94 38.85 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.546 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.46 175.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.945 0.898 . . . . 0.0 109.872 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.5 mm-40 -135.36 163.05 53.69 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.318 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.54 1.7 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.466 2.777 . . . . 0.0 113.599 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 18' ' ' GLU . 71.0 m -127.05 -3.41 6.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.716 0.689 . . . . 0.0 110.997 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.25 75.27 8.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.0 OUTLIER -61.08 171.31 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.157 0.983 . . . . 0.0 110.178 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.449 HD13 ' CE2' ' B' ' 59' ' ' TYR . 13.0 mm -54.37 -28.3 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.64 -18.72 65.06 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.836 -1.165 . . . . 0.0 110.487 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -86.33 -45.93 10.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.132 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 3.4 m -66.34 -33.79 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 122.664 0.386 . . . . 0.0 110.989 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.43 ' HE3' HG23 ' B' ' 23' ' ' ILE . 93.8 mttt -56.26 -32.98 65.01 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.855 172.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.18 -27.88 53.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.995 -0.441 . . . . 0.0 110.948 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -67.08 -32.05 72.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.26 -31.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.99 89.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.91 -31.9 71.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.271 0.558 . . . . 0.0 111.231 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -84.1 -22.47 31.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -135.96 -36.2 0.76 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.89 8.3 15.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.3 129.63 74.45 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.75 152.52 69.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.632 2.221 . . . . 0.0 110.842 -176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.41 -15.22 41.7 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.23 2.62 . . . . 0.0 110.73 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.01 -6.86 59.47 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -125.32 -11.51 6.9 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.37 165.0 25.4 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.518 1.054 . . . . 0.0 112.208 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -153.59 142.56 21.2 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp -136.14 138.41 41.97 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.128 -0.358 . . . . 0.0 110.711 -168.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mp -133.43 150.23 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.188 0.995 . . . . 0.0 108.87 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -148.5 139.12 22.79 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.542 1.137 . . . . 0.0 109.092 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 10.41 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.713 0.805 . . . . 0.0 113.034 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.66 12.14 36.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.675 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.14 159.88 32.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.632 1.216 . . . . 0.0 109.651 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -95.61 138.5 33.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.903 0.881 . . . . 0.0 108.753 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.7 157.13 16.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -125.22 148.69 48.53 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 121.433 0.635 . . . . 0.0 112.164 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.02 -0.11 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.178 0.991 . . . . 0.0 111.89 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.35 8.28 37.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -108.88 -147.71 0.42 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.594 0.758 . . . . 0.0 110.517 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.0 p -152.13 157.07 41.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 127.313 2.245 . . . . 0.0 107.378 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.26 -26.25 68.69 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 121.361 0.601 . . . . 0.0 109.871 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -66.43 -25.11 66.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.853 1.261 . . . . 0.0 111.765 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.82 -12.01 59.94 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.447 0.699 . . . . 0.0 111.903 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.449 ' CE2' HD13 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -117.68 21.3 13.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 46.95 27.27 0.7 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.66 141.78 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.109 0.413 . . . . 0.0 110.262 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -130.31 -177.84 4.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.53 1.132 . . . . 0.0 108.747 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -60.96 143.26 55.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 53.53 26.27 5.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.415 1.086 . . . . 0.0 113.418 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -72.65 -14.91 61.7 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 61.53 141.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.467 1.907 . . . . 0.0 112.367 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.98 -177.07 5.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.55 129.9 33.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 110.728 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.6 tp -112.28 141.5 45.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.252 1.421 . . . . 0.0 110.467 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.12 161.0 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -148.84 171.69 15.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.684 -0.635 . . . . 0.0 112.677 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.58 173.58 6.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.128 0.971 . . . . 0.0 109.568 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.51 25.59 6.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.539 0.735 . . . . 0.0 109.631 -178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 . . . . . 0 N--CA 1.465 0.299 0 C-N-CA 126.677 1.991 . . . . 0.0 114.454 -178.689 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 494' ' ' GLN . 74.7 Cg_endo -75.72 -172.53 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 124.744 3.629 . . . . 0.0 109.605 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 31.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.445 1.498 . . . . 0.0 113.152 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.1 pp0? -75.29 -25.97 58.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.812 0.845 . . . . 0.0 112.629 -176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.11 2.62 1.17 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.2 162.47 72.96 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 122.959 0.503 . . . . 0.0 110.566 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 152.54 15.31 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.281 3.32 . . . . 0.0 112.397 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.1 66.62 2.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.802 0.81 . . . . 0.0 112.064 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 159.49 -25.04 0.32 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.668 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.86 166.55 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.363 0.665 . . . . 0.0 110.584 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.94 143.03 40.56 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.127 0.971 . . . . 0.0 109.317 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.501 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.52 -34.47 76.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.25 -177.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.51 4.53 5.9 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.883 -0.511 . . . . 0.0 111.754 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.12 11.29 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.402 0.681 . . . . 0.0 110.535 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -14.99 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.395 1.078 . . . . 0.0 109.545 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -85.44 29.27 0.69 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.566 0.746 . . . . 0.0 111.228 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -103.65 7.83 37.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.931 0.893 . . . . 0.0 111.153 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.52 156.9 63.33 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.615 1.166 . . . . 0.0 110.348 -172.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 162.87 30.87 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.981 3.12 . . . . 0.0 112.856 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . 0.441 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -27.3 64.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.7 0.8 . . . . 0.0 112.064 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -9.2 58.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.219 0.208 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.28 -15.68 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.278 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . 0.441 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 12.9 mm-40 -57.85 -39.54 77.97 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.484 1.038 . . . . 0.0 108.9 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.7 -16.24 64.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.169 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -90.29 -8.78 50.03 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.246 -0.406 . . . . 0.0 111.76 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.59 -34.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.56 -6.58 11.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.373 0.669 . . . . 0.0 109.678 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 49.4 m -138.32 26.77 2.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.062 1.345 . . . . 0.0 109.485 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -129.67 43.45 1.31 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -63.48 7.2 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.262 2.225 . . . . 0.0 115.063 -170.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -146.97 -177.64 5.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.29 0.636 . . . . 0.0 109.708 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.86 -2.84 2.57 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.472 1.509 . . . . 0.0 112.941 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -157.24 152.56 26.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.936 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.18 34.2 1.21 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.411 1.084 . . . . 0.0 110.045 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.9 6.06 2.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.789 0.804 . . . . 0.0 110.728 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 111.696 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.584 0.231 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.73 172.7 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.55 -179.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.06 101.04 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.39 126.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.9 ttmt -102.82 133.88 47.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 111.903 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.444 ' C ' ' H ' ' B' ' 9' ' ' THR . 69.1 p -82.13 178.2 8.4 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 112.416 -172.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.67 14.43 0.19 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.689 1.196 . . . . 0.0 110.284 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.444 ' H ' ' C ' ' B' ' 7' ' ' THR . 31.8 p -129.32 5.66 5.26 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 120.871 -1.143 . . . . 0.0 112.418 -175.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 25.58 58.46 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.855 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -121.44 142.26 50.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -111.24 157.21 20.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.3 128.9 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -74.84 133.24 41.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.3 mt -145.12 133.59 21.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.329 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.25 126.5 39.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.11 177.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.844 0.858 . . . . 0.0 109.762 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -136.18 162.21 57.86 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.762 0.825 . . . . 0.0 110.117 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 35.1 Cg_exo -56.36 0.85 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.38 3.387 . . . . 0.0 113.371 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 18' ' ' GLU . 27.5 p -129.43 -6.59 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.845 0.858 . . . . 0.0 111.191 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.27 74.23 10.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.3 t -62.43 174.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.192 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -56.02 -26.08 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.69 -17.69 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.439 -1.413 . . . . 0.0 110.706 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -88.58 -43.86 11.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.86 0.864 . . . . 0.0 110.598 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 3.6 m -63.96 -31.24 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 C-N-CA 122.736 0.414 . . . . 0.0 110.597 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -56.58 -31.57 64.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.368 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.95 -30.32 55.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.448 0.567 . . . . 0.0 110.569 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.0 mptp? -70.03 -33.9 72.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -85.81 -30.12 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.95 -39.97 83.31 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.34 -31.05 71.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.158 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -83.43 -21.4 32.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -138.13 -36.32 0.6 Allowed 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.72 8.49 13.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.79 129.82 80.35 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.55 153.41 65.29 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.408 2.072 . . . . 0.0 111.224 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.23 -17.47 39.95 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.273 2.649 . . . . 0.0 110.653 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.49 -4.84 57.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.838 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -124.8 -15.43 6.47 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.94 163.06 28.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.866 1.212 . . . . 0.0 113.479 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -161.91 146.11 12.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.045 1.338 . . . . 0.0 107.627 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -132.87 160.44 36.96 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.134 0.493 . . . . 0.0 111.728 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.71 149.3 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 107.988 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -151.74 144.26 24.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.999 0.92 . . . . 0.0 109.355 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 14.09 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.526 0.73 . . . . 0.0 111.985 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.1 16.2 51.45 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.287 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 158.06 40.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.745 1.272 . . . . 0.0 109.867 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.16 145.44 26.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.55 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.445 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.3 mt -102.99 148.96 25.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.047 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -121.69 149.22 43.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.501 0.667 . . . . 0.0 112.064 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.74 2.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.211 1.004 . . . . 0.0 111.852 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.36 16.5 19.65 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.55 -148.59 0.41 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.591 1.156 . . . . 0.0 108.496 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.2 p -153.9 160.29 42.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.693 1.197 . . . . 0.0 108.851 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.14 -27.09 68.14 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.236 -0.29 . . . . 0.0 110.633 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 16.5 t -73.29 -28.52 62.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.94 0.496 . . . . 0.0 110.791 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.15 -12.69 61.35 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.65 21.14 13.15 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 174.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 47.97 22.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.438 HG23 ' HG ' ' B' ' 65' ' ' SER . 52.8 mt -57.47 141.69 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-O 121.208 0.528 . . . . 0.0 110.766 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -131.33 -177.54 4.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.141 1.376 . . . . 0.0 108.79 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -64.04 147.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.034 0.445 . . . . 0.0 110.955 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 53.78 25.92 5.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.819 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.438 ' HG ' HG23 ' B' ' 61' ' ' ILE . 86.5 p -72.88 -21.33 60.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 69.5 m 60.67 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.072 2.149 . . . . 0.0 112.622 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.53 -174.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.85 1.66 . . . . 0.0 108.155 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -137.49 149.83 47.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -134.44 133.22 40.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.949 1.3 . . . . 0.0 109.5 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 163.67 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.11 168.89 18.67 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -76.35 -176.27 3.57 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 125.371 1.468 . . . . 0.0 111.872 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.41 18.48 20.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.789 0.835 . . . . 0.0 111.585 -171.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 127.101 2.16 . . . . 0.0 114.042 -176.212 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.537 0.208 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.91 95.68 0.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.634 3.556 . . . . 0.0 111.548 -171.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.6 tt 21.26 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.699 2.399 . . . . 0.0 112.514 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.75 -26.45 16.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.011 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -139.74 4.88 2.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.359 0.664 . . . . 0.0 110.67 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.18 160.58 77.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.975 0.51 . . . . 0.0 109.694 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 499' ' ' GLY . 51.1 Cg_exo -57.28 155.64 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.049 3.166 . . . . 0.0 112.273 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.48 34.59 0.21 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.636 0.774 . . . . 0.0 111.775 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -173.38 35.84 0.13 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.352 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 501' ' ' ASP . 42.7 t -143.22 168.66 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.208 1.003 . . . . 0.0 109.293 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ASP . . . . . 0.409 ' N ' ' CG1' ' A' ' 500' ' ' VAL . 1.8 m-20 -137.53 148.27 45.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.964 1.306 . . . . 0.0 108.222 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' GLN . . . . . 0.562 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -76.77 -28.06 55.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.35 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.55 7.39 1.44 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.738 -0.601 . . . . 0.0 111.03 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' VAL . . . . . 0.427 ' HA ' HE21 ' A' ' 507' ' ' GLN . 31.0 m -138.03 12.1 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.729 0.811 . . . . 0.0 111.383 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -25.49 2.65 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.889 0.476 . . . . 0.0 111.048 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.53 -6.28 29.73 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.941 -0.474 . . . . 0.0 110.702 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.427 HE21 ' HA ' ' A' ' 504' ' ' VAL . 2.6 mp0 -87.54 -4.38 58.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.775 1.23 . . . . 0.0 110.238 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 74.0 mt -90.16 160.11 40.85 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.75 1.22 . . . . 0.0 109.957 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.61 167.64 26.06 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.469 2.779 . . . . 0.0 111.894 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.67 -22.79 62.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.87 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.36 -1.86 57.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.237 0.472 . . . . 0.0 111.684 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.78 -14.58 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -40.85 67.68 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.37 -0.831 . . . . 0.0 109.163 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.16 -7.94 55.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.18 0.592 . . . . 0.0 112.459 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.33 -22.65 18.21 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.521 0.6 . . . . 0.0 111.107 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.3 mp -104.42 -30.33 2.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.12 1.69 1.41 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.147 0.431 . . . . 0.0 110.376 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 516' ' ' ILE . 55.8 m -129.75 9.2 5.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.961 0.904 . . . . 0.0 110.921 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -79.23 138.95 21.27 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 0.29 2.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 12.9 t -162.66 179.82 7.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.596 0.358 . . . . 0.0 110.599 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.15 15.61 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.93 1.692 . . . . 0.0 113.729 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.15 147.27 26.24 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.618 0.367 . . . . 0.0 110.622 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' ASN . . . . . 0.428 ' HB2' ' CE ' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -154.15 10.65 0.39 Allowed 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 13.25 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.803 0.689 . . . . 0.0 111.219 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' LYS . . . . . 0.428 ' CE ' ' HB2' ' A' ' 524' ' ' ASN . 53.6 mtmt . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.363 1.065 . . . . 0.0 111.399 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.642 0.258 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.05 175.31 14.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.01 -177.45 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.67 0.788 . . . . 0.0 109.17 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.506 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 83.5 m-85 -135.68 98.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -93.2 117.87 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -93.3 132.7 37.26 Favored 'General case' 0 C--N 1.337 0.057 0 O-C-N 121.881 -0.512 . . . . 0.0 110.783 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -76.09 177.43 7.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.361 1.064 . . . . 0.0 111.976 -174.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.45 -5.95 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.933 1.293 . . . . 0.0 110.489 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 59.5 p -116.85 4.43 12.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.709 -0.62 . . . . 0.0 112.057 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.93 27.78 48.69 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 120.142 -0.254 . . . . 0.0 113.027 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.73 148.21 45.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 47.5 m -122.66 153.64 39.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.561 -170.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.36 132.3 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -83.92 134.7 34.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.7 mt -145.38 133.47 21.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.617 -172.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.84 128.41 37.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.474 0.71 . . . . 0.0 109.477 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.3 179.61 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.982 0.913 . . . . 0.0 109.69 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' B' ' 20' ' ' SER . 35.7 mt-10 -141.15 164.21 37.14 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.19 1.17 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.583 2.855 . . . . 0.0 113.64 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.431 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.7 m -129.31 -6.61 4.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.908 0.777 . . . . 0.0 111.228 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 21.3 m-20 -80.73 69.08 7.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 171.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.2 t -61.03 176.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.133 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.428 HG22 ' HE3' ' B' ' 27' ' ' LYS . 13.2 mm -52.17 -33.21 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -168.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.6 -22.89 62.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.342 0.974 . . . . 0.0 111.473 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.35 -41.36 22.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.23 -40.24 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 124.275 1.03 . . . . 0.0 110.035 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.428 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.1 mttt -56.73 -26.04 56.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.521 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -26.89 35.16 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.486 0.584 . . . . 0.0 110.772 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -67.1 -33.12 74.79 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.7 mt -87.29 -30.05 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -66.45 -36.67 83.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.715 0.293 . . . . 0.0 110.217 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -69.38 -33.54 73.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.398 0.618 . . . . 0.0 111.297 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -82.39 -24.48 34.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.583 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -134.15 -30.92 1.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.4 9.65 26.93 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.69 126.8 82.01 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 123.891 0.876 . . . . 0.0 108.922 -174.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.41 153.57 77.52 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.634 2.223 . . . . 0.0 111.23 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.24 -20.82 36.79 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.168 2.578 . . . . 0.0 111.823 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.82 -1.69 57.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -113.85 -13.72 12.57 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.335 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.66 170.34 16.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.041 0.837 . . . . 0.0 112.3 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -153.78 148.52 26.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.432 ' C ' HD11 ' B' ' 44' ' ' ILE . 10.7 tp -136.48 139.26 42.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 111.466 -171.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.432 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -135.44 153.17 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.71 1.204 . . . . 0.0 108.213 -177.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' B' ' 47' ' ' GLY . 27.3 t80 -148.35 135.62 20.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 124.566 1.147 . . . . 0.0 109.089 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.49 10.19 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.887 0.875 . . . . 0.0 113.187 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' B' ' 45' ' ' PHE . . . 103.29 12.01 32.3 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.454 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 157.68 37.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.764 1.282 . . . . 0.0 109.713 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -93.29 152.09 19.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.116 0.966 . . . . 0.0 108.418 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.07 168.36 10.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.641 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -136.15 153.09 51.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.514 0.674 . . . . 0.0 111.615 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.79 -1.54 14.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.287 1.035 . . . . 0.0 111.62 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 9.52 35.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -109.02 -155.88 0.57 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.968 0.907 . . . . 0.0 109.372 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -148.48 160.44 43.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.052 1.741 . . . . 0.0 107.415 172.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.64 -26.8 68.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -71.0 -26.27 63.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.019 1.328 . . . . 0.0 111.993 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.78 -15.23 61.65 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 122.891 0.476 . . . . 0.0 111.298 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -126.56 26.69 6.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.717 0.807 . . . . 0.0 109.786 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 p30 48.0 19.78 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.43 139.82 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.714 0.688 . . . . 0.0 110.373 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -130.08 -177.5 4.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.709 1.204 . . . . 0.0 109.217 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.02 143.42 51.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.039 0.447 . . . . 0.0 110.841 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 53.4 26.27 5.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -74.9 -11.94 60.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m 60.03 128.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.35 1.86 . . . . 0.0 112.117 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.59 -175.62 3.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.121 1.369 . . . . 0.0 108.077 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -137.68 145.43 42.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.45 137.9 50.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.534 1.133 . . . . 0.0 109.403 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.92 162.89 30.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.48 178.72 8.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 112.354 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -128.34 167.63 16.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.59 1.156 . . . . 0.0 109.799 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.537 HD11 ' H ' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -102.97 18.12 22.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.749 0.82 . . . . 0.0 112.711 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 129.351 3.061 . . . . 0.0 111.149 175.041 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.9 Cg_endo -77.57 -166.92 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.202 3.268 . . . . 0.0 107.685 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.572 HD11 ' H ' ' A' ' 493' ' ' LEU . 0.0 OUTLIER -65.06 28.4 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 176.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.583 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -63.04 -27.96 69.76 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.434 1.894 . . . . 0.0 112.992 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.98 1.93 0.77 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.72 161.77 76.41 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 122.61 0.364 . . . . 0.0 110.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.75 154.38 12.65 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.255 3.303 . . . . 0.0 112.005 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -80.12 57.55 2.73 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 122.343 1.068 . . . . 0.0 110.424 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.23 26.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.226 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 76.0 t -140.79 160.03 23.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.808 0.804 . . . . 0.0 109.441 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.17 145.16 48.99 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.673 0.749 . . . . 0.0 109.077 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.592 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.31 -28.98 70.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.406 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.92 -0.16 10.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.679 -0.638 . . . . 0.0 111.403 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.26 18.42 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.437 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.78 -18.5 5.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.074 0.95 . . . . 0.0 110.452 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -72.6 3.83 4.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.943 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -87.51 4.89 41.74 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.748 0.819 . . . . 0.0 110.463 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.02 149.54 42.7 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 123.614 0.765 . . . . 0.0 110.187 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.27 163.77 25.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.081 2.521 . . . . 0.0 111.57 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.21 63.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.53 -1.8 57.93 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.651 0.38 . . . . 0.0 110.761 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 23.2 mt -116.87 -16.83 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -54.45 -38.87 66.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.5 -7.23 57.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.42 0.688 . . . . 0.0 112.421 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.42 -20.9 17.49 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.262 0.483 . . . . 0.0 111.2 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.43 -34.3 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.42 -8.64 19.84 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 33.0 t -70.12 -43.73 70.39 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.472 0.309 . . . . 0.0 110.797 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 117.73 120.64 3.07 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -140.79 -176.22 4.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.585 0.707 . . . . 0.0 110.725 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 -172.13 4.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.796 1.638 . . . . 0.0 107.998 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 65.19 18.11 11.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.035 0.934 . . . . 0.0 112.603 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.01 146.39 31.9 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.095 0.958 . . . . 0.0 109.092 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 526' ' ' LYS . 58.2 m-80 -148.29 28.79 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.925 0.49 . . . . 0.0 112.005 -170.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.272 2.2 pp 50.92 6.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.697 1.599 . . . . 0.0 114.511 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 524' ' ' ASN . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.841 0.353 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -157.75 172.91 17.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.95 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -137.24 -179.37 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.272 0.629 . . . . 0.0 109.449 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.475 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 82.4 m-85 -132.33 100.4 4.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.64 103.09 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.626 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -85.41 135.3 33.93 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 122.455 0.302 . . . . 0.0 111.135 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.415 ' C ' ' H ' ' B' ' 9' ' ' THR . 70.7 p -83.76 176.32 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.38 0.672 . . . . 0.0 112.625 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -65.89 1.66 1.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.743 1.217 . . . . 0.0 111.001 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.415 ' H ' ' C ' ' B' ' 7' ' ' THR . 73.3 p -118.73 10.06 12.31 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.307 0.643 . . . . 0.0 111.311 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 28.36 66.27 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.892 -0.393 . . . . 0.0 113.199 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.71 146.59 49.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 26.7 m -122.78 154.31 38.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 111.547 -171.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 53.3 mt -130.75 131.94 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -82.89 134.76 35.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 69.2 mt -144.35 134.54 24.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -171.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.89 126.82 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.314 0.645 . . . . 0.0 109.433 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.26 174.23 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.898 0.879 . . . . 0.0 109.645 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.8 mm-40 -135.69 161.87 60.38 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.272 1.029 . . . . 0.0 108.631 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.45 2.24 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.31 2.674 . . . . 0.0 113.339 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.41 ' H ' ' C ' ' B' ' 18' ' ' GLU . 35.1 p -122.21 -10.2 8.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.98 0.912 . . . . 0.0 110.593 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -85.99 71.16 10.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.1 t -62.16 176.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.683 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.431 HG21 ' HE3' ' B' ' 27' ' ' LYS . 17.7 mm -51.14 -36.8 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -168.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -68.79 -21.67 64.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.371 0.987 . . . . 0.0 111.251 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -81.66 -40.38 22.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.36 -38.44 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.857 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG21 ' B' ' 23' ' ' ILE . 96.9 mttt -58.18 -23.13 54.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.524 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.62 -26.73 31.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.556 0.617 . . . . 0.0 110.73 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.85 -33.65 74.16 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.0 mt -85.85 -29.85 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -68.12 -37.6 81.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.33 -32.1 71.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.475 0.655 . . . . 0.0 111.323 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -83.01 -22.11 33.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -138.94 -31.25 0.72 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.74 9.39 19.0 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.2 mt -80.5 125.47 80.76 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.662 0.785 . . . . 0.0 109.337 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 159.38 48.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.216 2.611 . . . . 0.0 111.268 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -16.32 54.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.828 3.018 . . . . 0.0 110.851 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.47 -11.9 58.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.655 0.382 . . . . 0.0 111.999 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -120.85 -10.8 9.06 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -73.01 167.74 20.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.261 0.937 . . . . 0.0 112.04 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -159.21 90.1 0.95 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.88 1.272 . . . . 0.0 107.986 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -93.13 139.82 30.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.661 0.784 . . . . 0.0 112.201 -170.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.68 154.07 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.996 1.318 . . . . 0.0 109.145 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -151.59 142.81 23.29 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.593 1.157 . . . . 0.0 109.129 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 13.77 0.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.573 0.749 . . . . 0.0 112.615 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.7 13.86 48.96 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.275 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 161.78 31.53 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.559 1.18 . . . . 0.0 110.36 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.04 125.87 43.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.814 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.517 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.5 OUTLIER -76.0 175.35 8.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.991 -177.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -135.13 153.35 52.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 111.307 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.18 1.18 9.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.268 1.027 . . . . 0.0 111.697 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.64 11.76 27.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -112.47 -154.4 0.54 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.173 0.989 . . . . 0.0 109.563 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 4.5 p -148.97 159.56 44.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.794 1.638 . . . . 0.0 107.674 172.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 47.1 mt -63.27 -25.75 68.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -73.87 -25.45 60.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.467 1.107 . . . . 0.0 111.985 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.76 -15.96 61.65 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.09 0.556 . . . . 0.0 111.386 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.517 ' CD2' HD12 ' B' ' 50' ' ' LEU . 21.2 m-85 -125.71 25.98 6.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.367 0.667 . . . . 0.0 109.836 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p30 48.54 18.91 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 136.44 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.855 0.752 . . . . 0.0 110.187 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -130.4 -175.89 3.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.009 1.323 . . . . 0.0 109.458 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -59.93 143.89 50.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.281 0.563 . . . . 0.0 110.916 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 55.15 22.43 4.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.455 1.102 . . . . 0.0 113.331 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -72.44 -14.72 61.76 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 80.6 m 61.36 128.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.466 1.906 . . . . 0.0 112.051 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.59 178.62 6.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.941 1.296 . . . . 0.0 108.655 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -134.85 154.64 51.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -145.24 151.87 39.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.245 0.545 . . . . 0.0 110.507 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.04 161.2 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.68 170.05 16.49 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.155 0.502 . . . . 0.0 112.077 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -135.61 177.48 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.136 0.974 . . . . 0.0 109.538 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.5 OUTLIER -124.41 20.87 8.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.267 1.027 . . . . 0.0 112.385 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 62.28 -32.05 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.052 2.141 . . . . 0.0 113.94 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 148.17 -13.91 1.28 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 117.263 -1.854 . . . . 0.0 111.104 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 494' ' ' GLN . 93.3 Cg_endo -80.12 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 1 C-N-CA 125.408 4.072 . . . . 0.0 109.254 175.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.4 32.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.726 1.61 . . . . 0.0 113.078 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.4 pp0? -77.16 -27.95 53.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.281 0.633 . . . . 0.0 112.568 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.01 3.63 1.61 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.5 160.05 82.06 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 122.911 0.484 . . . . 0.0 109.781 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.1 149.43 15.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.52 2.813 . . . . 0.0 111.434 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -76.09 65.92 2.18 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 121.731 0.777 . . . . 0.0 112.256 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 165.76 -27.75 0.19 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.494 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.73 162.1 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 122.988 0.515 . . . . 0.0 109.948 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -131.15 144.74 51.6 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 109.868 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.522 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.16 -30.62 70.51 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.3 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -72.15 0.41 9.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.903 -0.498 . . . . 0.0 111.771 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.1 16.19 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 122.945 0.498 . . . . 0.0 110.617 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.98 -19.87 5.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.552 0.741 . . . . 0.0 109.846 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -73.49 4.77 4.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.023 0.529 . . . . 0.0 111.637 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -83.95 5.9 23.82 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.438 0.695 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.01 152.15 53.77 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 123.868 0.867 . . . . 0.0 110.174 -170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.8 164.1 25.53 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.845 2.364 . . . . 0.0 111.311 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.55 63.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.106 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 -3.29 58.4 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 122.464 0.306 . . . . 0.0 110.953 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.2 -15.27 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -54.96 -38.92 68.39 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.08 -10.4 59.36 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -89.38 -18.37 26.99 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.478 0.581 . . . . 0.0 111.186 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.91 -34.32 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.08 -9.07 14.15 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 171.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 m -63.14 -27.08 69.13 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 122.245 -0.284 . . . . 0.0 110.821 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 104.19 35.23 3.45 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -61.54 -179.96 0.2 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.613 1.197 . . . . 0.0 112.189 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.3 m -142.65 -171.97 3.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.162 -1.835 . . . . 0.0 108.91 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.76 13.13 8.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.233 1.013 . . . . 0.0 112.286 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -149.75 145.56 26.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.912 0.485 . . . . 0.0 110.252 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.553 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.2 m-80 -152.37 19.4 0.64 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.738 0.815 . . . . 0.0 110.105 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.02 -15.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.159 1.384 . . . . 0.0 112.445 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 124.072 0.949 . . . . 0.0 111.108 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.955 0.407 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.69 172.81 17.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.794 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.58 -179.64 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.548 0.739 . . . . 0.0 109.055 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -132.06 107.59 8.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -103.09 109.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.6 ttmt -93.54 139.11 31.12 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -86.9 176.0 7.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.044 0.938 . . . . 0.0 112.135 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.86 -20.84 59.46 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.577 1.151 . . . . 0.0 110.981 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -95.48 -2.83 47.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.968 -0.458 . . . . 0.0 110.471 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.56 24.64 27.8 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.278 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.55 140.07 52.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -109.42 159.23 17.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.546 -173.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -129.97 128.69 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -79.54 134.17 36.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -144.88 133.8 22.5 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -90.11 128.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.409 HG12 ' HE3' ' B' ' 29' ' ' LYS . 33.7 m -146.12 177.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 123.746 0.818 . . . . 0.0 110.104 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' B' ' 20' ' ' SER . 75.0 mm-40 -141.6 163.08 43.34 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 124.602 1.161 . . . . 0.0 108.941 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.434 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 38.2 Cg_exo -55.46 3.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.668 3.579 . . . . 0.0 113.647 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.472 ' H ' ' C ' ' B' ' 18' ' ' GLU . 19.2 t -134.0 -8.77 2.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.892 0.769 . . . . 0.0 111.482 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 8.2 m-20 -78.05 68.78 4.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.0 t -62.29 177.02 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.653 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.433 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.6 mm -51.29 -33.65 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -169.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.29 -22.14 61.99 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 119.266 0.939 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -81.79 -38.17 26.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.466 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 71.5 t -64.68 -40.54 89.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 110.138 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.433 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.6 mttt -56.86 -27.53 60.51 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.17 -23.04 44.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.427 0.558 . . . . 0.0 110.796 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.466 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 68.3 mmtt -69.76 -47.32 63.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.481 0.712 . . . . 0.0 109.434 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.44 -30.61 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.515 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.32 -39.4 78.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.71 0.29 . . . . 0.0 110.466 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.43 -31.25 70.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.31 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.35 -24.6 36.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.462 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.68 -34.53 0.68 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.63 8.7 13.7 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.74 126.48 88.45 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.13 153.78 73.98 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.672 2.248 . . . . 0.0 111.028 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.31 -17.33 39.66 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.617 2.878 . . . . 0.0 111.573 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.14 2.3 55.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.69 -16.76 10.66 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.91 164.13 24.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.619 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -154.53 124.18 6.59 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.459 ' C ' HD13 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -123.4 135.12 53.97 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.871 0.305 . . . . 0.0 111.513 -168.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.7 mp -129.53 149.92 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -151.03 143.08 24.01 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.844 1.257 . . . . 0.0 109.07 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.69 13.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.516 0.726 . . . . 0.0 112.326 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.99 14.58 48.56 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.453 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 163.42 29.33 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.486 1.143 . . . . 0.0 110.178 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.84 128.27 45.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' B' ' 59' ' ' TYR . 0.4 OUTLIER -77.18 172.82 12.64 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.015 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -135.5 156.27 49.16 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.542 0.687 . . . . 0.0 111.206 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.97 2.31 8.95 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.869 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.86 14.57 21.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -115.26 -154.13 0.54 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.375 1.07 . . . . 0.0 108.758 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 40.4 p -150.43 166.52 29.87 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.344 1.058 . . . . 0.0 108.386 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.3 -30.48 71.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 17.0 t -74.91 -29.76 61.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.351 0.66 . . . . 0.0 111.136 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.42 -16.17 63.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.723 0.409 . . . . 0.0 111.606 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.518 ' CD2' HD11 ' B' ' 50' ' ' LEU . 18.0 m-85 -130.1 25.57 5.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.654 0.781 . . . . 0.0 110.245 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 46.75 25.68 0.47 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.24 128.47 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -132.38 -171.24 2.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.71 1.204 . . . . 0.0 109.705 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -58.37 140.66 53.22 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.969 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 54.12 24.43 4.84 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.235 1.014 . . . . 0.0 113.15 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.7 m -72.22 -19.18 61.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m 60.99 135.79 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.508 1.923 . . . . 0.0 112.184 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.9 179.93 6.43 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.534 0.734 . . . . 0.0 109.145 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.58 143.72 45.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.048 0.451 . . . . 0.0 110.886 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -134.4 142.02 47.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.834 1.254 . . . . 0.0 110.495 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 85.2 t -142.93 160.26 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -147.67 171.89 14.93 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.8 175.9 5.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.508 1.123 . . . . 0.0 108.977 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' B' ' 75' ' ' GLY . 2.9 tp -124.4 18.98 8.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 59.94 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.041 2.136 . . . . 0.0 113.992 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.22 -10.66 2.02 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 CA-C-O 117.221 -1.877 . . . . 0.0 110.985 -179.823 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.2 Cg_endo -74.54 -164.03 0.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 125.125 3.883 . . . . 0.0 109.616 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 32.95 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.417 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -68.54 -36.7 79.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.56 2.34 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 112.047 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.09 161.12 75.14 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 122.985 0.514 . . . . 0.0 110.06 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 499' ' ' GLY . 75.1 Cg_exo -53.19 150.95 23.41 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.988 3.125 . . . . 0.0 112.18 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.55 35.82 0.19 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.87 0.843 . . . . 0.0 112.077 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -174.24 30.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.298 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.8 t -139.16 162.52 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 C-N-CA 123.619 0.768 . . . . 0.0 108.984 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.17 143.04 50.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.496 0.665 . . . . 0.0 110.046 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.78 -30.65 70.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.169 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.41 0.38 8.39 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.698 -0.626 . . . . 0.0 111.588 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.72 17.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.719 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.35 -21.58 5.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 109.706 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -72.37 10.15 0.86 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.283 0.633 . . . . 0.0 111.68 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -93.49 8.8 39.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.874 0.87 . . . . 0.0 110.743 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 31.4 mt -123.82 153.62 67.1 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.8 0.84 . . . . 0.0 111.331 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.8 158.49 56.72 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.987 2.458 . . . . 0.0 111.14 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.8 62.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.928 0.891 . . . . 0.0 112.847 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.17 -7.29 59.64 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.649 0.658 . . . . 0.0 111.133 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.79 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -65.21 -35.2 80.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 120.857 -1.152 . . . . 0.0 110.592 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.06 -1.78 8.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.42 0.288 . . . . 0.0 111.5 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.79 5.04 8.79 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 518' ' ' SER . 19.1 mm -106.05 -39.21 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.96 -5.52 2.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.701 0.8 . . . . 0.0 109.503 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 516' ' ' ILE . 42.8 m -142.16 27.66 1.75 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.272 1.429 . . . . 0.0 110.171 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.59 39.01 2.21 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.41 9.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.692 1.997 . . . . 0.0 115.421 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.9 m -142.4 171.09 14.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.746 0.819 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 1.1 tpm_? 60.57 12.92 3.87 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.65 1.58 . . . . 0.0 114.128 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.43 140.22 21.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.44 ' C ' ' H ' ' A' ' 526' ' ' LYS . 48.5 m-80 -150.25 32.17 0.66 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.027 0.531 . . . . 0.0 111.786 -170.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.262 1.9 pp 50.95 5.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.086 1.754 . . . . 0.0 115.362 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 524' ' ' ASN . 51.5 mtmt . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.849 1.26 . . . . 0.0 112.471 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.97 173.47 16.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.651 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.41 -179.61 2.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.3 133.25 51.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.86 107.12 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -84.71 132.8 34.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.981 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -76.1 173.52 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.096 0.958 . . . . 0.0 111.424 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.18 -23.19 66.47 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.794 0.838 . . . . 0.0 110.531 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -91.84 -10.46 39.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.924 -0.485 . . . . 0.0 111.322 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 28.75 7.1 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.37 -0.443 . . . . 0.0 113.751 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -121.82 145.57 47.93 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.51 158.02 25.28 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.7 mt -133.12 134.24 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -77.43 128.91 35.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 mt -137.24 130.33 30.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.97 126.97 35.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.009 0.923 . . . . 0.0 109.354 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.57 177.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.133 0.973 . . . . 0.0 109.447 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.4 mm-40 -136.9 162.49 55.52 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 108.619 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.69 5.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.487 2.792 . . . . 0.0 113.384 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.469 ' H ' ' C ' ' B' ' 18' ' ' GLU . 22.5 t -129.86 -8.93 4.45 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.626 0.648 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -81.11 76.01 8.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.7 t -66.08 177.1 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.445 -176.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.439 HG21 ' HE3' ' B' ' 27' ' ' LYS . 11.8 mm -52.12 -35.34 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.54 -21.73 65.45 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.934 0.788 . . . . 0.0 111.038 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -82.72 -42.67 17.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.6 -40.03 87.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 124.444 1.098 . . . . 0.0 110.395 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.439 ' HE3' HG21 ' B' ' 23' ' ' ILE . 89.8 mttt -58.75 -23.17 59.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.419 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.48 35.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.601 0.637 . . . . 0.0 110.762 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.26 -33.84 75.1 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.177 -0.327 . . . . 0.0 110.13 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -85.1 -30.51 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.85 -39.16 90.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.79 -31.81 71.94 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.232 0.539 . . . . 0.0 111.07 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -86.9 -22.09 25.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -135.16 -32.1 0.96 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.6 9.85 24.34 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -81.59 129.98 63.42 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.35 151.08 76.46 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.585 2.19 . . . . 0.0 110.826 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.52 -15.03 44.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.626 2.884 . . . . 0.0 111.37 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -88.15 -7.26 57.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -119.24 -9.85 9.86 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.5 176.26 4.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.176 0.898 . . . . 0.0 112.91 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -147.06 151.48 36.97 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 127.48 2.312 . . . . 0.0 105.768 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -146.71 116.8 7.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.308 0.958 . . . . 0.0 110.165 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.11 142.23 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.574 0.75 . . . . 0.0 109.299 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.32 158.41 26.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.564 172.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.12 20.89 1.93 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.33 73.62 Favored Glycine 0 C--N 1.341 0.847 0 C-N-CA 125.084 1.326 . . . . 0.0 112.57 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 161.73 35.8 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 117.693 0.746 . . . . 0.0 109.686 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -96.62 125.71 41.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' B' ' 50' ' ' LEU . 5.1 mp -74.76 159.75 31.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -124.92 148.4 48.36 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.49 0.662 . . . . 0.0 111.801 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.66 2.39 5.32 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.467 1.107 . . . . 0.0 111.672 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 15.61 23.61 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -121.14 -150.2 0.45 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 108.655 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -151.81 156.42 40.18 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 125.738 1.615 . . . . 0.0 108.871 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.79 -25.2 62.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -73.89 -24.29 59.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.265 1.026 . . . . 0.0 111.703 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.0 -15.19 60.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.254 0.621 . . . . 0.0 111.556 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.404 ' CE2' HD13 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -112.07 17.41 19.63 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 174.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.82 22.44 1.15 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.836 1.254 . . . . 0.0 114.227 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.525 HG23 ' HG ' ' B' ' 65' ' ' SER . 71.5 mt -62.81 144.78 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -132.82 178.67 6.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.918 0.887 . . . . 0.0 109.092 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -60.92 150.87 31.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.064 0.459 . . . . 0.0 111.253 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 60.06 17.68 6.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.869 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.525 ' HG ' HG23 ' B' ' 61' ' ' ILE . 87.6 p -70.08 179.48 2.32 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 109.934 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -134.61 126.85 30.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -121.61 -171.77 2.29 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -138.41 143.96 39.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.034 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -133.76 139.04 46.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.544 1.137 . . . . 0.0 109.944 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.94 165.89 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.49 172.66 12.56 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.25 0.477 . . . . 0.0 111.804 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -123.79 169.45 11.53 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.918 0.887 . . . . 0.0 110.078 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 75' ' ' GLY . 1.4 mp -112.58 13.49 20.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.986 0.915 . . . . 0.0 112.213 -170.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 61.9 -27.85 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.409 1.884 . . . . 0.0 113.866 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -110.94 6.75 29.26 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 117.1 -1.944 . . . . 0.0 110.991 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 494' ' ' GLN . 84.3 Cg_endo -76.18 -163.74 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 1 C-N-CA 125.392 4.062 . . . . 0.0 109.65 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.94 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.479 1.512 . . . . 0.0 112.868 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.1 pp0? -75.43 -26.26 58.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.49 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.15 5.68 1.3 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.67 157.51 90.0 Favored Pre-proline 0 N--CA 1.448 -0.55 0 O-C-N 121.923 -0.486 . . . . 0.0 110.163 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.16 154.66 27.36 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.857 3.038 . . . . 0.0 112.169 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -79.67 58.19 2.7 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 122.147 0.975 . . . . 0.0 109.866 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.98 28.34 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.142 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.13 163.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.527 0.663 . . . . 0.0 109.349 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.09 144.03 46.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.21 -31.98 73.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.621 -177.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.38 9.88 3.54 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.282 -0.886 . . . . 0.0 110.364 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.71 10.24 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.563 1.145 . . . . 0.0 109.466 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -25.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.219 -0.925 . . . . 0.0 112.728 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -69.12 -8.32 44.31 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.85 0.75 . . . . 0.0 111.939 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -81.32 -10.55 59.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.11 0.413 . . . . 0.0 110.795 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.82 162.44 70.29 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 124.695 1.198 . . . . 0.0 110.15 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.51 165.05 33.43 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.625 2.216 . . . . 0.0 111.258 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.92 -8.89 5.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.434 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -103.05 -2.35 27.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.301 0.64 . . . . 0.0 111.544 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.07 -13.48 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.21 -2.25 33.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.318 0.647 . . . . 0.0 112.185 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -100.5 -15.32 17.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.316 0.507 . . . . 0.0 111.408 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.32 -35.42 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.31 -11.17 49.17 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 t -73.08 -45.0 59.76 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.637 0.256 . . . . 0.0 110.959 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 130.9 123.24 2.48 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -146.28 173.6 12.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.452 1.101 . . . . 0.0 109.001 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 t -153.6 -171.87 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.605 1.162 . . . . 0.0 109.127 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 62.78 21.26 12.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.705 1.202 . . . . 0.0 112.021 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -144.88 155.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.964 0.906 . . . . 0.0 109.542 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.566 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -149.05 10.7 0.8 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -173.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.4 13.55 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.869 -172.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 51.7 mtmt . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 124.448 1.099 . . . . 0.0 112.335 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -157.87 171.3 20.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.814 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -138.22 -179.73 2.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.09 108.29 8.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.03 117.04 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.58 132.52 36.25 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.392 0.277 . . . . 0.0 111.332 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.42 ' C ' ' H ' ' B' ' 9' ' ' THR . 69.4 p -83.19 179.34 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.33 7.12 0.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.04 1.336 . . . . 0.0 110.846 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.42 ' H ' ' C ' ' B' ' 7' ' ' THR . 72.4 p -125.65 11.42 7.89 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.165 -0.959 . . . . 0.0 111.981 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 28.29 66.23 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.84 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -126.55 145.56 50.48 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 159.67 22.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.481 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -127.99 125.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -73.09 133.56 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.35 130.04 21.52 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.36 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -90.36 129.0 36.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.06 -177.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.956 0.902 . . . . 0.0 109.637 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.449 ' C ' ' H ' ' B' ' 20' ' ' SER . 37.6 mt-10 -144.14 162.87 38.21 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.85 2.86 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.818 2.345 . . . . 0.0 113.063 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 18' ' ' GLU . 28.4 p -126.16 -12.06 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.679 0.791 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.49 73.18 7.41 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.5 t -62.89 175.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.252 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.424 HG23 ' HE3' ' B' ' 27' ' ' LYS . 14.9 mm -51.08 -34.47 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -169.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.44 -22.65 64.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.553 1.07 . . . . 0.0 111.412 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.79 -36.45 25.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.48 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 83.3 t -68.08 -37.63 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 124.122 0.969 . . . . 0.0 110.207 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.424 ' HE3' HG23 ' B' ' 23' ' ' ILE . 96.0 mttt -60.96 -24.28 65.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.83 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.8 52.12 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.479 0.581 . . . . 0.0 110.771 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.7 mmtt -72.97 -50.59 22.4 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.565 0.746 . . . . 0.0 109.513 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -68.49 -31.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.52 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.96 -38.82 79.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.525 0.203 . . . . 0.0 110.77 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.78 -29.35 65.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.28 0.562 . . . . 0.0 111.405 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -80.48 -25.49 38.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.056 0.943 . . . . 0.0 113.227 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -138.0 -32.8 0.72 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.93 15.36 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.1 mt -76.15 128.63 82.44 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.85 155.47 62.28 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.694 2.263 . . . . 0.0 111.133 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.14 -16.06 43.91 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.897 3.064 . . . . 0.0 111.491 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.67 -13.38 51.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -114.88 -15.19 11.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.11 155.94 38.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.331 0.969 . . . . 0.0 111.21 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.56 90.99 1.84 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.658 1.183 . . . . 0.0 108.826 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' HD11 ' B' ' 44' ' ' ILE . 18.1 mt -85.57 139.76 31.17 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.012 0.434 . . . . 0.0 111.333 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.407 HD11 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -130.97 148.16 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.828 1.251 . . . . 0.0 107.858 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -148.84 141.72 24.7 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.258 1.023 . . . . 0.0 108.686 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.96 12.29 0.08 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.592 0.757 . . . . 0.0 112.583 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.42 39.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.635 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 161.65 33.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.411 1.105 . . . . 0.0 109.766 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -95.78 145.13 25.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -99.51 169.17 9.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.712 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -136.28 153.74 51.09 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.338 0.59 . . . . 0.0 111.987 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -72.84 1.03 9.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.241 1.016 . . . . 0.0 111.54 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.59 8.79 32.42 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -110.56 -154.04 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 109.323 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.8 p -149.06 158.58 44.29 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.63 1.572 . . . . 0.0 107.434 171.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.29 -25.21 68.21 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.9 p -74.06 -24.86 59.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.59 1.156 . . . . 0.0 111.568 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.79 -16.43 61.63 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.182 0.593 . . . . 0.0 111.531 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -125.05 25.94 7.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.516 0.726 . . . . 0.0 109.6 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.33 20.06 0.26 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.427 HG23 ' HG ' ' B' ' 65' ' ' SER . 60.2 mt -60.14 136.9 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 118.572 0.624 . . . . 0.0 111.083 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -132.57 -172.62 2.95 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.26 1.424 . . . . 0.0 109.403 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -60.85 145.49 49.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.674 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 51.44 26.53 3.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.533 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.427 ' HG ' HG23 ' B' ' 61' ' ' ILE . 77.6 p -69.37 -21.17 63.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.419 1.088 . . . . 0.0 113.424 -173.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m 59.87 126.07 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.176 2.19 . . . . 0.0 112.275 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -128.7 -175.88 3.67 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.068 1.347 . . . . 0.0 107.921 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -136.99 144.44 43.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -132.28 135.69 46.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.741 . . . . 0.0 110.088 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.22 166.89 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -146.26 171.99 14.14 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -104.99 177.73 4.77 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.999 1.32 . . . . 0.0 108.345 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' B' ' 75' ' ' GLY . 3.6 tp -122.75 18.8 10.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.849 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 61.19 -27.67 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.652 1.981 . . . . 0.0 113.761 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.52 -11.84 1.98 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 117.247 -1.863 . . . . 0.0 110.931 -179.282 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.421 ' CD1' ' H ' ' A' ' 491' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 38.6 Cg_exo -61.2 -162.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 125.117 3.878 . . . . 0.0 111.468 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 31.65 0.71 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.669 1.188 . . . . 0.0 110.671 169.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -68.7 -28.56 66.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.684 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.94 3.33 0.82 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.43 0.692 . . . . 0.0 112.73 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.75 160.88 81.01 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . 0.42 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 55.6 Cg_exo -51.85 157.74 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.316 3.344 . . . . 0.0 112.582 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -77.44 68.13 3.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.977 0.894 . . . . 0.0 112.375 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 157.18 -26.77 0.49 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.284 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.88 167.38 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.066 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.8 147.88 41.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.635 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -64.2 -30.28 71.35 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.851 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.1 9.41 3.73 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.213 -0.93 . . . . 0.0 110.813 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.96 9.28 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 109.522 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -19.17 0.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 113.071 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -71.55 -11.44 60.86 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.673 -0.642 . . . . 0.0 111.956 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -80.25 -9.47 59.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.016 0.371 . . . . 0.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.95 148.59 57.35 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 124.293 1.037 . . . . 0.0 109.44 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.35 164.45 23.03 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.658 2.239 . . . . 0.0 111.338 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.84 -21.52 63.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.888 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -87.42 1.45 53.36 Favored 'General case' 0 CA--C 1.524 -0.05 0 C-N-CA 122.692 0.397 . . . . 0.0 111.005 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 32.0 mt -119.34 -16.35 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -54.82 -41.39 70.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.93 -1.18 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.531 0.733 . . . . 0.0 112.487 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -105.77 -17.74 14.28 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.285 0.493 . . . . 0.0 111.9 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.49 -25.69 3.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.49 -5.79 12.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.319 0.248 . . . . 0.0 110.413 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 89.6 p -146.38 15.8 1.3 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -119.16 88.81 0.45 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 497' ' ' PRO . 10.2 mmmm -112.54 9.26 19.47 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -163.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.4 t -137.57 21.03 2.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.24 7.02 5.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.736 -0.602 . . . . 0.0 112.204 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.414 ' C ' ' ND2' ' A' ' 524' ' ' ASN . 1.1 pm0 -153.41 149.49 27.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.417 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.2 OUTLIER -144.27 17.43 1.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.28 1.032 . . . . 0.0 109.202 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.54 6.83 5.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.514 1.125 . . . . 0.0 109.876 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 49.5 mtmt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.519 1.128 . . . . 0.0 112.849 -173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 120.658 0.266 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -156.29 173.52 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.74 -179.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 123.654 0.782 . . . . 0.0 109.274 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.419 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 50.7 m-85 -133.57 94.95 3.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.114 0.483 . . . . 0.0 109.737 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -81.93 62.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.163 0.985 . . . . 0.0 111.771 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.5 ttmt -51.59 132.54 30.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.62 0.768 . . . . 0.0 111.28 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 65.9 p -76.06 175.47 8.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.128 -174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.28 -10.34 10.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.708 1.203 . . . . 0.0 110.675 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -112.67 -0.31 15.12 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 121.892 -0.505 . . . . 0.0 111.988 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 22.4 23.78 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.682 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.2 123.42 46.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.585 0.693 . . . . 0.0 110.149 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.9 OUTLIER -82.64 151.24 26.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 111.356 -177.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.35 120.42 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -77.9 136.78 38.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -149.77 137.39 20.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.385 0.274 . . . . 0.0 110.976 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.67 128.7 42.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.8 -179.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.837 0.855 . . . . 0.0 109.358 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' B' ' 20' ' ' SER . 35.4 mt-10 -142.15 164.0 36.38 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.454 0.701 . . . . 0.0 109.52 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 43.2 Cg_exo -54.72 1.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.465 3.443 . . . . 0.0 113.683 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.6 m -132.31 -7.77 3.35 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.805 0.729 . . . . 0.0 111.671 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 28.5 m-20 -81.39 68.61 7.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -63.33 178.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.191 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.467 HG23 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -52.74 -33.82 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -168.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.91 -23.43 63.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.224 0.92 . . . . 0.0 111.15 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -80.63 -41.66 23.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.04 -40.89 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 123.999 0.919 . . . . 0.0 110.077 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.467 ' HE3' HG23 ' B' ' 23' ' ' ILE . 94.5 mttt -56.55 -26.73 55.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.415 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 -28.39 34.98 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.627 0.649 . . . . 0.0 110.849 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.47 -32.82 74.64 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -86.15 -30.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -66.49 -36.31 82.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.19 -34.81 76.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.142 0.496 . . . . 0.0 111.325 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.03 -25.58 43.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.24 -31.23 0.91 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.92 10.28 22.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.1 127.36 77.09 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.0 154.13 67.09 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.807 2.338 . . . . 0.0 111.17 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.41 -14.25 41.96 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.717 2.945 . . . . 0.0 110.713 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.45 -8.78 58.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -123.42 -8.76 8.06 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.96 167.51 20.92 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.084 0.856 . . . . 0.0 111.731 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -154.24 138.94 17.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.447 ' C ' HD11 ' B' ' 44' ' ' ILE . 46.0 tp -134.92 135.58 41.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.796 0.725 . . . . 0.0 111.509 -169.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.447 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.3 mp -131.74 152.09 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.586 1.155 . . . . 0.0 108.667 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -149.31 138.67 21.53 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.59 1.156 . . . . 0.0 108.94 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.74 0.07 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.89 0.876 . . . . 0.0 112.876 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.42 13.17 36.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.407 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 159.48 36.81 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.631 1.216 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -93.8 150.52 20.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.15 170.28 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.419 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -136.38 153.89 50.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.586 0.708 . . . . 0.0 111.539 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.45 -1.01 14.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.414 1.086 . . . . 0.0 111.983 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.2 8.11 32.97 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -106.08 -155.79 0.56 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.162 0.985 . . . . 0.0 109.198 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 35.8 p -150.82 166.25 31.08 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.203 1.401 . . . . 0.0 107.958 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -29.23 70.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 12.2 t -73.4 -31.53 63.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.108 0.963 . . . . 0.0 111.329 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.93 -15.82 60.02 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.551 0.34 . . . . 0.0 111.443 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -128.28 24.9 5.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.673 0.789 . . . . 0.0 109.92 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.65 24.63 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.375 1.87 . . . . 0.0 115.541 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.9 138.53 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.627 0.649 . . . . 0.0 109.851 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.61 -175.16 3.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.662 1.185 . . . . 0.0 109.753 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -59.45 144.7 46.29 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 53.51 24.87 4.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.388 1.075 . . . . 0.0 113.238 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -74.86 -17.68 60.55 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m 59.54 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.271 1.828 . . . . 0.0 112.865 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -127.59 179.87 5.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.663 1.185 . . . . 0.0 108.522 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -134.9 97.5 3.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.098 0.475 . . . . 0.0 111.449 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.89 143.77 45.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.233 1.013 . . . . 0.0 110.497 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 44.9 t -143.71 166.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.35 168.74 22.53 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.623 -0.673 . . . . 0.0 111.722 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -79.35 176.25 9.86 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.924 0.49 . . . . 0.0 111.657 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.2 OUTLIER -104.89 14.32 29.69 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.26 0.624 . . . . 0.0 111.477 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 60.1 -35.46 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 128.054 2.542 . . . . 0.0 114.708 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 138.23 -14.33 3.51 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.477 -1.735 . . . . 0.0 110.792 -179.306 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 494' ' ' GLN . 98.0 Cg_endo -77.71 -161.39 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 125.279 3.986 . . . . 0.0 108.8 175.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.06 25.5 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.2 pp0? -65.22 -23.76 67.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.549 1.14 . . . . 0.0 112.656 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.85 6.26 1.79 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . 0.484 ' CD2' HE21 ' A' ' 502' ' ' GLN . 8.2 mp -64.22 156.63 74.62 Favored Pre-proline 0 N--CA 1.447 -0.586 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 157.5 5.81 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.204 3.269 . . . . 0.0 112.252 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.92 67.23 2.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.892 0.853 . . . . 0.0 112.302 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 158.51 -29.02 0.44 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.272 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.4 163.9 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.593 0.757 . . . . 0.0 109.838 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.19 157.67 44.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.023 0.529 . . . . 0.0 110.811 -173.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.484 HE21 ' CD2' ' A' ' 496' ' ' LEU . 36.1 mm-40 -60.61 -45.51 93.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.972 0.509 . . . . 0.0 110.614 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.58 7.23 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.139 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . 0.442 ' CA ' HE21 ' A' ' 507' ' ' GLN . 20.2 m -138.49 11.3 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.597 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -17.42 5.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.359 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.34 4.6 6.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.815 0.446 . . . . 0.0 111.302 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.442 HE21 ' CA ' ' A' ' 504' ' ' VAL . 10.2 mm-40 -81.38 7.15 12.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.057 0.943 . . . . 0.0 110.698 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 27.9 mt -121.92 155.01 61.17 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 123.837 0.855 . . . . 0.0 110.621 -168.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.4 167.28 27.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.525 2.817 . . . . 0.0 111.948 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.39 -15.31 24.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.214 1.006 . . . . 0.0 112.753 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -100.72 3.35 42.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.058 0.39 . . . . 0.0 111.786 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.9 mt -118.26 -15.45 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.85 -43.8 66.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.17 1.38 13.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.398 0.679 . . . . 0.0 112.805 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -104.29 -18.5 14.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.45 0.568 . . . . 0.0 111.388 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.27 -28.55 2.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.82 -2.54 9.74 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.168 0.587 . . . . 0.0 110.138 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 90.4 p -133.09 13.62 4.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.193 0.997 . . . . 0.0 111.076 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.79 39.37 2.12 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 2.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -141.25 -174.99 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.911 0.884 . . . . 0.0 109.953 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.2 OUTLIER 65.85 6.58 4.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.884 1.274 . . . . 0.0 113.065 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.15 161.85 41.59 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.116 0.416 . . . . 0.0 110.898 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -149.79 33.75 0.69 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.762 0.825 . . . . 0.0 111.078 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.83 7.02 4.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.515 0.726 . . . . 0.0 110.741 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.453 -0.318 0 C-N-CA 124.434 1.093 . . . . 0.0 111.717 -176.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.95 173.12 17.25 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.034 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -135.0 175.81 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 53.2 m-85 -128.88 89.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.433 0.635 . . . . 0.0 110.167 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.38 103.38 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.161 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.2 ttmt -85.17 135.52 33.93 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.436 ' C ' ' H ' ' B' ' 9' ' ' THR . 58.9 p -83.85 174.96 9.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.526 0.731 . . . . 0.0 112.368 -175.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.31 3.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.14 1.376 . . . . 0.0 111.418 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.436 ' H ' ' C ' ' B' ' 7' ' ' THR . 82.6 p -118.19 4.62 11.95 Favored 'General case' 0 CA--C 1.527 0.058 0 O-C-N 121.922 -0.486 . . . . 0.0 111.537 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.26 24.4 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.251 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.35 122.39 38.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.57 0.685 . . . . 0.0 110.134 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.7 OUTLIER -79.04 152.46 30.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.816 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.25 123.24 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -79.83 131.9 35.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -143.55 133.45 24.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.287 -174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.73 126.29 35.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -145.35 177.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 123.786 0.834 . . . . 0.0 109.919 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.1 mm-40 -138.91 162.24 53.66 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 124.05 0.94 . . . . 0.0 109.709 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.436 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 49.4 Cg_exo -54.58 -0.44 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 125.0 3.8 . . . . 0.0 113.896 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -130.91 -7.2 3.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.183 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 65.2 m-20 -81.55 69.62 8.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.9 t -62.9 177.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.808 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.416 HG21 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -51.79 -34.61 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.942 0.897 . . . . 0.0 113.215 -168.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.95 -22.42 63.18 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.094 0.861 . . . . 0.0 111.271 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -81.6 -40.85 22.38 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.9 -39.12 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 124.301 1.04 . . . . 0.0 110.217 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.416 ' HE3' HG21 ' B' ' 23' ' ' ILE . 95.7 mttt -57.4 -24.84 57.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.761 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.85 -28.34 33.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.509 0.595 . . . . 0.0 110.761 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -66.34 -33.32 75.46 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.06 -30.62 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.25 -39.35 86.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.695 0.283 . . . . 0.0 110.261 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.65 -31.67 71.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 111.243 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -83.71 -23.72 31.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.78 -32.84 0.88 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.81 9.03 21.61 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -78.2 129.47 75.18 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.47 151.44 70.72 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.574 2.183 . . . . 0.0 110.456 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 -14.47 37.37 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.23 2.62 . . . . 0.0 110.828 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.14 -8.64 59.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -124.07 -9.82 7.65 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -67.61 165.75 16.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.097 0.862 . . . . 0.0 111.655 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -154.47 102.58 2.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.459 ' C ' HD13 ' B' ' 44' ' ' ILE . 28.5 tp -101.36 135.93 42.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.256 0.623 . . . . 0.0 110.949 -169.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.1 mp -129.81 154.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -118.52 -112.05 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 122.914 0.485 . . . . 0.0 110.494 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.99 -3.18 3.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.303 0.641 . . . . 0.0 111.732 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.88 3.03 2.08 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.553 1.073 . . . . 0.0 111.448 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 154.89 37.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.451 0.643 . . . . 0.0 109.567 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -87.96 128.62 35.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.619 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -76.14 172.71 12.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.602 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -133.63 153.44 51.67 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.663 0.744 . . . . 0.0 111.656 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.49 1.48 9.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 111.917 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.29 14.01 25.75 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -115.57 -154.59 0.55 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.353 1.061 . . . . 0.0 108.997 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.0 p -150.14 165.82 31.7 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.812 1.245 . . . . 0.0 108.142 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.14 -29.33 70.71 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 11.5 t -73.24 -31.36 64.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.654 0.782 . . . . 0.0 111.183 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.96 -15.7 63.23 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 122.87 0.468 . . . . 0.0 111.894 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' B' ' 50' ' ' LEU . 15.7 m-85 -130.49 26.44 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.846 0.858 . . . . 0.0 109.989 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.83 30.89 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.446 HG21 ' HG ' ' B' ' 65' ' ' SER . 73.2 mt -70.92 132.85 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.83 -174.0 3.79 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.477 1.111 . . . . 0.0 109.542 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -56.7 143.08 37.74 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.058 0.456 . . . . 0.0 111.477 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 53.45 27.79 6.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.201 1.0 . . . . 0.0 112.942 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.446 ' HG ' HG21 ' B' ' 61' ' ' ILE . 71.1 p -69.7 -27.37 64.94 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m 61.57 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.012 2.125 . . . . 0.0 112.043 -174.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.54 -179.38 5.7 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.212 1.005 . . . . 0.0 108.806 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.51 151.95 50.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -138.55 142.64 39.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.573 0.749 . . . . 0.0 111.087 -175.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.12 165.32 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 126.352 1.861 . . . . 0.0 105.983 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.35 165.86 27.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.846 -0.534 . . . . 0.0 111.295 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -73.2 174.19 8.36 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' B' ' 75' ' ' GLY . 2.8 tp -107.31 17.78 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.009 0.524 . . . . 0.0 111.087 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 61.69 -28.0 0.06 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.845 2.058 . . . . 0.0 113.693 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 141.87 -11.69 2.63 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.065 -1.964 . . . . 0.0 110.579 -179.749 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.739 ' CD2' ' H ' ' A' ' 491' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.59 89.28 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.972 3.781 . . . . 0.0 111.937 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.8 tt 21.46 48.87 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.163 2.585 . . . . 0.0 112.214 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -95.95 -20.08 19.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.117 -172.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -145.57 6.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.79 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.15 151.64 93.31 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.15 164.05 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.836 3.024 . . . . 0.0 111.685 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.03 132.21 53.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.273 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 78.03 -23.02 2.76 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.698 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.99 163.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.71 1.255 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.91 164.83 28.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.182 0.593 . . . . 0.0 110.398 -173.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -66.72 -41.9 87.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.114 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.64 10.9 0.73 Allowed 'General case' 0 C--O 1.23 0.062 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.56 12.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.665 0.786 . . . . 0.0 110.35 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.8 OUTLIER -134.48 -26.26 1.44 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.274 0.488 . . . . 0.0 112.073 176.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.37 -13.43 62.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.402 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 8.6 mp0 -82.19 -12.07 58.34 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.195 0.452 . . . . 0.0 110.887 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.18 153.4 84.35 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 124.249 1.02 . . . . 0.0 109.508 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 166.29 30.4 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.1 2.533 . . . . 0.0 111.582 172.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.72 -22.19 56.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.554 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.04 3.16 55.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.995 0.362 . . . . 0.0 111.669 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.8 mt -117.94 -15.37 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.1 mp0 -52.9 -44.63 67.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.84 -6.65 39.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.401 0.68 . . . . 0.0 112.469 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.86 -20.44 16.17 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.448 0.567 . . . . 0.0 111.039 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.76 -31.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.44 -3.31 8.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.745 0.418 . . . . 0.0 109.988 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -136.17 15.79 3.25 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.092 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -114.54 28.26 8.32 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.156 0.408 . . . . 0.0 112.199 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 1.45 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.2 t -136.01 32.3 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.79 -2.16 0.95 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.66 159.28 39.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -147.35 28.45 0.99 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.957 -172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.42 6.8 3.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.563 0.697 . . . . 0.0 110.073 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 C--N 1.338 0.097 0 C-N-CA 123.878 0.871 . . . . 0.0 112.222 -174.487 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -129.42 165.6 21.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.339 0.656 . . . . 0.0 110.75 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.78 166.64 2.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 164.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.542 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 8.9 m-85 -125.75 133.93 51.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -126.79 109.86 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -84.64 139.38 32.09 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.227 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.424 ' C ' ' H ' ' B' ' 9' ' ' THR . 71.8 p -84.91 177.82 7.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.073 0.949 . . . . 0.0 112.082 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.42 6.08 0.87 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.791 1.236 . . . . 0.0 110.945 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.424 ' H ' ' C ' ' B' ' 7' ' ' THR . 58.8 p -125.38 6.15 7.69 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.812 -0.555 . . . . 0.0 112.113 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.84 26.58 53.21 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 119.954 -0.359 . . . . 0.0 113.172 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -124.01 145.58 49.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.272 0.629 . . . . 0.0 109.465 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.542 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 8.0 m -122.82 147.18 46.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.215 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.9 mt -123.86 123.76 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -77.44 132.84 38.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -128.74 177.36 7.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 127.44 22.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -149.96 -179.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.087 0.955 . . . . 0.0 109.449 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.2 mm-40 -136.83 163.14 51.64 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.342 1.057 . . . . 0.0 108.358 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 2.7 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.205 2.604 . . . . 0.0 113.553 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.412 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.2 m -125.77 -6.44 6.82 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.976 0.807 . . . . 0.0 110.779 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -83.79 75.13 10.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 3.8 t -64.76 175.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.205 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.489 HG21 ' HE3' ' B' ' 27' ' ' LYS . 14.3 mm -50.49 -36.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.43 -21.78 65.54 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.325 0.966 . . . . 0.0 111.262 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -82.48 -41.85 19.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.69 -39.81 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.591 1.157 . . . . 0.0 110.134 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.489 ' HE3' HG21 ' B' ' 23' ' ' ILE . 95.8 mttt -56.09 -26.51 49.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.501 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.68 -27.76 45.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.421 0.555 . . . . 0.0 110.896 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -68.66 -33.01 73.26 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.01 -28.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.07 -39.74 82.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 122.298 -0.251 . . . . 0.0 110.329 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.63 -30.17 68.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 111.592 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -82.83 -23.7 33.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.937 0.895 . . . . 0.0 113.363 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -137.34 -35.82 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.27 9.13 13.58 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.19 127.11 84.18 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 153.18 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.558 2.172 . . . . 0.0 111.184 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.43 -16.03 42.7 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.459 2.772 . . . . 0.0 110.314 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -80.9 -6.32 58.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.769 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -121.46 -21.61 6.21 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.99 162.95 13.04 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.109 0.868 . . . . 0.0 112.998 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -152.08 127.63 10.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.406 ' C ' HD13 ' B' ' 44' ' ' ILE . 37.1 tp -127.29 132.21 50.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.957 0.344 . . . . 0.0 110.522 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.406 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -130.6 148.86 33.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 109.16 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -151.7 143.5 23.72 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.098 0.959 . . . . 0.0 109.36 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 12.48 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.772 0.829 . . . . 0.0 112.427 -172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 16.39 41.69 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.211 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.3 159.51 36.72 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.71 1.255 . . . . 0.0 110.16 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -96.08 129.26 43.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.679 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.477 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 13.6 mt -81.46 162.23 23.37 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.755 -174.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -127.48 147.76 50.31 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.445 0.64 . . . . 0.0 111.82 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.45 0.34 8.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.361 1.065 . . . . 0.0 111.691 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.18 13.53 31.2 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -118.57 -149.64 0.44 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.306 1.042 . . . . 0.0 108.942 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.466 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.19 157.17 41.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 125.747 1.619 . . . . 0.0 108.65 176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -60.56 -25.11 65.94 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -72.74 -25.21 61.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.365 1.066 . . . . 0.0 111.482 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.7 -14.68 60.35 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.342 0.657 . . . . 0.0 111.558 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -114.04 17.27 17.92 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 117.804 0.274 . . . . 0.0 110.344 175.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.54 27.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.304 1.442 . . . . 0.0 114.187 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 145.96 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -125.33 -177.42 3.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.498 0.719 . . . . 0.0 109.474 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -72.2 145.14 48.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.649 0.738 . . . . 0.0 112.086 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 58.61 16.58 4.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 111.449 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -65.23 -176.54 0.31 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.93 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -130.26 134.79 47.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.097 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -132.19 -177.03 4.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.246 1.419 . . . . 0.0 108.871 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -136.02 147.79 48.1 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.262 0.225 . . . . 0.0 110.564 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -132.73 138.94 47.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.064 0.946 . . . . 0.0 110.691 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 82.2 t -146.97 165.88 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -145.46 168.25 21.02 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.914 0.779 . . . . 0.0 112.34 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.83 175.92 3.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.435 1.094 . . . . 0.0 112.056 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tp -96.45 16.44 18.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.617 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 62.97 -39.27 0.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.595 2.358 . . . . 0.0 114.066 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.49 -20.89 5.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.407 -1.774 . . . . 0.0 110.904 -179.247 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 494' ' ' GLN . 86.0 Cg_endo -79.34 -167.27 0.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.86 3.707 . . . . 0.0 109.128 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 33.1 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.645 1.578 . . . . 0.0 112.837 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.9 pp0? -74.19 -28.76 61.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.445 0.698 . . . . 0.0 112.599 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.72 5.41 1.77 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.1 159.96 84.02 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 122.497 0.319 . . . . 0.0 110.668 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.0 151.07 21.72 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.535 3.49 . . . . 0.0 112.408 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -80.94 54.5 2.21 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 122.301 1.048 . . . . 0.0 109.989 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.48 28.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.833 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.52 165.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.595 0.758 . . . . 0.0 109.03 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.14 145.93 40.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.885 0.874 . . . . 0.0 108.676 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -59.79 -29.7 68.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -72.42 1.12 8.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.441 0.564 . . . . 0.0 111.642 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.53 16.54 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.22 0.608 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.81 -15.4 5.96 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.084 0.954 . . . . 0.0 109.498 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -77.85 1.5 20.21 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.95 -0.469 . . . . 0.0 111.635 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.12 3.05 40.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.95 0.5 . . . . 0.0 110.003 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.58 149.35 39.75 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.723 1.209 . . . . 0.0 109.606 -170.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.8 161.63 44.69 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.036 2.49 . . . . 0.0 110.768 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.92 -21.59 63.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.403 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.3 -6.23 59.26 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 117.823 0.283 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 44.6 mt -110.97 -17.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 172.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -55.63 -42.04 74.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.09 -13.63 62.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 111.589 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.24 -15.02 26.33 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.658 0.383 . . . . 0.0 111.344 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.8 -37.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.33 -6.96 5.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.434 0.694 . . . . 0.0 110.187 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 45.0 m -65.59 -28.27 69.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.526 -0.274 . . . . 0.0 111.134 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.4 39.16 2.65 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -61.85 -179.81 0.22 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.642 1.21 . . . . 0.0 112.418 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -149.01 -167.44 2.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.493 -1.685 . . . . 0.0 109.214 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.65 19.43 11.71 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.077 0.951 . . . . 0.0 111.975 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -142.82 145.99 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.511 0.724 . . . . 0.0 109.41 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.75 18.77 2.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.027 0.442 . . . . 0.0 111.927 -172.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.43 10.07 4.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.875 0.845 . . . . 0.0 109.671 -169.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 -179.063 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -158.1 174.23 15.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.954 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.36 175.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -124.4 117.9 25.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.37 101.73 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -82.35 134.36 35.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.898 0.479 . . . . 0.0 110.917 -173.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.412 ' C ' ' H ' ' B' ' 9' ' ' THR . 81.9 p -80.46 175.35 10.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.456 0.702 . . . . 0.0 111.649 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.91 3.67 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.261 1.025 . . . . 0.0 111.485 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.412 ' H ' ' C ' ' B' ' 7' ' ' THR . 76.5 p -119.87 9.24 11.25 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.732 -0.605 . . . . 0.0 111.787 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.26 25.51 57.09 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 120.088 -0.284 . . . . 0.0 113.133 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.81 140.65 52.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.64 158.59 25.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.117 0.484 . . . . 0.0 111.572 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.12 131.95 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 130.47 36.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -139.52 130.19 25.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.3 128.25 35.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.93 179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.596 0.758 . . . . 0.0 110.416 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.6 mm-40 -132.73 160.08 69.89 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.12 1.4 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.246 2.631 . . . . 0.0 113.304 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 18' ' ' GLU . 33.7 p -124.56 -3.66 7.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.823 0.849 . . . . 0.0 111.049 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.02 69.03 6.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.9 t -58.5 174.4 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.805 1.242 . . . . 0.0 110.722 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.633 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 16.9 mm -50.39 -31.01 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.26 -19.7 62.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.037 -1.04 . . . . 0.0 111.519 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -86.07 -45.76 11.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.504 0.722 . . . . 0.0 110.714 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.633 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.3 OUTLIER -66.6 -28.72 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 C-N-CA 122.686 0.395 . . . . 0.0 110.643 -176.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.533 ' HE3' HG23 ' B' ' 23' ' ' ILE . 90.5 mttt -56.59 -29.48 62.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.312 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.8 -29.16 40.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.246 0.475 . . . . 0.0 111.25 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.84 -34.28 73.42 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.951 0.341 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -85.92 -27.79 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -69.57 -39.49 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.01 -31.88 72.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.622 0.725 . . . . 0.0 111.172 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -83.05 -22.52 33.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.61 -31.71 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 8.46 17.63 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -76.77 127.53 83.85 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.52 157.67 58.21 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.759 2.306 . . . . 0.0 111.48 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.64 -13.78 37.95 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.722 2.948 . . . . 0.0 110.338 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.5 -8.13 58.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -126.28 -11.44 6.36 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.35 162.49 28.48 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.341 0.973 . . . . 0.0 111.785 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -154.84 125.73 7.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.433 ' C ' HD11 ' B' ' 44' ' ' ILE . 0.5 OUTLIER -122.41 139.63 53.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.005 0.366 . . . . 0.0 111.323 -168.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.433 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -134.4 150.93 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.789 1.235 . . . . 0.0 108.911 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -148.63 138.66 22.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.109 1.364 . . . . 0.0 109.05 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.5 13.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.72 0.808 . . . . 0.0 112.651 -174.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.89 15.07 40.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.077 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 157.2 42.64 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.004 1.402 . . . . 0.0 109.921 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -90.15 153.03 20.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.481 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 13.2 mt -109.53 161.94 14.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.197 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -128.49 144.27 51.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.253 0.549 . . . . 0.0 111.704 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.24 0.16 6.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.388 1.075 . . . . 0.0 111.7 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.71 11.7 32.6 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -114.69 -149.13 0.44 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.653 1.181 . . . . 0.0 108.775 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.4 p -154.5 158.49 39.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 125.807 1.643 . . . . 0.0 109.024 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.02 -29.29 68.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.64 -25.73 64.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.635 1.174 . . . . 0.0 111.723 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.11 -10.77 59.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.678 0.391 . . . . 0.0 111.054 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -117.39 17.19 14.67 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.33 13.57 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.7 143.99 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 119.027 0.831 . . . . 0.0 111.428 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 109.697 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.06 147.96 49.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.27 17.89 7.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.839 0.855 . . . . 0.0 112.068 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.5 t -70.98 175.05 5.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -132.39 133.88 44.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.479 0.712 . . . . 0.0 109.094 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.87 179.62 5.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.42 0.688 . . . . 0.0 110.045 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -134.07 138.67 45.47 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.615 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.72 137.87 48.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.666 1.186 . . . . 0.0 110.025 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -136.32 159.37 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pp -143.73 169.89 16.9 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.615 0.643 . . . . 0.0 112.733 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.17 -179.51 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' B' ' 75' ' ' GLY . 3.6 tp -126.87 18.31 7.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.898 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 58.59 -26.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 127.412 2.285 . . . . 0.0 114.578 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 142.55 -9.56 2.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.243 0 CA-C-O 117.328 -1.818 . . . . 0.0 111.066 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 494' ' ' GLN . 37.6 Cg_exo -59.09 -170.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 125.212 3.942 . . . . 0.0 112.041 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.15 29.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.809 1.243 . . . . 0.0 111.15 172.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -66.45 -34.74 78.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 112.953 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.48 11.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.841 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . 0.463 HD13 HE21 ' A' ' 502' ' ' GLN . 87.8 mt -76.81 161.0 75.46 Favored Pre-proline 0 N--CA 1.448 -0.572 0 O-C-N 122.028 -0.42 . . . . 0.0 109.975 175.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.62 155.19 5.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.293 3.329 . . . . 0.0 112.649 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.6 64.88 3.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 122.031 0.919 . . . . 0.0 112.138 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 161.3 -28.55 0.29 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.075 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.41 164.42 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -139.15 160.82 38.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.081 -0.387 . . . . 0.0 110.856 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.463 HE21 HD13 ' A' ' 496' ' ' LEU . 1.5 mp0 -59.44 -51.54 69.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.82 0.848 . . . . 0.0 108.737 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.65 3.73 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.167 -1.379 . . . . 0.0 113.262 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.56 15.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.523 0.601 . . . . 0.0 111.719 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.05 -17.8 5.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.438 1.095 . . . . 0.0 109.435 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 502' ' ' GLN . 55.6 mtmt -75.8 0.66 17.24 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 111.604 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.26 -7.82 58.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.3 mp -89.49 156.06 48.22 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.829 1.252 . . . . 0.0 109.777 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.88 167.65 25.79 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.703 2.935 . . . . 0.0 111.183 170.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.9 -16.3 49.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.806 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.09 -2.03 41.05 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.495 0.588 . . . . 0.0 111.913 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.08 -16.06 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -44.94 70.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.491 -0.756 . . . . 0.0 109.367 170.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.54 -0.97 22.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.22 0.608 . . . . 0.0 112.505 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -105.04 -17.53 14.47 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.535 0.607 . . . . 0.0 111.745 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.22 -27.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 520' ' ' LYS . 64.3 mt -74.48 -0.26 16.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.363 0.665 . . . . 0.0 110.892 172.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 44.8 m -136.03 24.76 3.3 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -142.55 -32.09 0.11 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 517' ' ' LEU . 51.0 mttt 43.96 26.52 0.14 Allowed 'General case' 0 C--N 1.339 0.139 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 169.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.8 t -148.98 173.15 13.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.32 11.6 2.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.131 1.372 . . . . 0.0 112.877 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -141.15 137.7 32.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.718 0.407 . . . . 0.0 110.255 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -150.4 23.68 0.81 Allowed 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.591 0.756 . . . . 0.0 109.778 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.28 8.28 3.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.181 0 C-N-CA 124.624 1.17 . . . . 0.0 112.539 -174.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.12 175.68 13.18 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.383 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 178.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.619 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 89.7 m-85 -134.84 99.22 4.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 110.0 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.22 133.27 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.12 134.03 53.03 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -79.52 178.18 8.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.35 1.46 . . . . 0.0 112.975 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.73 14.04 0.42 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.986 1.315 . . . . 0.0 110.499 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.0 p -132.29 11.96 4.58 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.272 -0.893 . . . . 0.0 112.095 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.05 66.62 Favored Glycine 0 C--N 1.338 0.643 0 O-C-N 122.287 -0.258 . . . . 0.0 112.745 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -120.79 142.33 49.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.619 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 23.5 m -115.63 144.8 43.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.99 126.82 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -78.17 136.98 37.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -146.16 133.15 20.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -92.86 128.74 38.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.84 178.24 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.222 1.009 . . . . 0.0 109.258 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' B' ' 20' ' ' SER . 36.1 mt-10 -143.77 163.95 33.0 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.44 4.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.397 2.732 . . . . 0.0 113.354 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.454 ' H ' ' C ' ' B' ' 18' ' ' GLU . 23.7 p -126.26 -12.41 6.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.705 0.802 . . . . 0.0 111.108 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.83 71.64 10.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.7 t -61.5 174.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.282 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.406 HG21 ' HE3' ' B' ' 27' ' ' LYS . 14.2 mm -50.25 -35.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -168.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -69.68 -22.32 63.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.421 1.009 . . . . 0.0 111.355 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -80.95 -36.49 30.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.475 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.8 t -67.13 -37.22 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 C-N-CA 123.936 0.894 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.406 ' HE3' HG21 ' B' ' 23' ' ' ILE . 97.6 mttt -61.01 -24.64 66.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.63 -23.51 53.34 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.49 0.586 . . . . 0.0 110.558 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.475 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.0 mmtt -72.99 -45.98 54.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.621 0.768 . . . . 0.0 109.282 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.04 -31.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -68.93 -38.65 79.63 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.431 0.292 . . . . 0.0 110.643 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.1 -30.29 68.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.314 0.578 . . . . 0.0 111.341 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -82.63 -22.88 34.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.73 -175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -138.71 -31.72 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.77 9.56 20.66 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -76.71 130.68 75.67 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.43 153.89 50.33 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.761 2.307 . . . . 0.0 111.045 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.35 -15.45 45.72 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.47 -13.95 60.41 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.803 0.441 . . . . 0.0 112.123 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -125.39 -16.11 5.98 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.26 165.52 18.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.609 1.095 . . . . 0.0 112.795 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -160.23 152.38 20.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 24.0 mt -135.67 146.86 48.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.033 0.379 . . . . 0.0 110.48 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 149.01 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.404 ' C ' ' H ' ' B' ' 47' ' ' GLY . 42.0 t80 -149.25 139.63 22.38 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 108.835 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 112.813 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 45' ' ' PHE . . . 99.4 13.76 37.55 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.593 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 160.71 32.38 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.457 1.128 . . . . 0.0 110.043 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -96.7 133.76 40.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.631 -170.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.25 164.06 20.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.652 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -136.82 153.71 50.72 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-O 121.475 0.655 . . . . 0.0 111.686 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -72.26 0.4 9.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.752 1.221 . . . . 0.0 111.667 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.83 13.73 26.97 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -116.08 -154.14 0.54 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.314 1.045 . . . . 0.0 109.388 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.2 p -148.44 158.34 44.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.71 1.604 . . . . 0.0 107.603 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.1 -24.9 68.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -74.2 -25.78 59.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.361 1.064 . . . . 0.0 111.892 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.68 -15.58 62.22 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.528 . . . . 0.0 111.3 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.9 24.13 7.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.315 0.646 . . . . 0.0 110.056 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 p30 47.87 20.49 0.23 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.111 1.764 . . . . 0.0 115.597 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.67 138.04 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.761 0.709 . . . . 0.0 110.188 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -128.41 -173.07 2.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.477 1.111 . . . . 0.0 110.033 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.68 141.74 58.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.801 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 54.68 22.11 3.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.381 1.072 . . . . 0.0 113.428 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -69.99 -15.37 63.02 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.7 m 57.97 133.71 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.984 2.114 . . . . 0.0 112.615 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -134.72 -177.69 4.73 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.327 1.451 . . . . 0.0 108.238 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -134.49 138.86 45.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.56 131.56 53.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.34 1.456 . . . . 0.0 110.133 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.03 159.63 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.12 165.98 26.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.791 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.23 153.94 29.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.0 109.995 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' B' ' 75' ' ' GLY . 85.0 mt -95.74 23.25 6.37 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.691 1.596 . . . . 0.0 110.261 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? 61.86 -28.18 0.06 Allowed 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 127.053 2.141 . . . . 0.0 112.795 -170.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 137.89 -7.83 3.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.585 -1.675 . . . . 0.0 110.845 179.588 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.559 ' C ' ' H ' ' A' ' 494' ' ' GLN . 40.5 Cg_exo -58.7 -171.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.861 3.707 . . . . 0.0 111.225 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 29.56 0.07 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.689 1.195 . . . . 0.0 110.622 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -64.09 -36.89 85.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.31 1.044 . . . . 0.0 112.814 -174.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.63 3.31 1.46 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.88 155.01 92.68 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.85 151.83 7.8 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.917 3.078 . . . . 0.0 111.646 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -75.23 69.1 2.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.961 0.886 . . . . 0.0 112.634 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 162.51 -29.27 0.27 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.03 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.0 165.27 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.604 0.762 . . . . 0.0 109.568 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.78 145.73 36.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.507 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.16 -28.07 67.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.45 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.33 0.72 11.26 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.605 -0.684 . . . . 0.0 111.717 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.25 16.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.359 0.599 . . . . 0.0 110.603 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -17.49 5.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.714 1.206 . . . . 0.0 109.223 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.31 3.3 7.55 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.881 -0.512 . . . . 0.0 111.65 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -85.57 -6.16 59.2 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 508' ' ' LEU . 2.7 mp -93.15 155.91 40.72 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.329 1.451 . . . . 0.0 109.704 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.74 167.58 26.89 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.02 2.48 . . . . 0.0 111.547 170.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.27 -17.54 53.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.431 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.15 3.74 51.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.545 0.338 . . . . 0.0 111.767 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.87 -14.71 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.0 -41.47 67.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.02 -1.1 30.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.628 0.771 . . . . 0.0 112.375 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.93 -18.65 14.95 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.387 0.539 . . . . 0.0 111.306 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.02 -31.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.38 -3.77 15.59 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.806 0.443 . . . . 0.0 110.495 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.3 m -131.99 10.86 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 111.41 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.48 -44.8 1.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 83.3 mttt 49.77 6.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 33.8 t -161.81 179.55 8.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.351 0.523 . . . . 0.0 109.963 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 70.43 3.04 4.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.116 1.766 . . . . 0.0 112.912 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -154.23 155.14 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.181 0.515 . . . . 0.0 110.931 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -145.55 29.12 1.15 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.54 6.95 4.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 109.851 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.457 -0.095 0 C-N-CA 125.091 1.357 . . . . 0.0 112.119 -176.636 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -158.84 176.04 12.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.867 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.66 177.42 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.3 115.54 17.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.51 126.06 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.0 ttmt -101.94 136.87 41.02 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.022 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.466 ' C ' ' H ' ' B' ' 9' ' ' THR . 73.5 p -86.74 178.66 6.95 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.104 0.962 . . . . 0.0 112.386 -171.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.0 12.96 0.17 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.981 1.312 . . . . 0.0 110.377 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.466 ' H ' ' C ' ' B' ' 7' ' ' THR . 28.1 p -126.26 5.68 7.05 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.165 -0.96 . . . . 0.0 111.758 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.57 62.3 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.592 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -125.85 140.44 52.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.493 0.646 . . . . 0.0 110.006 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -106.28 158.47 16.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.097 -175.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.24 125.89 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 19.8 m -75.41 132.28 40.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.4 mt -141.95 131.14 23.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.62 127.87 35.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.42 -179.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.777 0.831 . . . . 0.0 109.731 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.9 mt-10 -143.82 164.72 28.36 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 123.874 0.869 . . . . 0.0 108.921 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.432 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 32.9 Cg_exo -56.07 1.05 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.169 3.246 . . . . 0.0 113.449 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.7 m -131.78 -7.06 3.59 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.782 0.719 . . . . 0.0 111.651 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.73 72.14 7.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.6 t -62.82 175.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.704 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.4 -34.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.16 -23.81 63.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.726 1.148 . . . . 0.0 111.139 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -81.12 -38.33 27.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.471 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 81.8 t -66.85 -37.88 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 123.695 0.798 . . . . 0.0 109.867 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -61.99 -23.52 66.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.039 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 -22.68 52.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.459 0.572 . . . . 0.0 110.541 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.471 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 64.7 mmtt -73.55 -48.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.62 0.768 . . . . 0.0 109.862 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.62 -30.8 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -69.46 -40.04 77.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.28 -0.262 . . . . 0.0 110.66 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.68 -30.76 70.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.463 0.649 . . . . 0.0 111.456 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -80.82 -25.1 38.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.926 -1.033 . . . . 0.0 113.449 -175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -138.03 -33.65 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.68 8.97 15.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.93 127.51 86.77 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.3 153.72 61.54 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.645 2.23 . . . . 0.0 110.693 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.59 -17.88 48.41 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 110.885 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.69 -5.34 58.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.46 -15.52 6.61 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.27 165.86 17.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.682 1.128 . . . . 0.0 112.413 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.449 ' C ' HD12 ' B' ' 44' ' ' ILE . 15.8 mt -129.17 138.62 51.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 110.785 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.449 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.5 mp -131.91 148.33 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.432 1.093 . . . . 0.0 108.585 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.401 ' C ' ' H ' ' B' ' 47' ' ' GLY . 37.3 t80 -149.16 141.19 23.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.065 0.946 . . . . 0.0 109.228 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.65 12.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.752 0.821 . . . . 0.0 112.608 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 45' ' ' PHE . . . 97.51 14.63 40.37 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.458 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 158.84 37.98 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.833 1.316 . . . . 0.0 109.964 173.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -95.82 132.83 40.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.812 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.481 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.5 mt -80.23 159.79 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.156 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -128.86 150.06 50.5 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.513 0.673 . . . . 0.0 111.901 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -66.63 -18.71 65.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.737 1.215 . . . . 0.0 111.944 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.19 15.18 63.52 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -122.86 -151.56 0.48 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.429 1.091 . . . . 0.0 109.67 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 34.2 p -154.67 161.27 41.63 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.138 1.375 . . . . 0.0 108.881 174.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.54 -28.44 67.1 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.614 0.188 . . . . 0.0 111.226 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 31.0 t -75.47 -25.56 57.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.741 0.416 . . . . 0.0 110.736 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.45 -12.96 62.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.471 0.308 . . . . 0.0 111.369 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -116.39 19.45 14.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 p30 49.14 20.27 0.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.71 144.67 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 118.036 0.38 . . . . 0.0 110.043 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -130.14 -176.76 4.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.035 0.934 . . . . 0.0 109.963 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.93 146.8 54.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.24 16.82 7.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.298 1.039 . . . . 0.0 112.415 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -70.56 175.08 5.1 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -129.6 132.37 46.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.704 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -130.61 -177.1 4.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.473 1.109 . . . . 0.0 108.782 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -135.32 136.94 41.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -124.16 131.87 53.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 0.0 109.566 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -142.65 166.13 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.84 172.39 13.4 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.12 178.71 5.79 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.257 1.023 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.503 HD22 ' H ' ' B' ' 73' ' ' LEU . 0.9 OUTLIER -132.42 17.97 4.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.327 1.451 . . . . 0.0 109.041 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 50.52 -55.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.499 2.72 . . . . 0.0 115.645 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.18 -12.64 1.24 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 117.33 -1.816 . . . . 0.0 110.774 179.513 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 494' ' ' GLN . 85.6 Cg_endo -77.04 -162.95 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 1 C-N-CA 125.341 4.027 . . . . 0.0 108.969 175.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -67.68 25.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.0 pp0? -66.3 -24.44 66.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.66 1.184 . . . . 0.0 112.75 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.01 7.11 1.6 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . 0.456 ' CD2' HE21 ' A' ' 502' ' ' GLN . 7.8 mp -61.72 160.34 27.93 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 158.36 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 124.011 3.141 . . . . 0.0 111.549 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.18 66.89 3.88 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.849 0.833 . . . . 0.0 112.695 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 156.44 -23.94 0.51 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.54 168.04 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.679 0.792 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.9 157.11 45.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.677 0.791 . . . . 0.0 110.563 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.456 HE21 ' CD2' ' A' ' 496' ' ' LEU . 35.6 mm-40 -61.19 -46.77 89.12 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.135 0.574 . . . . 0.0 110.692 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.94 7.87 0.84 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.63 10.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.425 0.69 . . . . 0.0 111.257 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.84 -10.54 7.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.668 0.787 . . . . 0.0 109.936 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.52 17.7 4.39 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 111.339 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -89.53 6.35 41.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.645 0.778 . . . . 0.0 110.95 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.31 62.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.925 0.89 . . . . 0.0 110.938 -170.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.35 166.4 23.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.303 3.335 . . . . 0.0 113.028 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . 0.412 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -26.69 63.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.043 0.937 . . . . 0.0 111.832 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.07 -4.8 49.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.316 0.246 . . . . 0.0 111.447 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.14 -12.88 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.253 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.412 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 26.5 mm-40 -56.02 -40.73 73.86 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.64 -14.12 62.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.374 0.67 . . . . 0.0 112.412 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -89.96 -21.5 22.4 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.201 0.455 . . . . 0.0 111.464 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.2 mp -102.43 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 53.0 mt -65.97 -0.05 2.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 516' ' ' ILE . 50.1 m -133.76 17.58 3.89 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.792 1.237 . . . . 0.0 110.126 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -98.74 35.92 4.34 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.376 0.989 . . . . 0.0 111.38 -177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 0.37 0.06 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -177.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.9 t -149.56 173.05 14.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.497 0.719 . . . . 0.0 110.069 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.9 OUTLIER 63.11 7.49 2.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.14 1.776 . . . . 0.0 113.682 -178.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -155.39 150.88 27.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.385 0.539 . . . . 0.0 111.576 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.06 35.65 1.11 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.596 1.158 . . . . 0.0 109.383 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.62 4.46 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.122 0.969 . . . . 0.0 110.765 -172.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.87 1.268 . . . . 0.0 111.969 -176.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.637 0.256 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.75 174.75 14.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.831 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.29 -178.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 123.768 0.827 . . . . 0.0 109.029 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -134.83 106.23 6.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -97.45 112.79 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -92.62 129.81 38.44 Favored 'General case' 0 C--O 1.23 0.047 0 O-C-N 122.258 -0.276 . . . . 0.0 111.392 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.474 ' C ' ' H ' ' B' ' 9' ' ' THR . 74.4 p -78.65 177.89 8.26 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.591 1.156 . . . . 0.0 112.354 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.88 17.78 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.947 1.299 . . . . 0.0 110.425 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.474 ' H ' ' C ' ' B' ' 7' ' ' THR . 49.6 p -133.15 6.35 3.88 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 121.226 -0.921 . . . . 0.0 111.911 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.57 26.78 58.43 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 122.208 -0.307 . . . . 0.0 112.55 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -124.71 143.65 50.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.755 0.822 . . . . 0.0 108.877 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.12 159.12 26.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.585 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.02 130.4 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -79.63 131.9 36.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -143.4 133.56 24.4 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.754 0.252 . . . . 0.0 110.602 -173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -92.91 128.66 38.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.48 175.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.167 0.987 . . . . 0.0 109.534 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -135.49 160.84 66.32 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 124.259 1.023 . . . . 0.0 109.108 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.33 3.67 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.585 2.857 . . . . 0.0 113.502 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.426 ' H ' ' C ' ' B' ' 18' ' ' GLU . 29.8 p -125.74 -6.7 6.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.861 0.864 . . . . 0.0 110.874 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -86.5 78.6 9.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.3 t -63.59 172.19 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.811 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.573 HG12 ' HH ' ' B' ' 59' ' ' TYR . 16.6 mm -55.05 -27.59 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -67.68 -20.24 65.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 120.644 -1.285 . . . . 0.0 110.645 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.67 -45.25 12.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 110.167 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 3.1 m -66.36 -33.52 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 123.193 0.597 . . . . 0.0 110.93 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.446 ' HE3' HG21 ' B' ' 23' ' ' ILE . 95.0 mttt -56.77 -32.11 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.862 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -27.39 46.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.251 0.478 . . . . 0.0 110.924 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -67.57 -32.59 73.45 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.187 0.449 . . . . 0.0 109.932 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -83.91 -31.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.17 -39.97 86.53 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.8 0.334 . . . . 0.0 110.273 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.18 -31.41 71.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.206 0.527 . . . . 0.0 111.183 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.6 -24.79 31.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.663 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -135.31 -35.04 0.84 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.83 7.86 16.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -77.87 128.26 79.65 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.57 154.8 55.09 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.053 2.502 . . . . 0.0 111.373 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.63 -14.41 41.92 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.352 2.701 . . . . 0.0 110.227 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.52 -8.02 59.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.84 -18.79 5.46 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.26 162.15 20.68 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.517 1.053 . . . . 0.0 112.167 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -151.58 136.15 17.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.416 ' C ' HD13 ' B' ' 44' ' ' ILE . 41.2 tp -134.18 136.23 43.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.241 0.473 . . . . 0.0 111.141 -168.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.416 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -132.52 150.74 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.266 1.026 . . . . 0.0 108.909 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -150.47 143.1 24.54 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.468 1.107 . . . . 0.0 109.287 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.94 13.42 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.545 0.738 . . . . 0.0 112.585 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.26 15.77 43.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.32 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 158.97 40.16 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.653 1.226 . . . . 0.0 109.966 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -90.74 150.32 21.67 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.811 -172.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.501 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -106.93 162.7 13.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.162 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -133.1 148.5 52.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.091 0.948 . . . . 0.0 112.542 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.51 -1.81 9.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.284 1.034 . . . . 0.0 111.905 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.47 6.2 33.71 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -107.65 -147.97 0.41 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.367 0.584 . . . . 0.0 109.699 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.2 p -152.13 155.94 38.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.85 2.06 . . . . 0.0 107.743 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.31 -24.04 67.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.185 0.448 . . . . 0.0 110.05 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -71.19 -25.32 62.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.25 1.02 . . . . 0.0 111.494 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.11 -13.99 60.19 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.101 0.56 . . . . 0.0 111.531 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.573 ' HH ' HG12 ' B' ' 23' ' ' ILE . 0.2 OUTLIER -115.06 20.7 14.83 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.29 21.21 0.34 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.83 140.11 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-O 121.213 0.53 . . . . 0.0 110.271 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.39 -173.93 3.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.912 1.285 . . . . 0.0 109.343 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.86 142.97 58.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.081 0.467 . . . . 0.0 110.717 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 54.29 25.26 5.71 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.173 0.989 . . . . 0.0 113.11 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.52 -15.44 60.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 60.11 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.34 1.856 . . . . 0.0 112.955 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.61 -178.12 4.86 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.377 1.471 . . . . 0.0 108.719 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -135.54 120.78 18.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.519 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 35.8 tp -103.25 136.03 43.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.729 1.212 . . . . 0.0 110.088 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.67 169.29 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.75 170.1 18.96 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.416 -0.803 . . . . 0.0 111.566 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.23 -177.2 5.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.795 0.838 . . . . 0.0 110.644 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.59 18.34 3.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 56.79 -45.46 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.374 2.67 . . . . 0.0 114.799 -169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.69 -12.5 1.32 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 117.247 -1.863 . . . . 0.0 110.809 179.805 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.557 ' C ' ' H ' ' A' ' 494' ' ' GLN . 58.5 Cg_endo -84.63 -159.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 1 C-N-CA 125.575 4.184 . . . . 0.0 108.073 174.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.14 27.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.557 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.0 pp0? -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 0.0 113.084 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.54 5.92 1.84 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . 0.475 ' CD2' HE21 ' A' ' 502' ' ' GLN . 6.0 mp -60.85 138.48 93.66 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.17 159.99 11.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.793 2.995 . . . . 0.0 111.387 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.16 56.76 2.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.174 0.988 . . . . 0.0 109.903 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 176.24 27.75 0.03 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.423 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.95 162.34 13.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 124.128 0.971 . . . . 0.0 108.498 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.07 156.6 47.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 110.259 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.475 HE21 ' CD2' ' A' ' 496' ' ' LEU . 32.3 mm-40 -59.52 -40.64 87.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.055 0.542 . . . . 0.0 109.893 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.36 1.56 2.16 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.25 13.51 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 122.039 -0.413 . . . . 0.0 111.202 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.446 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.4 OUTLIER -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.288 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -73.66 -8.11 54.66 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.689 -0.632 . . . . 0.0 110.474 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.18 -5.74 58.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.544 1.138 . . . . 0.0 110.206 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 48.1 mt -87.1 155.81 54.92 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 123.976 0.91 . . . . 0.0 109.934 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.7 162.52 37.57 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.879 2.386 . . . . 0.0 110.811 169.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.09 -15.5 23.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.513 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -96.9 0.88 49.77 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.092 0.405 . . . . 0.0 111.343 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.2 mt -114.97 -19.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.081 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -48.89 -54.59 14.76 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.38 -11.72 3.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . 0.418 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 7.8 mm-40 -91.8 -25.28 19.09 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.103 0.41 . . . . 0.0 110.498 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.424 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 3.3 mm -95.72 -38.06 8.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 118.364 0.529 . . . . 0.0 109.691 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -10.66 58.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 22.7 t -63.97 -55.78 19.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.359 0.664 . . . . 0.0 110.847 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 135.21 133.96 3.32 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 516' ' ' ILE . 59.3 mttm -143.14 158.43 43.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.088 0.955 . . . . 0.0 109.127 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.2 m -146.88 30.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.22 1.008 . . . . 0.0 113.003 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.34 15.78 2.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.973 1.309 . . . . 0.0 111.631 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 523' ' ' GLU . 1.0 OUTLIER -139.08 151.8 47.03 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.218 1.007 . . . . 0.0 109.441 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 526' ' ' LYS . 20.7 m-80 -148.59 27.97 0.89 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.3 0.64 . . . . 0.0 111.459 -171.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.276 3.9 pp 48.13 12.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.722 1.609 . . . . 0.0 114.041 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 524' ' ' ASN . 33.9 mtmm . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 126.334 1.854 . . . . 0.0 111.606 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -158.8 174.08 15.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.166 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.58 179.22 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.45 99.62 4.72 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.55 124.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.1 ttmt -108.41 135.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.025 0.44 . . . . 0.0 111.455 -173.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -72.58 171.83 11.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.208 1.003 . . . . 0.0 112.436 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.58 -1.66 3.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.791 1.236 . . . . 0.0 110.336 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.9 p -115.93 -5.76 12.02 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.725 -0.609 . . . . 0.0 112.567 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.89 19.59 14.8 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.549 -0.584 . . . . 0.0 113.89 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -121.17 137.55 54.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.835 0.817 . . . . 0.0 109.744 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.4 OUTLIER -106.86 159.67 16.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.05 -174.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.72 127.22 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -78.67 132.84 37.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -143.96 132.98 22.8 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.655 0.264 . . . . 0.0 110.392 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.01 128.66 37.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 179.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.493 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.0 mm-40 -131.57 160.09 68.9 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.65 1.07 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.129 2.553 . . . . 0.0 113.5 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.6 m -125.27 -2.21 7.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.609 0.641 . . . . 0.0 111.067 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -80.25 68.04 6.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 2.9 t -57.4 173.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.877 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.625 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 14.1 mm -51.89 -28.29 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -168.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -73.37 -19.93 60.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.512 1.051 . . . . 0.0 111.435 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -85.35 -45.6 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.611 0.764 . . . . 0.0 110.834 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.625 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.1 OUTLIER -66.46 -28.31 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 122.667 0.387 . . . . 0.0 110.521 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.519 ' HE3' HG21 ' B' ' 23' ' ' ILE . 90.1 mttt -58.11 -29.9 65.86 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.862 172.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.95 41.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.957 0.344 . . . . 0.0 111.042 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.46 -31.19 71.78 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.074 0.397 . . . . 0.0 109.99 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.14 -30.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.65 -40.03 84.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.792 0.33 . . . . 0.0 110.204 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.72 -32.72 74.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.3 0.571 . . . . 0.0 111.223 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -82.02 -24.46 35.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.98 -34.52 0.8 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.08 8.12 15.73 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.5 mt -75.7 128.9 82.79 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.56 152.79 70.38 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.664 2.243 . . . . 0.0 111.071 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.98 -15.3 36.23 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.379 2.719 . . . . 0.0 110.566 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.84 -7.97 59.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -124.23 -15.72 6.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -65.52 164.9 13.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.139 0.881 . . . . 0.0 112.299 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -152.89 135.42 15.18 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' HD11 ' B' ' 44' ' ' ILE . 36.7 tp -131.83 138.11 48.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 118.568 0.622 . . . . 0.0 110.917 -168.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.407 HD11 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -134.93 149.18 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.306 1.043 . . . . 0.0 109.047 -172.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -153.2 146.57 24.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.016 0.926 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 15.2 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.195 0.598 . . . . 0.0 111.848 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.39 56.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.417 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 158.4 40.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.535 1.167 . . . . 0.0 109.87 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.92 144.47 26.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.721 -1.127 . . . . 0.0 107.98 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 17.2 mt -101.33 159.5 15.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.767 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -125.32 144.97 50.24 Favored 'General case' 0 CA--C 1.524 -0.054 0 CA-C-O 121.357 0.599 . . . . 0.0 112.085 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.64 -0.66 7.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.555 1.142 . . . . 0.0 111.827 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.76 11.57 38.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.79 -149.19 0.44 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 109.298 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.501 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -153.17 157.91 41.0 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.861 1.665 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.81 -28.96 69.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -68.4 -26.04 65.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.828 1.251 . . . . 0.0 111.779 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -75.13 -12.12 60.24 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.057 0.543 . . . . 0.0 111.603 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.29 17.74 14.62 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.89 27.39 1.59 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.637 1.575 . . . . 0.0 114.408 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.84 141.24 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -129.81 -174.03 3.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.696 1.199 . . . . 0.0 109.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.39 143.56 57.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.642 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 54.35 24.3 5.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.924 0.89 . . . . 0.0 113.244 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -72.4 -16.81 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.0 m 60.0 132.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.316 1.846 . . . . 0.0 112.674 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.62 -179.7 5.62 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.709 1.204 . . . . 0.0 108.776 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -135.64 122.51 21.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 110.72 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.09 140.46 36.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.107 1.363 . . . . 0.0 110.064 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.87 162.86 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.86 171.66 16.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.658 -0.651 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -91.25 174.9 7.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.429 0.692 . . . . 0.0 110.116 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -122.14 25.5 8.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.518 0.727 . . . . 0.0 110.268 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 66.01 -25.33 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 113.61 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -139.68 8.87 3.11 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 117.287 -1.84 . . . . 0.0 111.065 179.162 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 494' ' ' GLN . 71.6 Cg_endo -76.72 -167.1 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 1 C-N-CA 125.686 4.258 . . . . 0.0 109.862 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 32.09 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.866 1.267 . . . . 0.0 112.737 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -69.63 -35.39 75.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.73 4.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.351 0.661 . . . . 0.0 112.123 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 99.0 mt -68.98 160.98 75.78 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 122.755 0.422 . . . . 0.0 109.923 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.62 147.77 38.09 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.785 2.99 . . . . 0.0 111.642 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.83 54.69 1.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.292 1.044 . . . . 0.0 110.257 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.67 25.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.165 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 45.0 t -136.47 162.02 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 118.357 1.079 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -121.67 143.65 49.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.264 0.626 . . . . 0.0 109.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.41 ' N ' HE21 ' A' ' 502' ' ' GLN . 0.0 OUTLIER -68.96 -32.44 72.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.645 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.87 10.63 1.73 Allowed 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.303 -0.873 . . . . 0.0 110.575 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 83.1 t -129.86 8.52 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.585 1.154 . . . . 0.0 109.827 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.37 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.247 -0.908 . . . . 0.0 112.738 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -69.47 -9.15 52.51 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.479 -0.763 . . . . 0.0 112.1 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -80.74 -11.0 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.945 0.339 . . . . 0.0 110.803 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.21 150.59 68.27 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.125 0.97 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.37 163.38 26.83 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.565 2.177 . . . . 0.0 111.165 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.54 -23.59 64.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.287 0.635 . . . . 0.0 112.117 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.66 -1.22 56.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 122.352 0.261 . . . . 0.0 111.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 33.1 mt -117.44 -13.88 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -55.24 -43.56 74.67 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.81 -5.74 40.15 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.387 0.675 . . . . 0.0 112.469 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.63 -17.41 17.04 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.254 0.479 . . . . 0.0 111.967 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.3 mp -103.77 -28.47 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.61 -3.8 2.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.891 0.476 . . . . 0.0 110.049 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 516' ' ' ILE . 52.5 m -137.24 17.51 2.97 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.725 1.21 . . . . 0.0 110.709 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -115.34 43.8 1.61 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.67 0.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.0 t -145.23 178.23 8.23 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.514 0.726 . . . . 0.0 110.232 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.21 2.03 3.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.822 1.649 . . . . 0.0 112.958 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.42 141.2 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.175 0.443 . . . . 0.0 110.726 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 526' ' ' LYS . 34.4 m-80 -144.18 36.67 1.24 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.429 0.692 . . . . 0.0 110.244 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.335 0.5 OUTLIER 56.84 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.387 1.875 . . . . 0.0 114.715 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.547 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 C-N-CA 125.082 1.353 . . . . 0.0 110.352 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.277 0.084 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -157.2 173.23 17.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.05 179.98 3.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 123.823 0.849 . . . . 0.0 109.114 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -131.93 101.29 5.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.51 104.62 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -90.99 135.59 33.64 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.675 0.39 . . . . 0.0 112.02 -172.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.7 p -77.62 173.1 12.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.634 0.774 . . . . 0.0 111.973 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.94 -22.85 63.0 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.168 0.987 . . . . 0.0 110.321 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -94.61 -5.08 46.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.767 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.17 25.38 14.39 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.579 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -120.8 144.27 48.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.14 159.75 24.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 111.439 -173.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 mt -129.74 131.98 66.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 42.8 m -84.01 133.94 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.1 mt -145.39 138.29 26.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.26 127.3 44.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.9 176.73 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.069 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.0 mm-40 -135.54 161.87 60.56 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 108.795 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.63 1.59 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.293 2.662 . . . . 0.0 113.593 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.8 m -127.17 -5.89 6.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.586 0.63 . . . . 0.0 110.846 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -83.4 71.29 10.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.5 t -63.68 176.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.686 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.459 HG21 ' HE3' ' B' ' 27' ' ' LYS . 15.3 mm -51.55 -35.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -168.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.1 -20.71 65.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.296 0.953 . . . . 0.0 111.03 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -84.79 -42.73 14.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.49 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.382 1.073 . . . . 0.0 110.4 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.459 ' HE3' HG21 ' B' ' 23' ' ' ILE . 89.6 mttt -56.22 -23.61 36.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.945 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -27.11 31.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.35 0.523 . . . . 0.0 110.592 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.23 -36.43 77.2 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.052 0.387 . . . . 0.0 110.129 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -83.09 -32.43 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.07 -38.36 85.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.2 -32.56 72.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.295 0.569 . . . . 0.0 111.399 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -80.53 -24.75 39.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.205 1.002 . . . . 0.0 113.472 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.71 -31.26 0.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.58 9.44 23.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.06 131.24 76.14 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.51 157.57 61.28 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.427 2.085 . . . . 0.0 111.03 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.1 -11.07 30.8 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.868 3.045 . . . . 0.0 112.045 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.34 -5.5 29.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -126.11 3.54 7.18 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.5 -54.47 19.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 60.6 82.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.506 1.922 . . . . 0.0 110.919 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.418 ' C ' HD11 ' B' ' 44' ' ' ILE . 26.2 tp -90.1 137.09 32.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.573 1.149 . . . . 0.0 111.173 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.418 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.0 mp -133.42 149.93 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.551 1.14 . . . . 0.0 108.881 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -153.62 149.85 28.02 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.035 0.934 . . . . 0.0 109.378 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.17 16.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.626 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.38 56.42 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.124 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 160.5 37.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.449 1.125 . . . . 0.0 110.759 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.67 124.42 38.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.521 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.475 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -79.49 164.25 24.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.524 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -126.79 147.86 49.98 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.4 0.619 . . . . 0.0 111.89 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.13 -1.91 16.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.11 0.964 . . . . 0.0 111.996 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.09 14.64 44.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -120.29 -149.84 0.44 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.578 1.151 . . . . 0.0 108.988 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.95 156.84 39.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 126.068 1.747 . . . . 0.0 108.903 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -60.57 -24.41 65.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -73.31 -25.03 60.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 111.41 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -75.57 -14.07 60.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.161 0.584 . . . . 0.0 111.818 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.475 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -115.74 21.18 14.1 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 p30 49.49 19.46 0.37 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.7 138.66 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 121.338 0.589 . . . . 0.0 110.56 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -130.38 -177.52 4.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.966 1.306 . . . . 0.0 108.871 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -60.61 145.16 49.97 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.022 0.439 . . . . 0.0 110.778 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 55.66 22.78 5.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.212 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -74.4 -14.23 60.83 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 74.9 m 61.16 130.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.187 1.795 . . . . 0.0 112.11 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.88 -179.9 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.601 1.16 . . . . 0.0 108.687 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -135.59 152.77 51.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -140.14 138.47 35.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.464 1.106 . . . . 0.0 108.528 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.91 68.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.89 163.88 1.78 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -72.61 -168.75 0.47 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.319 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' B' ' 75' ' ' GLY . 13.8 tp -101.97 17.38 23.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.5 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 62.67 -27.3 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.155 2.182 . . . . 0.0 114.416 -175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 148.38 -14.06 1.24 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.444 -1.753 . . . . 0.0 111.164 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.435 ' H ' HD11 ' A' ' 491' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 494' ' ' GLN . 96.2 Cg_endo -81.31 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 1 C-N-CA 125.47 4.113 . . . . 0.0 109.023 178.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.93 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.326 1.85 . . . . 0.0 113.181 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.562 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.7 pp0? -71.75 -27.2 62.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.052 0.941 . . . . 0.0 112.291 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -150.17 4.41 0.54 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.75 142.87 94.49 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.253 0.479 . . . . 0.0 110.273 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.04 157.45 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.051 3.167 . . . . 0.0 111.226 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.12 57.41 2.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 122.52 1.153 . . . . 0.0 110.08 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.71 26.7 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.829 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.44 164.34 6.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.693 0.747 . . . . 0.0 109.156 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -134.45 144.0 47.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.0 109.419 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.0 -28.82 69.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.491 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -71.38 -0.9 11.28 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.694 -0.629 . . . . 0.0 111.824 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.84 18.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.0 OUTLIER -124.85 -20.93 4.86 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.24 1.016 . . . . 0.0 110.081 176.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -71.61 5.84 2.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -87.87 7.72 29.4 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.755 0.822 . . . . 0.0 110.578 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 39.1 mt -116.02 157.33 45.26 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 124.204 1.002 . . . . 0.0 111.258 -171.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.94 163.31 35.67 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.857 2.371 . . . . 0.0 110.373 167.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.19 -18.4 36.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.192 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.04 -4.93 58.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.103 0.561 . . . . 0.0 111.429 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.5 mt -117.32 -15.9 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -51.61 -50.72 59.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.86 -14.1 13.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.06 -18.35 27.47 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.641 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.5 mm -104.37 -40.93 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 505' ' ' PHE . 0.3 OUTLIER -64.62 -10.58 27.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.0 t -58.28 -35.71 72.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.113 0.565 . . . . 0.0 111.123 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 105.5 38.88 2.33 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -58.44 172.07 0.52 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.754 1.222 . . . . 0.0 111.912 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.4 m -146.37 34.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.759 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.6 15.63 4.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.745 1.218 . . . . 0.0 111.375 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.52 143.46 26.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.043 0.937 . . . . 0.0 109.176 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -148.77 38.4 0.83 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.217 0.607 . . . . 0.0 112.149 -168.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.41 19.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.804 1.642 . . . . 0.0 114.197 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -176.662 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.51 173.33 16.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.413 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.39 179.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 123.139 0.576 . . . . 0.0 109.774 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -133.18 106.28 7.49 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.43 69.39 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.908 0.483 . . . . 0.0 111.284 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -58.68 133.25 55.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.901 0.481 . . . . 0.0 111.519 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.39 175.58 10.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.59 -23.44 67.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.354 0.662 . . . . 0.0 110.228 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.2 p -89.32 -22.07 22.83 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.905 -0.497 . . . . 0.0 110.39 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.52 4.69 21.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.021 0.368 . . . . 0.0 114.021 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -83.57 153.81 24.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.97 159.17 38.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.742 0.701 . . . . 0.0 109.398 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.77 126.75 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m -79.26 129.96 34.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -140.59 133.36 28.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.21 129.22 39.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.43 178.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.864 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.1 mm-40 -132.66 161.5 63.0 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.964 0.906 . . . . 0.0 108.579 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.7 3.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.98 2.453 . . . . 0.0 113.429 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.434 ' H ' ' C ' ' B' ' 18' ' ' GLU . 59.8 m -125.79 -4.12 7.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.739 0.7 . . . . 0.0 110.825 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.1 76.92 10.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.2 t -62.34 171.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.8 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.439 HG22 ' HE3' ' B' ' 27' ' ' LYS . 12.2 mm -55.31 -28.04 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -168.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.1 -19.51 65.65 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.87 -1.144 . . . . 0.0 110.427 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -85.12 -46.11 11.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.853 0.861 . . . . 0.0 110.079 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 2.8 m -66.43 -34.48 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.118 0.567 . . . . 0.0 110.973 -173.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.439 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -56.33 -31.99 64.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.165 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.82 47.86 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.386 0.539 . . . . 0.0 110.856 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -68.1 -33.28 74.23 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.987 0.358 . . . . 0.0 110.086 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.77 -31.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.76 -39.4 87.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 -31.53 71.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.333 0.587 . . . . 0.0 111.275 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -83.95 -22.2 31.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -139.67 -30.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.53 8.26 19.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -76.17 128.56 82.56 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.67 154.8 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.493 2.128 . . . . 0.0 110.771 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.71 -14.19 38.71 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.543 2.829 . . . . 0.0 110.94 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.47 -6.21 58.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -118.99 -18.13 8.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.85 162.68 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.45 1.023 . . . . 0.0 112.339 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -155.03 128.76 8.62 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.36 128.73 36.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.893 0.315 . . . . 0.0 110.984 -168.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.77 155.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -120.96 -111.69 0.33 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 122.695 0.398 . . . . 0.0 110.685 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.85 -4.9 3.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.302 0.641 . . . . 0.0 111.689 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.97 1.69 2.0 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.596 1.093 . . . . 0.0 111.519 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 154.71 33.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.704 0.764 . . . . 0.0 109.554 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.97 129.95 35.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.348 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.466 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.0 mt -77.68 162.67 26.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.83 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -127.98 146.92 50.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.432 0.634 . . . . 0.0 111.706 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.45 -1.33 10.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.438 1.095 . . . . 0.0 111.798 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 16.05 35.13 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -121.34 -148.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.307 1.043 . . . . 0.0 109.45 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.458 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.3 p -152.36 156.19 39.08 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 126.257 1.823 . . . . 0.0 108.357 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.04 -23.99 66.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -71.88 -25.29 61.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.281 1.032 . . . . 0.0 111.545 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.43 -12.88 60.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.098 0.559 . . . . 0.0 111.515 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.09 20.77 13.61 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.7 25.21 0.4 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.12 142.4 16.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.171 0.51 . . . . 0.0 110.112 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -130.39 -173.47 3.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.058 1.343 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.89 142.54 58.24 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.0 110.409 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 55.92 21.2 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.252 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -71.85 -16.61 62.15 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 84.4 m 62.33 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.16 1.784 . . . . 0.0 112.226 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -145.47 -176.48 5.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.728 1.211 . . . . 0.0 108.708 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -136.48 104.98 5.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.37 129.77 36.23 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.694 0.798 . . . . 0.0 109.146 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.24 52.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.431 0.634 . . . . 0.0 109.378 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.85 168.88 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 114.209 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -94.47 172.28 8.29 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.498 0.719 . . . . 0.0 109.802 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.9 26.31 9.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.948 1.299 . . . . 0.0 111.734 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -48.42 -33.2 8.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.376 1.07 . . . . 0.0 112.504 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.64 -15.66 7.98 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.326 -178.091 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.565 ' C ' ' H ' ' A' ' 494' ' ' GLN . 87.6 Cg_endo -77.58 -167.61 0.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.95 3.766 . . . . 0.0 108.319 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -65.26 26.92 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -65.43 -28.91 69.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.471 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -148.09 6.39 0.78 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.79 159.38 85.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.59 155.0 22.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.853 3.035 . . . . 0.0 111.954 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -83.69 55.31 3.18 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 122.423 1.106 . . . . 0.0 109.509 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.74 26.5 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.995 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 86.4 t -146.74 164.35 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.49 143.13 45.66 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.036 0.934 . . . . 0.0 108.751 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.54 -24.11 67.03 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.852 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.94 1.84 4.09 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.737 -0.602 . . . . 0.0 111.601 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.53 11.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.672 0.789 . . . . 0.0 110.647 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -17.72 7.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.985 0.914 . . . . 0.0 109.875 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.72 3.15 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.957 -0.465 . . . . 0.0 111.345 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -88.65 -5.12 58.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -93.04 159.31 35.88 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.179 1.392 . . . . 0.0 110.128 -173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.22 165.48 31.81 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.295 2.663 . . . . 0.0 111.325 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.75 -12.51 10.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.027 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.5 1.17 40.81 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.058 0.543 . . . . 0.0 111.43 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 52.0 mt -119.16 -14.48 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -43.91 67.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 169.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.74 -4.42 37.43 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.424 0.689 . . . . 0.0 112.388 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -100.12 -21.64 15.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.501 0.591 . . . . 0.0 111.433 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.69 -34.41 4.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.64 -3.35 3.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.667 0.387 . . . . 0.0 110.516 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 41.5 m -137.44 18.32 2.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.361 0.664 . . . . 0.0 111.409 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.54 -39.51 5.29 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp 49.43 1.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.7 t -167.76 -172.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.981 0.809 . . . . 0.0 109.818 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 68.0 11.56 8.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.469 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -153.92 154.34 33.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.559 0.343 . . . . 0.0 110.854 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -149.72 46.93 0.94 Allowed 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.856 0.863 . . . . 0.0 110.795 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 1.1 pt? 44.14 19.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.961 1.704 . . . . 0.0 113.95 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.944 1.297 . . . . 0.0 112.625 -177.318 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -158.44 173.66 16.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.094 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.78 179.28 4.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -134.69 103.27 5.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.58 113.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.42 130.8 37.99 Favored 'General case' 0 N--CA 1.458 -0.052 0 O-C-N 122.205 -0.31 . . . . 0.0 111.222 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -72.3 174.37 7.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.417 1.087 . . . . 0.0 112.058 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.12 -5.02 8.56 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.073 0.949 . . . . 0.0 110.17 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -112.97 1.36 15.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.556 -0.715 . . . . 0.0 111.528 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.28 26.05 31.86 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.606 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -123.56 145.01 49.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.17 159.94 21.82 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.434 -174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -129.45 127.69 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -77.81 130.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -140.67 131.23 25.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.11 127.32 35.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.622 0.769 . . . . 0.0 108.998 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.1 178.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.183 0.993 . . . . 0.0 109.444 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.8 mt-10 -141.45 163.81 39.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.19 2.25 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.531 2.821 . . . . 0.0 113.62 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.433 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.7 m -129.42 -5.64 4.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.058 0.845 . . . . 0.0 111.215 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.89 68.32 9.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 9.2 t -61.25 179.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.921 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.433 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 11.4 mm -59.24 -11.91 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -168.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.85 -17.96 28.62 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.815 1.189 . . . . 0.0 110.483 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -85.02 -40.82 16.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.537 0.735 . . . . 0.0 109.993 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 20.4 m -64.36 -31.11 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 123.728 0.811 . . . . 0.0 110.155 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.53 -25.28 66.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.83 -26.44 29.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.314 0.507 . . . . 0.0 110.821 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -70.34 -36.5 74.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.096 0.407 . . . . 0.0 110.392 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -81.76 -30.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -68.16 -39.73 82.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.24 -31.21 71.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.246 0.545 . . . . 0.0 111.348 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -82.5 -24.2 34.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.57 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -136.77 -33.82 0.77 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 9.52 17.66 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.8 mt -76.64 129.87 78.15 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.83 156.1 61.18 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 111.055 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.1 -14.14 40.01 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.967 3.111 . . . . 0.0 110.804 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -90.45 -3.0 57.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -123.91 -11.81 7.59 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.88 167.64 21.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.103 0.865 . . . . 0.0 112.464 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -158.67 134.55 8.95 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.93 1.292 . . . . 0.0 108.002 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.446 ' C ' HD11 ' B' ' 44' ' ' ILE . 16.7 mt -126.47 141.49 51.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.531 0.333 . . . . 0.0 110.43 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.446 HD11 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -129.31 148.72 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -148.36 134.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.833 0.853 . . . . 0.0 109.009 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.93 19.87 0.71 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.556 0.742 . . . . 0.0 112.827 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.59 25.37 39.17 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 123.04 0.352 . . . . 0.0 112.749 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.607 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.8 ttmm -123.37 125.59 45.28 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.119 0.568 . . . . 0.0 110.756 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -76.57 110.8 11.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.531 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -68.63 171.11 8.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -174.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -132.52 152.85 51.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.676 0.751 . . . . 0.0 112.004 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.88 -1.82 15.67 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.455 1.102 . . . . 0.0 111.892 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.28 15.06 36.23 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -117.88 -154.7 0.57 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.326 1.05 . . . . 0.0 109.16 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.453 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.7 p -149.64 159.67 44.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.599 1.56 . . . . 0.0 107.9 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.62 -27.27 69.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -71.25 -25.75 62.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.34 1.056 . . . . 0.0 112.143 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.95 -16.94 61.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.828 0.451 . . . . 0.0 111.323 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.607 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.1 m-85 -128.64 26.87 5.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.187 0.595 . . . . 0.0 110.065 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.84 28.47 0.59 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.82 132.91 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.8 -173.11 3.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 109.747 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.12 142.24 37.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.093 0.473 . . . . 0.0 111.264 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 52.97 27.14 5.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.806 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.9 p -69.59 -24.96 63.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m 59.99 127.65 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.019 2.128 . . . . 0.0 112.161 -174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -131.29 -176.83 4.15 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.094 1.358 . . . . 0.0 108.238 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -135.56 135.26 40.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.93 135.16 55.0 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.748 1.219 . . . . 0.0 110.085 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -139.37 160.2 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.64 172.16 14.01 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.98 -177.19 5.7 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 123.968 0.907 . . . . 0.0 112.76 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' B' ' 75' ' ' GLY . 9.0 tp -110.02 22.09 16.02 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.901 0.881 . . . . 0.0 111.422 -169.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 64.05 -25.81 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.809 2.044 . . . . 0.0 113.352 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 147.03 -12.93 1.46 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 117.255 -1.859 . . . . 0.0 111.042 -179.669 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.1 Cg_endo -77.33 -165.47 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 125.113 3.875 . . . . 0.0 109.319 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.3 pt? -69.92 27.65 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 492' ' ' PRO . 4.2 pp0? -64.5 -25.91 68.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 0.0 111.785 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -149.88 4.8 0.57 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.88 162.16 74.8 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 122.105 -0.372 . . . . 0.0 110.561 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.61 151.42 31.39 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.183 3.255 . . . . 0.0 111.616 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.74 55.33 2.35 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 122.196 0.998 . . . . 0.0 109.939 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 168.93 31.33 0.02 OUTLIER Glycine 0 CA--C 1.527 0.816 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.019 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 49.0 t -141.86 165.03 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.801 0.801 . . . . 0.0 109.657 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.9 141.04 47.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.391 1.076 . . . . 0.0 109.306 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.17 -33.73 76.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.074 -177.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.76 5.2 3.33 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.54 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.9 11.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.513 0.725 . . . . 0.0 111.013 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.14 -13.68 8.92 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.835 0.854 . . . . 0.0 109.939 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -82.68 18.76 1.46 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.412 0.685 . . . . 0.0 111.921 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -94.46 7.69 44.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.542 0.737 . . . . 0.0 111.415 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 156.81 69.37 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.594 1.158 . . . . 0.0 110.495 -171.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.35 164.66 22.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.157 3.238 . . . . 0.0 113.054 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -59.11 -25.48 63.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.622 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.94 -6.56 51.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.47 0.308 . . . . 0.0 111.251 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 18.1 mt -118.1 -12.74 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 170.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 23.6 mm-40 -58.41 -39.7 80.46 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.84 -11.03 60.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.391 0.676 . . . . 0.0 112.204 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.69 -19.35 21.92 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.255 0.48 . . . . 0.0 111.553 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.3 mp -105.61 -27.18 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 65.7 mt -64.47 -2.96 2.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 516' ' ' ILE . 50.4 m -138.42 21.0 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.959 1.304 . . . . 0.0 110.024 173.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -107.23 46.64 1.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.476 1.036 . . . . 0.0 110.993 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -56.46 2.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.3 t -149.06 -175.95 5.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.468 0.651 . . . . 0.0 111.039 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 65.76 3.79 2.64 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.523 1.929 . . . . 0.0 114.652 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -155.36 148.58 24.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.1 0.864 . . . . 0.0 111.43 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 526' ' ' LYS . 37.1 m-80 -147.19 43.83 1.14 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.952 0.901 . . . . 0.0 111.116 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.298 3.2 pp 50.19 9.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.623 1.569 . . . . 0.0 114.051 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 524' ' ' ASN . 43.5 mtmt . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 127.752 2.421 . . . . 0.0 110.368 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.704 0.288 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.4 172.94 17.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.251 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.48 -177.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.597 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 96.2 m-85 -130.66 128.25 40.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.77 121.13 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.27 142.6 33.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -172.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -88.37 178.79 6.47 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.146 1.379 . . . . 0.0 112.912 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.97 6.47 1.54 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.839 1.255 . . . . 0.0 110.239 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -124.55 9.0 8.35 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.94 -1.1 . . . . 0.0 111.993 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.74 60.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 120.133 -0.259 . . . . 0.0 113.211 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -119.76 139.48 52.24 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.597 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 9.0 m -113.43 142.5 45.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.41 132.9 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -87.08 133.79 33.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 mt -142.6 135.04 27.78 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.47 130.3 37.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 109.086 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.57 179.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.788 0.835 . . . . 0.0 109.89 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' B' ' 20' ' ' SER . 35.4 mt-10 -140.21 163.46 43.77 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.86 2.92 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.463 2.775 . . . . 0.0 113.722 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.446 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.0 m -127.73 -7.1 5.63 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.771 0.714 . . . . 0.0 110.971 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.82 67.57 5.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.1 t -59.61 175.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.786 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.8 mm -49.94 -34.73 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.55 -21.39 61.89 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.363 0.983 . . . . 0.0 111.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -81.76 -37.21 27.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.46 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.5 t -64.77 -39.4 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.226 1.01 . . . . 0.0 109.862 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -59.04 -28.08 66.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.758 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -24.13 54.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.516 0.598 . . . . 0.0 110.6 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 69.1 mmtt -69.76 -44.54 69.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.528 0.731 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.12 -30.22 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.581 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.57 -40.74 80.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.29 -30.55 70.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.176 0.512 . . . . 0.0 111.352 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -85.63 -19.58 30.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.5 -40.01 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.361 0.528 . . . . 0.0 112.001 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.29 9.04 12.14 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.6 mt -79.18 128.53 75.62 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.34 151.98 66.08 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.76 2.306 . . . . 0.0 110.812 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.65 -15.48 41.2 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.251 2.634 . . . . 0.0 110.441 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -7.97 59.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.781 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -124.3 -13.39 7.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -69.96 165.18 22.28 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.619 1.1 . . . . 0.0 111.999 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -154.64 141.49 19.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.449 ' C ' HD13 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -135.95 139.48 43.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.567 0.621 . . . . 0.0 111.398 -169.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.449 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -130.85 148.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.751 0.82 . . . . 0.0 109.197 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -149.87 134.16 17.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.935 0.894 . . . . 0.0 108.867 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.3 19.98 0.86 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.59 0.756 . . . . 0.0 112.504 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 24.29 44.96 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 123.009 0.338 . . . . 0.0 112.55 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.609 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.7 ttmm -120.56 124.56 45.62 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 122.797 0.439 . . . . 0.0 110.432 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -75.93 108.79 9.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' B' ' 59' ' ' TYR . 1.0 OUTLIER -68.02 170.26 8.64 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.452 -174.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -132.49 153.64 50.7 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 121.64 0.733 . . . . 0.0 111.393 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.76 3.01 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.408 1.083 . . . . 0.0 111.769 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.96 16.8 20.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -118.25 -154.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.598 1.159 . . . . 0.0 109.087 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.466 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -148.88 159.58 44.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.304 1.442 . . . . 0.0 108.479 172.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.31 -27.62 69.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -25.2 60.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.361 1.064 . . . . 0.0 111.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.81 -18.88 61.42 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.302 0.641 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.609 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 22.9 m-85 -129.23 26.76 5.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.553 0.741 . . . . 0.0 109.991 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.27 31.01 0.74 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.18 125.12 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -131.18 -173.25 3.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.456 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.24 141.39 35.56 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 111.585 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.5 24.96 3.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.666 1.186 . . . . 0.0 113.627 174.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -70.67 -17.68 62.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m 59.41 130.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.17 2.188 . . . . 0.0 112.32 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -138.89 -178.34 5.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.392 1.077 . . . . 0.0 109.076 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.85 147.34 48.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.912 0.387 . . . . 0.0 111.275 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.5 tp -132.66 137.97 47.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.282 1.433 . . . . 0.0 110.033 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -143.84 165.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.37 170.56 15.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.876 0.762 . . . . 0.0 112.833 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.98 178.08 5.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.1 0.96 . . . . 0.0 111.377 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -112.15 21.54 15.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.008 -173.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 62.82 -30.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 127.2 2.2 . . . . 0.0 114.183 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 138.42 -12.41 3.5 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.408 -1.773 . . . . 0.0 111.483 -179.418 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.5 Cg_endo -80.25 -167.45 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.609 4.206 . . . . 0.0 108.905 174.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.03 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 112.972 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 492' ' ' PRO . 3.1 pp0? -76.83 -26.0 53.86 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.28 1.42 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . 0.443 HD22 HE21 ' A' ' 502' ' ' GLN . 6.5 mp -64.84 160.94 50.63 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.53 154.46 24.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.68 2.92 . . . . 0.0 110.851 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.8 66.41 5.27 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.845 0.831 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 164.22 -24.1 0.18 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.114 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.0 169.0 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.522 0.729 . . . . 0.0 110.281 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.42 153.91 51.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.716 0.806 . . . . 0.0 110.665 -175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.443 HE21 HD22 ' A' ' 496' ' ' LEU . 36.2 mm-40 -63.77 -43.73 95.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.51 8.36 0.85 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.024 0.53 . . . . 0.0 112.335 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . 0.466 ' CA ' HE21 ' A' ' 507' ' ' GLN . 19.1 m -138.2 9.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.13 0.572 . . . . 0.0 111.097 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -122.0 -20.69 6.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.336 0.654 . . . . 0.0 110.062 178.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.56 7.75 2.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.203 0.601 . . . . 0.0 111.927 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.466 HE21 ' CA ' ' A' ' 504' ' ' VAL . 14.5 mm-40 -84.29 8.63 15.36 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.996 0.918 . . . . 0.0 111.357 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.43 159.67 56.52 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 123.18 0.592 . . . . 0.0 112.215 -167.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.95 164.35 31.77 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.249 2.632 . . . . 0.0 110.567 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.89 56.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.914 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.74 -5.75 59.33 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.875 0.47 . . . . 0.0 111.691 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.51 -15.26 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -53.34 -41.66 66.0 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.337 -0.852 . . . . 0.0 108.863 169.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.29 -19.14 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.953 0.501 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -85.48 -21.51 28.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.888 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 518' ' ' SER . 2.6 mm -98.05 -31.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 118.916 0.78 . . . . 0.0 109.253 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.92 -0.97 2.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 110.078 172.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 516' ' ' ILE . 10.5 t -135.64 16.65 3.35 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.508 1.123 . . . . 0.0 110.63 177.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -100.98 38.43 3.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -1.65 0.11 Allowed 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -174.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.3 t -151.45 175.01 12.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.527 0.731 . . . . 0.0 109.919 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.48 3.78 3.0 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.701 1.6 . . . . 0.0 113.579 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.52 156.16 34.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.796 0.438 . . . . 0.0 111.04 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -156.64 27.1 0.33 Allowed 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.85 -0.27 1.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.997 0.919 . . . . 0.0 111.163 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -169.426 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.391 0.139 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.18 173.98 15.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.19 -178.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.263 1.025 . . . . 0.0 109.182 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.425 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 55.5 m-85 -133.21 86.94 2.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.485 0.66 . . . . 0.0 109.974 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -80.41 101.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.948 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.5 ttmt -85.51 140.58 30.55 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.843 0.457 . . . . 0.0 111.358 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -84.82 173.21 10.81 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.71 0.804 . . . . 0.0 111.575 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.23 -16.69 55.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.7 0.8 . . . . 0.0 110.88 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -97.47 -0.65 45.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.048 0.539 . . . . 0.0 110.538 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.67 25.98 26.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.094 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.505 ' HZ1' HG12 ' B' ' 13' ' ' ILE . 12.9 tmtt? -118.93 120.27 36.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.467 0.633 . . . . 0.0 110.491 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.8 OUTLIER -75.95 155.85 34.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.253 0.549 . . . . 0.0 110.947 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.505 HG12 ' HZ1' ' B' ' 11' ' ' LYS . 54.0 mt -133.26 112.78 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -71.65 133.87 45.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -150.23 136.53 18.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 122.309 0.243 . . . . 0.0 111.035 -174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.4 126.62 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.401 HG12 ' HE3' ' B' ' 29' ' ' LYS . 28.4 m -144.4 179.13 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.323 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.5 mm-40 -131.06 160.73 65.54 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.011 0.924 . . . . 0.0 108.803 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.19 0.6 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.769 2.98 . . . . 0.0 113.569 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.418 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.8 m -125.46 -4.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.662 0.664 . . . . 0.0 110.802 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -80.71 65.49 5.88 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -59.95 177.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.566 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.643 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 15.9 mm -52.93 -24.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 113.831 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.17 -19.73 50.21 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.694 1.134 . . . . 0.0 111.558 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.17 -44.08 13.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.613 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.643 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER -65.61 -26.22 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 123.046 0.539 . . . . 0.0 110.389 -177.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.443 ' HE3' HG21 ' B' ' 23' ' ' ILE . 91.2 mttt -59.97 -31.29 69.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 122.202 -0.311 . . . . 0.0 111.285 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.06 53.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.297 0.499 . . . . 0.0 110.597 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.401 ' HE3' HG12 ' B' ' 17' ' ' VAL . 3.9 mptp? -67.64 -36.06 80.06 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -85.57 -28.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -66.87 -39.04 87.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.39 -33.06 74.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.388 0.613 . . . . 0.0 111.386 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -83.14 -21.22 33.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -137.9 -34.59 0.67 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.511 0.596 . . . . 0.0 112.56 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.89 9.05 19.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.9 mt -77.29 130.37 74.97 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 153.85 67.55 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.47 2.113 . . . . 0.0 111.112 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.54 -15.97 38.22 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.321 2.68 . . . . 0.0 110.493 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.9 -7.82 59.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -124.03 -14.32 7.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -70.15 164.67 23.68 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 112.726 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -154.69 146.61 23.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.32 145.01 51.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.451 0.569 . . . . 0.0 111.001 -170.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.67 148.23 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.583 1.153 . . . . 0.0 108.385 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -149.14 138.91 21.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.354 1.062 . . . . 0.0 108.992 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.62 12.51 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.622 0.769 . . . . 0.0 112.669 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.03 14.19 40.31 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.524 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 159.88 33.76 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.622 1.211 . . . . 0.0 109.46 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -92.1 153.65 19.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.756 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.76 166.38 12.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -137.31 153.79 50.2 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.496 0.665 . . . . 0.0 112.191 -173.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.49 -1.89 12.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.449 1.1 . . . . 0.0 111.697 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 7.1 37.69 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.99 -154.51 0.53 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.906 0.883 . . . . 0.0 109.451 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 3.1 p -149.72 160.21 43.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.027 1.731 . . . . 0.0 107.823 173.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.63 -27.08 68.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -71.7 -26.71 62.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.92 1.288 . . . . 0.0 112.138 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.44 -15.81 61.82 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 122.749 0.419 . . . . 0.0 111.261 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -126.52 27.83 6.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.648 0.779 . . . . 0.0 109.699 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.91 28.2 0.34 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 171.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.75 140.4 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.525 0.602 . . . . 0.0 109.611 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -130.71 -174.52 3.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.602 1.161 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.81 144.29 56.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.66 21.72 3.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.861 0.865 . . . . 0.0 113.159 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -72.92 -17.32 61.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 75.4 m 61.41 139.47 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.326 1.851 . . . . 0.0 112.104 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -141.27 179.92 6.49 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.114 0.566 . . . . 0.0 109.505 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.49 139.27 43.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.405 0.282 . . . . 0.0 110.523 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.24 134.78 47.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 110.075 -172.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 52.4 t -142.13 168.47 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -142.74 170.46 15.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.975 -0.453 . . . . 0.0 111.676 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -66.78 168.47 9.54 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.595 0.758 . . . . 0.0 110.879 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.2 OUTLIER -105.17 18.57 22.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.182 0.593 . . . . 0.0 110.591 -176.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 61.19 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.506 2.322 . . . . 0.0 114.898 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -98.48 4.35 59.96 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 175.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.048 -1.973 . . . . 0.0 110.772 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 491' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 494' ' ' GLN . 90.3 Cg_endo -78.89 -168.3 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 124.641 3.561 . . . . 0.0 107.711 170.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.08 31.56 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.666 1.586 . . . . 0.0 113.74 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -69.2 -32.45 71.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.944 0.897 . . . . 0.0 112.466 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.03 2.38 0.9 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 64.1 mt -71.8 150.11 92.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.99 158.49 17.24 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.779 2.986 . . . . 0.0 111.696 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.55 55.59 2.0 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 122.241 1.02 . . . . 0.0 109.673 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.41 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.094 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.31 166.14 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.762 0.825 . . . . 0.0 109.578 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -143.66 139.17 29.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.575 1.55 . . . . 0.0 107.08 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.65 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.97 -28.29 68.79 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.393 -177.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.67 3.91 5.74 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.338 -0.851 . . . . 0.0 111.161 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . 0.4 ' N ' HE22 ' A' ' 507' ' ' GLN . 27.3 m -137.23 17.36 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.472 1.109 . . . . 0.0 110.225 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.62 -19.41 1.38 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.466 0.706 . . . . 0.0 111.622 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -72.09 -0.31 11.46 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.371 -0.831 . . . . 0.0 112.649 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.4 HE22 ' N ' ' A' ' 504' ' ' VAL . 7.5 mp0 -95.95 -7.92 35.22 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.691 0.678 . . . . 0.0 109.851 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.38 159.91 78.8 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.06 163.72 37.46 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.974 2.449 . . . . 0.0 111.253 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -15.17 20.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.841 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -95.98 -1.31 49.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.552 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 54.9 mt -115.45 -16.99 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -41.75 66.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.8 -5.57 51.23 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 28.4 mm-40 -97.49 -24.1 15.74 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.806 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.4 -35.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.47 -8.0 23.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 15.3 t -72.76 -50.23 25.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.68 0.392 . . . . 0.0 111.468 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 144.37 141.91 3.82 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.841 -2.503 . . . . 0.0 106.841 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 515' ' ' GLU . 71.6 mmtt -149.36 176.73 10.3 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.931 0.893 . . . . 0.0 109.223 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -157.7 179.43 9.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.473 1.509 . . . . 0.0 108.868 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . 0.414 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.3 OUTLIER 60.83 21.73 11.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.461 1.104 . . . . 0.0 112.671 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -146.85 147.1 30.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.739 0.415 . . . . 0.0 110.247 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.6 m-80 -148.44 40.25 0.92 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.475 0.71 . . . . 0.0 110.902 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.286 4.4 pp 47.75 13.18 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.932 1.693 . . . . 0.0 114.228 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 524' ' ' ASN . 48.6 mtmt . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 126.411 1.884 . . . . 0.0 111.225 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.725 0.298 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -155.17 175.23 14.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.87 -177.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 123.958 0.903 . . . . 0.0 108.627 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.572 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 99.9 m-85 -136.36 97.72 3.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.268 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.61 135.16 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 35.5 ttmt -117.17 136.74 52.82 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.092 0.472 . . . . 0.0 111.742 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -73.12 173.84 8.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.737 1.215 . . . . 0.0 112.047 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.09 0.28 4.88 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.256 1.023 . . . . 0.0 110.792 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -118.27 -3.14 11.04 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.2 20.4 18.2 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.8 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -119.57 138.86 52.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.871 0.835 . . . . 0.0 109.86 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 6.3 m -111.41 152.38 27.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.012 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.75 131.6 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -86.37 135.05 33.66 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -146.36 134.23 21.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.696 0.225 . . . . 0.0 110.939 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.93 125.94 38.85 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.546 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.46 175.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.945 0.898 . . . . 0.0 109.872 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.5 mm-40 -135.36 163.05 53.69 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.318 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.54 1.7 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.466 2.777 . . . . 0.0 113.599 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 18' ' ' GLU . 71.0 m -127.05 -3.41 6.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.716 0.689 . . . . 0.0 110.997 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.25 75.27 8.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.0 OUTLIER -61.08 171.31 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.157 0.983 . . . . 0.0 110.178 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.449 HD13 ' CE2' ' B' ' 59' ' ' TYR . 13.0 mm -54.37 -28.3 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.64 -18.72 65.06 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.836 -1.165 . . . . 0.0 110.487 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -86.33 -45.93 10.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.132 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 3.4 m -66.34 -33.79 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 122.664 0.386 . . . . 0.0 110.989 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.43 ' HE3' HG23 ' B' ' 23' ' ' ILE . 93.8 mttt -56.26 -32.98 65.01 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.855 172.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.18 -27.88 53.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.995 -0.441 . . . . 0.0 110.948 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -67.08 -32.05 72.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.26 -31.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.99 89.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.91 -31.9 71.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.271 0.558 . . . . 0.0 111.231 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -84.1 -22.47 31.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -135.96 -36.2 0.76 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.89 8.3 15.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.3 129.63 74.45 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.75 152.52 69.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.632 2.221 . . . . 0.0 110.842 -176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.41 -15.22 41.7 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.23 2.62 . . . . 0.0 110.73 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.01 -6.86 59.47 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -125.32 -11.51 6.9 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.37 165.0 25.4 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.518 1.054 . . . . 0.0 112.208 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -153.59 142.56 21.2 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp -136.14 138.41 41.97 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.128 -0.358 . . . . 0.0 110.711 -168.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mp -133.43 150.23 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.188 0.995 . . . . 0.0 108.87 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -148.5 139.12 22.79 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.542 1.137 . . . . 0.0 109.092 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 10.41 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.713 0.805 . . . . 0.0 113.034 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.66 12.14 36.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.675 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.14 159.88 32.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.632 1.216 . . . . 0.0 109.651 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -95.61 138.5 33.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.903 0.881 . . . . 0.0 108.753 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.7 157.13 16.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -125.22 148.69 48.53 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 121.433 0.635 . . . . 0.0 112.164 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.02 -0.11 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.178 0.991 . . . . 0.0 111.89 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.35 8.28 37.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -108.88 -147.71 0.42 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.594 0.758 . . . . 0.0 110.517 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.0 p -152.13 157.07 41.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 127.313 2.245 . . . . 0.0 107.378 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.26 -26.25 68.69 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 121.361 0.601 . . . . 0.0 109.871 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -66.43 -25.11 66.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.853 1.261 . . . . 0.0 111.765 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.82 -12.01 59.94 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.447 0.699 . . . . 0.0 111.903 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.449 ' CE2' HD13 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -117.68 21.3 13.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 46.95 27.27 0.7 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.66 141.78 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.109 0.413 . . . . 0.0 110.262 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -130.31 -177.84 4.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.53 1.132 . . . . 0.0 108.747 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -60.96 143.26 55.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 53.53 26.27 5.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.415 1.086 . . . . 0.0 113.418 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -72.65 -14.91 61.7 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 61.53 141.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.467 1.907 . . . . 0.0 112.367 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.98 -177.07 5.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.55 129.9 33.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 110.728 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.6 tp -112.28 141.5 45.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.252 1.421 . . . . 0.0 110.467 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.12 161.0 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -148.84 171.69 15.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.684 -0.635 . . . . 0.0 112.677 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.58 173.58 6.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.128 0.971 . . . . 0.0 109.568 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -126.51 25.59 6.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.539 0.735 . . . . 0.0 109.631 -178.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 63.4 -23.01 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.677 1.991 . . . . 0.0 114.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -132.68 8.75 5.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 117.651 -1.638 . . . . 0.0 110.599 179.334 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 494' ' ' GLN . 74.7 Cg_endo -75.72 -172.53 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 124.744 3.629 . . . . 0.0 109.605 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 31.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.445 1.498 . . . . 0.0 113.152 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.1 pp0? -75.29 -25.97 58.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.812 0.845 . . . . 0.0 112.629 -176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.11 2.62 1.17 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.2 162.47 72.96 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 122.959 0.503 . . . . 0.0 110.566 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 152.54 15.31 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.281 3.32 . . . . 0.0 112.397 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.1 66.62 2.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.802 0.81 . . . . 0.0 112.064 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 159.49 -25.04 0.32 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.668 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.86 166.55 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.363 0.665 . . . . 0.0 110.584 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.94 143.03 40.56 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.127 0.971 . . . . 0.0 109.317 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.501 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.52 -34.47 76.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.25 -177.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.51 4.53 5.9 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.883 -0.511 . . . . 0.0 111.754 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.12 11.29 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.402 0.681 . . . . 0.0 110.535 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -14.99 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.395 1.078 . . . . 0.0 109.545 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -85.44 29.27 0.69 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.566 0.746 . . . . 0.0 111.228 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -103.65 7.83 37.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.931 0.893 . . . . 0.0 111.153 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.52 156.9 63.33 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.615 1.166 . . . . 0.0 110.348 -172.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 162.87 30.87 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.981 3.12 . . . . 0.0 112.856 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . 0.441 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -27.3 64.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.7 0.8 . . . . 0.0 112.064 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -9.2 58.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.219 0.208 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.28 -15.68 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.278 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.441 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 12.9 mm-40 -57.85 -39.54 77.97 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.484 1.038 . . . . 0.0 108.9 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.7 -16.24 64.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.169 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -90.29 -8.78 50.03 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.246 -0.406 . . . . 0.0 111.76 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.59 -34.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.56 -6.58 11.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.373 0.669 . . . . 0.0 109.678 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 49.4 m -138.32 26.77 2.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.062 1.345 . . . . 0.0 109.485 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -129.67 43.45 1.31 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -63.48 7.2 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.262 2.225 . . . . 0.0 115.063 -170.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -146.97 -177.64 5.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.29 0.636 . . . . 0.0 109.708 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.86 -2.84 2.57 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.472 1.509 . . . . 0.0 112.941 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -157.24 152.56 26.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.936 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.18 34.2 1.21 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.411 1.084 . . . . 0.0 110.045 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.9 6.06 2.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.789 0.804 . . . . 0.0 110.728 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 111.696 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.584 0.231 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.73 172.7 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.55 -179.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.06 101.04 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.39 126.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.9 ttmt -102.82 133.88 47.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 111.903 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.444 ' C ' ' H ' ' B' ' 9' ' ' THR . 69.1 p -82.13 178.2 8.4 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 112.416 -172.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.67 14.43 0.19 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.689 1.196 . . . . 0.0 110.284 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.444 ' H ' ' C ' ' B' ' 7' ' ' THR . 31.8 p -129.32 5.66 5.26 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 120.871 -1.143 . . . . 0.0 112.418 -175.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 25.58 58.46 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.855 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -121.44 142.26 50.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -111.24 157.21 20.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.3 128.9 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -74.84 133.24 41.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.3 mt -145.12 133.59 21.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.329 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.25 126.5 39.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.11 177.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.844 0.858 . . . . 0.0 109.762 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -136.18 162.21 57.86 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.762 0.825 . . . . 0.0 110.117 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 35.1 Cg_exo -56.36 0.85 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.38 3.387 . . . . 0.0 113.371 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 18' ' ' GLU . 27.5 p -129.43 -6.59 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.845 0.858 . . . . 0.0 111.191 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.27 74.23 10.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.3 t -62.43 174.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.192 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -56.02 -26.08 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.69 -17.69 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.439 -1.413 . . . . 0.0 110.706 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -88.58 -43.86 11.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.86 0.864 . . . . 0.0 110.598 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 3.6 m -63.96 -31.24 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 C-N-CA 122.736 0.414 . . . . 0.0 110.597 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -56.58 -31.57 64.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.368 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.95 -30.32 55.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.448 0.567 . . . . 0.0 110.569 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.0 mptp? -70.03 -33.9 72.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -85.81 -30.12 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.95 -39.97 83.31 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.34 -31.05 71.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.158 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -83.43 -21.4 32.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -138.13 -36.32 0.6 Allowed 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.72 8.49 13.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.79 129.82 80.35 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.55 153.41 65.29 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.408 2.072 . . . . 0.0 111.224 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.23 -17.47 39.95 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.273 2.649 . . . . 0.0 110.653 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.49 -4.84 57.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.838 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -124.8 -15.43 6.47 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.94 163.06 28.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.866 1.212 . . . . 0.0 113.479 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -161.91 146.11 12.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.045 1.338 . . . . 0.0 107.627 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -132.87 160.44 36.96 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.134 0.493 . . . . 0.0 111.728 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.71 149.3 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 107.988 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -151.74 144.26 24.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.999 0.92 . . . . 0.0 109.355 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 14.09 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.526 0.73 . . . . 0.0 111.985 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.1 16.2 51.45 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.287 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 158.06 40.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.745 1.272 . . . . 0.0 109.867 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.16 145.44 26.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.55 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.445 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.3 mt -102.99 148.96 25.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.047 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -121.69 149.22 43.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.501 0.667 . . . . 0.0 112.064 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.74 2.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.211 1.004 . . . . 0.0 111.852 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.36 16.5 19.65 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.55 -148.59 0.41 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.591 1.156 . . . . 0.0 108.496 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.2 p -153.9 160.29 42.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.693 1.197 . . . . 0.0 108.851 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.14 -27.09 68.14 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.236 -0.29 . . . . 0.0 110.633 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 16.5 t -73.29 -28.52 62.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.94 0.496 . . . . 0.0 110.791 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.15 -12.69 61.35 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.65 21.14 13.15 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 174.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 47.97 22.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.438 HG23 ' HG ' ' B' ' 65' ' ' SER . 52.8 mt -57.47 141.69 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-O 121.208 0.528 . . . . 0.0 110.766 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -131.33 -177.54 4.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.141 1.376 . . . . 0.0 108.79 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -64.04 147.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.034 0.445 . . . . 0.0 110.955 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 53.78 25.92 5.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.819 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.438 ' HG ' HG23 ' B' ' 61' ' ' ILE . 86.5 p -72.88 -21.33 60.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 69.5 m 60.67 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.072 2.149 . . . . 0.0 112.622 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.53 -174.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.85 1.66 . . . . 0.0 108.155 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -137.49 149.83 47.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -134.44 133.22 40.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.949 1.3 . . . . 0.0 109.5 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 163.67 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.11 168.89 18.67 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -76.35 -176.27 3.57 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 125.371 1.468 . . . . 0.0 111.872 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.2 OUTLIER -109.41 18.48 20.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.789 0.835 . . . . 0.0 111.585 -171.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 63.41 -32.86 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.101 2.16 . . . . 0.0 114.042 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.54 -13.26 2.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 117.292 -1.838 . . . . 0.0 111.681 -179.288 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.537 0.208 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.91 95.68 0.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.634 3.556 . . . . 0.0 111.548 -171.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.6 tt 21.26 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.699 2.399 . . . . 0.0 112.514 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.75 -26.45 16.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.011 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -139.74 4.88 2.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.359 0.664 . . . . 0.0 110.67 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.18 160.58 77.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.975 0.51 . . . . 0.0 109.694 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 499' ' ' GLY . 51.1 Cg_exo -57.28 155.64 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.049 3.166 . . . . 0.0 112.273 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.48 34.59 0.21 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.636 0.774 . . . . 0.0 111.775 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -173.38 35.84 0.13 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.352 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 501' ' ' ASP . 42.7 t -143.22 168.66 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.208 1.003 . . . . 0.0 109.293 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ASP . . . . . 0.409 ' N ' ' CG1' ' A' ' 500' ' ' VAL . 1.8 m-20 -137.53 148.27 45.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.964 1.306 . . . . 0.0 108.222 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' GLN . . . . . 0.562 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -76.77 -28.06 55.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.35 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.55 7.39 1.44 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.738 -0.601 . . . . 0.0 111.03 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' VAL . . . . . 0.427 ' HA ' HE21 ' A' ' 507' ' ' GLN . 31.0 m -138.03 12.1 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.729 0.811 . . . . 0.0 111.383 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -25.49 2.65 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.889 0.476 . . . . 0.0 111.048 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.53 -6.28 29.73 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.941 -0.474 . . . . 0.0 110.702 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.427 HE21 ' HA ' ' A' ' 504' ' ' VAL . 2.6 mp0 -87.54 -4.38 58.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.775 1.23 . . . . 0.0 110.238 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 74.0 mt -90.16 160.11 40.85 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.75 1.22 . . . . 0.0 109.957 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.61 167.64 26.06 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.469 2.779 . . . . 0.0 111.894 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.67 -22.79 62.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.87 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.36 -1.86 57.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.237 0.472 . . . . 0.0 111.684 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.78 -14.58 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -40.85 67.68 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.37 -0.831 . . . . 0.0 109.163 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.16 -7.94 55.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.18 0.592 . . . . 0.0 112.459 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.33 -22.65 18.21 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.521 0.6 . . . . 0.0 111.107 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 518' ' ' SER . 1.3 mp -104.42 -30.33 2.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.12 1.69 1.41 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.147 0.431 . . . . 0.0 110.376 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 516' ' ' ILE . 55.8 m -129.75 9.2 5.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.961 0.904 . . . . 0.0 110.921 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -79.23 138.95 21.27 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 0.29 2.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 12.9 t -162.66 179.82 7.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.596 0.358 . . . . 0.0 110.599 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.15 15.61 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.93 1.692 . . . . 0.0 113.729 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.15 147.27 26.24 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.618 0.367 . . . . 0.0 110.622 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' ASN . . . . . 0.428 ' HB2' ' CE ' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -154.15 10.65 0.39 Allowed 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 13.25 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.803 0.689 . . . . 0.0 111.219 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LYS . . . . . 0.428 ' CE ' ' HB2' ' A' ' 524' ' ' ASN . 53.6 mtmt . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.363 1.065 . . . . 0.0 111.399 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.642 0.258 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.05 175.31 14.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.01 -177.45 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.67 0.788 . . . . 0.0 109.17 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.506 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 83.5 m-85 -135.68 98.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -93.2 117.87 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -93.3 132.7 37.26 Favored 'General case' 0 C--N 1.337 0.057 0 O-C-N 121.881 -0.512 . . . . 0.0 110.783 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -76.09 177.43 7.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.361 1.064 . . . . 0.0 111.976 -174.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.45 -5.95 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.933 1.293 . . . . 0.0 110.489 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 59.5 p -116.85 4.43 12.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.709 -0.62 . . . . 0.0 112.057 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.93 27.78 48.69 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 120.142 -0.254 . . . . 0.0 113.027 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.73 148.21 45.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 47.5 m -122.66 153.64 39.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.561 -170.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.36 132.3 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -83.92 134.7 34.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.7 mt -145.38 133.47 21.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.617 -172.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.84 128.41 37.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.474 0.71 . . . . 0.0 109.477 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.3 179.61 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.982 0.913 . . . . 0.0 109.69 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' B' ' 20' ' ' SER . 35.7 mt-10 -141.15 164.21 37.14 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.19 1.17 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.583 2.855 . . . . 0.0 113.64 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.431 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.7 m -129.31 -6.61 4.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.908 0.777 . . . . 0.0 111.228 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 21.3 m-20 -80.73 69.08 7.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 171.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.2 t -61.03 176.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.133 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.428 HG22 ' HE3' ' B' ' 27' ' ' LYS . 13.2 mm -52.17 -33.21 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -168.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.6 -22.89 62.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.342 0.974 . . . . 0.0 111.473 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.35 -41.36 22.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.23 -40.24 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 124.275 1.03 . . . . 0.0 110.035 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.428 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.1 mttt -56.73 -26.04 56.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.521 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -26.89 35.16 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.486 0.584 . . . . 0.0 110.772 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -67.1 -33.12 74.79 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.7 mt -87.29 -30.05 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -66.45 -36.67 83.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.715 0.293 . . . . 0.0 110.217 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -69.38 -33.54 73.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.398 0.618 . . . . 0.0 111.297 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -82.39 -24.48 34.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.583 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -134.15 -30.92 1.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.4 9.65 26.93 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.69 126.8 82.01 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 123.891 0.876 . . . . 0.0 108.922 -174.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.41 153.57 77.52 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.634 2.223 . . . . 0.0 111.23 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.24 -20.82 36.79 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.168 2.578 . . . . 0.0 111.823 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.82 -1.69 57.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -113.85 -13.72 12.57 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.335 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.66 170.34 16.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.041 0.837 . . . . 0.0 112.3 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -153.78 148.52 26.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.432 ' C ' HD11 ' B' ' 44' ' ' ILE . 10.7 tp -136.48 139.26 42.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 111.466 -171.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.432 HD11 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -135.44 153.17 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.71 1.204 . . . . 0.0 108.213 -177.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' B' ' 47' ' ' GLY . 27.3 t80 -148.35 135.62 20.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 124.566 1.147 . . . . 0.0 109.089 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.49 10.19 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.887 0.875 . . . . 0.0 113.187 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' B' ' 45' ' ' PHE . . . 103.29 12.01 32.3 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.454 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 157.68 37.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.764 1.282 . . . . 0.0 109.713 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -93.29 152.09 19.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.116 0.966 . . . . 0.0 108.418 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.07 168.36 10.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.641 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -136.15 153.09 51.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.514 0.674 . . . . 0.0 111.615 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.79 -1.54 14.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.287 1.035 . . . . 0.0 111.62 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 9.52 35.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -109.02 -155.88 0.57 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.968 0.907 . . . . 0.0 109.372 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -148.48 160.44 43.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.052 1.741 . . . . 0.0 107.415 172.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.64 -26.8 68.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -71.0 -26.27 63.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.019 1.328 . . . . 0.0 111.993 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.78 -15.23 61.65 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 122.891 0.476 . . . . 0.0 111.298 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -126.56 26.69 6.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.717 0.807 . . . . 0.0 109.786 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 p30 48.0 19.78 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.43 139.82 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.714 0.688 . . . . 0.0 110.373 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -130.08 -177.5 4.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.709 1.204 . . . . 0.0 109.217 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.02 143.42 51.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.039 0.447 . . . . 0.0 110.841 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 53.4 26.27 5.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -74.9 -11.94 60.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m 60.03 128.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.35 1.86 . . . . 0.0 112.117 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.59 -175.62 3.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.121 1.369 . . . . 0.0 108.077 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -137.68 145.43 42.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.45 137.9 50.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.534 1.133 . . . . 0.0 109.403 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.92 162.89 30.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.48 178.72 8.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 112.354 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -128.34 167.63 16.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.59 1.156 . . . . 0.0 109.799 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.537 HD11 ' H ' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -102.97 18.12 22.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.749 0.82 . . . . 0.0 112.711 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 120.56 -30.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 129.351 3.061 . . . . 0.0 111.149 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.58 2.24 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 116.749 -2.139 . . . . 0.0 111.854 179.803 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.9 Cg_endo -77.57 -166.92 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.202 3.268 . . . . 0.0 107.685 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.845 HD13 ' H ' ' A' ' 493' ' ' LEU . 0.0 OUTLIER -65.06 28.4 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 176.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -63.04 -27.96 69.76 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.434 1.894 . . . . 0.0 112.992 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.98 1.93 0.77 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.72 161.77 76.41 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 122.61 0.364 . . . . 0.0 110.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.75 154.38 12.65 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.255 3.303 . . . . 0.0 112.005 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -80.12 57.55 2.73 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 122.343 1.068 . . . . 0.0 110.424 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.23 26.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.226 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 76.0 t -140.79 160.03 23.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.808 0.804 . . . . 0.0 109.441 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.17 145.16 48.99 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.673 0.749 . . . . 0.0 109.077 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.651 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.9 OUTLIER -62.31 -28.98 70.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.406 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.92 -0.16 10.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.679 -0.638 . . . . 0.0 111.403 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.26 18.42 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.437 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.78 -18.5 5.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.074 0.95 . . . . 0.0 110.452 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -72.6 3.83 4.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.943 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -87.51 4.89 41.74 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.748 0.819 . . . . 0.0 110.463 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.02 149.54 42.7 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 123.614 0.765 . . . . 0.0 110.187 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.27 163.77 25.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.081 2.521 . . . . 0.0 111.57 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.21 63.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.53 -1.8 57.93 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.651 0.38 . . . . 0.0 110.761 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 23.2 mt -116.87 -16.83 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -54.45 -38.87 66.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.5 -7.23 57.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.42 0.688 . . . . 0.0 112.421 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.42 -20.9 17.49 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.262 0.483 . . . . 0.0 111.2 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.43 -34.3 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.42 -8.64 19.84 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 33.0 t -70.12 -43.73 70.39 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.472 0.309 . . . . 0.0 110.797 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 117.73 120.64 3.07 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -140.79 -176.22 4.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.585 0.707 . . . . 0.0 110.725 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 -172.13 4.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.796 1.638 . . . . 0.0 107.998 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 65.19 18.11 11.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.035 0.934 . . . . 0.0 112.603 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.01 146.39 31.9 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.095 0.958 . . . . 0.0 109.092 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -148.29 28.79 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.925 0.49 . . . . 0.0 112.005 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.272 2.2 pp 50.92 6.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.697 1.599 . . . . 0.0 114.511 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -176.139 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.841 0.353 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -157.75 172.91 17.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.95 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -137.24 -179.37 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.272 0.629 . . . . 0.0 109.449 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.82 ' HB3' HG21 ' B' ' 12' ' ' THR . 82.4 m-85 -132.33 100.4 4.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.64 103.09 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.626 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -85.41 135.3 33.93 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 122.455 0.302 . . . . 0.0 111.135 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.7 p -83.76 176.32 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.38 0.672 . . . . 0.0 112.625 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -65.89 1.66 1.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.743 1.217 . . . . 0.0 111.001 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.3 p -118.73 10.06 12.31 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.307 0.643 . . . . 0.0 111.311 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 28.36 66.27 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.892 -0.393 . . . . 0.0 113.199 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.71 146.59 49.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.82 HG21 ' HB3' ' B' ' 4' ' ' PHE . 26.7 m -122.78 154.31 38.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 111.547 -171.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 53.3 mt -130.75 131.94 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -82.89 134.76 35.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 69.2 mt -144.35 134.54 24.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -171.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.89 126.82 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.314 0.645 . . . . 0.0 109.433 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.26 174.23 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.898 0.879 . . . . 0.0 109.645 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.405 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.8 mm-40 -135.69 161.87 60.38 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.272 1.029 . . . . 0.0 108.631 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.45 2.24 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.31 2.674 . . . . 0.0 113.339 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.4 ' H ' ' C ' ' B' ' 18' ' ' GLU . 35.1 p -122.21 -10.2 8.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.98 0.912 . . . . 0.0 110.593 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 76.2 m-20 -85.99 71.16 10.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.1 t -62.16 176.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.683 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 17.7 mm -51.14 -36.8 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -168.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -68.79 -21.67 64.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.371 0.987 . . . . 0.0 111.251 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -81.66 -40.38 22.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.36 -38.44 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.857 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.9 mttt -58.18 -23.13 54.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.524 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.62 -26.73 31.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.556 0.617 . . . . 0.0 110.73 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.85 -33.65 74.16 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.0 mt -85.85 -29.85 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -68.12 -37.6 81.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.33 -32.1 71.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.475 0.655 . . . . 0.0 111.323 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -83.01 -22.11 33.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -138.94 -31.25 0.72 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.74 9.39 19.0 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.2 mt -80.5 125.47 80.76 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.662 0.785 . . . . 0.0 109.337 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 159.38 48.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.216 2.611 . . . . 0.0 111.268 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -16.32 54.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.828 3.018 . . . . 0.0 110.851 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.47 -11.9 58.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.655 0.382 . . . . 0.0 111.999 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -120.85 -10.8 9.06 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -73.01 167.74 20.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.261 0.937 . . . . 0.0 112.04 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -159.21 90.1 0.95 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.88 1.272 . . . . 0.0 107.986 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.677 ' C ' HD12 ' B' ' 44' ' ' ILE . 23.3 tp -93.13 139.82 30.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.661 0.784 . . . . 0.0 112.201 -170.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -134.68 154.07 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.996 1.318 . . . . 0.0 109.145 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' B' ' 50' ' ' LEU . 43.1 t80 -151.59 142.81 23.29 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.593 1.157 . . . . 0.0 109.129 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 13.77 0.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.573 0.749 . . . . 0.0 112.615 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.7 13.86 48.96 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.275 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 161.78 31.53 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.559 1.18 . . . . 0.0 110.36 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.04 125.87 43.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.814 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.5 OUTLIER -76.0 175.35 8.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.991 -177.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -135.13 153.35 52.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 111.307 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.18 1.18 9.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.268 1.027 . . . . 0.0 111.697 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.64 11.76 27.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -112.47 -154.4 0.54 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.173 0.989 . . . . 0.0 109.563 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 4.5 p -148.97 159.56 44.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.794 1.638 . . . . 0.0 107.674 172.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 47.1 mt -63.27 -25.75 68.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -73.87 -25.45 60.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.467 1.107 . . . . 0.0 111.985 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.76 -15.96 61.65 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.09 0.556 . . . . 0.0 111.386 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.64 ' CD2' HD12 ' B' ' 50' ' ' LEU . 21.2 m-85 -125.71 25.98 6.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.367 0.667 . . . . 0.0 109.836 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p30 48.54 18.91 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 136.44 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.855 0.752 . . . . 0.0 110.187 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -130.4 -175.89 3.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.009 1.323 . . . . 0.0 109.458 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -59.93 143.89 50.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.281 0.563 . . . . 0.0 110.916 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 55.15 22.43 4.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.455 1.102 . . . . 0.0 113.331 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -72.44 -14.72 61.76 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 80.6 m 61.36 128.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.466 1.906 . . . . 0.0 112.051 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.59 178.62 6.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.941 1.296 . . . . 0.0 108.655 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -134.85 154.64 51.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -145.24 151.87 39.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.245 0.545 . . . . 0.0 110.507 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.04 161.2 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.467 ' H ' HD23 ' B' ' 71' ' ' LEU . 2.2 pt? -140.68 170.05 16.49 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.155 0.502 . . . . 0.0 112.077 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -135.61 177.48 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.136 0.974 . . . . 0.0 109.538 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 73' ' ' LEU . 0.5 OUTLIER -124.41 20.87 8.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.267 1.027 . . . . 0.0 112.385 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 . . . . . 0 N--CA 1.467 0.399 0 C-N-CA 127.052 2.141 . . . . 0.0 113.94 -175.381 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 494' ' ' GLN . 93.3 Cg_endo -80.12 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 1 C-N-CA 125.408 4.072 . . . . 0.0 109.254 175.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.4 32.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.726 1.61 . . . . 0.0 113.078 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.4 pp0? -77.16 -27.95 53.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.281 0.633 . . . . 0.0 112.568 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.01 3.63 1.61 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.5 160.05 82.06 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 122.911 0.484 . . . . 0.0 109.781 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.1 149.43 15.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.52 2.813 . . . . 0.0 111.434 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -76.09 65.92 2.18 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 121.731 0.777 . . . . 0.0 112.256 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 165.76 -27.75 0.19 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.494 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.73 162.1 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 122.988 0.515 . . . . 0.0 109.948 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -131.15 144.74 51.6 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 109.868 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.535 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.5 pm0 -61.16 -30.62 70.51 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.3 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -72.15 0.41 9.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.903 -0.498 . . . . 0.0 111.771 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.1 16.19 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 122.945 0.498 . . . . 0.0 110.617 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.98 -19.87 5.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.552 0.741 . . . . 0.0 109.846 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -73.49 4.77 4.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.023 0.529 . . . . 0.0 111.637 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -83.95 5.9 23.82 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.438 0.695 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.01 152.15 53.77 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 123.868 0.867 . . . . 0.0 110.174 -170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.8 164.1 25.53 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.845 2.364 . . . . 0.0 111.311 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.55 63.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.106 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 -3.29 58.4 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 122.464 0.306 . . . . 0.0 110.953 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.2 -15.27 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -54.96 -38.92 68.39 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.08 -10.4 59.36 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 516' ' ' ILE . 11.2 mm-40 -89.38 -18.37 26.99 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.478 0.581 . . . . 0.0 111.186 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 515' ' ' GLU . 1.2 mp -107.91 -34.32 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.08 -9.07 14.15 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 171.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 m -63.14 -27.08 69.13 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 122.245 -0.284 . . . . 0.0 110.821 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 104.19 35.23 3.45 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -61.54 -179.96 0.2 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.613 1.197 . . . . 0.0 112.189 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.3 m -142.65 -171.97 3.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.162 -1.835 . . . . 0.0 108.91 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.76 13.13 8.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.233 1.013 . . . . 0.0 112.286 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -149.75 145.56 26.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.912 0.485 . . . . 0.0 110.252 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.2 m-80 -152.37 19.4 0.64 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.738 0.815 . . . . 0.0 110.105 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.02 -15.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.159 1.384 . . . . 0.0 112.445 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 124.072 0.949 . . . . 0.0 111.108 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.955 0.407 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.69 172.81 17.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.794 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.58 -179.64 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.548 0.739 . . . . 0.0 109.055 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -132.06 107.59 8.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -103.09 109.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.6 ttmt -93.54 139.11 31.12 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -86.9 176.0 7.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.044 0.938 . . . . 0.0 112.135 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.86 -20.84 59.46 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.577 1.151 . . . . 0.0 110.981 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -95.48 -2.83 47.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.968 -0.458 . . . . 0.0 110.471 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.56 24.64 27.8 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.278 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.55 140.07 52.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -109.42 159.23 17.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.546 -173.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -129.97 128.69 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -79.54 134.17 36.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -144.88 133.8 22.5 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -90.11 128.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.12 177.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 123.746 0.818 . . . . 0.0 110.104 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 75.0 mm-40 -141.6 163.08 43.34 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 124.602 1.161 . . . . 0.0 108.941 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 38.2 Cg_exo -55.46 3.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.668 3.579 . . . . 0.0 113.647 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 18' ' ' GLU . 19.2 t -134.0 -8.77 2.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.892 0.769 . . . . 0.0 111.482 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 8.2 m-20 -78.05 68.78 4.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.0 t -62.29 177.02 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.653 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.424 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.6 mm -51.29 -33.65 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -169.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.29 -22.14 61.99 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 119.266 0.939 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.79 -38.17 26.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.478 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 71.5 t -64.68 -40.54 89.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 110.138 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.6 mttt -56.86 -27.53 60.51 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.17 -23.04 44.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.427 0.558 . . . . 0.0 110.796 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 68.3 mmtt -69.76 -47.32 63.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.481 0.712 . . . . 0.0 109.434 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.44 -30.61 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.515 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.32 -39.4 78.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.71 0.29 . . . . 0.0 110.466 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.43 -31.25 70.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.31 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.35 -24.6 36.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.462 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.68 -34.53 0.68 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.63 8.7 13.7 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.74 126.48 88.45 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.13 153.78 73.98 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.672 2.248 . . . . 0.0 111.028 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.31 -17.33 39.66 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.617 2.878 . . . . 0.0 111.573 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.14 2.3 55.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.69 -16.76 10.66 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.91 164.13 24.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.619 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -154.53 124.18 6.59 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.535 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -123.4 135.12 53.97 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.871 0.305 . . . . 0.0 111.513 -168.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.535 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.7 mp -129.53 149.92 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -151.03 143.08 24.01 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.844 1.257 . . . . 0.0 109.07 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.69 13.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.516 0.726 . . . . 0.0 112.326 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.99 14.58 48.56 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.453 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 163.42 29.33 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.486 1.143 . . . . 0.0 110.178 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.84 128.27 45.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.4 OUTLIER -77.18 172.82 12.64 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.015 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -135.5 156.27 49.16 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.542 0.687 . . . . 0.0 111.206 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.97 2.31 8.95 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.869 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.86 14.57 21.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -115.26 -154.13 0.54 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.375 1.07 . . . . 0.0 108.758 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 40.4 p -150.43 166.52 29.87 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.344 1.058 . . . . 0.0 108.386 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.3 -30.48 71.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 17.0 t -74.91 -29.76 61.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.351 0.66 . . . . 0.0 111.136 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.42 -16.17 63.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.723 0.409 . . . . 0.0 111.606 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' B' ' 50' ' ' LEU . 18.0 m-85 -130.1 25.57 5.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.654 0.781 . . . . 0.0 110.245 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 46.75 25.68 0.47 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.24 128.47 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -132.38 -171.24 2.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.71 1.204 . . . . 0.0 109.705 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -58.37 140.66 53.22 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.969 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 54.12 24.43 4.84 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.235 1.014 . . . . 0.0 113.15 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.7 m -72.22 -19.18 61.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m 60.99 135.79 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.508 1.923 . . . . 0.0 112.184 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.9 179.93 6.43 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.534 0.734 . . . . 0.0 109.145 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.58 143.72 45.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.048 0.451 . . . . 0.0 110.886 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -134.4 142.02 47.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.834 1.254 . . . . 0.0 110.495 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 85.2 t -142.93 160.26 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -147.67 171.89 14.93 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.8 175.9 5.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.508 1.123 . . . . 0.0 108.977 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tp -124.4 18.98 8.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 127.041 2.136 . . . . 0.0 113.992 -172.732 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.2 Cg_endo -74.54 -164.03 0.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 125.125 3.883 . . . . 0.0 109.616 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 32.95 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.417 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 494' ' ' GLN . 0.0 OUTLIER -68.54 -36.7 79.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.56 2.34 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 112.047 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.09 161.12 75.14 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 122.985 0.514 . . . . 0.0 110.06 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 499' ' ' GLY . 75.1 Cg_exo -53.19 150.95 23.41 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.988 3.125 . . . . 0.0 112.18 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.55 35.82 0.19 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.87 0.843 . . . . 0.0 112.077 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -174.24 30.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.298 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.8 t -139.16 162.52 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 C-N-CA 123.619 0.768 . . . . 0.0 108.984 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.17 143.04 50.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.496 0.665 . . . . 0.0 110.046 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.557 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.7 OUTLIER -60.78 -30.65 70.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.169 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.41 0.38 8.39 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.698 -0.626 . . . . 0.0 111.588 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.72 17.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.719 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.35 -21.58 5.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 109.706 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -72.37 10.15 0.86 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.283 0.633 . . . . 0.0 111.68 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -93.49 8.8 39.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.874 0.87 . . . . 0.0 110.743 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 31.4 mt -123.82 153.62 67.1 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.8 0.84 . . . . 0.0 111.331 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.8 158.49 56.72 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.987 2.458 . . . . 0.0 111.14 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.8 62.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.928 0.891 . . . . 0.0 112.847 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.17 -7.29 59.64 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.649 0.658 . . . . 0.0 111.133 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.79 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -65.21 -35.2 80.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 120.857 -1.152 . . . . 0.0 110.592 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.06 -1.78 8.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.42 0.288 . . . . 0.0 111.5 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.79 5.04 8.79 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.05 -39.21 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.96 -5.52 2.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.701 0.8 . . . . 0.0 109.503 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.8 m -142.16 27.66 1.75 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.272 1.429 . . . . 0.0 110.171 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.59 39.01 2.21 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.41 9.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.692 1.997 . . . . 0.0 115.421 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.9 m -142.4 171.09 14.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.746 0.819 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 1.1 tpm_? 60.57 12.92 3.87 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.65 1.58 . . . . 0.0 114.128 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.43 140.22 21.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.25 32.17 0.66 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.027 0.531 . . . . 0.0 111.786 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' LEU . . . . . 0.489 ' C ' HD12 ' A' ' 525' ' ' LEU 0.262 1.9 pp 50.95 5.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.086 1.754 . . . . 0.0 115.362 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.849 1.26 . . . . 0.0 112.471 -178.152 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.97 173.47 16.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.651 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.41 -179.61 2.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.3 133.25 51.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.86 107.12 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -84.71 132.8 34.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.981 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -76.1 173.52 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.096 0.958 . . . . 0.0 111.424 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.18 -23.19 66.47 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.794 0.838 . . . . 0.0 110.531 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -91.84 -10.46 39.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.924 -0.485 . . . . 0.0 111.322 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 28.75 7.1 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.37 -0.443 . . . . 0.0 113.751 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -121.82 145.57 47.93 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.51 158.02 25.28 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.7 mt -133.12 134.24 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -77.43 128.91 35.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 mt -137.24 130.33 30.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.97 126.97 35.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.009 0.923 . . . . 0.0 109.354 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.57 177.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.133 0.973 . . . . 0.0 109.447 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.4 mm-40 -136.9 162.49 55.52 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 108.619 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.69 5.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.487 2.792 . . . . 0.0 113.384 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.425 ' H ' ' C ' ' B' ' 18' ' ' GLU . 22.5 t -129.86 -8.93 4.45 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.626 0.648 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -81.11 76.01 8.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.7 t -66.08 177.1 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.445 -176.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' B' ' 27' ' ' LYS . 11.8 mm -52.12 -35.34 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.54 -21.73 65.45 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.934 0.788 . . . . 0.0 111.038 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -82.72 -42.67 17.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.6 -40.03 87.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 124.444 1.098 . . . . 0.0 110.395 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.8 mttt -58.75 -23.17 59.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.419 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.48 35.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.601 0.637 . . . . 0.0 110.762 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.26 -33.84 75.1 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.177 -0.327 . . . . 0.0 110.13 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -85.1 -30.51 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.85 -39.16 90.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.79 -31.81 71.94 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.232 0.539 . . . . 0.0 111.07 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -86.9 -22.09 25.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -135.16 -32.1 0.96 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.6 9.85 24.34 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -81.59 129.98 63.42 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.35 151.08 76.46 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.585 2.19 . . . . 0.0 110.826 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.52 -15.03 44.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.626 2.884 . . . . 0.0 111.37 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -88.15 -7.26 57.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -119.24 -9.85 9.86 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.5 176.26 4.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.176 0.898 . . . . 0.0 112.91 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -147.06 151.48 36.97 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 127.48 2.312 . . . . 0.0 105.768 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.46 ' C ' HD12 ' B' ' 44' ' ' ILE . 43.6 tp -146.71 116.8 7.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.308 0.958 . . . . 0.0 110.165 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.46 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.2 mp -125.11 142.23 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.574 0.75 . . . . 0.0 109.299 -174.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.539 ' CB ' HD22 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -161.32 158.41 26.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.564 172.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.12 20.89 1.93 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.33 73.62 Favored Glycine 0 C--N 1.341 0.847 0 C-N-CA 125.084 1.326 . . . . 0.0 112.57 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 161.73 35.8 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 117.693 0.746 . . . . 0.0 109.686 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -96.62 125.71 41.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.1 mp -74.76 159.75 31.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -124.92 148.4 48.36 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.49 0.662 . . . . 0.0 111.801 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.66 2.39 5.32 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.467 1.107 . . . . 0.0 111.672 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 15.61 23.61 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -121.14 -150.2 0.45 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 108.655 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -151.81 156.42 40.18 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 125.738 1.615 . . . . 0.0 108.871 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.79 -25.2 62.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -73.89 -24.29 59.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.265 1.026 . . . . 0.0 111.703 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.0 -15.19 60.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.254 0.621 . . . . 0.0 111.556 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 17.41 19.63 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.82 22.44 1.15 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.836 1.254 . . . . 0.0 114.227 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.81 144.78 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -132.82 178.67 6.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.918 0.887 . . . . 0.0 109.092 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -60.92 150.87 31.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.064 0.459 . . . . 0.0 111.253 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 60.06 17.68 6.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.869 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 87.6 p -70.08 179.48 2.32 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 109.934 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -134.61 126.85 30.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.539 HD22 ' CB ' ' B' ' 45' ' ' PHE . 14.3 mt -121.61 -171.77 2.29 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -138.41 143.96 39.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.034 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.453 HD13 ' C ' ' B' ' 69' ' ' LEU . 1.9 tm? -133.76 139.04 46.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.544 1.137 . . . . 0.0 109.944 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.94 165.89 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.411 ' C ' HD12 ' B' ' 71' ' ' LEU . 3.7 pp -138.49 172.66 12.56 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.25 0.477 . . . . 0.0 111.804 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -123.79 169.45 11.53 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.918 0.887 . . . . 0.0 110.078 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.58 13.49 20.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.986 0.915 . . . . 0.0 112.213 -170.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 126.409 1.884 . . . . 0.0 113.866 -175.095 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 494' ' ' GLN . 84.3 Cg_endo -76.18 -163.74 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 1 C-N-CA 125.392 4.062 . . . . 0.0 109.65 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.94 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.479 1.512 . . . . 0.0 112.868 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.1 pp0? -75.43 -26.26 58.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.49 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.15 5.68 1.3 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.67 157.51 90.0 Favored Pre-proline 0 N--CA 1.448 -0.55 0 O-C-N 121.923 -0.486 . . . . 0.0 110.163 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.16 154.66 27.36 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.857 3.038 . . . . 0.0 112.169 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -79.67 58.19 2.7 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 122.147 0.975 . . . . 0.0 109.866 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.98 28.34 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.142 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.13 163.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.527 0.663 . . . . 0.0 109.349 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.09 144.03 46.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -65.21 -31.98 73.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.621 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.38 9.88 3.54 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.282 -0.886 . . . . 0.0 110.364 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 504' ' ' VAL . 95.7 t -129.71 10.24 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.563 1.145 . . . . 0.0 109.466 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -25.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.219 -0.925 . . . . 0.0 112.728 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -69.12 -8.32 44.31 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.85 0.75 . . . . 0.0 111.939 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -81.32 -10.55 59.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.11 0.413 . . . . 0.0 110.795 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.82 162.44 70.29 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 124.695 1.198 . . . . 0.0 110.15 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.51 165.05 33.43 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.625 2.216 . . . . 0.0 111.258 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.92 -8.89 5.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.434 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -103.05 -2.35 27.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.301 0.64 . . . . 0.0 111.544 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.07 -13.48 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.21 -2.25 33.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.318 0.647 . . . . 0.0 112.185 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -100.5 -15.32 17.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.316 0.507 . . . . 0.0 111.408 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.32 -35.42 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.31 -11.17 49.17 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 t -73.08 -45.0 59.76 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.637 0.256 . . . . 0.0 110.959 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 130.9 123.24 2.48 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -146.28 173.6 12.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.452 1.101 . . . . 0.0 109.001 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 t -153.6 -171.87 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.605 1.162 . . . . 0.0 109.127 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 62.78 21.26 12.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.705 1.202 . . . . 0.0 112.021 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -144.88 155.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.964 0.906 . . . . 0.0 109.542 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.626 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -149.05 10.7 0.8 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -173.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.4 13.55 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.869 -172.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.626 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 51.7 mtmt . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 124.448 1.099 . . . . 0.0 112.335 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -157.87 171.3 20.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.814 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -138.22 -179.73 2.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.09 108.29 8.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.03 117.04 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.58 132.52 36.25 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.392 0.277 . . . . 0.0 111.332 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -83.19 179.34 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.599 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.1 tm? -67.33 7.12 0.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.04 1.336 . . . . 0.0 110.846 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -125.65 11.42 7.89 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.165 -0.959 . . . . 0.0 111.981 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 28.29 66.23 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.84 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -126.55 145.56 50.48 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 159.67 22.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.481 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -127.99 125.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -73.09 133.56 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.35 130.04 21.52 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.36 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -90.36 129.0 36.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.06 -177.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.956 0.902 . . . . 0.0 109.637 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 37.6 mt-10 -144.14 162.87 38.21 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.85 2.86 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.818 2.345 . . . . 0.0 113.063 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.437 ' H ' ' C ' ' B' ' 18' ' ' GLU . 28.4 p -126.16 -12.06 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.679 0.791 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.7 m-20 -80.49 73.18 7.41 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 171.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.5 t -62.89 175.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.252 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.9 mm -51.08 -34.47 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -169.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.44 -22.65 64.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.553 1.07 . . . . 0.0 111.412 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.79 -36.45 25.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 83.3 t -68.08 -37.63 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 124.122 0.969 . . . . 0.0 110.207 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.0 mttt -60.96 -24.28 65.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.83 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.8 52.12 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.479 0.581 . . . . 0.0 110.771 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.487 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.7 mmtt -72.97 -50.59 22.4 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.565 0.746 . . . . 0.0 109.513 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -68.49 -31.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.52 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.96 -38.82 79.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.525 0.203 . . . . 0.0 110.77 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.78 -29.35 65.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.28 0.562 . . . . 0.0 111.405 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -80.48 -25.49 38.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.056 0.943 . . . . 0.0 113.227 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -138.0 -32.8 0.72 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.93 15.36 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.1 mt -76.15 128.63 82.44 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.85 155.47 62.28 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.694 2.263 . . . . 0.0 111.133 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.14 -16.06 43.91 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.897 3.064 . . . . 0.0 111.491 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.67 -13.38 51.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -114.88 -15.19 11.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.11 155.94 38.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.331 0.969 . . . . 0.0 111.21 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.56 90.99 1.84 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.658 1.183 . . . . 0.0 108.826 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.468 ' C ' HD12 ' B' ' 44' ' ' ILE . 18.1 mt -85.57 139.76 31.17 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.012 0.434 . . . . 0.0 111.333 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.468 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -130.97 148.16 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.828 1.251 . . . . 0.0 107.858 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -148.84 141.72 24.7 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.258 1.023 . . . . 0.0 108.686 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.96 12.29 0.08 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.592 0.757 . . . . 0.0 112.583 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.42 39.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.635 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 161.65 33.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.411 1.105 . . . . 0.0 109.766 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -95.78 145.13 25.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -99.51 169.17 9.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.712 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -136.28 153.74 51.09 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.338 0.59 . . . . 0.0 111.987 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -72.84 1.03 9.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.241 1.016 . . . . 0.0 111.54 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.59 8.79 32.42 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -110.56 -154.04 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 109.323 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.8 p -149.06 158.58 44.29 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.63 1.572 . . . . 0.0 107.434 171.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.29 -25.21 68.21 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.9 p -74.06 -24.86 59.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.59 1.156 . . . . 0.0 111.568 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.79 -16.43 61.63 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.182 0.593 . . . . 0.0 111.531 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -125.05 25.94 7.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.516 0.726 . . . . 0.0 109.6 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.33 20.06 0.26 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -60.14 136.9 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 118.572 0.624 . . . . 0.0 111.083 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -132.57 -172.62 2.95 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.26 1.424 . . . . 0.0 109.403 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -60.85 145.49 49.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.674 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 51.44 26.53 3.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.533 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 77.6 p -69.37 -21.17 63.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.419 1.088 . . . . 0.0 113.424 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m 59.87 126.07 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.176 2.19 . . . . 0.0 112.275 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -128.7 -175.88 3.67 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.068 1.347 . . . . 0.0 107.921 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -136.99 144.44 43.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -132.28 135.69 46.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.741 . . . . 0.0 110.088 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.22 166.89 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -146.26 171.99 14.14 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -104.99 177.73 4.77 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.999 1.32 . . . . 0.0 108.345 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.75 18.8 10.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.849 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 126.652 1.981 . . . . 0.0 113.761 -173.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 38.6 Cg_exo -61.2 -162.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 125.117 3.878 . . . . 0.0 111.468 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 31.65 0.71 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.669 1.188 . . . . 0.0 110.671 169.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -68.7 -28.56 66.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.684 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.94 3.33 0.82 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.43 0.692 . . . . 0.0 112.73 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.75 160.88 81.01 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.85 157.74 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.316 3.344 . . . . 0.0 112.582 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -77.44 68.13 3.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.977 0.894 . . . . 0.0 112.375 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 157.18 -26.77 0.49 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.284 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.88 167.38 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.066 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.8 147.88 41.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.656 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.9 OUTLIER -64.2 -30.28 71.35 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.851 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.1 9.41 3.73 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.213 -0.93 . . . . 0.0 110.813 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 504' ' ' VAL . 81.9 t -129.96 9.28 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 109.522 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -19.17 0.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 113.071 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -71.55 -11.44 60.86 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.673 -0.642 . . . . 0.0 111.956 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 9.6 mp0 -80.25 -9.47 59.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.016 0.371 . . . . 0.0 110.349 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.95 148.59 57.35 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 124.293 1.037 . . . . 0.0 109.44 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.35 164.45 23.03 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.658 2.239 . . . . 0.0 111.338 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.84 -21.52 63.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.888 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -87.42 1.45 53.36 Favored 'General case' 0 CA--C 1.524 -0.05 0 C-N-CA 122.692 0.397 . . . . 0.0 111.005 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 32.0 mt -119.34 -16.35 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -54.82 -41.39 70.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.93 -1.18 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.531 0.733 . . . . 0.0 112.487 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -105.77 -17.74 14.28 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.285 0.493 . . . . 0.0 111.9 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.49 -25.69 3.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.49 -5.79 12.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.319 0.248 . . . . 0.0 110.413 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 89.6 p -146.38 15.8 1.3 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -119.16 88.81 0.45 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -112.54 9.26 19.47 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -163.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.4 t -137.57 21.03 2.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.24 7.02 5.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.736 -0.602 . . . . 0.0 112.204 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -153.41 149.49 27.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.1 OUTLIER -144.27 17.43 1.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.28 1.032 . . . . 0.0 109.202 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.54 6.83 5.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.514 1.125 . . . . 0.0 109.876 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 49.5 mtmt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.519 1.128 . . . . 0.0 112.849 -173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 120.658 0.266 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -156.29 173.52 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.74 -179.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 123.654 0.782 . . . . 0.0 109.274 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.418 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 50.7 m-85 -133.57 94.95 3.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.114 0.483 . . . . 0.0 109.737 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -81.93 62.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.163 0.985 . . . . 0.0 111.771 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.5 ttmt -51.59 132.54 30.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.62 0.768 . . . . 0.0 111.28 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 65.9 p -76.06 175.47 8.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.128 -174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.28 -10.34 10.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.708 1.203 . . . . 0.0 110.675 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -112.67 -0.31 15.12 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 121.892 -0.505 . . . . 0.0 111.988 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 22.4 23.78 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.682 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.2 123.42 46.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.585 0.693 . . . . 0.0 110.149 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.9 OUTLIER -82.64 151.24 26.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 111.356 -177.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.35 120.42 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -77.9 136.78 38.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' B' ' 33' ' ' LYS . 67.1 mt -149.77 137.39 20.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.385 0.274 . . . . 0.0 110.976 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.67 128.7 42.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.8 -179.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.837 0.855 . . . . 0.0 109.358 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.442 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -142.15 164.0 36.38 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.454 0.701 . . . . 0.0 109.52 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 43.2 Cg_exo -54.72 1.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.465 3.443 . . . . 0.0 113.683 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.411 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.6 m -132.31 -7.77 3.35 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.805 0.729 . . . . 0.0 111.671 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 28.5 m-20 -81.39 68.61 7.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -63.33 178.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.191 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.46 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -52.74 -33.82 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -168.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.91 -23.43 63.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.224 0.92 . . . . 0.0 111.15 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -80.63 -41.66 23.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.04 -40.89 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 123.999 0.919 . . . . 0.0 110.077 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.5 mttt -56.55 -26.73 55.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.415 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 -28.39 34.98 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.627 0.649 . . . . 0.0 110.849 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.529 ' HB3' HD22 ' B' ' 15' ' ' LEU . 5.1 mptp? -65.47 -32.82 74.64 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -86.15 -30.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -66.49 -36.31 82.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.19 -34.81 76.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.142 0.496 . . . . 0.0 111.325 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.8 mmtm -79.03 -25.58 43.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.24 -31.23 0.91 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.92 10.28 22.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.1 127.36 77.09 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.0 154.13 67.09 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.807 2.338 . . . . 0.0 111.17 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.41 -14.25 41.96 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.717 2.945 . . . . 0.0 110.713 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.45 -8.78 58.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -123.42 -8.76 8.06 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.96 167.51 20.92 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.084 0.856 . . . . 0.0 111.731 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -154.24 138.94 17.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.47 ' C ' HD12 ' B' ' 44' ' ' ILE . 46.0 tp -134.92 135.58 41.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.796 0.725 . . . . 0.0 111.509 -169.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.47 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.3 mp -131.74 152.09 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.586 1.155 . . . . 0.0 108.667 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -149.31 138.67 21.53 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.59 1.156 . . . . 0.0 108.94 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.74 0.07 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.89 0.876 . . . . 0.0 112.876 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.42 13.17 36.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.407 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 159.48 36.81 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.631 1.216 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -93.8 150.52 20.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.486 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.6 mp -109.15 170.28 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.419 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -136.38 153.89 50.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.586 0.708 . . . . 0.0 111.539 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.45 -1.01 14.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.414 1.086 . . . . 0.0 111.983 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.2 8.11 32.97 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -106.08 -155.79 0.56 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.162 0.985 . . . . 0.0 109.198 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 35.8 p -150.82 166.25 31.08 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.203 1.401 . . . . 0.0 107.958 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -29.23 70.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 12.2 t -73.4 -31.53 63.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.108 0.963 . . . . 0.0 111.329 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.93 -15.82 60.02 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.551 0.34 . . . . 0.0 111.443 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -128.28 24.9 5.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.673 0.789 . . . . 0.0 109.92 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.65 24.63 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.375 1.87 . . . . 0.0 115.541 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.9 138.53 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.627 0.649 . . . . 0.0 109.851 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.61 -175.16 3.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.662 1.185 . . . . 0.0 109.753 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -59.45 144.7 46.29 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 53.51 24.87 4.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.388 1.075 . . . . 0.0 113.238 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -74.86 -17.68 60.55 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m 59.54 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.271 1.828 . . . . 0.0 112.865 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -127.59 179.87 5.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.663 1.185 . . . . 0.0 108.522 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -134.9 97.5 3.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.098 0.475 . . . . 0.0 111.449 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.89 143.77 45.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.233 1.013 . . . . 0.0 110.497 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 44.9 t -143.71 166.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.35 168.74 22.53 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.623 -0.673 . . . . 0.0 111.722 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -79.35 176.25 9.86 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.924 0.49 . . . . 0.0 111.657 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.89 14.32 29.69 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.26 0.624 . . . . 0.0 111.477 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 . . . . . 0 N--CA 1.462 0.162 0 C-N-CA 128.054 2.542 . . . . 0.0 114.708 -176.648 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 494' ' ' GLN . 98.0 Cg_endo -77.71 -161.39 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 125.279 3.986 . . . . 0.0 108.8 175.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.2 pt? -68.06 25.5 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.2 pp0? -65.22 -23.76 67.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.549 1.14 . . . . 0.0 112.656 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.85 6.26 1.79 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.22 156.63 74.62 Favored Pre-proline 0 N--CA 1.447 -0.586 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 157.5 5.81 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.204 3.269 . . . . 0.0 112.252 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.92 67.23 2.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.892 0.853 . . . . 0.0 112.302 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 158.51 -29.02 0.44 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.272 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.4 163.9 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.593 0.757 . . . . 0.0 109.838 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.19 157.67 44.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.023 0.529 . . . . 0.0 110.811 -173.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.61 -45.51 93.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.972 0.509 . . . . 0.0 110.614 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.58 7.23 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.139 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.49 11.3 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.597 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -17.42 5.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.359 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.34 4.6 6.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.815 0.446 . . . . 0.0 111.302 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -81.38 7.15 12.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.057 0.943 . . . . 0.0 110.698 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 27.9 mt -121.92 155.01 61.17 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 123.837 0.855 . . . . 0.0 110.621 -168.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.4 167.28 27.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.525 2.817 . . . . 0.0 111.948 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.39 -15.31 24.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.214 1.006 . . . . 0.0 112.753 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -100.72 3.35 42.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.058 0.39 . . . . 0.0 111.786 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.9 mt -118.26 -15.45 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.85 -43.8 66.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.17 1.38 13.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.398 0.679 . . . . 0.0 112.805 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -104.29 -18.5 14.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.45 0.568 . . . . 0.0 111.388 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.27 -28.55 2.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.82 -2.54 9.74 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.168 0.587 . . . . 0.0 110.138 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 90.4 p -133.09 13.62 4.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.193 0.997 . . . . 0.0 111.076 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.79 39.37 2.12 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 2.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -141.25 -174.99 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.911 0.884 . . . . 0.0 109.953 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.85 6.58 4.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.884 1.274 . . . . 0.0 113.065 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.15 161.85 41.59 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.116 0.416 . . . . 0.0 110.898 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -149.79 33.75 0.69 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.762 0.825 . . . . 0.0 111.078 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.83 7.02 4.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.515 0.726 . . . . 0.0 110.741 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.453 -0.318 0 C-N-CA 124.434 1.093 . . . . 0.0 111.717 -176.733 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.95 173.12 17.25 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.034 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -135.0 175.81 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.403 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 53.2 m-85 -128.88 89.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.433 0.635 . . . . 0.0 110.167 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.38 103.38 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.161 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.2 ttmt -85.17 135.52 33.93 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -83.85 174.96 9.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.526 0.731 . . . . 0.0 112.368 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.31 3.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.14 1.376 . . . . 0.0 111.418 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -118.19 4.62 11.95 Favored 'General case' 0 CA--C 1.527 0.058 0 O-C-N 121.922 -0.486 . . . . 0.0 111.537 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.26 24.4 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.251 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.35 122.39 38.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.57 0.685 . . . . 0.0 110.134 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.7 OUTLIER -79.04 152.46 30.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.816 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.25 123.24 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -79.83 131.9 35.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -143.55 133.45 24.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.287 -174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.73 126.29 35.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -145.35 177.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 123.786 0.834 . . . . 0.0 109.919 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.1 mm-40 -138.91 162.24 53.66 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 124.05 0.94 . . . . 0.0 109.709 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 49.4 Cg_exo -54.58 -0.44 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 125.0 3.8 . . . . 0.0 113.896 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -130.91 -7.2 3.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.183 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 65.2 m-20 -81.55 69.62 8.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.9 t -62.9 177.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.808 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.411 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -51.79 -34.61 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.942 0.897 . . . . 0.0 113.215 -168.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.95 -22.42 63.18 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.094 0.861 . . . . 0.0 111.271 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.6 -40.85 22.38 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.9 -39.12 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 124.301 1.04 . . . . 0.0 110.217 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.411 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.7 mttt -57.4 -24.84 57.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.761 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.85 -28.34 33.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.509 0.595 . . . . 0.0 110.761 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -66.34 -33.32 75.46 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.06 -30.62 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.25 -39.35 86.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.695 0.283 . . . . 0.0 110.261 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.65 -31.67 71.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 111.243 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -83.71 -23.72 31.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.78 -32.84 0.88 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.81 9.03 21.61 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -78.2 129.47 75.18 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.47 151.44 70.72 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.574 2.183 . . . . 0.0 110.456 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 -14.47 37.37 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.23 2.62 . . . . 0.0 110.828 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.14 -8.64 59.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -124.07 -9.82 7.65 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -67.61 165.75 16.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.097 0.862 . . . . 0.0 111.655 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -154.47 102.58 2.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' B' ' 44' ' ' ILE . 28.5 tp -101.36 135.93 42.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.256 0.623 . . . . 0.0 110.949 -169.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.1 mp -129.81 154.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -118.52 -112.05 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 122.914 0.485 . . . . 0.0 110.494 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.99 -3.18 3.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.303 0.641 . . . . 0.0 111.732 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.88 3.03 2.08 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.553 1.073 . . . . 0.0 111.448 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 154.89 37.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.451 0.643 . . . . 0.0 109.567 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -87.96 128.62 35.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.619 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.639 HD22 ' H ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -76.14 172.71 12.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.602 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -133.63 153.44 51.67 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.663 0.744 . . . . 0.0 111.656 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.49 1.48 9.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 111.917 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.29 14.01 25.75 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -115.57 -154.59 0.55 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.353 1.061 . . . . 0.0 108.997 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.0 p -150.14 165.82 31.7 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.812 1.245 . . . . 0.0 108.142 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.14 -29.33 70.71 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 11.5 t -73.24 -31.36 64.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.654 0.782 . . . . 0.0 111.183 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.96 -15.7 63.23 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 122.87 0.468 . . . . 0.0 111.894 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' B' ' 50' ' ' LEU . 15.7 m-85 -130.49 26.44 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.846 0.858 . . . . 0.0 109.989 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.83 30.89 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 132.85 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.83 -174.0 3.79 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.477 1.111 . . . . 0.0 109.542 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -56.7 143.08 37.74 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.058 0.456 . . . . 0.0 111.477 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 53.45 27.79 6.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.201 1.0 . . . . 0.0 112.942 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -69.7 -27.37 64.94 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m 61.57 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.012 2.125 . . . . 0.0 112.043 -174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.54 -179.38 5.7 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.212 1.005 . . . . 0.0 108.806 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.51 151.95 50.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -138.55 142.64 39.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.573 0.749 . . . . 0.0 111.087 -175.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.12 165.32 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 126.352 1.861 . . . . 0.0 105.983 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.35 165.86 27.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.846 -0.534 . . . . 0.0 111.295 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -73.2 174.19 8.36 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.31 17.78 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.009 0.524 . . . . 0.0 111.087 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.463 0.205 0 C-N-CA 126.845 2.058 . . . . 0.0 113.693 -173.857 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 491' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 92.3 Cg_endo -81.59 89.28 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.972 3.781 . . . . 0.0 111.937 -168.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.8 tt 21.46 48.87 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.163 2.585 . . . . 0.0 112.214 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -95.95 -20.08 19.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.117 -172.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -145.57 6.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.79 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.15 151.64 93.31 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.15 164.05 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.836 3.024 . . . . 0.0 111.685 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.03 132.21 53.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.273 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 78.03 -23.02 2.76 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.698 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.99 163.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.71 1.255 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.91 164.83 28.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.182 0.593 . . . . 0.0 110.398 -173.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -66.72 -41.9 87.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.114 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.64 10.9 0.73 Allowed 'General case' 0 C--O 1.23 0.062 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.56 12.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.665 0.786 . . . . 0.0 110.35 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -134.48 -26.26 1.44 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.274 0.488 . . . . 0.0 112.073 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.37 -13.43 62.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.435 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 8.6 mp0 -82.19 -12.07 58.34 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.195 0.452 . . . . 0.0 110.887 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.18 153.4 84.35 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 124.249 1.02 . . . . 0.0 109.508 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 166.29 30.4 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.1 2.533 . . . . 0.0 111.582 172.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.72 -22.19 56.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.554 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.04 3.16 55.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.995 0.362 . . . . 0.0 111.669 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.8 mt -117.94 -15.37 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -52.9 -44.63 67.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.84 -6.65 39.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.401 0.68 . . . . 0.0 112.469 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.86 -20.44 16.17 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.448 0.567 . . . . 0.0 111.039 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.76 -31.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.44 -3.31 8.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.745 0.418 . . . . 0.0 109.988 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -136.17 15.79 3.25 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.092 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -114.54 28.26 8.32 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.156 0.408 . . . . 0.0 112.199 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 1.45 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.2 t -136.01 32.3 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.79 -2.16 0.95 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.66 159.28 39.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -147.35 28.45 0.99 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.957 -172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.42 6.8 3.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.563 0.697 . . . . 0.0 110.073 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 C--N 1.338 0.097 0 C-N-CA 123.878 0.871 . . . . 0.0 112.222 -174.487 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -129.42 165.6 21.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.339 0.656 . . . . 0.0 110.75 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.78 166.64 2.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 164.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.541 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 8.9 m-85 -125.75 133.93 51.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -126.79 109.86 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -84.64 139.38 32.09 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.227 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -84.91 177.82 7.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.073 0.949 . . . . 0.0 112.082 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.42 6.08 0.87 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.791 1.236 . . . . 0.0 110.945 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -125.38 6.15 7.69 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.812 -0.555 . . . . 0.0 112.113 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.84 26.58 53.21 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 119.954 -0.359 . . . . 0.0 113.172 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -124.01 145.58 49.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.272 0.629 . . . . 0.0 109.465 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 8.0 m -122.82 147.18 46.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.215 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.9 mt -123.86 123.76 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -77.44 132.84 38.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -128.74 177.36 7.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 127.44 22.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -149.96 -179.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.087 0.955 . . . . 0.0 109.449 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -136.83 163.14 51.64 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.342 1.057 . . . . 0.0 108.358 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 2.7 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.205 2.604 . . . . 0.0 113.553 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -125.77 -6.44 6.82 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.976 0.807 . . . . 0.0 110.779 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -83.79 75.13 10.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 3.8 t -64.76 175.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.205 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.492 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.3 mm -50.49 -36.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.43 -21.78 65.54 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.325 0.966 . . . . 0.0 111.262 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -82.48 -41.85 19.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.69 -39.81 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.591 1.157 . . . . 0.0 110.134 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.8 mttt -56.09 -26.51 49.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.501 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.68 -27.76 45.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.421 0.555 . . . . 0.0 110.896 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -68.66 -33.01 73.26 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.01 -28.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.07 -39.74 82.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 122.298 -0.251 . . . . 0.0 110.329 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.63 -30.17 68.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 111.592 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -82.83 -23.7 33.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.937 0.895 . . . . 0.0 113.363 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -137.34 -35.82 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.27 9.13 13.58 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.19 127.11 84.18 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 153.18 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.558 2.172 . . . . 0.0 111.184 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.43 -16.03 42.7 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.459 2.772 . . . . 0.0 110.314 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -80.9 -6.32 58.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.769 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -121.46 -21.61 6.21 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.99 162.95 13.04 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.109 0.868 . . . . 0.0 112.998 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -152.08 127.63 10.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.425 ' C ' HD12 ' B' ' 44' ' ' ILE . 37.1 tp -127.29 132.21 50.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.957 0.344 . . . . 0.0 110.522 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.425 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -130.6 148.86 33.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 109.16 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -151.7 143.5 23.72 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.098 0.959 . . . . 0.0 109.36 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 12.48 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.772 0.829 . . . . 0.0 112.427 -172.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 16.39 41.69 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.211 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.3 159.51 36.72 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.71 1.255 . . . . 0.0 110.16 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -96.08 129.26 43.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.679 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.491 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.6 mt -81.46 162.23 23.37 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.755 -174.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -127.48 147.76 50.31 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.445 0.64 . . . . 0.0 111.82 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.45 0.34 8.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.361 1.065 . . . . 0.0 111.691 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.18 13.53 31.2 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -118.57 -149.64 0.44 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.306 1.042 . . . . 0.0 108.942 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.19 157.17 41.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 125.747 1.619 . . . . 0.0 108.65 176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -60.56 -25.11 65.94 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -72.74 -25.21 61.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.365 1.066 . . . . 0.0 111.482 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.7 -14.68 60.35 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.342 0.657 . . . . 0.0 111.558 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.491 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -114.04 17.27 17.92 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 117.804 0.274 . . . . 0.0 110.344 175.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.54 27.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.304 1.442 . . . . 0.0 114.187 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 145.96 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -125.33 -177.42 3.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.498 0.719 . . . . 0.0 109.474 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -72.2 145.14 48.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.649 0.738 . . . . 0.0 112.086 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 58.61 16.58 4.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 111.449 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -65.23 -176.54 0.31 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.93 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -130.26 134.79 47.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.097 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -132.19 -177.03 4.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.246 1.419 . . . . 0.0 108.871 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -136.02 147.79 48.1 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.262 0.225 . . . . 0.0 110.564 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -132.73 138.94 47.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.064 0.946 . . . . 0.0 110.691 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 82.2 t -146.97 165.88 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -145.46 168.25 21.02 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.914 0.779 . . . . 0.0 112.34 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.83 175.92 3.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.435 1.094 . . . . 0.0 112.056 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tp -96.45 16.44 18.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.617 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 127.595 2.358 . . . . 0.0 114.066 -175.141 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 494' ' ' GLN . 86.0 Cg_endo -79.34 -167.27 0.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.86 3.707 . . . . 0.0 109.128 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 33.1 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.645 1.578 . . . . 0.0 112.837 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.9 pp0? -74.19 -28.76 61.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.445 0.698 . . . . 0.0 112.599 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.72 5.41 1.77 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.1 159.96 84.02 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 122.497 0.319 . . . . 0.0 110.668 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.0 151.07 21.72 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.535 3.49 . . . . 0.0 112.408 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -80.94 54.5 2.21 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 122.301 1.048 . . . . 0.0 109.989 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.48 28.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.833 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.52 165.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.595 0.758 . . . . 0.0 109.03 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.14 145.93 40.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.885 0.874 . . . . 0.0 108.676 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.597 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.8 OUTLIER -59.79 -29.7 68.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -72.42 1.12 8.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.441 0.564 . . . . 0.0 111.642 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.53 16.54 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.22 0.608 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.81 -15.4 5.96 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.084 0.954 . . . . 0.0 109.498 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -77.85 1.5 20.21 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.95 -0.469 . . . . 0.0 111.635 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -85.12 3.05 40.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.95 0.5 . . . . 0.0 110.003 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.58 149.35 39.75 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.723 1.209 . . . . 0.0 109.606 -170.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.8 161.63 44.69 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.036 2.49 . . . . 0.0 110.768 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.92 -21.59 63.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.403 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.3 -6.23 59.26 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 117.823 0.283 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 44.6 mt -110.97 -17.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 172.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -55.63 -42.04 74.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.09 -13.63 62.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 111.589 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.24 -15.02 26.33 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.658 0.383 . . . . 0.0 111.344 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.8 -37.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.33 -6.96 5.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.434 0.694 . . . . 0.0 110.187 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 45.0 m -65.59 -28.27 69.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.526 -0.274 . . . . 0.0 111.134 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.4 39.16 2.65 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -61.85 -179.81 0.22 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.642 1.21 . . . . 0.0 112.418 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -149.01 -167.44 2.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.493 -1.685 . . . . 0.0 109.214 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.65 19.43 11.71 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.077 0.951 . . . . 0.0 111.975 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -142.82 145.99 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.511 0.724 . . . . 0.0 109.41 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.452 ' HB2' ' HE2' ' A' ' 526' ' ' LYS . 0.2 OUTLIER -138.75 18.77 2.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.027 0.442 . . . . 0.0 111.927 -172.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.43 10.07 4.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.875 0.845 . . . . 0.0 109.671 -169.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 524' ' ' ASN . 31.2 mtmm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -158.1 174.23 15.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.954 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.36 175.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -124.4 117.9 25.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.37 101.73 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -82.35 134.36 35.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.898 0.479 . . . . 0.0 110.917 -173.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -80.46 175.35 10.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.456 0.702 . . . . 0.0 111.649 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.428 HD22 HG13 ' B' ' 70' ' ' VAL . 21.6 tp -66.91 3.67 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.261 1.025 . . . . 0.0 111.485 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -119.87 9.24 11.25 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.732 -0.605 . . . . 0.0 111.787 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.26 25.51 57.09 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 120.088 -0.284 . . . . 0.0 113.133 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.81 140.65 52.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.64 158.59 25.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.117 0.484 . . . . 0.0 111.572 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.12 131.95 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 130.47 36.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -139.52 130.19 25.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.3 128.25 35.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.93 179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.596 0.758 . . . . 0.0 110.416 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.6 mm-40 -132.73 160.08 69.89 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.12 1.4 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.246 2.631 . . . . 0.0 113.304 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 18' ' ' GLU . 33.7 p -124.56 -3.66 7.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.823 0.849 . . . . 0.0 111.049 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.02 69.03 6.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.528 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.9 t -58.5 174.4 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.805 1.242 . . . . 0.0 110.722 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.67 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 16.9 mm -50.39 -31.01 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.26 -19.7 62.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.037 -1.04 . . . . 0.0 111.519 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -86.07 -45.76 11.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.504 0.722 . . . . 0.0 110.714 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.67 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.3 OUTLIER -66.6 -28.72 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 C-N-CA 122.686 0.395 . . . . 0.0 110.643 -176.054 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.53 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.5 mttt -56.59 -29.48 62.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.312 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.8 -29.16 40.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.246 0.475 . . . . 0.0 111.25 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.84 -34.28 73.42 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.951 0.341 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -85.92 -27.79 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -69.57 -39.49 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.01 -31.88 72.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.622 0.725 . . . . 0.0 111.172 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -83.05 -22.52 33.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.61 -31.71 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 8.46 17.63 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -76.77 127.53 83.85 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.52 157.67 58.21 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.759 2.306 . . . . 0.0 111.48 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.64 -13.78 37.95 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.722 2.948 . . . . 0.0 110.338 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.5 -8.13 58.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -126.28 -11.44 6.36 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.35 162.49 28.48 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.341 0.973 . . . . 0.0 111.785 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -154.84 125.73 7.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.454 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.5 OUTLIER -122.41 139.63 53.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.005 0.366 . . . . 0.0 111.323 -168.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.454 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -134.4 150.93 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.789 1.235 . . . . 0.0 108.911 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.489 ' HB3' HD21 ' B' ' 50' ' ' LEU . 18.8 t80 -148.63 138.66 22.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.109 1.364 . . . . 0.0 109.05 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.5 13.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.72 0.808 . . . . 0.0 112.651 -174.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.89 15.07 40.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.077 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 157.2 42.64 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.004 1.402 . . . . 0.0 109.921 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -90.15 153.03 20.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.525 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.2 mt -109.53 161.94 14.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.197 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -128.49 144.27 51.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.253 0.549 . . . . 0.0 111.704 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.24 0.16 6.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.388 1.075 . . . . 0.0 111.7 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.71 11.7 32.6 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -114.69 -149.13 0.44 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.653 1.181 . . . . 0.0 108.775 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.4 p -154.5 158.49 39.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 125.807 1.643 . . . . 0.0 109.024 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.02 -29.29 68.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.64 -25.73 64.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.635 1.174 . . . . 0.0 111.723 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.11 -10.77 59.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.678 0.391 . . . . 0.0 111.054 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.525 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -117.39 17.19 14.67 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.33 13.57 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.7 143.99 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 119.027 0.831 . . . . 0.0 111.428 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 109.697 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.06 147.96 49.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.27 17.89 7.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.839 0.855 . . . . 0.0 112.068 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.5 t -70.98 175.05 5.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -132.39 133.88 44.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.479 0.712 . . . . 0.0 109.094 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.87 179.62 5.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.42 0.688 . . . . 0.0 110.045 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -134.07 138.67 45.47 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.615 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.72 137.87 48.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.666 1.186 . . . . 0.0 110.025 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.428 HG13 HD22 ' B' ' 8' ' ' LEU . 75.7 t -136.32 159.37 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pp -143.73 169.89 16.9 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.615 0.643 . . . . 0.0 112.733 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.17 -179.51 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 tp -126.87 18.31 7.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.898 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 . . . . . 0 N--CA 1.463 0.18 0 C-N-CA 127.412 2.285 . . . . 0.0 114.578 -173.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 494' ' ' GLN . 37.6 Cg_exo -59.09 -170.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 125.212 3.942 . . . . 0.0 112.041 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.15 29.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.809 1.243 . . . . 0.0 111.15 172.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -66.45 -34.74 78.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 112.953 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.48 11.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.841 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.81 161.0 75.46 Favored Pre-proline 0 N--CA 1.448 -0.572 0 O-C-N 122.028 -0.42 . . . . 0.0 109.975 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.62 155.19 5.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.293 3.329 . . . . 0.0 112.649 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.6 64.88 3.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 122.031 0.919 . . . . 0.0 112.138 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 161.3 -28.55 0.29 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.075 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.41 164.42 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -139.15 160.82 38.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.081 -0.387 . . . . 0.0 110.856 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.8 mp0 -59.44 -51.54 69.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.82 0.848 . . . . 0.0 108.737 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.65 3.73 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.167 -1.379 . . . . 0.0 113.262 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.56 15.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.523 0.601 . . . . 0.0 111.719 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.05 -17.8 5.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.438 1.095 . . . . 0.0 109.435 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 502' ' ' GLN . 55.6 mtmt -75.8 0.66 17.24 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 111.604 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -86.26 -7.82 58.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.3 mp -89.49 156.06 48.22 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.829 1.252 . . . . 0.0 109.777 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.88 167.65 25.79 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.703 2.935 . . . . 0.0 111.183 170.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.9 -16.3 49.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.806 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.09 -2.03 41.05 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.495 0.588 . . . . 0.0 111.913 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.08 -16.06 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -44.94 70.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.491 -0.756 . . . . 0.0 109.367 170.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.54 -0.97 22.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.22 0.608 . . . . 0.0 112.505 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -105.04 -17.53 14.47 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.535 0.607 . . . . 0.0 111.745 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.22 -27.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' LEU . . . . . 0.433 ' O ' ' HE3' ' A' ' 520' ' ' LYS . 64.3 mt -74.48 -0.26 16.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.363 0.665 . . . . 0.0 110.892 172.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 44.8 m -136.03 24.76 3.3 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -142.55 -32.09 0.11 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 517' ' ' LEU . 51.0 mttt 43.96 26.52 0.14 Allowed 'General case' 0 C--N 1.339 0.139 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 169.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.8 t -148.98 173.15 13.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.32 11.6 2.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.131 1.372 . . . . 0.0 112.877 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -141.15 137.7 32.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.718 0.407 . . . . 0.0 110.255 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -150.4 23.68 0.81 Allowed 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.591 0.756 . . . . 0.0 109.778 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.28 8.28 3.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.181 0 C-N-CA 124.624 1.17 . . . . 0.0 112.539 -174.88 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.12 175.68 13.18 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.383 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 178.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.623 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 89.7 m-85 -134.84 99.22 4.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 110.0 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.22 133.27 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.12 134.03 53.03 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -79.52 178.18 8.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.35 1.46 . . . . 0.0 112.975 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.45 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.5 OUTLIER -73.73 14.04 0.42 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.986 1.315 . . . . 0.0 110.499 173.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.0 p -132.29 11.96 4.58 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.272 -0.893 . . . . 0.0 112.095 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.05 66.62 Favored Glycine 0 C--N 1.338 0.643 0 O-C-N 122.287 -0.258 . . . . 0.0 112.745 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -120.79 142.33 49.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.623 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 23.5 m -115.63 144.8 43.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.99 126.82 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -78.17 136.98 37.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -146.16 133.15 20.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -92.86 128.74 38.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.84 178.24 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.222 1.009 . . . . 0.0 109.258 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' B' ' 20' ' ' SER . 36.1 mt-10 -143.77 163.95 33.0 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.44 4.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.397 2.732 . . . . 0.0 113.354 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 18' ' ' GLU . 23.7 p -126.26 -12.41 6.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.705 0.802 . . . . 0.0 111.108 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.1 m-20 -83.83 71.64 10.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.7 t -61.5 174.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.282 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.25 -35.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -69.68 -22.32 63.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.421 1.009 . . . . 0.0 111.355 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -80.95 -36.49 30.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.485 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.8 t -67.13 -37.22 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 C-N-CA 123.936 0.894 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.01 -24.64 66.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.63 -23.51 53.34 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.49 0.586 . . . . 0.0 110.558 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.0 mmtt -72.99 -45.98 54.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.621 0.768 . . . . 0.0 109.282 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.04 -31.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -68.93 -38.65 79.63 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.431 0.292 . . . . 0.0 110.643 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.1 -30.29 68.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.314 0.578 . . . . 0.0 111.341 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -82.63 -22.88 34.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.73 -175.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -138.71 -31.72 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.77 9.56 20.66 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -76.71 130.68 75.67 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.43 153.89 50.33 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.761 2.307 . . . . 0.0 111.045 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.35 -15.45 45.72 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.47 -13.95 60.41 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.803 0.441 . . . . 0.0 112.123 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -125.39 -16.11 5.98 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.26 165.52 18.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.609 1.095 . . . . 0.0 112.795 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -160.23 152.38 20.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 24.0 mt -135.67 146.86 48.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.033 0.379 . . . . 0.0 110.48 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 149.01 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -149.25 139.63 22.38 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 108.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 112.813 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.4 13.76 37.55 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.593 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 160.71 32.38 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.457 1.128 . . . . 0.0 110.043 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -96.7 133.76 40.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.631 -170.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' B' ' 59' ' ' TYR . 22.6 mt -83.25 164.06 20.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.652 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -136.82 153.71 50.72 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-O 121.475 0.655 . . . . 0.0 111.686 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -72.26 0.4 9.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.752 1.221 . . . . 0.0 111.667 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.83 13.73 26.97 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -116.08 -154.14 0.54 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.314 1.045 . . . . 0.0 109.388 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.2 p -148.44 158.34 44.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.71 1.604 . . . . 0.0 107.603 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.1 -24.9 68.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -74.2 -25.78 59.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.361 1.064 . . . . 0.0 111.892 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.68 -15.58 62.22 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.528 . . . . 0.0 111.3 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.439 ' CD2' HD22 ' B' ' 50' ' ' LEU . 22.2 m-85 -125.9 24.13 7.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.315 0.646 . . . . 0.0 110.056 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 p30 47.87 20.49 0.23 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.111 1.764 . . . . 0.0 115.597 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.67 138.04 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.761 0.709 . . . . 0.0 110.188 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -128.41 -173.07 2.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.477 1.111 . . . . 0.0 110.033 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.68 141.74 58.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.801 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 54.68 22.11 3.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.381 1.072 . . . . 0.0 113.428 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -69.99 -15.37 63.02 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -173.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.7 m 57.97 133.71 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.984 2.114 . . . . 0.0 112.615 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -134.72 -177.69 4.73 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.327 1.451 . . . . 0.0 108.238 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -134.49 138.86 45.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.56 131.56 53.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.34 1.456 . . . . 0.0 110.133 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.03 159.63 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.12 165.98 26.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.791 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.23 153.94 29.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.0 109.995 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.74 23.25 6.37 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.691 1.596 . . . . 0.0 110.261 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? . . . . . 0 CA--C 1.523 -0.072 0 C-N-CA 127.053 2.141 . . . . 0.0 112.795 -170.203 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 494' ' ' GLN . 40.5 Cg_exo -58.7 -171.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.861 3.707 . . . . 0.0 111.225 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 29.56 0.07 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.689 1.195 . . . . 0.0 110.622 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -64.09 -36.89 85.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.31 1.044 . . . . 0.0 112.814 -174.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.63 3.31 1.46 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.88 155.01 92.68 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.85 151.83 7.8 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.917 3.078 . . . . 0.0 111.646 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -75.23 69.1 2.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.961 0.886 . . . . 0.0 112.634 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 162.51 -29.27 0.27 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.03 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.0 165.27 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.604 0.762 . . . . 0.0 109.568 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.78 145.73 36.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.562 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.1 pm0 -60.16 -28.07 67.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.45 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.33 0.72 11.26 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.605 -0.684 . . . . 0.0 111.717 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.25 16.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.359 0.599 . . . . 0.0 110.603 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -17.49 5.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.714 1.206 . . . . 0.0 109.223 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.31 3.3 7.55 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.881 -0.512 . . . . 0.0 111.65 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -85.57 -6.16 59.2 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 508' ' ' LEU . 2.7 mp -93.15 155.91 40.72 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.329 1.451 . . . . 0.0 109.704 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.74 167.58 26.89 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.02 2.48 . . . . 0.0 111.547 170.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.27 -17.54 53.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.431 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.15 3.74 51.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.545 0.338 . . . . 0.0 111.767 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.87 -14.71 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.0 -41.47 67.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.02 -1.1 30.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.628 0.771 . . . . 0.0 112.375 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.93 -18.65 14.95 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.387 0.539 . . . . 0.0 111.306 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.02 -31.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.38 -3.77 15.59 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.806 0.443 . . . . 0.0 110.495 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' SER . . . . . 0.414 ' HA ' ' HE3' ' A' ' 520' ' ' LYS . 50.3 m -131.99 10.86 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 111.41 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.48 -44.8 1.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 518' ' ' SER . 83.3 mttt 49.77 6.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 172.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 33.8 t -161.81 179.55 8.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.351 0.523 . . . . 0.0 109.963 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 70.43 3.04 4.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.116 1.766 . . . . 0.0 112.912 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -154.23 155.14 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.181 0.515 . . . . 0.0 110.931 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -145.55 29.12 1.15 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.54 6.95 4.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 109.851 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.457 -0.095 0 C-N-CA 125.091 1.357 . . . . 0.0 112.119 -176.636 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -158.84 176.04 12.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.867 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.66 177.42 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.3 115.54 17.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.51 126.06 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.0 ttmt -101.94 136.87 41.02 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.022 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.418 ' C ' ' H ' ' B' ' 9' ' ' THR . 73.5 p -86.74 178.66 6.95 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.104 0.962 . . . . 0.0 112.386 -171.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.575 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -70.0 12.96 0.17 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.981 1.312 . . . . 0.0 110.377 174.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.418 ' H ' ' C ' ' B' ' 7' ' ' THR . 28.1 p -126.26 5.68 7.05 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.165 -0.96 . . . . 0.0 111.758 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.57 62.3 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.592 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -125.85 140.44 52.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.493 0.646 . . . . 0.0 110.006 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -106.28 158.47 16.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.097 -175.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.24 125.89 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 19.8 m -75.41 132.28 40.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.4 mt -141.95 131.14 23.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.62 127.87 35.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.42 -179.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.777 0.831 . . . . 0.0 109.731 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 34.9 mt-10 -143.82 164.72 28.36 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 123.874 0.869 . . . . 0.0 108.921 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 32.9 Cg_exo -56.07 1.05 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.169 3.246 . . . . 0.0 113.449 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.409 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.7 m -131.78 -7.06 3.59 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.782 0.719 . . . . 0.0 111.651 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.5 m-20 -80.73 72.14 7.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.6 t -62.82 175.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.704 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.4 -34.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.16 -23.81 63.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.726 1.148 . . . . 0.0 111.139 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.12 -38.33 27.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.469 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 81.8 t -66.85 -37.88 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 123.695 0.798 . . . . 0.0 109.867 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -61.99 -23.52 66.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.039 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 -22.68 52.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.459 0.572 . . . . 0.0 110.541 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 64.7 mmtt -73.55 -48.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.62 0.768 . . . . 0.0 109.862 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.62 -30.8 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -69.46 -40.04 77.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.28 -0.262 . . . . 0.0 110.66 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.68 -30.76 70.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.463 0.649 . . . . 0.0 111.456 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -80.82 -25.1 38.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.926 -1.033 . . . . 0.0 113.449 -175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -138.03 -33.65 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.68 8.97 15.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.93 127.51 86.77 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.3 153.72 61.54 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.645 2.23 . . . . 0.0 110.693 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.59 -17.88 48.41 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 110.885 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.69 -5.34 58.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.46 -15.52 6.61 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.27 165.86 17.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.682 1.128 . . . . 0.0 112.413 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.471 ' C ' HD12 ' B' ' 44' ' ' ILE . 15.8 mt -129.17 138.62 51.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 110.785 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.471 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.5 mp -131.91 148.33 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.432 1.093 . . . . 0.0 108.585 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.16 141.19 23.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.065 0.946 . . . . 0.0 109.228 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.65 12.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.752 0.821 . . . . 0.0 112.608 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.51 14.63 40.37 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.458 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 158.84 37.98 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.833 1.316 . . . . 0.0 109.964 173.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -95.82 132.83 40.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.812 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.476 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.5 mt -80.23 159.79 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.156 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -128.86 150.06 50.5 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.513 0.673 . . . . 0.0 111.901 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -66.63 -18.71 65.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.737 1.215 . . . . 0.0 111.944 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.19 15.18 63.52 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -122.86 -151.56 0.48 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.429 1.091 . . . . 0.0 109.67 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 34.2 p -154.67 161.27 41.63 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.138 1.375 . . . . 0.0 108.881 174.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.54 -28.44 67.1 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.614 0.188 . . . . 0.0 111.226 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 31.0 t -75.47 -25.56 57.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.741 0.416 . . . . 0.0 110.736 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.45 -12.96 62.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.471 0.308 . . . . 0.0 111.369 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -116.39 19.45 14.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 p30 49.14 20.27 0.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.71 144.67 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 118.036 0.38 . . . . 0.0 110.043 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -130.14 -176.76 4.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.035 0.934 . . . . 0.0 109.963 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.93 146.8 54.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.24 16.82 7.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.298 1.039 . . . . 0.0 112.415 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -70.56 175.08 5.1 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -129.6 132.37 46.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.704 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -130.61 -177.1 4.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.473 1.109 . . . . 0.0 108.782 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -135.32 136.94 41.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.42 HD13 ' C ' ' B' ' 69' ' ' LEU . 3.0 tm? -124.16 131.87 53.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 0.0 109.566 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -142.65 166.13 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.84 172.39 13.4 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.12 178.71 5.79 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.257 1.023 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.644 HD23 ' H ' ' B' ' 73' ' ' LEU . 0.9 OUTLIER -132.42 17.97 4.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.327 1.451 . . . . 0.0 109.041 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 . . . . . 0 CA--C 1.53 0.185 0 C-N-CA 128.499 2.72 . . . . 0.0 115.645 -169.444 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 494' ' ' GLN . 85.6 Cg_endo -77.04 -162.95 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 1 C-N-CA 125.341 4.027 . . . . 0.0 108.969 175.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.3 pt? -67.68 25.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.0 pp0? -66.3 -24.44 66.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.66 1.184 . . . . 0.0 112.75 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.01 7.11 1.6 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.72 160.34 27.93 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 158.36 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 124.011 3.141 . . . . 0.0 111.549 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.18 66.89 3.88 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.849 0.833 . . . . 0.0 112.695 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 156.44 -23.94 0.51 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.54 168.04 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.679 0.792 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.9 157.11 45.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.677 0.791 . . . . 0.0 110.563 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -61.19 -46.77 89.12 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.135 0.574 . . . . 0.0 110.692 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.94 7.87 0.84 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.63 10.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.425 0.69 . . . . 0.0 111.257 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.84 -10.54 7.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.668 0.787 . . . . 0.0 109.936 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.52 17.7 4.39 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 111.339 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -89.53 6.35 41.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.645 0.778 . . . . 0.0 110.95 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.31 62.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.925 0.89 . . . . 0.0 110.938 -170.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.35 166.4 23.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.303 3.335 . . . . 0.0 113.028 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -26.69 63.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.043 0.937 . . . . 0.0 111.832 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.07 -4.8 49.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.316 0.246 . . . . 0.0 111.447 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.14 -12.88 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.253 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 26.5 mm-40 -56.02 -40.73 73.86 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.64 -14.12 62.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.374 0.67 . . . . 0.0 112.412 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -89.96 -21.5 22.4 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.201 0.455 . . . . 0.0 111.464 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.43 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 53.0 mt -65.97 -0.05 2.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.1 m -133.76 17.58 3.89 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.792 1.237 . . . . 0.0 110.126 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -98.74 35.92 4.34 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.376 0.989 . . . . 0.0 111.38 -177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 0.37 0.06 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -177.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.9 t -149.56 173.05 14.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.497 0.719 . . . . 0.0 110.069 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.11 7.49 2.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.14 1.776 . . . . 0.0 113.682 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -155.39 150.88 27.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.385 0.539 . . . . 0.0 111.576 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.06 35.65 1.11 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.596 1.158 . . . . 0.0 109.383 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.62 4.46 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.122 0.969 . . . . 0.0 110.765 -172.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.87 1.268 . . . . 0.0 111.969 -176.673 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.637 0.256 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.75 174.75 14.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.831 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.29 -178.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 123.768 0.827 . . . . 0.0 109.029 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -134.83 106.23 6.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -97.45 112.79 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -92.62 129.81 38.44 Favored 'General case' 0 C--O 1.23 0.047 0 O-C-N 122.258 -0.276 . . . . 0.0 111.392 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.427 ' C ' ' H ' ' B' ' 9' ' ' THR . 74.4 p -78.65 177.89 8.26 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.591 1.156 . . . . 0.0 112.354 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.436 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -70.88 17.78 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.947 1.299 . . . . 0.0 110.425 175.241 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.427 ' H ' ' C ' ' B' ' 7' ' ' THR . 49.6 p -133.15 6.35 3.88 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 121.226 -0.921 . . . . 0.0 111.911 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.57 26.78 58.43 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 122.208 -0.307 . . . . 0.0 112.55 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -124.71 143.65 50.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.755 0.822 . . . . 0.0 108.877 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.12 159.12 26.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.585 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.02 130.4 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -79.63 131.9 36.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -143.4 133.56 24.4 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.754 0.252 . . . . 0.0 110.602 -173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -92.91 128.66 38.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.48 175.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.167 0.987 . . . . 0.0 109.534 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -135.49 160.84 66.32 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 124.259 1.023 . . . . 0.0 109.108 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.33 3.67 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.585 2.857 . . . . 0.0 113.502 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 18' ' ' GLU . 29.8 p -125.74 -6.7 6.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.861 0.864 . . . . 0.0 110.874 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -86.5 78.6 9.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.3 t -63.59 172.19 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.811 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' B' ' 26' ' ' VAL . 16.6 mm -55.05 -27.59 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -67.68 -20.24 65.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 120.644 -1.285 . . . . 0.0 110.645 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.67 -45.25 12.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 110.167 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.1 m -66.36 -33.52 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 123.193 0.597 . . . . 0.0 110.93 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.429 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.0 mttt -56.77 -32.11 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.862 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -27.39 46.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.251 0.478 . . . . 0.0 110.924 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -67.57 -32.59 73.45 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.187 0.449 . . . . 0.0 109.932 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -83.91 -31.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.17 -39.97 86.53 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.8 0.334 . . . . 0.0 110.273 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.18 -31.41 71.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.206 0.527 . . . . 0.0 111.183 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.6 -24.79 31.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.663 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -135.31 -35.04 0.84 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.83 7.86 16.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -77.87 128.26 79.65 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.57 154.8 55.09 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.053 2.502 . . . . 0.0 111.373 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.63 -14.41 41.92 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.352 2.701 . . . . 0.0 110.227 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.52 -8.02 59.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -124.84 -18.79 5.46 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.26 162.15 20.68 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.517 1.053 . . . . 0.0 112.167 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -151.58 136.15 17.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.438 ' C ' HD12 ' B' ' 44' ' ' ILE . 41.2 tp -134.18 136.23 43.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.241 0.473 . . . . 0.0 111.141 -168.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.438 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -132.52 150.74 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.266 1.026 . . . . 0.0 108.909 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -150.47 143.1 24.54 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.468 1.107 . . . . 0.0 109.287 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.94 13.42 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.545 0.738 . . . . 0.0 112.585 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.26 15.77 43.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.32 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 158.97 40.16 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.653 1.226 . . . . 0.0 109.966 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -90.74 150.32 21.67 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.811 -172.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' B' ' 59' ' ' TYR . 15.4 mt -106.93 162.7 13.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.162 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -133.1 148.5 52.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.091 0.948 . . . . 0.0 112.542 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.51 -1.81 9.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.284 1.034 . . . . 0.0 111.905 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.47 6.2 33.71 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -107.65 -147.97 0.41 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.367 0.584 . . . . 0.0 109.699 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.509 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.2 p -152.13 155.94 38.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.85 2.06 . . . . 0.0 107.743 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.31 -24.04 67.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.185 0.448 . . . . 0.0 110.05 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -71.19 -25.32 62.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.25 1.02 . . . . 0.0 111.494 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.11 -13.99 60.19 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.101 0.56 . . . . 0.0 111.531 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.526 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -115.06 20.7 14.83 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.29 21.21 0.34 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.83 140.11 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-O 121.213 0.53 . . . . 0.0 110.271 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.39 -173.93 3.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.912 1.285 . . . . 0.0 109.343 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.86 142.97 58.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.081 0.467 . . . . 0.0 110.717 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 54.29 25.26 5.71 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.173 0.989 . . . . 0.0 113.11 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.52 -15.44 60.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 60.11 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.34 1.856 . . . . 0.0 112.955 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.61 -178.12 4.86 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.377 1.471 . . . . 0.0 108.719 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -135.54 120.78 18.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.519 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 35.8 tp -103.25 136.03 43.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.729 1.212 . . . . 0.0 110.088 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.67 169.29 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.75 170.1 18.96 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.416 -0.803 . . . . 0.0 111.566 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.23 -177.2 5.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.795 0.838 . . . . 0.0 110.644 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.59 18.34 3.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 128.374 2.67 . . . . 0.0 114.799 -169.925 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 494' ' ' GLN . 58.5 Cg_endo -84.63 -159.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 1 C-N-CA 125.575 4.184 . . . . 0.0 108.073 174.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.429 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.1 pt? -67.14 27.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.0 pp0? -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 0.0 113.084 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.54 5.92 1.84 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.85 138.48 93.66 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.17 159.99 11.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.793 2.995 . . . . 0.0 111.387 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.16 56.76 2.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.174 0.988 . . . . 0.0 109.903 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 176.24 27.75 0.03 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.423 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.95 162.34 13.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 124.128 0.971 . . . . 0.0 108.498 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.07 156.6 47.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 110.259 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -59.52 -40.64 87.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.055 0.542 . . . . 0.0 109.893 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.36 1.56 2.16 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.25 13.51 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 122.039 -0.413 . . . . 0.0 111.202 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.558 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.4 OUTLIER -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.288 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -73.66 -8.11 54.66 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.689 -0.632 . . . . 0.0 110.474 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -88.18 -5.74 58.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.544 1.138 . . . . 0.0 110.206 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 48.1 mt -87.1 155.81 54.92 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 123.976 0.91 . . . . 0.0 109.934 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.7 162.52 37.57 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.879 2.386 . . . . 0.0 110.811 169.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.09 -15.5 23.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.513 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -96.9 0.88 49.77 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.092 0.405 . . . . 0.0 111.343 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.2 mt -114.97 -19.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.081 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' GLN . . . . . 0.698 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -48.89 -54.59 14.76 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.38 -11.72 3.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' GLU . . . . . 0.424 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 7.8 mm-40 -91.8 -25.28 19.09 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.103 0.41 . . . . 0.0 110.498 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' ILE . . . . . 0.438 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 3.3 mm -95.72 -38.06 8.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 118.364 0.529 . . . . 0.0 109.691 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -68.83 -10.66 58.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 22.7 t -63.97 -55.78 19.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.359 0.664 . . . . 0.0 110.847 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 135.21 133.96 3.32 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 516' ' ' ILE . 59.3 mttm -143.14 158.43 43.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.088 0.955 . . . . 0.0 109.127 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.2 m -146.88 30.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.22 1.008 . . . . 0.0 113.003 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.34 15.78 2.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.973 1.309 . . . . 0.0 111.631 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 523' ' ' GLU . 1.0 OUTLIER -139.08 151.8 47.03 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.218 1.007 . . . . 0.0 109.441 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -148.59 27.97 0.89 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.3 0.64 . . . . 0.0 111.459 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.276 3.9 pp 48.13 12.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.722 1.609 . . . . 0.0 114.041 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 126.334 1.854 . . . . 0.0 111.606 178.64 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -158.8 174.08 15.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.166 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.58 179.22 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.45 99.62 4.72 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.55 124.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.1 ttmt -108.41 135.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.025 0.44 . . . . 0.0 111.455 -173.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -72.58 171.83 11.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.208 1.003 . . . . 0.0 112.436 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.58 -1.66 3.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.791 1.236 . . . . 0.0 110.336 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.9 p -115.93 -5.76 12.02 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.725 -0.609 . . . . 0.0 112.567 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.89 19.59 14.8 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.549 -0.584 . . . . 0.0 113.89 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -121.17 137.55 54.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.835 0.817 . . . . 0.0 109.744 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.4 OUTLIER -106.86 159.67 16.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.05 -174.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.72 127.22 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -78.67 132.84 37.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -143.96 132.98 22.8 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.655 0.264 . . . . 0.0 110.392 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.01 128.66 37.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 179.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.493 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.0 mm-40 -131.57 160.09 68.9 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.65 1.07 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.129 2.553 . . . . 0.0 113.5 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.6 m -125.27 -2.21 7.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.609 0.641 . . . . 0.0 111.067 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -80.25 68.04 6.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.511 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 2.9 t -57.4 173.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.877 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.662 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 14.1 mm -51.89 -28.29 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -168.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -73.37 -19.93 60.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.512 1.051 . . . . 0.0 111.435 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -85.35 -45.6 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.611 0.764 . . . . 0.0 110.834 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.1 OUTLIER -66.46 -28.31 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 122.667 0.387 . . . . 0.0 110.521 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.1 mttt -58.11 -29.9 65.86 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.862 172.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.95 41.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.957 0.344 . . . . 0.0 111.042 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.46 -31.19 71.78 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.074 0.397 . . . . 0.0 109.99 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.14 -30.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.65 -40.03 84.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.792 0.33 . . . . 0.0 110.204 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.72 -32.72 74.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.3 0.571 . . . . 0.0 111.223 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -82.02 -24.46 35.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.98 -34.52 0.8 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.08 8.12 15.73 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.5 mt -75.7 128.9 82.79 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.56 152.79 70.38 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.664 2.243 . . . . 0.0 111.071 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.98 -15.3 36.23 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.379 2.719 . . . . 0.0 110.566 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.84 -7.97 59.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -124.23 -15.72 6.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -65.52 164.9 13.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.139 0.881 . . . . 0.0 112.299 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -152.89 135.42 15.18 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 36.7 tp -131.83 138.11 48.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 118.568 0.622 . . . . 0.0 110.917 -168.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -134.93 149.18 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.306 1.043 . . . . 0.0 109.047 -172.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -153.2 146.57 24.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.016 0.926 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 15.2 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.195 0.598 . . . . 0.0 111.848 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.39 56.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.417 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 158.4 40.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.535 1.167 . . . . 0.0 109.87 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.92 144.47 26.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.721 -1.127 . . . . 0.0 107.98 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 17.2 mt -101.33 159.5 15.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.767 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -125.32 144.97 50.24 Favored 'General case' 0 CA--C 1.524 -0.054 0 CA-C-O 121.357 0.599 . . . . 0.0 112.085 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.64 -0.66 7.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.555 1.142 . . . . 0.0 111.827 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.76 11.57 38.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.79 -149.19 0.44 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 109.298 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -153.17 157.91 41.0 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.861 1.665 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.81 -28.96 69.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -68.4 -26.04 65.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.828 1.251 . . . . 0.0 111.779 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -75.13 -12.12 60.24 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.057 0.543 . . . . 0.0 111.603 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.29 17.74 14.62 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.89 27.39 1.59 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.637 1.575 . . . . 0.0 114.408 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.84 141.24 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -129.81 -174.03 3.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.696 1.199 . . . . 0.0 109.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.39 143.56 57.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.642 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 54.35 24.3 5.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.924 0.89 . . . . 0.0 113.244 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -72.4 -16.81 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.0 m 60.0 132.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.316 1.846 . . . . 0.0 112.674 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.62 -179.7 5.62 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.709 1.204 . . . . 0.0 108.776 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -135.64 122.51 21.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 110.72 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.09 140.46 36.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.107 1.363 . . . . 0.0 110.064 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.87 162.86 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.86 171.66 16.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.658 -0.651 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -91.25 174.9 7.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.429 0.692 . . . . 0.0 110.116 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.14 25.5 8.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.518 0.727 . . . . 0.0 110.268 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 113.61 -178.4 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 494' ' ' GLN . 71.6 Cg_endo -76.72 -167.1 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 1 C-N-CA 125.686 4.258 . . . . 0.0 109.862 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 32.09 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.866 1.267 . . . . 0.0 112.737 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -69.63 -35.39 75.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.013 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.73 4.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.351 0.661 . . . . 0.0 112.123 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' LEU . . . . . 0.408 HD21 ' CZ ' ' A' ' 505' ' ' PHE . 99.0 mt -68.98 160.98 75.78 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 122.755 0.422 . . . . 0.0 109.923 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.62 147.77 38.09 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.785 2.99 . . . . 0.0 111.642 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.83 54.69 1.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.292 1.044 . . . . 0.0 110.257 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.67 25.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.165 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 45.0 t -136.47 162.02 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 118.357 1.079 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -121.67 143.65 49.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.264 0.626 . . . . 0.0 109.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -68.96 -32.44 72.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.645 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.87 10.63 1.73 Allowed 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.303 -0.873 . . . . 0.0 110.575 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 504' ' ' VAL . 83.1 t -129.86 8.52 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.585 1.154 . . . . 0.0 109.827 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 496' ' ' LEU . 0.0 OUTLIER -137.14 -23.37 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.247 -0.908 . . . . 0.0 112.738 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -69.47 -9.15 52.51 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.479 -0.763 . . . . 0.0 112.1 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 10.1 mp0 -80.74 -11.0 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.945 0.339 . . . . 0.0 110.803 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.21 150.59 68.27 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.125 0.97 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.37 163.38 26.83 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.565 2.177 . . . . 0.0 111.165 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.54 -23.59 64.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.287 0.635 . . . . 0.0 112.117 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.66 -1.22 56.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 122.352 0.261 . . . . 0.0 111.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 33.1 mt -117.44 -13.88 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -55.24 -43.56 74.67 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.81 -5.74 40.15 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.387 0.675 . . . . 0.0 112.469 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.63 -17.41 17.04 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.254 0.479 . . . . 0.0 111.967 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.77 -28.47 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.61 -3.8 2.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.891 0.476 . . . . 0.0 110.049 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 52.5 m -137.24 17.51 2.97 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.725 1.21 . . . . 0.0 110.709 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -115.34 43.8 1.61 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.67 0.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.0 t -145.23 178.23 8.23 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.514 0.726 . . . . 0.0 110.232 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.21 2.03 3.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.822 1.649 . . . . 0.0 112.958 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.42 141.2 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.175 0.443 . . . . 0.0 110.726 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 526' ' ' LYS . 34.4 m-80 -144.18 36.67 1.24 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.429 0.692 . . . . 0.0 110.244 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 525' ' ' LEU 0.335 0.5 OUTLIER 56.84 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.387 1.875 . . . . 0.0 114.715 -177.486 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 C-N-CA 125.082 1.353 . . . . 0.0 110.352 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.277 0.084 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -157.2 173.23 17.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.05 179.98 3.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 123.823 0.849 . . . . 0.0 109.114 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -131.93 101.29 5.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.51 104.62 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -90.99 135.59 33.64 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.675 0.39 . . . . 0.0 112.02 -172.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.7 p -77.62 173.1 12.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.634 0.774 . . . . 0.0 111.973 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.94 -22.85 63.0 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.168 0.987 . . . . 0.0 110.321 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -94.61 -5.08 46.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.767 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.17 25.38 14.39 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.579 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -120.8 144.27 48.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.14 159.75 24.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 111.439 -173.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 mt -129.74 131.98 66.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 42.8 m -84.01 133.94 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.1 mt -145.39 138.29 26.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.26 127.3 44.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.9 176.73 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.069 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.54 161.87 60.56 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 108.795 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.63 1.59 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.293 2.662 . . . . 0.0 113.593 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -127.17 -5.89 6.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.586 0.63 . . . . 0.0 110.846 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -83.4 71.29 10.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.5 t -63.68 176.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.686 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.456 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.3 mm -51.55 -35.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -168.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.1 -20.71 65.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.296 0.953 . . . . 0.0 111.03 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -84.79 -42.73 14.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.49 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.382 1.073 . . . . 0.0 110.4 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.456 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.6 mttt -56.22 -23.61 36.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.945 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -27.11 31.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.35 0.523 . . . . 0.0 110.592 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.23 -36.43 77.2 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.052 0.387 . . . . 0.0 110.129 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -83.09 -32.43 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.07 -38.36 85.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.2 -32.56 72.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.295 0.569 . . . . 0.0 111.399 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -80.53 -24.75 39.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.205 1.002 . . . . 0.0 113.472 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.71 -31.26 0.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.58 9.44 23.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.06 131.24 76.14 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.51 157.57 61.28 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.427 2.085 . . . . 0.0 111.03 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.1 -11.07 30.8 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.868 3.045 . . . . 0.0 112.045 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.34 -5.5 29.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -126.11 3.54 7.18 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.5 -54.47 19.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 60.6 82.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.506 1.922 . . . . 0.0 110.919 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' B' ' 44' ' ' ILE . 26.2 tp -90.1 137.09 32.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.573 1.149 . . . . 0.0 111.173 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.513 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.0 mp -133.42 149.93 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.551 1.14 . . . . 0.0 108.881 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -153.62 149.85 28.02 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.035 0.934 . . . . 0.0 109.378 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.17 16.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.626 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.38 56.42 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.124 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 160.5 37.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.449 1.125 . . . . 0.0 110.759 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.67 124.42 38.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.521 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -79.49 164.25 24.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.524 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -126.79 147.86 49.98 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.4 0.619 . . . . 0.0 111.89 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.13 -1.91 16.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.11 0.964 . . . . 0.0 111.996 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.09 14.64 44.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -120.29 -149.84 0.44 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.578 1.151 . . . . 0.0 108.988 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.95 156.84 39.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 126.068 1.747 . . . . 0.0 108.903 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -60.57 -24.41 65.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -73.31 -25.03 60.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 111.41 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -75.57 -14.07 60.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.161 0.584 . . . . 0.0 111.818 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -115.74 21.18 14.1 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 p30 49.49 19.46 0.37 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.7 138.66 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 121.338 0.589 . . . . 0.0 110.56 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -130.38 -177.52 4.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.966 1.306 . . . . 0.0 108.871 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -60.61 145.16 49.97 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.022 0.439 . . . . 0.0 110.778 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 55.66 22.78 5.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.212 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -74.4 -14.23 60.83 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 74.9 m 61.16 130.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.187 1.795 . . . . 0.0 112.11 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.88 -179.9 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.601 1.16 . . . . 0.0 108.687 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -135.59 152.77 51.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -140.14 138.47 35.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.464 1.106 . . . . 0.0 108.528 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.91 68.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.89 163.88 1.78 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -72.61 -168.75 0.47 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.319 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.97 17.38 23.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.5 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 . . . . . 0 N--CA 1.465 0.318 0 C-N-CA 127.155 2.182 . . . . 0.0 114.416 -175.385 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 494' ' ' GLN . 96.2 Cg_endo -81.31 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 1 C-N-CA 125.47 4.113 . . . . 0.0 109.023 178.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.93 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.326 1.85 . . . . 0.0 113.181 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.7 pp0? -71.75 -27.2 62.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.052 0.941 . . . . 0.0 112.291 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -150.17 4.41 0.54 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 505' ' ' PHE . 4.2 mm? -61.75 142.87 94.49 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.253 0.479 . . . . 0.0 110.273 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.04 157.45 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.051 3.167 . . . . 0.0 111.226 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.12 57.41 2.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 122.52 1.153 . . . . 0.0 110.08 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.71 26.7 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.829 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 501' ' ' ASP . 60.5 t -147.44 164.34 6.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.693 0.747 . . . . 0.0 109.156 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 500' ' ' VAL . 6.2 t70 -134.45 144.0 47.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.0 109.419 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.549 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.5 OUTLIER -61.0 -28.82 69.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.491 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -71.38 -0.9 11.28 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.694 -0.629 . . . . 0.0 111.824 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.84 18.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.626 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.0 OUTLIER -124.85 -20.93 4.86 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.24 1.016 . . . . 0.0 110.081 176.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -71.61 5.84 2.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -87.87 7.72 29.4 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.755 0.822 . . . . 0.0 110.578 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 39.1 mt -116.02 157.33 45.26 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 124.204 1.002 . . . . 0.0 111.258 -171.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.94 163.31 35.67 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.857 2.371 . . . . 0.0 110.373 167.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.19 -18.4 36.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.192 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.04 -4.93 58.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.103 0.561 . . . . 0.0 111.429 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.5 mt -117.32 -15.9 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' GLN . . . . . 0.684 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -51.61 -50.72 59.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.86 -14.1 13.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.06 -18.35 27.47 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.641 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.5 mm -104.37 -40.93 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' LEU . . . . . 0.684 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -64.62 -10.58 27.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.0 t -58.28 -35.71 72.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.113 0.565 . . . . 0.0 111.123 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 105.5 38.88 2.33 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -58.44 172.07 0.52 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.754 1.222 . . . . 0.0 111.912 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.4 m -146.37 34.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.759 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.6 15.63 4.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.745 1.218 . . . . 0.0 111.375 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.52 143.46 26.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.043 0.937 . . . . 0.0 109.176 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -148.77 38.4 0.83 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.217 0.607 . . . . 0.0 112.149 -168.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.41 19.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.804 1.642 . . . . 0.0 114.197 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -176.662 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.51 173.33 16.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.413 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.39 179.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 123.139 0.576 . . . . 0.0 109.774 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -133.18 106.28 7.49 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.43 69.39 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.908 0.483 . . . . 0.0 111.284 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -58.68 133.25 55.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.901 0.481 . . . . 0.0 111.519 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.39 175.58 10.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.459 ' O ' HD13 ' B' ' 8' ' ' LEU . 3.2 tm? -64.59 -23.44 67.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.354 0.662 . . . . 0.0 110.228 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.2 p -89.32 -22.07 22.83 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.905 -0.497 . . . . 0.0 110.39 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.52 4.69 21.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.021 0.368 . . . . 0.0 114.021 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -83.57 153.81 24.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.97 159.17 38.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.742 0.701 . . . . 0.0 109.398 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.77 126.75 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m -79.26 129.96 34.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -140.59 133.36 28.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.21 129.22 39.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.43 178.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.864 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.1 mm-40 -132.66 161.5 63.0 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.964 0.906 . . . . 0.0 108.579 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.7 3.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.98 2.453 . . . . 0.0 113.429 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 18' ' ' GLU . 59.8 m -125.79 -4.12 7.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.739 0.7 . . . . 0.0 110.825 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.1 76.92 10.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.2 t -62.34 171.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.8 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.582 ' HA ' HG22 ' B' ' 26' ' ' VAL . 12.2 mm -55.31 -28.04 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -168.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.1 -19.51 65.65 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.87 -1.144 . . . . 0.0 110.427 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -85.12 -46.11 11.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.853 0.861 . . . . 0.0 110.079 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' B' ' 23' ' ' ILE . 2.8 m -66.43 -34.48 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.118 0.567 . . . . 0.0 110.973 -173.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -56.33 -31.99 64.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.165 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.82 47.86 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.386 0.539 . . . . 0.0 110.856 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -68.1 -33.28 74.23 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.987 0.358 . . . . 0.0 110.086 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.77 -31.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.76 -39.4 87.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 -31.53 71.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.333 0.587 . . . . 0.0 111.275 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -83.95 -22.2 31.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -139.67 -30.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.53 8.26 19.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -76.17 128.56 82.56 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.67 154.8 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.493 2.128 . . . . 0.0 110.771 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.71 -14.19 38.71 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.543 2.829 . . . . 0.0 110.94 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.47 -6.21 58.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -118.99 -18.13 8.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.85 162.68 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.45 1.023 . . . . 0.0 112.339 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -155.03 128.76 8.62 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.439 ' C ' HD12 ' B' ' 44' ' ' ILE . 52.0 tp -133.36 128.73 36.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.893 0.315 . . . . 0.0 110.984 -168.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.439 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.4 mp -122.77 155.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -120.96 -111.69 0.33 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 122.695 0.398 . . . . 0.0 110.685 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.85 -4.9 3.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.302 0.641 . . . . 0.0 111.689 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.97 1.69 2.0 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.596 1.093 . . . . 0.0 111.519 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 154.71 33.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.704 0.764 . . . . 0.0 109.554 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.97 129.95 35.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.348 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.459 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.0 mt -77.68 162.67 26.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.83 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -127.98 146.92 50.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.432 0.634 . . . . 0.0 111.706 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.45 -1.33 10.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.438 1.095 . . . . 0.0 111.798 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 16.05 35.13 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -121.34 -148.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.307 1.043 . . . . 0.0 109.45 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.3 p -152.36 156.19 39.08 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 126.257 1.823 . . . . 0.0 108.357 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.04 -23.99 66.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -71.88 -25.29 61.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.281 1.032 . . . . 0.0 111.545 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.43 -12.88 60.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.098 0.559 . . . . 0.0 111.515 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.09 20.77 13.61 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.7 25.21 0.4 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.12 142.4 16.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.171 0.51 . . . . 0.0 110.112 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -130.39 -173.47 3.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.058 1.343 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.89 142.54 58.24 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.0 110.409 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 55.92 21.2 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.252 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -71.85 -16.61 62.15 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 84.4 m 62.33 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.16 1.784 . . . . 0.0 112.226 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -145.47 -176.48 5.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.728 1.211 . . . . 0.0 108.708 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -136.48 104.98 5.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.37 129.77 36.23 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.694 0.798 . . . . 0.0 109.146 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.24 52.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.431 0.634 . . . . 0.0 109.378 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.85 168.88 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 114.209 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -94.47 172.28 8.29 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.498 0.719 . . . . 0.0 109.802 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.9 26.31 9.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.948 1.299 . . . . 0.0 111.734 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 124.376 1.07 . . . . 0.0 112.504 -174.85 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 494' ' ' GLN . 87.6 Cg_endo -77.58 -167.61 0.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.95 3.766 . . . . 0.0 108.319 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.2 pt? -65.26 26.92 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -65.43 -28.91 69.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.471 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -148.09 6.39 0.78 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.79 159.38 85.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.59 155.0 22.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.853 3.035 . . . . 0.0 111.954 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -83.69 55.31 3.18 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 122.423 1.106 . . . . 0.0 109.509 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.74 26.5 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.995 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 501' ' ' ASP . 86.4 t -146.74 164.35 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ASP . . . . . 0.425 ' N ' HG12 ' A' ' 500' ' ' VAL . 20.8 m-20 -135.49 143.13 45.66 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.036 0.934 . . . . 0.0 108.751 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.682 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.9 pm0 -65.54 -24.11 67.03 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.94 1.84 4.09 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.737 -0.602 . . . . 0.0 111.601 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.53 11.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.672 0.789 . . . . 0.0 110.647 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -17.72 7.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.985 0.914 . . . . 0.0 109.875 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.72 3.15 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.957 -0.465 . . . . 0.0 111.345 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.65 -5.12 58.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 512' ' ' ILE . 4.1 mp -93.04 159.31 35.88 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.179 1.392 . . . . 0.0 110.128 -173.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.22 165.48 31.81 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.295 2.663 . . . . 0.0 111.325 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.75 -12.51 10.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.027 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.5 1.17 40.81 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.058 0.543 . . . . 0.0 111.43 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.447 HG22 HD23 ' A' ' 508' ' ' LEU . 52.0 mt -119.16 -14.48 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -43.91 67.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 169.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.74 -4.42 37.43 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.424 0.689 . . . . 0.0 112.388 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -100.12 -21.64 15.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.501 0.591 . . . . 0.0 111.433 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.69 -34.41 4.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.64 -3.35 3.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.667 0.387 . . . . 0.0 110.516 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 41.5 m -137.44 18.32 2.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.361 0.664 . . . . 0.0 111.409 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.54 -39.51 5.29 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp 49.43 1.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.7 t -167.76 -172.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.981 0.809 . . . . 0.0 109.818 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 68.0 11.56 8.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.469 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -153.92 154.34 33.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.559 0.343 . . . . 0.0 110.854 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.408 ' C ' HD23 ' A' ' 525' ' ' LEU . 60.7 m-80 -149.72 46.93 0.94 Allowed 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.856 0.863 . . . . 0.0 110.795 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 524' ' ' ASN . 1.1 pt? 44.14 19.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.961 1.704 . . . . 0.0 113.95 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.944 1.297 . . . . 0.0 112.625 -177.318 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -158.44 173.66 16.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.094 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.78 179.28 4.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -134.69 103.27 5.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.58 113.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.42 130.8 37.99 Favored 'General case' 0 N--CA 1.458 -0.052 0 O-C-N 122.205 -0.31 . . . . 0.0 111.222 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -72.3 174.37 7.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.417 1.087 . . . . 0.0 112.058 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.523 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.7 tm? -66.12 -5.02 8.56 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.073 0.949 . . . . 0.0 110.17 174.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -112.97 1.36 15.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.556 -0.715 . . . . 0.0 111.528 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.28 26.05 31.86 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.606 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -123.56 145.01 49.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.17 159.94 21.82 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.434 -174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -129.45 127.69 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -77.81 130.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.405 ' CD2' ' HG3' ' B' ' 33' ' ' LYS . 60.0 mt -140.67 131.23 25.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.11 127.32 35.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.622 0.769 . . . . 0.0 108.998 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.1 178.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.183 0.993 . . . . 0.0 109.444 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.8 mt-10 -141.45 163.81 39.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.19 2.25 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.531 2.821 . . . . 0.0 113.62 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.7 m -129.42 -5.64 4.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.058 0.845 . . . . 0.0 111.215 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 26.4 m-20 -82.89 68.32 9.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 9.2 t -61.25 179.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.921 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.597 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.4 mm -59.24 -11.91 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -168.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.85 -17.96 28.62 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.815 1.189 . . . . 0.0 110.483 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -85.02 -40.82 16.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.537 0.735 . . . . 0.0 109.993 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' B' ' 23' ' ' ILE . 20.4 m -64.36 -31.11 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 123.728 0.811 . . . . 0.0 110.155 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.53 -25.28 66.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.83 -26.44 29.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.314 0.507 . . . . 0.0 110.821 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -70.34 -36.5 74.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.096 0.407 . . . . 0.0 110.392 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -81.76 -30.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -68.16 -39.73 82.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.24 -31.21 71.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.246 0.545 . . . . 0.0 111.348 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' B' ' 15' ' ' LEU . 38.8 mmtm -82.5 -24.2 34.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.57 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -136.77 -33.82 0.77 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 9.52 17.66 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.8 mt -76.64 129.87 78.15 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.83 156.1 61.18 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 111.055 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.1 -14.14 40.01 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.967 3.111 . . . . 0.0 110.804 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -90.45 -3.0 57.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -123.91 -11.81 7.59 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.88 167.64 21.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.103 0.865 . . . . 0.0 112.464 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -158.67 134.55 8.95 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.93 1.292 . . . . 0.0 108.002 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.51 ' C ' HD12 ' B' ' 44' ' ' ILE . 16.7 mt -126.47 141.49 51.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.531 0.333 . . . . 0.0 110.43 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.51 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -129.31 148.72 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -148.36 134.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.833 0.853 . . . . 0.0 109.009 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.93 19.87 0.71 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.556 0.742 . . . . 0.0 112.827 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.59 25.37 39.17 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 123.04 0.352 . . . . 0.0 112.749 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.8 ttmm -123.37 125.59 45.28 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.119 0.568 . . . . 0.0 110.756 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -76.57 110.8 11.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.598 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -68.63 171.11 8.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -174.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -132.52 152.85 51.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.676 0.751 . . . . 0.0 112.004 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.88 -1.82 15.67 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.455 1.102 . . . . 0.0 111.892 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.28 15.06 36.23 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -117.88 -154.7 0.57 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.326 1.05 . . . . 0.0 109.16 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.7 p -149.64 159.67 44.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.599 1.56 . . . . 0.0 107.9 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.62 -27.27 69.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -71.25 -25.75 62.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.34 1.056 . . . . 0.0 112.143 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.95 -16.94 61.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.828 0.451 . . . . 0.0 111.323 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.599 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.1 m-85 -128.64 26.87 5.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.187 0.595 . . . . 0.0 110.065 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.84 28.47 0.59 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.82 132.91 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.8 -173.11 3.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 109.747 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.12 142.24 37.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.093 0.473 . . . . 0.0 111.264 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 52.97 27.14 5.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.806 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.9 p -69.59 -24.96 63.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m 59.99 127.65 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.019 2.128 . . . . 0.0 112.161 -174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -131.29 -176.83 4.15 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.094 1.358 . . . . 0.0 108.238 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -135.56 135.26 40.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.93 135.16 55.0 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.748 1.219 . . . . 0.0 110.085 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -139.37 160.2 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 71' ' ' LEU . 1.1 pt? -146.64 172.16 14.01 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.98 -177.19 5.7 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 123.968 0.907 . . . . 0.0 112.76 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tp -110.02 22.09 16.02 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.901 0.881 . . . . 0.0 111.422 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 126.809 2.044 . . . . 0.0 113.352 -174.675 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.1 Cg_endo -77.33 -165.47 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 125.113 3.875 . . . . 0.0 109.319 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.517 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.3 pt? -69.92 27.65 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 492' ' ' PRO . 4.2 pp0? -64.5 -25.91 68.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 0.0 111.785 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -149.88 4.8 0.57 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.88 162.16 74.8 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 122.105 -0.372 . . . . 0.0 110.561 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.61 151.42 31.39 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.183 3.255 . . . . 0.0 111.616 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.74 55.33 2.35 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 122.196 0.998 . . . . 0.0 109.939 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 168.93 31.33 0.02 OUTLIER Glycine 0 CA--C 1.527 0.816 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.019 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 49.0 t -141.86 165.03 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.801 0.801 . . . . 0.0 109.657 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.9 141.04 47.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.391 1.076 . . . . 0.0 109.306 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.597 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.4 OUTLIER -65.17 -33.73 76.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.074 -177.058 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.76 5.2 3.33 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.54 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.9 11.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.513 0.725 . . . . 0.0 111.013 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.14 -13.68 8.92 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.835 0.854 . . . . 0.0 109.939 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -82.68 18.76 1.46 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.412 0.685 . . . . 0.0 111.921 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -94.46 7.69 44.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.542 0.737 . . . . 0.0 111.415 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 156.81 69.37 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.594 1.158 . . . . 0.0 110.495 -171.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.35 164.66 22.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.157 3.238 . . . . 0.0 113.054 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -59.11 -25.48 63.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.622 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.94 -6.56 51.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.47 0.308 . . . . 0.0 111.251 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 18.1 mt -118.1 -12.74 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 170.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' GLN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 23.6 mm-40 -58.41 -39.7 80.46 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.84 -11.03 60.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.391 0.676 . . . . 0.0 112.204 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.69 -19.35 21.92 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.255 0.48 . . . . 0.0 111.553 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.61 -27.18 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 65.7 mt -64.47 -2.96 2.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.4 m -138.42 21.0 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.959 1.304 . . . . 0.0 110.024 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -107.23 46.64 1.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.476 1.036 . . . . 0.0 110.993 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -56.46 2.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.3 t -149.06 -175.95 5.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.468 0.651 . . . . 0.0 111.039 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 65.76 3.79 2.64 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.523 1.929 . . . . 0.0 114.652 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -155.36 148.58 24.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.1 0.864 . . . . 0.0 111.43 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 526' ' ' LYS . 37.1 m-80 -147.19 43.83 1.14 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.952 0.901 . . . . 0.0 111.116 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 525' ' ' LEU 0.298 3.2 pp 50.19 9.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.623 1.569 . . . . 0.0 114.051 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 524' ' ' ASN . 43.5 mtmt . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 127.752 2.421 . . . . 0.0 110.368 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.704 0.288 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.4 172.94 17.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.251 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.48 -177.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.602 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 96.2 m-85 -130.66 128.25 40.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.77 121.13 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.27 142.6 33.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -172.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -88.37 178.79 6.47 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.146 1.379 . . . . 0.0 112.912 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.598 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.1 tm? -70.97 6.47 1.54 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.839 1.255 . . . . 0.0 110.239 173.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -124.55 9.0 8.35 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.94 -1.1 . . . . 0.0 111.993 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.74 60.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 120.133 -0.259 . . . . 0.0 113.211 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -119.76 139.48 52.24 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 9.0 m -113.43 142.5 45.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.41 132.9 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -87.08 133.79 33.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 mt -142.6 135.04 27.78 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.47 130.3 37.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 109.086 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.57 179.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.788 0.835 . . . . 0.0 109.89 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.433 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -140.21 163.46 43.77 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.86 2.92 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.463 2.775 . . . . 0.0 113.722 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.416 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.0 m -127.73 -7.1 5.63 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.771 0.714 . . . . 0.0 110.971 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.6 m-20 -79.82 67.57 5.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 171.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.1 t -59.61 175.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.786 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.422 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.8 mm -49.94 -34.73 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.55 -21.39 61.89 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.363 0.983 . . . . 0.0 111.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.76 -37.21 27.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.47 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.5 t -64.77 -39.4 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.226 1.01 . . . . 0.0 109.862 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -59.04 -28.08 66.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.758 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -24.13 54.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.516 0.598 . . . . 0.0 110.6 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 69.1 mmtt -69.76 -44.54 69.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.528 0.731 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.12 -30.22 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.581 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.57 -40.74 80.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.29 -30.55 70.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.176 0.512 . . . . 0.0 111.352 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -85.63 -19.58 30.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.5 -40.01 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.361 0.528 . . . . 0.0 112.001 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.29 9.04 12.14 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.6 mt -79.18 128.53 75.62 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.34 151.98 66.08 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.76 2.306 . . . . 0.0 110.812 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.65 -15.48 41.2 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.251 2.634 . . . . 0.0 110.441 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -7.97 59.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.781 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -124.3 -13.39 7.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -69.96 165.18 22.28 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.619 1.1 . . . . 0.0 111.999 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -154.64 141.49 19.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.483 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -135.95 139.48 43.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.567 0.621 . . . . 0.0 111.398 -169.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.483 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -130.85 148.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.751 0.82 . . . . 0.0 109.197 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -149.87 134.16 17.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.935 0.894 . . . . 0.0 108.867 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.3 19.98 0.86 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.59 0.756 . . . . 0.0 112.504 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 24.29 44.96 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 123.009 0.338 . . . . 0.0 112.55 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.602 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.7 ttmm -120.56 124.56 45.62 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 122.797 0.439 . . . . 0.0 110.432 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -75.93 108.79 9.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' B' ' 59' ' ' TYR . 1.0 OUTLIER -68.02 170.26 8.64 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.452 -174.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -132.49 153.64 50.7 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 121.64 0.733 . . . . 0.0 111.393 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.76 3.01 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.408 1.083 . . . . 0.0 111.769 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.96 16.8 20.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -118.25 -154.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.598 1.159 . . . . 0.0 109.087 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -148.88 159.58 44.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.304 1.442 . . . . 0.0 108.479 172.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.31 -27.62 69.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -25.2 60.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.361 1.064 . . . . 0.0 111.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.81 -18.88 61.42 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.302 0.641 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.602 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 22.9 m-85 -129.23 26.76 5.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.553 0.741 . . . . 0.0 109.991 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.27 31.01 0.74 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.18 125.12 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -131.18 -173.25 3.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.456 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.24 141.39 35.56 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 111.585 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.5 24.96 3.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.666 1.186 . . . . 0.0 113.627 174.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -70.67 -17.68 62.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m 59.41 130.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.17 2.188 . . . . 0.0 112.32 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -138.89 -178.34 5.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.392 1.077 . . . . 0.0 109.076 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.85 147.34 48.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.912 0.387 . . . . 0.0 111.275 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.5 tp -132.66 137.97 47.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.282 1.433 . . . . 0.0 110.033 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -143.84 165.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.37 170.56 15.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.876 0.762 . . . . 0.0 112.833 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.98 178.08 5.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.1 0.96 . . . . 0.0 111.377 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 21.54 15.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.008 -173.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 . . . . . 0 N--CA 1.463 0.217 0 C-N-CA 127.2 2.2 . . . . 0.0 114.183 -176.197 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.5 Cg_endo -80.25 -167.45 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.609 4.206 . . . . 0.0 108.905 174.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.03 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 112.972 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 492' ' ' PRO . 3.1 pp0? -76.83 -26.0 53.86 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.28 1.42 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.84 160.94 50.63 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.53 154.46 24.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.68 2.92 . . . . 0.0 110.851 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.8 66.41 5.27 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.845 0.831 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 164.22 -24.1 0.18 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.114 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 78.3 t -68.0 169.0 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.522 0.729 . . . . 0.0 110.281 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 0.4 OUTLIER -135.42 153.91 51.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.716 0.806 . . . . 0.0 110.665 -175.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -63.77 -43.73 95.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.51 8.36 0.85 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.024 0.53 . . . . 0.0 112.335 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.2 9.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.13 0.572 . . . . 0.0 111.097 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -122.0 -20.69 6.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.336 0.654 . . . . 0.0 110.062 178.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.56 7.75 2.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.203 0.601 . . . . 0.0 111.927 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -84.29 8.63 15.36 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.996 0.918 . . . . 0.0 111.357 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.43 159.67 56.52 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 123.18 0.592 . . . . 0.0 112.215 -167.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.95 164.35 31.77 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.249 2.632 . . . . 0.0 110.567 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.89 56.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.914 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.74 -5.75 59.33 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.875 0.47 . . . . 0.0 111.691 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.441 ' CD1' HD11 ' B' ' 44' ' ' ILE . 40.3 mt -118.51 -15.26 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' GLN . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -53.34 -41.66 66.0 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.337 -0.852 . . . . 0.0 108.863 169.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.29 -19.14 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.953 0.501 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -85.48 -21.51 28.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.888 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 518' ' ' SER . 2.6 mm -98.05 -31.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 118.916 0.78 . . . . 0.0 109.253 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.92 -0.97 2.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 110.078 172.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 516' ' ' ILE . 10.5 t -135.64 16.65 3.35 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.508 1.123 . . . . 0.0 110.63 177.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -100.98 38.43 3.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -1.65 0.11 Allowed 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -174.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.3 t -151.45 175.01 12.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.527 0.731 . . . . 0.0 109.919 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.48 3.78 3.0 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.701 1.6 . . . . 0.0 113.579 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.52 156.16 34.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.796 0.438 . . . . 0.0 111.04 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -156.64 27.1 0.33 Allowed 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.85 -0.27 1.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.997 0.919 . . . . 0.0 111.163 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -169.426 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.391 0.139 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.18 173.98 15.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.19 -178.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.263 1.025 . . . . 0.0 109.182 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.428 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 55.5 m-85 -133.21 86.94 2.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.485 0.66 . . . . 0.0 109.974 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -80.41 101.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.948 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.5 ttmt -85.51 140.58 30.55 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.843 0.457 . . . . 0.0 111.358 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -84.82 173.21 10.81 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.71 0.804 . . . . 0.0 111.575 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.23 -16.69 55.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.7 0.8 . . . . 0.0 110.88 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -97.47 -0.65 45.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.048 0.539 . . . . 0.0 110.538 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.67 25.98 26.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.094 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -118.93 120.27 36.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.467 0.633 . . . . 0.0 110.491 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.8 OUTLIER -75.95 155.85 34.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.253 0.549 . . . . 0.0 110.947 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.26 112.78 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -71.65 133.87 45.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' B' ' 29' ' ' LYS . 64.2 mt -150.23 136.53 18.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 122.309 0.243 . . . . 0.0 111.035 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.4 126.62 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.429 HG12 ' HE3' ' B' ' 29' ' ' LYS . 28.4 m -144.4 179.13 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.323 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -131.06 160.73 65.54 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.011 0.924 . . . . 0.0 108.803 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.19 0.6 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.769 2.98 . . . . 0.0 113.569 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -125.46 -4.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.662 0.664 . . . . 0.0 110.802 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -80.71 65.49 5.88 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -59.95 177.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.566 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.672 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 15.9 mm -52.93 -24.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 113.831 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.17 -19.73 50.21 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.694 1.134 . . . . 0.0 111.558 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -85.17 -44.08 13.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.613 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER -65.61 -26.22 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 123.046 0.539 . . . . 0.0 110.389 -177.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 91.2 mttt -59.97 -31.29 69.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 122.202 -0.311 . . . . 0.0 111.285 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.06 53.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.297 0.499 . . . . 0.0 110.597 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.538 ' HB3' HD22 ' B' ' 15' ' ' LEU . 3.9 mptp? -67.64 -36.06 80.06 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -85.57 -28.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -66.87 -39.04 87.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.39 -33.06 74.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.388 0.613 . . . . 0.0 111.386 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.514 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.5 mmtm -83.14 -21.22 33.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -137.9 -34.59 0.67 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.511 0.596 . . . . 0.0 112.56 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.89 9.05 19.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.9 mt -77.29 130.37 74.97 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 153.85 67.55 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.47 2.113 . . . . 0.0 111.112 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.54 -15.97 38.22 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.321 2.68 . . . . 0.0 110.493 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.9 -7.82 59.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -124.03 -14.32 7.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -70.15 164.67 23.68 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 112.726 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -154.69 146.61 23.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -129.32 145.01 51.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.451 0.569 . . . . 0.0 111.001 -170.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -136.67 148.23 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.583 1.153 . . . . 0.0 108.385 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -149.14 138.91 21.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.354 1.062 . . . . 0.0 108.992 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.62 12.51 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.622 0.769 . . . . 0.0 112.669 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.03 14.19 40.31 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.524 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 159.88 33.76 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.622 1.211 . . . . 0.0 109.46 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -92.1 153.65 19.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.756 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.447 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.8 mp -116.76 166.38 12.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -137.31 153.79 50.2 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.496 0.665 . . . . 0.0 112.191 -173.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.49 -1.89 12.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.449 1.1 . . . . 0.0 111.697 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 7.1 37.69 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.99 -154.51 0.53 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.906 0.883 . . . . 0.0 109.451 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 3.1 p -149.72 160.21 43.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.027 1.731 . . . . 0.0 107.823 173.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.63 -27.08 68.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -71.7 -26.71 62.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.92 1.288 . . . . 0.0 112.138 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.44 -15.81 61.82 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 122.749 0.419 . . . . 0.0 111.261 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -126.52 27.83 6.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.648 0.779 . . . . 0.0 109.699 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.91 28.2 0.34 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 171.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.75 140.4 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.525 0.602 . . . . 0.0 109.611 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -130.71 -174.52 3.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.602 1.161 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.81 144.29 56.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.66 21.72 3.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.861 0.865 . . . . 0.0 113.159 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -72.92 -17.32 61.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 75.4 m 61.41 139.47 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.326 1.851 . . . . 0.0 112.104 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -141.27 179.92 6.49 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.114 0.566 . . . . 0.0 109.505 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.49 139.27 43.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.405 0.282 . . . . 0.0 110.523 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.436 HD13 ' C ' ' B' ' 69' ' ' LEU . 2.6 tm? -130.24 134.78 47.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 110.075 -172.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.434 HG12 ' N ' ' B' ' 71' ' ' LEU . 52.4 t -142.13 168.47 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.434 ' N ' HG12 ' B' ' 70' ' ' VAL . 1.2 pp -142.74 170.46 15.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.975 -0.453 . . . . 0.0 111.676 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -66.78 168.47 9.54 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.595 0.758 . . . . 0.0 110.879 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.17 18.57 22.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.182 0.593 . . . . 0.0 110.591 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 127.506 2.322 . . . . 0.0 114.898 -177.742 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.458 ' CD1' HD21 ' A' ' 517' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 494' ' ' GLN . 90.3 Cg_endo -78.89 -168.3 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 124.641 3.561 . . . . 0.0 107.711 170.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.08 31.56 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.666 1.586 . . . . 0.0 113.74 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -69.2 -32.45 71.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.944 0.897 . . . . 0.0 112.466 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 517' ' ' LEU . . . -146.03 2.38 0.9 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 496' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 497' ' ' PRO . 64.1 mt -71.8 150.11 92.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 497' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 496' ' ' LEU . 51.4 Cg_exo -56.99 158.49 17.24 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.779 2.986 . . . . 0.0 111.696 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.55 55.59 2.0 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 122.241 1.02 . . . . 0.0 109.673 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.41 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.094 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 501' ' ' ASP . 95.4 t -141.31 166.14 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.762 0.825 . . . . 0.0 109.578 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 500' ' ' VAL . 2.9 m-20 -143.66 139.17 29.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.575 1.55 . . . . 0.0 107.08 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.675 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.4 pm0 -65.97 -28.29 68.79 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.393 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.67 3.91 5.74 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.338 -0.851 . . . . 0.0 111.161 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' VAL . . . . . 0.416 ' N ' HE22 ' A' ' 507' ' ' GLN . 27.3 m -137.23 17.36 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.472 1.109 . . . . 0.0 110.225 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.62 -19.41 1.38 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.466 0.706 . . . . 0.0 111.622 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -72.09 -0.31 11.46 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.371 -0.831 . . . . 0.0 112.649 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 504' ' ' VAL . 7.5 mp0 -95.95 -7.92 35.22 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.691 0.678 . . . . 0.0 109.851 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.38 159.91 78.8 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.06 163.72 37.46 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.974 2.449 . . . . 0.0 111.253 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -15.17 20.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.841 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -95.98 -1.31 49.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.552 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 54.9 mt -115.45 -16.99 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -41.75 66.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.8 -5.57 51.23 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 28.4 mm-40 -97.49 -24.1 15.74 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.806 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.4 -35.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 495' ' ' ALA . 88.5 mt -66.47 -8.0 23.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 15.3 t -72.76 -50.23 25.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.68 0.392 . . . . 0.0 111.468 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 144.37 141.91 3.82 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.841 -2.503 . . . . 0.0 106.841 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 515' ' ' GLU . 71.6 mmtt -149.36 176.73 10.3 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.931 0.893 . . . . 0.0 109.223 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -157.7 179.43 9.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.473 1.509 . . . . 0.0 108.868 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' ARG . . . . . 0.416 ' HA ' ' HE ' ' A' ' 522' ' ' ARG . 0.3 OUTLIER 60.83 21.73 11.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.461 1.104 . . . . 0.0 112.671 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -146.85 147.1 30.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.739 0.415 . . . . 0.0 110.247 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -148.44 40.25 0.92 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.475 0.71 . . . . 0.0 110.902 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.286 4.4 pp 47.75 13.18 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.932 1.693 . . . . 0.0 114.228 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 126.411 1.884 . . . . 0.0 111.225 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.725 0.298 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -155.17 175.23 14.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.87 -177.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 123.958 0.903 . . . . 0.0 108.627 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.573 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 99.9 m-85 -136.36 97.72 3.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.268 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.61 135.16 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -117.17 136.74 52.82 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.092 0.472 . . . . 0.0 111.742 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -73.12 173.84 8.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.737 1.215 . . . . 0.0 112.047 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.09 0.28 4.88 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.256 1.023 . . . . 0.0 110.792 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -118.27 -3.14 11.04 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.2 20.4 18.2 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.8 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -119.57 138.86 52.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.871 0.835 . . . . 0.0 109.86 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 6.3 m -111.41 152.38 27.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.012 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.75 131.6 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -86.37 135.05 33.66 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -146.36 134.23 21.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.696 0.225 . . . . 0.0 110.939 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.93 125.94 38.85 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.546 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.46 175.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.945 0.898 . . . . 0.0 109.872 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -135.36 163.05 53.69 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.318 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.54 1.7 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.466 2.777 . . . . 0.0 113.599 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -127.05 -3.41 6.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.716 0.689 . . . . 0.0 110.997 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.25 75.27 8.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.0 OUTLIER -61.08 171.31 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.157 0.983 . . . . 0.0 110.178 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' B' ' 26' ' ' VAL . 13.0 mm -54.37 -28.3 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.64 -18.72 65.06 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.836 -1.165 . . . . 0.0 110.487 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -86.33 -45.93 10.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.132 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.4 m -66.34 -33.79 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 122.664 0.386 . . . . 0.0 110.989 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' B' ' 23' ' ' ILE . 93.8 mttt -56.26 -32.98 65.01 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.855 172.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.18 -27.88 53.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.995 -0.441 . . . . 0.0 110.948 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -67.08 -32.05 72.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.26 -31.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.99 89.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.91 -31.9 71.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.271 0.558 . . . . 0.0 111.231 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -84.1 -22.47 31.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -135.96 -36.2 0.76 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.89 8.3 15.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.3 129.63 74.45 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.75 152.52 69.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.632 2.221 . . . . 0.0 110.842 -176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.41 -15.22 41.7 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.23 2.62 . . . . 0.0 110.73 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.01 -6.86 59.47 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -125.32 -11.51 6.9 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.37 165.0 25.4 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.518 1.054 . . . . 0.0 112.208 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -153.59 142.56 21.2 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.408 ' C ' HD12 ' B' ' 44' ' ' ILE . 39.0 tp -136.14 138.41 41.97 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.128 -0.358 . . . . 0.0 110.711 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.408 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -133.43 150.23 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.188 0.995 . . . . 0.0 108.87 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -148.5 139.12 22.79 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.542 1.137 . . . . 0.0 109.092 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 10.41 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.713 0.805 . . . . 0.0 113.034 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.66 12.14 36.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.675 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.14 159.88 32.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.632 1.216 . . . . 0.0 109.651 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -95.61 138.5 33.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.903 0.881 . . . . 0.0 108.753 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.519 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.9 mp -95.7 157.13 16.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -125.22 148.69 48.53 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 121.433 0.635 . . . . 0.0 112.164 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.02 -0.11 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.178 0.991 . . . . 0.0 111.89 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.35 8.28 37.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -108.88 -147.71 0.42 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.594 0.758 . . . . 0.0 110.517 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.521 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.0 p -152.13 157.07 41.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 127.313 2.245 . . . . 0.0 107.378 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.26 -26.25 68.69 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 121.361 0.601 . . . . 0.0 109.871 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -66.43 -25.11 66.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.853 1.261 . . . . 0.0 111.765 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.82 -12.01 59.94 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.447 0.699 . . . . 0.0 111.903 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.443 ' CE2' HD11 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -117.68 21.3 13.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.835 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 46.95 27.27 0.7 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.66 141.78 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.109 0.413 . . . . 0.0 110.262 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -130.31 -177.84 4.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.53 1.132 . . . . 0.0 108.747 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -60.96 143.26 55.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 53.53 26.27 5.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.415 1.086 . . . . 0.0 113.418 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -72.65 -14.91 61.7 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 61.53 141.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.467 1.907 . . . . 0.0 112.367 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.98 -177.07 5.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.55 129.9 33.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 110.728 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.6 tp -112.28 141.5 45.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.252 1.421 . . . . 0.0 110.467 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.12 161.0 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.422 ' H ' HD23 ' B' ' 71' ' ' LEU . 1.4 pt? -148.84 171.69 15.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.684 -0.635 . . . . 0.0 112.677 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.58 173.58 6.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.128 0.971 . . . . 0.0 109.568 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.51 25.59 6.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.539 0.735 . . . . 0.0 109.631 -178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 . . . . . 0 N--CA 1.465 0.299 0 C-N-CA 126.677 1.991 . . . . 0.0 114.454 -178.689 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 494' ' ' GLN . 74.7 Cg_endo -75.72 -172.53 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 124.744 3.629 . . . . 0.0 109.605 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 31.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.445 1.498 . . . . 0.0 113.152 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 494' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.1 pp0? -75.29 -25.97 58.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.812 0.845 . . . . 0.0 112.629 -176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.11 2.62 1.17 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.2 162.47 72.96 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 122.959 0.503 . . . . 0.0 110.566 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 152.54 15.31 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.281 3.32 . . . . 0.0 112.397 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.1 66.62 2.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.802 0.81 . . . . 0.0 112.064 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 159.49 -25.04 0.32 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.668 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.86 166.55 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.363 0.665 . . . . 0.0 110.584 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.94 143.03 40.56 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.127 0.971 . . . . 0.0 109.317 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.562 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.1 OUTLIER -62.52 -34.47 76.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.25 -177.453 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.51 4.53 5.9 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.883 -0.511 . . . . 0.0 111.754 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.12 11.29 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.402 0.681 . . . . 0.0 110.535 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -14.99 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.395 1.078 . . . . 0.0 109.545 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -85.44 29.27 0.69 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.566 0.746 . . . . 0.0 111.228 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -103.65 7.83 37.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.931 0.893 . . . . 0.0 111.153 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.52 156.9 63.33 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.615 1.166 . . . . 0.0 110.348 -172.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 162.87 30.87 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.981 3.12 . . . . 0.0 112.856 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -27.3 64.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.7 0.8 . . . . 0.0 112.064 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -9.2 58.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.219 0.208 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.28 -15.68 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.278 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 12.9 mm-40 -57.85 -39.54 77.97 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.484 1.038 . . . . 0.0 108.9 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.7 -16.24 64.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.169 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -90.29 -8.78 50.03 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.246 -0.406 . . . . 0.0 111.76 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.59 -34.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.56 -6.58 11.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.373 0.669 . . . . 0.0 109.678 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 49.4 m -138.32 26.77 2.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.062 1.345 . . . . 0.0 109.485 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -129.67 43.45 1.31 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -63.48 7.2 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.262 2.225 . . . . 0.0 115.063 -170.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -146.97 -177.64 5.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.29 0.636 . . . . 0.0 109.708 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.86 -2.84 2.57 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.472 1.509 . . . . 0.0 112.941 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -157.24 152.56 26.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.936 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.18 34.2 1.21 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.411 1.084 . . . . 0.0 110.045 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.9 6.06 2.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.789 0.804 . . . . 0.0 110.728 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 111.696 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.584 0.231 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.73 172.7 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.55 -179.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.06 101.04 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.39 126.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.9 ttmt -102.82 133.88 47.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 111.903 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -82.13 178.2 8.4 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 112.416 -172.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.449 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -71.67 14.43 0.19 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.689 1.196 . . . . 0.0 110.284 173.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -129.32 5.66 5.26 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 120.871 -1.143 . . . . 0.0 112.418 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 25.58 58.46 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.855 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -121.44 142.26 50.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -111.24 157.21 20.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.3 128.9 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -74.84 133.24 41.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.3 mt -145.12 133.59 21.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.329 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.25 126.5 39.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.11 177.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.844 0.858 . . . . 0.0 109.762 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -136.18 162.21 57.86 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.762 0.825 . . . . 0.0 110.117 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 35.1 Cg_exo -56.36 0.85 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.38 3.387 . . . . 0.0 113.371 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 27.5 p -129.43 -6.59 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.845 0.858 . . . . 0.0 111.191 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.27 74.23 10.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.3 t -62.43 174.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.192 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.561 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.7 mm -56.02 -26.08 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.69 -17.69 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.439 -1.413 . . . . 0.0 110.706 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -88.58 -43.86 11.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.86 0.864 . . . . 0.0 110.598 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.6 m -63.96 -31.24 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 C-N-CA 122.736 0.414 . . . . 0.0 110.597 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -56.58 -31.57 64.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.368 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.95 -30.32 55.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.448 0.567 . . . . 0.0 110.569 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.0 mptp? -70.03 -33.9 72.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -85.81 -30.12 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.95 -39.97 83.31 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.34 -31.05 71.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.158 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -83.43 -21.4 32.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -138.13 -36.32 0.6 Allowed 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.72 8.49 13.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.79 129.82 80.35 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.55 153.41 65.29 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.408 2.072 . . . . 0.0 111.224 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.23 -17.47 39.95 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.273 2.649 . . . . 0.0 110.653 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.49 -4.84 57.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.838 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -124.8 -15.43 6.47 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.94 163.06 28.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.866 1.212 . . . . 0.0 113.479 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -161.91 146.11 12.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.045 1.338 . . . . 0.0 107.627 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.41 ' C ' HD12 ' B' ' 44' ' ' ILE . 4.2 mp -132.87 160.44 36.96 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.134 0.493 . . . . 0.0 111.728 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.41 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.1 mp -135.71 149.3 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 107.988 -176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' B' ' 50' ' ' LEU . 54.8 t80 -151.74 144.26 24.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.999 0.92 . . . . 0.0 109.355 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 14.09 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.526 0.73 . . . . 0.0 111.985 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.1 16.2 51.45 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.287 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 158.06 40.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.745 1.272 . . . . 0.0 109.867 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.16 145.44 26.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.55 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.486 HD22 ' CD1' ' B' ' 59' ' ' TYR . 14.3 mt -102.99 148.96 25.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.047 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -121.69 149.22 43.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.501 0.667 . . . . 0.0 112.064 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.74 2.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.211 1.004 . . . . 0.0 111.852 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.36 16.5 19.65 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.55 -148.59 0.41 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.591 1.156 . . . . 0.0 108.496 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.2 p -153.9 160.29 42.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.693 1.197 . . . . 0.0 108.851 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.14 -27.09 68.14 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.236 -0.29 . . . . 0.0 110.633 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 16.5 t -73.29 -28.52 62.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.94 0.496 . . . . 0.0 110.791 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.15 -12.69 61.35 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.65 21.14 13.15 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 174.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 47.97 22.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -57.47 141.69 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-O 121.208 0.528 . . . . 0.0 110.766 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -131.33 -177.54 4.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.141 1.376 . . . . 0.0 108.79 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -64.04 147.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.034 0.445 . . . . 0.0 110.955 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 53.78 25.92 5.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.819 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -72.88 -21.33 60.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 69.5 m 60.67 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.072 2.149 . . . . 0.0 112.622 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.53 -174.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.85 1.66 . . . . 0.0 108.155 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -137.49 149.83 47.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 69' ' ' LEU . 2.7 tm? -134.44 133.22 40.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.949 1.3 . . . . 0.0 109.5 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 163.67 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.11 168.89 18.67 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -76.35 -176.27 3.57 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 125.371 1.468 . . . . 0.0 111.872 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.41 18.48 20.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.789 0.835 . . . . 0.0 111.585 -171.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 127.101 2.16 . . . . 0.0 114.042 -176.212 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.537 0.208 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.91 95.68 0.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.634 3.556 . . . . 0.0 111.548 -171.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.6 tt 21.26 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.699 2.399 . . . . 0.0 112.514 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.75 -26.45 16.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.011 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -139.74 4.88 2.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.359 0.664 . . . . 0.0 110.67 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.18 160.58 77.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.975 0.51 . . . . 0.0 109.694 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 155.64 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.049 3.166 . . . . 0.0 112.273 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.48 34.59 0.21 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.636 0.774 . . . . 0.0 111.775 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . -173.38 35.84 0.13 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.352 -174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 42.7 t -143.22 168.66 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.208 1.003 . . . . 0.0 109.293 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 1.8 m-20 -137.53 148.27 45.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.964 1.306 . . . . 0.0 108.222 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 502' ' ' GLN . . . . . 0.611 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.4 OUTLIER -76.77 -28.06 55.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.35 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.55 7.39 1.44 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.738 -0.601 . . . . 0.0 111.03 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.03 12.1 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.729 0.811 . . . . 0.0 111.383 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -25.49 2.65 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.889 0.476 . . . . 0.0 111.048 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.504 ' HB2' HE22 ' A' ' 507' ' ' GLN . 50.9 mtmt -69.53 -6.28 29.73 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.941 -0.474 . . . . 0.0 110.702 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.504 HE22 ' HB2' ' A' ' 506' ' ' LYS . 2.0 mp0 -87.54 -4.38 58.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.775 1.23 . . . . 0.0 110.238 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 74.0 mt -90.16 160.11 40.85 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.75 1.22 . . . . 0.0 109.957 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.61 167.64 26.06 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.469 2.779 . . . . 0.0 111.894 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.67 -22.79 62.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.87 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.36 -1.86 57.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.237 0.472 . . . . 0.0 111.684 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.78 -14.58 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -40.85 67.68 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.37 -0.831 . . . . 0.0 109.163 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.16 -7.94 55.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.18 0.592 . . . . 0.0 112.459 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.33 -22.65 18.21 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.521 0.6 . . . . 0.0 111.107 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.42 -30.33 2.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.12 1.69 1.41 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.147 0.431 . . . . 0.0 110.376 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -129.75 9.2 5.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.961 0.904 . . . . 0.0 110.921 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -79.23 138.95 21.27 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 0.29 2.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 12.9 t -162.66 179.82 7.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.596 0.358 . . . . 0.0 110.599 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.15 15.61 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.93 1.692 . . . . 0.0 113.729 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.15 147.27 26.24 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.618 0.367 . . . . 0.0 110.622 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' ASN . . . . . 0.48 ' HB2' ' CE ' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -154.15 10.65 0.39 Allowed 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.76 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 13.25 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.803 0.689 . . . . 0.0 111.219 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' LYS . . . . . 0.48 ' CE ' ' HB2' ' A' ' 524' ' ' ASN . 53.6 mtmt . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.363 1.065 . . . . 0.0 111.399 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.642 0.258 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.05 175.31 14.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.01 -177.45 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.67 0.788 . . . . 0.0 109.17 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.814 ' HB3' HG21 ' B' ' 12' ' ' THR . 83.5 m-85 -135.68 98.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -93.2 117.87 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -93.3 132.7 37.26 Favored 'General case' 0 C--N 1.337 0.057 0 O-C-N 121.881 -0.512 . . . . 0.0 110.783 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -76.09 177.43 7.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.361 1.064 . . . . 0.0 111.976 -174.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.45 -5.95 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.933 1.293 . . . . 0.0 110.489 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 59.5 p -116.85 4.43 12.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.709 -0.62 . . . . 0.0 112.057 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.93 27.78 48.69 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 120.142 -0.254 . . . . 0.0 113.027 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.73 148.21 45.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.814 HG21 ' HB3' ' B' ' 4' ' ' PHE . 47.5 m -122.66 153.64 39.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.561 -170.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.36 132.3 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -83.92 134.7 34.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.7 mt -145.38 133.47 21.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.617 -172.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.84 128.41 37.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.474 0.71 . . . . 0.0 109.477 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.3 179.61 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.982 0.913 . . . . 0.0 109.69 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.7 mt-10 -141.15 164.21 37.14 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.19 1.17 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.583 2.855 . . . . 0.0 113.64 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.402 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.7 m -129.31 -6.61 4.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.908 0.777 . . . . 0.0 111.228 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 21.3 m-20 -80.73 69.08 7.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 171.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.2 t -61.03 176.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.133 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.419 HG22 ' HE3' ' B' ' 27' ' ' LYS . 13.2 mm -52.17 -33.21 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -168.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.6 -22.89 62.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.342 0.974 . . . . 0.0 111.473 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.35 -41.36 22.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.23 -40.24 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 124.275 1.03 . . . . 0.0 110.035 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.419 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.1 mttt -56.73 -26.04 56.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.521 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -26.89 35.16 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.486 0.584 . . . . 0.0 110.772 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -67.1 -33.12 74.79 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.7 mt -87.29 -30.05 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -66.45 -36.67 83.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.715 0.293 . . . . 0.0 110.217 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -69.38 -33.54 73.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.398 0.618 . . . . 0.0 111.297 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -82.39 -24.48 34.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.583 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -134.15 -30.92 1.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.4 9.65 26.93 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.69 126.8 82.01 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 123.891 0.876 . . . . 0.0 108.922 -174.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.41 153.57 77.52 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.634 2.223 . . . . 0.0 111.23 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.24 -20.82 36.79 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.168 2.578 . . . . 0.0 111.823 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.82 -1.69 57.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -113.85 -13.72 12.57 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.335 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.66 170.34 16.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.041 0.837 . . . . 0.0 112.3 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -153.78 148.52 26.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.45 ' C ' HD12 ' B' ' 44' ' ' ILE . 10.7 tp -136.48 139.26 42.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 111.466 -171.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.45 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -135.44 153.17 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.71 1.204 . . . . 0.0 108.213 -177.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.35 135.62 20.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 124.566 1.147 . . . . 0.0 109.089 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.49 10.19 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.887 0.875 . . . . 0.0 113.187 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.29 12.01 32.3 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.454 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 157.68 37.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.764 1.282 . . . . 0.0 109.713 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -93.29 152.09 19.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.116 0.966 . . . . 0.0 108.418 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.455 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -115.07 168.36 10.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -136.15 153.09 51.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.514 0.674 . . . . 0.0 111.615 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.79 -1.54 14.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.287 1.035 . . . . 0.0 111.62 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 9.52 35.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -109.02 -155.88 0.57 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.968 0.907 . . . . 0.0 109.372 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -148.48 160.44 43.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.052 1.741 . . . . 0.0 107.415 172.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.64 -26.8 68.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -71.0 -26.27 63.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.019 1.328 . . . . 0.0 111.993 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.78 -15.23 61.65 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 122.891 0.476 . . . . 0.0 111.298 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -126.56 26.69 6.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.717 0.807 . . . . 0.0 109.786 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 p30 48.0 19.78 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.43 139.82 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.714 0.688 . . . . 0.0 110.373 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -130.08 -177.5 4.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.709 1.204 . . . . 0.0 109.217 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.02 143.42 51.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.039 0.447 . . . . 0.0 110.841 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 53.4 26.27 5.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -74.9 -11.94 60.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m 60.03 128.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.35 1.86 . . . . 0.0 112.117 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.59 -175.62 3.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.121 1.369 . . . . 0.0 108.077 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -137.68 145.43 42.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.45 137.9 50.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.534 1.133 . . . . 0.0 109.403 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.92 162.89 30.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.433 ' C ' HD12 ' B' ' 71' ' ' LEU . 2.5 pp -147.48 178.72 8.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 112.354 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -128.34 167.63 16.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.59 1.156 . . . . 0.0 109.799 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.573 ' H ' HD13 ' B' ' 73' ' ' LEU . 0.0 OUTLIER -102.97 18.12 22.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.749 0.82 . . . . 0.0 112.711 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 129.351 3.061 . . . . 0.0 111.149 175.041 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.9 Cg_endo -77.57 -166.92 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.202 3.268 . . . . 0.0 107.685 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.845 HD13 ' H ' ' A' ' 493' ' ' LEU . 0.0 OUTLIER -65.06 28.4 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 176.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -63.04 -27.96 69.76 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.434 1.894 . . . . 0.0 112.992 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.98 1.93 0.77 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.72 161.77 76.41 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 122.61 0.364 . . . . 0.0 110.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.75 154.38 12.65 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.255 3.303 . . . . 0.0 112.005 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -80.12 57.55 2.73 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 122.343 1.068 . . . . 0.0 110.424 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.23 26.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.226 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 76.0 t -140.79 160.03 23.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.808 0.804 . . . . 0.0 109.441 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.17 145.16 48.99 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.673 0.749 . . . . 0.0 109.077 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.651 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.9 OUTLIER -62.31 -28.98 70.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.406 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.92 -0.16 10.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.679 -0.638 . . . . 0.0 111.403 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.26 18.42 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.437 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.78 -18.5 5.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.074 0.95 . . . . 0.0 110.452 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -72.6 3.83 4.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.943 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -87.51 4.89 41.74 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.748 0.819 . . . . 0.0 110.463 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.02 149.54 42.7 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 123.614 0.765 . . . . 0.0 110.187 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.27 163.77 25.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.081 2.521 . . . . 0.0 111.57 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.21 63.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.53 -1.8 57.93 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.651 0.38 . . . . 0.0 110.761 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 23.2 mt -116.87 -16.83 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -54.45 -38.87 66.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.5 -7.23 57.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.42 0.688 . . . . 0.0 112.421 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.42 -20.9 17.49 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.262 0.483 . . . . 0.0 111.2 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.43 -34.3 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.42 -8.64 19.84 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 33.0 t -70.12 -43.73 70.39 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.472 0.309 . . . . 0.0 110.797 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 117.73 120.64 3.07 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -140.79 -176.22 4.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.585 0.707 . . . . 0.0 110.725 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 -172.13 4.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.796 1.638 . . . . 0.0 107.998 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 65.19 18.11 11.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.035 0.934 . . . . 0.0 112.603 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.01 146.39 31.9 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.095 0.958 . . . . 0.0 109.092 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -148.29 28.79 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.925 0.49 . . . . 0.0 112.005 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.272 2.2 pp 50.92 6.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.697 1.599 . . . . 0.0 114.511 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -176.139 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.841 0.353 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -157.75 172.91 17.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.95 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -137.24 -179.37 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.272 0.629 . . . . 0.0 109.449 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.82 ' HB3' HG21 ' B' ' 12' ' ' THR . 82.4 m-85 -132.33 100.4 4.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.64 103.09 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.626 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -85.41 135.3 33.93 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 122.455 0.302 . . . . 0.0 111.135 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.7 p -83.76 176.32 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.38 0.672 . . . . 0.0 112.625 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -65.89 1.66 1.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.743 1.217 . . . . 0.0 111.001 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.3 p -118.73 10.06 12.31 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.307 0.643 . . . . 0.0 111.311 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 28.36 66.27 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.892 -0.393 . . . . 0.0 113.199 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.71 146.59 49.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.82 HG21 ' HB3' ' B' ' 4' ' ' PHE . 26.7 m -122.78 154.31 38.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 111.547 -171.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 53.3 mt -130.75 131.94 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -82.89 134.76 35.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 69.2 mt -144.35 134.54 24.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -171.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.89 126.82 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.314 0.645 . . . . 0.0 109.433 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.26 174.23 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.898 0.879 . . . . 0.0 109.645 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.405 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.8 mm-40 -135.69 161.87 60.38 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.272 1.029 . . . . 0.0 108.631 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.45 2.24 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.31 2.674 . . . . 0.0 113.339 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.4 ' H ' ' C ' ' B' ' 18' ' ' GLU . 35.1 p -122.21 -10.2 8.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.98 0.912 . . . . 0.0 110.593 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 76.2 m-20 -85.99 71.16 10.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.1 t -62.16 176.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.683 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 17.7 mm -51.14 -36.8 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -168.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -68.79 -21.67 64.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.371 0.987 . . . . 0.0 111.251 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -81.66 -40.38 22.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.36 -38.44 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.857 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.9 mttt -58.18 -23.13 54.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.524 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.62 -26.73 31.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.556 0.617 . . . . 0.0 110.73 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.85 -33.65 74.16 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.0 mt -85.85 -29.85 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -68.12 -37.6 81.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.33 -32.1 71.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.475 0.655 . . . . 0.0 111.323 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -83.01 -22.11 33.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -138.94 -31.25 0.72 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.74 9.39 19.0 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.2 mt -80.5 125.47 80.76 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.662 0.785 . . . . 0.0 109.337 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 159.38 48.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.216 2.611 . . . . 0.0 111.268 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -16.32 54.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.828 3.018 . . . . 0.0 110.851 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.47 -11.9 58.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.655 0.382 . . . . 0.0 111.999 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -120.85 -10.8 9.06 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -73.01 167.74 20.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.261 0.937 . . . . 0.0 112.04 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -159.21 90.1 0.95 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.88 1.272 . . . . 0.0 107.986 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.677 ' C ' HD12 ' B' ' 44' ' ' ILE . 23.3 tp -93.13 139.82 30.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.661 0.784 . . . . 0.0 112.201 -170.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -134.68 154.07 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.996 1.318 . . . . 0.0 109.145 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' B' ' 50' ' ' LEU . 43.1 t80 -151.59 142.81 23.29 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.593 1.157 . . . . 0.0 109.129 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 13.77 0.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.573 0.749 . . . . 0.0 112.615 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.7 13.86 48.96 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.275 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 161.78 31.53 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.559 1.18 . . . . 0.0 110.36 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.04 125.87 43.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.814 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.5 OUTLIER -76.0 175.35 8.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.991 -177.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -135.13 153.35 52.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 111.307 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.18 1.18 9.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.268 1.027 . . . . 0.0 111.697 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.64 11.76 27.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -112.47 -154.4 0.54 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.173 0.989 . . . . 0.0 109.563 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 4.5 p -148.97 159.56 44.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.794 1.638 . . . . 0.0 107.674 172.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 47.1 mt -63.27 -25.75 68.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -73.87 -25.45 60.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.467 1.107 . . . . 0.0 111.985 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.76 -15.96 61.65 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.09 0.556 . . . . 0.0 111.386 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.64 ' CD2' HD12 ' B' ' 50' ' ' LEU . 21.2 m-85 -125.71 25.98 6.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.367 0.667 . . . . 0.0 109.836 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p30 48.54 18.91 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 136.44 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.855 0.752 . . . . 0.0 110.187 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -130.4 -175.89 3.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.009 1.323 . . . . 0.0 109.458 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -59.93 143.89 50.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.281 0.563 . . . . 0.0 110.916 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 55.15 22.43 4.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.455 1.102 . . . . 0.0 113.331 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -72.44 -14.72 61.76 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 80.6 m 61.36 128.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.466 1.906 . . . . 0.0 112.051 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.59 178.62 6.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.941 1.296 . . . . 0.0 108.655 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -134.85 154.64 51.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -145.24 151.87 39.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.245 0.545 . . . . 0.0 110.507 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.04 161.2 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.467 ' H ' HD23 ' B' ' 71' ' ' LEU . 2.2 pt? -140.68 170.05 16.49 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.155 0.502 . . . . 0.0 112.077 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -135.61 177.48 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.136 0.974 . . . . 0.0 109.538 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 73' ' ' LEU . 0.5 OUTLIER -124.41 20.87 8.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.267 1.027 . . . . 0.0 112.385 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 62.28 -32.05 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.052 2.141 . . . . 0.0 113.94 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 148.17 -13.91 1.28 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 117.263 -1.854 . . . . 0.0 111.104 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 494' ' ' GLN . 93.3 Cg_endo -80.12 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 1 C-N-CA 125.408 4.072 . . . . 0.0 109.254 175.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.4 32.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.726 1.61 . . . . 0.0 113.078 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.4 pp0? -77.16 -27.95 53.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.281 0.633 . . . . 0.0 112.568 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.01 3.63 1.61 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.5 160.05 82.06 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 122.911 0.484 . . . . 0.0 109.781 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.1 149.43 15.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.52 2.813 . . . . 0.0 111.434 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -76.09 65.92 2.18 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 121.731 0.777 . . . . 0.0 112.256 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 165.76 -27.75 0.19 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.494 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.73 162.1 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 122.988 0.515 . . . . 0.0 109.948 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -131.15 144.74 51.6 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 109.868 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.535 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.5 pm0 -61.16 -30.62 70.51 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.3 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -72.15 0.41 9.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.903 -0.498 . . . . 0.0 111.771 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.1 16.19 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 122.945 0.498 . . . . 0.0 110.617 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.98 -19.87 5.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.552 0.741 . . . . 0.0 109.846 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -73.49 4.77 4.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.023 0.529 . . . . 0.0 111.637 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -83.95 5.9 23.82 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.438 0.695 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.01 152.15 53.77 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 123.868 0.867 . . . . 0.0 110.174 -170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.8 164.1 25.53 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.845 2.364 . . . . 0.0 111.311 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.55 63.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.106 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 -3.29 58.4 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 122.464 0.306 . . . . 0.0 110.953 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.2 -15.27 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -54.96 -38.92 68.39 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.08 -10.4 59.36 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 516' ' ' ILE . 11.2 mm-40 -89.38 -18.37 26.99 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.478 0.581 . . . . 0.0 111.186 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 515' ' ' GLU . 1.2 mp -107.91 -34.32 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.08 -9.07 14.15 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 171.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 m -63.14 -27.08 69.13 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 122.245 -0.284 . . . . 0.0 110.821 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 104.19 35.23 3.45 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -61.54 -179.96 0.2 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.613 1.197 . . . . 0.0 112.189 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.3 m -142.65 -171.97 3.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.162 -1.835 . . . . 0.0 108.91 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.76 13.13 8.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.233 1.013 . . . . 0.0 112.286 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -149.75 145.56 26.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.912 0.485 . . . . 0.0 110.252 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.2 m-80 -152.37 19.4 0.64 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.738 0.815 . . . . 0.0 110.105 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.02 -15.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.159 1.384 . . . . 0.0 112.445 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 124.072 0.949 . . . . 0.0 111.108 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.955 0.407 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.69 172.81 17.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.794 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.58 -179.64 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.548 0.739 . . . . 0.0 109.055 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -132.06 107.59 8.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -103.09 109.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.6 ttmt -93.54 139.11 31.12 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -86.9 176.0 7.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.044 0.938 . . . . 0.0 112.135 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.86 -20.84 59.46 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.577 1.151 . . . . 0.0 110.981 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -95.48 -2.83 47.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.968 -0.458 . . . . 0.0 110.471 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.56 24.64 27.8 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.278 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.55 140.07 52.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -109.42 159.23 17.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.546 -173.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -129.97 128.69 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -79.54 134.17 36.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -144.88 133.8 22.5 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -90.11 128.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.12 177.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 123.746 0.818 . . . . 0.0 110.104 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 75.0 mm-40 -141.6 163.08 43.34 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 124.602 1.161 . . . . 0.0 108.941 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 38.2 Cg_exo -55.46 3.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.668 3.579 . . . . 0.0 113.647 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 18' ' ' GLU . 19.2 t -134.0 -8.77 2.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.892 0.769 . . . . 0.0 111.482 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 8.2 m-20 -78.05 68.78 4.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.0 t -62.29 177.02 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.653 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.424 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.6 mm -51.29 -33.65 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -169.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.29 -22.14 61.99 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 119.266 0.939 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.79 -38.17 26.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.478 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 71.5 t -64.68 -40.54 89.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 110.138 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.6 mttt -56.86 -27.53 60.51 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.17 -23.04 44.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.427 0.558 . . . . 0.0 110.796 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 68.3 mmtt -69.76 -47.32 63.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.481 0.712 . . . . 0.0 109.434 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.44 -30.61 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.515 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.32 -39.4 78.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.71 0.29 . . . . 0.0 110.466 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.43 -31.25 70.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.31 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.35 -24.6 36.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.462 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.68 -34.53 0.68 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.63 8.7 13.7 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.74 126.48 88.45 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.13 153.78 73.98 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.672 2.248 . . . . 0.0 111.028 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.31 -17.33 39.66 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.617 2.878 . . . . 0.0 111.573 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.14 2.3 55.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.69 -16.76 10.66 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.91 164.13 24.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.619 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -154.53 124.18 6.59 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.535 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -123.4 135.12 53.97 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.871 0.305 . . . . 0.0 111.513 -168.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.535 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.7 mp -129.53 149.92 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -151.03 143.08 24.01 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.844 1.257 . . . . 0.0 109.07 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.69 13.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.516 0.726 . . . . 0.0 112.326 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.99 14.58 48.56 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.453 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 163.42 29.33 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.486 1.143 . . . . 0.0 110.178 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.84 128.27 45.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.4 OUTLIER -77.18 172.82 12.64 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.015 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -135.5 156.27 49.16 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.542 0.687 . . . . 0.0 111.206 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.97 2.31 8.95 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.869 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.86 14.57 21.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -115.26 -154.13 0.54 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.375 1.07 . . . . 0.0 108.758 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 40.4 p -150.43 166.52 29.87 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.344 1.058 . . . . 0.0 108.386 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.3 -30.48 71.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 17.0 t -74.91 -29.76 61.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.351 0.66 . . . . 0.0 111.136 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.42 -16.17 63.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.723 0.409 . . . . 0.0 111.606 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' B' ' 50' ' ' LEU . 18.0 m-85 -130.1 25.57 5.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.654 0.781 . . . . 0.0 110.245 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 46.75 25.68 0.47 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.24 128.47 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -132.38 -171.24 2.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.71 1.204 . . . . 0.0 109.705 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -58.37 140.66 53.22 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.969 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 54.12 24.43 4.84 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.235 1.014 . . . . 0.0 113.15 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.7 m -72.22 -19.18 61.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m 60.99 135.79 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.508 1.923 . . . . 0.0 112.184 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.9 179.93 6.43 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.534 0.734 . . . . 0.0 109.145 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.58 143.72 45.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.048 0.451 . . . . 0.0 110.886 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -134.4 142.02 47.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.834 1.254 . . . . 0.0 110.495 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 85.2 t -142.93 160.26 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -147.67 171.89 14.93 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.8 175.9 5.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.508 1.123 . . . . 0.0 108.977 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' B' ' 75' ' ' GLY . 2.9 tp -124.4 18.98 8.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 59.94 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.041 2.136 . . . . 0.0 113.992 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.22 -10.66 2.02 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 CA-C-O 117.221 -1.877 . . . . 0.0 110.985 -179.823 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.2 Cg_endo -74.54 -164.03 0.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 125.125 3.883 . . . . 0.0 109.616 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 32.95 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.417 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 494' ' ' GLN . 0.0 OUTLIER -68.54 -36.7 79.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.56 2.34 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 112.047 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.09 161.12 75.14 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 122.985 0.514 . . . . 0.0 110.06 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 499' ' ' GLY . 75.1 Cg_exo -53.19 150.95 23.41 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.988 3.125 . . . . 0.0 112.18 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.55 35.82 0.19 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.87 0.843 . . . . 0.0 112.077 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -174.24 30.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.298 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.8 t -139.16 162.52 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 C-N-CA 123.619 0.768 . . . . 0.0 108.984 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.17 143.04 50.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.496 0.665 . . . . 0.0 110.046 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.557 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.7 OUTLIER -60.78 -30.65 70.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.169 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.41 0.38 8.39 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.698 -0.626 . . . . 0.0 111.588 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.72 17.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.719 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.35 -21.58 5.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 109.706 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -72.37 10.15 0.86 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.283 0.633 . . . . 0.0 111.68 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -93.49 8.8 39.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.874 0.87 . . . . 0.0 110.743 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 31.4 mt -123.82 153.62 67.1 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.8 0.84 . . . . 0.0 111.331 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.8 158.49 56.72 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.987 2.458 . . . . 0.0 111.14 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.8 62.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.928 0.891 . . . . 0.0 112.847 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.17 -7.29 59.64 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.649 0.658 . . . . 0.0 111.133 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.79 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -65.21 -35.2 80.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 120.857 -1.152 . . . . 0.0 110.592 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.06 -1.78 8.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.42 0.288 . . . . 0.0 111.5 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.79 5.04 8.79 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.05 -39.21 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.96 -5.52 2.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.701 0.8 . . . . 0.0 109.503 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.8 m -142.16 27.66 1.75 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.272 1.429 . . . . 0.0 110.171 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.59 39.01 2.21 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.41 9.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.692 1.997 . . . . 0.0 115.421 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.9 m -142.4 171.09 14.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.746 0.819 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 1.1 tpm_? 60.57 12.92 3.87 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.65 1.58 . . . . 0.0 114.128 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.43 140.22 21.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.25 32.17 0.66 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.027 0.531 . . . . 0.0 111.786 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' LEU . . . . . 0.489 ' C ' HD12 ' A' ' 525' ' ' LEU 0.262 1.9 pp 50.95 5.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.086 1.754 . . . . 0.0 115.362 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.849 1.26 . . . . 0.0 112.471 -178.152 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.97 173.47 16.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.651 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.41 -179.61 2.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.3 133.25 51.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.86 107.12 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -84.71 132.8 34.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.981 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -76.1 173.52 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.096 0.958 . . . . 0.0 111.424 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.18 -23.19 66.47 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.794 0.838 . . . . 0.0 110.531 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -91.84 -10.46 39.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.924 -0.485 . . . . 0.0 111.322 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 28.75 7.1 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.37 -0.443 . . . . 0.0 113.751 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -121.82 145.57 47.93 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.51 158.02 25.28 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.7 mt -133.12 134.24 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -77.43 128.91 35.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 mt -137.24 130.33 30.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.97 126.97 35.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.009 0.923 . . . . 0.0 109.354 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.57 177.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.133 0.973 . . . . 0.0 109.447 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.4 mm-40 -136.9 162.49 55.52 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 108.619 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.69 5.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.487 2.792 . . . . 0.0 113.384 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.425 ' H ' ' C ' ' B' ' 18' ' ' GLU . 22.5 t -129.86 -8.93 4.45 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.626 0.648 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -81.11 76.01 8.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.7 t -66.08 177.1 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.445 -176.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' B' ' 27' ' ' LYS . 11.8 mm -52.12 -35.34 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.54 -21.73 65.45 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.934 0.788 . . . . 0.0 111.038 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -82.72 -42.67 17.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.6 -40.03 87.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 124.444 1.098 . . . . 0.0 110.395 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.8 mttt -58.75 -23.17 59.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.419 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.48 35.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.601 0.637 . . . . 0.0 110.762 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.26 -33.84 75.1 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.177 -0.327 . . . . 0.0 110.13 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -85.1 -30.51 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.85 -39.16 90.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.79 -31.81 71.94 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.232 0.539 . . . . 0.0 111.07 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -86.9 -22.09 25.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -135.16 -32.1 0.96 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.6 9.85 24.34 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -81.59 129.98 63.42 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.35 151.08 76.46 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.585 2.19 . . . . 0.0 110.826 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.52 -15.03 44.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.626 2.884 . . . . 0.0 111.37 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -88.15 -7.26 57.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -119.24 -9.85 9.86 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.5 176.26 4.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.176 0.898 . . . . 0.0 112.91 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -147.06 151.48 36.97 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 127.48 2.312 . . . . 0.0 105.768 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.46 ' C ' HD12 ' B' ' 44' ' ' ILE . 43.6 tp -146.71 116.8 7.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.308 0.958 . . . . 0.0 110.165 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.46 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.2 mp -125.11 142.23 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.574 0.75 . . . . 0.0 109.299 -174.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.539 ' CB ' HD22 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -161.32 158.41 26.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.564 172.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.12 20.89 1.93 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.33 73.62 Favored Glycine 0 C--N 1.341 0.847 0 C-N-CA 125.084 1.326 . . . . 0.0 112.57 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 161.73 35.8 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 117.693 0.746 . . . . 0.0 109.686 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -96.62 125.71 41.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.1 mp -74.76 159.75 31.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -124.92 148.4 48.36 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.49 0.662 . . . . 0.0 111.801 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.66 2.39 5.32 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.467 1.107 . . . . 0.0 111.672 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 15.61 23.61 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -121.14 -150.2 0.45 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 108.655 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -151.81 156.42 40.18 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 125.738 1.615 . . . . 0.0 108.871 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.79 -25.2 62.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -73.89 -24.29 59.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.265 1.026 . . . . 0.0 111.703 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.0 -15.19 60.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.254 0.621 . . . . 0.0 111.556 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 17.41 19.63 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.82 22.44 1.15 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.836 1.254 . . . . 0.0 114.227 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.81 144.78 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -132.82 178.67 6.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.918 0.887 . . . . 0.0 109.092 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -60.92 150.87 31.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.064 0.459 . . . . 0.0 111.253 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 60.06 17.68 6.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.869 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 87.6 p -70.08 179.48 2.32 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 109.934 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -134.61 126.85 30.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.539 HD22 ' CB ' ' B' ' 45' ' ' PHE . 14.3 mt -121.61 -171.77 2.29 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -138.41 143.96 39.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.034 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.453 HD13 ' C ' ' B' ' 69' ' ' LEU . 1.9 tm? -133.76 139.04 46.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.544 1.137 . . . . 0.0 109.944 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.94 165.89 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.411 ' C ' HD12 ' B' ' 71' ' ' LEU . 3.7 pp -138.49 172.66 12.56 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.25 0.477 . . . . 0.0 111.804 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -123.79 169.45 11.53 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.918 0.887 . . . . 0.0 110.078 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' B' ' 75' ' ' GLY . 1.4 mp -112.58 13.49 20.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.986 0.915 . . . . 0.0 112.213 -170.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 61.9 -27.85 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.409 1.884 . . . . 0.0 113.866 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -110.94 6.75 29.26 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 117.1 -1.944 . . . . 0.0 110.991 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 494' ' ' GLN . 84.3 Cg_endo -76.18 -163.74 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 1 C-N-CA 125.392 4.062 . . . . 0.0 109.65 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.94 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.479 1.512 . . . . 0.0 112.868 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.1 pp0? -75.43 -26.26 58.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.49 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.15 5.68 1.3 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.67 157.51 90.0 Favored Pre-proline 0 N--CA 1.448 -0.55 0 O-C-N 121.923 -0.486 . . . . 0.0 110.163 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.16 154.66 27.36 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.857 3.038 . . . . 0.0 112.169 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -79.67 58.19 2.7 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 122.147 0.975 . . . . 0.0 109.866 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.98 28.34 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.142 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.13 163.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.527 0.663 . . . . 0.0 109.349 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.09 144.03 46.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -65.21 -31.98 73.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.621 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.38 9.88 3.54 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.282 -0.886 . . . . 0.0 110.364 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 504' ' ' VAL . 95.7 t -129.71 10.24 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.563 1.145 . . . . 0.0 109.466 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -25.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.219 -0.925 . . . . 0.0 112.728 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -69.12 -8.32 44.31 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.85 0.75 . . . . 0.0 111.939 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -81.32 -10.55 59.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.11 0.413 . . . . 0.0 110.795 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.82 162.44 70.29 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 124.695 1.198 . . . . 0.0 110.15 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.51 165.05 33.43 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.625 2.216 . . . . 0.0 111.258 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.92 -8.89 5.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.434 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -103.05 -2.35 27.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.301 0.64 . . . . 0.0 111.544 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.07 -13.48 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.21 -2.25 33.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.318 0.647 . . . . 0.0 112.185 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -100.5 -15.32 17.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.316 0.507 . . . . 0.0 111.408 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.32 -35.42 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.31 -11.17 49.17 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 t -73.08 -45.0 59.76 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.637 0.256 . . . . 0.0 110.959 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 130.9 123.24 2.48 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -146.28 173.6 12.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.452 1.101 . . . . 0.0 109.001 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 t -153.6 -171.87 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.605 1.162 . . . . 0.0 109.127 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 62.78 21.26 12.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.705 1.202 . . . . 0.0 112.021 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -144.88 155.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.964 0.906 . . . . 0.0 109.542 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.626 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -149.05 10.7 0.8 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -173.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.4 13.55 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.869 -172.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.626 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 51.7 mtmt . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 124.448 1.099 . . . . 0.0 112.335 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -157.87 171.3 20.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.814 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -138.22 -179.73 2.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.09 108.29 8.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.03 117.04 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.58 132.52 36.25 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.392 0.277 . . . . 0.0 111.332 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -83.19 179.34 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.599 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.1 tm? -67.33 7.12 0.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.04 1.336 . . . . 0.0 110.846 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -125.65 11.42 7.89 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.165 -0.959 . . . . 0.0 111.981 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 28.29 66.23 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.84 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -126.55 145.56 50.48 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 159.67 22.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.481 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -127.99 125.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -73.09 133.56 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.35 130.04 21.52 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.36 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -90.36 129.0 36.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.06 -177.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.956 0.902 . . . . 0.0 109.637 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 37.6 mt-10 -144.14 162.87 38.21 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.85 2.86 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.818 2.345 . . . . 0.0 113.063 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.437 ' H ' ' C ' ' B' ' 18' ' ' GLU . 28.4 p -126.16 -12.06 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.679 0.791 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.7 m-20 -80.49 73.18 7.41 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 171.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.5 t -62.89 175.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.252 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.9 mm -51.08 -34.47 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -169.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.44 -22.65 64.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.553 1.07 . . . . 0.0 111.412 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.79 -36.45 25.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 83.3 t -68.08 -37.63 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 124.122 0.969 . . . . 0.0 110.207 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.0 mttt -60.96 -24.28 65.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.83 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.8 52.12 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.479 0.581 . . . . 0.0 110.771 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.487 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.7 mmtt -72.97 -50.59 22.4 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.565 0.746 . . . . 0.0 109.513 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -68.49 -31.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.52 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.96 -38.82 79.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.525 0.203 . . . . 0.0 110.77 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.78 -29.35 65.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.28 0.562 . . . . 0.0 111.405 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -80.48 -25.49 38.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.056 0.943 . . . . 0.0 113.227 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -138.0 -32.8 0.72 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.93 15.36 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.1 mt -76.15 128.63 82.44 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.85 155.47 62.28 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.694 2.263 . . . . 0.0 111.133 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.14 -16.06 43.91 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.897 3.064 . . . . 0.0 111.491 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.67 -13.38 51.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -114.88 -15.19 11.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.11 155.94 38.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.331 0.969 . . . . 0.0 111.21 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.56 90.99 1.84 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.658 1.183 . . . . 0.0 108.826 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.468 ' C ' HD12 ' B' ' 44' ' ' ILE . 18.1 mt -85.57 139.76 31.17 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.012 0.434 . . . . 0.0 111.333 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.468 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -130.97 148.16 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.828 1.251 . . . . 0.0 107.858 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -148.84 141.72 24.7 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.258 1.023 . . . . 0.0 108.686 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.96 12.29 0.08 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.592 0.757 . . . . 0.0 112.583 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.42 39.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.635 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 161.65 33.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.411 1.105 . . . . 0.0 109.766 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -95.78 145.13 25.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -99.51 169.17 9.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.712 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -136.28 153.74 51.09 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.338 0.59 . . . . 0.0 111.987 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -72.84 1.03 9.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.241 1.016 . . . . 0.0 111.54 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.59 8.79 32.42 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -110.56 -154.04 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 109.323 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.8 p -149.06 158.58 44.29 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.63 1.572 . . . . 0.0 107.434 171.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.29 -25.21 68.21 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.9 p -74.06 -24.86 59.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.59 1.156 . . . . 0.0 111.568 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.79 -16.43 61.63 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.182 0.593 . . . . 0.0 111.531 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -125.05 25.94 7.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.516 0.726 . . . . 0.0 109.6 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.33 20.06 0.26 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -60.14 136.9 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 118.572 0.624 . . . . 0.0 111.083 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -132.57 -172.62 2.95 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.26 1.424 . . . . 0.0 109.403 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -60.85 145.49 49.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.674 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 51.44 26.53 3.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.533 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 77.6 p -69.37 -21.17 63.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.419 1.088 . . . . 0.0 113.424 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m 59.87 126.07 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.176 2.19 . . . . 0.0 112.275 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -128.7 -175.88 3.67 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.068 1.347 . . . . 0.0 107.921 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -136.99 144.44 43.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -132.28 135.69 46.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.741 . . . . 0.0 110.088 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.22 166.89 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -146.26 171.99 14.14 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -104.99 177.73 4.77 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.999 1.32 . . . . 0.0 108.345 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' B' ' 75' ' ' GLY . 3.6 tp -122.75 18.8 10.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.849 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 61.19 -27.67 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.652 1.981 . . . . 0.0 113.761 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.52 -11.84 1.98 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 117.247 -1.863 . . . . 0.0 110.931 -179.282 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 38.6 Cg_exo -61.2 -162.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 125.117 3.878 . . . . 0.0 111.468 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 31.65 0.71 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.669 1.188 . . . . 0.0 110.671 169.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -68.7 -28.56 66.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.684 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.94 3.33 0.82 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.43 0.692 . . . . 0.0 112.73 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.75 160.88 81.01 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.85 157.74 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.316 3.344 . . . . 0.0 112.582 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -77.44 68.13 3.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.977 0.894 . . . . 0.0 112.375 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 157.18 -26.77 0.49 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.284 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.88 167.38 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.066 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.8 147.88 41.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.656 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.9 OUTLIER -64.2 -30.28 71.35 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.851 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.1 9.41 3.73 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.213 -0.93 . . . . 0.0 110.813 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 504' ' ' VAL . 81.9 t -129.96 9.28 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 109.522 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -19.17 0.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 113.071 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -71.55 -11.44 60.86 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.673 -0.642 . . . . 0.0 111.956 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 9.6 mp0 -80.25 -9.47 59.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.016 0.371 . . . . 0.0 110.349 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.95 148.59 57.35 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 124.293 1.037 . . . . 0.0 109.44 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.35 164.45 23.03 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.658 2.239 . . . . 0.0 111.338 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.84 -21.52 63.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.888 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -87.42 1.45 53.36 Favored 'General case' 0 CA--C 1.524 -0.05 0 C-N-CA 122.692 0.397 . . . . 0.0 111.005 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 32.0 mt -119.34 -16.35 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -54.82 -41.39 70.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.93 -1.18 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.531 0.733 . . . . 0.0 112.487 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -105.77 -17.74 14.28 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.285 0.493 . . . . 0.0 111.9 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.49 -25.69 3.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.49 -5.79 12.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.319 0.248 . . . . 0.0 110.413 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 89.6 p -146.38 15.8 1.3 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -119.16 88.81 0.45 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -112.54 9.26 19.47 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -163.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.4 t -137.57 21.03 2.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.24 7.02 5.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.736 -0.602 . . . . 0.0 112.204 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -153.41 149.49 27.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.1 OUTLIER -144.27 17.43 1.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.28 1.032 . . . . 0.0 109.202 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.54 6.83 5.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.514 1.125 . . . . 0.0 109.876 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 49.5 mtmt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.519 1.128 . . . . 0.0 112.849 -173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 120.658 0.266 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -156.29 173.52 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.74 -179.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 123.654 0.782 . . . . 0.0 109.274 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.418 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 50.7 m-85 -133.57 94.95 3.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.114 0.483 . . . . 0.0 109.737 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -81.93 62.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.163 0.985 . . . . 0.0 111.771 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.5 ttmt -51.59 132.54 30.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.62 0.768 . . . . 0.0 111.28 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 65.9 p -76.06 175.47 8.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.128 -174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.28 -10.34 10.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.708 1.203 . . . . 0.0 110.675 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -112.67 -0.31 15.12 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 121.892 -0.505 . . . . 0.0 111.988 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 22.4 23.78 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.682 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.2 123.42 46.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.585 0.693 . . . . 0.0 110.149 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.9 OUTLIER -82.64 151.24 26.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 111.356 -177.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.35 120.42 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -77.9 136.78 38.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' B' ' 33' ' ' LYS . 67.1 mt -149.77 137.39 20.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.385 0.274 . . . . 0.0 110.976 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.67 128.7 42.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.8 -179.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.837 0.855 . . . . 0.0 109.358 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.442 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -142.15 164.0 36.38 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.454 0.701 . . . . 0.0 109.52 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 43.2 Cg_exo -54.72 1.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.465 3.443 . . . . 0.0 113.683 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.411 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.6 m -132.31 -7.77 3.35 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.805 0.729 . . . . 0.0 111.671 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 28.5 m-20 -81.39 68.61 7.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -63.33 178.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.191 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.46 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -52.74 -33.82 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -168.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.91 -23.43 63.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.224 0.92 . . . . 0.0 111.15 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -80.63 -41.66 23.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.04 -40.89 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 123.999 0.919 . . . . 0.0 110.077 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.5 mttt -56.55 -26.73 55.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.415 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 -28.39 34.98 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.627 0.649 . . . . 0.0 110.849 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.529 ' HB3' HD22 ' B' ' 15' ' ' LEU . 5.1 mptp? -65.47 -32.82 74.64 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -86.15 -30.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -66.49 -36.31 82.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.19 -34.81 76.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.142 0.496 . . . . 0.0 111.325 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.8 mmtm -79.03 -25.58 43.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.24 -31.23 0.91 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.92 10.28 22.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.1 127.36 77.09 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.0 154.13 67.09 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.807 2.338 . . . . 0.0 111.17 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.41 -14.25 41.96 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.717 2.945 . . . . 0.0 110.713 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.45 -8.78 58.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -123.42 -8.76 8.06 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.96 167.51 20.92 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.084 0.856 . . . . 0.0 111.731 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -154.24 138.94 17.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.47 ' C ' HD12 ' B' ' 44' ' ' ILE . 46.0 tp -134.92 135.58 41.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.796 0.725 . . . . 0.0 111.509 -169.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.47 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.3 mp -131.74 152.09 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.586 1.155 . . . . 0.0 108.667 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -149.31 138.67 21.53 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.59 1.156 . . . . 0.0 108.94 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.74 0.07 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.89 0.876 . . . . 0.0 112.876 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.42 13.17 36.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.407 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 159.48 36.81 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.631 1.216 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -93.8 150.52 20.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.486 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.6 mp -109.15 170.28 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.419 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -136.38 153.89 50.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.586 0.708 . . . . 0.0 111.539 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.45 -1.01 14.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.414 1.086 . . . . 0.0 111.983 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.2 8.11 32.97 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -106.08 -155.79 0.56 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.162 0.985 . . . . 0.0 109.198 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 35.8 p -150.82 166.25 31.08 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.203 1.401 . . . . 0.0 107.958 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -29.23 70.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 12.2 t -73.4 -31.53 63.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.108 0.963 . . . . 0.0 111.329 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.93 -15.82 60.02 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.551 0.34 . . . . 0.0 111.443 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -128.28 24.9 5.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.673 0.789 . . . . 0.0 109.92 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.65 24.63 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.375 1.87 . . . . 0.0 115.541 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.9 138.53 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.627 0.649 . . . . 0.0 109.851 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.61 -175.16 3.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.662 1.185 . . . . 0.0 109.753 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -59.45 144.7 46.29 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 53.51 24.87 4.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.388 1.075 . . . . 0.0 113.238 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -74.86 -17.68 60.55 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m 59.54 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.271 1.828 . . . . 0.0 112.865 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -127.59 179.87 5.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.663 1.185 . . . . 0.0 108.522 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -134.9 97.5 3.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.098 0.475 . . . . 0.0 111.449 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.89 143.77 45.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.233 1.013 . . . . 0.0 110.497 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 44.9 t -143.71 166.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.35 168.74 22.53 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.623 -0.673 . . . . 0.0 111.722 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -79.35 176.25 9.86 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.924 0.49 . . . . 0.0 111.657 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.89 14.32 29.69 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.26 0.624 . . . . 0.0 111.477 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 60.1 -35.46 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 128.054 2.542 . . . . 0.0 114.708 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.23 -14.33 3.51 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.477 -1.735 . . . . 0.0 110.792 -179.306 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 494' ' ' GLN . 98.0 Cg_endo -77.71 -161.39 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 125.279 3.986 . . . . 0.0 108.8 175.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.2 pt? -68.06 25.5 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.2 pp0? -65.22 -23.76 67.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.549 1.14 . . . . 0.0 112.656 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.85 6.26 1.79 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.22 156.63 74.62 Favored Pre-proline 0 N--CA 1.447 -0.586 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 157.5 5.81 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.204 3.269 . . . . 0.0 112.252 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.92 67.23 2.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.892 0.853 . . . . 0.0 112.302 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 158.51 -29.02 0.44 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.272 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.4 163.9 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.593 0.757 . . . . 0.0 109.838 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.19 157.67 44.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.023 0.529 . . . . 0.0 110.811 -173.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.61 -45.51 93.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.972 0.509 . . . . 0.0 110.614 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.58 7.23 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.139 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.49 11.3 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.597 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -17.42 5.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.359 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.34 4.6 6.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.815 0.446 . . . . 0.0 111.302 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -81.38 7.15 12.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.057 0.943 . . . . 0.0 110.698 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 27.9 mt -121.92 155.01 61.17 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 123.837 0.855 . . . . 0.0 110.621 -168.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.4 167.28 27.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.525 2.817 . . . . 0.0 111.948 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.39 -15.31 24.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.214 1.006 . . . . 0.0 112.753 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -100.72 3.35 42.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.058 0.39 . . . . 0.0 111.786 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.9 mt -118.26 -15.45 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.85 -43.8 66.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.17 1.38 13.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.398 0.679 . . . . 0.0 112.805 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -104.29 -18.5 14.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.45 0.568 . . . . 0.0 111.388 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.27 -28.55 2.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.82 -2.54 9.74 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.168 0.587 . . . . 0.0 110.138 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 90.4 p -133.09 13.62 4.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.193 0.997 . . . . 0.0 111.076 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.79 39.37 2.12 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 2.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -141.25 -174.99 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.911 0.884 . . . . 0.0 109.953 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.85 6.58 4.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.884 1.274 . . . . 0.0 113.065 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.15 161.85 41.59 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.116 0.416 . . . . 0.0 110.898 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -149.79 33.75 0.69 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.762 0.825 . . . . 0.0 111.078 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.83 7.02 4.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.515 0.726 . . . . 0.0 110.741 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.453 -0.318 0 C-N-CA 124.434 1.093 . . . . 0.0 111.717 -176.733 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.95 173.12 17.25 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.034 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -135.0 175.81 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.403 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 53.2 m-85 -128.88 89.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.433 0.635 . . . . 0.0 110.167 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.38 103.38 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.161 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.2 ttmt -85.17 135.52 33.93 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -83.85 174.96 9.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.526 0.731 . . . . 0.0 112.368 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.31 3.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.14 1.376 . . . . 0.0 111.418 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -118.19 4.62 11.95 Favored 'General case' 0 CA--C 1.527 0.058 0 O-C-N 121.922 -0.486 . . . . 0.0 111.537 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.26 24.4 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.251 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.35 122.39 38.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.57 0.685 . . . . 0.0 110.134 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.7 OUTLIER -79.04 152.46 30.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.816 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.25 123.24 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -79.83 131.9 35.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -143.55 133.45 24.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.287 -174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.73 126.29 35.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -145.35 177.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 123.786 0.834 . . . . 0.0 109.919 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.1 mm-40 -138.91 162.24 53.66 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 124.05 0.94 . . . . 0.0 109.709 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 49.4 Cg_exo -54.58 -0.44 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 125.0 3.8 . . . . 0.0 113.896 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -130.91 -7.2 3.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.183 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 65.2 m-20 -81.55 69.62 8.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.9 t -62.9 177.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.808 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.411 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -51.79 -34.61 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.942 0.897 . . . . 0.0 113.215 -168.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.95 -22.42 63.18 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.094 0.861 . . . . 0.0 111.271 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.6 -40.85 22.38 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.9 -39.12 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 124.301 1.04 . . . . 0.0 110.217 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.411 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.7 mttt -57.4 -24.84 57.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.761 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.85 -28.34 33.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.509 0.595 . . . . 0.0 110.761 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -66.34 -33.32 75.46 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.06 -30.62 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.25 -39.35 86.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.695 0.283 . . . . 0.0 110.261 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.65 -31.67 71.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 111.243 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -83.71 -23.72 31.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.78 -32.84 0.88 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.81 9.03 21.61 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -78.2 129.47 75.18 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.47 151.44 70.72 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.574 2.183 . . . . 0.0 110.456 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 -14.47 37.37 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.23 2.62 . . . . 0.0 110.828 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.14 -8.64 59.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -124.07 -9.82 7.65 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -67.61 165.75 16.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.097 0.862 . . . . 0.0 111.655 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -154.47 102.58 2.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' B' ' 44' ' ' ILE . 28.5 tp -101.36 135.93 42.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.256 0.623 . . . . 0.0 110.949 -169.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.1 mp -129.81 154.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -118.52 -112.05 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 122.914 0.485 . . . . 0.0 110.494 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.99 -3.18 3.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.303 0.641 . . . . 0.0 111.732 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.88 3.03 2.08 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.553 1.073 . . . . 0.0 111.448 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 154.89 37.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.451 0.643 . . . . 0.0 109.567 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -87.96 128.62 35.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.619 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.639 HD22 ' H ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -76.14 172.71 12.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.602 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -133.63 153.44 51.67 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.663 0.744 . . . . 0.0 111.656 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.49 1.48 9.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 111.917 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.29 14.01 25.75 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -115.57 -154.59 0.55 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.353 1.061 . . . . 0.0 108.997 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.0 p -150.14 165.82 31.7 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.812 1.245 . . . . 0.0 108.142 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.14 -29.33 70.71 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 11.5 t -73.24 -31.36 64.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.654 0.782 . . . . 0.0 111.183 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.96 -15.7 63.23 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 122.87 0.468 . . . . 0.0 111.894 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' B' ' 50' ' ' LEU . 15.7 m-85 -130.49 26.44 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.846 0.858 . . . . 0.0 109.989 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.83 30.89 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 132.85 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.83 -174.0 3.79 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.477 1.111 . . . . 0.0 109.542 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -56.7 143.08 37.74 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.058 0.456 . . . . 0.0 111.477 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 53.45 27.79 6.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.201 1.0 . . . . 0.0 112.942 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -69.7 -27.37 64.94 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m 61.57 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.012 2.125 . . . . 0.0 112.043 -174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.54 -179.38 5.7 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.212 1.005 . . . . 0.0 108.806 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.51 151.95 50.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -138.55 142.64 39.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.573 0.749 . . . . 0.0 111.087 -175.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.12 165.32 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 126.352 1.861 . . . . 0.0 105.983 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.35 165.86 27.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.846 -0.534 . . . . 0.0 111.295 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -73.2 174.19 8.36 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' B' ' 75' ' ' GLY . 2.8 tp -107.31 17.78 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.009 0.524 . . . . 0.0 111.087 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 61.69 -28.0 0.06 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.845 2.058 . . . . 0.0 113.693 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 141.87 -11.69 2.63 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.065 -1.964 . . . . 0.0 110.579 -179.749 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 491' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 92.3 Cg_endo -81.59 89.28 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.972 3.781 . . . . 0.0 111.937 -168.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.8 tt 21.46 48.87 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.163 2.585 . . . . 0.0 112.214 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -95.95 -20.08 19.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.117 -172.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -145.57 6.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.79 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.15 151.64 93.31 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.15 164.05 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.836 3.024 . . . . 0.0 111.685 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.03 132.21 53.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.273 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 78.03 -23.02 2.76 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.698 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.99 163.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.71 1.255 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.91 164.83 28.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.182 0.593 . . . . 0.0 110.398 -173.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -66.72 -41.9 87.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.114 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.64 10.9 0.73 Allowed 'General case' 0 C--O 1.23 0.062 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.56 12.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.665 0.786 . . . . 0.0 110.35 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -134.48 -26.26 1.44 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.274 0.488 . . . . 0.0 112.073 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.37 -13.43 62.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.435 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 8.6 mp0 -82.19 -12.07 58.34 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.195 0.452 . . . . 0.0 110.887 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.18 153.4 84.35 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 124.249 1.02 . . . . 0.0 109.508 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 166.29 30.4 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.1 2.533 . . . . 0.0 111.582 172.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.72 -22.19 56.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.554 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.04 3.16 55.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.995 0.362 . . . . 0.0 111.669 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.8 mt -117.94 -15.37 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -52.9 -44.63 67.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.84 -6.65 39.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.401 0.68 . . . . 0.0 112.469 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.86 -20.44 16.17 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.448 0.567 . . . . 0.0 111.039 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.76 -31.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.44 -3.31 8.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.745 0.418 . . . . 0.0 109.988 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -136.17 15.79 3.25 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.092 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -114.54 28.26 8.32 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.156 0.408 . . . . 0.0 112.199 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 1.45 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.2 t -136.01 32.3 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.79 -2.16 0.95 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.66 159.28 39.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -147.35 28.45 0.99 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.957 -172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.42 6.8 3.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.563 0.697 . . . . 0.0 110.073 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 C--N 1.338 0.097 0 C-N-CA 123.878 0.871 . . . . 0.0 112.222 -174.487 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -129.42 165.6 21.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.339 0.656 . . . . 0.0 110.75 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.78 166.64 2.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 164.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.541 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 8.9 m-85 -125.75 133.93 51.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -126.79 109.86 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -84.64 139.38 32.09 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.227 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -84.91 177.82 7.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.073 0.949 . . . . 0.0 112.082 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.42 6.08 0.87 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.791 1.236 . . . . 0.0 110.945 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -125.38 6.15 7.69 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.812 -0.555 . . . . 0.0 112.113 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.84 26.58 53.21 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 119.954 -0.359 . . . . 0.0 113.172 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -124.01 145.58 49.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.272 0.629 . . . . 0.0 109.465 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 8.0 m -122.82 147.18 46.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.215 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.9 mt -123.86 123.76 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -77.44 132.84 38.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -128.74 177.36 7.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 127.44 22.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -149.96 -179.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.087 0.955 . . . . 0.0 109.449 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -136.83 163.14 51.64 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.342 1.057 . . . . 0.0 108.358 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 2.7 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.205 2.604 . . . . 0.0 113.553 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -125.77 -6.44 6.82 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.976 0.807 . . . . 0.0 110.779 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -83.79 75.13 10.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 3.8 t -64.76 175.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.205 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.492 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.3 mm -50.49 -36.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.43 -21.78 65.54 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.325 0.966 . . . . 0.0 111.262 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -82.48 -41.85 19.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.69 -39.81 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.591 1.157 . . . . 0.0 110.134 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.8 mttt -56.09 -26.51 49.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.501 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.68 -27.76 45.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.421 0.555 . . . . 0.0 110.896 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -68.66 -33.01 73.26 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.01 -28.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.07 -39.74 82.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 122.298 -0.251 . . . . 0.0 110.329 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.63 -30.17 68.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 111.592 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -82.83 -23.7 33.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.937 0.895 . . . . 0.0 113.363 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -137.34 -35.82 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.27 9.13 13.58 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.19 127.11 84.18 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 153.18 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.558 2.172 . . . . 0.0 111.184 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.43 -16.03 42.7 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.459 2.772 . . . . 0.0 110.314 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -80.9 -6.32 58.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.769 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -121.46 -21.61 6.21 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.99 162.95 13.04 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.109 0.868 . . . . 0.0 112.998 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -152.08 127.63 10.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.425 ' C ' HD12 ' B' ' 44' ' ' ILE . 37.1 tp -127.29 132.21 50.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.957 0.344 . . . . 0.0 110.522 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.425 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -130.6 148.86 33.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 109.16 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -151.7 143.5 23.72 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.098 0.959 . . . . 0.0 109.36 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 12.48 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.772 0.829 . . . . 0.0 112.427 -172.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 16.39 41.69 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.211 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.3 159.51 36.72 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.71 1.255 . . . . 0.0 110.16 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -96.08 129.26 43.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.679 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.491 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.6 mt -81.46 162.23 23.37 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.755 -174.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -127.48 147.76 50.31 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.445 0.64 . . . . 0.0 111.82 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.45 0.34 8.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.361 1.065 . . . . 0.0 111.691 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.18 13.53 31.2 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -118.57 -149.64 0.44 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.306 1.042 . . . . 0.0 108.942 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.19 157.17 41.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 125.747 1.619 . . . . 0.0 108.65 176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -60.56 -25.11 65.94 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -72.74 -25.21 61.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.365 1.066 . . . . 0.0 111.482 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.7 -14.68 60.35 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.342 0.657 . . . . 0.0 111.558 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.491 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -114.04 17.27 17.92 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 117.804 0.274 . . . . 0.0 110.344 175.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.54 27.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.304 1.442 . . . . 0.0 114.187 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 145.96 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -125.33 -177.42 3.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.498 0.719 . . . . 0.0 109.474 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -72.2 145.14 48.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.649 0.738 . . . . 0.0 112.086 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 58.61 16.58 4.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 111.449 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -65.23 -176.54 0.31 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.93 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -130.26 134.79 47.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.097 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -132.19 -177.03 4.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.246 1.419 . . . . 0.0 108.871 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -136.02 147.79 48.1 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.262 0.225 . . . . 0.0 110.564 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -132.73 138.94 47.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.064 0.946 . . . . 0.0 110.691 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 82.2 t -146.97 165.88 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -145.46 168.25 21.02 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.914 0.779 . . . . 0.0 112.34 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.83 175.92 3.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.435 1.094 . . . . 0.0 112.056 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tp -96.45 16.44 18.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.617 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 62.97 -39.27 0.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.595 2.358 . . . . 0.0 114.066 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.49 -20.89 5.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.407 -1.774 . . . . 0.0 110.904 -179.247 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 494' ' ' GLN . 86.0 Cg_endo -79.34 -167.27 0.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.86 3.707 . . . . 0.0 109.128 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 33.1 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.645 1.578 . . . . 0.0 112.837 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.9 pp0? -74.19 -28.76 61.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.445 0.698 . . . . 0.0 112.599 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.72 5.41 1.77 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.1 159.96 84.02 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 122.497 0.319 . . . . 0.0 110.668 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.0 151.07 21.72 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.535 3.49 . . . . 0.0 112.408 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -80.94 54.5 2.21 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 122.301 1.048 . . . . 0.0 109.989 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.48 28.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.833 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.52 165.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.595 0.758 . . . . 0.0 109.03 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.14 145.93 40.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.885 0.874 . . . . 0.0 108.676 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.597 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.8 OUTLIER -59.79 -29.7 68.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -72.42 1.12 8.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.441 0.564 . . . . 0.0 111.642 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.53 16.54 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.22 0.608 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.81 -15.4 5.96 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.084 0.954 . . . . 0.0 109.498 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -77.85 1.5 20.21 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.95 -0.469 . . . . 0.0 111.635 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -85.12 3.05 40.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.95 0.5 . . . . 0.0 110.003 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.58 149.35 39.75 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.723 1.209 . . . . 0.0 109.606 -170.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.8 161.63 44.69 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.036 2.49 . . . . 0.0 110.768 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.92 -21.59 63.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.403 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.3 -6.23 59.26 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 117.823 0.283 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 44.6 mt -110.97 -17.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 172.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -55.63 -42.04 74.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.09 -13.63 62.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 111.589 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.24 -15.02 26.33 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.658 0.383 . . . . 0.0 111.344 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.8 -37.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.33 -6.96 5.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.434 0.694 . . . . 0.0 110.187 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 45.0 m -65.59 -28.27 69.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.526 -0.274 . . . . 0.0 111.134 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.4 39.16 2.65 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -61.85 -179.81 0.22 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.642 1.21 . . . . 0.0 112.418 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -149.01 -167.44 2.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.493 -1.685 . . . . 0.0 109.214 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.65 19.43 11.71 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.077 0.951 . . . . 0.0 111.975 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -142.82 145.99 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.511 0.724 . . . . 0.0 109.41 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.452 ' HB2' ' HE2' ' A' ' 526' ' ' LYS . 0.2 OUTLIER -138.75 18.77 2.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.027 0.442 . . . . 0.0 111.927 -172.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.43 10.07 4.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.875 0.845 . . . . 0.0 109.671 -169.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 524' ' ' ASN . 31.2 mtmm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -158.1 174.23 15.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.954 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.36 175.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -124.4 117.9 25.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.37 101.73 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -82.35 134.36 35.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.898 0.479 . . . . 0.0 110.917 -173.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -80.46 175.35 10.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.456 0.702 . . . . 0.0 111.649 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.428 HD22 HG13 ' B' ' 70' ' ' VAL . 21.6 tp -66.91 3.67 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.261 1.025 . . . . 0.0 111.485 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -119.87 9.24 11.25 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.732 -0.605 . . . . 0.0 111.787 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.26 25.51 57.09 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 120.088 -0.284 . . . . 0.0 113.133 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.81 140.65 52.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.64 158.59 25.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.117 0.484 . . . . 0.0 111.572 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.12 131.95 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 130.47 36.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -139.52 130.19 25.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.3 128.25 35.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.93 179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.596 0.758 . . . . 0.0 110.416 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.6 mm-40 -132.73 160.08 69.89 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.12 1.4 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.246 2.631 . . . . 0.0 113.304 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 18' ' ' GLU . 33.7 p -124.56 -3.66 7.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.823 0.849 . . . . 0.0 111.049 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.02 69.03 6.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.528 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.9 t -58.5 174.4 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.805 1.242 . . . . 0.0 110.722 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.67 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 16.9 mm -50.39 -31.01 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.26 -19.7 62.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.037 -1.04 . . . . 0.0 111.519 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -86.07 -45.76 11.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.504 0.722 . . . . 0.0 110.714 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.67 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.3 OUTLIER -66.6 -28.72 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 C-N-CA 122.686 0.395 . . . . 0.0 110.643 -176.054 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.53 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.5 mttt -56.59 -29.48 62.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.312 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.8 -29.16 40.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.246 0.475 . . . . 0.0 111.25 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.84 -34.28 73.42 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.951 0.341 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -85.92 -27.79 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -69.57 -39.49 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.01 -31.88 72.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.622 0.725 . . . . 0.0 111.172 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -83.05 -22.52 33.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.61 -31.71 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 8.46 17.63 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -76.77 127.53 83.85 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.52 157.67 58.21 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.759 2.306 . . . . 0.0 111.48 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.64 -13.78 37.95 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.722 2.948 . . . . 0.0 110.338 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.5 -8.13 58.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -126.28 -11.44 6.36 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.35 162.49 28.48 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.341 0.973 . . . . 0.0 111.785 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -154.84 125.73 7.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.454 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.5 OUTLIER -122.41 139.63 53.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.005 0.366 . . . . 0.0 111.323 -168.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.454 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -134.4 150.93 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.789 1.235 . . . . 0.0 108.911 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.489 ' HB3' HD21 ' B' ' 50' ' ' LEU . 18.8 t80 -148.63 138.66 22.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.109 1.364 . . . . 0.0 109.05 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.5 13.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.72 0.808 . . . . 0.0 112.651 -174.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.89 15.07 40.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.077 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 157.2 42.64 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.004 1.402 . . . . 0.0 109.921 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -90.15 153.03 20.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.525 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.2 mt -109.53 161.94 14.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.197 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -128.49 144.27 51.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.253 0.549 . . . . 0.0 111.704 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.24 0.16 6.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.388 1.075 . . . . 0.0 111.7 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.71 11.7 32.6 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -114.69 -149.13 0.44 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.653 1.181 . . . . 0.0 108.775 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.4 p -154.5 158.49 39.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 125.807 1.643 . . . . 0.0 109.024 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.02 -29.29 68.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.64 -25.73 64.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.635 1.174 . . . . 0.0 111.723 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.11 -10.77 59.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.678 0.391 . . . . 0.0 111.054 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.525 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -117.39 17.19 14.67 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.33 13.57 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.7 143.99 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 119.027 0.831 . . . . 0.0 111.428 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 109.697 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.06 147.96 49.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.27 17.89 7.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.839 0.855 . . . . 0.0 112.068 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.5 t -70.98 175.05 5.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -132.39 133.88 44.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.479 0.712 . . . . 0.0 109.094 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.87 179.62 5.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.42 0.688 . . . . 0.0 110.045 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -134.07 138.67 45.47 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.615 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.72 137.87 48.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.666 1.186 . . . . 0.0 110.025 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.428 HG13 HD22 ' B' ' 8' ' ' LEU . 75.7 t -136.32 159.37 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pp -143.73 169.89 16.9 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.615 0.643 . . . . 0.0 112.733 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.17 -179.51 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' B' ' 75' ' ' GLY . 3.6 tp -126.87 18.31 7.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.898 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 58.59 -26.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 127.412 2.285 . . . . 0.0 114.578 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 142.55 -9.56 2.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.243 0 CA-C-O 117.328 -1.818 . . . . 0.0 111.066 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 494' ' ' GLN . 37.6 Cg_exo -59.09 -170.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 125.212 3.942 . . . . 0.0 112.041 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.15 29.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.809 1.243 . . . . 0.0 111.15 172.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -66.45 -34.74 78.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 112.953 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.48 11.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.841 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.81 161.0 75.46 Favored Pre-proline 0 N--CA 1.448 -0.572 0 O-C-N 122.028 -0.42 . . . . 0.0 109.975 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.62 155.19 5.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.293 3.329 . . . . 0.0 112.649 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.6 64.88 3.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 122.031 0.919 . . . . 0.0 112.138 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 161.3 -28.55 0.29 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.075 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.41 164.42 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -139.15 160.82 38.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.081 -0.387 . . . . 0.0 110.856 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.8 mp0 -59.44 -51.54 69.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.82 0.848 . . . . 0.0 108.737 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.65 3.73 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.167 -1.379 . . . . 0.0 113.262 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.56 15.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.523 0.601 . . . . 0.0 111.719 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.05 -17.8 5.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.438 1.095 . . . . 0.0 109.435 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 502' ' ' GLN . 55.6 mtmt -75.8 0.66 17.24 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 111.604 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -86.26 -7.82 58.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.3 mp -89.49 156.06 48.22 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.829 1.252 . . . . 0.0 109.777 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.88 167.65 25.79 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.703 2.935 . . . . 0.0 111.183 170.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.9 -16.3 49.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.806 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.09 -2.03 41.05 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.495 0.588 . . . . 0.0 111.913 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.08 -16.06 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -44.94 70.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.491 -0.756 . . . . 0.0 109.367 170.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.54 -0.97 22.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.22 0.608 . . . . 0.0 112.505 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -105.04 -17.53 14.47 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.535 0.607 . . . . 0.0 111.745 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.22 -27.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' LEU . . . . . 0.433 ' O ' ' HE3' ' A' ' 520' ' ' LYS . 64.3 mt -74.48 -0.26 16.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.363 0.665 . . . . 0.0 110.892 172.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 44.8 m -136.03 24.76 3.3 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -142.55 -32.09 0.11 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 517' ' ' LEU . 51.0 mttt 43.96 26.52 0.14 Allowed 'General case' 0 C--N 1.339 0.139 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 169.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.8 t -148.98 173.15 13.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.32 11.6 2.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.131 1.372 . . . . 0.0 112.877 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -141.15 137.7 32.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.718 0.407 . . . . 0.0 110.255 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -150.4 23.68 0.81 Allowed 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.591 0.756 . . . . 0.0 109.778 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.28 8.28 3.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.181 0 C-N-CA 124.624 1.17 . . . . 0.0 112.539 -174.88 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.12 175.68 13.18 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.383 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 178.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.623 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 89.7 m-85 -134.84 99.22 4.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 110.0 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.22 133.27 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.12 134.03 53.03 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -79.52 178.18 8.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.35 1.46 . . . . 0.0 112.975 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.45 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.5 OUTLIER -73.73 14.04 0.42 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.986 1.315 . . . . 0.0 110.499 173.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.0 p -132.29 11.96 4.58 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.272 -0.893 . . . . 0.0 112.095 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.05 66.62 Favored Glycine 0 C--N 1.338 0.643 0 O-C-N 122.287 -0.258 . . . . 0.0 112.745 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -120.79 142.33 49.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.623 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 23.5 m -115.63 144.8 43.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.99 126.82 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -78.17 136.98 37.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -146.16 133.15 20.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -92.86 128.74 38.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.84 178.24 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.222 1.009 . . . . 0.0 109.258 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' B' ' 20' ' ' SER . 36.1 mt-10 -143.77 163.95 33.0 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.44 4.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.397 2.732 . . . . 0.0 113.354 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 18' ' ' GLU . 23.7 p -126.26 -12.41 6.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.705 0.802 . . . . 0.0 111.108 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.1 m-20 -83.83 71.64 10.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.7 t -61.5 174.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.282 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.25 -35.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -69.68 -22.32 63.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.421 1.009 . . . . 0.0 111.355 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -80.95 -36.49 30.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.485 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.8 t -67.13 -37.22 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 C-N-CA 123.936 0.894 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.01 -24.64 66.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.63 -23.51 53.34 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.49 0.586 . . . . 0.0 110.558 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.0 mmtt -72.99 -45.98 54.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.621 0.768 . . . . 0.0 109.282 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.04 -31.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -68.93 -38.65 79.63 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.431 0.292 . . . . 0.0 110.643 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.1 -30.29 68.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.314 0.578 . . . . 0.0 111.341 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -82.63 -22.88 34.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.73 -175.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -138.71 -31.72 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.77 9.56 20.66 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -76.71 130.68 75.67 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.43 153.89 50.33 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.761 2.307 . . . . 0.0 111.045 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.35 -15.45 45.72 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.47 -13.95 60.41 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.803 0.441 . . . . 0.0 112.123 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -125.39 -16.11 5.98 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.26 165.52 18.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.609 1.095 . . . . 0.0 112.795 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -160.23 152.38 20.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 24.0 mt -135.67 146.86 48.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.033 0.379 . . . . 0.0 110.48 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 149.01 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -149.25 139.63 22.38 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 108.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 112.813 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.4 13.76 37.55 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.593 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 160.71 32.38 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.457 1.128 . . . . 0.0 110.043 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -96.7 133.76 40.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.631 -170.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' B' ' 59' ' ' TYR . 22.6 mt -83.25 164.06 20.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.652 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -136.82 153.71 50.72 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-O 121.475 0.655 . . . . 0.0 111.686 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -72.26 0.4 9.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.752 1.221 . . . . 0.0 111.667 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.83 13.73 26.97 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -116.08 -154.14 0.54 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.314 1.045 . . . . 0.0 109.388 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.2 p -148.44 158.34 44.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.71 1.604 . . . . 0.0 107.603 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.1 -24.9 68.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -74.2 -25.78 59.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.361 1.064 . . . . 0.0 111.892 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.68 -15.58 62.22 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.528 . . . . 0.0 111.3 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.439 ' CD2' HD22 ' B' ' 50' ' ' LEU . 22.2 m-85 -125.9 24.13 7.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.315 0.646 . . . . 0.0 110.056 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 p30 47.87 20.49 0.23 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.111 1.764 . . . . 0.0 115.597 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.67 138.04 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.761 0.709 . . . . 0.0 110.188 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -128.41 -173.07 2.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.477 1.111 . . . . 0.0 110.033 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.68 141.74 58.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.801 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 54.68 22.11 3.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.381 1.072 . . . . 0.0 113.428 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -69.99 -15.37 63.02 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -173.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.7 m 57.97 133.71 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.984 2.114 . . . . 0.0 112.615 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -134.72 -177.69 4.73 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.327 1.451 . . . . 0.0 108.238 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -134.49 138.86 45.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.56 131.56 53.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.34 1.456 . . . . 0.0 110.133 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.03 159.63 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.12 165.98 26.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.791 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.23 153.94 29.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.0 109.995 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' B' ' 75' ' ' GLY . 85.0 mt -95.74 23.25 6.37 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.691 1.596 . . . . 0.0 110.261 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? 61.86 -28.18 0.06 Allowed 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 127.053 2.141 . . . . 0.0 112.795 -170.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 137.89 -7.83 3.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.585 -1.675 . . . . 0.0 110.845 179.588 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 494' ' ' GLN . 40.5 Cg_exo -58.7 -171.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.861 3.707 . . . . 0.0 111.225 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 29.56 0.07 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.689 1.195 . . . . 0.0 110.622 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -64.09 -36.89 85.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.31 1.044 . . . . 0.0 112.814 -174.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.63 3.31 1.46 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.88 155.01 92.68 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.85 151.83 7.8 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.917 3.078 . . . . 0.0 111.646 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -75.23 69.1 2.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.961 0.886 . . . . 0.0 112.634 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 162.51 -29.27 0.27 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.03 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.0 165.27 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.604 0.762 . . . . 0.0 109.568 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.78 145.73 36.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.562 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.1 pm0 -60.16 -28.07 67.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.45 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.33 0.72 11.26 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.605 -0.684 . . . . 0.0 111.717 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.25 16.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.359 0.599 . . . . 0.0 110.603 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -17.49 5.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.714 1.206 . . . . 0.0 109.223 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.31 3.3 7.55 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.881 -0.512 . . . . 0.0 111.65 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -85.57 -6.16 59.2 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 508' ' ' LEU . 2.7 mp -93.15 155.91 40.72 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.329 1.451 . . . . 0.0 109.704 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.74 167.58 26.89 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.02 2.48 . . . . 0.0 111.547 170.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.27 -17.54 53.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.431 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.15 3.74 51.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.545 0.338 . . . . 0.0 111.767 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.87 -14.71 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.0 -41.47 67.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.02 -1.1 30.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.628 0.771 . . . . 0.0 112.375 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.93 -18.65 14.95 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.387 0.539 . . . . 0.0 111.306 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.02 -31.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.38 -3.77 15.59 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.806 0.443 . . . . 0.0 110.495 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' SER . . . . . 0.414 ' HA ' ' HE3' ' A' ' 520' ' ' LYS . 50.3 m -131.99 10.86 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 111.41 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.48 -44.8 1.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 518' ' ' SER . 83.3 mttt 49.77 6.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 172.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 33.8 t -161.81 179.55 8.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.351 0.523 . . . . 0.0 109.963 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 70.43 3.04 4.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.116 1.766 . . . . 0.0 112.912 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -154.23 155.14 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.181 0.515 . . . . 0.0 110.931 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -145.55 29.12 1.15 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.54 6.95 4.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 109.851 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.457 -0.095 0 C-N-CA 125.091 1.357 . . . . 0.0 112.119 -176.636 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -158.84 176.04 12.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.867 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.66 177.42 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.3 115.54 17.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.51 126.06 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.0 ttmt -101.94 136.87 41.02 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.022 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.418 ' C ' ' H ' ' B' ' 9' ' ' THR . 73.5 p -86.74 178.66 6.95 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.104 0.962 . . . . 0.0 112.386 -171.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.575 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -70.0 12.96 0.17 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.981 1.312 . . . . 0.0 110.377 174.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.418 ' H ' ' C ' ' B' ' 7' ' ' THR . 28.1 p -126.26 5.68 7.05 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.165 -0.96 . . . . 0.0 111.758 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.57 62.3 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.592 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -125.85 140.44 52.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.493 0.646 . . . . 0.0 110.006 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -106.28 158.47 16.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.097 -175.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.24 125.89 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 19.8 m -75.41 132.28 40.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.4 mt -141.95 131.14 23.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.62 127.87 35.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.42 -179.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.777 0.831 . . . . 0.0 109.731 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 34.9 mt-10 -143.82 164.72 28.36 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 123.874 0.869 . . . . 0.0 108.921 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 32.9 Cg_exo -56.07 1.05 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.169 3.246 . . . . 0.0 113.449 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.409 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.7 m -131.78 -7.06 3.59 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.782 0.719 . . . . 0.0 111.651 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.5 m-20 -80.73 72.14 7.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.6 t -62.82 175.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.704 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.4 -34.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.16 -23.81 63.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.726 1.148 . . . . 0.0 111.139 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.12 -38.33 27.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.469 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 81.8 t -66.85 -37.88 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 123.695 0.798 . . . . 0.0 109.867 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -61.99 -23.52 66.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.039 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 -22.68 52.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.459 0.572 . . . . 0.0 110.541 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 64.7 mmtt -73.55 -48.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.62 0.768 . . . . 0.0 109.862 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.62 -30.8 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -69.46 -40.04 77.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.28 -0.262 . . . . 0.0 110.66 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.68 -30.76 70.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.463 0.649 . . . . 0.0 111.456 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -80.82 -25.1 38.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.926 -1.033 . . . . 0.0 113.449 -175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -138.03 -33.65 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.68 8.97 15.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.93 127.51 86.77 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.3 153.72 61.54 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.645 2.23 . . . . 0.0 110.693 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.59 -17.88 48.41 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 110.885 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.69 -5.34 58.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.46 -15.52 6.61 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.27 165.86 17.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.682 1.128 . . . . 0.0 112.413 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.471 ' C ' HD12 ' B' ' 44' ' ' ILE . 15.8 mt -129.17 138.62 51.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 110.785 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.471 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.5 mp -131.91 148.33 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.432 1.093 . . . . 0.0 108.585 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.16 141.19 23.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.065 0.946 . . . . 0.0 109.228 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.65 12.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.752 0.821 . . . . 0.0 112.608 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.51 14.63 40.37 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.458 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 158.84 37.98 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.833 1.316 . . . . 0.0 109.964 173.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -95.82 132.83 40.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.812 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.476 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.5 mt -80.23 159.79 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.156 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -128.86 150.06 50.5 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.513 0.673 . . . . 0.0 111.901 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -66.63 -18.71 65.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.737 1.215 . . . . 0.0 111.944 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.19 15.18 63.52 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -122.86 -151.56 0.48 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.429 1.091 . . . . 0.0 109.67 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 34.2 p -154.67 161.27 41.63 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.138 1.375 . . . . 0.0 108.881 174.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.54 -28.44 67.1 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.614 0.188 . . . . 0.0 111.226 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 31.0 t -75.47 -25.56 57.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.741 0.416 . . . . 0.0 110.736 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.45 -12.96 62.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.471 0.308 . . . . 0.0 111.369 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -116.39 19.45 14.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 p30 49.14 20.27 0.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.71 144.67 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 118.036 0.38 . . . . 0.0 110.043 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -130.14 -176.76 4.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.035 0.934 . . . . 0.0 109.963 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.93 146.8 54.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.24 16.82 7.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.298 1.039 . . . . 0.0 112.415 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -70.56 175.08 5.1 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -129.6 132.37 46.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.704 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -130.61 -177.1 4.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.473 1.109 . . . . 0.0 108.782 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -135.32 136.94 41.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.42 HD13 ' C ' ' B' ' 69' ' ' LEU . 3.0 tm? -124.16 131.87 53.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 0.0 109.566 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -142.65 166.13 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.84 172.39 13.4 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.12 178.71 5.79 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.257 1.023 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.644 HD23 ' H ' ' B' ' 73' ' ' LEU . 0.9 OUTLIER -132.42 17.97 4.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.327 1.451 . . . . 0.0 109.041 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 50.52 -55.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.499 2.72 . . . . 0.0 115.645 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.18 -12.64 1.24 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 117.33 -1.816 . . . . 0.0 110.774 179.513 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 494' ' ' GLN . 85.6 Cg_endo -77.04 -162.95 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 1 C-N-CA 125.341 4.027 . . . . 0.0 108.969 175.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.3 pt? -67.68 25.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.0 pp0? -66.3 -24.44 66.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.66 1.184 . . . . 0.0 112.75 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.01 7.11 1.6 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.72 160.34 27.93 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 158.36 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 124.011 3.141 . . . . 0.0 111.549 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.18 66.89 3.88 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.849 0.833 . . . . 0.0 112.695 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 156.44 -23.94 0.51 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.54 168.04 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.679 0.792 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.9 157.11 45.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.677 0.791 . . . . 0.0 110.563 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -61.19 -46.77 89.12 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.135 0.574 . . . . 0.0 110.692 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.94 7.87 0.84 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.63 10.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.425 0.69 . . . . 0.0 111.257 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.84 -10.54 7.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.668 0.787 . . . . 0.0 109.936 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.52 17.7 4.39 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 111.339 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -89.53 6.35 41.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.645 0.778 . . . . 0.0 110.95 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.31 62.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.925 0.89 . . . . 0.0 110.938 -170.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.35 166.4 23.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.303 3.335 . . . . 0.0 113.028 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -26.69 63.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.043 0.937 . . . . 0.0 111.832 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.07 -4.8 49.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.316 0.246 . . . . 0.0 111.447 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.14 -12.88 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.253 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 26.5 mm-40 -56.02 -40.73 73.86 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.64 -14.12 62.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.374 0.67 . . . . 0.0 112.412 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -89.96 -21.5 22.4 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.201 0.455 . . . . 0.0 111.464 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.43 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 53.0 mt -65.97 -0.05 2.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.1 m -133.76 17.58 3.89 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.792 1.237 . . . . 0.0 110.126 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -98.74 35.92 4.34 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.376 0.989 . . . . 0.0 111.38 -177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 0.37 0.06 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -177.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.9 t -149.56 173.05 14.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.497 0.719 . . . . 0.0 110.069 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.11 7.49 2.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.14 1.776 . . . . 0.0 113.682 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -155.39 150.88 27.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.385 0.539 . . . . 0.0 111.576 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.06 35.65 1.11 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.596 1.158 . . . . 0.0 109.383 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.62 4.46 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.122 0.969 . . . . 0.0 110.765 -172.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.87 1.268 . . . . 0.0 111.969 -176.673 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.637 0.256 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.75 174.75 14.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.831 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.29 -178.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 123.768 0.827 . . . . 0.0 109.029 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -134.83 106.23 6.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -97.45 112.79 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -92.62 129.81 38.44 Favored 'General case' 0 C--O 1.23 0.047 0 O-C-N 122.258 -0.276 . . . . 0.0 111.392 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.427 ' C ' ' H ' ' B' ' 9' ' ' THR . 74.4 p -78.65 177.89 8.26 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.591 1.156 . . . . 0.0 112.354 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.436 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -70.88 17.78 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.947 1.299 . . . . 0.0 110.425 175.241 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.427 ' H ' ' C ' ' B' ' 7' ' ' THR . 49.6 p -133.15 6.35 3.88 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 121.226 -0.921 . . . . 0.0 111.911 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.57 26.78 58.43 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 122.208 -0.307 . . . . 0.0 112.55 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -124.71 143.65 50.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.755 0.822 . . . . 0.0 108.877 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.12 159.12 26.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.585 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.02 130.4 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -79.63 131.9 36.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -143.4 133.56 24.4 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.754 0.252 . . . . 0.0 110.602 -173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -92.91 128.66 38.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.48 175.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.167 0.987 . . . . 0.0 109.534 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -135.49 160.84 66.32 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 124.259 1.023 . . . . 0.0 109.108 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.33 3.67 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.585 2.857 . . . . 0.0 113.502 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 18' ' ' GLU . 29.8 p -125.74 -6.7 6.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.861 0.864 . . . . 0.0 110.874 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -86.5 78.6 9.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.3 t -63.59 172.19 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.811 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' B' ' 26' ' ' VAL . 16.6 mm -55.05 -27.59 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -67.68 -20.24 65.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 120.644 -1.285 . . . . 0.0 110.645 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.67 -45.25 12.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 110.167 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.1 m -66.36 -33.52 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 123.193 0.597 . . . . 0.0 110.93 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.429 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.0 mttt -56.77 -32.11 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.862 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -27.39 46.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.251 0.478 . . . . 0.0 110.924 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -67.57 -32.59 73.45 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.187 0.449 . . . . 0.0 109.932 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -83.91 -31.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.17 -39.97 86.53 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.8 0.334 . . . . 0.0 110.273 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.18 -31.41 71.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.206 0.527 . . . . 0.0 111.183 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.6 -24.79 31.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.663 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -135.31 -35.04 0.84 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.83 7.86 16.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -77.87 128.26 79.65 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.57 154.8 55.09 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.053 2.502 . . . . 0.0 111.373 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.63 -14.41 41.92 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.352 2.701 . . . . 0.0 110.227 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.52 -8.02 59.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -124.84 -18.79 5.46 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.26 162.15 20.68 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.517 1.053 . . . . 0.0 112.167 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -151.58 136.15 17.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.438 ' C ' HD12 ' B' ' 44' ' ' ILE . 41.2 tp -134.18 136.23 43.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.241 0.473 . . . . 0.0 111.141 -168.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.438 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -132.52 150.74 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.266 1.026 . . . . 0.0 108.909 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -150.47 143.1 24.54 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.468 1.107 . . . . 0.0 109.287 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.94 13.42 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.545 0.738 . . . . 0.0 112.585 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.26 15.77 43.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.32 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 158.97 40.16 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.653 1.226 . . . . 0.0 109.966 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -90.74 150.32 21.67 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.811 -172.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' B' ' 59' ' ' TYR . 15.4 mt -106.93 162.7 13.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.162 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -133.1 148.5 52.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.091 0.948 . . . . 0.0 112.542 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.51 -1.81 9.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.284 1.034 . . . . 0.0 111.905 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.47 6.2 33.71 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -107.65 -147.97 0.41 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.367 0.584 . . . . 0.0 109.699 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.509 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.2 p -152.13 155.94 38.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.85 2.06 . . . . 0.0 107.743 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.31 -24.04 67.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.185 0.448 . . . . 0.0 110.05 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -71.19 -25.32 62.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.25 1.02 . . . . 0.0 111.494 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.11 -13.99 60.19 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.101 0.56 . . . . 0.0 111.531 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.526 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -115.06 20.7 14.83 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.29 21.21 0.34 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.83 140.11 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-O 121.213 0.53 . . . . 0.0 110.271 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.39 -173.93 3.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.912 1.285 . . . . 0.0 109.343 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.86 142.97 58.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.081 0.467 . . . . 0.0 110.717 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 54.29 25.26 5.71 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.173 0.989 . . . . 0.0 113.11 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.52 -15.44 60.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 60.11 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.34 1.856 . . . . 0.0 112.955 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.61 -178.12 4.86 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.377 1.471 . . . . 0.0 108.719 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -135.54 120.78 18.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.519 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 35.8 tp -103.25 136.03 43.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.729 1.212 . . . . 0.0 110.088 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.67 169.29 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.75 170.1 18.96 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.416 -0.803 . . . . 0.0 111.566 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.23 -177.2 5.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.795 0.838 . . . . 0.0 110.644 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.59 18.34 3.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 56.79 -45.46 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.374 2.67 . . . . 0.0 114.799 -169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.69 -12.5 1.32 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 117.247 -1.863 . . . . 0.0 110.809 179.805 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 494' ' ' GLN . 58.5 Cg_endo -84.63 -159.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 1 C-N-CA 125.575 4.184 . . . . 0.0 108.073 174.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.429 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.1 pt? -67.14 27.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.0 pp0? -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 0.0 113.084 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.54 5.92 1.84 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.85 138.48 93.66 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.17 159.99 11.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.793 2.995 . . . . 0.0 111.387 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.16 56.76 2.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.174 0.988 . . . . 0.0 109.903 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 176.24 27.75 0.03 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.423 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.95 162.34 13.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 124.128 0.971 . . . . 0.0 108.498 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.07 156.6 47.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 110.259 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -59.52 -40.64 87.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.055 0.542 . . . . 0.0 109.893 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.36 1.56 2.16 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.25 13.51 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 122.039 -0.413 . . . . 0.0 111.202 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.558 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.4 OUTLIER -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.288 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -73.66 -8.11 54.66 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.689 -0.632 . . . . 0.0 110.474 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -88.18 -5.74 58.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.544 1.138 . . . . 0.0 110.206 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 48.1 mt -87.1 155.81 54.92 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 123.976 0.91 . . . . 0.0 109.934 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.7 162.52 37.57 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.879 2.386 . . . . 0.0 110.811 169.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.09 -15.5 23.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.513 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -96.9 0.88 49.77 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.092 0.405 . . . . 0.0 111.343 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.2 mt -114.97 -19.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.081 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.698 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -48.89 -54.59 14.76 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.38 -11.72 3.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' GLU . . . . . 0.424 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 7.8 mm-40 -91.8 -25.28 19.09 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.103 0.41 . . . . 0.0 110.498 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' ILE . . . . . 0.438 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 3.3 mm -95.72 -38.06 8.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 118.364 0.529 . . . . 0.0 109.691 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -68.83 -10.66 58.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 22.7 t -63.97 -55.78 19.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.359 0.664 . . . . 0.0 110.847 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 135.21 133.96 3.32 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 516' ' ' ILE . 59.3 mttm -143.14 158.43 43.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.088 0.955 . . . . 0.0 109.127 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.2 m -146.88 30.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.22 1.008 . . . . 0.0 113.003 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.34 15.78 2.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.973 1.309 . . . . 0.0 111.631 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 523' ' ' GLU . 1.0 OUTLIER -139.08 151.8 47.03 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.218 1.007 . . . . 0.0 109.441 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -148.59 27.97 0.89 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.3 0.64 . . . . 0.0 111.459 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.276 3.9 pp 48.13 12.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.722 1.609 . . . . 0.0 114.041 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 126.334 1.854 . . . . 0.0 111.606 178.64 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -158.8 174.08 15.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.166 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.58 179.22 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.45 99.62 4.72 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.55 124.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.1 ttmt -108.41 135.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.025 0.44 . . . . 0.0 111.455 -173.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -72.58 171.83 11.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.208 1.003 . . . . 0.0 112.436 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.58 -1.66 3.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.791 1.236 . . . . 0.0 110.336 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.9 p -115.93 -5.76 12.02 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.725 -0.609 . . . . 0.0 112.567 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.89 19.59 14.8 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.549 -0.584 . . . . 0.0 113.89 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -121.17 137.55 54.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.835 0.817 . . . . 0.0 109.744 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.4 OUTLIER -106.86 159.67 16.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.05 -174.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.72 127.22 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -78.67 132.84 37.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -143.96 132.98 22.8 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.655 0.264 . . . . 0.0 110.392 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.01 128.66 37.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 179.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.493 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.0 mm-40 -131.57 160.09 68.9 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.65 1.07 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.129 2.553 . . . . 0.0 113.5 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.6 m -125.27 -2.21 7.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.609 0.641 . . . . 0.0 111.067 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -80.25 68.04 6.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.511 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 2.9 t -57.4 173.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.877 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.662 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 14.1 mm -51.89 -28.29 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -168.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -73.37 -19.93 60.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.512 1.051 . . . . 0.0 111.435 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -85.35 -45.6 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.611 0.764 . . . . 0.0 110.834 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.1 OUTLIER -66.46 -28.31 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 122.667 0.387 . . . . 0.0 110.521 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.1 mttt -58.11 -29.9 65.86 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.862 172.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.95 41.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.957 0.344 . . . . 0.0 111.042 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.46 -31.19 71.78 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.074 0.397 . . . . 0.0 109.99 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.14 -30.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.65 -40.03 84.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.792 0.33 . . . . 0.0 110.204 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.72 -32.72 74.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.3 0.571 . . . . 0.0 111.223 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -82.02 -24.46 35.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.98 -34.52 0.8 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.08 8.12 15.73 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.5 mt -75.7 128.9 82.79 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.56 152.79 70.38 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.664 2.243 . . . . 0.0 111.071 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.98 -15.3 36.23 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.379 2.719 . . . . 0.0 110.566 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.84 -7.97 59.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -124.23 -15.72 6.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -65.52 164.9 13.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.139 0.881 . . . . 0.0 112.299 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -152.89 135.42 15.18 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 36.7 tp -131.83 138.11 48.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 118.568 0.622 . . . . 0.0 110.917 -168.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -134.93 149.18 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.306 1.043 . . . . 0.0 109.047 -172.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -153.2 146.57 24.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.016 0.926 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 15.2 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.195 0.598 . . . . 0.0 111.848 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.39 56.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.417 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 158.4 40.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.535 1.167 . . . . 0.0 109.87 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.92 144.47 26.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.721 -1.127 . . . . 0.0 107.98 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 17.2 mt -101.33 159.5 15.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.767 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -125.32 144.97 50.24 Favored 'General case' 0 CA--C 1.524 -0.054 0 CA-C-O 121.357 0.599 . . . . 0.0 112.085 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.64 -0.66 7.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.555 1.142 . . . . 0.0 111.827 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.76 11.57 38.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.79 -149.19 0.44 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 109.298 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -153.17 157.91 41.0 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.861 1.665 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.81 -28.96 69.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -68.4 -26.04 65.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.828 1.251 . . . . 0.0 111.779 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -75.13 -12.12 60.24 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.057 0.543 . . . . 0.0 111.603 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.29 17.74 14.62 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.89 27.39 1.59 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.637 1.575 . . . . 0.0 114.408 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.84 141.24 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -129.81 -174.03 3.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.696 1.199 . . . . 0.0 109.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.39 143.56 57.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.642 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 54.35 24.3 5.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.924 0.89 . . . . 0.0 113.244 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -72.4 -16.81 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.0 m 60.0 132.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.316 1.846 . . . . 0.0 112.674 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.62 -179.7 5.62 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.709 1.204 . . . . 0.0 108.776 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -135.64 122.51 21.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 110.72 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.09 140.46 36.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.107 1.363 . . . . 0.0 110.064 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.87 162.86 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.86 171.66 16.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.658 -0.651 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -91.25 174.9 7.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.429 0.692 . . . . 0.0 110.116 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -122.14 25.5 8.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.518 0.727 . . . . 0.0 110.268 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 66.01 -25.33 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 113.61 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -139.68 8.87 3.11 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 176.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 117.287 -1.84 . . . . 0.0 111.065 179.162 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 494' ' ' GLN . 71.6 Cg_endo -76.72 -167.1 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 1 C-N-CA 125.686 4.258 . . . . 0.0 109.862 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 32.09 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.866 1.267 . . . . 0.0 112.737 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -69.63 -35.39 75.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.013 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.73 4.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.351 0.661 . . . . 0.0 112.123 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' LEU . . . . . 0.408 HD21 ' CZ ' ' A' ' 505' ' ' PHE . 99.0 mt -68.98 160.98 75.78 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 122.755 0.422 . . . . 0.0 109.923 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.62 147.77 38.09 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.785 2.99 . . . . 0.0 111.642 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.83 54.69 1.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.292 1.044 . . . . 0.0 110.257 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.67 25.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.165 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 45.0 t -136.47 162.02 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 118.357 1.079 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -121.67 143.65 49.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.264 0.626 . . . . 0.0 109.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -68.96 -32.44 72.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.645 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.87 10.63 1.73 Allowed 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.303 -0.873 . . . . 0.0 110.575 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 504' ' ' VAL . 83.1 t -129.86 8.52 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.585 1.154 . . . . 0.0 109.827 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 496' ' ' LEU . 0.0 OUTLIER -137.14 -23.37 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.247 -0.908 . . . . 0.0 112.738 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -69.47 -9.15 52.51 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.479 -0.763 . . . . 0.0 112.1 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 507' ' ' GLN . 10.1 mp0 -80.74 -11.0 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.945 0.339 . . . . 0.0 110.803 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.21 150.59 68.27 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.125 0.97 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.37 163.38 26.83 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.565 2.177 . . . . 0.0 111.165 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.54 -23.59 64.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.287 0.635 . . . . 0.0 112.117 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.66 -1.22 56.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 122.352 0.261 . . . . 0.0 111.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 33.1 mt -117.44 -13.88 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -55.24 -43.56 74.67 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.81 -5.74 40.15 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.387 0.675 . . . . 0.0 112.469 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.63 -17.41 17.04 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.254 0.479 . . . . 0.0 111.967 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.77 -28.47 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.61 -3.8 2.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.891 0.476 . . . . 0.0 110.049 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 52.5 m -137.24 17.51 2.97 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.725 1.21 . . . . 0.0 110.709 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -115.34 43.8 1.61 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.67 0.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.0 t -145.23 178.23 8.23 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.514 0.726 . . . . 0.0 110.232 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.21 2.03 3.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.822 1.649 . . . . 0.0 112.958 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.42 141.2 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.175 0.443 . . . . 0.0 110.726 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 526' ' ' LYS . 34.4 m-80 -144.18 36.67 1.24 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.429 0.692 . . . . 0.0 110.244 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 525' ' ' LEU 0.335 0.5 OUTLIER 56.84 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.387 1.875 . . . . 0.0 114.715 -177.486 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 C-N-CA 125.082 1.353 . . . . 0.0 110.352 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.277 0.084 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -157.2 173.23 17.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.05 179.98 3.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 123.823 0.849 . . . . 0.0 109.114 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -131.93 101.29 5.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.51 104.62 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -90.99 135.59 33.64 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.675 0.39 . . . . 0.0 112.02 -172.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.7 p -77.62 173.1 12.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.634 0.774 . . . . 0.0 111.973 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.94 -22.85 63.0 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.168 0.987 . . . . 0.0 110.321 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -94.61 -5.08 46.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.767 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.17 25.38 14.39 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.579 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -120.8 144.27 48.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.14 159.75 24.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 111.439 -173.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 mt -129.74 131.98 66.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 42.8 m -84.01 133.94 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.1 mt -145.39 138.29 26.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.26 127.3 44.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.9 176.73 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.069 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.54 161.87 60.56 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 108.795 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.63 1.59 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.293 2.662 . . . . 0.0 113.593 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -127.17 -5.89 6.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.586 0.63 . . . . 0.0 110.846 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -83.4 71.29 10.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.5 t -63.68 176.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.686 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.456 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.3 mm -51.55 -35.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -168.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.1 -20.71 65.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.296 0.953 . . . . 0.0 111.03 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -84.79 -42.73 14.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.49 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.382 1.073 . . . . 0.0 110.4 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.456 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.6 mttt -56.22 -23.61 36.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.945 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -27.11 31.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.35 0.523 . . . . 0.0 110.592 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.23 -36.43 77.2 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.052 0.387 . . . . 0.0 110.129 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -83.09 -32.43 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.07 -38.36 85.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.2 -32.56 72.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.295 0.569 . . . . 0.0 111.399 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -80.53 -24.75 39.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.205 1.002 . . . . 0.0 113.472 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.71 -31.26 0.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.58 9.44 23.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.06 131.24 76.14 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.51 157.57 61.28 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.427 2.085 . . . . 0.0 111.03 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.1 -11.07 30.8 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.868 3.045 . . . . 0.0 112.045 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.34 -5.5 29.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -126.11 3.54 7.18 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.5 -54.47 19.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 60.6 82.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.506 1.922 . . . . 0.0 110.919 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' B' ' 44' ' ' ILE . 26.2 tp -90.1 137.09 32.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.573 1.149 . . . . 0.0 111.173 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.513 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.0 mp -133.42 149.93 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.551 1.14 . . . . 0.0 108.881 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -153.62 149.85 28.02 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.035 0.934 . . . . 0.0 109.378 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.17 16.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.626 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.38 56.42 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.124 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 160.5 37.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.449 1.125 . . . . 0.0 110.759 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.67 124.42 38.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.521 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -79.49 164.25 24.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.524 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -126.79 147.86 49.98 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.4 0.619 . . . . 0.0 111.89 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.13 -1.91 16.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.11 0.964 . . . . 0.0 111.996 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.09 14.64 44.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -120.29 -149.84 0.44 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.578 1.151 . . . . 0.0 108.988 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.95 156.84 39.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 126.068 1.747 . . . . 0.0 108.903 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -60.57 -24.41 65.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -73.31 -25.03 60.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 111.41 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -75.57 -14.07 60.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.161 0.584 . . . . 0.0 111.818 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -115.74 21.18 14.1 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 p30 49.49 19.46 0.37 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.7 138.66 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 121.338 0.589 . . . . 0.0 110.56 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -130.38 -177.52 4.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.966 1.306 . . . . 0.0 108.871 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -60.61 145.16 49.97 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.022 0.439 . . . . 0.0 110.778 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 55.66 22.78 5.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.212 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -74.4 -14.23 60.83 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 74.9 m 61.16 130.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.187 1.795 . . . . 0.0 112.11 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.88 -179.9 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.601 1.16 . . . . 0.0 108.687 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -135.59 152.77 51.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -140.14 138.47 35.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.464 1.106 . . . . 0.0 108.528 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.91 68.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.89 163.88 1.78 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -72.61 -168.75 0.47 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.319 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' B' ' 75' ' ' GLY . 13.8 tp -101.97 17.38 23.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.5 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 62.67 -27.3 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.155 2.182 . . . . 0.0 114.416 -175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 148.38 -14.06 1.24 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.444 -1.753 . . . . 0.0 111.164 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 494' ' ' GLN . 96.2 Cg_endo -81.31 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 1 C-N-CA 125.47 4.113 . . . . 0.0 109.023 178.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.93 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.326 1.85 . . . . 0.0 113.181 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.7 pp0? -71.75 -27.2 62.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.052 0.941 . . . . 0.0 112.291 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -150.17 4.41 0.54 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 505' ' ' PHE . 4.2 mm? -61.75 142.87 94.49 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.253 0.479 . . . . 0.0 110.273 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.04 157.45 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.051 3.167 . . . . 0.0 111.226 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.12 57.41 2.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 122.52 1.153 . . . . 0.0 110.08 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.71 26.7 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.829 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 501' ' ' ASP . 60.5 t -147.44 164.34 6.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.693 0.747 . . . . 0.0 109.156 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 500' ' ' VAL . 6.2 t70 -134.45 144.0 47.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.0 109.419 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.549 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.5 OUTLIER -61.0 -28.82 69.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.491 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -71.38 -0.9 11.28 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.694 -0.629 . . . . 0.0 111.824 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.84 18.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.626 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.0 OUTLIER -124.85 -20.93 4.86 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.24 1.016 . . . . 0.0 110.081 176.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -71.61 5.84 2.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -87.87 7.72 29.4 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.755 0.822 . . . . 0.0 110.578 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 39.1 mt -116.02 157.33 45.26 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 124.204 1.002 . . . . 0.0 111.258 -171.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.94 163.31 35.67 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.857 2.371 . . . . 0.0 110.373 167.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.19 -18.4 36.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.192 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.04 -4.93 58.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.103 0.561 . . . . 0.0 111.429 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.5 mt -117.32 -15.9 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.684 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -51.61 -50.72 59.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.86 -14.1 13.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.06 -18.35 27.47 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.641 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.5 mm -104.37 -40.93 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' LEU . . . . . 0.684 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -64.62 -10.58 27.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.0 t -58.28 -35.71 72.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.113 0.565 . . . . 0.0 111.123 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 105.5 38.88 2.33 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -58.44 172.07 0.52 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.754 1.222 . . . . 0.0 111.912 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.4 m -146.37 34.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.759 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.6 15.63 4.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.745 1.218 . . . . 0.0 111.375 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.52 143.46 26.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.043 0.937 . . . . 0.0 109.176 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -148.77 38.4 0.83 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.217 0.607 . . . . 0.0 112.149 -168.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.41 19.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.804 1.642 . . . . 0.0 114.197 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -176.662 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.51 173.33 16.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.413 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.39 179.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 123.139 0.576 . . . . 0.0 109.774 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -133.18 106.28 7.49 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.43 69.39 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.908 0.483 . . . . 0.0 111.284 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -58.68 133.25 55.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.901 0.481 . . . . 0.0 111.519 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.39 175.58 10.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.459 ' O ' HD13 ' B' ' 8' ' ' LEU . 3.2 tm? -64.59 -23.44 67.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.354 0.662 . . . . 0.0 110.228 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.2 p -89.32 -22.07 22.83 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.905 -0.497 . . . . 0.0 110.39 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.52 4.69 21.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.021 0.368 . . . . 0.0 114.021 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -83.57 153.81 24.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.97 159.17 38.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.742 0.701 . . . . 0.0 109.398 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.77 126.75 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m -79.26 129.96 34.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -140.59 133.36 28.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.21 129.22 39.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.43 178.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.864 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.1 mm-40 -132.66 161.5 63.0 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.964 0.906 . . . . 0.0 108.579 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.7 3.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.98 2.453 . . . . 0.0 113.429 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 18' ' ' GLU . 59.8 m -125.79 -4.12 7.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.739 0.7 . . . . 0.0 110.825 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.1 76.92 10.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.2 t -62.34 171.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.8 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.582 ' HA ' HG22 ' B' ' 26' ' ' VAL . 12.2 mm -55.31 -28.04 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -168.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.1 -19.51 65.65 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.87 -1.144 . . . . 0.0 110.427 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -85.12 -46.11 11.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.853 0.861 . . . . 0.0 110.079 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' B' ' 23' ' ' ILE . 2.8 m -66.43 -34.48 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.118 0.567 . . . . 0.0 110.973 -173.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -56.33 -31.99 64.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.165 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.82 47.86 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.386 0.539 . . . . 0.0 110.856 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -68.1 -33.28 74.23 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.987 0.358 . . . . 0.0 110.086 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.77 -31.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.76 -39.4 87.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 -31.53 71.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.333 0.587 . . . . 0.0 111.275 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -83.95 -22.2 31.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -139.67 -30.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.53 8.26 19.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -76.17 128.56 82.56 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.67 154.8 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.493 2.128 . . . . 0.0 110.771 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.71 -14.19 38.71 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.543 2.829 . . . . 0.0 110.94 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.47 -6.21 58.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -118.99 -18.13 8.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.85 162.68 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.45 1.023 . . . . 0.0 112.339 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -155.03 128.76 8.62 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.439 ' C ' HD12 ' B' ' 44' ' ' ILE . 52.0 tp -133.36 128.73 36.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.893 0.315 . . . . 0.0 110.984 -168.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.439 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.4 mp -122.77 155.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -120.96 -111.69 0.33 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 122.695 0.398 . . . . 0.0 110.685 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.85 -4.9 3.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.302 0.641 . . . . 0.0 111.689 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.97 1.69 2.0 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.596 1.093 . . . . 0.0 111.519 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 154.71 33.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.704 0.764 . . . . 0.0 109.554 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.97 129.95 35.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.348 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.459 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.0 mt -77.68 162.67 26.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.83 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -127.98 146.92 50.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.432 0.634 . . . . 0.0 111.706 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.45 -1.33 10.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.438 1.095 . . . . 0.0 111.798 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 16.05 35.13 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -121.34 -148.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.307 1.043 . . . . 0.0 109.45 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.3 p -152.36 156.19 39.08 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 126.257 1.823 . . . . 0.0 108.357 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.04 -23.99 66.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -71.88 -25.29 61.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.281 1.032 . . . . 0.0 111.545 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.43 -12.88 60.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.098 0.559 . . . . 0.0 111.515 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.09 20.77 13.61 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.7 25.21 0.4 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.12 142.4 16.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.171 0.51 . . . . 0.0 110.112 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -130.39 -173.47 3.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.058 1.343 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.89 142.54 58.24 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.0 110.409 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 55.92 21.2 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.252 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -71.85 -16.61 62.15 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 84.4 m 62.33 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.16 1.784 . . . . 0.0 112.226 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -145.47 -176.48 5.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.728 1.211 . . . . 0.0 108.708 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -136.48 104.98 5.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.37 129.77 36.23 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.694 0.798 . . . . 0.0 109.146 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.24 52.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.431 0.634 . . . . 0.0 109.378 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.85 168.88 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 114.209 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -94.47 172.28 8.29 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.498 0.719 . . . . 0.0 109.802 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.9 26.31 9.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.948 1.299 . . . . 0.0 111.734 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -48.42 -33.2 8.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.376 1.07 . . . . 0.0 112.504 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.64 -15.66 7.98 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.326 -178.091 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 494' ' ' GLN . 87.6 Cg_endo -77.58 -167.61 0.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.95 3.766 . . . . 0.0 108.319 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.447 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.2 pt? -65.26 26.92 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -65.43 -28.91 69.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.471 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -148.09 6.39 0.78 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.79 159.38 85.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.59 155.0 22.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.853 3.035 . . . . 0.0 111.954 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -83.69 55.31 3.18 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 122.423 1.106 . . . . 0.0 109.509 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.74 26.5 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.995 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 501' ' ' ASP . 86.4 t -146.74 164.35 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ASP . . . . . 0.425 ' N ' HG12 ' A' ' 500' ' ' VAL . 20.8 m-20 -135.49 143.13 45.66 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.036 0.934 . . . . 0.0 108.751 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.682 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.9 pm0 -65.54 -24.11 67.03 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.94 1.84 4.09 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.737 -0.602 . . . . 0.0 111.601 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.53 11.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.672 0.789 . . . . 0.0 110.647 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -17.72 7.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.985 0.914 . . . . 0.0 109.875 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.72 3.15 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.957 -0.465 . . . . 0.0 111.345 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.65 -5.12 58.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 512' ' ' ILE . 4.1 mp -93.04 159.31 35.88 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.179 1.392 . . . . 0.0 110.128 -173.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.22 165.48 31.81 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.295 2.663 . . . . 0.0 111.325 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.75 -12.51 10.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.027 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.5 1.17 40.81 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.058 0.543 . . . . 0.0 111.43 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.447 HG22 HD23 ' A' ' 508' ' ' LEU . 52.0 mt -119.16 -14.48 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -43.91 67.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 169.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.74 -4.42 37.43 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.424 0.689 . . . . 0.0 112.388 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -100.12 -21.64 15.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.501 0.591 . . . . 0.0 111.433 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.69 -34.41 4.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.64 -3.35 3.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.667 0.387 . . . . 0.0 110.516 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 41.5 m -137.44 18.32 2.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.361 0.664 . . . . 0.0 111.409 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.54 -39.51 5.29 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp 49.43 1.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.7 t -167.76 -172.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.981 0.809 . . . . 0.0 109.818 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 68.0 11.56 8.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.469 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -153.92 154.34 33.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.559 0.343 . . . . 0.0 110.854 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.408 ' C ' HD23 ' A' ' 525' ' ' LEU . 60.7 m-80 -149.72 46.93 0.94 Allowed 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.856 0.863 . . . . 0.0 110.795 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 524' ' ' ASN . 1.1 pt? 44.14 19.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.961 1.704 . . . . 0.0 113.95 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.944 1.297 . . . . 0.0 112.625 -177.318 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -158.44 173.66 16.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.094 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.78 179.28 4.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -134.69 103.27 5.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.58 113.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.42 130.8 37.99 Favored 'General case' 0 N--CA 1.458 -0.052 0 O-C-N 122.205 -0.31 . . . . 0.0 111.222 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -72.3 174.37 7.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.417 1.087 . . . . 0.0 112.058 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.523 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.7 tm? -66.12 -5.02 8.56 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.073 0.949 . . . . 0.0 110.17 174.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -112.97 1.36 15.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.556 -0.715 . . . . 0.0 111.528 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.28 26.05 31.86 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.606 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -123.56 145.01 49.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.17 159.94 21.82 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.434 -174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -129.45 127.69 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -77.81 130.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.405 ' CD2' ' HG3' ' B' ' 33' ' ' LYS . 60.0 mt -140.67 131.23 25.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.11 127.32 35.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.622 0.769 . . . . 0.0 108.998 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.1 178.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.183 0.993 . . . . 0.0 109.444 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.8 mt-10 -141.45 163.81 39.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.19 2.25 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.531 2.821 . . . . 0.0 113.62 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.7 m -129.42 -5.64 4.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.058 0.845 . . . . 0.0 111.215 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 26.4 m-20 -82.89 68.32 9.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 9.2 t -61.25 179.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.921 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.597 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.4 mm -59.24 -11.91 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -168.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.85 -17.96 28.62 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.815 1.189 . . . . 0.0 110.483 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -85.02 -40.82 16.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.537 0.735 . . . . 0.0 109.993 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' B' ' 23' ' ' ILE . 20.4 m -64.36 -31.11 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 123.728 0.811 . . . . 0.0 110.155 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.53 -25.28 66.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.83 -26.44 29.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.314 0.507 . . . . 0.0 110.821 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -70.34 -36.5 74.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.096 0.407 . . . . 0.0 110.392 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -81.76 -30.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -68.16 -39.73 82.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.24 -31.21 71.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.246 0.545 . . . . 0.0 111.348 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' B' ' 15' ' ' LEU . 38.8 mmtm -82.5 -24.2 34.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.57 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -136.77 -33.82 0.77 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 9.52 17.66 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.8 mt -76.64 129.87 78.15 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.83 156.1 61.18 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 111.055 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.1 -14.14 40.01 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.967 3.111 . . . . 0.0 110.804 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -90.45 -3.0 57.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -123.91 -11.81 7.59 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.88 167.64 21.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.103 0.865 . . . . 0.0 112.464 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -158.67 134.55 8.95 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.93 1.292 . . . . 0.0 108.002 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.51 ' C ' HD12 ' B' ' 44' ' ' ILE . 16.7 mt -126.47 141.49 51.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.531 0.333 . . . . 0.0 110.43 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.51 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -129.31 148.72 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -148.36 134.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.833 0.853 . . . . 0.0 109.009 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.93 19.87 0.71 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.556 0.742 . . . . 0.0 112.827 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.59 25.37 39.17 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 123.04 0.352 . . . . 0.0 112.749 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.8 ttmm -123.37 125.59 45.28 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.119 0.568 . . . . 0.0 110.756 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -76.57 110.8 11.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.598 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -68.63 171.11 8.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -174.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -132.52 152.85 51.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.676 0.751 . . . . 0.0 112.004 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.88 -1.82 15.67 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.455 1.102 . . . . 0.0 111.892 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.28 15.06 36.23 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -117.88 -154.7 0.57 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.326 1.05 . . . . 0.0 109.16 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.7 p -149.64 159.67 44.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.599 1.56 . . . . 0.0 107.9 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.62 -27.27 69.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -71.25 -25.75 62.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.34 1.056 . . . . 0.0 112.143 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.95 -16.94 61.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.828 0.451 . . . . 0.0 111.323 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.599 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.1 m-85 -128.64 26.87 5.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.187 0.595 . . . . 0.0 110.065 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.84 28.47 0.59 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.82 132.91 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.8 -173.11 3.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 109.747 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.12 142.24 37.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.093 0.473 . . . . 0.0 111.264 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 52.97 27.14 5.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.806 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.9 p -69.59 -24.96 63.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m 59.99 127.65 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.019 2.128 . . . . 0.0 112.161 -174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -131.29 -176.83 4.15 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.094 1.358 . . . . 0.0 108.238 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -135.56 135.26 40.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.93 135.16 55.0 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.748 1.219 . . . . 0.0 110.085 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -139.37 160.2 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 71' ' ' LEU . 1.1 pt? -146.64 172.16 14.01 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.98 -177.19 5.7 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 123.968 0.907 . . . . 0.0 112.76 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' B' ' 75' ' ' GLY . 9.0 tp -110.02 22.09 16.02 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.901 0.881 . . . . 0.0 111.422 -169.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 64.05 -25.81 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.809 2.044 . . . . 0.0 113.352 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 147.03 -12.93 1.46 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 117.255 -1.859 . . . . 0.0 111.042 -179.669 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.1 Cg_endo -77.33 -165.47 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 125.113 3.875 . . . . 0.0 109.319 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.517 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.3 pt? -69.92 27.65 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 492' ' ' PRO . 4.2 pp0? -64.5 -25.91 68.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 0.0 111.785 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -149.88 4.8 0.57 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.88 162.16 74.8 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 122.105 -0.372 . . . . 0.0 110.561 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.61 151.42 31.39 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.183 3.255 . . . . 0.0 111.616 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.74 55.33 2.35 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 122.196 0.998 . . . . 0.0 109.939 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 168.93 31.33 0.02 OUTLIER Glycine 0 CA--C 1.527 0.816 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.019 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 49.0 t -141.86 165.03 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.801 0.801 . . . . 0.0 109.657 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.9 141.04 47.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.391 1.076 . . . . 0.0 109.306 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.597 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.4 OUTLIER -65.17 -33.73 76.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.074 -177.058 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.76 5.2 3.33 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.54 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.9 11.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.513 0.725 . . . . 0.0 111.013 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.14 -13.68 8.92 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.835 0.854 . . . . 0.0 109.939 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -82.68 18.76 1.46 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.412 0.685 . . . . 0.0 111.921 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -94.46 7.69 44.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.542 0.737 . . . . 0.0 111.415 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 156.81 69.37 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.594 1.158 . . . . 0.0 110.495 -171.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.35 164.66 22.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.157 3.238 . . . . 0.0 113.054 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -59.11 -25.48 63.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.622 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.94 -6.56 51.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.47 0.308 . . . . 0.0 111.251 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 18.1 mt -118.1 -12.74 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 170.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 23.6 mm-40 -58.41 -39.7 80.46 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.84 -11.03 60.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.391 0.676 . . . . 0.0 112.204 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.69 -19.35 21.92 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.255 0.48 . . . . 0.0 111.553 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.61 -27.18 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 65.7 mt -64.47 -2.96 2.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.4 m -138.42 21.0 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.959 1.304 . . . . 0.0 110.024 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -107.23 46.64 1.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.476 1.036 . . . . 0.0 110.993 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -56.46 2.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.3 t -149.06 -175.95 5.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.468 0.651 . . . . 0.0 111.039 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 65.76 3.79 2.64 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.523 1.929 . . . . 0.0 114.652 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -155.36 148.58 24.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.1 0.864 . . . . 0.0 111.43 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 526' ' ' LYS . 37.1 m-80 -147.19 43.83 1.14 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.952 0.901 . . . . 0.0 111.116 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 525' ' ' LEU 0.298 3.2 pp 50.19 9.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.623 1.569 . . . . 0.0 114.051 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 524' ' ' ASN . 43.5 mtmt . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 127.752 2.421 . . . . 0.0 110.368 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.704 0.288 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.4 172.94 17.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.251 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.48 -177.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.602 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 96.2 m-85 -130.66 128.25 40.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.77 121.13 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.27 142.6 33.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -172.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -88.37 178.79 6.47 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.146 1.379 . . . . 0.0 112.912 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.598 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.1 tm? -70.97 6.47 1.54 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.839 1.255 . . . . 0.0 110.239 173.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -124.55 9.0 8.35 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.94 -1.1 . . . . 0.0 111.993 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.74 60.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 120.133 -0.259 . . . . 0.0 113.211 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -119.76 139.48 52.24 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 9.0 m -113.43 142.5 45.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.41 132.9 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -87.08 133.79 33.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 mt -142.6 135.04 27.78 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.47 130.3 37.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 109.086 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.57 179.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.788 0.835 . . . . 0.0 109.89 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.433 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -140.21 163.46 43.77 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.86 2.92 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.463 2.775 . . . . 0.0 113.722 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.416 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.0 m -127.73 -7.1 5.63 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.771 0.714 . . . . 0.0 110.971 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.6 m-20 -79.82 67.57 5.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 171.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.1 t -59.61 175.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.786 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.422 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.8 mm -49.94 -34.73 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.55 -21.39 61.89 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.363 0.983 . . . . 0.0 111.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.76 -37.21 27.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.47 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.5 t -64.77 -39.4 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.226 1.01 . . . . 0.0 109.862 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -59.04 -28.08 66.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.758 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -24.13 54.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.516 0.598 . . . . 0.0 110.6 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 69.1 mmtt -69.76 -44.54 69.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.528 0.731 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.12 -30.22 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.581 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.57 -40.74 80.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.29 -30.55 70.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.176 0.512 . . . . 0.0 111.352 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -85.63 -19.58 30.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.5 -40.01 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.361 0.528 . . . . 0.0 112.001 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.29 9.04 12.14 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.6 mt -79.18 128.53 75.62 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.34 151.98 66.08 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.76 2.306 . . . . 0.0 110.812 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.65 -15.48 41.2 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.251 2.634 . . . . 0.0 110.441 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -7.97 59.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.781 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -124.3 -13.39 7.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -69.96 165.18 22.28 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.619 1.1 . . . . 0.0 111.999 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -154.64 141.49 19.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.483 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -135.95 139.48 43.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.567 0.621 . . . . 0.0 111.398 -169.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.483 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -130.85 148.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.751 0.82 . . . . 0.0 109.197 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -149.87 134.16 17.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.935 0.894 . . . . 0.0 108.867 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.3 19.98 0.86 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.59 0.756 . . . . 0.0 112.504 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 24.29 44.96 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 123.009 0.338 . . . . 0.0 112.55 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.602 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.7 ttmm -120.56 124.56 45.62 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 122.797 0.439 . . . . 0.0 110.432 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -75.93 108.79 9.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' B' ' 59' ' ' TYR . 1.0 OUTLIER -68.02 170.26 8.64 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.452 -174.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -132.49 153.64 50.7 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 121.64 0.733 . . . . 0.0 111.393 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.76 3.01 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.408 1.083 . . . . 0.0 111.769 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.96 16.8 20.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -118.25 -154.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.598 1.159 . . . . 0.0 109.087 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -148.88 159.58 44.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.304 1.442 . . . . 0.0 108.479 172.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.31 -27.62 69.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -25.2 60.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.361 1.064 . . . . 0.0 111.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.81 -18.88 61.42 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.302 0.641 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.602 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 22.9 m-85 -129.23 26.76 5.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.553 0.741 . . . . 0.0 109.991 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.27 31.01 0.74 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.18 125.12 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -131.18 -173.25 3.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.456 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.24 141.39 35.56 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 111.585 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.5 24.96 3.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.666 1.186 . . . . 0.0 113.627 174.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -70.67 -17.68 62.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m 59.41 130.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.17 2.188 . . . . 0.0 112.32 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -138.89 -178.34 5.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.392 1.077 . . . . 0.0 109.076 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.85 147.34 48.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.912 0.387 . . . . 0.0 111.275 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.5 tp -132.66 137.97 47.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.282 1.433 . . . . 0.0 110.033 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -143.84 165.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.37 170.56 15.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.876 0.762 . . . . 0.0 112.833 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.98 178.08 5.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.1 0.96 . . . . 0.0 111.377 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -112.15 21.54 15.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.008 -173.088 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 62.82 -30.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 127.2 2.2 . . . . 0.0 114.183 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 138.42 -12.41 3.5 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.408 -1.773 . . . . 0.0 111.483 -179.418 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.5 Cg_endo -80.25 -167.45 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.609 4.206 . . . . 0.0 108.905 174.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.03 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 112.972 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 492' ' ' PRO . 3.1 pp0? -76.83 -26.0 53.86 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.28 1.42 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.84 160.94 50.63 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.53 154.46 24.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.68 2.92 . . . . 0.0 110.851 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.8 66.41 5.27 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.845 0.831 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 164.22 -24.1 0.18 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.114 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 78.3 t -68.0 169.0 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.522 0.729 . . . . 0.0 110.281 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 0.4 OUTLIER -135.42 153.91 51.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.716 0.806 . . . . 0.0 110.665 -175.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -63.77 -43.73 95.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.51 8.36 0.85 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.024 0.53 . . . . 0.0 112.335 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.2 9.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.13 0.572 . . . . 0.0 111.097 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -122.0 -20.69 6.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.336 0.654 . . . . 0.0 110.062 178.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.56 7.75 2.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.203 0.601 . . . . 0.0 111.927 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -84.29 8.63 15.36 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.996 0.918 . . . . 0.0 111.357 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.43 159.67 56.52 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 123.18 0.592 . . . . 0.0 112.215 -167.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.95 164.35 31.77 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.249 2.632 . . . . 0.0 110.567 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.89 56.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.914 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.74 -5.75 59.33 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.875 0.47 . . . . 0.0 111.691 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.441 ' CD1' HD11 ' B' ' 44' ' ' ILE . 40.3 mt -118.51 -15.26 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -53.34 -41.66 66.0 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.337 -0.852 . . . . 0.0 108.863 169.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.29 -19.14 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.953 0.501 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -85.48 -21.51 28.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.888 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 518' ' ' SER . 2.6 mm -98.05 -31.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 118.916 0.78 . . . . 0.0 109.253 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.92 -0.97 2.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 110.078 172.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 516' ' ' ILE . 10.5 t -135.64 16.65 3.35 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.508 1.123 . . . . 0.0 110.63 177.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -100.98 38.43 3.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -1.65 0.11 Allowed 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -174.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.3 t -151.45 175.01 12.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.527 0.731 . . . . 0.0 109.919 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.48 3.78 3.0 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.701 1.6 . . . . 0.0 113.579 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.52 156.16 34.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.796 0.438 . . . . 0.0 111.04 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -156.64 27.1 0.33 Allowed 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.85 -0.27 1.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.997 0.919 . . . . 0.0 111.163 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -169.426 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.391 0.139 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.18 173.98 15.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.19 -178.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.263 1.025 . . . . 0.0 109.182 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.428 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 55.5 m-85 -133.21 86.94 2.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.485 0.66 . . . . 0.0 109.974 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -80.41 101.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.948 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.5 ttmt -85.51 140.58 30.55 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.843 0.457 . . . . 0.0 111.358 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -84.82 173.21 10.81 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.71 0.804 . . . . 0.0 111.575 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.23 -16.69 55.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.7 0.8 . . . . 0.0 110.88 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -97.47 -0.65 45.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.048 0.539 . . . . 0.0 110.538 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.67 25.98 26.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.094 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -118.93 120.27 36.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.467 0.633 . . . . 0.0 110.491 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.8 OUTLIER -75.95 155.85 34.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.253 0.549 . . . . 0.0 110.947 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.26 112.78 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -71.65 133.87 45.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' B' ' 29' ' ' LYS . 64.2 mt -150.23 136.53 18.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 122.309 0.243 . . . . 0.0 111.035 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.4 126.62 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.429 HG12 ' HE3' ' B' ' 29' ' ' LYS . 28.4 m -144.4 179.13 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.323 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -131.06 160.73 65.54 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.011 0.924 . . . . 0.0 108.803 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.19 0.6 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.769 2.98 . . . . 0.0 113.569 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -125.46 -4.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.662 0.664 . . . . 0.0 110.802 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -80.71 65.49 5.88 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -59.95 177.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.566 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.672 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 15.9 mm -52.93 -24.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 113.831 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.17 -19.73 50.21 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.694 1.134 . . . . 0.0 111.558 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -85.17 -44.08 13.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.613 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER -65.61 -26.22 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 123.046 0.539 . . . . 0.0 110.389 -177.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 91.2 mttt -59.97 -31.29 69.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 122.202 -0.311 . . . . 0.0 111.285 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.06 53.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.297 0.499 . . . . 0.0 110.597 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.538 ' HB3' HD22 ' B' ' 15' ' ' LEU . 3.9 mptp? -67.64 -36.06 80.06 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -85.57 -28.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -66.87 -39.04 87.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.39 -33.06 74.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.388 0.613 . . . . 0.0 111.386 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.514 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.5 mmtm -83.14 -21.22 33.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -137.9 -34.59 0.67 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.511 0.596 . . . . 0.0 112.56 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.89 9.05 19.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.9 mt -77.29 130.37 74.97 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 153.85 67.55 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.47 2.113 . . . . 0.0 111.112 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.54 -15.97 38.22 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.321 2.68 . . . . 0.0 110.493 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.9 -7.82 59.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -124.03 -14.32 7.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -70.15 164.67 23.68 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 112.726 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -154.69 146.61 23.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -129.32 145.01 51.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.451 0.569 . . . . 0.0 111.001 -170.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -136.67 148.23 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.583 1.153 . . . . 0.0 108.385 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -149.14 138.91 21.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.354 1.062 . . . . 0.0 108.992 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.62 12.51 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.622 0.769 . . . . 0.0 112.669 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.03 14.19 40.31 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.524 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 159.88 33.76 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.622 1.211 . . . . 0.0 109.46 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -92.1 153.65 19.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.756 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.447 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.8 mp -116.76 166.38 12.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -137.31 153.79 50.2 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.496 0.665 . . . . 0.0 112.191 -173.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.49 -1.89 12.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.449 1.1 . . . . 0.0 111.697 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 7.1 37.69 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.99 -154.51 0.53 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.906 0.883 . . . . 0.0 109.451 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 3.1 p -149.72 160.21 43.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.027 1.731 . . . . 0.0 107.823 173.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.63 -27.08 68.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -71.7 -26.71 62.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.92 1.288 . . . . 0.0 112.138 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.44 -15.81 61.82 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 122.749 0.419 . . . . 0.0 111.261 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -126.52 27.83 6.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.648 0.779 . . . . 0.0 109.699 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.91 28.2 0.34 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 171.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.75 140.4 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.525 0.602 . . . . 0.0 109.611 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -130.71 -174.52 3.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.602 1.161 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.81 144.29 56.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.66 21.72 3.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.861 0.865 . . . . 0.0 113.159 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -72.92 -17.32 61.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 75.4 m 61.41 139.47 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.326 1.851 . . . . 0.0 112.104 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -141.27 179.92 6.49 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.114 0.566 . . . . 0.0 109.505 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.49 139.27 43.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.405 0.282 . . . . 0.0 110.523 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.436 HD13 ' C ' ' B' ' 69' ' ' LEU . 2.6 tm? -130.24 134.78 47.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 110.075 -172.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.434 HG12 ' N ' ' B' ' 71' ' ' LEU . 52.4 t -142.13 168.47 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.434 ' N ' HG12 ' B' ' 70' ' ' VAL . 1.2 pp -142.74 170.46 15.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.975 -0.453 . . . . 0.0 111.676 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -66.78 168.47 9.54 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.595 0.758 . . . . 0.0 110.879 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.17 18.57 22.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.182 0.593 . . . . 0.0 110.591 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 61.19 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.506 2.322 . . . . 0.0 114.898 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.35 59.96 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.048 -1.973 . . . . 0.0 110.772 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.458 ' CD1' HD21 ' A' ' 517' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 494' ' ' GLN . 90.3 Cg_endo -78.89 -168.3 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 124.641 3.561 . . . . 0.0 107.711 170.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.08 31.56 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.666 1.586 . . . . 0.0 113.74 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -69.2 -32.45 71.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.944 0.897 . . . . 0.0 112.466 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 517' ' ' LEU . . . -146.03 2.38 0.9 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 496' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 497' ' ' PRO . 64.1 mt -71.8 150.11 92.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 496' ' ' LEU . 51.4 Cg_exo -56.99 158.49 17.24 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.779 2.986 . . . . 0.0 111.696 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.55 55.59 2.0 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 122.241 1.02 . . . . 0.0 109.673 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.41 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.094 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 501' ' ' ASP . 95.4 t -141.31 166.14 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.762 0.825 . . . . 0.0 109.578 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 500' ' ' VAL . 2.9 m-20 -143.66 139.17 29.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.575 1.55 . . . . 0.0 107.08 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.675 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 1.4 pm0 -65.97 -28.29 68.79 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.393 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.67 3.91 5.74 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.338 -0.851 . . . . 0.0 111.161 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' VAL . . . . . 0.416 ' N ' HE22 ' A' ' 507' ' ' GLN . 27.3 m -137.23 17.36 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.472 1.109 . . . . 0.0 110.225 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.62 -19.41 1.38 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.466 0.706 . . . . 0.0 111.622 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -72.09 -0.31 11.46 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.371 -0.831 . . . . 0.0 112.649 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 504' ' ' VAL . 7.5 mp0 -95.95 -7.92 35.22 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.691 0.678 . . . . 0.0 109.851 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.38 159.91 78.8 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.06 163.72 37.46 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.974 2.449 . . . . 0.0 111.253 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -15.17 20.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.841 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -95.98 -1.31 49.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.552 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 54.9 mt -115.45 -16.99 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -41.75 66.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.8 -5.57 51.23 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 28.4 mm-40 -97.49 -24.1 15.74 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.806 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.4 -35.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 495' ' ' ALA . 88.5 mt -66.47 -8.0 23.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 15.3 t -72.76 -50.23 25.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.68 0.392 . . . . 0.0 111.468 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 144.37 141.91 3.82 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.841 -2.503 . . . . 0.0 106.841 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 515' ' ' GLU . 71.6 mmtt -149.36 176.73 10.3 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.931 0.893 . . . . 0.0 109.223 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -157.7 179.43 9.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.473 1.509 . . . . 0.0 108.868 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.3 OUTLIER 60.83 21.73 11.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.461 1.104 . . . . 0.0 112.671 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -146.85 147.1 30.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.739 0.415 . . . . 0.0 110.247 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -148.44 40.25 0.92 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.475 0.71 . . . . 0.0 110.902 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.286 4.4 pp 47.75 13.18 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.932 1.693 . . . . 0.0 114.228 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 126.411 1.884 . . . . 0.0 111.225 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.725 0.298 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -155.17 175.23 14.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.87 -177.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 123.958 0.903 . . . . 0.0 108.627 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.573 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 99.9 m-85 -136.36 97.72 3.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.268 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.61 135.16 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -117.17 136.74 52.82 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.092 0.472 . . . . 0.0 111.742 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -73.12 173.84 8.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.737 1.215 . . . . 0.0 112.047 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.09 0.28 4.88 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.256 1.023 . . . . 0.0 110.792 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -118.27 -3.14 11.04 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.2 20.4 18.2 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.8 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -119.57 138.86 52.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.871 0.835 . . . . 0.0 109.86 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 6.3 m -111.41 152.38 27.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.012 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.75 131.6 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -86.37 135.05 33.66 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -146.36 134.23 21.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.696 0.225 . . . . 0.0 110.939 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.93 125.94 38.85 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.546 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.46 175.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.945 0.898 . . . . 0.0 109.872 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -135.36 163.05 53.69 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.318 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.54 1.7 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.466 2.777 . . . . 0.0 113.599 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -127.05 -3.41 6.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.716 0.689 . . . . 0.0 110.997 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.25 75.27 8.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.0 OUTLIER -61.08 171.31 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.157 0.983 . . . . 0.0 110.178 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' B' ' 26' ' ' VAL . 13.0 mm -54.37 -28.3 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.64 -18.72 65.06 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.836 -1.165 . . . . 0.0 110.487 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -86.33 -45.93 10.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.132 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.4 m -66.34 -33.79 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 122.664 0.386 . . . . 0.0 110.989 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' B' ' 23' ' ' ILE . 93.8 mttt -56.26 -32.98 65.01 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.855 172.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.18 -27.88 53.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.995 -0.441 . . . . 0.0 110.948 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -67.08 -32.05 72.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.26 -31.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.99 89.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.91 -31.9 71.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.271 0.558 . . . . 0.0 111.231 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -84.1 -22.47 31.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -135.96 -36.2 0.76 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.89 8.3 15.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.3 129.63 74.45 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.75 152.52 69.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.632 2.221 . . . . 0.0 110.842 -176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.41 -15.22 41.7 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.23 2.62 . . . . 0.0 110.73 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.01 -6.86 59.47 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -125.32 -11.51 6.9 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.37 165.0 25.4 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.518 1.054 . . . . 0.0 112.208 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -153.59 142.56 21.2 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.408 ' C ' HD12 ' B' ' 44' ' ' ILE . 39.0 tp -136.14 138.41 41.97 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.128 -0.358 . . . . 0.0 110.711 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.408 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -133.43 150.23 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.188 0.995 . . . . 0.0 108.87 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -148.5 139.12 22.79 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.542 1.137 . . . . 0.0 109.092 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 10.41 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.713 0.805 . . . . 0.0 113.034 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.66 12.14 36.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.675 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.14 159.88 32.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.632 1.216 . . . . 0.0 109.651 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -95.61 138.5 33.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.903 0.881 . . . . 0.0 108.753 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.519 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.9 mp -95.7 157.13 16.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -125.22 148.69 48.53 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 121.433 0.635 . . . . 0.0 112.164 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.02 -0.11 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.178 0.991 . . . . 0.0 111.89 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.35 8.28 37.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -108.88 -147.71 0.42 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.594 0.758 . . . . 0.0 110.517 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.521 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.0 p -152.13 157.07 41.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 127.313 2.245 . . . . 0.0 107.378 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.26 -26.25 68.69 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 121.361 0.601 . . . . 0.0 109.871 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -66.43 -25.11 66.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.853 1.261 . . . . 0.0 111.765 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.82 -12.01 59.94 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.447 0.699 . . . . 0.0 111.903 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.443 ' CE2' HD11 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -117.68 21.3 13.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 46.95 27.27 0.7 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.66 141.78 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.109 0.413 . . . . 0.0 110.262 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -130.31 -177.84 4.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.53 1.132 . . . . 0.0 108.747 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -60.96 143.26 55.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 53.53 26.27 5.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.415 1.086 . . . . 0.0 113.418 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -72.65 -14.91 61.7 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 61.53 141.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.467 1.907 . . . . 0.0 112.367 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.98 -177.07 5.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.55 129.9 33.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 110.728 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.6 tp -112.28 141.5 45.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.252 1.421 . . . . 0.0 110.467 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.12 161.0 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.422 ' H ' HD23 ' B' ' 71' ' ' LEU . 1.4 pt? -148.84 171.69 15.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.684 -0.635 . . . . 0.0 112.677 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.58 173.58 6.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.128 0.971 . . . . 0.0 109.568 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -126.51 25.59 6.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.539 0.735 . . . . 0.0 109.631 -178.062 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 63.4 -23.01 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.677 1.991 . . . . 0.0 114.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -132.68 8.75 5.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 117.651 -1.638 . . . . 0.0 110.599 179.334 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 494' ' ' GLN . 74.7 Cg_endo -75.72 -172.53 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 124.744 3.629 . . . . 0.0 109.605 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 31.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.445 1.498 . . . . 0.0 113.152 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 494' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.1 pp0? -75.29 -25.97 58.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.812 0.845 . . . . 0.0 112.629 -176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.11 2.62 1.17 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.2 162.47 72.96 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 122.959 0.503 . . . . 0.0 110.566 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 152.54 15.31 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.281 3.32 . . . . 0.0 112.397 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.1 66.62 2.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.802 0.81 . . . . 0.0 112.064 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 159.49 -25.04 0.32 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.668 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.86 166.55 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.363 0.665 . . . . 0.0 110.584 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.94 143.03 40.56 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.127 0.971 . . . . 0.0 109.317 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.562 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.1 OUTLIER -62.52 -34.47 76.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.25 -177.453 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.51 4.53 5.9 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.883 -0.511 . . . . 0.0 111.754 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.12 11.29 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.402 0.681 . . . . 0.0 110.535 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -14.99 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.395 1.078 . . . . 0.0 109.545 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -85.44 29.27 0.69 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.566 0.746 . . . . 0.0 111.228 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -103.65 7.83 37.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.931 0.893 . . . . 0.0 111.153 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.52 156.9 63.33 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.615 1.166 . . . . 0.0 110.348 -172.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 162.87 30.87 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.981 3.12 . . . . 0.0 112.856 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -27.3 64.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.7 0.8 . . . . 0.0 112.064 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -9.2 58.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.219 0.208 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.28 -15.68 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.278 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 12.9 mm-40 -57.85 -39.54 77.97 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.484 1.038 . . . . 0.0 108.9 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.7 -16.24 64.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.169 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -90.29 -8.78 50.03 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.246 -0.406 . . . . 0.0 111.76 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.59 -34.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.56 -6.58 11.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.373 0.669 . . . . 0.0 109.678 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 49.4 m -138.32 26.77 2.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.062 1.345 . . . . 0.0 109.485 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -129.67 43.45 1.31 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -63.48 7.2 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.262 2.225 . . . . 0.0 115.063 -170.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -146.97 -177.64 5.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.29 0.636 . . . . 0.0 109.708 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.86 -2.84 2.57 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.472 1.509 . . . . 0.0 112.941 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -157.24 152.56 26.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.936 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.18 34.2 1.21 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.411 1.084 . . . . 0.0 110.045 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.9 6.06 2.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.789 0.804 . . . . 0.0 110.728 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 111.696 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.584 0.231 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.73 172.7 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.55 -179.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.06 101.04 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.39 126.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.9 ttmt -102.82 133.88 47.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 111.903 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -82.13 178.2 8.4 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 112.416 -172.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.449 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -71.67 14.43 0.19 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.689 1.196 . . . . 0.0 110.284 173.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -129.32 5.66 5.26 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 120.871 -1.143 . . . . 0.0 112.418 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 25.58 58.46 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.855 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -121.44 142.26 50.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -111.24 157.21 20.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.3 128.9 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -74.84 133.24 41.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.3 mt -145.12 133.59 21.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.329 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.25 126.5 39.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.11 177.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.844 0.858 . . . . 0.0 109.762 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -136.18 162.21 57.86 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.762 0.825 . . . . 0.0 110.117 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 35.1 Cg_exo -56.36 0.85 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.38 3.387 . . . . 0.0 113.371 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 27.5 p -129.43 -6.59 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.845 0.858 . . . . 0.0 111.191 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.27 74.23 10.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.3 t -62.43 174.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.192 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.561 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.7 mm -56.02 -26.08 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.69 -17.69 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.439 -1.413 . . . . 0.0 110.706 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -88.58 -43.86 11.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.86 0.864 . . . . 0.0 110.598 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.6 m -63.96 -31.24 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 C-N-CA 122.736 0.414 . . . . 0.0 110.597 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -56.58 -31.57 64.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.368 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.95 -30.32 55.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.448 0.567 . . . . 0.0 110.569 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.0 mptp? -70.03 -33.9 72.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -85.81 -30.12 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.95 -39.97 83.31 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.34 -31.05 71.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.158 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -83.43 -21.4 32.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -138.13 -36.32 0.6 Allowed 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.72 8.49 13.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.79 129.82 80.35 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.55 153.41 65.29 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.408 2.072 . . . . 0.0 111.224 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.23 -17.47 39.95 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.273 2.649 . . . . 0.0 110.653 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.49 -4.84 57.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.838 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -124.8 -15.43 6.47 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.94 163.06 28.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.866 1.212 . . . . 0.0 113.479 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -161.91 146.11 12.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.045 1.338 . . . . 0.0 107.627 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.41 ' C ' HD12 ' B' ' 44' ' ' ILE . 4.2 mp -132.87 160.44 36.96 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.134 0.493 . . . . 0.0 111.728 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.41 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.1 mp -135.71 149.3 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 107.988 -176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' B' ' 50' ' ' LEU . 54.8 t80 -151.74 144.26 24.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.999 0.92 . . . . 0.0 109.355 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 14.09 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.526 0.73 . . . . 0.0 111.985 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.1 16.2 51.45 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.287 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 158.06 40.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.745 1.272 . . . . 0.0 109.867 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.16 145.44 26.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.55 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.486 HD22 ' CD1' ' B' ' 59' ' ' TYR . 14.3 mt -102.99 148.96 25.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.047 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -121.69 149.22 43.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.501 0.667 . . . . 0.0 112.064 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.74 2.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.211 1.004 . . . . 0.0 111.852 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.36 16.5 19.65 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.55 -148.59 0.41 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.591 1.156 . . . . 0.0 108.496 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.2 p -153.9 160.29 42.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.693 1.197 . . . . 0.0 108.851 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.14 -27.09 68.14 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.236 -0.29 . . . . 0.0 110.633 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 16.5 t -73.29 -28.52 62.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.94 0.496 . . . . 0.0 110.791 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.15 -12.69 61.35 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.65 21.14 13.15 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 174.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 47.97 22.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -57.47 141.69 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-O 121.208 0.528 . . . . 0.0 110.766 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -131.33 -177.54 4.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.141 1.376 . . . . 0.0 108.79 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -64.04 147.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.034 0.445 . . . . 0.0 110.955 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 53.78 25.92 5.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.819 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -72.88 -21.33 60.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 69.5 m 60.67 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.072 2.149 . . . . 0.0 112.622 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.53 -174.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.85 1.66 . . . . 0.0 108.155 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -137.49 149.83 47.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 69' ' ' LEU . 2.7 tm? -134.44 133.22 40.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.949 1.3 . . . . 0.0 109.5 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 163.67 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.11 168.89 18.67 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -76.35 -176.27 3.57 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 125.371 1.468 . . . . 0.0 111.872 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.2 OUTLIER -109.41 18.48 20.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.789 0.835 . . . . 0.0 111.585 -171.381 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 63.41 -32.86 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.101 2.16 . . . . 0.0 114.042 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.54 -13.26 2.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 117.292 -1.838 . . . . 0.0 111.681 -179.288 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.537 0.208 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.91 95.68 0.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.634 3.556 . . . . 0.0 111.548 -171.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.6 tt 21.26 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.699 2.399 . . . . 0.0 112.514 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.75 -26.45 16.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.011 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -139.74 4.88 2.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.359 0.664 . . . . 0.0 110.67 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.18 160.58 77.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.975 0.51 . . . . 0.0 109.694 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 155.64 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.049 3.166 . . . . 0.0 112.273 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.48 34.59 0.21 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.636 0.774 . . . . 0.0 111.775 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . -173.38 35.84 0.13 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.352 -174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 42.7 t -143.22 168.66 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.208 1.003 . . . . 0.0 109.293 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 1.8 m-20 -137.53 148.27 45.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.964 1.306 . . . . 0.0 108.222 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 502' ' ' GLN . . . . . 0.611 ' CD ' ' H ' ' A' ' 502' ' ' GLN . 0.4 OUTLIER -76.77 -28.06 55.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.35 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.55 7.39 1.44 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.738 -0.601 . . . . 0.0 111.03 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.03 12.1 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.729 0.811 . . . . 0.0 111.383 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -25.49 2.65 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.889 0.476 . . . . 0.0 111.048 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.504 ' HB2' HE22 ' A' ' 507' ' ' GLN . 50.9 mtmt -69.53 -6.28 29.73 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.941 -0.474 . . . . 0.0 110.702 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.504 HE22 ' HB2' ' A' ' 506' ' ' LYS . 2.0 mp0 -87.54 -4.38 58.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.775 1.23 . . . . 0.0 110.238 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 74.0 mt -90.16 160.11 40.85 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.75 1.22 . . . . 0.0 109.957 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.61 167.64 26.06 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.469 2.779 . . . . 0.0 111.894 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.67 -22.79 62.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.87 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.36 -1.86 57.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.237 0.472 . . . . 0.0 111.684 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.78 -14.58 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -40.85 67.68 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.37 -0.831 . . . . 0.0 109.163 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.16 -7.94 55.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.18 0.592 . . . . 0.0 112.459 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.33 -22.65 18.21 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.521 0.6 . . . . 0.0 111.107 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.42 -30.33 2.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.12 1.69 1.41 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.147 0.431 . . . . 0.0 110.376 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -129.75 9.2 5.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.961 0.904 . . . . 0.0 110.921 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -79.23 138.95 21.27 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 0.29 2.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 12.9 t -162.66 179.82 7.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.596 0.358 . . . . 0.0 110.599 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.15 15.61 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.93 1.692 . . . . 0.0 113.729 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.15 147.27 26.24 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.618 0.367 . . . . 0.0 110.622 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' ASN . . . . . 0.48 ' HB2' ' CE ' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -154.15 10.65 0.39 Allowed 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 13.25 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.803 0.689 . . . . 0.0 111.219 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LYS . . . . . 0.48 ' CE ' ' HB2' ' A' ' 524' ' ' ASN . 53.6 mtmt . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.363 1.065 . . . . 0.0 111.399 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.642 0.258 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.05 175.31 14.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.01 -177.45 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.67 0.788 . . . . 0.0 109.17 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.814 ' HB3' HG21 ' B' ' 12' ' ' THR . 83.5 m-85 -135.68 98.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -93.2 117.87 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -93.3 132.7 37.26 Favored 'General case' 0 C--N 1.337 0.057 0 O-C-N 121.881 -0.512 . . . . 0.0 110.783 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -76.09 177.43 7.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.361 1.064 . . . . 0.0 111.976 -174.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.45 -5.95 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.933 1.293 . . . . 0.0 110.489 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 59.5 p -116.85 4.43 12.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.709 -0.62 . . . . 0.0 112.057 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.93 27.78 48.69 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 120.142 -0.254 . . . . 0.0 113.027 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.73 148.21 45.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.814 HG21 ' HB3' ' B' ' 4' ' ' PHE . 47.5 m -122.66 153.64 39.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.561 -170.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.36 132.3 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -83.92 134.7 34.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.7 mt -145.38 133.47 21.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.617 -172.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.84 128.41 37.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.474 0.71 . . . . 0.0 109.477 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.3 179.61 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.982 0.913 . . . . 0.0 109.69 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.7 mt-10 -141.15 164.21 37.14 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.19 1.17 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.583 2.855 . . . . 0.0 113.64 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.402 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.7 m -129.31 -6.61 4.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.908 0.777 . . . . 0.0 111.228 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 21.3 m-20 -80.73 69.08 7.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 171.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.2 t -61.03 176.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.133 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.419 HG22 ' HE3' ' B' ' 27' ' ' LYS . 13.2 mm -52.17 -33.21 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -168.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.6 -22.89 62.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.342 0.974 . . . . 0.0 111.473 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.35 -41.36 22.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.23 -40.24 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 124.275 1.03 . . . . 0.0 110.035 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.419 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.1 mttt -56.73 -26.04 56.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.521 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -26.89 35.16 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.486 0.584 . . . . 0.0 110.772 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -67.1 -33.12 74.79 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.7 mt -87.29 -30.05 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -66.45 -36.67 83.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.715 0.293 . . . . 0.0 110.217 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -69.38 -33.54 73.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.398 0.618 . . . . 0.0 111.297 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -82.39 -24.48 34.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.583 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -134.15 -30.92 1.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.4 9.65 26.93 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.69 126.8 82.01 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 123.891 0.876 . . . . 0.0 108.922 -174.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.41 153.57 77.52 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.634 2.223 . . . . 0.0 111.23 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.24 -20.82 36.79 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.168 2.578 . . . . 0.0 111.823 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.82 -1.69 57.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -113.85 -13.72 12.57 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.335 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.66 170.34 16.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.041 0.837 . . . . 0.0 112.3 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -153.78 148.52 26.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.45 ' C ' HD12 ' B' ' 44' ' ' ILE . 10.7 tp -136.48 139.26 42.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 111.466 -171.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.45 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -135.44 153.17 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.71 1.204 . . . . 0.0 108.213 -177.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.35 135.62 20.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 124.566 1.147 . . . . 0.0 109.089 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.49 10.19 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.887 0.875 . . . . 0.0 113.187 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.29 12.01 32.3 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.454 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 157.68 37.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.764 1.282 . . . . 0.0 109.713 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -93.29 152.09 19.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.116 0.966 . . . . 0.0 108.418 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.455 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -115.07 168.36 10.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -136.15 153.09 51.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.514 0.674 . . . . 0.0 111.615 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.79 -1.54 14.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.287 1.035 . . . . 0.0 111.62 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 9.52 35.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -109.02 -155.88 0.57 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.968 0.907 . . . . 0.0 109.372 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -148.48 160.44 43.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.052 1.741 . . . . 0.0 107.415 172.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.64 -26.8 68.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -71.0 -26.27 63.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.019 1.328 . . . . 0.0 111.993 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.78 -15.23 61.65 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 122.891 0.476 . . . . 0.0 111.298 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -126.56 26.69 6.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.717 0.807 . . . . 0.0 109.786 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 p30 48.0 19.78 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.43 139.82 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.714 0.688 . . . . 0.0 110.373 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -130.08 -177.5 4.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.709 1.204 . . . . 0.0 109.217 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.02 143.42 51.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.039 0.447 . . . . 0.0 110.841 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 53.4 26.27 5.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -74.9 -11.94 60.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m 60.03 128.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.35 1.86 . . . . 0.0 112.117 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.59 -175.62 3.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.121 1.369 . . . . 0.0 108.077 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -137.68 145.43 42.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.45 137.9 50.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.534 1.133 . . . . 0.0 109.403 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.92 162.89 30.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.433 ' C ' HD12 ' B' ' 71' ' ' LEU . 2.5 pp -147.48 178.72 8.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 112.354 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -128.34 167.63 16.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.59 1.156 . . . . 0.0 109.799 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.573 ' H ' HD13 ' B' ' 73' ' ' LEU . 0.0 OUTLIER -102.97 18.12 22.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.749 0.82 . . . . 0.0 112.711 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 120.56 -30.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 129.351 3.061 . . . . 0.0 111.149 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.58 2.24 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 116.749 -2.139 . . . . 0.0 111.854 179.803 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.9 Cg_endo -77.57 -166.92 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.202 3.268 . . . . 0.0 107.685 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.845 ' H ' HD13 ' A' ' 493' ' ' LEU . 0.0 OUTLIER -65.06 28.4 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 176.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -63.04 -27.96 69.76 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.434 1.894 . . . . 0.0 112.992 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.98 1.93 0.77 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.72 161.77 76.41 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 122.61 0.364 . . . . 0.0 110.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.75 154.38 12.65 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.255 3.303 . . . . 0.0 112.005 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -80.12 57.55 2.73 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 122.343 1.068 . . . . 0.0 110.424 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.23 26.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.226 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 76.0 t -140.79 160.03 23.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.808 0.804 . . . . 0.0 109.441 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.17 145.16 48.99 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.673 0.749 . . . . 0.0 109.077 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.31 -28.98 70.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.406 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.92 -0.16 10.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.679 -0.638 . . . . 0.0 111.403 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.26 18.42 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.437 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.78 -18.5 5.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.074 0.95 . . . . 0.0 110.452 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -72.6 3.83 4.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.943 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -87.51 4.89 41.74 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.748 0.819 . . . . 0.0 110.463 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.02 149.54 42.7 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 123.614 0.765 . . . . 0.0 110.187 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.27 163.77 25.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.081 2.521 . . . . 0.0 111.57 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.21 63.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.53 -1.8 57.93 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.651 0.38 . . . . 0.0 110.761 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 23.2 mt -116.87 -16.83 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -54.45 -38.87 66.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.5 -7.23 57.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.42 0.688 . . . . 0.0 112.421 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.42 -20.9 17.49 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.262 0.483 . . . . 0.0 111.2 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.43 -34.3 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.42 -8.64 19.84 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 33.0 t -70.12 -43.73 70.39 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.472 0.309 . . . . 0.0 110.797 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 117.73 120.64 3.07 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -140.79 -176.22 4.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.585 0.707 . . . . 0.0 110.725 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 -172.13 4.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.796 1.638 . . . . 0.0 107.998 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 65.19 18.11 11.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.035 0.934 . . . . 0.0 112.603 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.01 146.39 31.9 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.095 0.958 . . . . 0.0 109.092 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -148.29 28.79 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.925 0.49 . . . . 0.0 112.005 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.272 2.2 pp 50.92 6.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.697 1.599 . . . . 0.0 114.511 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -176.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.841 0.353 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -157.75 172.91 17.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.95 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -137.24 -179.37 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.272 0.629 . . . . 0.0 109.449 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.82 ' HB3' HG21 ' B' ' 12' ' ' THR . 82.4 m-85 -132.33 100.4 4.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.64 103.09 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.626 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -85.41 135.3 33.93 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 122.455 0.302 . . . . 0.0 111.135 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.7 p -83.76 176.32 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.38 0.672 . . . . 0.0 112.625 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -65.89 1.66 1.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.743 1.217 . . . . 0.0 111.001 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.3 p -118.73 10.06 12.31 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.307 0.643 . . . . 0.0 111.311 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 28.36 66.27 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.892 -0.393 . . . . 0.0 113.199 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.71 146.59 49.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.82 HG21 ' HB3' ' B' ' 4' ' ' PHE . 26.7 m -122.78 154.31 38.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 111.547 -171.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 53.3 mt -130.75 131.94 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -82.89 134.76 35.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 69.2 mt -144.35 134.54 24.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -171.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.89 126.82 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.314 0.645 . . . . 0.0 109.433 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.26 174.23 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.898 0.879 . . . . 0.0 109.645 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.405 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.8 mm-40 -135.69 161.87 60.38 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.272 1.029 . . . . 0.0 108.631 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.45 2.24 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.31 2.674 . . . . 0.0 113.339 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.4 ' H ' ' C ' ' B' ' 18' ' ' GLU . 35.1 p -122.21 -10.2 8.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.98 0.912 . . . . 0.0 110.593 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 76.2 m-20 -85.99 71.16 10.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.1 t -62.16 176.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.683 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 17.7 mm -51.14 -36.8 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -168.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -68.79 -21.67 64.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.371 0.987 . . . . 0.0 111.251 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -81.66 -40.38 22.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.36 -38.44 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.857 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.9 mttt -58.18 -23.13 54.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.524 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.62 -26.73 31.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.556 0.617 . . . . 0.0 110.73 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.85 -33.65 74.16 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.0 mt -85.85 -29.85 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -68.12 -37.6 81.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.33 -32.1 71.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.475 0.655 . . . . 0.0 111.323 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -83.01 -22.11 33.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -138.94 -31.25 0.72 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.74 9.39 19.0 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.2 mt -80.5 125.47 80.76 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.662 0.785 . . . . 0.0 109.337 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 159.38 48.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.216 2.611 . . . . 0.0 111.268 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -16.32 54.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.828 3.018 . . . . 0.0 110.851 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.47 -11.9 58.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.655 0.382 . . . . 0.0 111.999 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -120.85 -10.8 9.06 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -73.01 167.74 20.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.261 0.937 . . . . 0.0 112.04 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -159.21 90.1 0.95 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.88 1.272 . . . . 0.0 107.986 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.677 ' C ' HD12 ' B' ' 44' ' ' ILE . 23.3 tp -93.13 139.82 30.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.661 0.784 . . . . 0.0 112.201 -170.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -134.68 154.07 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.996 1.318 . . . . 0.0 109.145 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' B' ' 50' ' ' LEU . 43.1 t80 -151.59 142.81 23.29 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.593 1.157 . . . . 0.0 109.129 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 13.77 0.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.573 0.749 . . . . 0.0 112.615 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.7 13.86 48.96 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.275 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 161.78 31.53 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.559 1.18 . . . . 0.0 110.36 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.04 125.87 43.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.814 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.5 OUTLIER -76.0 175.35 8.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.991 -177.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -135.13 153.35 52.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 111.307 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.18 1.18 9.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.268 1.027 . . . . 0.0 111.697 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.64 11.76 27.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -112.47 -154.4 0.54 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.173 0.989 . . . . 0.0 109.563 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 4.5 p -148.97 159.56 44.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.794 1.638 . . . . 0.0 107.674 172.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 47.1 mt -63.27 -25.75 68.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -73.87 -25.45 60.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.467 1.107 . . . . 0.0 111.985 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.76 -15.96 61.65 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.09 0.556 . . . . 0.0 111.386 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.64 ' CD2' HD12 ' B' ' 50' ' ' LEU . 21.2 m-85 -125.71 25.98 6.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.367 0.667 . . . . 0.0 109.836 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p30 48.54 18.91 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 136.44 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.855 0.752 . . . . 0.0 110.187 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -130.4 -175.89 3.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.009 1.323 . . . . 0.0 109.458 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -59.93 143.89 50.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.281 0.563 . . . . 0.0 110.916 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 55.15 22.43 4.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.455 1.102 . . . . 0.0 113.331 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -72.44 -14.72 61.76 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 80.6 m 61.36 128.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.466 1.906 . . . . 0.0 112.051 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.59 178.62 6.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.941 1.296 . . . . 0.0 108.655 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -134.85 154.64 51.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -145.24 151.87 39.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.245 0.545 . . . . 0.0 110.507 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.04 161.2 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.467 ' H ' HD23 ' B' ' 71' ' ' LEU . 2.2 pt? -140.68 170.05 16.49 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.155 0.502 . . . . 0.0 112.077 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -135.61 177.48 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.136 0.974 . . . . 0.0 109.538 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.63 ' H ' HD23 ' B' ' 73' ' ' LEU . 0.5 OUTLIER -124.41 20.87 8.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.267 1.027 . . . . 0.0 112.385 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 . . . . . 0 N--CA 1.467 0.399 0 C-N-CA 127.052 2.141 . . . . 0.0 113.94 -175.381 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 494' ' ' GLN . 93.3 Cg_endo -80.12 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 1 C-N-CA 125.408 4.072 . . . . 0.0 109.254 175.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.4 32.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.726 1.61 . . . . 0.0 113.078 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.4 pp0? -77.16 -27.95 53.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.281 0.633 . . . . 0.0 112.568 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.01 3.63 1.61 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.5 160.05 82.06 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 122.911 0.484 . . . . 0.0 109.781 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.1 149.43 15.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.52 2.813 . . . . 0.0 111.434 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -76.09 65.92 2.18 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 121.731 0.777 . . . . 0.0 112.256 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 165.76 -27.75 0.19 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.494 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.73 162.1 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 122.988 0.515 . . . . 0.0 109.948 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -131.15 144.74 51.6 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 109.868 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.572 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.16 -30.62 70.51 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.3 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -72.15 0.41 9.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.903 -0.498 . . . . 0.0 111.771 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.1 16.19 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 122.945 0.498 . . . . 0.0 110.617 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.98 -19.87 5.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.552 0.741 . . . . 0.0 109.846 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -73.49 4.77 4.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.023 0.529 . . . . 0.0 111.637 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -83.95 5.9 23.82 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.438 0.695 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.01 152.15 53.77 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 123.868 0.867 . . . . 0.0 110.174 -170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.8 164.1 25.53 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.845 2.364 . . . . 0.0 111.311 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.55 63.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.106 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 -3.29 58.4 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 122.464 0.306 . . . . 0.0 110.953 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.2 -15.27 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -54.96 -38.92 68.39 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.08 -10.4 59.36 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 516' ' ' ILE . 11.2 mm-40 -89.38 -18.37 26.99 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.478 0.581 . . . . 0.0 111.186 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 515' ' ' GLU . 1.2 mp -107.91 -34.32 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.08 -9.07 14.15 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 171.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 m -63.14 -27.08 69.13 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 122.245 -0.284 . . . . 0.0 110.821 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 104.19 35.23 3.45 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -61.54 -179.96 0.2 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.613 1.197 . . . . 0.0 112.189 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.3 m -142.65 -171.97 3.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.162 -1.835 . . . . 0.0 108.91 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.76 13.13 8.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.233 1.013 . . . . 0.0 112.286 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -149.75 145.56 26.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.912 0.485 . . . . 0.0 110.252 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.2 m-80 -152.37 19.4 0.64 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.738 0.815 . . . . 0.0 110.105 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.02 -15.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.159 1.384 . . . . 0.0 112.445 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 124.072 0.949 . . . . 0.0 111.108 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.955 0.407 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.69 172.81 17.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.794 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.58 -179.64 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.548 0.739 . . . . 0.0 109.055 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -132.06 107.59 8.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -103.09 109.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.6 ttmt -93.54 139.11 31.12 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -86.9 176.0 7.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.044 0.938 . . . . 0.0 112.135 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.86 -20.84 59.46 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.577 1.151 . . . . 0.0 110.981 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -95.48 -2.83 47.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.968 -0.458 . . . . 0.0 110.471 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.56 24.64 27.8 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.278 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.55 140.07 52.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -109.42 159.23 17.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.546 -173.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -129.97 128.69 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -79.54 134.17 36.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -144.88 133.8 22.5 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -90.11 128.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.12 177.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 123.746 0.818 . . . . 0.0 110.104 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 75.0 mm-40 -141.6 163.08 43.34 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 124.602 1.161 . . . . 0.0 108.941 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 38.2 Cg_exo -55.46 3.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.668 3.579 . . . . 0.0 113.647 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 18' ' ' GLU . 19.2 t -134.0 -8.77 2.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.892 0.769 . . . . 0.0 111.482 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 8.2 m-20 -78.05 68.78 4.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.0 t -62.29 177.02 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.653 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.424 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.6 mm -51.29 -33.65 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -169.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.29 -22.14 61.99 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 119.266 0.939 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -81.79 -38.17 26.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.478 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 71.5 t -64.68 -40.54 89.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 110.138 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.6 mttt -56.86 -27.53 60.51 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.17 -23.04 44.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.427 0.558 . . . . 0.0 110.796 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 68.3 mmtt -69.76 -47.32 63.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.481 0.712 . . . . 0.0 109.434 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.44 -30.61 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.515 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.32 -39.4 78.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.71 0.29 . . . . 0.0 110.466 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.43 -31.25 70.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.31 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.35 -24.6 36.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.462 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.68 -34.53 0.68 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.63 8.7 13.7 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.74 126.48 88.45 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.13 153.78 73.98 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.672 2.248 . . . . 0.0 111.028 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.31 -17.33 39.66 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.617 2.878 . . . . 0.0 111.573 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.14 2.3 55.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.69 -16.76 10.66 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.91 164.13 24.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.619 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -154.53 124.18 6.59 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.535 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -123.4 135.12 53.97 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.871 0.305 . . . . 0.0 111.513 -168.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.535 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.7 mp -129.53 149.92 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -151.03 143.08 24.01 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.844 1.257 . . . . 0.0 109.07 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.69 13.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.516 0.726 . . . . 0.0 112.326 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.99 14.58 48.56 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.453 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 163.42 29.33 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.486 1.143 . . . . 0.0 110.178 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.84 128.27 45.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.4 OUTLIER -77.18 172.82 12.64 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.015 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -135.5 156.27 49.16 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.542 0.687 . . . . 0.0 111.206 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.97 2.31 8.95 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.869 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.86 14.57 21.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -115.26 -154.13 0.54 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.375 1.07 . . . . 0.0 108.758 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 40.4 p -150.43 166.52 29.87 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.344 1.058 . . . . 0.0 108.386 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.3 -30.48 71.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 17.0 t -74.91 -29.76 61.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.351 0.66 . . . . 0.0 111.136 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.42 -16.17 63.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.723 0.409 . . . . 0.0 111.606 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' B' ' 50' ' ' LEU . 18.0 m-85 -130.1 25.57 5.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.654 0.781 . . . . 0.0 110.245 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 46.75 25.68 0.47 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.24 128.47 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -132.38 -171.24 2.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.71 1.204 . . . . 0.0 109.705 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -58.37 140.66 53.22 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.969 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 54.12 24.43 4.84 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.235 1.014 . . . . 0.0 113.15 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.7 m -72.22 -19.18 61.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m 60.99 135.79 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.508 1.923 . . . . 0.0 112.184 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.9 179.93 6.43 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.534 0.734 . . . . 0.0 109.145 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.58 143.72 45.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.048 0.451 . . . . 0.0 110.886 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -134.4 142.02 47.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.834 1.254 . . . . 0.0 110.495 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 85.2 t -142.93 160.26 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -147.67 171.89 14.93 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.8 175.9 5.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.508 1.123 . . . . 0.0 108.977 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tp -124.4 18.98 8.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 127.041 2.136 . . . . 0.0 113.992 -172.732 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.2 Cg_endo -74.54 -164.03 0.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 125.125 3.883 . . . . 0.0 109.616 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 32.95 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.417 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 494' ' ' GLN . 0.0 OUTLIER -68.54 -36.7 79.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.56 2.34 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 112.047 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.09 161.12 75.14 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 122.985 0.514 . . . . 0.0 110.06 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 499' ' ' GLY . 75.1 Cg_exo -53.19 150.95 23.41 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.988 3.125 . . . . 0.0 112.18 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.55 35.82 0.19 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.87 0.843 . . . . 0.0 112.077 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -174.24 30.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.298 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.8 t -139.16 162.52 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 C-N-CA 123.619 0.768 . . . . 0.0 108.984 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.17 143.04 50.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.496 0.665 . . . . 0.0 110.046 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.557 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.78 -30.65 70.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.169 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.41 0.38 8.39 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.698 -0.626 . . . . 0.0 111.588 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.72 17.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.719 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.35 -21.58 5.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 109.706 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -72.37 10.15 0.86 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.283 0.633 . . . . 0.0 111.68 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -93.49 8.8 39.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.874 0.87 . . . . 0.0 110.743 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 31.4 mt -123.82 153.62 67.1 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.8 0.84 . . . . 0.0 111.331 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.8 158.49 56.72 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.987 2.458 . . . . 0.0 111.14 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.8 62.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.928 0.891 . . . . 0.0 112.847 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.17 -7.29 59.64 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.649 0.658 . . . . 0.0 111.133 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.79 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -65.21 -35.2 80.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 120.857 -1.152 . . . . 0.0 110.592 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.06 -1.78 8.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.42 0.288 . . . . 0.0 111.5 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.79 5.04 8.79 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.05 -39.21 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.96 -5.52 2.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.701 0.8 . . . . 0.0 109.503 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.8 m -142.16 27.66 1.75 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.272 1.429 . . . . 0.0 110.171 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.59 39.01 2.21 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.41 9.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.692 1.997 . . . . 0.0 115.421 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.9 m -142.4 171.09 14.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.746 0.819 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 1.1 tpm_? 60.57 12.92 3.87 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.65 1.58 . . . . 0.0 114.128 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.43 140.22 21.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.25 32.17 0.66 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.027 0.531 . . . . 0.0 111.786 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . 0.489 HD12 ' C ' ' A' ' 525' ' ' LEU 0.262 1.9 pp 50.95 5.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.086 1.754 . . . . 0.0 115.362 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.849 1.26 . . . . 0.0 112.471 -178.152 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.97 173.47 16.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.651 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.41 -179.61 2.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.3 133.25 51.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.86 107.12 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -84.71 132.8 34.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.981 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -76.1 173.52 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.096 0.958 . . . . 0.0 111.424 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.18 -23.19 66.47 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.794 0.838 . . . . 0.0 110.531 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -91.84 -10.46 39.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.924 -0.485 . . . . 0.0 111.322 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 28.75 7.1 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.37 -0.443 . . . . 0.0 113.751 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -121.82 145.57 47.93 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.51 158.02 25.28 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.7 mt -133.12 134.24 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -77.43 128.91 35.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 mt -137.24 130.33 30.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.97 126.97 35.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.009 0.923 . . . . 0.0 109.354 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.57 177.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.133 0.973 . . . . 0.0 109.447 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.4 mm-40 -136.9 162.49 55.52 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 108.619 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.69 5.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.487 2.792 . . . . 0.0 113.384 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.425 ' H ' ' C ' ' B' ' 18' ' ' GLU . 22.5 t -129.86 -8.93 4.45 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.626 0.648 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -81.11 76.01 8.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.7 t -66.08 177.1 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.445 -176.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' B' ' 27' ' ' LYS . 11.8 mm -52.12 -35.34 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.54 -21.73 65.45 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.934 0.788 . . . . 0.0 111.038 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -82.72 -42.67 17.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.6 -40.03 87.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 124.444 1.098 . . . . 0.0 110.395 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.8 mttt -58.75 -23.17 59.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.419 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.48 35.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.601 0.637 . . . . 0.0 110.762 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.26 -33.84 75.1 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.177 -0.327 . . . . 0.0 110.13 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -85.1 -30.51 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.85 -39.16 90.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.79 -31.81 71.94 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.232 0.539 . . . . 0.0 111.07 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -86.9 -22.09 25.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -135.16 -32.1 0.96 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.6 9.85 24.34 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -81.59 129.98 63.42 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.35 151.08 76.46 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.585 2.19 . . . . 0.0 110.826 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.52 -15.03 44.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.626 2.884 . . . . 0.0 111.37 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -88.15 -7.26 57.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -119.24 -9.85 9.86 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.5 176.26 4.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.176 0.898 . . . . 0.0 112.91 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -147.06 151.48 36.97 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 127.48 2.312 . . . . 0.0 105.768 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.46 ' C ' HD12 ' B' ' 44' ' ' ILE . 43.6 tp -146.71 116.8 7.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.308 0.958 . . . . 0.0 110.165 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.46 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.2 mp -125.11 142.23 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.574 0.75 . . . . 0.0 109.299 -174.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.539 ' CB ' HD22 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -161.32 158.41 26.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.564 172.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.12 20.89 1.93 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.33 73.62 Favored Glycine 0 C--N 1.341 0.847 0 C-N-CA 125.084 1.326 . . . . 0.0 112.57 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 161.73 35.8 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 117.693 0.746 . . . . 0.0 109.686 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -96.62 125.71 41.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.1 mp -74.76 159.75 31.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -124.92 148.4 48.36 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.49 0.662 . . . . 0.0 111.801 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.66 2.39 5.32 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.467 1.107 . . . . 0.0 111.672 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 15.61 23.61 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -121.14 -150.2 0.45 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 108.655 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -151.81 156.42 40.18 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 125.738 1.615 . . . . 0.0 108.871 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.79 -25.2 62.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -73.89 -24.29 59.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.265 1.026 . . . . 0.0 111.703 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.0 -15.19 60.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.254 0.621 . . . . 0.0 111.556 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 17.41 19.63 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.82 22.44 1.15 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.836 1.254 . . . . 0.0 114.227 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.81 144.78 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -132.82 178.67 6.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.918 0.887 . . . . 0.0 109.092 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -60.92 150.87 31.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.064 0.459 . . . . 0.0 111.253 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 60.06 17.68 6.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.869 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 87.6 p -70.08 179.48 2.32 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 109.934 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -134.61 126.85 30.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.539 HD22 ' CB ' ' B' ' 45' ' ' PHE . 14.3 mt -121.61 -171.77 2.29 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -138.41 143.96 39.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.034 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.453 HD13 ' C ' ' B' ' 69' ' ' LEU . 1.9 tm? -133.76 139.04 46.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.544 1.137 . . . . 0.0 109.944 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.94 165.89 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.411 HD12 ' C ' ' B' ' 71' ' ' LEU . 3.7 pp -138.49 172.66 12.56 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.25 0.477 . . . . 0.0 111.804 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -123.79 169.45 11.53 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.918 0.887 . . . . 0.0 110.078 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.58 13.49 20.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.986 0.915 . . . . 0.0 112.213 -170.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 126.409 1.884 . . . . 0.0 113.866 -175.095 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 494' ' ' GLN . 84.3 Cg_endo -76.18 -163.74 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 1 C-N-CA 125.392 4.062 . . . . 0.0 109.65 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.94 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.479 1.512 . . . . 0.0 112.868 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.1 pp0? -75.43 -26.26 58.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.49 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.15 5.68 1.3 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.67 157.51 90.0 Favored Pre-proline 0 N--CA 1.448 -0.55 0 O-C-N 121.923 -0.486 . . . . 0.0 110.163 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.16 154.66 27.36 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.857 3.038 . . . . 0.0 112.169 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -79.67 58.19 2.7 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 122.147 0.975 . . . . 0.0 109.866 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.98 28.34 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.142 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.13 163.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.527 0.663 . . . . 0.0 109.349 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.09 144.03 46.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.21 -31.98 73.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.621 -177.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.38 9.88 3.54 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.282 -0.886 . . . . 0.0 110.364 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 504' ' ' VAL . 95.7 t -129.71 10.24 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.563 1.145 . . . . 0.0 109.466 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -25.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.219 -0.925 . . . . 0.0 112.728 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -69.12 -8.32 44.31 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.85 0.75 . . . . 0.0 111.939 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -81.32 -10.55 59.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.11 0.413 . . . . 0.0 110.795 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.82 162.44 70.29 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 124.695 1.198 . . . . 0.0 110.15 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.51 165.05 33.43 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.625 2.216 . . . . 0.0 111.258 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.92 -8.89 5.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.434 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -103.05 -2.35 27.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.301 0.64 . . . . 0.0 111.544 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.07 -13.48 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.21 -2.25 33.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.318 0.647 . . . . 0.0 112.185 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -100.5 -15.32 17.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.316 0.507 . . . . 0.0 111.408 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.32 -35.42 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.31 -11.17 49.17 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 t -73.08 -45.0 59.76 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.637 0.256 . . . . 0.0 110.959 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 130.9 123.24 2.48 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -146.28 173.6 12.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.452 1.101 . . . . 0.0 109.001 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 t -153.6 -171.87 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.605 1.162 . . . . 0.0 109.127 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 62.78 21.26 12.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.705 1.202 . . . . 0.0 112.021 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -144.88 155.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.964 0.906 . . . . 0.0 109.542 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.626 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -149.05 10.7 0.8 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -173.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.4 13.55 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.869 -172.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.626 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 51.7 mtmt . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 124.448 1.099 . . . . 0.0 112.335 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -157.87 171.3 20.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.814 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -138.22 -179.73 2.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.09 108.29 8.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.03 117.04 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.58 132.52 36.25 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.392 0.277 . . . . 0.0 111.332 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -83.19 179.34 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.599 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.1 tm? -67.33 7.12 0.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.04 1.336 . . . . 0.0 110.846 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -125.65 11.42 7.89 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.165 -0.959 . . . . 0.0 111.981 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 28.29 66.23 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.84 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -126.55 145.56 50.48 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 159.67 22.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.481 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -127.99 125.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -73.09 133.56 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.35 130.04 21.52 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.36 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -90.36 129.0 36.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.06 -177.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.956 0.902 . . . . 0.0 109.637 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 37.6 mt-10 -144.14 162.87 38.21 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.85 2.86 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.818 2.345 . . . . 0.0 113.063 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.437 ' H ' ' C ' ' B' ' 18' ' ' GLU . 28.4 p -126.16 -12.06 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.679 0.791 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.7 m-20 -80.49 73.18 7.41 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 171.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.5 t -62.89 175.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.252 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.9 mm -51.08 -34.47 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -169.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.44 -22.65 64.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.553 1.07 . . . . 0.0 111.412 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.79 -36.45 25.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 83.3 t -68.08 -37.63 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 124.122 0.969 . . . . 0.0 110.207 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.0 mttt -60.96 -24.28 65.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.83 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.8 52.12 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.479 0.581 . . . . 0.0 110.771 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.487 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.7 mmtt -72.97 -50.59 22.4 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.565 0.746 . . . . 0.0 109.513 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -68.49 -31.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.52 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.96 -38.82 79.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.525 0.203 . . . . 0.0 110.77 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.78 -29.35 65.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.28 0.562 . . . . 0.0 111.405 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -80.48 -25.49 38.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.056 0.943 . . . . 0.0 113.227 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -138.0 -32.8 0.72 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.93 15.36 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.1 mt -76.15 128.63 82.44 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.85 155.47 62.28 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.694 2.263 . . . . 0.0 111.133 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.14 -16.06 43.91 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.897 3.064 . . . . 0.0 111.491 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.67 -13.38 51.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -114.88 -15.19 11.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.11 155.94 38.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.331 0.969 . . . . 0.0 111.21 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.56 90.99 1.84 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.658 1.183 . . . . 0.0 108.826 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.468 ' C ' HD12 ' B' ' 44' ' ' ILE . 18.1 mt -85.57 139.76 31.17 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.012 0.434 . . . . 0.0 111.333 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.468 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -130.97 148.16 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.828 1.251 . . . . 0.0 107.858 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -148.84 141.72 24.7 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.258 1.023 . . . . 0.0 108.686 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.96 12.29 0.08 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.592 0.757 . . . . 0.0 112.583 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.42 39.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.635 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 161.65 33.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.411 1.105 . . . . 0.0 109.766 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -95.78 145.13 25.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -99.51 169.17 9.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.712 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -136.28 153.74 51.09 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.338 0.59 . . . . 0.0 111.987 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -72.84 1.03 9.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.241 1.016 . . . . 0.0 111.54 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.59 8.79 32.42 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -110.56 -154.04 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 109.323 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.8 p -149.06 158.58 44.29 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.63 1.572 . . . . 0.0 107.434 171.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.29 -25.21 68.21 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.9 p -74.06 -24.86 59.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.59 1.156 . . . . 0.0 111.568 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.79 -16.43 61.63 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.182 0.593 . . . . 0.0 111.531 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -125.05 25.94 7.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.516 0.726 . . . . 0.0 109.6 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.33 20.06 0.26 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -60.14 136.9 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 118.572 0.624 . . . . 0.0 111.083 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -132.57 -172.62 2.95 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.26 1.424 . . . . 0.0 109.403 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -60.85 145.49 49.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.674 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 51.44 26.53 3.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.533 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 77.6 p -69.37 -21.17 63.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.419 1.088 . . . . 0.0 113.424 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m 59.87 126.07 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.176 2.19 . . . . 0.0 112.275 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -128.7 -175.88 3.67 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.068 1.347 . . . . 0.0 107.921 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -136.99 144.44 43.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -132.28 135.69 46.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.741 . . . . 0.0 110.088 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.22 166.89 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -146.26 171.99 14.14 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -104.99 177.73 4.77 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.999 1.32 . . . . 0.0 108.345 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.75 18.8 10.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.849 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 126.652 1.981 . . . . 0.0 113.761 -173.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 38.6 Cg_exo -61.2 -162.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 125.117 3.878 . . . . 0.0 111.468 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 31.65 0.71 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.669 1.188 . . . . 0.0 110.671 169.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -68.7 -28.56 66.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.684 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.94 3.33 0.82 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.43 0.692 . . . . 0.0 112.73 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.75 160.88 81.01 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.85 157.74 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.316 3.344 . . . . 0.0 112.582 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -77.44 68.13 3.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.977 0.894 . . . . 0.0 112.375 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 157.18 -26.77 0.49 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.284 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.88 167.38 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.066 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.8 147.88 41.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.656 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -64.2 -30.28 71.35 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.851 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.1 9.41 3.73 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.213 -0.93 . . . . 0.0 110.813 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 504' ' ' VAL . 81.9 t -129.96 9.28 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 109.522 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -19.17 0.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 113.071 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -71.55 -11.44 60.86 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.673 -0.642 . . . . 0.0 111.956 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.437 ' CD ' ' H ' ' A' ' 507' ' ' GLN . 9.6 mp0 -80.25 -9.47 59.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.016 0.371 . . . . 0.0 110.349 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.95 148.59 57.35 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 124.293 1.037 . . . . 0.0 109.44 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.35 164.45 23.03 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.658 2.239 . . . . 0.0 111.338 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.84 -21.52 63.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.888 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -87.42 1.45 53.36 Favored 'General case' 0 CA--C 1.524 -0.05 0 C-N-CA 122.692 0.397 . . . . 0.0 111.005 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 32.0 mt -119.34 -16.35 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -54.82 -41.39 70.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.93 -1.18 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.531 0.733 . . . . 0.0 112.487 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -105.77 -17.74 14.28 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.285 0.493 . . . . 0.0 111.9 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.49 -25.69 3.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.49 -5.79 12.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.319 0.248 . . . . 0.0 110.413 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 89.6 p -146.38 15.8 1.3 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -119.16 88.81 0.45 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -112.54 9.26 19.47 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -163.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.4 t -137.57 21.03 2.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.24 7.02 5.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.736 -0.602 . . . . 0.0 112.204 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.414 ' C ' ' ND2' ' A' ' 524' ' ' ASN . 1.1 pm0 -153.41 149.49 27.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.2 OUTLIER -144.27 17.43 1.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.28 1.032 . . . . 0.0 109.202 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.54 6.83 5.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.514 1.125 . . . . 0.0 109.876 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 49.5 mtmt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.519 1.128 . . . . 0.0 112.849 -173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 120.658 0.266 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -156.29 173.52 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.74 -179.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 123.654 0.782 . . . . 0.0 109.274 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.418 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 50.7 m-85 -133.57 94.95 3.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.114 0.483 . . . . 0.0 109.737 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -81.93 62.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.163 0.985 . . . . 0.0 111.771 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.5 ttmt -51.59 132.54 30.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.62 0.768 . . . . 0.0 111.28 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 65.9 p -76.06 175.47 8.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.128 -174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.28 -10.34 10.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.708 1.203 . . . . 0.0 110.675 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -112.67 -0.31 15.12 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 121.892 -0.505 . . . . 0.0 111.988 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 22.4 23.78 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.682 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.2 123.42 46.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.585 0.693 . . . . 0.0 110.149 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.9 OUTLIER -82.64 151.24 26.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 111.356 -177.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.35 120.42 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -77.9 136.78 38.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' B' ' 33' ' ' LYS . 67.1 mt -149.77 137.39 20.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.385 0.274 . . . . 0.0 110.976 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.67 128.7 42.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.8 -179.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.837 0.855 . . . . 0.0 109.358 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.442 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -142.15 164.0 36.38 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.454 0.701 . . . . 0.0 109.52 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 43.2 Cg_exo -54.72 1.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.465 3.443 . . . . 0.0 113.683 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.411 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.6 m -132.31 -7.77 3.35 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.805 0.729 . . . . 0.0 111.671 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 28.5 m-20 -81.39 68.61 7.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -63.33 178.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.191 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.46 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -52.74 -33.82 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -168.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.91 -23.43 63.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.224 0.92 . . . . 0.0 111.15 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -80.63 -41.66 23.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.04 -40.89 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 123.999 0.919 . . . . 0.0 110.077 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.5 mttt -56.55 -26.73 55.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.415 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 -28.39 34.98 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.627 0.649 . . . . 0.0 110.849 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.529 ' HB3' HD22 ' B' ' 15' ' ' LEU . 5.1 mptp? -65.47 -32.82 74.64 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -86.15 -30.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -66.49 -36.31 82.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.19 -34.81 76.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.142 0.496 . . . . 0.0 111.325 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.8 mmtm -79.03 -25.58 43.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.24 -31.23 0.91 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.92 10.28 22.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.1 127.36 77.09 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.0 154.13 67.09 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.807 2.338 . . . . 0.0 111.17 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.41 -14.25 41.96 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.717 2.945 . . . . 0.0 110.713 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.45 -8.78 58.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -123.42 -8.76 8.06 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.96 167.51 20.92 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.084 0.856 . . . . 0.0 111.731 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -154.24 138.94 17.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.47 ' C ' HD12 ' B' ' 44' ' ' ILE . 46.0 tp -134.92 135.58 41.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.796 0.725 . . . . 0.0 111.509 -169.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.47 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.3 mp -131.74 152.09 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.586 1.155 . . . . 0.0 108.667 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -149.31 138.67 21.53 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.59 1.156 . . . . 0.0 108.94 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.74 0.07 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.89 0.876 . . . . 0.0 112.876 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.42 13.17 36.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.407 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 159.48 36.81 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.631 1.216 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -93.8 150.52 20.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.486 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.6 mp -109.15 170.28 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.419 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -136.38 153.89 50.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.586 0.708 . . . . 0.0 111.539 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.45 -1.01 14.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.414 1.086 . . . . 0.0 111.983 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.2 8.11 32.97 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -106.08 -155.79 0.56 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.162 0.985 . . . . 0.0 109.198 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 35.8 p -150.82 166.25 31.08 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.203 1.401 . . . . 0.0 107.958 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -29.23 70.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 12.2 t -73.4 -31.53 63.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.108 0.963 . . . . 0.0 111.329 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.93 -15.82 60.02 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.551 0.34 . . . . 0.0 111.443 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -128.28 24.9 5.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.673 0.789 . . . . 0.0 109.92 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.65 24.63 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.375 1.87 . . . . 0.0 115.541 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.9 138.53 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.627 0.649 . . . . 0.0 109.851 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.61 -175.16 3.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.662 1.185 . . . . 0.0 109.753 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -59.45 144.7 46.29 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 53.51 24.87 4.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.388 1.075 . . . . 0.0 113.238 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -74.86 -17.68 60.55 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m 59.54 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.271 1.828 . . . . 0.0 112.865 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -127.59 179.87 5.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.663 1.185 . . . . 0.0 108.522 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -134.9 97.5 3.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.098 0.475 . . . . 0.0 111.449 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.89 143.77 45.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.233 1.013 . . . . 0.0 110.497 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 44.9 t -143.71 166.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.35 168.74 22.53 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.623 -0.673 . . . . 0.0 111.722 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -79.35 176.25 9.86 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.924 0.49 . . . . 0.0 111.657 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.89 14.32 29.69 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.26 0.624 . . . . 0.0 111.477 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 . . . . . 0 N--CA 1.462 0.162 0 C-N-CA 128.054 2.542 . . . . 0.0 114.708 -176.648 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 494' ' ' GLN . 98.0 Cg_endo -77.71 -161.39 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 125.279 3.986 . . . . 0.0 108.8 175.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.2 pt? -68.06 25.5 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.2 pp0? -65.22 -23.76 67.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.549 1.14 . . . . 0.0 112.656 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.85 6.26 1.79 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.49 ' CD2' HE21 ' A' ' 502' ' ' GLN . 8.2 mp -64.22 156.63 74.62 Favored Pre-proline 0 N--CA 1.447 -0.586 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 157.5 5.81 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.204 3.269 . . . . 0.0 112.252 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.92 67.23 2.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.892 0.853 . . . . 0.0 112.302 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 158.51 -29.02 0.44 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.272 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.4 163.9 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.593 0.757 . . . . 0.0 109.838 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.19 157.67 44.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.023 0.529 . . . . 0.0 110.811 -173.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.49 HE21 ' CD2' ' A' ' 496' ' ' LEU . 36.1 mm-40 -60.61 -45.51 93.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.972 0.509 . . . . 0.0 110.614 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.58 7.23 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.139 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.456 ' CA ' HE21 ' A' ' 507' ' ' GLN . 20.2 m -138.49 11.3 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.597 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -17.42 5.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.359 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.34 4.6 6.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.815 0.446 . . . . 0.0 111.302 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.456 HE21 ' CA ' ' A' ' 504' ' ' VAL . 10.2 mm-40 -81.38 7.15 12.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.057 0.943 . . . . 0.0 110.698 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 27.9 mt -121.92 155.01 61.17 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 123.837 0.855 . . . . 0.0 110.621 -168.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.4 167.28 27.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.525 2.817 . . . . 0.0 111.948 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.39 -15.31 24.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.214 1.006 . . . . 0.0 112.753 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -100.72 3.35 42.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.058 0.39 . . . . 0.0 111.786 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.9 mt -118.26 -15.45 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.85 -43.8 66.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.17 1.38 13.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.398 0.679 . . . . 0.0 112.805 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -104.29 -18.5 14.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.45 0.568 . . . . 0.0 111.388 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.27 -28.55 2.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.82 -2.54 9.74 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.168 0.587 . . . . 0.0 110.138 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 90.4 p -133.09 13.62 4.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.193 0.997 . . . . 0.0 111.076 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.79 39.37 2.12 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 2.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -141.25 -174.99 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.911 0.884 . . . . 0.0 109.953 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.85 6.58 4.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.884 1.274 . . . . 0.0 113.065 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.15 161.85 41.59 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.116 0.416 . . . . 0.0 110.898 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -149.79 33.75 0.69 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.762 0.825 . . . . 0.0 111.078 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.83 7.02 4.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.515 0.726 . . . . 0.0 110.741 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.453 -0.318 0 C-N-CA 124.434 1.093 . . . . 0.0 111.717 -176.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.95 173.12 17.25 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.034 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -135.0 175.81 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.403 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 53.2 m-85 -128.88 89.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.433 0.635 . . . . 0.0 110.167 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.38 103.38 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.161 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.2 ttmt -85.17 135.52 33.93 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -83.85 174.96 9.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.526 0.731 . . . . 0.0 112.368 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.31 3.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.14 1.376 . . . . 0.0 111.418 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -118.19 4.62 11.95 Favored 'General case' 0 CA--C 1.527 0.058 0 O-C-N 121.922 -0.486 . . . . 0.0 111.537 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.26 24.4 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.251 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.35 122.39 38.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.57 0.685 . . . . 0.0 110.134 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.7 OUTLIER -79.04 152.46 30.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.816 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.25 123.24 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -79.83 131.9 35.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -143.55 133.45 24.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.287 -174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.73 126.29 35.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -145.35 177.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 123.786 0.834 . . . . 0.0 109.919 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.1 mm-40 -138.91 162.24 53.66 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 124.05 0.94 . . . . 0.0 109.709 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 49.4 Cg_exo -54.58 -0.44 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 125.0 3.8 . . . . 0.0 113.896 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -130.91 -7.2 3.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.183 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 65.2 m-20 -81.55 69.62 8.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.9 t -62.9 177.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.808 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.411 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -51.79 -34.61 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.942 0.897 . . . . 0.0 113.215 -168.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.95 -22.42 63.18 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.094 0.861 . . . . 0.0 111.271 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -81.6 -40.85 22.38 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.9 -39.12 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 124.301 1.04 . . . . 0.0 110.217 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.411 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.7 mttt -57.4 -24.84 57.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.761 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.85 -28.34 33.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.509 0.595 . . . . 0.0 110.761 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -66.34 -33.32 75.46 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.06 -30.62 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.25 -39.35 86.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.695 0.283 . . . . 0.0 110.261 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.65 -31.67 71.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 111.243 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -83.71 -23.72 31.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.78 -32.84 0.88 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.81 9.03 21.61 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -78.2 129.47 75.18 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.47 151.44 70.72 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.574 2.183 . . . . 0.0 110.456 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 -14.47 37.37 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.23 2.62 . . . . 0.0 110.828 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.14 -8.64 59.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -124.07 -9.82 7.65 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -67.61 165.75 16.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.097 0.862 . . . . 0.0 111.655 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -154.47 102.58 2.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' B' ' 44' ' ' ILE . 28.5 tp -101.36 135.93 42.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.256 0.623 . . . . 0.0 110.949 -169.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.1 mp -129.81 154.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -118.52 -112.05 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 122.914 0.485 . . . . 0.0 110.494 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.99 -3.18 3.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.303 0.641 . . . . 0.0 111.732 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.88 3.03 2.08 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.553 1.073 . . . . 0.0 111.448 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 154.89 37.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.451 0.643 . . . . 0.0 109.567 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -87.96 128.62 35.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.619 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.639 HD22 ' H ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -76.14 172.71 12.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.602 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -133.63 153.44 51.67 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.663 0.744 . . . . 0.0 111.656 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.49 1.48 9.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 111.917 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.29 14.01 25.75 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -115.57 -154.59 0.55 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.353 1.061 . . . . 0.0 108.997 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.0 p -150.14 165.82 31.7 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.812 1.245 . . . . 0.0 108.142 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.14 -29.33 70.71 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 11.5 t -73.24 -31.36 64.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.654 0.782 . . . . 0.0 111.183 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.96 -15.7 63.23 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 122.87 0.468 . . . . 0.0 111.894 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' B' ' 50' ' ' LEU . 15.7 m-85 -130.49 26.44 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.846 0.858 . . . . 0.0 109.989 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.83 30.89 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 132.85 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.83 -174.0 3.79 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.477 1.111 . . . . 0.0 109.542 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -56.7 143.08 37.74 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.058 0.456 . . . . 0.0 111.477 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 53.45 27.79 6.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.201 1.0 . . . . 0.0 112.942 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -69.7 -27.37 64.94 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m 61.57 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.012 2.125 . . . . 0.0 112.043 -174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.54 -179.38 5.7 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.212 1.005 . . . . 0.0 108.806 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.51 151.95 50.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -138.55 142.64 39.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.573 0.749 . . . . 0.0 111.087 -175.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.12 165.32 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 126.352 1.861 . . . . 0.0 105.983 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.35 165.86 27.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.846 -0.534 . . . . 0.0 111.295 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -73.2 174.19 8.36 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.31 17.78 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.009 0.524 . . . . 0.0 111.087 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.463 0.205 0 C-N-CA 126.845 2.058 . . . . 0.0 113.693 -173.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 491' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 92.3 Cg_endo -81.59 89.28 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.972 3.781 . . . . 0.0 111.937 -168.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.8 tt 21.46 48.87 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.163 2.585 . . . . 0.0 112.214 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -95.95 -20.08 19.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.117 -172.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -145.57 6.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.79 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.15 151.64 93.31 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.15 164.05 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.836 3.024 . . . . 0.0 111.685 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.03 132.21 53.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.273 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 78.03 -23.02 2.76 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.698 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.99 163.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.71 1.255 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.91 164.83 28.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.182 0.593 . . . . 0.0 110.398 -173.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -66.72 -41.9 87.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.114 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.64 10.9 0.73 Allowed 'General case' 0 C--O 1.23 0.062 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.56 12.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.665 0.786 . . . . 0.0 110.35 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -134.48 -26.26 1.44 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.274 0.488 . . . . 0.0 112.073 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.37 -13.43 62.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 507' ' ' GLN . 8.6 mp0 -82.19 -12.07 58.34 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.195 0.452 . . . . 0.0 110.887 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.18 153.4 84.35 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 124.249 1.02 . . . . 0.0 109.508 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 166.29 30.4 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.1 2.533 . . . . 0.0 111.582 172.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.72 -22.19 56.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.554 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.04 3.16 55.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.995 0.362 . . . . 0.0 111.669 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.8 mt -117.94 -15.37 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -52.9 -44.63 67.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.84 -6.65 39.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.401 0.68 . . . . 0.0 112.469 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.86 -20.44 16.17 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.448 0.567 . . . . 0.0 111.039 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.76 -31.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.44 -3.31 8.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.745 0.418 . . . . 0.0 109.988 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -136.17 15.79 3.25 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.092 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -114.54 28.26 8.32 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.156 0.408 . . . . 0.0 112.199 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 1.45 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.2 t -136.01 32.3 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.79 -2.16 0.95 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.66 159.28 39.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -147.35 28.45 0.99 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.957 -172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.42 6.8 3.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.563 0.697 . . . . 0.0 110.073 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 C--N 1.338 0.097 0 C-N-CA 123.878 0.871 . . . . 0.0 112.222 -174.487 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -129.42 165.6 21.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.339 0.656 . . . . 0.0 110.75 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.78 166.64 2.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 164.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.541 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 8.9 m-85 -125.75 133.93 51.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -126.79 109.86 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -84.64 139.38 32.09 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.227 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -84.91 177.82 7.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.073 0.949 . . . . 0.0 112.082 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.42 6.08 0.87 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.791 1.236 . . . . 0.0 110.945 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -125.38 6.15 7.69 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.812 -0.555 . . . . 0.0 112.113 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.84 26.58 53.21 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 119.954 -0.359 . . . . 0.0 113.172 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -124.01 145.58 49.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.272 0.629 . . . . 0.0 109.465 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 8.0 m -122.82 147.18 46.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.215 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.9 mt -123.86 123.76 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -77.44 132.84 38.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -128.74 177.36 7.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 127.44 22.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -149.96 -179.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.087 0.955 . . . . 0.0 109.449 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -136.83 163.14 51.64 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.342 1.057 . . . . 0.0 108.358 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 2.7 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.205 2.604 . . . . 0.0 113.553 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -125.77 -6.44 6.82 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.976 0.807 . . . . 0.0 110.779 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -83.79 75.13 10.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 3.8 t -64.76 175.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.205 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.492 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.3 mm -50.49 -36.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.43 -21.78 65.54 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.325 0.966 . . . . 0.0 111.262 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -82.48 -41.85 19.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.69 -39.81 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.591 1.157 . . . . 0.0 110.134 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.8 mttt -56.09 -26.51 49.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.501 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.68 -27.76 45.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.421 0.555 . . . . 0.0 110.896 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -68.66 -33.01 73.26 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.01 -28.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.07 -39.74 82.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 122.298 -0.251 . . . . 0.0 110.329 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.63 -30.17 68.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 111.592 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -82.83 -23.7 33.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.937 0.895 . . . . 0.0 113.363 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -137.34 -35.82 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.27 9.13 13.58 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.19 127.11 84.18 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 153.18 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.558 2.172 . . . . 0.0 111.184 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.43 -16.03 42.7 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.459 2.772 . . . . 0.0 110.314 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -80.9 -6.32 58.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.769 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -121.46 -21.61 6.21 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.99 162.95 13.04 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.109 0.868 . . . . 0.0 112.998 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -152.08 127.63 10.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.425 ' C ' HD12 ' B' ' 44' ' ' ILE . 37.1 tp -127.29 132.21 50.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.957 0.344 . . . . 0.0 110.522 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.425 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -130.6 148.86 33.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 109.16 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -151.7 143.5 23.72 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.098 0.959 . . . . 0.0 109.36 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 12.48 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.772 0.829 . . . . 0.0 112.427 -172.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 16.39 41.69 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.211 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.3 159.51 36.72 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.71 1.255 . . . . 0.0 110.16 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -96.08 129.26 43.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.679 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.491 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.6 mt -81.46 162.23 23.37 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.755 -174.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -127.48 147.76 50.31 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.445 0.64 . . . . 0.0 111.82 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.45 0.34 8.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.361 1.065 . . . . 0.0 111.691 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.18 13.53 31.2 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -118.57 -149.64 0.44 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.306 1.042 . . . . 0.0 108.942 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.19 157.17 41.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 125.747 1.619 . . . . 0.0 108.65 176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -60.56 -25.11 65.94 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -72.74 -25.21 61.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.365 1.066 . . . . 0.0 111.482 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.7 -14.68 60.35 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.342 0.657 . . . . 0.0 111.558 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.491 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -114.04 17.27 17.92 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 117.804 0.274 . . . . 0.0 110.344 175.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.54 27.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.304 1.442 . . . . 0.0 114.187 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 145.96 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -125.33 -177.42 3.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.498 0.719 . . . . 0.0 109.474 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -72.2 145.14 48.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.649 0.738 . . . . 0.0 112.086 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 58.61 16.58 4.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 111.449 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -65.23 -176.54 0.31 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.93 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -130.26 134.79 47.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.097 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -132.19 -177.03 4.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.246 1.419 . . . . 0.0 108.871 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -136.02 147.79 48.1 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.262 0.225 . . . . 0.0 110.564 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -132.73 138.94 47.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.064 0.946 . . . . 0.0 110.691 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 82.2 t -146.97 165.88 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -145.46 168.25 21.02 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.914 0.779 . . . . 0.0 112.34 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.83 175.92 3.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.435 1.094 . . . . 0.0 112.056 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tp -96.45 16.44 18.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.617 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 127.595 2.358 . . . . 0.0 114.066 -175.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 494' ' ' GLN . 86.0 Cg_endo -79.34 -167.27 0.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.86 3.707 . . . . 0.0 109.128 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 33.1 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.645 1.578 . . . . 0.0 112.837 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.9 pp0? -74.19 -28.76 61.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.445 0.698 . . . . 0.0 112.599 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.72 5.41 1.77 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.1 159.96 84.02 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 122.497 0.319 . . . . 0.0 110.668 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.0 151.07 21.72 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.535 3.49 . . . . 0.0 112.408 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -80.94 54.5 2.21 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 122.301 1.048 . . . . 0.0 109.989 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.48 28.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.833 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.52 165.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.595 0.758 . . . . 0.0 109.03 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.14 145.93 40.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.885 0.874 . . . . 0.0 108.676 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.597 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -59.79 -29.7 68.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -72.42 1.12 8.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.441 0.564 . . . . 0.0 111.642 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.53 16.54 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.22 0.608 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.81 -15.4 5.96 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.084 0.954 . . . . 0.0 109.498 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -77.85 1.5 20.21 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.95 -0.469 . . . . 0.0 111.635 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.12 3.05 40.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.95 0.5 . . . . 0.0 110.003 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.58 149.35 39.75 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.723 1.209 . . . . 0.0 109.606 -170.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.8 161.63 44.69 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.036 2.49 . . . . 0.0 110.768 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.92 -21.59 63.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.403 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.3 -6.23 59.26 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 117.823 0.283 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 44.6 mt -110.97 -17.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 172.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -55.63 -42.04 74.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.09 -13.63 62.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 111.589 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.24 -15.02 26.33 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.658 0.383 . . . . 0.0 111.344 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.8 -37.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.33 -6.96 5.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.434 0.694 . . . . 0.0 110.187 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 45.0 m -65.59 -28.27 69.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.526 -0.274 . . . . 0.0 111.134 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.4 39.16 2.65 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -61.85 -179.81 0.22 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.642 1.21 . . . . 0.0 112.418 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -149.01 -167.44 2.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.493 -1.685 . . . . 0.0 109.214 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.65 19.43 11.71 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.077 0.951 . . . . 0.0 111.975 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -142.82 145.99 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.511 0.724 . . . . 0.0 109.41 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.452 ' HB2' ' HE2' ' A' ' 526' ' ' LYS . 0.1 OUTLIER -138.75 18.77 2.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.027 0.442 . . . . 0.0 111.927 -172.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.43 10.07 4.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.875 0.845 . . . . 0.0 109.671 -169.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 524' ' ' ASN . 31.2 mtmm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -158.1 174.23 15.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.954 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.36 175.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -124.4 117.9 25.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.37 101.73 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -82.35 134.36 35.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.898 0.479 . . . . 0.0 110.917 -173.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -80.46 175.35 10.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.456 0.702 . . . . 0.0 111.649 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.428 HD22 HG13 ' B' ' 70' ' ' VAL . 21.6 tp -66.91 3.67 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.261 1.025 . . . . 0.0 111.485 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -119.87 9.24 11.25 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.732 -0.605 . . . . 0.0 111.787 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.26 25.51 57.09 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 120.088 -0.284 . . . . 0.0 113.133 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.81 140.65 52.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.64 158.59 25.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.117 0.484 . . . . 0.0 111.572 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.12 131.95 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 130.47 36.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -139.52 130.19 25.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.3 128.25 35.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.93 179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.596 0.758 . . . . 0.0 110.416 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.6 mm-40 -132.73 160.08 69.89 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.12 1.4 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.246 2.631 . . . . 0.0 113.304 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 18' ' ' GLU . 33.7 p -124.56 -3.66 7.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.823 0.849 . . . . 0.0 111.049 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.02 69.03 6.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.528 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.9 t -58.5 174.4 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.805 1.242 . . . . 0.0 110.722 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.67 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 16.9 mm -50.39 -31.01 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.26 -19.7 62.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.037 -1.04 . . . . 0.0 111.519 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -86.07 -45.76 11.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.504 0.722 . . . . 0.0 110.714 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.67 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.3 OUTLIER -66.6 -28.72 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 C-N-CA 122.686 0.395 . . . . 0.0 110.643 -176.054 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.53 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.5 mttt -56.59 -29.48 62.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.312 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.8 -29.16 40.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.246 0.475 . . . . 0.0 111.25 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.84 -34.28 73.42 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.951 0.341 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -85.92 -27.79 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -69.57 -39.49 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.01 -31.88 72.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.622 0.725 . . . . 0.0 111.172 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -83.05 -22.52 33.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.61 -31.71 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 8.46 17.63 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -76.77 127.53 83.85 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.52 157.67 58.21 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.759 2.306 . . . . 0.0 111.48 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.64 -13.78 37.95 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.722 2.948 . . . . 0.0 110.338 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.5 -8.13 58.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -126.28 -11.44 6.36 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.35 162.49 28.48 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.341 0.973 . . . . 0.0 111.785 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -154.84 125.73 7.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.454 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.5 OUTLIER -122.41 139.63 53.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.005 0.366 . . . . 0.0 111.323 -168.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.454 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -134.4 150.93 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.789 1.235 . . . . 0.0 108.911 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.489 ' HB3' HD21 ' B' ' 50' ' ' LEU . 18.8 t80 -148.63 138.66 22.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.109 1.364 . . . . 0.0 109.05 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.5 13.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.72 0.808 . . . . 0.0 112.651 -174.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.89 15.07 40.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.077 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 157.2 42.64 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.004 1.402 . . . . 0.0 109.921 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -90.15 153.03 20.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.525 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.2 mt -109.53 161.94 14.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.197 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -128.49 144.27 51.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.253 0.549 . . . . 0.0 111.704 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.24 0.16 6.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.388 1.075 . . . . 0.0 111.7 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.71 11.7 32.6 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -114.69 -149.13 0.44 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.653 1.181 . . . . 0.0 108.775 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.4 p -154.5 158.49 39.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 125.807 1.643 . . . . 0.0 109.024 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.02 -29.29 68.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.64 -25.73 64.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.635 1.174 . . . . 0.0 111.723 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.11 -10.77 59.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.678 0.391 . . . . 0.0 111.054 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.525 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -117.39 17.19 14.67 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.33 13.57 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.7 143.99 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 119.027 0.831 . . . . 0.0 111.428 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 109.697 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.06 147.96 49.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.27 17.89 7.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.839 0.855 . . . . 0.0 112.068 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.5 t -70.98 175.05 5.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -132.39 133.88 44.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.479 0.712 . . . . 0.0 109.094 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.87 179.62 5.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.42 0.688 . . . . 0.0 110.045 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -134.07 138.67 45.47 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.615 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.72 137.87 48.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.666 1.186 . . . . 0.0 110.025 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.428 HG13 HD22 ' B' ' 8' ' ' LEU . 75.7 t -136.32 159.37 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pp -143.73 169.89 16.9 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.615 0.643 . . . . 0.0 112.733 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.17 -179.51 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 tp -126.87 18.31 7.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.898 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 . . . . . 0 N--CA 1.463 0.18 0 C-N-CA 127.412 2.285 . . . . 0.0 114.578 -173.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 494' ' ' GLN . 37.6 Cg_exo -59.09 -170.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 125.212 3.942 . . . . 0.0 112.041 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.15 29.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.809 1.243 . . . . 0.0 111.15 172.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -66.45 -34.74 78.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 112.953 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.48 11.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.841 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.538 HD12 HE21 ' A' ' 502' ' ' GLN . 87.8 mt -76.81 161.0 75.46 Favored Pre-proline 0 N--CA 1.448 -0.572 0 O-C-N 122.028 -0.42 . . . . 0.0 109.975 175.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.62 155.19 5.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.293 3.329 . . . . 0.0 112.649 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.6 64.88 3.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 122.031 0.919 . . . . 0.0 112.138 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 161.3 -28.55 0.29 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.075 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.41 164.42 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -139.15 160.82 38.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.081 -0.387 . . . . 0.0 110.856 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.538 HE21 HD12 ' A' ' 496' ' ' LEU . 1.5 mp0 -59.44 -51.54 69.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.82 0.848 . . . . 0.0 108.737 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.65 3.73 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.167 -1.379 . . . . 0.0 113.262 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.56 15.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.523 0.601 . . . . 0.0 111.719 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.05 -17.8 5.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.438 1.095 . . . . 0.0 109.435 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 502' ' ' GLN . 55.6 mtmt -75.8 0.66 17.24 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 111.604 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.26 -7.82 58.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.3 mp -89.49 156.06 48.22 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.829 1.252 . . . . 0.0 109.777 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.88 167.65 25.79 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.703 2.935 . . . . 0.0 111.183 170.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.9 -16.3 49.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.806 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.09 -2.03 41.05 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.495 0.588 . . . . 0.0 111.913 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.08 -16.06 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -44.94 70.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.491 -0.756 . . . . 0.0 109.367 170.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.54 -0.97 22.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.22 0.608 . . . . 0.0 112.505 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -105.04 -17.53 14.47 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.535 0.607 . . . . 0.0 111.745 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.22 -27.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . 0.433 ' O ' ' HE3' ' A' ' 520' ' ' LYS . 64.3 mt -74.48 -0.26 16.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.363 0.665 . . . . 0.0 110.892 172.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 44.8 m -136.03 24.76 3.3 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -142.55 -32.09 0.11 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 517' ' ' LEU . 51.0 mttt 43.96 26.52 0.14 Allowed 'General case' 0 C--N 1.339 0.139 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 169.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.8 t -148.98 173.15 13.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.32 11.6 2.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.131 1.372 . . . . 0.0 112.877 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -141.15 137.7 32.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.718 0.407 . . . . 0.0 110.255 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -150.4 23.68 0.81 Allowed 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.591 0.756 . . . . 0.0 109.778 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.28 8.28 3.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.181 0 C-N-CA 124.624 1.17 . . . . 0.0 112.539 -174.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.12 175.68 13.18 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.383 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 178.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.623 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 89.7 m-85 -134.84 99.22 4.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 110.0 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.22 133.27 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.12 134.03 53.03 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -79.52 178.18 8.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.35 1.46 . . . . 0.0 112.975 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.45 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.5 OUTLIER -73.73 14.04 0.42 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.986 1.315 . . . . 0.0 110.499 173.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.0 p -132.29 11.96 4.58 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.272 -0.893 . . . . 0.0 112.095 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.05 66.62 Favored Glycine 0 C--N 1.338 0.643 0 O-C-N 122.287 -0.258 . . . . 0.0 112.745 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -120.79 142.33 49.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.623 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 23.5 m -115.63 144.8 43.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.99 126.82 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -78.17 136.98 37.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -146.16 133.15 20.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -92.86 128.74 38.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.84 178.24 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.222 1.009 . . . . 0.0 109.258 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' B' ' 20' ' ' SER . 36.1 mt-10 -143.77 163.95 33.0 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.44 4.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.397 2.732 . . . . 0.0 113.354 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 18' ' ' GLU . 23.7 p -126.26 -12.41 6.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.705 0.802 . . . . 0.0 111.108 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.1 m-20 -83.83 71.64 10.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.7 t -61.5 174.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.282 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.25 -35.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -69.68 -22.32 63.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.421 1.009 . . . . 0.0 111.355 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -80.95 -36.49 30.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.485 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.8 t -67.13 -37.22 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 C-N-CA 123.936 0.894 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.01 -24.64 66.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.63 -23.51 53.34 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.49 0.586 . . . . 0.0 110.558 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.0 mmtt -72.99 -45.98 54.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.621 0.768 . . . . 0.0 109.282 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.04 -31.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -68.93 -38.65 79.63 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.431 0.292 . . . . 0.0 110.643 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.1 -30.29 68.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.314 0.578 . . . . 0.0 111.341 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -82.63 -22.88 34.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.73 -175.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -138.71 -31.72 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.77 9.56 20.66 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -76.71 130.68 75.67 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.43 153.89 50.33 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.761 2.307 . . . . 0.0 111.045 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.35 -15.45 45.72 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.47 -13.95 60.41 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.803 0.441 . . . . 0.0 112.123 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -125.39 -16.11 5.98 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.26 165.52 18.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.609 1.095 . . . . 0.0 112.795 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -160.23 152.38 20.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 24.0 mt -135.67 146.86 48.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.033 0.379 . . . . 0.0 110.48 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 149.01 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -149.25 139.63 22.38 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 108.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 112.813 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.4 13.76 37.55 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.593 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 160.71 32.38 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.457 1.128 . . . . 0.0 110.043 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -96.7 133.76 40.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.631 -170.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' B' ' 59' ' ' TYR . 22.6 mt -83.25 164.06 20.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.652 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -136.82 153.71 50.72 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-O 121.475 0.655 . . . . 0.0 111.686 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -72.26 0.4 9.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.752 1.221 . . . . 0.0 111.667 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.83 13.73 26.97 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -116.08 -154.14 0.54 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.314 1.045 . . . . 0.0 109.388 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.2 p -148.44 158.34 44.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.71 1.604 . . . . 0.0 107.603 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.1 -24.9 68.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -74.2 -25.78 59.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.361 1.064 . . . . 0.0 111.892 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.68 -15.58 62.22 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.528 . . . . 0.0 111.3 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.439 ' CD2' HD22 ' B' ' 50' ' ' LEU . 22.2 m-85 -125.9 24.13 7.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.315 0.646 . . . . 0.0 110.056 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 p30 47.87 20.49 0.23 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.111 1.764 . . . . 0.0 115.597 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.67 138.04 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.761 0.709 . . . . 0.0 110.188 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -128.41 -173.07 2.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.477 1.111 . . . . 0.0 110.033 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.68 141.74 58.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.801 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 54.68 22.11 3.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.381 1.072 . . . . 0.0 113.428 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -69.99 -15.37 63.02 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -173.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.7 m 57.97 133.71 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.984 2.114 . . . . 0.0 112.615 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -134.72 -177.69 4.73 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.327 1.451 . . . . 0.0 108.238 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -134.49 138.86 45.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.56 131.56 53.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.34 1.456 . . . . 0.0 110.133 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.03 159.63 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.12 165.98 26.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.791 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.23 153.94 29.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.0 109.995 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.74 23.25 6.37 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.691 1.596 . . . . 0.0 110.261 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? . . . . . 0 CA--C 1.523 -0.072 0 C-N-CA 127.053 2.141 . . . . 0.0 112.795 -170.203 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 494' ' ' GLN . 40.5 Cg_exo -58.7 -171.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.861 3.707 . . . . 0.0 111.225 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 29.56 0.07 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.689 1.195 . . . . 0.0 110.622 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -64.09 -36.89 85.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.31 1.044 . . . . 0.0 112.814 -174.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.63 3.31 1.46 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.88 155.01 92.68 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.85 151.83 7.8 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.917 3.078 . . . . 0.0 111.646 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -75.23 69.1 2.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.961 0.886 . . . . 0.0 112.634 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 162.51 -29.27 0.27 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.03 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.0 165.27 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.604 0.762 . . . . 0.0 109.568 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.78 145.73 36.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.562 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.16 -28.07 67.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.45 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.33 0.72 11.26 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.605 -0.684 . . . . 0.0 111.717 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.25 16.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.359 0.599 . . . . 0.0 110.603 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -17.49 5.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.714 1.206 . . . . 0.0 109.223 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.31 3.3 7.55 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.881 -0.512 . . . . 0.0 111.65 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -85.57 -6.16 59.2 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 508' ' ' LEU . 2.7 mp -93.15 155.91 40.72 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.329 1.451 . . . . 0.0 109.704 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.74 167.58 26.89 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.02 2.48 . . . . 0.0 111.547 170.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.27 -17.54 53.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.431 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.15 3.74 51.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.545 0.338 . . . . 0.0 111.767 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.87 -14.71 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.0 -41.47 67.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.02 -1.1 30.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.628 0.771 . . . . 0.0 112.375 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.93 -18.65 14.95 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.387 0.539 . . . . 0.0 111.306 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.02 -31.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.38 -3.77 15.59 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.806 0.443 . . . . 0.0 110.495 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . 0.414 ' HA ' ' HE3' ' A' ' 520' ' ' LYS . 50.3 m -131.99 10.86 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 111.41 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.48 -44.8 1.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 518' ' ' SER . 83.3 mttt 49.77 6.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 172.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 33.8 t -161.81 179.55 8.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.351 0.523 . . . . 0.0 109.963 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 70.43 3.04 4.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.116 1.766 . . . . 0.0 112.912 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -154.23 155.14 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.181 0.515 . . . . 0.0 110.931 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -145.55 29.12 1.15 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.54 6.95 4.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 109.851 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.457 -0.095 0 C-N-CA 125.091 1.357 . . . . 0.0 112.119 -176.636 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -158.84 176.04 12.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.867 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.66 177.42 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.3 115.54 17.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.51 126.06 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.0 ttmt -101.94 136.87 41.02 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.022 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.418 ' C ' ' H ' ' B' ' 9' ' ' THR . 73.5 p -86.74 178.66 6.95 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.104 0.962 . . . . 0.0 112.386 -171.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.575 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -70.0 12.96 0.17 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.981 1.312 . . . . 0.0 110.377 174.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.418 ' H ' ' C ' ' B' ' 7' ' ' THR . 28.1 p -126.26 5.68 7.05 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.165 -0.96 . . . . 0.0 111.758 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.57 62.3 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.592 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -125.85 140.44 52.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.493 0.646 . . . . 0.0 110.006 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -106.28 158.47 16.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.097 -175.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.24 125.89 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 19.8 m -75.41 132.28 40.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.4 mt -141.95 131.14 23.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.62 127.87 35.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.42 -179.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.777 0.831 . . . . 0.0 109.731 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 34.9 mt-10 -143.82 164.72 28.36 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 123.874 0.869 . . . . 0.0 108.921 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 32.9 Cg_exo -56.07 1.05 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.169 3.246 . . . . 0.0 113.449 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.409 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.7 m -131.78 -7.06 3.59 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.782 0.719 . . . . 0.0 111.651 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.5 m-20 -80.73 72.14 7.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.6 t -62.82 175.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.704 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.4 -34.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.16 -23.81 63.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.726 1.148 . . . . 0.0 111.139 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -81.12 -38.33 27.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.469 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 81.8 t -66.85 -37.88 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 123.695 0.798 . . . . 0.0 109.867 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -61.99 -23.52 66.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.039 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 -22.68 52.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.459 0.572 . . . . 0.0 110.541 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 64.7 mmtt -73.55 -48.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.62 0.768 . . . . 0.0 109.862 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.62 -30.8 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -69.46 -40.04 77.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.28 -0.262 . . . . 0.0 110.66 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.68 -30.76 70.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.463 0.649 . . . . 0.0 111.456 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -80.82 -25.1 38.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.926 -1.033 . . . . 0.0 113.449 -175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -138.03 -33.65 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.68 8.97 15.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.93 127.51 86.77 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.3 153.72 61.54 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.645 2.23 . . . . 0.0 110.693 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.59 -17.88 48.41 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 110.885 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.69 -5.34 58.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.46 -15.52 6.61 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.27 165.86 17.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.682 1.128 . . . . 0.0 112.413 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.471 ' C ' HD12 ' B' ' 44' ' ' ILE . 15.8 mt -129.17 138.62 51.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 110.785 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.471 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.5 mp -131.91 148.33 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.432 1.093 . . . . 0.0 108.585 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.16 141.19 23.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.065 0.946 . . . . 0.0 109.228 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.65 12.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.752 0.821 . . . . 0.0 112.608 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.51 14.63 40.37 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.458 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 158.84 37.98 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.833 1.316 . . . . 0.0 109.964 173.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -95.82 132.83 40.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.812 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.476 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.5 mt -80.23 159.79 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.156 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -128.86 150.06 50.5 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.513 0.673 . . . . 0.0 111.901 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -66.63 -18.71 65.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.737 1.215 . . . . 0.0 111.944 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.19 15.18 63.52 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -122.86 -151.56 0.48 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.429 1.091 . . . . 0.0 109.67 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 34.2 p -154.67 161.27 41.63 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.138 1.375 . . . . 0.0 108.881 174.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.54 -28.44 67.1 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.614 0.188 . . . . 0.0 111.226 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 31.0 t -75.47 -25.56 57.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.741 0.416 . . . . 0.0 110.736 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.45 -12.96 62.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.471 0.308 . . . . 0.0 111.369 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -116.39 19.45 14.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 p30 49.14 20.27 0.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.71 144.67 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 118.036 0.38 . . . . 0.0 110.043 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -130.14 -176.76 4.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.035 0.934 . . . . 0.0 109.963 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.93 146.8 54.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.24 16.82 7.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.298 1.039 . . . . 0.0 112.415 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -70.56 175.08 5.1 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -129.6 132.37 46.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.704 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -130.61 -177.1 4.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.473 1.109 . . . . 0.0 108.782 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -135.32 136.94 41.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.42 HD13 ' C ' ' B' ' 69' ' ' LEU . 3.0 tm? -124.16 131.87 53.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 0.0 109.566 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -142.65 166.13 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.84 172.39 13.4 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.12 178.71 5.79 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.257 1.023 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 73' ' ' LEU . 0.9 OUTLIER -132.42 17.97 4.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.327 1.451 . . . . 0.0 109.041 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 . . . . . 0 CA--C 1.53 0.185 0 C-N-CA 128.499 2.72 . . . . 0.0 115.645 -169.444 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 494' ' ' GLN . 85.6 Cg_endo -77.04 -162.95 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 1 C-N-CA 125.341 4.027 . . . . 0.0 108.969 175.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.3 pt? -67.68 25.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.0 pp0? -66.3 -24.44 66.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.66 1.184 . . . . 0.0 112.75 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.01 7.11 1.6 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.458 ' CD2' HE21 ' A' ' 502' ' ' GLN . 7.8 mp -61.72 160.34 27.93 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 158.36 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 124.011 3.141 . . . . 0.0 111.549 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.18 66.89 3.88 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.849 0.833 . . . . 0.0 112.695 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 156.44 -23.94 0.51 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.54 168.04 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.679 0.792 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.9 157.11 45.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.677 0.791 . . . . 0.0 110.563 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.458 HE21 ' CD2' ' A' ' 496' ' ' LEU . 35.6 mm-40 -61.19 -46.77 89.12 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.135 0.574 . . . . 0.0 110.692 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.94 7.87 0.84 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.63 10.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.425 0.69 . . . . 0.0 111.257 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.84 -10.54 7.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.668 0.787 . . . . 0.0 109.936 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.52 17.7 4.39 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 111.339 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -89.53 6.35 41.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.645 0.778 . . . . 0.0 110.95 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.31 62.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.925 0.89 . . . . 0.0 110.938 -170.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.35 166.4 23.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.303 3.335 . . . . 0.0 113.028 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -26.69 63.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.043 0.937 . . . . 0.0 111.832 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.07 -4.8 49.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.316 0.246 . . . . 0.0 111.447 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.14 -12.88 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.253 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 26.5 mm-40 -56.02 -40.73 73.86 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.64 -14.12 62.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.374 0.67 . . . . 0.0 112.412 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -89.96 -21.5 22.4 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.201 0.455 . . . . 0.0 111.464 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.43 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 53.0 mt -65.97 -0.05 2.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.1 m -133.76 17.58 3.89 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.792 1.237 . . . . 0.0 110.126 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -98.74 35.92 4.34 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.376 0.989 . . . . 0.0 111.38 -177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 0.37 0.06 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -177.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.9 t -149.56 173.05 14.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.497 0.719 . . . . 0.0 110.069 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.11 7.49 2.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.14 1.776 . . . . 0.0 113.682 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -155.39 150.88 27.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.385 0.539 . . . . 0.0 111.576 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.06 35.65 1.11 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.596 1.158 . . . . 0.0 109.383 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.62 4.46 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.122 0.969 . . . . 0.0 110.765 -172.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.87 1.268 . . . . 0.0 111.969 -176.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.637 0.256 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.75 174.75 14.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.831 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.29 -178.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 123.768 0.827 . . . . 0.0 109.029 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -134.83 106.23 6.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -97.45 112.79 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -92.62 129.81 38.44 Favored 'General case' 0 C--O 1.23 0.047 0 O-C-N 122.258 -0.276 . . . . 0.0 111.392 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.427 ' C ' ' H ' ' B' ' 9' ' ' THR . 74.4 p -78.65 177.89 8.26 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.591 1.156 . . . . 0.0 112.354 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.436 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -70.88 17.78 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.947 1.299 . . . . 0.0 110.425 175.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.427 ' H ' ' C ' ' B' ' 7' ' ' THR . 49.6 p -133.15 6.35 3.88 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 121.226 -0.921 . . . . 0.0 111.911 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.57 26.78 58.43 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 122.208 -0.307 . . . . 0.0 112.55 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -124.71 143.65 50.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.755 0.822 . . . . 0.0 108.877 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.12 159.12 26.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.585 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.02 130.4 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -79.63 131.9 36.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -143.4 133.56 24.4 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.754 0.252 . . . . 0.0 110.602 -173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -92.91 128.66 38.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.48 175.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.167 0.987 . . . . 0.0 109.534 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -135.49 160.84 66.32 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 124.259 1.023 . . . . 0.0 109.108 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.33 3.67 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.585 2.857 . . . . 0.0 113.502 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 18' ' ' GLU . 29.8 p -125.74 -6.7 6.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.861 0.864 . . . . 0.0 110.874 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -86.5 78.6 9.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.3 t -63.59 172.19 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.811 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' B' ' 26' ' ' VAL . 16.6 mm -55.05 -27.59 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -67.68 -20.24 65.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 120.644 -1.285 . . . . 0.0 110.645 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.67 -45.25 12.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 110.167 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.1 m -66.36 -33.52 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 123.193 0.597 . . . . 0.0 110.93 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.429 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.0 mttt -56.77 -32.11 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.862 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -27.39 46.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.251 0.478 . . . . 0.0 110.924 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -67.57 -32.59 73.45 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.187 0.449 . . . . 0.0 109.932 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -83.91 -31.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.17 -39.97 86.53 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.8 0.334 . . . . 0.0 110.273 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.18 -31.41 71.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.206 0.527 . . . . 0.0 111.183 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.6 -24.79 31.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.663 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -135.31 -35.04 0.84 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.83 7.86 16.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -77.87 128.26 79.65 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.57 154.8 55.09 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.053 2.502 . . . . 0.0 111.373 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.63 -14.41 41.92 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.352 2.701 . . . . 0.0 110.227 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.52 -8.02 59.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.84 -18.79 5.46 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.26 162.15 20.68 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.517 1.053 . . . . 0.0 112.167 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -151.58 136.15 17.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.438 ' C ' HD12 ' B' ' 44' ' ' ILE . 41.2 tp -134.18 136.23 43.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.241 0.473 . . . . 0.0 111.141 -168.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.438 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -132.52 150.74 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.266 1.026 . . . . 0.0 108.909 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -150.47 143.1 24.54 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.468 1.107 . . . . 0.0 109.287 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.94 13.42 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.545 0.738 . . . . 0.0 112.585 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.26 15.77 43.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.32 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 158.97 40.16 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.653 1.226 . . . . 0.0 109.966 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -90.74 150.32 21.67 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.811 -172.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' B' ' 59' ' ' TYR . 15.4 mt -106.93 162.7 13.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.162 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -133.1 148.5 52.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.091 0.948 . . . . 0.0 112.542 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.51 -1.81 9.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.284 1.034 . . . . 0.0 111.905 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.47 6.2 33.71 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -107.65 -147.97 0.41 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.367 0.584 . . . . 0.0 109.699 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.509 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.2 p -152.13 155.94 38.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.85 2.06 . . . . 0.0 107.743 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.31 -24.04 67.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.185 0.448 . . . . 0.0 110.05 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -71.19 -25.32 62.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.25 1.02 . . . . 0.0 111.494 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.11 -13.99 60.19 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.101 0.56 . . . . 0.0 111.531 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.526 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -115.06 20.7 14.83 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.29 21.21 0.34 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.83 140.11 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-O 121.213 0.53 . . . . 0.0 110.271 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.39 -173.93 3.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.912 1.285 . . . . 0.0 109.343 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.86 142.97 58.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.081 0.467 . . . . 0.0 110.717 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 54.29 25.26 5.71 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.173 0.989 . . . . 0.0 113.11 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.52 -15.44 60.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 60.11 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.34 1.856 . . . . 0.0 112.955 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.61 -178.12 4.86 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.377 1.471 . . . . 0.0 108.719 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -135.54 120.78 18.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.519 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 35.8 tp -103.25 136.03 43.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.729 1.212 . . . . 0.0 110.088 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.67 169.29 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.75 170.1 18.96 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.416 -0.803 . . . . 0.0 111.566 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.23 -177.2 5.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.795 0.838 . . . . 0.0 110.644 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.59 18.34 3.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 128.374 2.67 . . . . 0.0 114.799 -169.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 494' ' ' GLN . 58.5 Cg_endo -84.63 -159.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 1 C-N-CA 125.575 4.184 . . . . 0.0 108.073 174.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.429 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.1 pt? -67.14 27.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.0 pp0? -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 0.0 113.084 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.54 5.92 1.84 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.487 ' CD2' HE21 ' A' ' 502' ' ' GLN . 6.0 mp -60.85 138.48 93.66 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.17 159.99 11.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.793 2.995 . . . . 0.0 111.387 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.16 56.76 2.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.174 0.988 . . . . 0.0 109.903 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 176.24 27.75 0.03 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.423 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.95 162.34 13.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 124.128 0.971 . . . . 0.0 108.498 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.07 156.6 47.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 110.259 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.487 HE21 ' CD2' ' A' ' 496' ' ' LEU . 32.3 mm-40 -59.52 -40.64 87.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.055 0.542 . . . . 0.0 109.893 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.36 1.56 2.16 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.25 13.51 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 122.039 -0.413 . . . . 0.0 111.202 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.558 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.4 OUTLIER -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.288 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -73.66 -8.11 54.66 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.689 -0.632 . . . . 0.0 110.474 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.18 -5.74 58.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.544 1.138 . . . . 0.0 110.206 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 48.1 mt -87.1 155.81 54.92 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 123.976 0.91 . . . . 0.0 109.934 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.7 162.52 37.57 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.879 2.386 . . . . 0.0 110.811 169.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.09 -15.5 23.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.513 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -96.9 0.88 49.77 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.092 0.405 . . . . 0.0 111.343 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.2 mt -114.97 -19.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.081 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . 0.698 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -48.89 -54.59 14.76 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.38 -11.72 3.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . 0.424 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 7.8 mm-40 -91.8 -25.28 19.09 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.103 0.41 . . . . 0.0 110.498 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . 0.438 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 3.3 mm -95.72 -38.06 8.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 118.364 0.529 . . . . 0.0 109.691 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -68.83 -10.66 58.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 22.7 t -63.97 -55.78 19.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.359 0.664 . . . . 0.0 110.847 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 135.21 133.96 3.32 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 516' ' ' ILE . 59.3 mttm -143.14 158.43 43.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.088 0.955 . . . . 0.0 109.127 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.2 m -146.88 30.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.22 1.008 . . . . 0.0 113.003 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.34 15.78 2.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.973 1.309 . . . . 0.0 111.631 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 523' ' ' GLU . 1.0 OUTLIER -139.08 151.8 47.03 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.218 1.007 . . . . 0.0 109.441 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -148.59 27.97 0.89 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.3 0.64 . . . . 0.0 111.459 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.276 3.9 pp 48.13 12.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.722 1.609 . . . . 0.0 114.041 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 126.334 1.854 . . . . 0.0 111.606 178.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -158.8 174.08 15.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.166 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.58 179.22 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.45 99.62 4.72 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.55 124.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.1 ttmt -108.41 135.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.025 0.44 . . . . 0.0 111.455 -173.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -72.58 171.83 11.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.208 1.003 . . . . 0.0 112.436 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.58 -1.66 3.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.791 1.236 . . . . 0.0 110.336 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.9 p -115.93 -5.76 12.02 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.725 -0.609 . . . . 0.0 112.567 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.89 19.59 14.8 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.549 -0.584 . . . . 0.0 113.89 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -121.17 137.55 54.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.835 0.817 . . . . 0.0 109.744 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.4 OUTLIER -106.86 159.67 16.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.05 -174.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.72 127.22 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -78.67 132.84 37.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -143.96 132.98 22.8 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.655 0.264 . . . . 0.0 110.392 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.01 128.66 37.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 179.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.493 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.0 mm-40 -131.57 160.09 68.9 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.65 1.07 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.129 2.553 . . . . 0.0 113.5 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.6 m -125.27 -2.21 7.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.609 0.641 . . . . 0.0 111.067 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -80.25 68.04 6.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.511 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 2.9 t -57.4 173.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.877 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.662 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 14.1 mm -51.89 -28.29 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -168.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -73.37 -19.93 60.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.512 1.051 . . . . 0.0 111.435 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -85.35 -45.6 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.611 0.764 . . . . 0.0 110.834 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.1 OUTLIER -66.46 -28.31 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 122.667 0.387 . . . . 0.0 110.521 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.1 mttt -58.11 -29.9 65.86 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.862 172.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.95 41.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.957 0.344 . . . . 0.0 111.042 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.46 -31.19 71.78 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.074 0.397 . . . . 0.0 109.99 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.14 -30.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.65 -40.03 84.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.792 0.33 . . . . 0.0 110.204 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.72 -32.72 74.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.3 0.571 . . . . 0.0 111.223 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -82.02 -24.46 35.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.98 -34.52 0.8 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.08 8.12 15.73 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.5 mt -75.7 128.9 82.79 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.56 152.79 70.38 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.664 2.243 . . . . 0.0 111.071 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.98 -15.3 36.23 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.379 2.719 . . . . 0.0 110.566 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.84 -7.97 59.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -124.23 -15.72 6.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -65.52 164.9 13.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.139 0.881 . . . . 0.0 112.299 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -152.89 135.42 15.18 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 36.7 tp -131.83 138.11 48.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 118.568 0.622 . . . . 0.0 110.917 -168.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -134.93 149.18 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.306 1.043 . . . . 0.0 109.047 -172.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -153.2 146.57 24.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.016 0.926 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 15.2 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.195 0.598 . . . . 0.0 111.848 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.39 56.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.417 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 158.4 40.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.535 1.167 . . . . 0.0 109.87 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.92 144.47 26.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.721 -1.127 . . . . 0.0 107.98 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 17.2 mt -101.33 159.5 15.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.767 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -125.32 144.97 50.24 Favored 'General case' 0 CA--C 1.524 -0.054 0 CA-C-O 121.357 0.599 . . . . 0.0 112.085 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.64 -0.66 7.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.555 1.142 . . . . 0.0 111.827 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.76 11.57 38.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.79 -149.19 0.44 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 109.298 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -153.17 157.91 41.0 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.861 1.665 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.81 -28.96 69.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -68.4 -26.04 65.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.828 1.251 . . . . 0.0 111.779 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -75.13 -12.12 60.24 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.057 0.543 . . . . 0.0 111.603 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.29 17.74 14.62 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.89 27.39 1.59 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.637 1.575 . . . . 0.0 114.408 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.84 141.24 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -129.81 -174.03 3.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.696 1.199 . . . . 0.0 109.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.39 143.56 57.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.642 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 54.35 24.3 5.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.924 0.89 . . . . 0.0 113.244 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -72.4 -16.81 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.0 m 60.0 132.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.316 1.846 . . . . 0.0 112.674 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.62 -179.7 5.62 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.709 1.204 . . . . 0.0 108.776 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -135.64 122.51 21.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 110.72 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.09 140.46 36.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.107 1.363 . . . . 0.0 110.064 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.87 162.86 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.86 171.66 16.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.658 -0.651 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -91.25 174.9 7.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.429 0.692 . . . . 0.0 110.116 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.14 25.5 8.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.518 0.727 . . . . 0.0 110.268 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 113.61 -178.4 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 494' ' ' GLN . 71.6 Cg_endo -76.72 -167.1 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 1 C-N-CA 125.686 4.258 . . . . 0.0 109.862 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 32.09 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.866 1.267 . . . . 0.0 112.737 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -69.63 -35.39 75.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.73 4.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.351 0.661 . . . . 0.0 112.123 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.408 HD21 ' CZ ' ' A' ' 505' ' ' PHE . 99.0 mt -68.98 160.98 75.78 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 122.755 0.422 . . . . 0.0 109.923 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.62 147.77 38.09 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.785 2.99 . . . . 0.0 111.642 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.83 54.69 1.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.292 1.044 . . . . 0.0 110.257 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.67 25.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.165 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 45.0 t -136.47 162.02 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 118.357 1.079 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -121.67 143.65 49.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.264 0.626 . . . . 0.0 109.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.437 ' N ' HE21 ' A' ' 502' ' ' GLN . 0.0 OUTLIER -68.96 -32.44 72.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.645 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.87 10.63 1.73 Allowed 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.303 -0.873 . . . . 0.0 110.575 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 504' ' ' VAL . 83.1 t -129.86 8.52 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.585 1.154 . . . . 0.0 109.827 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 496' ' ' LEU . 0.0 OUTLIER -137.14 -23.37 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.247 -0.908 . . . . 0.0 112.738 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -69.47 -9.15 52.51 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.479 -0.763 . . . . 0.0 112.1 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 507' ' ' GLN . 10.1 mp0 -80.74 -11.0 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.945 0.339 . . . . 0.0 110.803 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.21 150.59 68.27 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.125 0.97 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.37 163.38 26.83 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.565 2.177 . . . . 0.0 111.165 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.54 -23.59 64.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.287 0.635 . . . . 0.0 112.117 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.66 -1.22 56.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 122.352 0.261 . . . . 0.0 111.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 33.1 mt -117.44 -13.88 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -55.24 -43.56 74.67 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.81 -5.74 40.15 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.387 0.675 . . . . 0.0 112.469 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.63 -17.41 17.04 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.254 0.479 . . . . 0.0 111.967 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.77 -28.47 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.61 -3.8 2.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.891 0.476 . . . . 0.0 110.049 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 52.5 m -137.24 17.51 2.97 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.725 1.21 . . . . 0.0 110.709 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -115.34 43.8 1.61 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.67 0.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.0 t -145.23 178.23 8.23 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.514 0.726 . . . . 0.0 110.232 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.21 2.03 3.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.822 1.649 . . . . 0.0 112.958 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.42 141.2 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.175 0.443 . . . . 0.0 110.726 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 526' ' ' LYS . 34.4 m-80 -144.18 36.67 1.24 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.429 0.692 . . . . 0.0 110.244 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 525' ' ' LEU 0.335 0.5 OUTLIER 56.84 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.387 1.875 . . . . 0.0 114.715 -177.486 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 C-N-CA 125.082 1.353 . . . . 0.0 110.352 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.277 0.084 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -157.2 173.23 17.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.05 179.98 3.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 123.823 0.849 . . . . 0.0 109.114 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -131.93 101.29 5.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.51 104.62 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -90.99 135.59 33.64 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.675 0.39 . . . . 0.0 112.02 -172.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.7 p -77.62 173.1 12.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.634 0.774 . . . . 0.0 111.973 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.94 -22.85 63.0 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.168 0.987 . . . . 0.0 110.321 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -94.61 -5.08 46.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.767 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.17 25.38 14.39 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.579 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -120.8 144.27 48.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.14 159.75 24.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 111.439 -173.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 mt -129.74 131.98 66.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 42.8 m -84.01 133.94 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.1 mt -145.39 138.29 26.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.26 127.3 44.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.9 176.73 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.069 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.54 161.87 60.56 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 108.795 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.63 1.59 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.293 2.662 . . . . 0.0 113.593 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -127.17 -5.89 6.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.586 0.63 . . . . 0.0 110.846 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -83.4 71.29 10.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.5 t -63.68 176.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.686 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.456 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.3 mm -51.55 -35.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -168.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.1 -20.71 65.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.296 0.953 . . . . 0.0 111.03 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -84.79 -42.73 14.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.49 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.382 1.073 . . . . 0.0 110.4 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.456 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.6 mttt -56.22 -23.61 36.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.945 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -27.11 31.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.35 0.523 . . . . 0.0 110.592 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.23 -36.43 77.2 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.052 0.387 . . . . 0.0 110.129 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -83.09 -32.43 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.07 -38.36 85.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.2 -32.56 72.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.295 0.569 . . . . 0.0 111.399 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -80.53 -24.75 39.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.205 1.002 . . . . 0.0 113.472 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.71 -31.26 0.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.58 9.44 23.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.06 131.24 76.14 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.51 157.57 61.28 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.427 2.085 . . . . 0.0 111.03 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.1 -11.07 30.8 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.868 3.045 . . . . 0.0 112.045 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.34 -5.5 29.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -126.11 3.54 7.18 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.5 -54.47 19.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 60.6 82.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.506 1.922 . . . . 0.0 110.919 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' B' ' 44' ' ' ILE . 26.2 tp -90.1 137.09 32.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.573 1.149 . . . . 0.0 111.173 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.513 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.0 mp -133.42 149.93 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.551 1.14 . . . . 0.0 108.881 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -153.62 149.85 28.02 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.035 0.934 . . . . 0.0 109.378 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.17 16.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.626 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.38 56.42 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.124 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 160.5 37.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.449 1.125 . . . . 0.0 110.759 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.67 124.42 38.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.521 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -79.49 164.25 24.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.524 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -126.79 147.86 49.98 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.4 0.619 . . . . 0.0 111.89 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.13 -1.91 16.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.11 0.964 . . . . 0.0 111.996 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.09 14.64 44.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -120.29 -149.84 0.44 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.578 1.151 . . . . 0.0 108.988 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.95 156.84 39.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 126.068 1.747 . . . . 0.0 108.903 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -60.57 -24.41 65.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -73.31 -25.03 60.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 111.41 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -75.57 -14.07 60.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.161 0.584 . . . . 0.0 111.818 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -115.74 21.18 14.1 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 p30 49.49 19.46 0.37 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.7 138.66 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 121.338 0.589 . . . . 0.0 110.56 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -130.38 -177.52 4.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.966 1.306 . . . . 0.0 108.871 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -60.61 145.16 49.97 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.022 0.439 . . . . 0.0 110.778 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 55.66 22.78 5.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.212 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -74.4 -14.23 60.83 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 74.9 m 61.16 130.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.187 1.795 . . . . 0.0 112.11 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.88 -179.9 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.601 1.16 . . . . 0.0 108.687 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -135.59 152.77 51.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -140.14 138.47 35.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.464 1.106 . . . . 0.0 108.528 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.91 68.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.89 163.88 1.78 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -72.61 -168.75 0.47 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.319 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.97 17.38 23.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.5 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 . . . . . 0 N--CA 1.465 0.318 0 C-N-CA 127.155 2.182 . . . . 0.0 114.416 -175.385 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 494' ' ' GLN . 96.2 Cg_endo -81.31 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 1 C-N-CA 125.47 4.113 . . . . 0.0 109.023 178.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.93 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.326 1.85 . . . . 0.0 113.181 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.7 pp0? -71.75 -27.2 62.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.052 0.941 . . . . 0.0 112.291 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -150.17 4.41 0.54 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 505' ' ' PHE . 4.2 mm? -61.75 142.87 94.49 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.253 0.479 . . . . 0.0 110.273 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.04 157.45 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.051 3.167 . . . . 0.0 111.226 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.12 57.41 2.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 122.52 1.153 . . . . 0.0 110.08 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.71 26.7 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.829 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 501' ' ' ASP . 60.5 t -147.44 164.34 6.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.693 0.747 . . . . 0.0 109.156 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 500' ' ' VAL . 6.2 t70 -134.45 144.0 47.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.0 109.419 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.549 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.0 -28.82 69.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.491 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -71.38 -0.9 11.28 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.694 -0.629 . . . . 0.0 111.824 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.84 18.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.626 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.0 OUTLIER -124.85 -20.93 4.86 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.24 1.016 . . . . 0.0 110.081 176.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -71.61 5.84 2.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -87.87 7.72 29.4 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.755 0.822 . . . . 0.0 110.578 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 39.1 mt -116.02 157.33 45.26 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 124.204 1.002 . . . . 0.0 111.258 -171.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.94 163.31 35.67 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.857 2.371 . . . . 0.0 110.373 167.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.19 -18.4 36.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.192 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.04 -4.93 58.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.103 0.561 . . . . 0.0 111.429 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.5 mt -117.32 -15.9 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . 0.684 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -51.61 -50.72 59.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.86 -14.1 13.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.06 -18.35 27.47 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.641 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.5 mm -104.37 -40.93 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . 0.684 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -64.62 -10.58 27.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.0 t -58.28 -35.71 72.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.113 0.565 . . . . 0.0 111.123 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 105.5 38.88 2.33 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -58.44 172.07 0.52 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.754 1.222 . . . . 0.0 111.912 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.4 m -146.37 34.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.759 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.6 15.63 4.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.745 1.218 . . . . 0.0 111.375 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.52 143.46 26.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.043 0.937 . . . . 0.0 109.176 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -148.77 38.4 0.83 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.217 0.607 . . . . 0.0 112.149 -168.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.41 19.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.804 1.642 . . . . 0.0 114.197 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -176.662 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.51 173.33 16.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.413 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.39 179.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 123.139 0.576 . . . . 0.0 109.774 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -133.18 106.28 7.49 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.43 69.39 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.908 0.483 . . . . 0.0 111.284 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -58.68 133.25 55.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.901 0.481 . . . . 0.0 111.519 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.39 175.58 10.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 8' ' ' LEU . 3.2 tm? -64.59 -23.44 67.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.354 0.662 . . . . 0.0 110.228 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.2 p -89.32 -22.07 22.83 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.905 -0.497 . . . . 0.0 110.39 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.52 4.69 21.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.021 0.368 . . . . 0.0 114.021 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -83.57 153.81 24.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.97 159.17 38.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.742 0.701 . . . . 0.0 109.398 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.77 126.75 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m -79.26 129.96 34.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -140.59 133.36 28.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.21 129.22 39.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.43 178.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.864 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.1 mm-40 -132.66 161.5 63.0 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.964 0.906 . . . . 0.0 108.579 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.7 3.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.98 2.453 . . . . 0.0 113.429 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 18' ' ' GLU . 59.8 m -125.79 -4.12 7.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.739 0.7 . . . . 0.0 110.825 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.1 76.92 10.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.2 t -62.34 171.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.8 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.582 ' HA ' HG22 ' B' ' 26' ' ' VAL . 12.2 mm -55.31 -28.04 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -168.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.1 -19.51 65.65 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.87 -1.144 . . . . 0.0 110.427 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -85.12 -46.11 11.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.853 0.861 . . . . 0.0 110.079 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' B' ' 23' ' ' ILE . 2.8 m -66.43 -34.48 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.118 0.567 . . . . 0.0 110.973 -173.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -56.33 -31.99 64.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.165 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.82 47.86 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.386 0.539 . . . . 0.0 110.856 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -68.1 -33.28 74.23 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.987 0.358 . . . . 0.0 110.086 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.77 -31.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.76 -39.4 87.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 -31.53 71.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.333 0.587 . . . . 0.0 111.275 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -83.95 -22.2 31.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -139.67 -30.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.53 8.26 19.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -76.17 128.56 82.56 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.67 154.8 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.493 2.128 . . . . 0.0 110.771 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.71 -14.19 38.71 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.543 2.829 . . . . 0.0 110.94 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.47 -6.21 58.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -118.99 -18.13 8.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.85 162.68 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.45 1.023 . . . . 0.0 112.339 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -155.03 128.76 8.62 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.439 ' C ' HD12 ' B' ' 44' ' ' ILE . 52.0 tp -133.36 128.73 36.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.893 0.315 . . . . 0.0 110.984 -168.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.439 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.4 mp -122.77 155.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -120.96 -111.69 0.33 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 122.695 0.398 . . . . 0.0 110.685 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.85 -4.9 3.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.302 0.641 . . . . 0.0 111.689 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.97 1.69 2.0 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.596 1.093 . . . . 0.0 111.519 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 154.71 33.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.704 0.764 . . . . 0.0 109.554 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.97 129.95 35.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.348 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.459 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.0 mt -77.68 162.67 26.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.83 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -127.98 146.92 50.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.432 0.634 . . . . 0.0 111.706 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.45 -1.33 10.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.438 1.095 . . . . 0.0 111.798 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 16.05 35.13 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -121.34 -148.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.307 1.043 . . . . 0.0 109.45 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.3 p -152.36 156.19 39.08 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 126.257 1.823 . . . . 0.0 108.357 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.04 -23.99 66.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -71.88 -25.29 61.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.281 1.032 . . . . 0.0 111.545 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.43 -12.88 60.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.098 0.559 . . . . 0.0 111.515 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.09 20.77 13.61 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.7 25.21 0.4 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.12 142.4 16.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.171 0.51 . . . . 0.0 110.112 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -130.39 -173.47 3.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.058 1.343 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.89 142.54 58.24 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.0 110.409 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 55.92 21.2 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.252 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -71.85 -16.61 62.15 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 84.4 m 62.33 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.16 1.784 . . . . 0.0 112.226 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -145.47 -176.48 5.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.728 1.211 . . . . 0.0 108.708 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -136.48 104.98 5.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.37 129.77 36.23 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.694 0.798 . . . . 0.0 109.146 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.24 52.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.431 0.634 . . . . 0.0 109.378 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.85 168.88 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 114.209 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -94.47 172.28 8.29 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.498 0.719 . . . . 0.0 109.802 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.9 26.31 9.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.948 1.299 . . . . 0.0 111.734 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 124.376 1.07 . . . . 0.0 112.504 -174.85 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 494' ' ' GLN . 87.6 Cg_endo -77.58 -167.61 0.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.95 3.766 . . . . 0.0 108.319 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.447 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.2 pt? -65.26 26.92 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -65.43 -28.91 69.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.471 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -148.09 6.39 0.78 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.79 159.38 85.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.59 155.0 22.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.853 3.035 . . . . 0.0 111.954 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -83.69 55.31 3.18 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 122.423 1.106 . . . . 0.0 109.509 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.74 26.5 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.995 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 501' ' ' ASP . 86.4 t -146.74 164.35 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . 0.425 ' N ' HG12 ' A' ' 500' ' ' VAL . 20.8 m-20 -135.49 143.13 45.66 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.036 0.934 . . . . 0.0 108.751 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.682 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.54 -24.11 67.03 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.852 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.94 1.84 4.09 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.737 -0.602 . . . . 0.0 111.601 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.53 11.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.672 0.789 . . . . 0.0 110.647 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -17.72 7.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.985 0.914 . . . . 0.0 109.875 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.72 3.15 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.957 -0.465 . . . . 0.0 111.345 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -88.65 -5.12 58.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 512' ' ' ILE . 4.1 mp -93.04 159.31 35.88 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.179 1.392 . . . . 0.0 110.128 -173.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.22 165.48 31.81 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.295 2.663 . . . . 0.0 111.325 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.75 -12.51 10.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.027 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.5 1.17 40.81 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.058 0.543 . . . . 0.0 111.43 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.447 HG22 HD23 ' A' ' 508' ' ' LEU . 52.0 mt -119.16 -14.48 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -43.91 67.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 169.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.74 -4.42 37.43 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.424 0.689 . . . . 0.0 112.388 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -100.12 -21.64 15.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.501 0.591 . . . . 0.0 111.433 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.69 -34.41 4.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.64 -3.35 3.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.667 0.387 . . . . 0.0 110.516 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 41.5 m -137.44 18.32 2.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.361 0.664 . . . . 0.0 111.409 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.54 -39.51 5.29 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp 49.43 1.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.7 t -167.76 -172.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.981 0.809 . . . . 0.0 109.818 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 68.0 11.56 8.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.469 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -153.92 154.34 33.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.559 0.343 . . . . 0.0 110.854 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.408 ' C ' HD23 ' A' ' 525' ' ' LEU . 60.7 m-80 -149.72 46.93 0.94 Allowed 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.856 0.863 . . . . 0.0 110.795 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 524' ' ' ASN . 1.1 pt? 44.14 19.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.961 1.704 . . . . 0.0 113.95 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.944 1.297 . . . . 0.0 112.625 -177.318 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -158.44 173.66 16.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.094 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.78 179.28 4.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -134.69 103.27 5.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.58 113.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.42 130.8 37.99 Favored 'General case' 0 N--CA 1.458 -0.052 0 O-C-N 122.205 -0.31 . . . . 0.0 111.222 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -72.3 174.37 7.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.417 1.087 . . . . 0.0 112.058 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.523 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.7 tm? -66.12 -5.02 8.56 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.073 0.949 . . . . 0.0 110.17 174.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -112.97 1.36 15.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.556 -0.715 . . . . 0.0 111.528 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.28 26.05 31.86 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.606 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -123.56 145.01 49.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.17 159.94 21.82 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.434 -174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -129.45 127.69 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -77.81 130.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.405 ' CD2' ' HG3' ' B' ' 33' ' ' LYS . 60.0 mt -140.67 131.23 25.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.11 127.32 35.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.622 0.769 . . . . 0.0 108.998 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.1 178.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.183 0.993 . . . . 0.0 109.444 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.8 mt-10 -141.45 163.81 39.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.19 2.25 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.531 2.821 . . . . 0.0 113.62 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.7 m -129.42 -5.64 4.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.058 0.845 . . . . 0.0 111.215 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 26.4 m-20 -82.89 68.32 9.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 9.2 t -61.25 179.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.921 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.597 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.4 mm -59.24 -11.91 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -168.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.85 -17.96 28.62 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.815 1.189 . . . . 0.0 110.483 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -85.02 -40.82 16.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.537 0.735 . . . . 0.0 109.993 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' B' ' 23' ' ' ILE . 20.4 m -64.36 -31.11 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 123.728 0.811 . . . . 0.0 110.155 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.53 -25.28 66.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.83 -26.44 29.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.314 0.507 . . . . 0.0 110.821 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -70.34 -36.5 74.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.096 0.407 . . . . 0.0 110.392 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -81.76 -30.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -68.16 -39.73 82.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.24 -31.21 71.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.246 0.545 . . . . 0.0 111.348 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' B' ' 15' ' ' LEU . 38.8 mmtm -82.5 -24.2 34.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.57 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -136.77 -33.82 0.77 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 9.52 17.66 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.8 mt -76.64 129.87 78.15 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.83 156.1 61.18 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 111.055 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.1 -14.14 40.01 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.967 3.111 . . . . 0.0 110.804 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -90.45 -3.0 57.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -123.91 -11.81 7.59 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.88 167.64 21.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.103 0.865 . . . . 0.0 112.464 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -158.67 134.55 8.95 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.93 1.292 . . . . 0.0 108.002 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.51 ' C ' HD12 ' B' ' 44' ' ' ILE . 16.7 mt -126.47 141.49 51.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.531 0.333 . . . . 0.0 110.43 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.51 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -129.31 148.72 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -148.36 134.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.833 0.853 . . . . 0.0 109.009 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.93 19.87 0.71 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.556 0.742 . . . . 0.0 112.827 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.59 25.37 39.17 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 123.04 0.352 . . . . 0.0 112.749 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.8 ttmm -123.37 125.59 45.28 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.119 0.568 . . . . 0.0 110.756 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -76.57 110.8 11.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.598 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -68.63 171.11 8.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -174.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -132.52 152.85 51.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.676 0.751 . . . . 0.0 112.004 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.88 -1.82 15.67 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.455 1.102 . . . . 0.0 111.892 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.28 15.06 36.23 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -117.88 -154.7 0.57 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.326 1.05 . . . . 0.0 109.16 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.7 p -149.64 159.67 44.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.599 1.56 . . . . 0.0 107.9 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.62 -27.27 69.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -71.25 -25.75 62.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.34 1.056 . . . . 0.0 112.143 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.95 -16.94 61.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.828 0.451 . . . . 0.0 111.323 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.599 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.1 m-85 -128.64 26.87 5.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.187 0.595 . . . . 0.0 110.065 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.84 28.47 0.59 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.82 132.91 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.8 -173.11 3.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 109.747 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.12 142.24 37.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.093 0.473 . . . . 0.0 111.264 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 52.97 27.14 5.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.806 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.9 p -69.59 -24.96 63.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m 59.99 127.65 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.019 2.128 . . . . 0.0 112.161 -174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -131.29 -176.83 4.15 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.094 1.358 . . . . 0.0 108.238 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -135.56 135.26 40.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.93 135.16 55.0 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.748 1.219 . . . . 0.0 110.085 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -139.37 160.2 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 71' ' ' LEU . 1.1 pt? -146.64 172.16 14.01 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.98 -177.19 5.7 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 123.968 0.907 . . . . 0.0 112.76 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tp -110.02 22.09 16.02 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.901 0.881 . . . . 0.0 111.422 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 126.809 2.044 . . . . 0.0 113.352 -174.675 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.1 Cg_endo -77.33 -165.47 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 125.113 3.875 . . . . 0.0 109.319 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.517 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.3 pt? -69.92 27.65 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 492' ' ' PRO . 4.2 pp0? -64.5 -25.91 68.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 0.0 111.785 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -149.88 4.8 0.57 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.88 162.16 74.8 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 122.105 -0.372 . . . . 0.0 110.561 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.61 151.42 31.39 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.183 3.255 . . . . 0.0 111.616 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.74 55.33 2.35 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 122.196 0.998 . . . . 0.0 109.939 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 168.93 31.33 0.02 OUTLIER Glycine 0 CA--C 1.527 0.816 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.019 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 49.0 t -141.86 165.03 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.801 0.801 . . . . 0.0 109.657 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.9 141.04 47.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.391 1.076 . . . . 0.0 109.306 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.597 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.17 -33.73 76.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.074 -177.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.76 5.2 3.33 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.54 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.41 ' HA ' HE21 ' A' ' 507' ' ' GLN . 16.5 m -136.9 11.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.513 0.725 . . . . 0.0 111.013 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.14 -13.68 8.92 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.835 0.854 . . . . 0.0 109.939 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -82.68 18.76 1.46 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.412 0.685 . . . . 0.0 111.921 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 504' ' ' VAL . 25.2 mm-40 -94.46 7.69 44.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.542 0.737 . . . . 0.0 111.415 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 156.81 69.37 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.594 1.158 . . . . 0.0 110.495 -171.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.35 164.66 22.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.157 3.238 . . . . 0.0 113.054 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -59.11 -25.48 63.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.622 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.94 -6.56 51.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.47 0.308 . . . . 0.0 111.251 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 18.1 mt -118.1 -12.74 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 170.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 23.6 mm-40 -58.41 -39.7 80.46 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.84 -11.03 60.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.391 0.676 . . . . 0.0 112.204 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.69 -19.35 21.92 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.255 0.48 . . . . 0.0 111.553 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.61 -27.18 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 65.7 mt -64.47 -2.96 2.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.4 m -138.42 21.0 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.959 1.304 . . . . 0.0 110.024 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -107.23 46.64 1.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.476 1.036 . . . . 0.0 110.993 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -56.46 2.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.3 t -149.06 -175.95 5.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.468 0.651 . . . . 0.0 111.039 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 65.76 3.79 2.64 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.523 1.929 . . . . 0.0 114.652 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -155.36 148.58 24.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.1 0.864 . . . . 0.0 111.43 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 526' ' ' LYS . 37.1 m-80 -147.19 43.83 1.14 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.952 0.901 . . . . 0.0 111.116 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 525' ' ' LEU 0.298 3.2 pp 50.19 9.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.623 1.569 . . . . 0.0 114.051 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 524' ' ' ASN . 43.5 mtmt . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 127.752 2.421 . . . . 0.0 110.368 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.704 0.288 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.4 172.94 17.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.251 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.48 -177.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.602 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 96.2 m-85 -130.66 128.25 40.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.77 121.13 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.27 142.6 33.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -172.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -88.37 178.79 6.47 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.146 1.379 . . . . 0.0 112.912 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.598 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.1 tm? -70.97 6.47 1.54 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.839 1.255 . . . . 0.0 110.239 173.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -124.55 9.0 8.35 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.94 -1.1 . . . . 0.0 111.993 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.74 60.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 120.133 -0.259 . . . . 0.0 113.211 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -119.76 139.48 52.24 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 9.0 m -113.43 142.5 45.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.41 132.9 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -87.08 133.79 33.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 mt -142.6 135.04 27.78 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.47 130.3 37.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 109.086 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.57 179.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.788 0.835 . . . . 0.0 109.89 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.433 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -140.21 163.46 43.77 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.86 2.92 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.463 2.775 . . . . 0.0 113.722 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.416 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.0 m -127.73 -7.1 5.63 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.771 0.714 . . . . 0.0 110.971 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.6 m-20 -79.82 67.57 5.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 171.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.1 t -59.61 175.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.786 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.422 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.8 mm -49.94 -34.73 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.55 -21.39 61.89 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.363 0.983 . . . . 0.0 111.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -81.76 -37.21 27.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.47 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.5 t -64.77 -39.4 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.226 1.01 . . . . 0.0 109.862 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -59.04 -28.08 66.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.758 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -24.13 54.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.516 0.598 . . . . 0.0 110.6 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 69.1 mmtt -69.76 -44.54 69.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.528 0.731 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.12 -30.22 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.581 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.57 -40.74 80.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.29 -30.55 70.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.176 0.512 . . . . 0.0 111.352 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -85.63 -19.58 30.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.5 -40.01 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.361 0.528 . . . . 0.0 112.001 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.29 9.04 12.14 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.6 mt -79.18 128.53 75.62 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.34 151.98 66.08 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.76 2.306 . . . . 0.0 110.812 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.65 -15.48 41.2 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.251 2.634 . . . . 0.0 110.441 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -7.97 59.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.781 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -124.3 -13.39 7.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -69.96 165.18 22.28 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.619 1.1 . . . . 0.0 111.999 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -154.64 141.49 19.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.483 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -135.95 139.48 43.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.567 0.621 . . . . 0.0 111.398 -169.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.483 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -130.85 148.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.751 0.82 . . . . 0.0 109.197 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -149.87 134.16 17.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.935 0.894 . . . . 0.0 108.867 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.3 19.98 0.86 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.59 0.756 . . . . 0.0 112.504 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 24.29 44.96 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 123.009 0.338 . . . . 0.0 112.55 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.602 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.7 ttmm -120.56 124.56 45.62 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 122.797 0.439 . . . . 0.0 110.432 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -75.93 108.79 9.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' B' ' 59' ' ' TYR . 1.0 OUTLIER -68.02 170.26 8.64 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.452 -174.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -132.49 153.64 50.7 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 121.64 0.733 . . . . 0.0 111.393 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.76 3.01 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.408 1.083 . . . . 0.0 111.769 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.96 16.8 20.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -118.25 -154.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.598 1.159 . . . . 0.0 109.087 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -148.88 159.58 44.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.304 1.442 . . . . 0.0 108.479 172.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.31 -27.62 69.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -25.2 60.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.361 1.064 . . . . 0.0 111.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.81 -18.88 61.42 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.302 0.641 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.602 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 22.9 m-85 -129.23 26.76 5.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.553 0.741 . . . . 0.0 109.991 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.27 31.01 0.74 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.18 125.12 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -131.18 -173.25 3.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.456 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.24 141.39 35.56 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 111.585 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.5 24.96 3.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.666 1.186 . . . . 0.0 113.627 174.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -70.67 -17.68 62.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m 59.41 130.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.17 2.188 . . . . 0.0 112.32 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -138.89 -178.34 5.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.392 1.077 . . . . 0.0 109.076 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.85 147.34 48.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.912 0.387 . . . . 0.0 111.275 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.5 tp -132.66 137.97 47.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.282 1.433 . . . . 0.0 110.033 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -143.84 165.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.37 170.56 15.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.876 0.762 . . . . 0.0 112.833 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.98 178.08 5.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.1 0.96 . . . . 0.0 111.377 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 21.54 15.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.008 -173.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 . . . . . 0 N--CA 1.463 0.217 0 C-N-CA 127.2 2.2 . . . . 0.0 114.183 -176.197 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.5 Cg_endo -80.25 -167.45 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.609 4.206 . . . . 0.0 108.905 174.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.03 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 112.972 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 492' ' ' PRO . 3.1 pp0? -76.83 -26.0 53.86 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.28 1.42 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.551 HD22 HE21 ' A' ' 502' ' ' GLN . 6.5 mp -64.84 160.94 50.63 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.53 154.46 24.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.68 2.92 . . . . 0.0 110.851 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.8 66.41 5.27 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.845 0.831 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 164.22 -24.1 0.18 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.114 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 78.3 t -68.0 169.0 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.522 0.729 . . . . 0.0 110.281 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 0.4 OUTLIER -135.42 153.91 51.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.716 0.806 . . . . 0.0 110.665 -175.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.551 HE21 HD22 ' A' ' 496' ' ' LEU . 36.2 mm-40 -63.77 -43.73 95.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.51 8.36 0.85 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.024 0.53 . . . . 0.0 112.335 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.476 ' CA ' HE21 ' A' ' 507' ' ' GLN . 19.1 m -138.2 9.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.13 0.572 . . . . 0.0 111.097 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -122.0 -20.69 6.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.336 0.654 . . . . 0.0 110.062 178.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.56 7.75 2.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.203 0.601 . . . . 0.0 111.927 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.476 HE21 ' CA ' ' A' ' 504' ' ' VAL . 14.5 mm-40 -84.29 8.63 15.36 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.996 0.918 . . . . 0.0 111.357 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.43 159.67 56.52 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 123.18 0.592 . . . . 0.0 112.215 -167.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.95 164.35 31.77 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.249 2.632 . . . . 0.0 110.567 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.89 56.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.914 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.74 -5.75 59.33 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.875 0.47 . . . . 0.0 111.691 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.441 ' CD1' HD11 ' B' ' 44' ' ' ILE . 40.3 mt -118.51 -15.26 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -53.34 -41.66 66.0 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.337 -0.852 . . . . 0.0 108.863 169.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.29 -19.14 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.953 0.501 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -85.48 -21.51 28.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.888 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 518' ' ' SER . 2.6 mm -98.05 -31.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 118.916 0.78 . . . . 0.0 109.253 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.92 -0.97 2.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 110.078 172.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 516' ' ' ILE . 10.5 t -135.64 16.65 3.35 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.508 1.123 . . . . 0.0 110.63 177.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -100.98 38.43 3.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -1.65 0.11 Allowed 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -174.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.3 t -151.45 175.01 12.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.527 0.731 . . . . 0.0 109.919 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.48 3.78 3.0 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.701 1.6 . . . . 0.0 113.579 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.52 156.16 34.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.796 0.438 . . . . 0.0 111.04 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -156.64 27.1 0.33 Allowed 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.85 -0.27 1.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.997 0.919 . . . . 0.0 111.163 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -169.426 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.391 0.139 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.18 173.98 15.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.19 -178.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.263 1.025 . . . . 0.0 109.182 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.428 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 55.5 m-85 -133.21 86.94 2.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.485 0.66 . . . . 0.0 109.974 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -80.41 101.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.948 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.5 ttmt -85.51 140.58 30.55 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.843 0.457 . . . . 0.0 111.358 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -84.82 173.21 10.81 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.71 0.804 . . . . 0.0 111.575 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.23 -16.69 55.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.7 0.8 . . . . 0.0 110.88 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -97.47 -0.65 45.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.048 0.539 . . . . 0.0 110.538 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.67 25.98 26.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.094 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -118.93 120.27 36.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.467 0.633 . . . . 0.0 110.491 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.8 OUTLIER -75.95 155.85 34.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.253 0.549 . . . . 0.0 110.947 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.26 112.78 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -71.65 133.87 45.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' B' ' 29' ' ' LYS . 64.2 mt -150.23 136.53 18.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 122.309 0.243 . . . . 0.0 111.035 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.4 126.62 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.429 HG12 ' HE3' ' B' ' 29' ' ' LYS . 28.4 m -144.4 179.13 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.323 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -131.06 160.73 65.54 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.011 0.924 . . . . 0.0 108.803 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.19 0.6 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.769 2.98 . . . . 0.0 113.569 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -125.46 -4.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.662 0.664 . . . . 0.0 110.802 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -80.71 65.49 5.88 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -59.95 177.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.566 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.672 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 15.9 mm -52.93 -24.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 113.831 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.17 -19.73 50.21 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.694 1.134 . . . . 0.0 111.558 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.17 -44.08 13.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.613 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER -65.61 -26.22 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 123.046 0.539 . . . . 0.0 110.389 -177.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 91.2 mttt -59.97 -31.29 69.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 122.202 -0.311 . . . . 0.0 111.285 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.06 53.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.297 0.499 . . . . 0.0 110.597 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.538 ' HB3' HD22 ' B' ' 15' ' ' LEU . 3.9 mptp? -67.64 -36.06 80.06 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -85.57 -28.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -66.87 -39.04 87.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.39 -33.06 74.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.388 0.613 . . . . 0.0 111.386 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.514 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.5 mmtm -83.14 -21.22 33.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -137.9 -34.59 0.67 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.511 0.596 . . . . 0.0 112.56 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.89 9.05 19.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.9 mt -77.29 130.37 74.97 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 153.85 67.55 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.47 2.113 . . . . 0.0 111.112 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.54 -15.97 38.22 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.321 2.68 . . . . 0.0 110.493 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.9 -7.82 59.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -124.03 -14.32 7.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -70.15 164.67 23.68 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 112.726 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -154.69 146.61 23.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -129.32 145.01 51.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.451 0.569 . . . . 0.0 111.001 -170.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -136.67 148.23 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.583 1.153 . . . . 0.0 108.385 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -149.14 138.91 21.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.354 1.062 . . . . 0.0 108.992 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.62 12.51 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.622 0.769 . . . . 0.0 112.669 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.03 14.19 40.31 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.524 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 159.88 33.76 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.622 1.211 . . . . 0.0 109.46 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -92.1 153.65 19.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.756 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.447 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.8 mp -116.76 166.38 12.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -137.31 153.79 50.2 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.496 0.665 . . . . 0.0 112.191 -173.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.49 -1.89 12.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.449 1.1 . . . . 0.0 111.697 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 7.1 37.69 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.99 -154.51 0.53 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.906 0.883 . . . . 0.0 109.451 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 3.1 p -149.72 160.21 43.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.027 1.731 . . . . 0.0 107.823 173.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.63 -27.08 68.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -71.7 -26.71 62.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.92 1.288 . . . . 0.0 112.138 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.44 -15.81 61.82 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 122.749 0.419 . . . . 0.0 111.261 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -126.52 27.83 6.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.648 0.779 . . . . 0.0 109.699 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.91 28.2 0.34 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 171.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.75 140.4 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.525 0.602 . . . . 0.0 109.611 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -130.71 -174.52 3.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.602 1.161 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.81 144.29 56.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.66 21.72 3.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.861 0.865 . . . . 0.0 113.159 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -72.92 -17.32 61.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 75.4 m 61.41 139.47 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.326 1.851 . . . . 0.0 112.104 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -141.27 179.92 6.49 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.114 0.566 . . . . 0.0 109.505 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.49 139.27 43.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.405 0.282 . . . . 0.0 110.523 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.436 ' C ' HD13 ' B' ' 69' ' ' LEU . 2.6 tm? -130.24 134.78 47.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 110.075 -172.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.434 HG12 ' N ' ' B' ' 71' ' ' LEU . 52.4 t -142.13 168.47 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.434 ' N ' HG12 ' B' ' 70' ' ' VAL . 1.2 pp -142.74 170.46 15.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.975 -0.453 . . . . 0.0 111.676 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -66.78 168.47 9.54 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.595 0.758 . . . . 0.0 110.879 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.17 18.57 22.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.182 0.593 . . . . 0.0 110.591 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 127.506 2.322 . . . . 0.0 114.898 -177.742 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.458 ' CD1' HD21 ' A' ' 517' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 494' ' ' GLN . 90.3 Cg_endo -78.89 -168.3 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 124.641 3.561 . . . . 0.0 107.711 170.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.08 31.56 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.666 1.586 . . . . 0.0 113.74 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -69.2 -32.45 71.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.944 0.897 . . . . 0.0 112.466 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 517' ' ' LEU . . . -146.03 2.38 0.9 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 497' ' ' PRO . 64.1 mt -71.8 150.11 92.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 496' ' ' LEU . 51.4 Cg_exo -56.99 158.49 17.24 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.779 2.986 . . . . 0.0 111.696 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.55 55.59 2.0 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 122.241 1.02 . . . . 0.0 109.673 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.41 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.094 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 501' ' ' ASP . 95.4 t -141.31 166.14 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.762 0.825 . . . . 0.0 109.578 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 500' ' ' VAL . 2.9 m-20 -143.66 139.17 29.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.575 1.55 . . . . 0.0 107.08 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.675 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.97 -28.29 68.79 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.393 -177.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.67 3.91 5.74 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.338 -0.851 . . . . 0.0 111.161 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.416 ' N ' HE22 ' A' ' 507' ' ' GLN . 27.3 m -137.23 17.36 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.472 1.109 . . . . 0.0 110.225 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.62 -19.41 1.38 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.466 0.706 . . . . 0.0 111.622 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -72.09 -0.31 11.46 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.371 -0.831 . . . . 0.0 112.649 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 504' ' ' VAL . 7.5 mp0 -95.95 -7.92 35.22 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.691 0.678 . . . . 0.0 109.851 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.38 159.91 78.8 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.06 163.72 37.46 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.974 2.449 . . . . 0.0 111.253 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -15.17 20.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.841 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -95.98 -1.31 49.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.552 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 54.9 mt -115.45 -16.99 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -41.75 66.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.8 -5.57 51.23 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 28.4 mm-40 -97.49 -24.1 15.74 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.806 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.4 -35.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 495' ' ' ALA . 88.5 mt -66.47 -8.0 23.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 15.3 t -72.76 -50.23 25.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.68 0.392 . . . . 0.0 111.468 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 144.37 141.91 3.82 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.841 -2.503 . . . . 0.0 106.841 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 515' ' ' GLU . 71.6 mmtt -149.36 176.73 10.3 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.931 0.893 . . . . 0.0 109.223 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -157.7 179.43 9.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.473 1.509 . . . . 0.0 108.868 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.3 OUTLIER 60.83 21.73 11.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.461 1.104 . . . . 0.0 112.671 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -146.85 147.1 30.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.739 0.415 . . . . 0.0 110.247 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -148.44 40.25 0.92 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.475 0.71 . . . . 0.0 110.902 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.286 4.4 pp 47.75 13.18 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.932 1.693 . . . . 0.0 114.228 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 126.411 1.884 . . . . 0.0 111.225 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.725 0.298 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -155.17 175.23 14.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.87 -177.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 123.958 0.903 . . . . 0.0 108.627 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.573 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 99.9 m-85 -136.36 97.72 3.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.268 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.61 135.16 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -117.17 136.74 52.82 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.092 0.472 . . . . 0.0 111.742 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -73.12 173.84 8.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.737 1.215 . . . . 0.0 112.047 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.09 0.28 4.88 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.256 1.023 . . . . 0.0 110.792 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -118.27 -3.14 11.04 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.2 20.4 18.2 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.8 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -119.57 138.86 52.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.871 0.835 . . . . 0.0 109.86 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 6.3 m -111.41 152.38 27.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.012 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.75 131.6 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -86.37 135.05 33.66 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -146.36 134.23 21.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.696 0.225 . . . . 0.0 110.939 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.93 125.94 38.85 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.546 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.46 175.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.945 0.898 . . . . 0.0 109.872 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -135.36 163.05 53.69 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.318 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.54 1.7 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.466 2.777 . . . . 0.0 113.599 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -127.05 -3.41 6.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.716 0.689 . . . . 0.0 110.997 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.25 75.27 8.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.0 OUTLIER -61.08 171.31 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.157 0.983 . . . . 0.0 110.178 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' B' ' 26' ' ' VAL . 13.0 mm -54.37 -28.3 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.64 -18.72 65.06 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.836 -1.165 . . . . 0.0 110.487 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -86.33 -45.93 10.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.132 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.4 m -66.34 -33.79 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 122.664 0.386 . . . . 0.0 110.989 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' B' ' 23' ' ' ILE . 93.8 mttt -56.26 -32.98 65.01 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.855 172.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.18 -27.88 53.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.995 -0.441 . . . . 0.0 110.948 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -67.08 -32.05 72.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.26 -31.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.99 89.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.91 -31.9 71.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.271 0.558 . . . . 0.0 111.231 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -84.1 -22.47 31.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -135.96 -36.2 0.76 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.89 8.3 15.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.3 129.63 74.45 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.75 152.52 69.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.632 2.221 . . . . 0.0 110.842 -176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.41 -15.22 41.7 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.23 2.62 . . . . 0.0 110.73 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.01 -6.86 59.47 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -125.32 -11.51 6.9 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.37 165.0 25.4 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.518 1.054 . . . . 0.0 112.208 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -153.59 142.56 21.2 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.408 ' C ' HD12 ' B' ' 44' ' ' ILE . 39.0 tp -136.14 138.41 41.97 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.128 -0.358 . . . . 0.0 110.711 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.408 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -133.43 150.23 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.188 0.995 . . . . 0.0 108.87 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -148.5 139.12 22.79 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.542 1.137 . . . . 0.0 109.092 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 10.41 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.713 0.805 . . . . 0.0 113.034 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.66 12.14 36.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.675 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.14 159.88 32.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.632 1.216 . . . . 0.0 109.651 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -95.61 138.5 33.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.903 0.881 . . . . 0.0 108.753 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.519 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.9 mp -95.7 157.13 16.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -125.22 148.69 48.53 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 121.433 0.635 . . . . 0.0 112.164 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.02 -0.11 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.178 0.991 . . . . 0.0 111.89 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.35 8.28 37.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -108.88 -147.71 0.42 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.594 0.758 . . . . 0.0 110.517 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.521 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.0 p -152.13 157.07 41.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 127.313 2.245 . . . . 0.0 107.378 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.26 -26.25 68.69 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 121.361 0.601 . . . . 0.0 109.871 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -66.43 -25.11 66.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.853 1.261 . . . . 0.0 111.765 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.82 -12.01 59.94 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.447 0.699 . . . . 0.0 111.903 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.443 ' CE2' HD11 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -117.68 21.3 13.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 46.95 27.27 0.7 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.66 141.78 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.109 0.413 . . . . 0.0 110.262 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -130.31 -177.84 4.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.53 1.132 . . . . 0.0 108.747 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -60.96 143.26 55.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 53.53 26.27 5.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.415 1.086 . . . . 0.0 113.418 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -72.65 -14.91 61.7 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 61.53 141.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.467 1.907 . . . . 0.0 112.367 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.98 -177.07 5.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.55 129.9 33.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 110.728 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.6 tp -112.28 141.5 45.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.252 1.421 . . . . 0.0 110.467 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.12 161.0 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.422 HD23 ' H ' ' B' ' 71' ' ' LEU . 1.4 pt? -148.84 171.69 15.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.684 -0.635 . . . . 0.0 112.677 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.58 173.58 6.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.128 0.971 . . . . 0.0 109.568 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.51 25.59 6.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.539 0.735 . . . . 0.0 109.631 -178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 . . . . . 0 N--CA 1.465 0.299 0 C-N-CA 126.677 1.991 . . . . 0.0 114.454 -178.689 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 494' ' ' GLN . 74.7 Cg_endo -75.72 -172.53 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 124.744 3.629 . . . . 0.0 109.605 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 31.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.445 1.498 . . . . 0.0 113.152 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.1 pp0? -75.29 -25.97 58.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.812 0.845 . . . . 0.0 112.629 -176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.11 2.62 1.17 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.2 162.47 72.96 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 122.959 0.503 . . . . 0.0 110.566 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 152.54 15.31 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.281 3.32 . . . . 0.0 112.397 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.1 66.62 2.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.802 0.81 . . . . 0.0 112.064 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 159.49 -25.04 0.32 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.668 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.86 166.55 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.363 0.665 . . . . 0.0 110.584 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.94 143.03 40.56 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.127 0.971 . . . . 0.0 109.317 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.562 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.52 -34.47 76.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.25 -177.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.51 4.53 5.9 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.883 -0.511 . . . . 0.0 111.754 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.401 ' HA ' HE21 ' A' ' 507' ' ' GLN . 11.7 m -135.12 11.29 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.402 0.681 . . . . 0.0 110.535 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -14.99 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.395 1.078 . . . . 0.0 109.545 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -85.44 29.27 0.69 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.566 0.746 . . . . 0.0 111.228 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 504' ' ' VAL . 28.8 mm-40 -103.65 7.83 37.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.931 0.893 . . . . 0.0 111.153 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.52 156.9 63.33 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.615 1.166 . . . . 0.0 110.348 -172.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 162.87 30.87 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.981 3.12 . . . . 0.0 112.856 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -27.3 64.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.7 0.8 . . . . 0.0 112.064 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -9.2 58.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.219 0.208 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.28 -15.68 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.278 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 12.9 mm-40 -57.85 -39.54 77.97 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.484 1.038 . . . . 0.0 108.9 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.7 -16.24 64.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.169 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -90.29 -8.78 50.03 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.246 -0.406 . . . . 0.0 111.76 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.59 -34.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.56 -6.58 11.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.373 0.669 . . . . 0.0 109.678 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 49.4 m -138.32 26.77 2.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.062 1.345 . . . . 0.0 109.485 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -129.67 43.45 1.31 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -63.48 7.2 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.262 2.225 . . . . 0.0 115.063 -170.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -146.97 -177.64 5.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.29 0.636 . . . . 0.0 109.708 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.86 -2.84 2.57 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.472 1.509 . . . . 0.0 112.941 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -157.24 152.56 26.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.936 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.18 34.2 1.21 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.411 1.084 . . . . 0.0 110.045 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.9 6.06 2.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.789 0.804 . . . . 0.0 110.728 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 111.696 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.584 0.231 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.73 172.7 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.55 -179.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.06 101.04 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.39 126.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.9 ttmt -102.82 133.88 47.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 111.903 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -82.13 178.2 8.4 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 112.416 -172.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.449 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -71.67 14.43 0.19 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.689 1.196 . . . . 0.0 110.284 173.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -129.32 5.66 5.26 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 120.871 -1.143 . . . . 0.0 112.418 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 25.58 58.46 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.855 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -121.44 142.26 50.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -111.24 157.21 20.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.3 128.9 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -74.84 133.24 41.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.3 mt -145.12 133.59 21.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.329 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.25 126.5 39.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.11 177.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.844 0.858 . . . . 0.0 109.762 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -136.18 162.21 57.86 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.762 0.825 . . . . 0.0 110.117 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 35.1 Cg_exo -56.36 0.85 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.38 3.387 . . . . 0.0 113.371 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 27.5 p -129.43 -6.59 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.845 0.858 . . . . 0.0 111.191 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.27 74.23 10.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.3 t -62.43 174.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.192 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.561 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.7 mm -56.02 -26.08 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.69 -17.69 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.439 -1.413 . . . . 0.0 110.706 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -88.58 -43.86 11.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.86 0.864 . . . . 0.0 110.598 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.6 m -63.96 -31.24 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 C-N-CA 122.736 0.414 . . . . 0.0 110.597 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -56.58 -31.57 64.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.368 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.95 -30.32 55.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.448 0.567 . . . . 0.0 110.569 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.0 mptp? -70.03 -33.9 72.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -85.81 -30.12 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.95 -39.97 83.31 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.34 -31.05 71.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.158 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -83.43 -21.4 32.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -138.13 -36.32 0.6 Allowed 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.72 8.49 13.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.79 129.82 80.35 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.55 153.41 65.29 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.408 2.072 . . . . 0.0 111.224 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.23 -17.47 39.95 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.273 2.649 . . . . 0.0 110.653 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.49 -4.84 57.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.838 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -124.8 -15.43 6.47 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.94 163.06 28.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.866 1.212 . . . . 0.0 113.479 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -161.91 146.11 12.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.045 1.338 . . . . 0.0 107.627 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.41 ' C ' HD12 ' B' ' 44' ' ' ILE . 4.2 mp -132.87 160.44 36.96 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.134 0.493 . . . . 0.0 111.728 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.41 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.1 mp -135.71 149.3 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 107.988 -176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' B' ' 50' ' ' LEU . 54.8 t80 -151.74 144.26 24.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.999 0.92 . . . . 0.0 109.355 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 14.09 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.526 0.73 . . . . 0.0 111.985 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.1 16.2 51.45 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.287 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 158.06 40.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.745 1.272 . . . . 0.0 109.867 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.16 145.44 26.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.55 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.486 HD22 ' CD1' ' B' ' 59' ' ' TYR . 14.3 mt -102.99 148.96 25.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.047 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -121.69 149.22 43.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.501 0.667 . . . . 0.0 112.064 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.74 2.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.211 1.004 . . . . 0.0 111.852 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.36 16.5 19.65 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.55 -148.59 0.41 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.591 1.156 . . . . 0.0 108.496 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.2 p -153.9 160.29 42.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.693 1.197 . . . . 0.0 108.851 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.14 -27.09 68.14 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.236 -0.29 . . . . 0.0 110.633 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 16.5 t -73.29 -28.52 62.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.94 0.496 . . . . 0.0 110.791 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.15 -12.69 61.35 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.65 21.14 13.15 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 174.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 47.97 22.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -57.47 141.69 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-O 121.208 0.528 . . . . 0.0 110.766 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -131.33 -177.54 4.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.141 1.376 . . . . 0.0 108.79 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -64.04 147.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.034 0.445 . . . . 0.0 110.955 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 53.78 25.92 5.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.819 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -72.88 -21.33 60.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 69.5 m 60.67 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.072 2.149 . . . . 0.0 112.622 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.53 -174.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.85 1.66 . . . . 0.0 108.155 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -137.49 149.83 47.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 69' ' ' LEU . 2.7 tm? -134.44 133.22 40.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.949 1.3 . . . . 0.0 109.5 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 163.67 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.11 168.89 18.67 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -76.35 -176.27 3.57 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 125.371 1.468 . . . . 0.0 111.872 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.41 18.48 20.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.789 0.835 . . . . 0.0 111.585 -171.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 127.101 2.16 . . . . 0.0 114.042 -176.212 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.537 0.208 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.91 95.68 0.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.634 3.556 . . . . 0.0 111.548 -171.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.6 tt 21.26 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.699 2.399 . . . . 0.0 112.514 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.75 -26.45 16.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.011 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -139.74 4.88 2.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.359 0.664 . . . . 0.0 110.67 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.18 160.58 77.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.975 0.51 . . . . 0.0 109.694 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 155.64 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.049 3.166 . . . . 0.0 112.273 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.48 34.59 0.21 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.636 0.774 . . . . 0.0 111.775 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . -173.38 35.84 0.13 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.352 -174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 42.7 t -143.22 168.66 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.208 1.003 . . . . 0.0 109.293 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 1.8 m-20 -137.53 148.27 45.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.964 1.306 . . . . 0.0 108.222 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' GLN . . . . . 0.611 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -76.77 -28.06 55.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.35 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.55 7.39 1.44 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.738 -0.601 . . . . 0.0 111.03 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' VAL . . . . . 0.437 ' HA ' HE21 ' A' ' 507' ' ' GLN . 31.0 m -138.03 12.1 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.729 0.811 . . . . 0.0 111.383 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -25.49 2.65 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.889 0.476 . . . . 0.0 111.048 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.53 -6.28 29.73 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.941 -0.474 . . . . 0.0 110.702 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 504' ' ' VAL . 2.6 mp0 -87.54 -4.38 58.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.775 1.23 . . . . 0.0 110.238 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 74.0 mt -90.16 160.11 40.85 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.75 1.22 . . . . 0.0 109.957 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.61 167.64 26.06 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.469 2.779 . . . . 0.0 111.894 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.67 -22.79 62.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.87 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.36 -1.86 57.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.237 0.472 . . . . 0.0 111.684 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.78 -14.58 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -40.85 67.68 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.37 -0.831 . . . . 0.0 109.163 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.16 -7.94 55.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.18 0.592 . . . . 0.0 112.459 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.33 -22.65 18.21 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.521 0.6 . . . . 0.0 111.107 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.42 -30.33 2.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.12 1.69 1.41 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.147 0.431 . . . . 0.0 110.376 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -129.75 9.2 5.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.961 0.904 . . . . 0.0 110.921 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -79.23 138.95 21.27 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 0.29 2.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 12.9 t -162.66 179.82 7.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.596 0.358 . . . . 0.0 110.599 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.15 15.61 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.93 1.692 . . . . 0.0 113.729 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.15 147.27 26.24 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.618 0.367 . . . . 0.0 110.622 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' ASN . . . . . 0.48 ' HB2' ' CE ' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -154.15 10.65 0.39 Allowed 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 13.25 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.803 0.689 . . . . 0.0 111.219 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' LYS . . . . . 0.48 ' CE ' ' HB2' ' A' ' 524' ' ' ASN . 53.6 mtmt . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.363 1.065 . . . . 0.0 111.399 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.642 0.258 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.05 175.31 14.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.01 -177.45 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.67 0.788 . . . . 0.0 109.17 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.814 ' HB3' HG21 ' B' ' 12' ' ' THR . 83.5 m-85 -135.68 98.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -93.2 117.87 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -93.3 132.7 37.26 Favored 'General case' 0 C--N 1.337 0.057 0 O-C-N 121.881 -0.512 . . . . 0.0 110.783 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -76.09 177.43 7.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.361 1.064 . . . . 0.0 111.976 -174.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.45 -5.95 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.933 1.293 . . . . 0.0 110.489 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 59.5 p -116.85 4.43 12.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.709 -0.62 . . . . 0.0 112.057 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.93 27.78 48.69 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 120.142 -0.254 . . . . 0.0 113.027 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.73 148.21 45.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.814 HG21 ' HB3' ' B' ' 4' ' ' PHE . 47.5 m -122.66 153.64 39.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.561 -170.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.36 132.3 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -83.92 134.7 34.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.7 mt -145.38 133.47 21.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.617 -172.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.84 128.41 37.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.474 0.71 . . . . 0.0 109.477 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.3 179.61 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.982 0.913 . . . . 0.0 109.69 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.7 mt-10 -141.15 164.21 37.14 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.19 1.17 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.583 2.855 . . . . 0.0 113.64 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.402 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.7 m -129.31 -6.61 4.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.908 0.777 . . . . 0.0 111.228 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 21.3 m-20 -80.73 69.08 7.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 171.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.2 t -61.03 176.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.133 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.419 HG22 ' HE3' ' B' ' 27' ' ' LYS . 13.2 mm -52.17 -33.21 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -168.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.6 -22.89 62.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.342 0.974 . . . . 0.0 111.473 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.35 -41.36 22.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.23 -40.24 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 124.275 1.03 . . . . 0.0 110.035 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.419 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.1 mttt -56.73 -26.04 56.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.521 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -26.89 35.16 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.486 0.584 . . . . 0.0 110.772 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -67.1 -33.12 74.79 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.7 mt -87.29 -30.05 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -66.45 -36.67 83.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.715 0.293 . . . . 0.0 110.217 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -69.38 -33.54 73.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.398 0.618 . . . . 0.0 111.297 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -82.39 -24.48 34.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.583 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -134.15 -30.92 1.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.4 9.65 26.93 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.69 126.8 82.01 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 123.891 0.876 . . . . 0.0 108.922 -174.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.41 153.57 77.52 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.634 2.223 . . . . 0.0 111.23 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.24 -20.82 36.79 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.168 2.578 . . . . 0.0 111.823 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.82 -1.69 57.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -113.85 -13.72 12.57 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.335 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.66 170.34 16.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.041 0.837 . . . . 0.0 112.3 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -153.78 148.52 26.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.45 ' C ' HD12 ' B' ' 44' ' ' ILE . 10.7 tp -136.48 139.26 42.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 111.466 -171.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.45 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -135.44 153.17 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.71 1.204 . . . . 0.0 108.213 -177.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.35 135.62 20.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 124.566 1.147 . . . . 0.0 109.089 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.49 10.19 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.887 0.875 . . . . 0.0 113.187 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.29 12.01 32.3 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.454 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 157.68 37.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.764 1.282 . . . . 0.0 109.713 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -93.29 152.09 19.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.116 0.966 . . . . 0.0 108.418 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.455 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -115.07 168.36 10.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -136.15 153.09 51.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.514 0.674 . . . . 0.0 111.615 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.79 -1.54 14.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.287 1.035 . . . . 0.0 111.62 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 9.52 35.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -109.02 -155.88 0.57 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.968 0.907 . . . . 0.0 109.372 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -148.48 160.44 43.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.052 1.741 . . . . 0.0 107.415 172.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.64 -26.8 68.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -71.0 -26.27 63.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.019 1.328 . . . . 0.0 111.993 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.78 -15.23 61.65 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 122.891 0.476 . . . . 0.0 111.298 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -126.56 26.69 6.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.717 0.807 . . . . 0.0 109.786 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 p30 48.0 19.78 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.43 139.82 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.714 0.688 . . . . 0.0 110.373 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -130.08 -177.5 4.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.709 1.204 . . . . 0.0 109.217 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.02 143.42 51.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.039 0.447 . . . . 0.0 110.841 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 53.4 26.27 5.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -74.9 -11.94 60.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m 60.03 128.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.35 1.86 . . . . 0.0 112.117 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.59 -175.62 3.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.121 1.369 . . . . 0.0 108.077 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -137.68 145.43 42.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.45 137.9 50.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.534 1.133 . . . . 0.0 109.403 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.92 162.89 30.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.433 HD12 ' C ' ' B' ' 71' ' ' LEU . 2.5 pp -147.48 178.72 8.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 112.354 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -128.34 167.63 16.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.59 1.156 . . . . 0.0 109.799 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.573 HD13 ' H ' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -102.97 18.12 22.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.749 0.82 . . . . 0.0 112.711 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 129.351 3.061 . . . . 0.0 111.149 175.041 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.9 Cg_endo -77.57 -166.92 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.202 3.268 . . . . 0.0 107.685 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.845 ' H ' HD13 ' A' ' 493' ' ' LEU . 0.0 OUTLIER -65.06 28.4 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 176.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -63.04 -27.96 69.76 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.434 1.894 . . . . 0.0 112.992 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.98 1.93 0.77 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.72 161.77 76.41 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 122.61 0.364 . . . . 0.0 110.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.75 154.38 12.65 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.255 3.303 . . . . 0.0 112.005 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -80.12 57.55 2.73 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 122.343 1.068 . . . . 0.0 110.424 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.23 26.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.226 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 76.0 t -140.79 160.03 23.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.808 0.804 . . . . 0.0 109.441 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.17 145.16 48.99 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.673 0.749 . . . . 0.0 109.077 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.31 -28.98 70.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.406 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.92 -0.16 10.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.679 -0.638 . . . . 0.0 111.403 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.26 18.42 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.437 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.78 -18.5 5.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.074 0.95 . . . . 0.0 110.452 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -72.6 3.83 4.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.943 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -87.51 4.89 41.74 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.748 0.819 . . . . 0.0 110.463 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.02 149.54 42.7 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 123.614 0.765 . . . . 0.0 110.187 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.27 163.77 25.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.081 2.521 . . . . 0.0 111.57 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.21 63.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.53 -1.8 57.93 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.651 0.38 . . . . 0.0 110.761 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 23.2 mt -116.87 -16.83 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -54.45 -38.87 66.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.5 -7.23 57.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.42 0.688 . . . . 0.0 112.421 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.42 -20.9 17.49 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.262 0.483 . . . . 0.0 111.2 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.43 -34.3 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.42 -8.64 19.84 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 33.0 t -70.12 -43.73 70.39 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.472 0.309 . . . . 0.0 110.797 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 117.73 120.64 3.07 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -140.79 -176.22 4.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.585 0.707 . . . . 0.0 110.725 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 -172.13 4.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.796 1.638 . . . . 0.0 107.998 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 65.19 18.11 11.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.035 0.934 . . . . 0.0 112.603 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.01 146.39 31.9 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.095 0.958 . . . . 0.0 109.092 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -148.29 28.79 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.925 0.49 . . . . 0.0 112.005 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.272 2.2 pp 50.92 6.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.697 1.599 . . . . 0.0 114.511 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -176.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.841 0.353 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -157.75 172.91 17.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.95 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -137.24 -179.37 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.272 0.629 . . . . 0.0 109.449 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.82 ' HB3' HG21 ' B' ' 12' ' ' THR . 82.4 m-85 -132.33 100.4 4.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.64 103.09 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.626 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -85.41 135.3 33.93 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 122.455 0.302 . . . . 0.0 111.135 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.7 p -83.76 176.32 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.38 0.672 . . . . 0.0 112.625 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -65.89 1.66 1.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.743 1.217 . . . . 0.0 111.001 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.3 p -118.73 10.06 12.31 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.307 0.643 . . . . 0.0 111.311 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 28.36 66.27 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.892 -0.393 . . . . 0.0 113.199 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.71 146.59 49.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.82 HG21 ' HB3' ' B' ' 4' ' ' PHE . 26.7 m -122.78 154.31 38.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 111.547 -171.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 53.3 mt -130.75 131.94 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -82.89 134.76 35.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 69.2 mt -144.35 134.54 24.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -171.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.89 126.82 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.314 0.645 . . . . 0.0 109.433 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.26 174.23 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.898 0.879 . . . . 0.0 109.645 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.405 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.8 mm-40 -135.69 161.87 60.38 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.272 1.029 . . . . 0.0 108.631 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.45 2.24 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.31 2.674 . . . . 0.0 113.339 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.4 ' H ' ' C ' ' B' ' 18' ' ' GLU . 35.1 p -122.21 -10.2 8.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.98 0.912 . . . . 0.0 110.593 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 76.2 m-20 -85.99 71.16 10.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.1 t -62.16 176.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.683 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 17.7 mm -51.14 -36.8 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -168.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -68.79 -21.67 64.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.371 0.987 . . . . 0.0 111.251 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -81.66 -40.38 22.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.36 -38.44 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.857 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.9 mttt -58.18 -23.13 54.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.524 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.62 -26.73 31.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.556 0.617 . . . . 0.0 110.73 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.85 -33.65 74.16 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.0 mt -85.85 -29.85 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -68.12 -37.6 81.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.33 -32.1 71.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.475 0.655 . . . . 0.0 111.323 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -83.01 -22.11 33.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -138.94 -31.25 0.72 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.74 9.39 19.0 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.2 mt -80.5 125.47 80.76 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.662 0.785 . . . . 0.0 109.337 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 159.38 48.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.216 2.611 . . . . 0.0 111.268 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -16.32 54.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.828 3.018 . . . . 0.0 110.851 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.47 -11.9 58.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.655 0.382 . . . . 0.0 111.999 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -120.85 -10.8 9.06 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -73.01 167.74 20.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.261 0.937 . . . . 0.0 112.04 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -159.21 90.1 0.95 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.88 1.272 . . . . 0.0 107.986 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.677 ' C ' HD12 ' B' ' 44' ' ' ILE . 23.3 tp -93.13 139.82 30.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.661 0.784 . . . . 0.0 112.201 -170.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -134.68 154.07 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.996 1.318 . . . . 0.0 109.145 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' B' ' 50' ' ' LEU . 43.1 t80 -151.59 142.81 23.29 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.593 1.157 . . . . 0.0 109.129 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 13.77 0.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.573 0.749 . . . . 0.0 112.615 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.7 13.86 48.96 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.275 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 161.78 31.53 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.559 1.18 . . . . 0.0 110.36 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.04 125.87 43.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.814 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.5 OUTLIER -76.0 175.35 8.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.991 -177.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -135.13 153.35 52.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 111.307 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.18 1.18 9.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.268 1.027 . . . . 0.0 111.697 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.64 11.76 27.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -112.47 -154.4 0.54 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.173 0.989 . . . . 0.0 109.563 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 4.5 p -148.97 159.56 44.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.794 1.638 . . . . 0.0 107.674 172.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 47.1 mt -63.27 -25.75 68.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -73.87 -25.45 60.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.467 1.107 . . . . 0.0 111.985 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.76 -15.96 61.65 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.09 0.556 . . . . 0.0 111.386 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.64 ' CD2' HD12 ' B' ' 50' ' ' LEU . 21.2 m-85 -125.71 25.98 6.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.367 0.667 . . . . 0.0 109.836 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p30 48.54 18.91 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 136.44 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.855 0.752 . . . . 0.0 110.187 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -130.4 -175.89 3.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.009 1.323 . . . . 0.0 109.458 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -59.93 143.89 50.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.281 0.563 . . . . 0.0 110.916 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 55.15 22.43 4.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.455 1.102 . . . . 0.0 113.331 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -72.44 -14.72 61.76 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 80.6 m 61.36 128.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.466 1.906 . . . . 0.0 112.051 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.59 178.62 6.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.941 1.296 . . . . 0.0 108.655 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -134.85 154.64 51.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -145.24 151.87 39.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.245 0.545 . . . . 0.0 110.507 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.04 161.2 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.467 ' H ' HD23 ' B' ' 71' ' ' LEU . 2.2 pt? -140.68 170.05 16.49 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.155 0.502 . . . . 0.0 112.077 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -135.61 177.48 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.136 0.974 . . . . 0.0 109.538 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.63 ' H ' HD23 ' B' ' 73' ' ' LEU . 0.5 OUTLIER -124.41 20.87 8.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.267 1.027 . . . . 0.0 112.385 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 62.28 -32.05 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.052 2.141 . . . . 0.0 113.94 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 148.17 -13.91 1.28 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 117.263 -1.854 . . . . 0.0 111.104 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 494' ' ' GLN . 93.3 Cg_endo -80.12 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 1 C-N-CA 125.408 4.072 . . . . 0.0 109.254 175.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.4 32.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.726 1.61 . . . . 0.0 113.078 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.4 pp0? -77.16 -27.95 53.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.281 0.633 . . . . 0.0 112.568 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.01 3.63 1.61 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.5 160.05 82.06 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 122.911 0.484 . . . . 0.0 109.781 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.1 149.43 15.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.52 2.813 . . . . 0.0 111.434 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -76.09 65.92 2.18 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 121.731 0.777 . . . . 0.0 112.256 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 165.76 -27.75 0.19 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.494 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.73 162.1 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 122.988 0.515 . . . . 0.0 109.948 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -131.15 144.74 51.6 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 109.868 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.572 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.16 -30.62 70.51 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.3 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -72.15 0.41 9.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.903 -0.498 . . . . 0.0 111.771 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.1 16.19 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 122.945 0.498 . . . . 0.0 110.617 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.98 -19.87 5.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.552 0.741 . . . . 0.0 109.846 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -73.49 4.77 4.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.023 0.529 . . . . 0.0 111.637 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -83.95 5.9 23.82 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.438 0.695 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.01 152.15 53.77 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 123.868 0.867 . . . . 0.0 110.174 -170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.8 164.1 25.53 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.845 2.364 . . . . 0.0 111.311 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.55 63.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.106 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 -3.29 58.4 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 122.464 0.306 . . . . 0.0 110.953 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.2 -15.27 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -54.96 -38.92 68.39 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.08 -10.4 59.36 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 516' ' ' ILE . 11.2 mm-40 -89.38 -18.37 26.99 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.478 0.581 . . . . 0.0 111.186 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 515' ' ' GLU . 1.2 mp -107.91 -34.32 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.08 -9.07 14.15 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 171.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 m -63.14 -27.08 69.13 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 122.245 -0.284 . . . . 0.0 110.821 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 104.19 35.23 3.45 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -61.54 -179.96 0.2 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.613 1.197 . . . . 0.0 112.189 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.3 m -142.65 -171.97 3.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.162 -1.835 . . . . 0.0 108.91 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.76 13.13 8.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.233 1.013 . . . . 0.0 112.286 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -149.75 145.56 26.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.912 0.485 . . . . 0.0 110.252 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 526' ' ' LYS . 59.2 m-80 -152.37 19.4 0.64 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.738 0.815 . . . . 0.0 110.105 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.02 -15.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.159 1.384 . . . . 0.0 112.445 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 124.072 0.949 . . . . 0.0 111.108 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.955 0.407 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.69 172.81 17.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.794 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.58 -179.64 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.548 0.739 . . . . 0.0 109.055 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -132.06 107.59 8.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -103.09 109.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.6 ttmt -93.54 139.11 31.12 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -86.9 176.0 7.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.044 0.938 . . . . 0.0 112.135 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.86 -20.84 59.46 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.577 1.151 . . . . 0.0 110.981 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -95.48 -2.83 47.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.968 -0.458 . . . . 0.0 110.471 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.56 24.64 27.8 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.278 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.55 140.07 52.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -109.42 159.23 17.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.546 -173.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -129.97 128.69 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -79.54 134.17 36.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -144.88 133.8 22.5 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -90.11 128.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.12 177.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 123.746 0.818 . . . . 0.0 110.104 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 75.0 mm-40 -141.6 163.08 43.34 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 124.602 1.161 . . . . 0.0 108.941 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 38.2 Cg_exo -55.46 3.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.668 3.579 . . . . 0.0 113.647 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 18' ' ' GLU . 19.2 t -134.0 -8.77 2.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.892 0.769 . . . . 0.0 111.482 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 8.2 m-20 -78.05 68.78 4.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.0 t -62.29 177.02 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.653 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.424 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.6 mm -51.29 -33.65 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -169.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.29 -22.14 61.99 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 119.266 0.939 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -81.79 -38.17 26.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.478 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 71.5 t -64.68 -40.54 89.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 110.138 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.6 mttt -56.86 -27.53 60.51 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.17 -23.04 44.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.427 0.558 . . . . 0.0 110.796 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 68.3 mmtt -69.76 -47.32 63.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.481 0.712 . . . . 0.0 109.434 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.44 -30.61 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.515 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.32 -39.4 78.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.71 0.29 . . . . 0.0 110.466 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.43 -31.25 70.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.31 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.35 -24.6 36.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.462 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.68 -34.53 0.68 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.63 8.7 13.7 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.74 126.48 88.45 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.13 153.78 73.98 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.672 2.248 . . . . 0.0 111.028 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.31 -17.33 39.66 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.617 2.878 . . . . 0.0 111.573 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.14 2.3 55.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.69 -16.76 10.66 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.91 164.13 24.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.619 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -154.53 124.18 6.59 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.535 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -123.4 135.12 53.97 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.871 0.305 . . . . 0.0 111.513 -168.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.535 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.7 mp -129.53 149.92 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -151.03 143.08 24.01 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.844 1.257 . . . . 0.0 109.07 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.69 13.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.516 0.726 . . . . 0.0 112.326 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.99 14.58 48.56 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.453 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 163.42 29.33 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.486 1.143 . . . . 0.0 110.178 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.84 128.27 45.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.4 OUTLIER -77.18 172.82 12.64 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.015 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -135.5 156.27 49.16 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.542 0.687 . . . . 0.0 111.206 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.97 2.31 8.95 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.869 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.86 14.57 21.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -115.26 -154.13 0.54 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.375 1.07 . . . . 0.0 108.758 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 40.4 p -150.43 166.52 29.87 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.344 1.058 . . . . 0.0 108.386 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.3 -30.48 71.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 17.0 t -74.91 -29.76 61.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.351 0.66 . . . . 0.0 111.136 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.42 -16.17 63.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.723 0.409 . . . . 0.0 111.606 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' B' ' 50' ' ' LEU . 18.0 m-85 -130.1 25.57 5.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.654 0.781 . . . . 0.0 110.245 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 46.75 25.68 0.47 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.24 128.47 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -132.38 -171.24 2.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.71 1.204 . . . . 0.0 109.705 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -58.37 140.66 53.22 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.969 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 54.12 24.43 4.84 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.235 1.014 . . . . 0.0 113.15 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.7 m -72.22 -19.18 61.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m 60.99 135.79 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.508 1.923 . . . . 0.0 112.184 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.9 179.93 6.43 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.534 0.734 . . . . 0.0 109.145 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.58 143.72 45.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.048 0.451 . . . . 0.0 110.886 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -134.4 142.02 47.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.834 1.254 . . . . 0.0 110.495 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 85.2 t -142.93 160.26 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -147.67 171.89 14.93 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.8 175.9 5.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.508 1.123 . . . . 0.0 108.977 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' B' ' 75' ' ' GLY . 2.9 tp -124.4 18.98 8.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 59.94 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.041 2.136 . . . . 0.0 113.992 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.22 -10.66 2.02 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 CA-C-O 117.221 -1.877 . . . . 0.0 110.985 -179.823 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 494' ' ' GLN . 72.2 Cg_endo -74.54 -164.03 0.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 125.125 3.883 . . . . 0.0 109.616 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 32.95 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.417 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 494' ' ' GLN . 0.0 OUTLIER -68.54 -36.7 79.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.56 2.34 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 112.047 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.09 161.12 75.14 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 122.985 0.514 . . . . 0.0 110.06 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 499' ' ' GLY . 75.1 Cg_exo -53.19 150.95 23.41 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.988 3.125 . . . . 0.0 112.18 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.55 35.82 0.19 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.87 0.843 . . . . 0.0 112.077 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 497' ' ' PRO . . . -174.24 30.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.298 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.8 t -139.16 162.52 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 C-N-CA 123.619 0.768 . . . . 0.0 108.984 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.17 143.04 50.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.496 0.665 . . . . 0.0 110.046 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.557 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.78 -30.65 70.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.169 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.41 0.38 8.39 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.698 -0.626 . . . . 0.0 111.588 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.72 17.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.719 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.35 -21.58 5.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 109.706 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -72.37 10.15 0.86 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.283 0.633 . . . . 0.0 111.68 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -93.49 8.8 39.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.874 0.87 . . . . 0.0 110.743 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 31.4 mt -123.82 153.62 67.1 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.8 0.84 . . . . 0.0 111.331 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.8 158.49 56.72 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.987 2.458 . . . . 0.0 111.14 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.8 62.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.928 0.891 . . . . 0.0 112.847 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.17 -7.29 59.64 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.649 0.658 . . . . 0.0 111.133 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.79 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -65.21 -35.2 80.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 120.857 -1.152 . . . . 0.0 110.592 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.06 -1.78 8.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.42 0.288 . . . . 0.0 111.5 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.79 5.04 8.79 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.05 -39.21 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.96 -5.52 2.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.701 0.8 . . . . 0.0 109.503 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.8 m -142.16 27.66 1.75 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.272 1.429 . . . . 0.0 110.171 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.59 39.01 2.21 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.41 9.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.692 1.997 . . . . 0.0 115.421 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.9 m -142.4 171.09 14.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.746 0.819 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 1.1 tpm_? 60.57 12.92 3.87 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.65 1.58 . . . . 0.0 114.128 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.43 140.22 21.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.25 32.17 0.66 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.027 0.531 . . . . 0.0 111.786 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . 0.489 HD12 ' C ' ' A' ' 525' ' ' LEU 0.262 1.9 pp 50.95 5.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.086 1.754 . . . . 0.0 115.362 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.849 1.26 . . . . 0.0 112.471 -178.152 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.97 173.47 16.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.651 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.41 -179.61 2.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.3 133.25 51.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.86 107.12 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -84.71 132.8 34.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.981 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -76.1 173.52 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.096 0.958 . . . . 0.0 111.424 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.18 -23.19 66.47 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.794 0.838 . . . . 0.0 110.531 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -91.84 -10.46 39.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.924 -0.485 . . . . 0.0 111.322 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 28.75 7.1 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.37 -0.443 . . . . 0.0 113.751 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -121.82 145.57 47.93 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.51 158.02 25.28 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.7 mt -133.12 134.24 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -77.43 128.91 35.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 mt -137.24 130.33 30.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.97 126.97 35.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.009 0.923 . . . . 0.0 109.354 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.57 177.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.133 0.973 . . . . 0.0 109.447 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' B' ' 20' ' ' SER . 79.4 mm-40 -136.9 162.49 55.52 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 108.619 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.69 5.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.487 2.792 . . . . 0.0 113.384 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.425 ' H ' ' C ' ' B' ' 18' ' ' GLU . 22.5 t -129.86 -8.93 4.45 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.626 0.648 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -81.11 76.01 8.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.7 t -66.08 177.1 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.445 -176.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' B' ' 27' ' ' LYS . 11.8 mm -52.12 -35.34 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.54 -21.73 65.45 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.934 0.788 . . . . 0.0 111.038 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -82.72 -42.67 17.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.6 -40.03 87.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 124.444 1.098 . . . . 0.0 110.395 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.8 mttt -58.75 -23.17 59.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.419 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.48 35.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.601 0.637 . . . . 0.0 110.762 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.26 -33.84 75.1 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.177 -0.327 . . . . 0.0 110.13 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -85.1 -30.51 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.85 -39.16 90.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.79 -31.81 71.94 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.232 0.539 . . . . 0.0 111.07 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -86.9 -22.09 25.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -135.16 -32.1 0.96 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.6 9.85 24.34 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -81.59 129.98 63.42 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.35 151.08 76.46 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.585 2.19 . . . . 0.0 110.826 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.52 -15.03 44.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.626 2.884 . . . . 0.0 111.37 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -88.15 -7.26 57.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -119.24 -9.85 9.86 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.5 176.26 4.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.176 0.898 . . . . 0.0 112.91 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -147.06 151.48 36.97 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 127.48 2.312 . . . . 0.0 105.768 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.46 ' C ' HD12 ' B' ' 44' ' ' ILE . 43.6 tp -146.71 116.8 7.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.308 0.958 . . . . 0.0 110.165 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.46 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.2 mp -125.11 142.23 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.574 0.75 . . . . 0.0 109.299 -174.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.539 ' CB ' HD22 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -161.32 158.41 26.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.564 172.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.12 20.89 1.93 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.33 73.62 Favored Glycine 0 C--N 1.341 0.847 0 C-N-CA 125.084 1.326 . . . . 0.0 112.57 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 161.73 35.8 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 117.693 0.746 . . . . 0.0 109.686 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -96.62 125.71 41.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.1 mp -74.76 159.75 31.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -124.92 148.4 48.36 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.49 0.662 . . . . 0.0 111.801 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.66 2.39 5.32 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.467 1.107 . . . . 0.0 111.672 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 15.61 23.61 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -121.14 -150.2 0.45 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 108.655 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -151.81 156.42 40.18 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 125.738 1.615 . . . . 0.0 108.871 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.79 -25.2 62.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -73.89 -24.29 59.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.265 1.026 . . . . 0.0 111.703 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.0 -15.19 60.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.254 0.621 . . . . 0.0 111.556 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 17.41 19.63 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.82 22.44 1.15 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.836 1.254 . . . . 0.0 114.227 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.81 144.78 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -132.82 178.67 6.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.918 0.887 . . . . 0.0 109.092 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -60.92 150.87 31.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.064 0.459 . . . . 0.0 111.253 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 60.06 17.68 6.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.869 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 87.6 p -70.08 179.48 2.32 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 109.934 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -134.61 126.85 30.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.539 HD22 ' CB ' ' B' ' 45' ' ' PHE . 14.3 mt -121.61 -171.77 2.29 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -138.41 143.96 39.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.034 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.453 HD13 ' C ' ' B' ' 69' ' ' LEU . 1.9 tm? -133.76 139.04 46.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.544 1.137 . . . . 0.0 109.944 -172.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.94 165.89 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.411 HD12 ' C ' ' B' ' 71' ' ' LEU . 3.7 pp -138.49 172.66 12.56 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.25 0.477 . . . . 0.0 111.804 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -123.79 169.45 11.53 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.918 0.887 . . . . 0.0 110.078 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' B' ' 75' ' ' GLY . 1.4 mp -112.58 13.49 20.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.986 0.915 . . . . 0.0 112.213 -170.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 61.9 -27.85 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.409 1.884 . . . . 0.0 113.866 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -110.94 6.75 29.26 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 117.1 -1.944 . . . . 0.0 110.991 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 494' ' ' GLN . 84.3 Cg_endo -76.18 -163.74 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 1 C-N-CA 125.392 4.062 . . . . 0.0 109.65 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.94 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.479 1.512 . . . . 0.0 112.868 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.1 pp0? -75.43 -26.26 58.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.49 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.15 5.68 1.3 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.67 157.51 90.0 Favored Pre-proline 0 N--CA 1.448 -0.55 0 O-C-N 121.923 -0.486 . . . . 0.0 110.163 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.16 154.66 27.36 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.857 3.038 . . . . 0.0 112.169 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -79.67 58.19 2.7 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 122.147 0.975 . . . . 0.0 109.866 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.98 28.34 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.142 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.13 163.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.527 0.663 . . . . 0.0 109.349 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.09 144.03 46.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.21 -31.98 73.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.621 -177.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.38 9.88 3.54 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.282 -0.886 . . . . 0.0 110.364 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 504' ' ' VAL . 95.7 t -129.71 10.24 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.563 1.145 . . . . 0.0 109.466 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -25.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.219 -0.925 . . . . 0.0 112.728 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -69.12 -8.32 44.31 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.85 0.75 . . . . 0.0 111.939 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -81.32 -10.55 59.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.11 0.413 . . . . 0.0 110.795 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.82 162.44 70.29 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 124.695 1.198 . . . . 0.0 110.15 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.51 165.05 33.43 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.625 2.216 . . . . 0.0 111.258 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.92 -8.89 5.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.434 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -103.05 -2.35 27.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.301 0.64 . . . . 0.0 111.544 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.07 -13.48 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.21 -2.25 33.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.318 0.647 . . . . 0.0 112.185 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -100.5 -15.32 17.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.316 0.507 . . . . 0.0 111.408 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.32 -35.42 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.31 -11.17 49.17 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 31.1 t -73.08 -45.0 59.76 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.637 0.256 . . . . 0.0 110.959 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 130.9 123.24 2.48 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -146.28 173.6 12.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.452 1.101 . . . . 0.0 109.001 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 t -153.6 -171.87 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.605 1.162 . . . . 0.0 109.127 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 62.78 21.26 12.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.705 1.202 . . . . 0.0 112.021 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -144.88 155.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.964 0.906 . . . . 0.0 109.542 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.626 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -149.05 10.7 0.8 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -173.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.4 13.55 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.869 -172.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.626 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 51.7 mtmt . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 124.448 1.099 . . . . 0.0 112.335 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -157.87 171.3 20.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.814 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -138.22 -179.73 2.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.09 108.29 8.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.03 117.04 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.58 132.52 36.25 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.392 0.277 . . . . 0.0 111.332 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -83.19 179.34 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.599 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.1 tm? -67.33 7.12 0.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.04 1.336 . . . . 0.0 110.846 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -125.65 11.42 7.89 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.165 -0.959 . . . . 0.0 111.981 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 28.29 66.23 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.84 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -126.55 145.56 50.48 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 159.67 22.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.481 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -127.99 125.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -73.09 133.56 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.35 130.04 21.52 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.36 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -90.36 129.0 36.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.06 -177.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.956 0.902 . . . . 0.0 109.637 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 37.6 mt-10 -144.14 162.87 38.21 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.85 2.86 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.818 2.345 . . . . 0.0 113.063 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.437 ' H ' ' C ' ' B' ' 18' ' ' GLU . 28.4 p -126.16 -12.06 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.679 0.791 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.7 m-20 -80.49 73.18 7.41 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 171.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.5 t -62.89 175.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.252 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.421 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.9 mm -51.08 -34.47 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -169.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.44 -22.65 64.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.553 1.07 . . . . 0.0 111.412 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.79 -36.45 25.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 83.3 t -68.08 -37.63 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 124.122 0.969 . . . . 0.0 110.207 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.0 mttt -60.96 -24.28 65.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.83 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.8 52.12 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.479 0.581 . . . . 0.0 110.771 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.487 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.7 mmtt -72.97 -50.59 22.4 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.565 0.746 . . . . 0.0 109.513 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -68.49 -31.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.52 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.96 -38.82 79.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.525 0.203 . . . . 0.0 110.77 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.78 -29.35 65.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.28 0.562 . . . . 0.0 111.405 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -80.48 -25.49 38.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.056 0.943 . . . . 0.0 113.227 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -138.0 -32.8 0.72 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.93 15.36 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.1 mt -76.15 128.63 82.44 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.85 155.47 62.28 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.694 2.263 . . . . 0.0 111.133 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.14 -16.06 43.91 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.897 3.064 . . . . 0.0 111.491 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.67 -13.38 51.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -114.88 -15.19 11.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.11 155.94 38.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.331 0.969 . . . . 0.0 111.21 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.56 90.99 1.84 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.658 1.183 . . . . 0.0 108.826 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.468 ' C ' HD12 ' B' ' 44' ' ' ILE . 18.1 mt -85.57 139.76 31.17 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.012 0.434 . . . . 0.0 111.333 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.468 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -130.97 148.16 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.828 1.251 . . . . 0.0 107.858 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -148.84 141.72 24.7 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.258 1.023 . . . . 0.0 108.686 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.96 12.29 0.08 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.592 0.757 . . . . 0.0 112.583 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.42 39.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.635 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 161.65 33.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.411 1.105 . . . . 0.0 109.766 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -95.78 145.13 25.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -99.51 169.17 9.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.712 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -136.28 153.74 51.09 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.338 0.59 . . . . 0.0 111.987 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -72.84 1.03 9.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.241 1.016 . . . . 0.0 111.54 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.59 8.79 32.42 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -110.56 -154.04 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 109.323 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.8 p -149.06 158.58 44.29 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.63 1.572 . . . . 0.0 107.434 171.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.29 -25.21 68.21 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.9 p -74.06 -24.86 59.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.59 1.156 . . . . 0.0 111.568 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.79 -16.43 61.63 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.182 0.593 . . . . 0.0 111.531 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -125.05 25.94 7.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.516 0.726 . . . . 0.0 109.6 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.33 20.06 0.26 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -60.14 136.9 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 118.572 0.624 . . . . 0.0 111.083 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -132.57 -172.62 2.95 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.26 1.424 . . . . 0.0 109.403 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -60.85 145.49 49.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.674 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 51.44 26.53 3.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.533 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 77.6 p -69.37 -21.17 63.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.419 1.088 . . . . 0.0 113.424 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m 59.87 126.07 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.176 2.19 . . . . 0.0 112.275 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -128.7 -175.88 3.67 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.068 1.347 . . . . 0.0 107.921 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -136.99 144.44 43.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -132.28 135.69 46.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.741 . . . . 0.0 110.088 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.22 166.89 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -146.26 171.99 14.14 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -104.99 177.73 4.77 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.999 1.32 . . . . 0.0 108.345 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' B' ' 75' ' ' GLY . 3.6 tp -122.75 18.8 10.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.849 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 61.19 -27.67 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.652 1.981 . . . . 0.0 113.761 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.52 -11.84 1.98 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 117.247 -1.863 . . . . 0.0 110.931 -179.282 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 38.6 Cg_exo -61.2 -162.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 125.117 3.878 . . . . 0.0 111.468 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 31.65 0.71 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.669 1.188 . . . . 0.0 110.671 169.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -68.7 -28.56 66.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.684 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.94 3.33 0.82 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.43 0.692 . . . . 0.0 112.73 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.75 160.88 81.01 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.85 157.74 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.316 3.344 . . . . 0.0 112.582 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -77.44 68.13 3.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.977 0.894 . . . . 0.0 112.375 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 157.18 -26.77 0.49 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.284 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.88 167.38 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.066 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.8 147.88 41.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.656 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -64.2 -30.28 71.35 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.851 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.1 9.41 3.73 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.213 -0.93 . . . . 0.0 110.813 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 504' ' ' VAL . 81.9 t -129.96 9.28 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 109.522 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -19.17 0.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 113.071 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -71.55 -11.44 60.86 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.673 -0.642 . . . . 0.0 111.956 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.437 ' CD ' ' H ' ' A' ' 507' ' ' GLN . 9.6 mp0 -80.25 -9.47 59.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.016 0.371 . . . . 0.0 110.349 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.95 148.59 57.35 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 124.293 1.037 . . . . 0.0 109.44 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.35 164.45 23.03 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.658 2.239 . . . . 0.0 111.338 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.84 -21.52 63.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.888 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -87.42 1.45 53.36 Favored 'General case' 0 CA--C 1.524 -0.05 0 C-N-CA 122.692 0.397 . . . . 0.0 111.005 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 32.0 mt -119.34 -16.35 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -54.82 -41.39 70.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.93 -1.18 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.531 0.733 . . . . 0.0 112.487 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -105.77 -17.74 14.28 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.285 0.493 . . . . 0.0 111.9 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.49 -25.69 3.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.49 -5.79 12.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.319 0.248 . . . . 0.0 110.413 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 89.6 p -146.38 15.8 1.3 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -119.16 88.81 0.45 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -112.54 9.26 19.47 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -163.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.4 t -137.57 21.03 2.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.24 7.02 5.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.736 -0.602 . . . . 0.0 112.204 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.414 ' C ' ' ND2' ' A' ' 524' ' ' ASN . 1.1 pm0 -153.41 149.49 27.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 526' ' ' LYS . 0.2 OUTLIER -144.27 17.43 1.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.28 1.032 . . . . 0.0 109.202 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.54 6.83 5.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.514 1.125 . . . . 0.0 109.876 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 524' ' ' ASN . 49.5 mtmt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.519 1.128 . . . . 0.0 112.849 -173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 120.658 0.266 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -156.29 173.52 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.74 -179.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 123.654 0.782 . . . . 0.0 109.274 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.418 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 50.7 m-85 -133.57 94.95 3.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.114 0.483 . . . . 0.0 109.737 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -81.93 62.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.163 0.985 . . . . 0.0 111.771 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.5 ttmt -51.59 132.54 30.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.62 0.768 . . . . 0.0 111.28 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 65.9 p -76.06 175.47 8.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.128 -174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.28 -10.34 10.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.708 1.203 . . . . 0.0 110.675 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -112.67 -0.31 15.12 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 121.892 -0.505 . . . . 0.0 111.988 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 22.4 23.78 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.682 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.2 123.42 46.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.585 0.693 . . . . 0.0 110.149 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.9 OUTLIER -82.64 151.24 26.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 111.356 -177.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.35 120.42 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -77.9 136.78 38.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' B' ' 33' ' ' LYS . 67.1 mt -149.77 137.39 20.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.385 0.274 . . . . 0.0 110.976 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.67 128.7 42.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.8 -179.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.837 0.855 . . . . 0.0 109.358 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.442 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -142.15 164.0 36.38 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.454 0.701 . . . . 0.0 109.52 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 43.2 Cg_exo -54.72 1.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.465 3.443 . . . . 0.0 113.683 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.411 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.6 m -132.31 -7.77 3.35 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.805 0.729 . . . . 0.0 111.671 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 28.5 m-20 -81.39 68.61 7.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -63.33 178.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.191 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.46 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -52.74 -33.82 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -168.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.91 -23.43 63.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.224 0.92 . . . . 0.0 111.15 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -80.63 -41.66 23.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.04 -40.89 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 123.999 0.919 . . . . 0.0 110.077 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.5 mttt -56.55 -26.73 55.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.415 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 -28.39 34.98 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.627 0.649 . . . . 0.0 110.849 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.529 ' HB3' HD22 ' B' ' 15' ' ' LEU . 5.1 mptp? -65.47 -32.82 74.64 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -86.15 -30.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -66.49 -36.31 82.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.19 -34.81 76.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.142 0.496 . . . . 0.0 111.325 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.8 mmtm -79.03 -25.58 43.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.24 -31.23 0.91 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.92 10.28 22.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.1 127.36 77.09 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.0 154.13 67.09 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.807 2.338 . . . . 0.0 111.17 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.41 -14.25 41.96 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.717 2.945 . . . . 0.0 110.713 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.45 -8.78 58.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -123.42 -8.76 8.06 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.96 167.51 20.92 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.084 0.856 . . . . 0.0 111.731 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -154.24 138.94 17.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.47 ' C ' HD12 ' B' ' 44' ' ' ILE . 46.0 tp -134.92 135.58 41.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.796 0.725 . . . . 0.0 111.509 -169.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.47 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.3 mp -131.74 152.09 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.586 1.155 . . . . 0.0 108.667 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -149.31 138.67 21.53 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.59 1.156 . . . . 0.0 108.94 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.74 0.07 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.89 0.876 . . . . 0.0 112.876 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.42 13.17 36.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.407 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 159.48 36.81 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.631 1.216 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -93.8 150.52 20.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.486 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.6 mp -109.15 170.28 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.419 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -136.38 153.89 50.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.586 0.708 . . . . 0.0 111.539 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.45 -1.01 14.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.414 1.086 . . . . 0.0 111.983 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.2 8.11 32.97 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -106.08 -155.79 0.56 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.162 0.985 . . . . 0.0 109.198 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 35.8 p -150.82 166.25 31.08 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.203 1.401 . . . . 0.0 107.958 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -29.23 70.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 12.2 t -73.4 -31.53 63.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.108 0.963 . . . . 0.0 111.329 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.93 -15.82 60.02 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.551 0.34 . . . . 0.0 111.443 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -128.28 24.9 5.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.673 0.789 . . . . 0.0 109.92 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.65 24.63 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.375 1.87 . . . . 0.0 115.541 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.9 138.53 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.627 0.649 . . . . 0.0 109.851 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.61 -175.16 3.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.662 1.185 . . . . 0.0 109.753 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -59.45 144.7 46.29 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 53.51 24.87 4.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.388 1.075 . . . . 0.0 113.238 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -74.86 -17.68 60.55 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m 59.54 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.271 1.828 . . . . 0.0 112.865 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -127.59 179.87 5.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.663 1.185 . . . . 0.0 108.522 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -134.9 97.5 3.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.098 0.475 . . . . 0.0 111.449 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.89 143.77 45.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.233 1.013 . . . . 0.0 110.497 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 44.9 t -143.71 166.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.35 168.74 22.53 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.623 -0.673 . . . . 0.0 111.722 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -79.35 176.25 9.86 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.924 0.49 . . . . 0.0 111.657 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.89 14.32 29.69 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.26 0.624 . . . . 0.0 111.477 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 60.1 -35.46 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 128.054 2.542 . . . . 0.0 114.708 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.23 -14.33 3.51 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.477 -1.735 . . . . 0.0 110.792 -179.306 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 494' ' ' GLN . 98.0 Cg_endo -77.71 -161.39 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 125.279 3.986 . . . . 0.0 108.8 175.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.2 pt? -68.06 25.5 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.2 pp0? -65.22 -23.76 67.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.549 1.14 . . . . 0.0 112.656 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.85 6.26 1.79 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.49 ' CD2' HE21 ' A' ' 502' ' ' GLN . 8.2 mp -64.22 156.63 74.62 Favored Pre-proline 0 N--CA 1.447 -0.586 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 157.5 5.81 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.204 3.269 . . . . 0.0 112.252 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.92 67.23 2.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.892 0.853 . . . . 0.0 112.302 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 158.51 -29.02 0.44 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.272 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.4 163.9 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.593 0.757 . . . . 0.0 109.838 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.19 157.67 44.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.023 0.529 . . . . 0.0 110.811 -173.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.49 HE21 ' CD2' ' A' ' 496' ' ' LEU . 36.1 mm-40 -60.61 -45.51 93.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.972 0.509 . . . . 0.0 110.614 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.58 7.23 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.139 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.456 ' CA ' HE21 ' A' ' 507' ' ' GLN . 20.2 m -138.49 11.3 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.597 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -17.42 5.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.359 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.34 4.6 6.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.815 0.446 . . . . 0.0 111.302 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.456 HE21 ' CA ' ' A' ' 504' ' ' VAL . 10.2 mm-40 -81.38 7.15 12.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.057 0.943 . . . . 0.0 110.698 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 27.9 mt -121.92 155.01 61.17 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 123.837 0.855 . . . . 0.0 110.621 -168.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.4 167.28 27.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.525 2.817 . . . . 0.0 111.948 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.39 -15.31 24.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.214 1.006 . . . . 0.0 112.753 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -100.72 3.35 42.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.058 0.39 . . . . 0.0 111.786 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.9 mt -118.26 -15.45 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.85 -43.8 66.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.17 1.38 13.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.398 0.679 . . . . 0.0 112.805 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -104.29 -18.5 14.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.45 0.568 . . . . 0.0 111.388 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.27 -28.55 2.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.82 -2.54 9.74 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.168 0.587 . . . . 0.0 110.138 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 90.4 p -133.09 13.62 4.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.193 0.997 . . . . 0.0 111.076 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -124.79 39.37 2.12 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 2.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -141.25 -174.99 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.911 0.884 . . . . 0.0 109.953 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.85 6.58 4.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.884 1.274 . . . . 0.0 113.065 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.15 161.85 41.59 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.116 0.416 . . . . 0.0 110.898 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -149.79 33.75 0.69 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.762 0.825 . . . . 0.0 111.078 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.83 7.02 4.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.515 0.726 . . . . 0.0 110.741 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.453 -0.318 0 C-N-CA 124.434 1.093 . . . . 0.0 111.717 -176.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -157.95 173.12 17.25 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.034 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -135.0 175.81 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.403 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 53.2 m-85 -128.88 89.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.433 0.635 . . . . 0.0 110.167 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.38 103.38 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.161 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.2 ttmt -85.17 135.52 33.93 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -83.85 174.96 9.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.526 0.731 . . . . 0.0 112.368 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.31 3.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.14 1.376 . . . . 0.0 111.418 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -118.19 4.62 11.95 Favored 'General case' 0 CA--C 1.527 0.058 0 O-C-N 121.922 -0.486 . . . . 0.0 111.537 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.26 24.4 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.251 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.35 122.39 38.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.57 0.685 . . . . 0.0 110.134 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.7 OUTLIER -79.04 152.46 30.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.816 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.25 123.24 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -79.83 131.9 35.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -143.55 133.45 24.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.287 -174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.73 126.29 35.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -145.35 177.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 123.786 0.834 . . . . 0.0 109.919 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 80.1 mm-40 -138.91 162.24 53.66 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 124.05 0.94 . . . . 0.0 109.709 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 49.4 Cg_exo -54.58 -0.44 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 125.0 3.8 . . . . 0.0 113.896 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -130.91 -7.2 3.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.974 0.806 . . . . 0.0 111.183 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 65.2 m-20 -81.55 69.62 8.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 8.9 t -62.9 177.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.808 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.411 HG22 ' HE3' ' B' ' 27' ' ' LYS . 16.1 mm -51.79 -34.61 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.942 0.897 . . . . 0.0 113.215 -168.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.95 -22.42 63.18 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.094 0.861 . . . . 0.0 111.271 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -81.6 -40.85 22.38 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.9 -39.12 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 124.301 1.04 . . . . 0.0 110.217 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.411 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.7 mttt -57.4 -24.84 57.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.761 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.85 -28.34 33.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.509 0.595 . . . . 0.0 110.761 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -66.34 -33.32 75.46 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.06 -30.62 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.25 -39.35 86.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.695 0.283 . . . . 0.0 110.261 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.65 -31.67 71.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 111.243 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -83.71 -23.72 31.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.78 -32.84 0.88 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.81 9.03 21.61 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -78.2 129.47 75.18 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.47 151.44 70.72 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.574 2.183 . . . . 0.0 110.456 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 -14.47 37.37 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.23 2.62 . . . . 0.0 110.828 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.14 -8.64 59.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -124.07 -9.82 7.65 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -67.61 165.75 16.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.097 0.862 . . . . 0.0 111.655 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -154.47 102.58 2.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' B' ' 44' ' ' ILE . 28.5 tp -101.36 135.93 42.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.256 0.623 . . . . 0.0 110.949 -169.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.1 mp -129.81 154.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -118.52 -112.05 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 122.914 0.485 . . . . 0.0 110.494 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.99 -3.18 3.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.303 0.641 . . . . 0.0 111.732 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.88 3.03 2.08 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.553 1.073 . . . . 0.0 111.448 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 154.89 37.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.451 0.643 . . . . 0.0 109.567 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -87.96 128.62 35.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.619 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.639 HD22 ' H ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -76.14 172.71 12.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.602 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -133.63 153.44 51.67 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.663 0.744 . . . . 0.0 111.656 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.49 1.48 9.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 111.917 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.29 14.01 25.75 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -115.57 -154.59 0.55 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.353 1.061 . . . . 0.0 108.997 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.0 p -150.14 165.82 31.7 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.812 1.245 . . . . 0.0 108.142 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.14 -29.33 70.71 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 11.5 t -73.24 -31.36 64.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.654 0.782 . . . . 0.0 111.183 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.96 -15.7 63.23 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 122.87 0.468 . . . . 0.0 111.894 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' B' ' 50' ' ' LEU . 15.7 m-85 -130.49 26.44 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.846 0.858 . . . . 0.0 109.989 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.83 30.89 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 132.85 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.83 -174.0 3.79 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.477 1.111 . . . . 0.0 109.542 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -56.7 143.08 37.74 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.058 0.456 . . . . 0.0 111.477 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 53.45 27.79 6.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.201 1.0 . . . . 0.0 112.942 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -69.7 -27.37 64.94 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m 61.57 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.012 2.125 . . . . 0.0 112.043 -174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.54 -179.38 5.7 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.212 1.005 . . . . 0.0 108.806 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.51 151.95 50.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -138.55 142.64 39.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.573 0.749 . . . . 0.0 111.087 -175.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.12 165.32 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 126.352 1.861 . . . . 0.0 105.983 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.35 165.86 27.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.846 -0.534 . . . . 0.0 111.295 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -73.2 174.19 8.36 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' B' ' 75' ' ' GLY . 2.8 tp -107.31 17.78 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.009 0.524 . . . . 0.0 111.087 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 61.69 -28.0 0.06 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.845 2.058 . . . . 0.0 113.693 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 141.87 -11.69 2.63 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.065 -1.964 . . . . 0.0 110.579 -179.749 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 491' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 491' ' ' LEU . 92.3 Cg_endo -81.59 89.28 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.972 3.781 . . . . 0.0 111.937 -168.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.8 tt 21.46 48.87 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.163 2.585 . . . . 0.0 112.214 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -95.95 -20.08 19.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.117 -172.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -145.57 6.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.79 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.15 151.64 93.31 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.15 164.05 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.836 3.024 . . . . 0.0 111.685 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.03 132.21 53.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.273 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 78.03 -23.02 2.76 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.698 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.99 163.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.71 1.255 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.91 164.83 28.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.182 0.593 . . . . 0.0 110.398 -173.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -66.72 -41.9 87.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.114 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.64 10.9 0.73 Allowed 'General case' 0 C--O 1.23 0.062 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.56 12.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.665 0.786 . . . . 0.0 110.35 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -134.48 -26.26 1.44 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.274 0.488 . . . . 0.0 112.073 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.37 -13.43 62.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 507' ' ' GLN . 8.6 mp0 -82.19 -12.07 58.34 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.195 0.452 . . . . 0.0 110.887 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.18 153.4 84.35 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 124.249 1.02 . . . . 0.0 109.508 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 166.29 30.4 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.1 2.533 . . . . 0.0 111.582 172.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.72 -22.19 56.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.554 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.04 3.16 55.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.995 0.362 . . . . 0.0 111.669 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.8 mt -117.94 -15.37 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -52.9 -44.63 67.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.84 -6.65 39.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.401 0.68 . . . . 0.0 112.469 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.86 -20.44 16.17 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.448 0.567 . . . . 0.0 111.039 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.76 -31.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.44 -3.31 8.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.745 0.418 . . . . 0.0 109.988 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -136.17 15.79 3.25 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.092 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -114.54 28.26 8.32 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.156 0.408 . . . . 0.0 112.199 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 1.45 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 8.2 t -136.01 32.3 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.79 -2.16 0.95 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.66 159.28 39.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -147.35 28.45 0.99 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.957 -172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.42 6.8 3.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.563 0.697 . . . . 0.0 110.073 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 C--N 1.338 0.097 0 C-N-CA 123.878 0.871 . . . . 0.0 112.222 -174.487 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -129.42 165.6 21.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.339 0.656 . . . . 0.0 110.75 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.78 166.64 2.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 164.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.541 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 8.9 m-85 -125.75 133.93 51.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -126.79 109.86 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -84.64 139.38 32.09 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.227 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -84.91 177.82 7.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.073 0.949 . . . . 0.0 112.082 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.42 6.08 0.87 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.791 1.236 . . . . 0.0 110.945 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -125.38 6.15 7.69 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.812 -0.555 . . . . 0.0 112.113 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.84 26.58 53.21 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 119.954 -0.359 . . . . 0.0 113.172 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -124.01 145.58 49.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.272 0.629 . . . . 0.0 109.465 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 8.0 m -122.82 147.18 46.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.215 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.9 mt -123.86 123.76 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -77.44 132.84 38.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -128.74 177.36 7.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 127.44 22.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -149.96 -179.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.087 0.955 . . . . 0.0 109.449 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -136.83 163.14 51.64 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.342 1.057 . . . . 0.0 108.358 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 2.7 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.205 2.604 . . . . 0.0 113.553 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -125.77 -6.44 6.82 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.976 0.807 . . . . 0.0 110.779 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -83.79 75.13 10.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 3.8 t -64.76 175.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.205 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.492 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.3 mm -50.49 -36.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.43 -21.78 65.54 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.325 0.966 . . . . 0.0 111.262 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -82.48 -41.85 19.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.69 -39.81 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.591 1.157 . . . . 0.0 110.134 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.8 mttt -56.09 -26.51 49.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.501 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.68 -27.76 45.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.421 0.555 . . . . 0.0 110.896 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -68.66 -33.01 73.26 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.01 -28.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.07 -39.74 82.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 122.298 -0.251 . . . . 0.0 110.329 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.63 -30.17 68.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 111.592 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -82.83 -23.7 33.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.937 0.895 . . . . 0.0 113.363 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -137.34 -35.82 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.27 9.13 13.58 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.19 127.11 84.18 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 153.18 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.558 2.172 . . . . 0.0 111.184 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.43 -16.03 42.7 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.459 2.772 . . . . 0.0 110.314 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -80.9 -6.32 58.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.769 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -121.46 -21.61 6.21 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.99 162.95 13.04 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.109 0.868 . . . . 0.0 112.998 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -152.08 127.63 10.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.425 ' C ' HD12 ' B' ' 44' ' ' ILE . 37.1 tp -127.29 132.21 50.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.957 0.344 . . . . 0.0 110.522 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.425 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -130.6 148.86 33.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 109.16 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -151.7 143.5 23.72 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.098 0.959 . . . . 0.0 109.36 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 12.48 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.772 0.829 . . . . 0.0 112.427 -172.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 16.39 41.69 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.211 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.3 159.51 36.72 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.71 1.255 . . . . 0.0 110.16 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -96.08 129.26 43.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.679 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.491 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.6 mt -81.46 162.23 23.37 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.755 -174.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -127.48 147.76 50.31 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.445 0.64 . . . . 0.0 111.82 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.45 0.34 8.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.361 1.065 . . . . 0.0 111.691 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.18 13.53 31.2 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -118.57 -149.64 0.44 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.306 1.042 . . . . 0.0 108.942 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.19 157.17 41.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 125.747 1.619 . . . . 0.0 108.65 176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -60.56 -25.11 65.94 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -72.74 -25.21 61.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.365 1.066 . . . . 0.0 111.482 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.7 -14.68 60.35 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.342 0.657 . . . . 0.0 111.558 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.491 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -114.04 17.27 17.92 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 117.804 0.274 . . . . 0.0 110.344 175.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.54 27.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.304 1.442 . . . . 0.0 114.187 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 145.96 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -125.33 -177.42 3.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.498 0.719 . . . . 0.0 109.474 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -72.2 145.14 48.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.649 0.738 . . . . 0.0 112.086 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 58.61 16.58 4.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 111.449 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -65.23 -176.54 0.31 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.93 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -130.26 134.79 47.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.097 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -132.19 -177.03 4.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.246 1.419 . . . . 0.0 108.871 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -136.02 147.79 48.1 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.262 0.225 . . . . 0.0 110.564 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -132.73 138.94 47.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.064 0.946 . . . . 0.0 110.691 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 82.2 t -146.97 165.88 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -145.46 168.25 21.02 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.914 0.779 . . . . 0.0 112.34 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.83 175.92 3.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.435 1.094 . . . . 0.0 112.056 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tp -96.45 16.44 18.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.617 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 62.97 -39.27 0.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.595 2.358 . . . . 0.0 114.066 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.49 -20.89 5.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.407 -1.774 . . . . 0.0 110.904 -179.247 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 494' ' ' GLN . 86.0 Cg_endo -79.34 -167.27 0.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.86 3.707 . . . . 0.0 109.128 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 33.1 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.645 1.578 . . . . 0.0 112.837 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.9 pp0? -74.19 -28.76 61.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.445 0.698 . . . . 0.0 112.599 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.72 5.41 1.77 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.1 159.96 84.02 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 122.497 0.319 . . . . 0.0 110.668 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.0 151.07 21.72 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.535 3.49 . . . . 0.0 112.408 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -80.94 54.5 2.21 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 122.301 1.048 . . . . 0.0 109.989 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 171.48 28.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.833 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.52 165.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.595 0.758 . . . . 0.0 109.03 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.14 145.93 40.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.885 0.874 . . . . 0.0 108.676 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.597 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -59.79 -29.7 68.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -72.42 1.12 8.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.441 0.564 . . . . 0.0 111.642 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.53 16.54 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.22 0.608 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.81 -15.4 5.96 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.084 0.954 . . . . 0.0 109.498 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -77.85 1.5 20.21 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.95 -0.469 . . . . 0.0 111.635 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.12 3.05 40.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.95 0.5 . . . . 0.0 110.003 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.58 149.35 39.75 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.723 1.209 . . . . 0.0 109.606 -170.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.8 161.63 44.69 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.036 2.49 . . . . 0.0 110.768 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.92 -21.59 63.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.403 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.3 -6.23 59.26 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 117.823 0.283 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 44.6 mt -110.97 -17.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 172.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -55.63 -42.04 74.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.09 -13.63 62.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 111.589 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.24 -15.02 26.33 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.658 0.383 . . . . 0.0 111.344 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.8 -37.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.33 -6.96 5.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.434 0.694 . . . . 0.0 110.187 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 45.0 m -65.59 -28.27 69.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.526 -0.274 . . . . 0.0 111.134 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.4 39.16 2.65 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -61.85 -179.81 0.22 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.642 1.21 . . . . 0.0 112.418 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -149.01 -167.44 2.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.493 -1.685 . . . . 0.0 109.214 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.65 19.43 11.71 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.077 0.951 . . . . 0.0 111.975 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -142.82 145.99 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.511 0.724 . . . . 0.0 109.41 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.452 ' HB2' ' HE2' ' A' ' 526' ' ' LYS . 0.1 OUTLIER -138.75 18.77 2.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.027 0.442 . . . . 0.0 111.927 -172.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.43 10.07 4.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.875 0.845 . . . . 0.0 109.671 -169.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 524' ' ' ASN . 31.2 mtmm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -158.1 174.23 15.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.954 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.36 175.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -124.4 117.9 25.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.37 101.73 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -82.35 134.36 35.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.898 0.479 . . . . 0.0 110.917 -173.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -80.46 175.35 10.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.456 0.702 . . . . 0.0 111.649 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.428 HD22 HG13 ' B' ' 70' ' ' VAL . 21.6 tp -66.91 3.67 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.261 1.025 . . . . 0.0 111.485 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -119.87 9.24 11.25 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.732 -0.605 . . . . 0.0 111.787 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.26 25.51 57.09 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 120.088 -0.284 . . . . 0.0 113.133 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.81 140.65 52.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.64 158.59 25.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.117 0.484 . . . . 0.0 111.572 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.12 131.95 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 130.47 36.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -139.52 130.19 25.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.3 128.25 35.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.93 179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.596 0.758 . . . . 0.0 110.416 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.6 mm-40 -132.73 160.08 69.89 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.12 1.4 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.246 2.631 . . . . 0.0 113.304 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 18' ' ' GLU . 33.7 p -124.56 -3.66 7.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.823 0.849 . . . . 0.0 111.049 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.02 69.03 6.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.528 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.9 t -58.5 174.4 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.805 1.242 . . . . 0.0 110.722 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.67 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 16.9 mm -50.39 -31.01 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.26 -19.7 62.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.037 -1.04 . . . . 0.0 111.519 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -86.07 -45.76 11.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.504 0.722 . . . . 0.0 110.714 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.67 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.3 OUTLIER -66.6 -28.72 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 C-N-CA 122.686 0.395 . . . . 0.0 110.643 -176.054 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.53 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.5 mttt -56.59 -29.48 62.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.312 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.8 -29.16 40.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.246 0.475 . . . . 0.0 111.25 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.84 -34.28 73.42 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.951 0.341 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -85.92 -27.79 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -69.57 -39.49 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.01 -31.88 72.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.622 0.725 . . . . 0.0 111.172 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -83.05 -22.52 33.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.61 -31.71 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 8.46 17.63 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -76.77 127.53 83.85 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.52 157.67 58.21 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.759 2.306 . . . . 0.0 111.48 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.64 -13.78 37.95 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.722 2.948 . . . . 0.0 110.338 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.5 -8.13 58.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -126.28 -11.44 6.36 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.35 162.49 28.48 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.341 0.973 . . . . 0.0 111.785 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -154.84 125.73 7.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.454 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.5 OUTLIER -122.41 139.63 53.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.005 0.366 . . . . 0.0 111.323 -168.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.454 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -134.4 150.93 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.789 1.235 . . . . 0.0 108.911 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.489 ' HB3' HD21 ' B' ' 50' ' ' LEU . 18.8 t80 -148.63 138.66 22.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.109 1.364 . . . . 0.0 109.05 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.5 13.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.72 0.808 . . . . 0.0 112.651 -174.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.89 15.07 40.68 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.077 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 157.2 42.64 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.004 1.402 . . . . 0.0 109.921 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -90.15 153.03 20.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.525 HD22 ' CD1' ' B' ' 59' ' ' TYR . 13.2 mt -109.53 161.94 14.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.197 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -128.49 144.27 51.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.253 0.549 . . . . 0.0 111.704 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.24 0.16 6.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.388 1.075 . . . . 0.0 111.7 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.71 11.7 32.6 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -114.69 -149.13 0.44 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.653 1.181 . . . . 0.0 108.775 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.4 p -154.5 158.49 39.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 125.807 1.643 . . . . 0.0 109.024 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.02 -29.29 68.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.64 -25.73 64.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.635 1.174 . . . . 0.0 111.723 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.11 -10.77 59.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.678 0.391 . . . . 0.0 111.054 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.525 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -117.39 17.19 14.67 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.33 13.57 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.7 143.99 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 119.027 0.831 . . . . 0.0 111.428 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 109.697 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.06 147.96 49.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.27 17.89 7.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.839 0.855 . . . . 0.0 112.068 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 22.5 t -70.98 175.05 5.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -132.39 133.88 44.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.479 0.712 . . . . 0.0 109.094 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.87 179.62 5.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.42 0.688 . . . . 0.0 110.045 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -134.07 138.67 45.47 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.615 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.72 137.87 48.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.666 1.186 . . . . 0.0 110.025 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.428 HG13 HD22 ' B' ' 8' ' ' LEU . 75.7 t -136.32 159.37 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 pp -143.73 169.89 16.9 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.615 0.643 . . . . 0.0 112.733 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.17 -179.51 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' B' ' 75' ' ' GLY . 3.6 tp -126.87 18.31 7.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.898 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 58.59 -26.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 127.412 2.285 . . . . 0.0 114.578 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 142.55 -9.56 2.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.243 0 CA-C-O 117.328 -1.818 . . . . 0.0 111.066 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 494' ' ' GLN . 37.6 Cg_exo -59.09 -170.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 125.212 3.942 . . . . 0.0 112.041 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.15 29.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.809 1.243 . . . . 0.0 111.15 172.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -66.45 -34.74 78.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 112.953 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -146.48 11.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.841 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.538 HD12 HE21 ' A' ' 502' ' ' GLN . 87.8 mt -76.81 161.0 75.46 Favored Pre-proline 0 N--CA 1.448 -0.572 0 O-C-N 122.028 -0.42 . . . . 0.0 109.975 175.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.62 155.19 5.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.293 3.329 . . . . 0.0 112.649 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.6 64.88 3.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 122.031 0.919 . . . . 0.0 112.138 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 161.3 -28.55 0.29 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.075 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.41 164.42 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -139.15 160.82 38.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.081 -0.387 . . . . 0.0 110.856 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.538 HE21 HD12 ' A' ' 496' ' ' LEU . 1.5 mp0 -59.44 -51.54 69.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.82 0.848 . . . . 0.0 108.737 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.65 3.73 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.167 -1.379 . . . . 0.0 113.262 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.56 15.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.523 0.601 . . . . 0.0 111.719 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.05 -17.8 5.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.438 1.095 . . . . 0.0 109.435 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 502' ' ' GLN . 55.6 mtmt -75.8 0.66 17.24 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 111.604 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.26 -7.82 58.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 3.3 mp -89.49 156.06 48.22 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.829 1.252 . . . . 0.0 109.777 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.88 167.65 25.79 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.703 2.935 . . . . 0.0 111.183 170.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.9 -16.3 49.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.806 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.09 -2.03 41.05 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.495 0.588 . . . . 0.0 111.913 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.08 -16.06 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -44.94 70.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.491 -0.756 . . . . 0.0 109.367 170.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.54 -0.97 22.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.22 0.608 . . . . 0.0 112.505 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -105.04 -17.53 14.47 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.535 0.607 . . . . 0.0 111.745 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.22 -27.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . 0.433 ' O ' ' HE3' ' A' ' 520' ' ' LYS . 64.3 mt -74.48 -0.26 16.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.363 0.665 . . . . 0.0 110.892 172.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 44.8 m -136.03 24.76 3.3 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -142.55 -32.09 0.11 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 517' ' ' LEU . 51.0 mttt 43.96 26.52 0.14 Allowed 'General case' 0 C--N 1.339 0.139 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 169.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 23.8 t -148.98 173.15 13.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.32 11.6 2.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.131 1.372 . . . . 0.0 112.877 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -141.15 137.7 32.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.718 0.407 . . . . 0.0 110.255 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -150.4 23.68 0.81 Allowed 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.591 0.756 . . . . 0.0 109.778 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.28 8.28 3.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.455 -0.181 0 C-N-CA 124.624 1.17 . . . . 0.0 112.539 -174.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.12 175.68 13.18 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.383 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 178.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.623 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 89.7 m-85 -134.84 99.22 4.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 110.0 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.22 133.27 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.12 134.03 53.03 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -79.52 178.18 8.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.35 1.46 . . . . 0.0 112.975 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.45 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.5 OUTLIER -73.73 14.04 0.42 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.986 1.315 . . . . 0.0 110.499 173.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.0 p -132.29 11.96 4.58 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.272 -0.893 . . . . 0.0 112.095 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.05 66.62 Favored Glycine 0 C--N 1.338 0.643 0 O-C-N 122.287 -0.258 . . . . 0.0 112.745 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -120.79 142.33 49.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.623 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 23.5 m -115.63 144.8 43.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.99 126.82 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -78.17 136.98 37.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -146.16 133.15 20.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -92.86 128.74 38.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.84 178.24 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.222 1.009 . . . . 0.0 109.258 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' B' ' 20' ' ' SER . 36.1 mt-10 -143.77 163.95 33.0 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.44 4.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.397 2.732 . . . . 0.0 113.354 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 18' ' ' GLU . 23.7 p -126.26 -12.41 6.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.705 0.802 . . . . 0.0 111.108 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.1 m-20 -83.83 71.64 10.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.7 t -61.5 174.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.282 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.25 -35.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -69.68 -22.32 63.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.421 1.009 . . . . 0.0 111.355 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -80.95 -36.49 30.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.485 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.8 t -67.13 -37.22 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 C-N-CA 123.936 0.894 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.01 -24.64 66.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.63 -23.51 53.34 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.49 0.586 . . . . 0.0 110.558 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 65.0 mmtt -72.99 -45.98 54.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.621 0.768 . . . . 0.0 109.282 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.04 -31.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -68.93 -38.65 79.63 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.431 0.292 . . . . 0.0 110.643 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.1 -30.29 68.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.314 0.578 . . . . 0.0 111.341 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -82.63 -22.88 34.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.73 -175.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -138.71 -31.72 0.72 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.77 9.56 20.66 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -76.71 130.68 75.67 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.43 153.89 50.33 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.761 2.307 . . . . 0.0 111.045 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.35 -15.45 45.72 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.47 -13.95 60.41 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.803 0.441 . . . . 0.0 112.123 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -125.39 -16.11 5.98 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.26 165.52 18.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.609 1.095 . . . . 0.0 112.795 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -160.23 152.38 20.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 24.0 mt -135.67 146.86 48.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.033 0.379 . . . . 0.0 110.48 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 149.01 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -149.25 139.63 22.38 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 108.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.16 11.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 112.813 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.4 13.76 37.55 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.593 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 160.71 32.38 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.457 1.128 . . . . 0.0 110.043 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -96.7 133.76 40.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.631 -170.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' B' ' 59' ' ' TYR . 22.6 mt -83.25 164.06 20.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.652 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -136.82 153.71 50.72 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-O 121.475 0.655 . . . . 0.0 111.686 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -72.26 0.4 9.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.752 1.221 . . . . 0.0 111.667 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.83 13.73 26.97 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -116.08 -154.14 0.54 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.314 1.045 . . . . 0.0 109.388 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 5.2 p -148.44 158.34 44.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.71 1.604 . . . . 0.0 107.603 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.1 -24.9 68.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -74.2 -25.78 59.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.361 1.064 . . . . 0.0 111.892 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.68 -15.58 62.22 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.528 . . . . 0.0 111.3 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.439 ' CD2' HD22 ' B' ' 50' ' ' LEU . 22.2 m-85 -125.9 24.13 7.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.315 0.646 . . . . 0.0 110.056 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 p30 47.87 20.49 0.23 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.111 1.764 . . . . 0.0 115.597 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.67 138.04 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.761 0.709 . . . . 0.0 110.188 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -128.41 -173.07 2.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.477 1.111 . . . . 0.0 110.033 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.68 141.74 58.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.801 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 54.68 22.11 3.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.381 1.072 . . . . 0.0 113.428 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -69.99 -15.37 63.02 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -173.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.7 m 57.97 133.71 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.984 2.114 . . . . 0.0 112.615 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -134.72 -177.69 4.73 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.327 1.451 . . . . 0.0 108.238 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -134.49 138.86 45.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.56 131.56 53.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.34 1.456 . . . . 0.0 110.133 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.03 159.63 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -145.12 165.98 26.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.791 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.23 153.94 29.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.0 109.995 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' B' ' 75' ' ' GLY . 85.0 mt -95.74 23.25 6.37 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.691 1.596 . . . . 0.0 110.261 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? 61.86 -28.18 0.06 Allowed 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 127.053 2.141 . . . . 0.0 112.795 -170.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 137.89 -7.83 3.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.585 -1.675 . . . . 0.0 110.845 179.588 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 494' ' ' GLN . 40.5 Cg_exo -58.7 -171.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.861 3.707 . . . . 0.0 111.225 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 29.56 0.07 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.689 1.195 . . . . 0.0 110.622 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -64.09 -36.89 85.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.31 1.044 . . . . 0.0 112.814 -174.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -142.63 3.31 1.46 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.88 155.01 92.68 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.85 151.83 7.8 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.917 3.078 . . . . 0.0 111.646 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -75.23 69.1 2.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.961 0.886 . . . . 0.0 112.634 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 162.51 -29.27 0.27 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.03 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.0 165.27 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.604 0.762 . . . . 0.0 109.568 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.78 145.73 36.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.562 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -60.16 -28.07 67.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.45 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.33 0.72 11.26 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.605 -0.684 . . . . 0.0 111.717 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.25 16.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.359 0.599 . . . . 0.0 110.603 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -17.49 5.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.714 1.206 . . . . 0.0 109.223 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.31 3.3 7.55 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.881 -0.512 . . . . 0.0 111.65 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -85.57 -6.16 59.2 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 508' ' ' LEU . 2.7 mp -93.15 155.91 40.72 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.329 1.451 . . . . 0.0 109.704 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.74 167.58 26.89 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.02 2.48 . . . . 0.0 111.547 170.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -61.27 -17.54 53.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.431 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.15 3.74 51.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.545 0.338 . . . . 0.0 111.767 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.87 -14.71 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.0 -41.47 67.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.02 -1.1 30.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.628 0.771 . . . . 0.0 112.375 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.93 -18.65 14.95 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.387 0.539 . . . . 0.0 111.306 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.02 -31.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.38 -3.77 15.59 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.806 0.443 . . . . 0.0 110.495 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . 0.414 ' HA ' ' HE3' ' A' ' 520' ' ' LYS . 50.3 m -131.99 10.86 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 111.41 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.48 -44.8 1.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 518' ' ' SER . 83.3 mttt 49.77 6.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 172.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 33.8 t -161.81 179.55 8.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.351 0.523 . . . . 0.0 109.963 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 70.43 3.04 4.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.116 1.766 . . . . 0.0 112.912 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -154.23 155.14 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.181 0.515 . . . . 0.0 110.931 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -145.55 29.12 1.15 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.54 6.95 4.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 109.851 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.457 -0.095 0 C-N-CA 125.091 1.357 . . . . 0.0 112.119 -176.636 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -158.84 176.04 12.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.867 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.66 177.42 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.3 115.54 17.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.51 126.06 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.0 ttmt -101.94 136.87 41.02 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.022 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.418 ' C ' ' H ' ' B' ' 9' ' ' THR . 73.5 p -86.74 178.66 6.95 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.104 0.962 . . . . 0.0 112.386 -171.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.575 ' O ' HD13 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -70.0 12.96 0.17 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.981 1.312 . . . . 0.0 110.377 174.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.418 ' H ' ' C ' ' B' ' 7' ' ' THR . 28.1 p -126.26 5.68 7.05 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.165 -0.96 . . . . 0.0 111.758 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.57 62.3 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.592 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -125.85 140.44 52.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.493 0.646 . . . . 0.0 110.006 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -106.28 158.47 16.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.097 -175.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.24 125.89 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 19.8 m -75.41 132.28 40.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.4 mt -141.95 131.14 23.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.62 127.87 35.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.42 -179.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.777 0.831 . . . . 0.0 109.731 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 34.9 mt-10 -143.82 164.72 28.36 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 123.874 0.869 . . . . 0.0 108.921 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 32.9 Cg_exo -56.07 1.05 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.169 3.246 . . . . 0.0 113.449 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.409 ' H ' ' C ' ' B' ' 18' ' ' GLU . 69.7 m -131.78 -7.06 3.59 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.782 0.719 . . . . 0.0 111.651 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 5.5 m-20 -80.73 72.14 7.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 7.6 t -62.82 175.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.704 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -50.4 -34.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.16 -23.81 63.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.726 1.148 . . . . 0.0 111.139 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -81.12 -38.33 27.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.469 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 81.8 t -66.85 -37.88 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 123.695 0.798 . . . . 0.0 109.867 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -61.99 -23.52 66.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.039 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 -22.68 52.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.459 0.572 . . . . 0.0 110.541 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 64.7 mmtt -73.55 -48.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.62 0.768 . . . . 0.0 109.862 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.62 -30.8 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -69.46 -40.04 77.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.28 -0.262 . . . . 0.0 110.66 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.68 -30.76 70.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.463 0.649 . . . . 0.0 111.456 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -80.82 -25.1 38.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.926 -1.033 . . . . 0.0 113.449 -175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -138.03 -33.65 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.68 8.97 15.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.93 127.51 86.77 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.3 153.72 61.54 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.645 2.23 . . . . 0.0 110.693 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.59 -17.88 48.41 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 110.885 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.69 -5.34 58.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.46 -15.52 6.61 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -68.27 165.86 17.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.682 1.128 . . . . 0.0 112.413 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.471 ' C ' HD12 ' B' ' 44' ' ' ILE . 15.8 mt -129.17 138.62 51.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 110.785 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.471 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.5 mp -131.91 148.33 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.432 1.093 . . . . 0.0 108.585 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.16 141.19 23.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.065 0.946 . . . . 0.0 109.228 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.65 12.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.752 0.821 . . . . 0.0 112.608 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.51 14.63 40.37 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.458 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 158.84 37.98 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.833 1.316 . . . . 0.0 109.964 173.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -95.82 132.83 40.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.812 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.476 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.5 mt -80.23 159.79 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.156 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -128.86 150.06 50.5 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.513 0.673 . . . . 0.0 111.901 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -66.63 -18.71 65.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.737 1.215 . . . . 0.0 111.944 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.19 15.18 63.52 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -122.86 -151.56 0.48 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.429 1.091 . . . . 0.0 109.67 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 34.2 p -154.67 161.27 41.63 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.138 1.375 . . . . 0.0 108.881 174.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.54 -28.44 67.1 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.614 0.188 . . . . 0.0 111.226 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 31.0 t -75.47 -25.56 57.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.741 0.416 . . . . 0.0 110.736 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.45 -12.96 62.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.471 0.308 . . . . 0.0 111.369 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -116.39 19.45 14.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 p30 49.14 20.27 0.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.71 144.67 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 118.036 0.38 . . . . 0.0 110.043 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -130.14 -176.76 4.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.035 0.934 . . . . 0.0 109.963 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.93 146.8 54.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.24 16.82 7.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.298 1.039 . . . . 0.0 112.415 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -70.56 175.08 5.1 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -129.6 132.37 46.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.704 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -130.61 -177.1 4.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.473 1.109 . . . . 0.0 108.782 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -135.32 136.94 41.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.42 HD13 ' C ' ' B' ' 69' ' ' LEU . 3.0 tm? -124.16 131.87 53.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 0.0 109.566 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -142.65 166.13 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.84 172.39 13.4 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.12 178.71 5.79 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.257 1.023 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 73' ' ' LEU . 0.9 OUTLIER -132.42 17.97 4.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.327 1.451 . . . . 0.0 109.041 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 50.52 -55.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.499 2.72 . . . . 0.0 115.645 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.18 -12.64 1.24 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 117.33 -1.816 . . . . 0.0 110.774 179.513 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 494' ' ' GLN . 85.6 Cg_endo -77.04 -162.95 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 1 C-N-CA 125.341 4.027 . . . . 0.0 108.969 175.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 493' ' ' LEU . 1.3 pt? -67.68 25.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 492' ' ' PRO . 5.0 pp0? -66.3 -24.44 66.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.66 1.184 . . . . 0.0 112.75 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.01 7.11 1.6 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.458 ' CD2' HE21 ' A' ' 502' ' ' GLN . 7.8 mp -61.72 160.34 27.93 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 158.36 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 124.011 3.141 . . . . 0.0 111.549 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.18 66.89 3.88 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.849 0.833 . . . . 0.0 112.695 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 156.44 -23.94 0.51 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.54 168.04 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.679 0.792 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.9 157.11 45.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.677 0.791 . . . . 0.0 110.563 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.458 HE21 ' CD2' ' A' ' 496' ' ' LEU . 35.6 mm-40 -61.19 -46.77 89.12 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.135 0.574 . . . . 0.0 110.692 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.94 7.87 0.84 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.63 10.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.425 0.69 . . . . 0.0 111.257 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.84 -10.54 7.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.668 0.787 . . . . 0.0 109.936 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.52 17.7 4.39 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 111.339 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -89.53 6.35 41.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.645 0.778 . . . . 0.0 110.95 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.31 62.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.925 0.89 . . . . 0.0 110.938 -170.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.35 166.4 23.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.303 3.335 . . . . 0.0 113.028 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -26.69 63.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.043 0.937 . . . . 0.0 111.832 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.07 -4.8 49.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.316 0.246 . . . . 0.0 111.447 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.14 -12.88 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.253 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 26.5 mm-40 -56.02 -40.73 73.86 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.64 -14.12 62.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.374 0.67 . . . . 0.0 112.412 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -89.96 -21.5 22.4 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.201 0.455 . . . . 0.0 111.464 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.43 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 53.0 mt -65.97 -0.05 2.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.1 m -133.76 17.58 3.89 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.792 1.237 . . . . 0.0 110.126 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -98.74 35.92 4.34 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.376 0.989 . . . . 0.0 111.38 -177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 0.37 0.06 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -177.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.9 t -149.56 173.05 14.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.497 0.719 . . . . 0.0 110.069 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.11 7.49 2.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.14 1.776 . . . . 0.0 113.682 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -155.39 150.88 27.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.385 0.539 . . . . 0.0 111.576 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.06 35.65 1.11 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.596 1.158 . . . . 0.0 109.383 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.62 4.46 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.122 0.969 . . . . 0.0 110.765 -172.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.87 1.268 . . . . 0.0 111.969 -176.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.637 0.256 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.75 174.75 14.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.831 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.29 -178.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 123.768 0.827 . . . . 0.0 109.029 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -134.83 106.23 6.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -97.45 112.79 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -92.62 129.81 38.44 Favored 'General case' 0 C--O 1.23 0.047 0 O-C-N 122.258 -0.276 . . . . 0.0 111.392 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.427 ' C ' ' H ' ' B' ' 9' ' ' THR . 74.4 p -78.65 177.89 8.26 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.591 1.156 . . . . 0.0 112.354 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.436 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -70.88 17.78 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.947 1.299 . . . . 0.0 110.425 175.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.427 ' H ' ' C ' ' B' ' 7' ' ' THR . 49.6 p -133.15 6.35 3.88 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 121.226 -0.921 . . . . 0.0 111.911 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.57 26.78 58.43 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 122.208 -0.307 . . . . 0.0 112.55 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -124.71 143.65 50.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.755 0.822 . . . . 0.0 108.877 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.12 159.12 26.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.585 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.02 130.4 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -79.63 131.9 36.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -143.4 133.56 24.4 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.754 0.252 . . . . 0.0 110.602 -173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -92.91 128.66 38.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.48 175.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.167 0.987 . . . . 0.0 109.534 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.4 mm-40 -135.49 160.84 66.32 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 124.259 1.023 . . . . 0.0 109.108 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.33 3.67 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.585 2.857 . . . . 0.0 113.502 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 18' ' ' GLU . 29.8 p -125.74 -6.7 6.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.861 0.864 . . . . 0.0 110.874 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -86.5 78.6 9.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.3 t -63.59 172.19 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.811 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' B' ' 26' ' ' VAL . 16.6 mm -55.05 -27.59 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -67.68 -20.24 65.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 120.644 -1.285 . . . . 0.0 110.645 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.67 -45.25 12.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 110.167 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.1 m -66.36 -33.52 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 123.193 0.597 . . . . 0.0 110.93 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.429 ' HE3' HG22 ' B' ' 23' ' ' ILE . 95.0 mttt -56.77 -32.11 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.862 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -27.39 46.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.251 0.478 . . . . 0.0 110.924 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -67.57 -32.59 73.45 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.187 0.449 . . . . 0.0 109.932 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -83.91 -31.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.17 -39.97 86.53 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.8 0.334 . . . . 0.0 110.273 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.18 -31.41 71.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.206 0.527 . . . . 0.0 111.183 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.6 -24.79 31.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.663 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -135.31 -35.04 0.84 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.83 7.86 16.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.2 mt -77.87 128.26 79.65 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.57 154.8 55.09 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.053 2.502 . . . . 0.0 111.373 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.63 -14.41 41.92 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.352 2.701 . . . . 0.0 110.227 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.52 -8.02 59.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.84 -18.79 5.46 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.26 162.15 20.68 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.517 1.053 . . . . 0.0 112.167 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -151.58 136.15 17.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.438 ' C ' HD12 ' B' ' 44' ' ' ILE . 41.2 tp -134.18 136.23 43.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.241 0.473 . . . . 0.0 111.141 -168.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.438 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.7 mp -132.52 150.74 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.266 1.026 . . . . 0.0 108.909 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -150.47 143.1 24.54 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.468 1.107 . . . . 0.0 109.287 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.94 13.42 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.545 0.738 . . . . 0.0 112.585 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.26 15.77 43.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.32 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 158.97 40.16 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.653 1.226 . . . . 0.0 109.966 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -90.74 150.32 21.67 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.811 -172.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' B' ' 59' ' ' TYR . 15.4 mt -106.93 162.7 13.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.162 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -133.1 148.5 52.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.091 0.948 . . . . 0.0 112.542 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.51 -1.81 9.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.284 1.034 . . . . 0.0 111.905 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.47 6.2 33.71 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -107.65 -147.97 0.41 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.367 0.584 . . . . 0.0 109.699 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.509 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.2 p -152.13 155.94 38.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.85 2.06 . . . . 0.0 107.743 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.31 -24.04 67.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.185 0.448 . . . . 0.0 110.05 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -71.19 -25.32 62.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.25 1.02 . . . . 0.0 111.494 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.11 -13.99 60.19 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.101 0.56 . . . . 0.0 111.531 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.526 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -115.06 20.7 14.83 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 48.29 21.21 0.34 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.83 140.11 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-O 121.213 0.53 . . . . 0.0 110.271 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -129.39 -173.93 3.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.912 1.285 . . . . 0.0 109.343 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.86 142.97 58.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.081 0.467 . . . . 0.0 110.717 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 54.29 25.26 5.71 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.173 0.989 . . . . 0.0 113.11 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.52 -15.44 60.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 60.11 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.34 1.856 . . . . 0.0 112.955 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.61 -178.12 4.86 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.377 1.471 . . . . 0.0 108.719 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -135.54 120.78 18.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.519 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 35.8 tp -103.25 136.03 43.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.729 1.212 . . . . 0.0 110.088 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.67 169.29 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.75 170.1 18.96 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.416 -0.803 . . . . 0.0 111.566 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.23 -177.2 5.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.795 0.838 . . . . 0.0 110.644 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.59 18.34 3.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 56.79 -45.46 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.374 2.67 . . . . 0.0 114.799 -169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.69 -12.5 1.32 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 117.247 -1.863 . . . . 0.0 110.809 179.805 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 494' ' ' GLN . 58.5 Cg_endo -84.63 -159.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 1 C-N-CA 125.575 4.184 . . . . 0.0 108.073 174.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.429 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.1 pt? -67.14 27.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.0 pp0? -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 0.0 113.084 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -141.54 5.92 1.84 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.487 ' CD2' HE21 ' A' ' 502' ' ' GLN . 6.0 mp -60.85 138.48 93.66 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.17 159.99 11.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.793 2.995 . . . . 0.0 111.387 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.16 56.76 2.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.174 0.988 . . . . 0.0 109.903 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 176.24 27.75 0.03 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.423 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.95 162.34 13.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 124.128 0.971 . . . . 0.0 108.498 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.07 156.6 47.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 110.259 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.487 HE21 ' CD2' ' A' ' 496' ' ' LEU . 32.3 mm-40 -59.52 -40.64 87.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.055 0.542 . . . . 0.0 109.893 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.36 1.56 2.16 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.25 13.51 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 122.039 -0.413 . . . . 0.0 111.202 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.558 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.4 OUTLIER -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.288 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -73.66 -8.11 54.66 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.689 -0.632 . . . . 0.0 110.474 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.18 -5.74 58.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.544 1.138 . . . . 0.0 110.206 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 48.1 mt -87.1 155.81 54.92 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 123.976 0.91 . . . . 0.0 109.934 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.7 162.52 37.57 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.879 2.386 . . . . 0.0 110.811 169.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.09 -15.5 23.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.513 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -96.9 0.88 49.77 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.092 0.405 . . . . 0.0 111.343 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.2 mt -114.97 -19.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.081 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.698 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -48.89 -54.59 14.76 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.38 -11.72 3.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . 0.424 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 7.8 mm-40 -91.8 -25.28 19.09 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.103 0.41 . . . . 0.0 110.498 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . 0.438 ' HA ' ' HE2' ' A' ' 520' ' ' LYS . 3.3 mm -95.72 -38.06 8.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 118.364 0.529 . . . . 0.0 109.691 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -68.83 -10.66 58.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 22.7 t -63.97 -55.78 19.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.359 0.664 . . . . 0.0 110.847 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 135.21 133.96 3.32 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 516' ' ' ILE . 59.3 mttm -143.14 158.43 43.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.088 0.955 . . . . 0.0 109.127 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.2 m -146.88 30.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.22 1.008 . . . . 0.0 113.003 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.34 15.78 2.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.973 1.309 . . . . 0.0 111.631 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 523' ' ' GLU . 1.0 OUTLIER -139.08 151.8 47.03 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.218 1.007 . . . . 0.0 109.441 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -148.59 27.97 0.89 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.3 0.64 . . . . 0.0 111.459 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.276 3.9 pp 48.13 12.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.722 1.609 . . . . 0.0 114.041 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 126.334 1.854 . . . . 0.0 111.606 178.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -158.8 174.08 15.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.166 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.58 179.22 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.45 99.62 4.72 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.55 124.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 30.1 ttmt -108.41 135.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.025 0.44 . . . . 0.0 111.455 -173.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -72.58 171.83 11.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.208 1.003 . . . . 0.0 112.436 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.58 -1.66 3.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.791 1.236 . . . . 0.0 110.336 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 46.9 p -115.93 -5.76 12.02 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.725 -0.609 . . . . 0.0 112.567 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.89 19.59 14.8 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.549 -0.584 . . . . 0.0 113.89 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -121.17 137.55 54.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.835 0.817 . . . . 0.0 109.744 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.4 OUTLIER -106.86 159.67 16.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.05 -174.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.72 127.22 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -78.67 132.84 37.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -143.96 132.98 22.8 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.655 0.264 . . . . 0.0 110.392 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.01 128.66 37.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 179.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.493 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 80.0 mm-40 -131.57 160.09 68.9 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.65 1.07 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.129 2.553 . . . . 0.0 113.5 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 68.6 m -125.27 -2.21 7.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.609 0.641 . . . . 0.0 111.067 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -80.25 68.04 6.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.511 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 2.9 t -57.4 173.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.877 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.662 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 14.1 mm -51.89 -28.29 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -168.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -73.37 -19.93 60.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.512 1.051 . . . . 0.0 111.435 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -85.35 -45.6 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.611 0.764 . . . . 0.0 110.834 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.1 OUTLIER -66.46 -28.31 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 122.667 0.387 . . . . 0.0 110.521 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' B' ' 23' ' ' ILE . 90.1 mttt -58.11 -29.9 65.86 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.862 172.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.95 41.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.957 0.344 . . . . 0.0 111.042 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.46 -31.19 71.78 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.074 0.397 . . . . 0.0 109.99 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.14 -30.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.65 -40.03 84.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.792 0.33 . . . . 0.0 110.204 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.72 -32.72 74.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.3 0.571 . . . . 0.0 111.223 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -82.02 -24.46 35.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.98 -34.52 0.8 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.08 8.12 15.73 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 94.5 mt -75.7 128.9 82.79 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.56 152.79 70.38 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.664 2.243 . . . . 0.0 111.071 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.98 -15.3 36.23 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.379 2.719 . . . . 0.0 110.566 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.84 -7.97 59.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -124.23 -15.72 6.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -65.52 164.9 13.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.139 0.881 . . . . 0.0 112.299 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -152.89 135.42 15.18 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 36.7 tp -131.83 138.11 48.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 118.568 0.622 . . . . 0.0 110.917 -168.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -134.93 149.18 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.306 1.043 . . . . 0.0 109.047 -172.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -153.2 146.57 24.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.016 0.926 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 15.2 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.195 0.598 . . . . 0.0 111.848 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.39 56.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.417 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 158.4 40.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.535 1.167 . . . . 0.0 109.87 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.92 144.47 26.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.721 -1.127 . . . . 0.0 107.98 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 17.2 mt -101.33 159.5 15.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.767 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -125.32 144.97 50.24 Favored 'General case' 0 CA--C 1.524 -0.054 0 CA-C-O 121.357 0.599 . . . . 0.0 112.085 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.64 -0.66 7.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.555 1.142 . . . . 0.0 111.827 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.76 11.57 38.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.79 -149.19 0.44 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 109.298 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -153.17 157.91 41.0 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.861 1.665 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.81 -28.96 69.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -68.4 -26.04 65.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.828 1.251 . . . . 0.0 111.779 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -75.13 -12.12 60.24 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.057 0.543 . . . . 0.0 111.603 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.29 17.74 14.62 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.89 27.39 1.59 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.637 1.575 . . . . 0.0 114.408 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.84 141.24 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -129.81 -174.03 3.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.696 1.199 . . . . 0.0 109.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.39 143.56 57.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.642 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 54.35 24.3 5.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.924 0.89 . . . . 0.0 113.244 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -72.4 -16.81 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.0 m 60.0 132.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.316 1.846 . . . . 0.0 112.674 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.62 -179.7 5.62 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.709 1.204 . . . . 0.0 108.776 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -135.64 122.51 21.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 110.72 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.09 140.46 36.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.107 1.363 . . . . 0.0 110.064 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.87 162.86 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.86 171.66 16.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.658 -0.651 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -91.25 174.9 7.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.429 0.692 . . . . 0.0 110.116 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -122.14 25.5 8.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.518 0.727 . . . . 0.0 110.268 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 66.01 -25.33 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 113.61 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -139.68 8.87 3.11 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 176.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 117.287 -1.84 . . . . 0.0 111.065 179.162 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 494' ' ' GLN . 71.6 Cg_endo -76.72 -167.1 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 1 C-N-CA 125.686 4.258 . . . . 0.0 109.862 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 32.09 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.866 1.267 . . . . 0.0 112.737 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 492' ' ' PRO . 0.0 OUTLIER -69.63 -35.39 75.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.73 4.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.351 0.661 . . . . 0.0 112.123 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.408 HD21 ' CZ ' ' A' ' 505' ' ' PHE . 99.0 mt -68.98 160.98 75.78 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 122.755 0.422 . . . . 0.0 109.923 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.62 147.77 38.09 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.785 2.99 . . . . 0.0 111.642 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.83 54.69 1.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.292 1.044 . . . . 0.0 110.257 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 170.67 25.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.165 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 45.0 t -136.47 162.02 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 118.357 1.079 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -121.67 143.65 49.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.264 0.626 . . . . 0.0 109.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.437 ' N ' HE21 ' A' ' 502' ' ' GLN . 0.0 OUTLIER -68.96 -32.44 72.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.645 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.87 10.63 1.73 Allowed 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.303 -0.873 . . . . 0.0 110.575 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 504' ' ' VAL . 83.1 t -129.86 8.52 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.585 1.154 . . . . 0.0 109.827 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 496' ' ' LEU . 0.0 OUTLIER -137.14 -23.37 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.247 -0.908 . . . . 0.0 112.738 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -69.47 -9.15 52.51 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.479 -0.763 . . . . 0.0 112.1 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 507' ' ' GLN . 10.1 mp0 -80.74 -11.0 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.945 0.339 . . . . 0.0 110.803 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.21 150.59 68.27 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.125 0.97 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.37 163.38 26.83 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.565 2.177 . . . . 0.0 111.165 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.54 -23.59 64.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.287 0.635 . . . . 0.0 112.117 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.66 -1.22 56.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 122.352 0.261 . . . . 0.0 111.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 33.1 mt -117.44 -13.88 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -55.24 -43.56 74.67 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.81 -5.74 40.15 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.387 0.675 . . . . 0.0 112.469 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.63 -17.41 17.04 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.254 0.479 . . . . 0.0 111.967 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.77 -28.47 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.61 -3.8 2.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.891 0.476 . . . . 0.0 110.049 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 52.5 m -137.24 17.51 2.97 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.725 1.21 . . . . 0.0 110.709 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -115.34 43.8 1.61 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.67 0.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.0 t -145.23 178.23 8.23 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.514 0.726 . . . . 0.0 110.232 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.21 2.03 3.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.822 1.649 . . . . 0.0 112.958 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.42 141.2 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.175 0.443 . . . . 0.0 110.726 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 526' ' ' LYS . 34.4 m-80 -144.18 36.67 1.24 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.429 0.692 . . . . 0.0 110.244 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 525' ' ' LEU 0.335 0.5 OUTLIER 56.84 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.387 1.875 . . . . 0.0 114.715 -177.486 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 524' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 C-N-CA 125.082 1.353 . . . . 0.0 110.352 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.277 0.084 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -157.2 173.23 17.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.05 179.98 3.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 123.823 0.849 . . . . 0.0 109.114 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -131.93 101.29 5.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.51 104.62 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -90.99 135.59 33.64 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.675 0.39 . . . . 0.0 112.02 -172.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.7 p -77.62 173.1 12.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.634 0.774 . . . . 0.0 111.973 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.94 -22.85 63.0 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.168 0.987 . . . . 0.0 110.321 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -94.61 -5.08 46.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.767 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.17 25.38 14.39 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.579 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -120.8 144.27 48.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.14 159.75 24.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 111.439 -173.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 mt -129.74 131.98 66.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 42.8 m -84.01 133.94 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.1 mt -145.39 138.29 26.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.26 127.3 44.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.9 176.73 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.069 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.54 161.87 60.56 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 108.795 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.63 1.59 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.293 2.662 . . . . 0.0 113.593 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -127.17 -5.89 6.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.586 0.63 . . . . 0.0 110.846 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -83.4 71.29 10.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.5 t -63.68 176.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.686 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.456 HG22 ' HE3' ' B' ' 27' ' ' LYS . 15.3 mm -51.55 -35.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -168.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.1 -20.71 65.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.296 0.953 . . . . 0.0 111.03 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -84.79 -42.73 14.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.49 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.382 1.073 . . . . 0.0 110.4 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.456 ' HE3' HG22 ' B' ' 23' ' ' ILE . 89.6 mttt -56.22 -23.61 36.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.945 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -27.11 31.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.35 0.523 . . . . 0.0 110.592 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.23 -36.43 77.2 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.052 0.387 . . . . 0.0 110.129 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -83.09 -32.43 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.07 -38.36 85.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.2 -32.56 72.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.295 0.569 . . . . 0.0 111.399 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -80.53 -24.75 39.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.205 1.002 . . . . 0.0 113.472 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -136.71 -31.26 0.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.58 9.44 23.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.06 131.24 76.14 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.51 157.57 61.28 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.427 2.085 . . . . 0.0 111.03 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.1 -11.07 30.8 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.868 3.045 . . . . 0.0 112.045 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.34 -5.5 29.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -126.11 3.54 7.18 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.5 -54.47 19.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 60.6 82.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.506 1.922 . . . . 0.0 110.919 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' B' ' 44' ' ' ILE . 26.2 tp -90.1 137.09 32.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.573 1.149 . . . . 0.0 111.173 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.513 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.0 mp -133.42 149.93 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.551 1.14 . . . . 0.0 108.881 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -153.62 149.85 28.02 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.035 0.934 . . . . 0.0 109.378 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.17 16.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.626 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.38 56.42 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.124 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 160.5 37.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.449 1.125 . . . . 0.0 110.759 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.67 124.42 38.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.521 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 15.4 mt -79.49 164.25 24.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.524 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -126.79 147.86 49.98 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.4 0.619 . . . . 0.0 111.89 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.13 -1.91 16.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.11 0.964 . . . . 0.0 111.996 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.09 14.64 44.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -120.29 -149.84 0.44 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.578 1.151 . . . . 0.0 108.988 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.1 p -152.95 156.84 39.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 126.068 1.747 . . . . 0.0 108.903 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -60.57 -24.41 65.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -73.31 -25.03 60.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 111.41 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -75.57 -14.07 60.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.161 0.584 . . . . 0.0 111.818 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -115.74 21.18 14.1 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 p30 49.49 19.46 0.37 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.7 138.66 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 121.338 0.589 . . . . 0.0 110.56 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -130.38 -177.52 4.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.966 1.306 . . . . 0.0 108.871 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -60.61 145.16 49.97 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.022 0.439 . . . . 0.0 110.778 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 55.66 22.78 5.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.212 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -74.4 -14.23 60.83 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 74.9 m 61.16 130.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.187 1.795 . . . . 0.0 112.11 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.88 -179.9 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.601 1.16 . . . . 0.0 108.687 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -135.59 152.77 51.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -140.14 138.47 35.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.464 1.106 . . . . 0.0 108.528 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.91 68.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.89 163.88 1.78 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -72.61 -168.75 0.47 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.319 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' B' ' 75' ' ' GLY . 13.8 tp -101.97 17.38 23.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.5 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 62.67 -27.3 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.155 2.182 . . . . 0.0 114.416 -175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 148.38 -14.06 1.24 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.444 -1.753 . . . . 0.0 111.164 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 492' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 494' ' ' GLN . 96.2 Cg_endo -81.31 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 1 C-N-CA 125.47 4.113 . . . . 0.0 109.023 178.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.93 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.326 1.85 . . . . 0.0 113.181 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.7 pp0? -71.75 -27.2 62.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.052 0.941 . . . . 0.0 112.291 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -150.17 4.41 0.54 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 505' ' ' PHE . 4.2 mm? -61.75 142.87 94.49 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.253 0.479 . . . . 0.0 110.273 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.04 157.45 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.051 3.167 . . . . 0.0 111.226 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.12 57.41 2.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 122.52 1.153 . . . . 0.0 110.08 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.71 26.7 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.829 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 501' ' ' ASP . 60.5 t -147.44 164.34 6.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.693 0.747 . . . . 0.0 109.156 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 500' ' ' VAL . 6.2 t70 -134.45 144.0 47.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.0 109.419 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.549 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -61.0 -28.82 69.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.491 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -71.38 -0.9 11.28 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.694 -0.629 . . . . 0.0 111.824 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.84 18.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.626 ' HZ ' HD21 ' A' ' 517' ' ' LEU . 0.0 OUTLIER -124.85 -20.93 4.86 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.24 1.016 . . . . 0.0 110.081 176.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -71.61 5.84 2.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -87.87 7.72 29.4 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.755 0.822 . . . . 0.0 110.578 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 39.1 mt -116.02 157.33 45.26 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 124.204 1.002 . . . . 0.0 111.258 -171.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.94 163.31 35.67 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.857 2.371 . . . . 0.0 110.373 167.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.19 -18.4 36.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.192 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.04 -4.93 58.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.103 0.561 . . . . 0.0 111.429 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.5 mt -117.32 -15.9 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.684 ' O ' HD22 ' A' ' 517' ' ' LEU . 1.0 OUTLIER -51.61 -50.72 59.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.86 -14.1 13.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.06 -18.35 27.47 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.641 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 3.5 mm -104.37 -40.93 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . 0.684 HD22 ' O ' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -64.62 -10.58 27.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 42.0 t -58.28 -35.71 72.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.113 0.565 . . . . 0.0 111.123 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 105.5 38.88 2.33 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -58.44 172.07 0.52 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.754 1.222 . . . . 0.0 111.912 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.4 m -146.37 34.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.759 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.6 15.63 4.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.745 1.218 . . . . 0.0 111.375 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.52 143.46 26.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.043 0.937 . . . . 0.0 109.176 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -148.77 38.4 0.83 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.217 0.607 . . . . 0.0 112.149 -168.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.41 19.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.804 1.642 . . . . 0.0 114.197 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -176.662 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -159.51 173.33 16.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.413 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.39 179.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 123.139 0.576 . . . . 0.0 109.774 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -133.18 106.28 7.49 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.43 69.39 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.908 0.483 . . . . 0.0 111.284 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -58.68 133.25 55.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.901 0.481 . . . . 0.0 111.519 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.39 175.58 10.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 8' ' ' LEU . 3.2 tm? -64.59 -23.44 67.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.354 0.662 . . . . 0.0 110.228 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.2 p -89.32 -22.07 22.83 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.905 -0.497 . . . . 0.0 110.39 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.52 4.69 21.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.021 0.368 . . . . 0.0 114.021 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -83.57 153.81 24.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.97 159.17 38.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.742 0.701 . . . . 0.0 109.398 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.77 126.75 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m -79.26 129.96 34.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -140.59 133.36 28.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.21 129.22 39.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.43 178.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.864 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' B' ' 20' ' ' SER . 81.1 mm-40 -132.66 161.5 63.0 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.964 0.906 . . . . 0.0 108.579 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.7 3.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.98 2.453 . . . . 0.0 113.429 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 18' ' ' GLU . 59.8 m -125.79 -4.12 7.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.739 0.7 . . . . 0.0 110.825 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.1 76.92 10.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.2 t -62.34 171.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.8 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.582 ' HA ' HG22 ' B' ' 26' ' ' VAL . 12.2 mm -55.31 -28.04 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -168.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.1 -19.51 65.65 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.87 -1.144 . . . . 0.0 110.427 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -85.12 -46.11 11.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.853 0.861 . . . . 0.0 110.079 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' B' ' 23' ' ' ILE . 2.8 m -66.43 -34.48 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.118 0.567 . . . . 0.0 110.973 -173.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -56.33 -31.99 64.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.165 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.82 47.86 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.386 0.539 . . . . 0.0 110.856 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.8 mptp? -68.1 -33.28 74.23 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.987 0.358 . . . . 0.0 110.086 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.77 -31.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.76 -39.4 87.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 -31.53 71.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.333 0.587 . . . . 0.0 111.275 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -83.95 -22.2 31.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -139.67 -30.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.53 8.26 19.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -76.17 128.56 82.56 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.67 154.8 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.493 2.128 . . . . 0.0 110.771 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.71 -14.19 38.71 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.543 2.829 . . . . 0.0 110.94 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.47 -6.21 58.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -118.99 -18.13 8.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.85 162.68 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.45 1.023 . . . . 0.0 112.339 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -155.03 128.76 8.62 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.439 ' C ' HD12 ' B' ' 44' ' ' ILE . 52.0 tp -133.36 128.73 36.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.893 0.315 . . . . 0.0 110.984 -168.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.439 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.4 mp -122.77 155.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -120.96 -111.69 0.33 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 122.695 0.398 . . . . 0.0 110.685 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.85 -4.9 3.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.302 0.641 . . . . 0.0 111.689 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.97 1.69 2.0 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.596 1.093 . . . . 0.0 111.519 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 154.71 33.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.704 0.764 . . . . 0.0 109.554 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.97 129.95 35.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.348 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.459 ' HB3' ' CZ ' ' B' ' 59' ' ' TYR . 14.0 mt -77.68 162.67 26.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.83 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -127.98 146.92 50.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.432 0.634 . . . . 0.0 111.706 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.45 -1.33 10.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.438 1.095 . . . . 0.0 111.798 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 16.05 35.13 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -121.34 -148.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.307 1.043 . . . . 0.0 109.45 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.3 p -152.36 156.19 39.08 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 126.257 1.823 . . . . 0.0 108.357 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.04 -23.99 66.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -71.88 -25.29 61.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.281 1.032 . . . . 0.0 111.545 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.43 -12.88 60.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.098 0.559 . . . . 0.0 111.515 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.09 20.77 13.61 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.7 25.21 0.4 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.12 142.4 16.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 121.171 0.51 . . . . 0.0 110.112 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -130.39 -173.47 3.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.058 1.343 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -62.89 142.54 58.24 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.0 110.409 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 55.92 21.2 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.252 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -71.85 -16.61 62.15 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 84.4 m 62.33 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.16 1.784 . . . . 0.0 112.226 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -145.47 -176.48 5.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.728 1.211 . . . . 0.0 108.708 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -136.48 104.98 5.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.37 129.77 36.23 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.694 0.798 . . . . 0.0 109.146 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.24 52.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.431 0.634 . . . . 0.0 109.378 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.85 168.88 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 114.209 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -94.47 172.28 8.29 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.498 0.719 . . . . 0.0 109.802 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.9 26.31 9.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.948 1.299 . . . . 0.0 111.734 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -48.42 -33.2 8.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.376 1.07 . . . . 0.0 112.504 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.64 -15.66 7.98 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.326 -178.091 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 494' ' ' GLN . 87.6 Cg_endo -77.58 -167.61 0.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.95 3.766 . . . . 0.0 108.319 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.447 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.2 pt? -65.26 26.92 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -65.43 -28.91 69.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.471 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -148.09 6.39 0.78 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.79 159.38 85.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.59 155.0 22.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.853 3.035 . . . . 0.0 111.954 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -83.69 55.31 3.18 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 122.423 1.106 . . . . 0.0 109.509 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 175.74 26.5 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.995 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 501' ' ' ASP . 86.4 t -146.74 164.35 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . 0.425 ' N ' HG12 ' A' ' 500' ' ' VAL . 20.8 m-20 -135.49 143.13 45.66 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.036 0.934 . . . . 0.0 108.751 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.682 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.54 -24.11 67.03 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.852 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.94 1.84 4.09 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.737 -0.602 . . . . 0.0 111.601 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.53 11.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.672 0.789 . . . . 0.0 110.647 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -17.72 7.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.985 0.914 . . . . 0.0 109.875 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.72 3.15 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.957 -0.465 . . . . 0.0 111.345 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -88.65 -5.12 58.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 512' ' ' ILE . 4.1 mp -93.04 159.31 35.88 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.179 1.392 . . . . 0.0 110.128 -173.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.22 165.48 31.81 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.295 2.663 . . . . 0.0 111.325 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.75 -12.51 10.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.027 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.5 1.17 40.81 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.058 0.543 . . . . 0.0 111.43 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.447 HG22 HD23 ' A' ' 508' ' ' LEU . 52.0 mt -119.16 -14.48 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -43.91 67.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 169.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.74 -4.42 37.43 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.424 0.689 . . . . 0.0 112.388 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -100.12 -21.64 15.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.501 0.591 . . . . 0.0 111.433 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.69 -34.41 4.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.64 -3.35 3.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.667 0.387 . . . . 0.0 110.516 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 41.5 m -137.44 18.32 2.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.361 0.664 . . . . 0.0 111.409 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.54 -39.51 5.29 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp 49.43 1.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.7 t -167.76 -172.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.981 0.809 . . . . 0.0 109.818 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 68.0 11.56 8.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.469 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -153.92 154.34 33.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.559 0.343 . . . . 0.0 110.854 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.408 ' C ' HD23 ' A' ' 525' ' ' LEU . 60.7 m-80 -149.72 46.93 0.94 Allowed 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.856 0.863 . . . . 0.0 110.795 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 524' ' ' ASN . 1.1 pt? 44.14 19.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.961 1.704 . . . . 0.0 113.95 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.944 1.297 . . . . 0.0 112.625 -177.318 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -158.44 173.66 16.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.094 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.78 179.28 4.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -134.69 103.27 5.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.58 113.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.42 130.8 37.99 Favored 'General case' 0 N--CA 1.458 -0.052 0 O-C-N 122.205 -0.31 . . . . 0.0 111.222 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -72.3 174.37 7.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.417 1.087 . . . . 0.0 112.058 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.523 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.7 tm? -66.12 -5.02 8.56 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.073 0.949 . . . . 0.0 110.17 174.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -112.97 1.36 15.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.556 -0.715 . . . . 0.0 111.528 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.28 26.05 31.86 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.606 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -123.56 145.01 49.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.17 159.94 21.82 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.434 -174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -129.45 127.69 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -77.81 130.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.405 ' CD2' ' HG3' ' B' ' 33' ' ' LYS . 60.0 mt -140.67 131.23 25.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.11 127.32 35.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.622 0.769 . . . . 0.0 108.998 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.1 178.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.183 0.993 . . . . 0.0 109.444 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 20' ' ' SER . 34.8 mt-10 -141.45 163.81 39.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.19 2.25 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.531 2.821 . . . . 0.0 113.62 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.7 m -129.42 -5.64 4.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.058 0.845 . . . . 0.0 111.215 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 26.4 m-20 -82.89 68.32 9.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 9.2 t -61.25 179.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.921 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.597 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.4 mm -59.24 -11.91 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -168.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.85 -17.96 28.62 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.815 1.189 . . . . 0.0 110.483 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -85.02 -40.82 16.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.537 0.735 . . . . 0.0 109.993 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' B' ' 23' ' ' ILE . 20.4 m -64.36 -31.11 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 123.728 0.811 . . . . 0.0 110.155 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.53 -25.28 66.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.83 -26.44 29.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.314 0.507 . . . . 0.0 110.821 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -70.34 -36.5 74.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.096 0.407 . . . . 0.0 110.392 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -81.76 -30.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -68.16 -39.73 82.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.24 -31.21 71.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.246 0.545 . . . . 0.0 111.348 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' B' ' 15' ' ' LEU . 38.8 mmtm -82.5 -24.2 34.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.57 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -136.77 -33.82 0.77 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 9.52 17.66 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 98.8 mt -76.64 129.87 78.15 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.83 156.1 61.18 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 111.055 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.1 -14.14 40.01 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.967 3.111 . . . . 0.0 110.804 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -90.45 -3.0 57.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -123.91 -11.81 7.59 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.88 167.64 21.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.103 0.865 . . . . 0.0 112.464 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -158.67 134.55 8.95 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.93 1.292 . . . . 0.0 108.002 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.51 ' C ' HD12 ' B' ' 44' ' ' ILE . 16.7 mt -126.47 141.49 51.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.531 0.333 . . . . 0.0 110.43 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.51 HD12 ' C ' ' B' ' 43' ' ' LEU . 2.9 mp -129.31 148.72 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -148.36 134.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.833 0.853 . . . . 0.0 109.009 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.93 19.87 0.71 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.556 0.742 . . . . 0.0 112.827 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.59 25.37 39.17 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 123.04 0.352 . . . . 0.0 112.749 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.8 ttmm -123.37 125.59 45.28 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.119 0.568 . . . . 0.0 110.756 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -76.57 110.8 11.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.598 HD12 ' CD2' ' B' ' 59' ' ' TYR . 0.8 OUTLIER -68.63 171.11 8.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -174.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -132.52 152.85 51.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.676 0.751 . . . . 0.0 112.004 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.88 -1.82 15.67 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.455 1.102 . . . . 0.0 111.892 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.28 15.06 36.23 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -117.88 -154.7 0.57 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.326 1.05 . . . . 0.0 109.16 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.7 p -149.64 159.67 44.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.599 1.56 . . . . 0.0 107.9 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.62 -27.27 69.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -71.25 -25.75 62.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.34 1.056 . . . . 0.0 112.143 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.95 -16.94 61.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.828 0.451 . . . . 0.0 111.323 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.599 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.1 m-85 -128.64 26.87 5.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.187 0.595 . . . . 0.0 110.065 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.84 28.47 0.59 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.82 132.91 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.8 -173.11 3.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 109.747 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.12 142.24 37.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.093 0.473 . . . . 0.0 111.264 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 52.97 27.14 5.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.806 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.9 p -69.59 -24.96 63.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m 59.99 127.65 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.019 2.128 . . . . 0.0 112.161 -174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -131.29 -176.83 4.15 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.094 1.358 . . . . 0.0 108.238 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -135.56 135.26 40.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.93 135.16 55.0 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.748 1.219 . . . . 0.0 110.085 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -139.37 160.2 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 71' ' ' LEU . 1.1 pt? -146.64 172.16 14.01 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.98 -177.19 5.7 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 123.968 0.907 . . . . 0.0 112.76 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' B' ' 75' ' ' GLY . 9.0 tp -110.02 22.09 16.02 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.901 0.881 . . . . 0.0 111.422 -169.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 64.05 -25.81 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.809 2.044 . . . . 0.0 113.352 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 147.03 -12.93 1.46 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 117.255 -1.859 . . . . 0.0 111.042 -179.669 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.1 Cg_endo -77.33 -165.47 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 125.113 3.875 . . . . 0.0 109.319 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.517 ' H ' ' CD2' ' A' ' 493' ' ' LEU . 1.3 pt? -69.92 27.65 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 492' ' ' PRO . 4.2 pp0? -64.5 -25.91 68.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 0.0 111.785 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -149.88 4.8 0.57 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.88 162.16 74.8 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 122.105 -0.372 . . . . 0.0 110.561 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.61 151.42 31.39 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.183 3.255 . . . . 0.0 111.616 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.74 55.33 2.35 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 122.196 0.998 . . . . 0.0 109.939 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 168.93 31.33 0.02 OUTLIER Glycine 0 CA--C 1.527 0.816 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.019 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 49.0 t -141.86 165.03 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.801 0.801 . . . . 0.0 109.657 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.9 141.04 47.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.391 1.076 . . . . 0.0 109.306 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.597 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.17 -33.73 76.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.074 -177.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.76 5.2 3.33 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.54 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.41 ' HA ' HE21 ' A' ' 507' ' ' GLN . 16.5 m -136.9 11.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.513 0.725 . . . . 0.0 111.013 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.14 -13.68 8.92 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.835 0.854 . . . . 0.0 109.939 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -82.68 18.76 1.46 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.412 0.685 . . . . 0.0 111.921 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 504' ' ' VAL . 25.2 mm-40 -94.46 7.69 44.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.542 0.737 . . . . 0.0 111.415 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 156.81 69.37 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.594 1.158 . . . . 0.0 110.495 -171.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.35 164.66 22.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.157 3.238 . . . . 0.0 113.054 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -59.11 -25.48 63.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.622 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.94 -6.56 51.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.47 0.308 . . . . 0.0 111.251 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 18.1 mt -118.1 -12.74 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 170.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 23.6 mm-40 -58.41 -39.7 80.46 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.84 -11.03 60.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.391 0.676 . . . . 0.0 112.204 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.69 -19.35 21.92 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.255 0.48 . . . . 0.0 111.553 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.61 -27.18 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 65.7 mt -64.47 -2.96 2.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 50.4 m -138.42 21.0 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.959 1.304 . . . . 0.0 110.024 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -107.23 46.64 1.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.476 1.036 . . . . 0.0 110.993 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -56.46 2.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.3 t -149.06 -175.95 5.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.468 0.651 . . . . 0.0 111.039 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 65.76 3.79 2.64 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.523 1.929 . . . . 0.0 114.652 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -155.36 148.58 24.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.1 0.864 . . . . 0.0 111.43 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 526' ' ' LYS . 37.1 m-80 -147.19 43.83 1.14 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.952 0.901 . . . . 0.0 111.116 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 525' ' ' LEU 0.298 3.2 pp 50.19 9.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.623 1.569 . . . . 0.0 114.051 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 524' ' ' ASN . 43.5 mtmt . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 127.752 2.421 . . . . 0.0 110.368 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.704 0.288 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.4 172.94 17.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.251 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.48 -177.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.602 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 96.2 m-85 -130.66 128.25 40.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.77 121.13 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.27 142.6 33.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -172.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -88.37 178.79 6.47 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.146 1.379 . . . . 0.0 112.912 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.598 HD13 ' O ' ' B' ' 8' ' ' LEU . 1.1 tm? -70.97 6.47 1.54 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.839 1.255 . . . . 0.0 110.239 173.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -124.55 9.0 8.35 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.94 -1.1 . . . . 0.0 111.993 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.74 60.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 120.133 -0.259 . . . . 0.0 113.211 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -119.76 139.48 52.24 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 9.0 m -113.43 142.5 45.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.41 132.9 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -87.08 133.79 33.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 mt -142.6 135.04 27.78 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.47 130.3 37.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 109.086 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.57 179.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.788 0.835 . . . . 0.0 109.89 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.433 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.4 mt-10 -140.21 163.46 43.77 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.86 2.92 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.463 2.775 . . . . 0.0 113.722 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.416 ' H ' ' C ' ' B' ' 18' ' ' GLU . 70.0 m -127.73 -7.1 5.63 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.771 0.714 . . . . 0.0 110.971 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 3.6 m-20 -79.82 67.57 5.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 171.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 6.1 t -59.61 175.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.786 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.422 HG22 ' HE3' ' B' ' 27' ' ' LYS . 14.8 mm -49.94 -34.73 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.55 -21.39 61.89 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.363 0.983 . . . . 0.0 111.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -81.76 -37.21 27.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.47 ' HA ' ' CG ' ' B' ' 29' ' ' LYS . 85.5 t -64.77 -39.4 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.226 1.01 . . . . 0.0 109.862 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 96.3 mttt -59.04 -28.08 66.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.758 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -24.13 54.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.516 0.598 . . . . 0.0 110.6 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' B' ' 26' ' ' VAL . 69.1 mmtt -69.76 -44.54 69.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.528 0.731 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.12 -30.22 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.581 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.57 -40.74 80.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.29 -30.55 70.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.176 0.512 . . . . 0.0 111.352 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -85.63 -19.58 30.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.5 -40.01 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.361 0.528 . . . . 0.0 112.001 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.29 9.04 12.14 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.6 mt -79.18 128.53 75.62 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.34 151.98 66.08 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.76 2.306 . . . . 0.0 110.812 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.65 -15.48 41.2 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.251 2.634 . . . . 0.0 110.441 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -7.97 59.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.781 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -124.3 -13.39 7.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -69.96 165.18 22.28 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.619 1.1 . . . . 0.0 111.999 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -154.64 141.49 19.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.483 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -135.95 139.48 43.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.567 0.621 . . . . 0.0 111.398 -169.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.483 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -130.85 148.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.751 0.82 . . . . 0.0 109.197 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -149.87 134.16 17.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.935 0.894 . . . . 0.0 108.867 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.3 19.98 0.86 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.59 0.756 . . . . 0.0 112.504 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 24.29 44.96 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 123.009 0.338 . . . . 0.0 112.55 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.602 ' HE3' ' CE1' ' B' ' 59' ' ' TYR . 5.7 ttmm -120.56 124.56 45.62 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 122.797 0.439 . . . . 0.0 110.432 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -75.93 108.79 9.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' B' ' 59' ' ' TYR . 1.0 OUTLIER -68.02 170.26 8.64 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.452 -174.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -132.49 153.64 50.7 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 121.64 0.733 . . . . 0.0 111.393 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.76 3.01 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.408 1.083 . . . . 0.0 111.769 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.96 16.8 20.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -118.25 -154.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.598 1.159 . . . . 0.0 109.087 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.6 p -148.88 159.58 44.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.304 1.442 . . . . 0.0 108.479 172.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.31 -27.62 69.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -25.2 60.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.361 1.064 . . . . 0.0 111.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.81 -18.88 61.42 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.302 0.641 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.602 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 22.9 m-85 -129.23 26.76 5.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.553 0.741 . . . . 0.0 109.991 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.27 31.01 0.74 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.18 125.12 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -131.18 -173.25 3.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.456 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.24 141.39 35.56 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 111.585 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.5 24.96 3.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.666 1.186 . . . . 0.0 113.627 174.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -70.67 -17.68 62.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m 59.41 130.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.17 2.188 . . . . 0.0 112.32 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -138.89 -178.34 5.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.392 1.077 . . . . 0.0 109.076 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.85 147.34 48.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.912 0.387 . . . . 0.0 111.275 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.5 tp -132.66 137.97 47.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.282 1.433 . . . . 0.0 110.033 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 t -143.84 165.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.37 170.56 15.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.876 0.762 . . . . 0.0 112.833 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.98 178.08 5.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.1 0.96 . . . . 0.0 111.377 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -112.15 21.54 15.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.008 -173.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 62.82 -30.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 127.2 2.2 . . . . 0.0 114.183 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 138.42 -12.41 3.5 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.408 -1.773 . . . . 0.0 111.483 -179.418 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 494' ' ' GLN . 83.5 Cg_endo -80.25 -167.45 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.609 4.206 . . . . 0.0 108.905 174.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.03 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 112.972 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 492' ' ' PRO . 3.1 pp0? -76.83 -26.0 53.86 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.28 1.42 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.551 HD22 HE21 ' A' ' 502' ' ' GLN . 6.5 mp -64.84 160.94 50.63 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.53 154.46 24.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.68 2.92 . . . . 0.0 110.851 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.8 66.41 5.27 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.845 0.831 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 164.22 -24.1 0.18 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.114 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 78.3 t -68.0 169.0 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.522 0.729 . . . . 0.0 110.281 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 0.4 OUTLIER -135.42 153.91 51.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.716 0.806 . . . . 0.0 110.665 -175.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.551 HE21 HD22 ' A' ' 496' ' ' LEU . 36.2 mm-40 -63.77 -43.73 95.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.51 8.36 0.85 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.024 0.53 . . . . 0.0 112.335 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.476 ' CA ' HE21 ' A' ' 507' ' ' GLN . 19.1 m -138.2 9.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.13 0.572 . . . . 0.0 111.097 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 513' ' ' GLN . 0.3 OUTLIER -122.0 -20.69 6.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.336 0.654 . . . . 0.0 110.062 178.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.56 7.75 2.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.203 0.601 . . . . 0.0 111.927 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.476 HE21 ' CA ' ' A' ' 504' ' ' VAL . 14.5 mm-40 -84.29 8.63 15.36 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.996 0.918 . . . . 0.0 111.357 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.43 159.67 56.52 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 123.18 0.592 . . . . 0.0 112.215 -167.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.95 164.35 31.77 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.249 2.632 . . . . 0.0 110.567 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.89 56.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.914 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.74 -5.75 59.33 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.875 0.47 . . . . 0.0 111.691 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.441 ' CD1' HD11 ' B' ' 44' ' ' ILE . 40.3 mt -118.51 -15.26 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -53.34 -41.66 66.0 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.337 -0.852 . . . . 0.0 108.863 169.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.29 -19.14 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.953 0.501 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -85.48 -21.51 28.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.888 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 518' ' ' SER . 2.6 mm -98.05 -31.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 118.916 0.78 . . . . 0.0 109.253 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.92 -0.97 2.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 110.078 172.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 516' ' ' ILE . 10.5 t -135.64 16.65 3.35 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.508 1.123 . . . . 0.0 110.63 177.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -100.98 38.43 3.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -1.65 0.11 Allowed 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -174.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.3 t -151.45 175.01 12.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.527 0.731 . . . . 0.0 109.919 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.48 3.78 3.0 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.701 1.6 . . . . 0.0 113.579 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.52 156.16 34.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.796 0.438 . . . . 0.0 111.04 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -156.64 27.1 0.33 Allowed 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.85 -0.27 1.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.997 0.919 . . . . 0.0 111.163 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -169.426 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.391 0.139 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.18 173.98 15.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.19 -178.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.263 1.025 . . . . 0.0 109.182 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.428 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 55.5 m-85 -133.21 86.94 2.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.485 0.66 . . . . 0.0 109.974 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -80.41 101.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.948 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 32.5 ttmt -85.51 140.58 30.55 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.843 0.457 . . . . 0.0 111.358 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -84.82 173.21 10.81 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.71 0.804 . . . . 0.0 111.575 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.23 -16.69 55.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.7 0.8 . . . . 0.0 110.88 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -97.47 -0.65 45.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.048 0.539 . . . . 0.0 110.538 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.67 25.98 26.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.094 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -118.93 120.27 36.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.467 0.633 . . . . 0.0 110.491 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.8 OUTLIER -75.95 155.85 34.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.253 0.549 . . . . 0.0 110.947 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.26 112.78 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -71.65 133.87 45.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' B' ' 29' ' ' LYS . 64.2 mt -150.23 136.53 18.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 122.309 0.243 . . . . 0.0 111.035 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.4 126.62 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.429 HG12 ' HE3' ' B' ' 29' ' ' LYS . 28.4 m -144.4 179.13 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.323 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -131.06 160.73 65.54 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.011 0.924 . . . . 0.0 108.803 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.19 0.6 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.769 2.98 . . . . 0.0 113.569 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -125.46 -4.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.662 0.664 . . . . 0.0 110.802 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -80.71 65.49 5.88 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.0 t -59.95 177.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.566 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.672 ' HA ' ' CG2' ' B' ' 26' ' ' VAL . 15.9 mm -52.93 -24.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 113.831 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.17 -19.73 50.21 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.694 1.134 . . . . 0.0 111.558 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.17 -44.08 13.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.613 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER -65.61 -26.22 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 123.046 0.539 . . . . 0.0 110.389 -177.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' B' ' 23' ' ' ILE . 91.2 mttt -59.97 -31.29 69.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 122.202 -0.311 . . . . 0.0 111.285 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.06 53.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.297 0.499 . . . . 0.0 110.597 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.538 ' HB3' HD22 ' B' ' 15' ' ' LEU . 3.9 mptp? -67.64 -36.06 80.06 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -85.57 -28.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -66.87 -39.04 87.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.39 -33.06 74.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.388 0.613 . . . . 0.0 111.386 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.514 ' HG3' HD21 ' B' ' 15' ' ' LEU . 41.5 mmtm -83.14 -21.22 33.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -137.9 -34.59 0.67 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.511 0.596 . . . . 0.0 112.56 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.89 9.05 19.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 95.9 mt -77.29 130.37 74.97 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 153.85 67.55 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.47 2.113 . . . . 0.0 111.112 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.54 -15.97 38.22 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.321 2.68 . . . . 0.0 110.493 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.9 -7.82 59.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -124.03 -14.32 7.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -70.15 164.67 23.68 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 112.726 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -154.69 146.61 23.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.456 ' C ' HD12 ' B' ' 44' ' ' ILE . 0.4 OUTLIER -129.32 145.01 51.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.451 0.569 . . . . 0.0 111.001 -170.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.456 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.2 mp -136.67 148.23 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.583 1.153 . . . . 0.0 108.385 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -149.14 138.91 21.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.354 1.062 . . . . 0.0 108.992 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.62 12.51 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.622 0.769 . . . . 0.0 112.669 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.03 14.19 40.31 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.524 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 159.88 33.76 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.622 1.211 . . . . 0.0 109.46 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -92.1 153.65 19.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.756 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.447 ' N ' HD12 ' B' ' 50' ' ' LEU . 4.8 mp -116.76 166.38 12.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -137.31 153.79 50.2 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.496 0.665 . . . . 0.0 112.191 -173.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.49 -1.89 12.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.449 1.1 . . . . 0.0 111.697 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 7.1 37.69 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.99 -154.51 0.53 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.906 0.883 . . . . 0.0 109.451 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 3.1 p -149.72 160.21 43.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.027 1.731 . . . . 0.0 107.823 173.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.63 -27.08 68.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -71.7 -26.71 62.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.92 1.288 . . . . 0.0 112.138 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.44 -15.81 61.82 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 122.749 0.419 . . . . 0.0 111.261 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -126.52 27.83 6.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.648 0.779 . . . . 0.0 109.699 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.91 28.2 0.34 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 171.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.75 140.4 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.525 0.602 . . . . 0.0 109.611 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -130.71 -174.52 3.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.602 1.161 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.81 144.29 56.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.66 21.72 3.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.861 0.865 . . . . 0.0 113.159 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -72.92 -17.32 61.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 75.4 m 61.41 139.47 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.326 1.851 . . . . 0.0 112.104 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -141.27 179.92 6.49 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.114 0.566 . . . . 0.0 109.505 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.49 139.27 43.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.405 0.282 . . . . 0.0 110.523 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.436 ' C ' HD13 ' B' ' 69' ' ' LEU . 2.6 tm? -130.24 134.78 47.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 110.075 -172.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.434 HG12 ' N ' ' B' ' 71' ' ' LEU . 52.4 t -142.13 168.47 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.434 ' N ' HG12 ' B' ' 70' ' ' VAL . 1.2 pp -142.74 170.46 15.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.975 -0.453 . . . . 0.0 111.676 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -66.78 168.47 9.54 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.595 0.758 . . . . 0.0 110.879 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.17 18.57 22.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.182 0.593 . . . . 0.0 110.591 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 61.19 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.506 2.322 . . . . 0.0 114.898 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.35 59.96 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.048 -1.973 . . . . 0.0 110.772 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.458 ' CD1' HD21 ' A' ' 517' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 494' ' ' GLN . 90.3 Cg_endo -78.89 -168.3 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 124.641 3.561 . . . . 0.0 107.711 170.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.08 31.56 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.666 1.586 . . . . 0.0 113.74 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 492' ' ' PRO . 1.8 pp0? -69.2 -32.45 71.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.944 0.897 . . . . 0.0 112.466 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 517' ' ' LEU . . . -146.03 2.38 0.9 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 497' ' ' PRO . 64.1 mt -71.8 150.11 92.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 496' ' ' LEU . 51.4 Cg_exo -56.99 158.49 17.24 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.779 2.986 . . . . 0.0 111.696 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.55 55.59 2.0 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 122.241 1.02 . . . . 0.0 109.673 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.41 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.094 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 501' ' ' ASP . 95.4 t -141.31 166.14 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.762 0.825 . . . . 0.0 109.578 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 500' ' ' VAL . 2.9 m-20 -143.66 139.17 29.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.575 1.55 . . . . 0.0 107.08 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.675 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -65.97 -28.29 68.79 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.393 -177.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.67 3.91 5.74 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.338 -0.851 . . . . 0.0 111.161 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.416 ' N ' HE22 ' A' ' 507' ' ' GLN . 27.3 m -137.23 17.36 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.472 1.109 . . . . 0.0 110.225 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.62 -19.41 1.38 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.466 0.706 . . . . 0.0 111.622 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -72.09 -0.31 11.46 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.371 -0.831 . . . . 0.0 112.649 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 504' ' ' VAL . 7.5 mp0 -95.95 -7.92 35.22 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.691 0.678 . . . . 0.0 109.851 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.38 159.91 78.8 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.06 163.72 37.46 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.974 2.449 . . . . 0.0 111.253 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -60.02 -15.17 20.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.841 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -95.98 -1.31 49.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.552 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 54.9 mt -115.45 -16.99 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -41.75 66.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.8 -5.57 51.23 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 520' ' ' LYS . 28.4 mm-40 -97.49 -24.1 15.74 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.806 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.4 -35.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 495' ' ' ALA . 88.5 mt -66.47 -8.0 23.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 15.3 t -72.76 -50.23 25.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.68 0.392 . . . . 0.0 111.468 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 144.37 141.91 3.82 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.841 -2.503 . . . . 0.0 106.841 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 515' ' ' GLU . 71.6 mmtt -149.36 176.73 10.3 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.931 0.893 . . . . 0.0 109.223 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.7 t -157.7 179.43 9.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.473 1.509 . . . . 0.0 108.868 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 522' ' ' ARG . 0.3 OUTLIER 60.83 21.73 11.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.461 1.104 . . . . 0.0 112.671 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -146.85 147.1 30.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.739 0.415 . . . . 0.0 110.247 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -148.44 40.25 0.92 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.475 0.71 . . . . 0.0 110.902 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . 0.286 4.4 pp 47.75 13.18 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.932 1.693 . . . . 0.0 114.228 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 126.411 1.884 . . . . 0.0 111.225 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.725 0.298 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -155.17 175.23 14.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.87 -177.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 123.958 0.903 . . . . 0.0 108.627 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.573 ' HB3' ' CG2' ' B' ' 12' ' ' THR . 99.9 m-85 -136.36 97.72 3.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.268 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.61 135.16 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -117.17 136.74 52.82 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.092 0.472 . . . . 0.0 111.742 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -73.12 173.84 8.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.737 1.215 . . . . 0.0 112.047 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.09 0.28 4.88 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.256 1.023 . . . . 0.0 110.792 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -118.27 -3.14 11.04 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.2 20.4 18.2 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.8 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -119.57 138.86 52.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.871 0.835 . . . . 0.0 109.86 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' B' ' 4' ' ' PHE . 6.3 m -111.41 152.38 27.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.012 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.75 131.6 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -86.37 135.05 33.66 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -146.36 134.23 21.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.696 0.225 . . . . 0.0 110.939 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.93 125.94 38.85 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.546 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.46 175.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.945 0.898 . . . . 0.0 109.872 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -135.36 163.05 53.69 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.318 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.54 1.7 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.466 2.777 . . . . 0.0 113.599 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -127.05 -3.41 6.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.716 0.689 . . . . 0.0 110.997 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.25 75.27 8.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 1.0 OUTLIER -61.08 171.31 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.157 0.983 . . . . 0.0 110.178 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' B' ' 26' ' ' VAL . 13.0 mm -54.37 -28.3 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.64 -18.72 65.06 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.836 -1.165 . . . . 0.0 110.487 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -86.33 -45.93 10.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.132 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.4 m -66.34 -33.79 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 122.664 0.386 . . . . 0.0 110.989 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' B' ' 23' ' ' ILE . 93.8 mttt -56.26 -32.98 65.01 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.855 172.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.18 -27.88 53.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.995 -0.441 . . . . 0.0 110.948 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.6 mptp? -67.08 -32.05 72.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.26 -31.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.99 89.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.91 -31.9 71.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.271 0.558 . . . . 0.0 111.231 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -84.1 -22.47 31.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -135.96 -36.2 0.76 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.89 8.3 15.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.3 129.63 74.45 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.75 152.52 69.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.632 2.221 . . . . 0.0 110.842 -176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.41 -15.22 41.7 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.23 2.62 . . . . 0.0 110.73 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.01 -6.86 59.47 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -125.32 -11.51 6.9 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.37 165.0 25.4 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.518 1.054 . . . . 0.0 112.208 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -153.59 142.56 21.2 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.408 ' C ' HD12 ' B' ' 44' ' ' ILE . 39.0 tp -136.14 138.41 41.97 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.128 -0.358 . . . . 0.0 110.711 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.408 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.8 mp -133.43 150.23 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.188 0.995 . . . . 0.0 108.87 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -148.5 139.12 22.79 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.542 1.137 . . . . 0.0 109.092 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 10.41 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.713 0.805 . . . . 0.0 113.034 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.66 12.14 36.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.675 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.14 159.88 32.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.632 1.216 . . . . 0.0 109.651 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -95.61 138.5 33.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.903 0.881 . . . . 0.0 108.753 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.519 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.9 mp -95.7 157.13 16.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -125.22 148.69 48.53 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 121.433 0.635 . . . . 0.0 112.164 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.02 -0.11 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.178 0.991 . . . . 0.0 111.89 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.35 8.28 37.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -108.88 -147.71 0.42 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.594 0.758 . . . . 0.0 110.517 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.521 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.0 p -152.13 157.07 41.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 127.313 2.245 . . . . 0.0 107.378 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.26 -26.25 68.69 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 121.361 0.601 . . . . 0.0 109.871 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -66.43 -25.11 66.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.853 1.261 . . . . 0.0 111.765 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.82 -12.01 59.94 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.447 0.699 . . . . 0.0 111.903 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.443 ' CE2' HD11 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -117.68 21.3 13.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 46.95 27.27 0.7 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.66 141.78 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.109 0.413 . . . . 0.0 110.262 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -130.31 -177.84 4.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.53 1.132 . . . . 0.0 108.747 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -60.96 143.26 55.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 53.53 26.27 5.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.415 1.086 . . . . 0.0 113.418 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -72.65 -14.91 61.7 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m 61.53 141.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.467 1.907 . . . . 0.0 112.367 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.98 -177.07 5.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.55 129.9 33.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 110.728 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.6 tp -112.28 141.5 45.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.252 1.421 . . . . 0.0 110.467 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.12 161.0 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.422 HD23 ' H ' ' B' ' 71' ' ' LEU . 1.4 pt? -148.84 171.69 15.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.684 -0.635 . . . . 0.0 112.677 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.58 173.58 6.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.128 0.971 . . . . 0.0 109.568 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.1 OUTLIER -126.51 25.59 6.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.539 0.735 . . . . 0.0 109.631 -178.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 63.4 -23.01 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.677 1.991 . . . . 0.0 114.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . -132.68 8.75 5.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 117.651 -1.638 . . . . 0.0 110.599 179.334 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 494' ' ' GLN . 74.7 Cg_endo -75.72 -172.53 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 124.744 3.629 . . . . 0.0 109.605 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 31.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.445 1.498 . . . . 0.0 113.152 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 492' ' ' PRO . 2.1 pp0? -75.29 -25.97 58.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.812 0.845 . . . . 0.0 112.629 -176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -144.11 2.62 1.17 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.2 162.47 72.96 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 122.959 0.503 . . . . 0.0 110.566 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 152.54 15.31 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.281 3.32 . . . . 0.0 112.397 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.1 66.62 2.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.802 0.81 . . . . 0.0 112.064 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . 159.49 -25.04 0.32 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.668 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.86 166.55 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.363 0.665 . . . . 0.0 110.584 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.94 143.03 40.56 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.127 0.971 . . . . 0.0 109.317 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.562 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -62.52 -34.47 76.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.25 -177.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.51 4.53 5.9 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.883 -0.511 . . . . 0.0 111.754 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.401 ' HA ' HE21 ' A' ' 507' ' ' GLN . 11.7 m -135.12 11.29 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.402 0.681 . . . . 0.0 110.535 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -14.99 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.395 1.078 . . . . 0.0 109.545 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -85.44 29.27 0.69 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.566 0.746 . . . . 0.0 111.228 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 504' ' ' VAL . 28.8 mm-40 -103.65 7.83 37.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.931 0.893 . . . . 0.0 111.153 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.52 156.9 63.33 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.615 1.166 . . . . 0.0 110.348 -172.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 162.87 30.87 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.981 3.12 . . . . 0.0 112.856 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 513' ' ' GLN . . . -58.52 -27.3 64.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.7 0.8 . . . . 0.0 112.064 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -9.2 58.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.219 0.208 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.28 -15.68 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.278 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 510' ' ' ALA . 12.9 mm-40 -57.85 -39.54 77.97 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.484 1.038 . . . . 0.0 108.9 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.7 -16.24 64.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.169 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -90.29 -8.78 50.03 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.246 -0.406 . . . . 0.0 111.76 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.59 -34.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.56 -6.58 11.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.373 0.669 . . . . 0.0 109.678 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 49.4 m -138.32 26.77 2.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.062 1.345 . . . . 0.0 109.485 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -129.67 43.45 1.31 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -63.48 7.2 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.262 2.225 . . . . 0.0 115.063 -170.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.8 t -146.97 -177.64 5.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.29 0.636 . . . . 0.0 109.708 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.86 -2.84 2.57 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.472 1.509 . . . . 0.0 112.941 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -157.24 152.56 26.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.936 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.18 34.2 1.21 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.411 1.084 . . . . 0.0 110.045 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.9 6.06 2.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.789 0.804 . . . . 0.0 110.728 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 111.696 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.584 0.231 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.73 172.7 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.55 -179.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.06 101.04 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.39 126.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 12' ' ' THR . 31.9 ttmt -102.82 133.88 47.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 111.903 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -82.13 178.2 8.4 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 112.416 -172.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.449 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.4 OUTLIER -71.67 14.43 0.19 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.689 1.196 . . . . 0.0 110.284 173.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -129.32 5.66 5.26 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 120.871 -1.143 . . . . 0.0 112.418 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 25.58 58.46 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.855 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -121.44 142.26 50.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 6' ' ' LYS . 0.5 OUTLIER -111.24 157.21 20.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.3 128.9 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -74.84 133.24 41.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.3 mt -145.12 133.59 21.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.329 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.25 126.5 39.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.11 177.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.844 0.858 . . . . 0.0 109.762 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -136.18 162.21 57.86 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.762 0.825 . . . . 0.0 110.117 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' B' ' 57' ' ' SER . 35.1 Cg_exo -56.36 0.85 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.38 3.387 . . . . 0.0 113.371 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 27.5 p -129.43 -6.59 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.845 0.858 . . . . 0.0 111.191 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.27 74.23 10.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 4.3 t -62.43 174.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.192 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.561 ' HA ' HG22 ' B' ' 26' ' ' VAL . 11.7 mm -56.02 -26.08 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.69 -17.69 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.439 -1.413 . . . . 0.0 110.706 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -88.58 -43.86 11.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.86 0.864 . . . . 0.0 110.598 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' B' ' 23' ' ' ILE . 3.6 m -63.96 -31.24 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 C-N-CA 122.736 0.414 . . . . 0.0 110.597 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -56.58 -31.57 64.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.368 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.95 -30.32 55.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.448 0.567 . . . . 0.0 110.569 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' B' ' 26' ' ' VAL . 4.0 mptp? -70.03 -33.9 72.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -85.81 -30.12 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.95 -39.97 83.31 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.34 -31.05 71.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.158 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -83.43 -21.4 32.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -138.13 -36.32 0.6 Allowed 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.72 8.49 13.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.79 129.82 80.35 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.55 153.41 65.29 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.408 2.072 . . . . 0.0 111.224 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.23 -17.47 39.95 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.273 2.649 . . . . 0.0 110.653 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.49 -4.84 57.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.838 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -124.8 -15.43 6.47 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.94 163.06 28.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.866 1.212 . . . . 0.0 113.479 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -161.91 146.11 12.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.045 1.338 . . . . 0.0 107.627 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.41 ' C ' HD12 ' B' ' 44' ' ' ILE . 4.2 mp -132.87 160.44 36.96 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.134 0.493 . . . . 0.0 111.728 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.41 HD12 ' C ' ' B' ' 43' ' ' LEU . 4.1 mp -135.71 149.3 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 107.988 -176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' B' ' 50' ' ' LEU . 54.8 t80 -151.74 144.26 24.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.999 0.92 . . . . 0.0 109.355 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.53 14.09 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.526 0.73 . . . . 0.0 111.985 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.1 16.2 51.45 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.287 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 158.06 40.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.745 1.272 . . . . 0.0 109.867 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.16 145.44 26.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.55 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.486 HD22 ' CD1' ' B' ' 59' ' ' TYR . 14.3 mt -102.99 148.96 25.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.047 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -121.69 149.22 43.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.501 0.667 . . . . 0.0 112.064 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.74 2.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.211 1.004 . . . . 0.0 111.852 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.36 16.5 19.65 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.55 -148.59 0.41 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.591 1.156 . . . . 0.0 108.496 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 38.2 p -153.9 160.29 42.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.693 1.197 . . . . 0.0 108.851 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.14 -27.09 68.14 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.236 -0.29 . . . . 0.0 110.633 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' B' ' 19' ' ' PRO . 16.5 t -73.29 -28.52 62.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.94 0.496 . . . . 0.0 110.791 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.15 -12.69 61.35 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.486 ' CD1' HD22 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -117.65 21.14 13.15 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 174.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 47.97 22.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -57.47 141.69 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-O 121.208 0.528 . . . . 0.0 110.766 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -131.33 -177.54 4.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.141 1.376 . . . . 0.0 108.79 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -64.04 147.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.034 0.445 . . . . 0.0 110.955 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 53.78 25.92 5.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.819 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -72.88 -21.33 60.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 69.5 m 60.67 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.072 2.149 . . . . 0.0 112.622 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.53 -174.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.85 1.66 . . . . 0.0 108.155 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -137.49 149.83 47.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 69' ' ' LEU . 2.7 tm? -134.44 133.22 40.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.949 1.3 . . . . 0.0 109.5 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 163.67 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.11 168.89 18.67 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -76.35 -176.27 3.57 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 125.371 1.468 . . . . 0.0 111.872 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' B' ' 75' ' ' GLY . 0.2 OUTLIER -109.41 18.48 20.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.789 0.835 . . . . 0.0 111.585 -171.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 63.41 -32.86 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.101 2.16 . . . . 0.0 114.042 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' B' ' 73' ' ' LEU . . . 144.54 -13.26 2.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 117.292 -1.838 . . . . 0.0 111.681 -179.288 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.537 0.208 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.91 95.68 0.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.634 3.556 . . . . 0.0 111.548 -171.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.6 tt 21.26 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.699 2.399 . . . . 0.0 112.514 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.75 -26.45 16.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.011 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . -139.74 4.88 2.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.359 0.664 . . . . 0.0 110.67 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.18 160.58 77.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.975 0.51 . . . . 0.0 109.694 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 155.64 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.049 3.166 . . . . 0.0 112.273 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.48 34.59 0.21 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.636 0.774 . . . . 0.0 111.775 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' GLY . . . . . . . . . . . . . . . -173.38 35.84 0.13 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.352 -174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 501' ' ' ASP . 42.7 t -143.22 168.66 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.208 1.003 . . . . 0.0 109.293 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 500' ' ' VAL . 1.8 m-20 -137.53 148.27 45.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.964 1.306 . . . . 0.0 108.222 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' GLN . . . . . 0.611 ' H ' ' CD ' ' A' ' 502' ' ' GLN . 0.0 OUTLIER -76.77 -28.06 55.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.35 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.55 7.39 1.44 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.738 -0.601 . . . . 0.0 111.03 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' VAL . . . . . 0.437 ' HA ' HE21 ' A' ' 507' ' ' GLN . 31.0 m -138.03 12.1 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.729 0.811 . . . . 0.0 111.383 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -25.49 2.65 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.889 0.476 . . . . 0.0 111.048 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.53 -6.28 29.73 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.941 -0.474 . . . . 0.0 110.702 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 504' ' ' VAL . 2.6 mp0 -87.54 -4.38 58.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.775 1.23 . . . . 0.0 110.238 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' LEU . . . . . . . . . . . . . 74.0 mt -90.16 160.11 40.85 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.75 1.22 . . . . 0.0 109.957 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.61 167.64 26.06 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.469 2.779 . . . . 0.0 111.894 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' ALA . . . . . . . . . . . . . . . -59.67 -22.79 62.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.87 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.36 -1.86 57.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.237 0.472 . . . . 0.0 111.684 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.78 -14.58 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -40.85 67.68 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.37 -0.831 . . . . 0.0 109.163 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.16 -7.94 55.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.18 0.592 . . . . 0.0 112.459 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.33 -22.65 18.21 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.521 0.6 . . . . 0.0 111.107 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.42 -30.33 2.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.12 1.69 1.41 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.147 0.431 . . . . 0.0 110.376 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' SER . . . . . . . . . . . . . 55.8 m -129.75 9.2 5.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.961 0.904 . . . . 0.0 110.921 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -79.23 138.95 21.27 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 0.29 2.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 12.9 t -162.66 179.82 7.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.596 0.358 . . . . 0.0 110.599 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.15 15.61 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.93 1.692 . . . . 0.0 113.729 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.15 147.27 26.24 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.618 0.367 . . . . 0.0 110.622 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' ASN . . . . . 0.48 ' HB2' ' CE ' ' A' ' 526' ' ' LYS . 0.0 OUTLIER -154.15 10.65 0.39 Allowed 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 13.25 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.803 0.689 . . . . 0.0 111.219 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LYS . . . . . 0.48 ' CE ' ' HB2' ' A' ' 524' ' ' ASN . 53.6 mtmt . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.363 1.065 . . . . 0.0 111.399 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.642 0.258 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -156.05 175.31 14.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.01 -177.45 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.67 0.788 . . . . 0.0 109.17 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.814 ' HB3' HG21 ' B' ' 12' ' ' THR . 83.5 m-85 -135.68 98.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 m -93.2 117.87 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -93.3 132.7 37.26 Favored 'General case' 0 C--N 1.337 0.057 0 O-C-N 121.881 -0.512 . . . . 0.0 110.783 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -76.09 177.43 7.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.361 1.064 . . . . 0.0 111.976 -174.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.45 -5.95 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.933 1.293 . . . . 0.0 110.489 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 59.5 p -116.85 4.43 12.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.709 -0.62 . . . . 0.0 112.057 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.93 27.78 48.69 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 120.142 -0.254 . . . . 0.0 113.027 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -122.73 148.21 45.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.814 HG21 ' HB3' ' B' ' 4' ' ' PHE . 47.5 m -122.66 153.64 39.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.561 -170.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.36 132.3 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -83.92 134.7 34.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 68.7 mt -145.38 133.47 21.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.617 -172.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.84 128.41 37.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.474 0.71 . . . . 0.0 109.477 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.3 179.61 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.982 0.913 . . . . 0.0 109.69 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' B' ' 21' ' ' ASP . 35.7 mt-10 -141.15 164.21 37.14 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.19 1.17 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.583 2.855 . . . . 0.0 113.64 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.402 ' H ' ' C ' ' B' ' 18' ' ' GLU . 67.7 m -129.31 -6.61 4.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.908 0.777 . . . . 0.0 111.228 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' B' ' 18' ' ' GLU . 21.3 m-20 -80.73 69.08 7.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 171.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' B' ' 55' ' ' THR . 10.2 t -61.03 176.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.133 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.419 HG22 ' HE3' ' B' ' 27' ' ' LYS . 13.2 mm -52.17 -33.21 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -168.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.6 -22.89 62.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.342 0.974 . . . . 0.0 111.473 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.35 -41.36 22.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.23 -40.24 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 124.275 1.03 . . . . 0.0 110.035 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.419 ' HE3' HG22 ' B' ' 23' ' ' ILE . 94.1 mttt -56.73 -26.04 56.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.521 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -26.89 35.16 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.486 0.584 . . . . 0.0 110.772 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -67.1 -33.12 74.79 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 98.7 mt -87.29 -30.05 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -66.45 -36.67 83.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.715 0.293 . . . . 0.0 110.217 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -69.38 -33.54 73.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.398 0.618 . . . . 0.0 111.297 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -82.39 -24.48 34.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.583 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -134.15 -30.92 1.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.4 9.65 26.93 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.69 126.8 82.01 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 123.891 0.876 . . . . 0.0 108.922 -174.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.41 153.57 77.52 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.634 2.223 . . . . 0.0 111.23 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.24 -20.82 36.79 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.168 2.578 . . . . 0.0 111.823 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -86.82 -1.69 57.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -113.85 -13.72 12.57 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.335 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.66 170.34 16.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.041 0.837 . . . . 0.0 112.3 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -153.78 148.52 26.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.45 ' C ' HD12 ' B' ' 44' ' ' ILE . 10.7 tp -136.48 139.26 42.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 111.466 -171.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.45 HD12 ' C ' ' B' ' 43' ' ' LEU . 3.6 mp -135.44 153.17 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.71 1.204 . . . . 0.0 108.213 -177.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.35 135.62 20.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 124.566 1.147 . . . . 0.0 109.089 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.49 10.19 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.887 0.875 . . . . 0.0 113.187 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.29 12.01 32.3 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.454 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 157.68 37.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.764 1.282 . . . . 0.0 109.713 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -93.29 152.09 19.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.116 0.966 . . . . 0.0 108.418 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.455 ' N ' HD12 ' B' ' 50' ' ' LEU . 5.0 mp -115.07 168.36 10.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -136.15 153.09 51.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.514 0.674 . . . . 0.0 111.615 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.79 -1.54 14.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.287 1.035 . . . . 0.0 111.62 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 9.52 35.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -109.02 -155.88 0.57 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.968 0.907 . . . . 0.0 109.372 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' B' ' 22' ' ' THR . 2.8 p -148.48 160.44 43.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.052 1.741 . . . . 0.0 107.415 172.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.64 -26.8 68.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -71.0 -26.27 63.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.019 1.328 . . . . 0.0 111.993 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.78 -15.23 61.65 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 122.891 0.476 . . . . 0.0 111.298 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -126.56 26.69 6.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.717 0.807 . . . . 0.0 109.786 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 p30 48.0 19.78 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.43 139.82 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.714 0.688 . . . . 0.0 110.373 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -130.08 -177.5 4.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.709 1.204 . . . . 0.0 109.217 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.02 143.42 51.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.039 0.447 . . . . 0.0 110.841 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 53.4 26.27 5.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -74.9 -11.94 60.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m 60.03 128.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.35 1.86 . . . . 0.0 112.117 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.59 -175.62 3.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.121 1.369 . . . . 0.0 108.077 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -137.68 145.43 42.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.45 137.9 50.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.534 1.133 . . . . 0.0 109.403 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.92 162.89 30.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.433 HD12 ' C ' ' B' ' 71' ' ' LEU . 2.5 pp -147.48 178.72 8.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 112.354 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -128.34 167.63 16.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.59 1.156 . . . . 0.0 109.799 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.573 HD13 ' H ' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -102.97 18.12 22.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.749 0.82 . . . . 0.0 112.711 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 120.56 -30.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 129.351 3.061 . . . . 0.0 111.149 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.58 2.24 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 116.749 -2.139 . . . . 0.0 111.854 179.803 . . . . . . . . 0 0 . 1 stop_ save_